PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Baert, F; Noman, M; Vermeire, S; Van Assche, G; D'Haens, G; Carbonez, A; Rutgeerts, P				Baert, F; Noman, M; Vermeire, S; Van Assche, G; D'Haens, G; Carbonez, A; Rutgeerts, P			Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Digestive Disease Week Meeting/Annual Meeting of the American-Gastroenterology-Association	MAY 19-23, 2002	SAN FRANCISCO, CALIFORNIA	Amer Gastroenterol Assoc			NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; CLINICAL-EXPERIENCE; METHOTREXATE; ANTIBODIES; SAFETY	BACKGROUND: Treatment with infliximab, a chimeric monoclonal IgG1 antibody against tumor necrosis factor, can result in the formation of antibodies against infliximab. We evaluated the clinical significance of these antibodies in patients with Crohn's disease. METHODS: In a cohort of 125 consecutive patients with Crohn's disease who were treated with infliximab infusions, we evaluated the concentrations of infliximab and of antibodies against infliximab, clinical data, side effects (including infusion reactions), and the use of concomitant medications before and 4, 8, and 12 weeks after each infusion. RESULTS: A mean of 3.9 infusions (range, 1 to 17) per patient were administered over a mean period of 10 months. Antibodies against infliximab were detected in 61 percent of patients. The presence of concentrations of 8.0 microg per milliliter or greater before an infusion predicted a shorter duration of response (35 days, as compared with 71 days among patients with concentrations of less than 8.0 microg per milliliter; P<0.001) and a higher risk of infusion reactions (relative risk, 2.40; 95 percent confidence interval, 1.65 to 3.66; P<0.001). Infliximab concentrations were significantly lower at four weeks among patients who had had an infusion reaction than among patients who had never had an infusion reaction (median, 1.2 vs. 14.1 microg per milliliter; P<0.001). Patients who had infusion reactions had a median duration of clinical response of 38.5 days, as compared with 65 days among patients who did not have an infusion reaction (P<0.001). Concomitant immunosuppressive therapy was predictive of low titers of antibodies against infliximab (P<0.001) and high concentrations of infliximab four weeks after an infusion (P<0.001). CONCLUSIONS: The development of antibodies against infliximab is associated with an increased risk of infusion reactions and a reduced duration of response to treatment. Concomitant immunosuppressive therapy reduces the magnitude of the immunogenic response.	Univ Hosp Gasthuisberg, Dept Internal Med, Div Gastroenterol, B-3000 Louvain, Belgium; Univ Louvain, Univ Ctr Stat, Louvain, Belgium	KU Leuven; University Hospital Leuven	Rutgeerts, P (corresponding author), Univ Hosp Gasthuisberg, Dept Internal Med, Div Gastroenterol, Herestr 49, B-3000 Louvain, Belgium.			Vermeire, Severine/0000-0001-9942-3019				Breedveld FC, 2000, LANCET, V355, P735, DOI 10.1016/S0140-6736(00)01034-5; *CENT, 2002, INFL SUMM PROD CHAR; Clark M, 2000, IMMUNOL TODAY, V21, P397, DOI 10.1016/S0167-5699(00)01680-7; Cohen RD, 2000, AM J GASTROENTEROL, V95, P3469; Cohen RD, 2001, INFLAMM BOWEL DIS, V7, pS17, DOI 10.1002/ibd.3780070505; Farrell RJ, 2000, AM J GASTROENTEROL, V95, P3490; Farrell RJ, 2001, GASTROENTEROLOGY, V120, pA69, DOI 10.1016/S0016-5085(01)80341-3; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hanauer SB, 1999, ALIMENT PHARM THERAP, V13, P16, DOI 10.1046/j.1365-2036.1999.00027.x; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Renner C, 2001, ANN HEMATOL, V80, pB127; Ricart E, 2001, AM J GASTROENTEROL, V96, P722, DOI 10.1111/j.1572-0241.2001.03612.x; Rutgeerts P, 1999, GASTROENTEROLOGY, V117, P761, DOI 10.1016/S0016-5085(99)70332-X; Schwab M, 2001, CLIN PHARMACOKINET, V40, P723, DOI 10.2165/00003088-200140100-00003; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Vaswani SK, 1998, ANN ALLERG ASTHMA IM, V81, P105, DOI 10.1016/S1081-1206(10)62794-9	18	1581	1745	0	53	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2003	348	7					601	608		10.1056/NEJMoa020888	http://dx.doi.org/10.1056/NEJMoa020888			8	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644HY	12584368				2022-12-28	WOS:000180912900005
J	Johns, MME; Barnes, M; Florencio, PS				Johns, MME; Barnes, M; Florencio, PS			Restoring balance to industry-academia relationships in an era of institutional financial conflicts of interest - Promoting research while maintaining trust	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-INTEREST; BIOMEDICAL-RESEARCH; LIFE SCIENCES; UNIVERSITY; BIOTECHNOLOGY; INCENTIVES; PHYSICIANS; GIFT	Economic partnerships between industry and academia accelerate medical innovation and enhance patient access to medical advances, but such partnerships have sometimes eroded public trust in the research enterprise. There is particular risk for conflict of interest when economic partnerships extend beyond a university's corporate interests to involve institutional decision makers. Institutions and institutional decision makers should fully disclose industry-related financial interests and relationships. Without legitimate justification for such interests, individuals should divest themselves from these interests or recuse themselves from responsibility for research oversight. Management of institutional partnerships also might entail the physical separation of certain facilities, the placement of restrictions on information shared between investment and research staffs, and provision of oversight by independent review panels made up of persons who have expertise in intellectual property, finance, and research, but who are not financially or otherwise dependent on the institution. Through these means, it is possible to restore balance to industry-academia relationships, thereby promoting progress while maintaining public trust in research.	Ropes & Gray, Hlth Care Grp, New York, NY 10022 USA; Emory Univ, Robert W Woodruff Hlth Sci Ctr, Atlanta, GA 30322 USA	Emory University	Barnes, M (corresponding author), Ropes & Gray, Hlth Care Grp, 885 3rd Ave,Suite 3200, New York, NY 10022 USA.							Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; ANGELL M, 2000, NIH C HUM SUBJ PROT; *ASS AM MED COLL T, 2002, PROT SUBJ PRES TRUST, V2; *ASS AM U TASK FOR, 2001, REP INF I FIN CONFL; *ASS U TECHN MAN, AUTM LIC SURV FY 199; *ASS U TECHN MAN, AUTM LIC SURV FY 200; Barnes M, 2002, J LAW MED ETHICS, V30, P390, DOI 10.1111/j.1748-720X.2002.tb00408.x; BARNES M, 2000, BUREAU NATL AFF, V9, P1378; BARNES M, IN PRESS SETON HALL; Blumenthal D, 1996, NEW ENGL J MED, V334, P368, DOI 10.1056/NEJM199602083340606; BLUMENTHAL D, 1986, SCIENCE, V232, P1361, DOI 10.1126/science.3715452; BOOTH W, 1988, SCIENCE, V242, P1497, DOI 10.1126/science.3201233; CALDART CC, 1983, SCI TECHNOL, V8, P24; Campbell EG, 1998, JAMA-J AM MED ASSOC, V279, P995, DOI 10.1001/jama.279.13.995; DAVIDSON RA, 1986, J GEN INTERN MED, V1, P155, DOI 10.1007/BF02602327; DeAngelis CD, 2001, JAMA-J AM MED ASSOC, V286, P89, DOI 10.1001/jama.286.1.89; Dueker KS, 1997, FOOD DRUG LAW J, V52, P453; EMANUEL EJ, 1995, NEW ENGL J MED, V332, P262, DOI 10.1056/NEJM199501263320412; ERTON RK, 1942, J LEG POLIT SCI, V1, P15; ETZKOWITZ H, 1989, SOC PROBL, V36, P14, DOI 10.1525/sp.1989.36.1.03a00020; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; GIAMATTI AB, 1982, SCIENCE, V218, P1278, DOI 10.1126/science.218.4579.1278; Gillis Justin, 2002, Washington Post, pA14; HILLMAN AL, 1989, NEW ENGL J MED, V321, P86, DOI 10.1056/NEJM198907133210205; *INT COMM MED J ED, UN REQ MAN SUBM BIOM; Jamison D.W., 2000, J ASS U TECHNOLOGY M, VXII, P23; KASSIRER JP, 1993, NEW ENGL J MED, V329, P570, DOI 10.1056/NEJM199308193290810; Kenney Martin, 1986, BIOTECHNOLOGY U IND; Korn D, 2000, JAMA-J AM MED ASSOC, V284, P2234, DOI 10.1001/jama.284.17.2234; KRIMSKY S, 1991, SCI TECHNOL HUM VAL, V16, P275, DOI 10.1177/016224399101600301; KUSZLER PC, 2001, WID L S J, V8, P115; Marshall E, 2001, SCIENCE, V292, P25, DOI 10.1126/science.292.5514.25; *OFF HUM RES PROT, 2001, FIN REL CLIN RES ISS; *PHARM RES MAN AM, 2002, PHRMA PRINC COND CLI; PRESS E, 2000, ATLANTIC MONTHLY, V285, P39; RELMAN AS, 1989, NEW ENGL J MED, V320, P933, DOI 10.1056/NEJM198904063201410; RELMAN AS, 1985, NEW ENGL J MED, V313, P749, DOI 10.1056/NEJM198509193131209; Shalala D, 2000, NEW ENGL J MED, V343, P808, DOI 10.1056/NEJM200009143431112; Steinbrook R, 2002, NEW ENGL J MED, V346, P716, DOI 10.1056/NEJM200202283460924; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; STOLBERG SG, 1999, NY TIMES MAG, P149; Stolberg Sheryl Gay, 1999, N Y Times Mag, P136; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812; VARRIN RD, 1985, SCIENCE, V227, P385, DOI 10.1126/science.11643811; WALTERSCHEID EC, 1990, HARVARD J LAW TECHNO, V3, P103; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373	46	78	84	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2003	289	6					741	746		10.1001/jama.289.6.741	http://dx.doi.org/10.1001/jama.289.6.741			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643WP	12585953				2022-12-28	WOS:000180886000029
J	Bradwell, AR; Carr-Smith, HD; Mead, GP; Harvey, TC; Drayson, MT				Bradwell, AR; Carr-Smith, HD; Mead, GP; Harvey, TC; Drayson, MT			Serum test for assessment of patients with Bence Jones myeloma	LANCET			English	Article								Bence Jones protein in urine (immunoglobulin free-light-chains) is characteristic of light-chain multiple myeloma. We aimed to compare a quantitative immunoassay for serum free-light-chains with urine tests. Of 224 patients with light-chain myeloma tested at entry to clinical trials, all were correctly identified from serum samples. During monitoring of 82 patients, changes, in serum and urine tree-light-chains corresponded, but urine became negative for free-light-chains in 26 patients, whereas it remained abnormal in serum in 73 patients. Serum assays could replace Bence Jones protein urine tests for patients with light-chain multiple myeloma.	Univ Birmingham, Sch Med, Div Immun & Infect, Birmingham B15 2TT, W Midlands, England; Binding Site, Birmingham, W Midlands, England; Manor Hosp, Walsall, W Midlands, England	University of Birmingham	Bradwell, AR (corresponding author), Univ Birmingham, Sch Med, Div Immun & Infect, Birmingham B15 2TT, W Midlands, England.	a.r.Bradwell@bham.ac.uk		Bradwell, Arthur/0000-0002-1562-1606; Drayson, Mark/0000-0002-1528-7564				Abraham RS, 2002, CLIN CHEM, V48, P655; Bence Jones H, 1847, LANCET, V50, P88, DOI [10.1016/S0140-6736(02)86528-X, DOI 10.1016/S0140-6736(02)86528-X]; Drayson M, 2001, BLOOD, V97, P2900, DOI 10.1182/blood.V97.9.2900; Katzmann JA, 2002, CLIN CHEM, V48, P1437; MAACK T, 1979, KIDNEY INT, V16, P251, DOI 10.1038/ki.1979.128	5	197	216	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					489	491		10.1016/S0140-6736(03)12457-9	http://dx.doi.org/10.1016/S0140-6736(03)12457-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583950				2022-12-28	WOS:000180900600015
J	Coury, F; Bencharif, L; Piens, MA; Grange, C; Durand, DV; Rousset, H				Coury, F; Bencharif, L; Piens, MA; Grange, C; Durand, DV; Rousset, H			Toe ulcers	LANCET			English	Editorial Material									Ctr Hosp Lyon Sud, Serv Med Interne, F-67495 Pierre Benite, France; Fac Med, Lab Parasitol Mycol Med, F-69373 Lyon, France	CHU Lyon	Rousset, H (corresponding author), Ctr Hosp Lyon Sud, Serv Med Interne, F-67495 Pierre Benite, France.	hugues.rousset@chu-lyon.fr		coury, fabienne/0000-0002-9175-8620				BERMAN SS, 1990, J VASC SURG, V12, P577, DOI 10.1067/mva.1990.23270; Farina C, 2000, SCAND J INFECT DIS, V32, P271, DOI 10.1080/00365540050165901; MILLER BM, 1983, ANN SURG, V197, P57, DOI 10.1097/00000658-198301001-00009; PIENS MA, 1986, ANN PATHOL, V6, P65; TEBIB JG, 1988, THORAX, V43, P73, DOI 10.1136/thx.43.1.73	5	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					486	486		10.1016/S0140-6736(03)12469-5	http://dx.doi.org/10.1016/S0140-6736(03)12469-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583948				2022-12-28	WOS:000180900600013
J	Larkin, RM; Alonso, JM; Ecker, JR; Chory, J				Larkin, RM; Alonso, JM; Ecker, JR; Chory, J			GUN4, a regulator of chlorophyll synthesis and intracellular signaling	SCIENCE			English	Article							CHELATASE H-SUBUNIT; MAGNESIUM-CHELATASE; NUCLEUS; CHLOROPLAST; BIOSYNTHESIS; ACCUMULATION; PROTEIN; IX	Nuclear genes control plastid differentiation in response to developmental signals, environmental signals, and retrograde signals from plastids themselves. In return, plastids emit signals that are essential for proper expression of many nuclear photosynthetic genes. Accumulation of magnesium-protoporphyrin IX (Mg-Proto), an intermediate in chlorophyll biosynthesis, is a plastid signal that represses nuclear transcription through a signaling pathway that, in Arabidopsis, requires the GUN4 gene. GUN4 binds the product and substrate of Mg-chelatase, an enzyme that produces Mg-Proto, and activates Mg-chelatase. Thus, GUN4 participates in plastid-to-nucleus signaling by regulating Mg-Proto synthesis or trafficking.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu	Alonso, Jose M/K-6826-2014; Ecker, Joseph R/B-9144-2008	Alonso, Jose M/0000-0001-7087-1571; Ecker, Joseph R/0000-0001-5799-5895; , Robert/0000-0002-4665-3731				[Anonymous], METHODS CHLOROPLAST; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; FALBEL TG, 1994, PLANT PHYSIOL, V104, P639, DOI 10.1104/pp.104.2.639; FIDAI S, 1995, FEBS LETT, V372, P264, DOI 10.1016/0014-5793(95)00995-L; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Guo RB, 1998, PLANT PHYSIOL, V116, P605, DOI 10.1104/pp.116.2.605; JACOBS JM, 1993, PLANT PHYSIOL, V101, P1181, DOI 10.1104/pp.101.4.1181; Jensen PE, 1998, BIOCHEM J, V334, P335, DOI 10.1042/bj3340335; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; LARKIN RM, UNPUB; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Popperl G, 1998, J PLANT PHYSIOL, V153, P40, DOI 10.1016/S0176-1617(98)80042-4; Reid JD, 2002, BIOCHEM SOC T, V30, P643, DOI 10.1042/bst0300643; Rodermel S, 2001, TRENDS PLANT SCI, V6, P471, DOI 10.1016/S1360-1385(01)02085-4; Shelnutt JA, 1998, CHEM SOC REV, V27, P31; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; Surpin M, 2002, PLANT CELL, V14, pS327, DOI 10.1105/tpc.010446; Takamiya K, 2000, TRENDS PLANT SCI, V5, P426, DOI 10.1016/S1360-1385(00)01735-0; TERRY MJ, 1993, ARCH BIOCHEM BIOPHYS, V306, P1, DOI 10.1006/abbi.1993.1473; THOMAS J, 1990, PLANT PHYSIOL, V94, P1414, DOI 10.1104/pp.94.3.1414; Walker CJ, 1997, BIOCHEM J, V327, P321	24	373	427	5	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					902	906		10.1126/science.1079978	http://dx.doi.org/10.1126/science.1079978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574634				2022-12-28	WOS:000180830900056
J	Zuev, PS; Sheridan, RS; Albu, TV; Truhlar, DG; Hrovat, DA; Borden, WT				Zuev, PS; Sheridan, RS; Albu, TV; Truhlar, DG; Hrovat, DA; Borden, WT			Carbon tunneling from a single quantum state	SCIENCE			English	Article							ELECTRON-SPIN RESONANCE; MATRIX-ISOLATION; KINETICS; CYCLOBUTADIENE; REARRANGEMENT; TEMPERATURE; BEHAVIOR	We observed ring expansion of 1-methylcyclobutylfluorocarbene at 8 kelvin, a reaction that involves carbon tunneling. The measured rate constants were 4.0x10(-6) per second in nitrogen and 4x10(-5) per second in argon. Calculations indicated that at this temperature the reaction proceeds from a single quantum state of the reactant so that the computed rate constant has achieved a temperature-independent limit. According to calculations, the tunneling contribution to the rate is 152 orders of magnitude greater than the contribution from passage over the barrier. We discuss environmental effects of the solid-state inert-gas matrix on the reaction rate.	Univ Nevada, Dept Chem 216, Reno, NV 89557 USA; Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Supercomp, Minneapolis, MN 55455 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle	Sheridan, RS (corresponding author), Univ Nevada, Dept Chem 216, Reno, NV 89557 USA.		Truhlar, Donald G./G-7076-2015	Truhlar, Donald G./0000-0002-7742-7294				Albu TV, 2002, J PHYS CHEM A, V106, P5323, DOI 10.1021/jp020544i; ARNOLD BR, 1991, J AM CHEM SOC, V113, P692, DOI 10.1021/ja00002a058; Balakrishnan N, 2001, CHEM PHYS LETT, V341, P652, DOI 10.1016/S0009-2614(01)00515-2; BUCHWALTER SL, 1979, J AM CHEM SOC, V101, P4688, DOI 10.1021/ja00510a042; CARPENTER BK, 1983, J AM CHEM SOC, V105, P1700, DOI 10.1021/ja00344a073; GARRETT BC, 1986, J AM CHEM SOC, V108, P3515, DOI 10.1021/ja00272a061; GOLDANSK.VI, 1973, SCIENCE, V182, P1344, DOI 10.1126/science.182.4119.1344; GRAHAM WH, 1965, J AM CHEM SOC, V87, P4396, DOI 10.1021/ja00947a040; HANCOCK GC, 1989, J CHEM PHYS, V91, P3492, DOI 10.1063/1.456879; Hehre W. J., 1986, AB INITIO MOL ORBITA; HO GJ, 1989, J AM CHEM SOC, V111, P6875, DOI 10.1021/ja00199a077; KIRYUKHIN DP, 1979, J CHIM PHYS PCB, V76, P1013, DOI 10.1051/jcp/1979761013; Kohen A, 1999, CHEM BIOL, V6, pR191, DOI 10.1016/S1074-5521(99)80058-1; LEFEBVRE R, 1990, J AM CHEM SOC, V112, P5052, DOI 10.1021/ja00169a008; LIU YP, 1993, J AM CHEM SOC, V115, P2408, DOI 10.1021/ja00059a041; Lynch BJ, 2000, J PHYS CHEM A, V104, P4811, DOI 10.1021/jp000497z; MILLER DJ, 1981, J AM CHEM SOC, V103, P3519, DOI 10.1021/ja00402a043; MOSS RA, 1985, J AM CHEM SOC, V107, P2743, DOI 10.1021/ja00295a029; MOSS RA, 1992, J AM CHEM SOC, V114, P959, DOI 10.1021/ja00029a025; ORENDT AM, 1988, J AM CHEM SOC, V110, P2648, DOI 10.1021/ja00216a049; Rempala P, 1999, J CHEM SOC PERK T 2, P2257, DOI 10.1039/a905042f; SANDER W, 1991, J AM CHEM SOC, V113, P5311, DOI 10.1021/ja00014a026; SPONSLER MB, 1989, J AM CHEM SOC, V111, P2240, DOI 10.1021/ja00188a045; TORIYAMA K, 1977, J AM CHEM SOC, V99, P5823, DOI 10.1021/ja00459a061; TRUHLAR DG, 1990, SCIENCE, V249, P491, DOI 10.1126/science.249.4968.491; Truhlar DG, 2002, ACCOUNTS CHEM RES, V35, P341, DOI 10.1021/ar0100226; TRUHLAR DG, 1984, ANNU REV PHYS CHEM, V35, P159, DOI 10.1146/annurev.physchem.35.1.159; WONCHOBA SE, 1995, PHYS REV B, V51, P9985, DOI 10.1103/PhysRevB.51.9985	28	146	147	3	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					867	870		10.1126/science.1079294	http://dx.doi.org/10.1126/science.1079294			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574623				2022-12-28	WOS:000180830900045
J	Ruban, AV; Wentworth, M; Yakushevska, AE; Andersson, J; Lee, PJ; Keegstra, W; Dekker, JP; Boekema, EJ; Jansson, S; Horton, P				Ruban, AV; Wentworth, M; Yakushevska, AE; Andersson, J; Lee, PJ; Keegstra, W; Dekker, JP; Boekema, EJ; Jansson, S; Horton, P			Plants lacking the main light-harvesting complex retain photosystem II macro-organization	NATURE			English	Article							A/B-BINDING PROTEIN; ANTENNA; MEMBRANE; MECHANISM; SPINACH	Photosystem II (PSII) is a key component of photosynthesis, the process of converting sunlight into the chemical energy of life. In plant cells, it forms a unique oligomeric macrostructure in membranes of the chloroplasts(1). Several light-harvesting antenna complexes are organized precisely in the PSII macrostructure-the major trimeric complexes (LHCII)(2) that bind 70% of PSII chlorophyll and three minor monomeric complexes(3)-which together form PSII supercomplexes(4-6). The antenna complexes are essential for collecting sunlight and regulating photosynthesis(7-9), but the relationship between these functions and their molecular architecture is unresolved. Here we report that antisense Arabidopsis plants lacking the proteins that form LHCII trimers(10) have PSII supercomplexes with almost identical abundance and structure to those found in wild-type plants. The place of LHCII is taken by a normally minor and monomeric complex, CP26, which is synthesized in large amounts and organized into trimers. Trimerization is clearly not a specific attribute of LHCII. Our results highlight the importance of the PSII macrostructure: in the absence of one of its main components, another protein is recruited to allow it to assemble and function.	Univ Sheffield, Robert Hill Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; Vrije Univ Amsterdam, Fac Sci, Div Phys & Astron, NL-1081 HV Amsterdam, Netherlands	University of Sheffield; University of Groningen; Umea University; Vrije Universiteit Amsterdam	Horton, P (corresponding author), Univ Sheffield, Robert Hill Inst, Dept Mol Biol & Biotechnol, Firth Court,Western Bank, Sheffield S10 2TN, S Yorkshire, England.	p.horton@sheffield.ac.uk	Jansson, Stefan/A-1119-2009; Horton, Peter/A-3958-2012	Jansson, Stefan/0000-0002-7906-6891; Horton, Peter/0000-0002-6095-1460				Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; ANDERSSON J, IN PRESS PLANT J; Barber J, 2002, CURR OPIN STRUC BIOL, V12, P523, DOI 10.1016/S0959-440X(02)00357-3; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Boekema EJ, 2000, J MOL BIOL, V301, P1123, DOI 10.1006/jmbi.2000.4037; Boekema EJ, 1999, BIOCHEMISTRY-US, V38, P2233, DOI 10.1021/bi9827161; Boekema EJ, 1999, EUR J BIOCHEM, V266, P444, DOI 10.1046/j.1432-1327.1999.00876.x; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; CAFFARRI S, 2001, PS2001 P 12 INT C PH, pS31; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Garab G, 1999, AUST J PLANT PHYSIOL, V26, P649, DOI 10.1071/PP99069; Haldrup A, 2001, TRENDS PLANT SCI, V6, P301, DOI 10.1016/S1360-1385(01)01953-7; Hankamer B, 1997, ANNU REV PLANT PHYS, V48, P641, DOI 10.1146/annurev.arplant.48.1.641; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; HOBE S, 1995, BIOCHEMISTRY-US, V34, P10224, DOI 10.1021/bi00032a016; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; JANSSON S, 1994, BBA-BIOENERGETICS, V1184, P1, DOI 10.1016/0005-2728(94)90148-1; KUHLBRANDT W, 1991, NATURE, V350, P130, DOI 10.1038/350130a0; Kuttkat A, 1996, EUR J BIOCHEM, V242, P288, DOI 10.1111/j.1432-1033.1996.0288r.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Nield J, 2000, NAT STRUCT BIOL, V7, P44; PAULSEN H, 1995, PHOTOCHEM PHOTOBIOL, V62, P367, DOI 10.1111/j.1751-1097.1995.tb02357.x; PETER GF, 1991, J BIOL CHEM, V266, P16745; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Walters RG, 1999, PLANTA, V209, P517, DOI 10.1007/s004250050756; Yakushevska AE, 2001, EUR J BIOCHEM, V268, P6020, DOI 10.1046/j.0014-2956.2001.02505.x; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	30	131	136	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2003	421	6923					648	652		10.1038/nature01344	http://dx.doi.org/10.1038/nature01344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571599	Green Accepted, Green Published			2022-12-28	WOS:000180803200046
J	Wong, KK; Maser, RS; Bachoo, RM; Menon, J; Carrasco, DR; Gu, YS; Alt, FW; DePinho, RA				Wong, KK; Maser, RS; Bachoo, RM; Menon, J; Carrasco, DR; Gu, YS; Alt, FW; DePinho, RA			Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing	NATURE			English	Article							ATAXIA-TELANGIECTASIA; STEM-CELL; MICE; DNA; CANCER; MOUSE; STABILITY; DEFECTS; LEADS	Ataxia-telangiectasia (A-T) results from the loss of ataxia-telangiectasia mutated (Atm) function and is characterized by accelerated telomere loss, genomic instability, progressive neurological degeneration, premature ageing and increased neoplasia incidence(1). Here we evaluate the functional interaction of Atm and telomeres in vivo. We examined the impact of Atm deficiency as a function of progressive telomere attrition at both the cellular and whole-organism level in mice doubly null for Atm and the telomerase RNA component (Terc)(2-4). These compound mutants showed increased telomere erosion and genomic instability, yet they experienced a substantial elimination of T-cell lymphomas associated with Atm deficiency. A generalized proliferation defect was evident in all cell types and tissues examined, and this defect extended to tissue stem/progenitor cell compartments, thereby providing a basis for progressive multi-organ system compromise, accelerated ageing and premature death. We show that Atm deficiency and telomere dysfunction act together to impair cellular and whole-organism viability, thus supporting the view that aspects of A-T pathophysiology are linked to the functional state of telomeres and its adverse effects on stem/progenitor cell reserves.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet & Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA 92507 USA; Univ Washington, Sch Med, Dept Radiat Oncol & Immunol, Seattle, WA 98195 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Washington; University of Washington Seattle	DePinho, RA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, 44 Binney St, Boston, MA 02115 USA.		Maser, Richard/B-2970-2012	wong, kwok kin/0000-0001-6323-235X; DePinho, Ronald/0000-0002-5625-577X				AHMED S, 1995, J NEUROSCI, V15, P5765; ALTMAN J, 1997, DEV CEREBELLAR SYSTE, P727; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Borghesani PR, 2000, P NATL ACAD SCI USA, V97, P3336, DOI 10.1073/pnas.050584897; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Eilam R, 1998, P NATL ACAD SCI USA, V95, P12653, DOI 10.1073/pnas.95.21.12653; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hande MP, 2001, HUM MOL GENET, V10, P519, DOI 10.1093/hmg/10.5.519; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Metcalfe JA, 1996, NAT GENET, V13, P350, DOI 10.1038/ng0796-350; Pandita TK, 2002, ONCOGENE, V21, P611, DOI 10.1038/sj.onc.1205060; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sekiguchi J, 2001, P NATL ACAD SCI USA, V98, P3243, DOI 10.1073/pnas.051632098; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Spector BD, 1982, ATAXIA TELANGIECTASI, P103; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	30	312	323	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					643	648		10.1038/nature01385	http://dx.doi.org/10.1038/nature01385			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12540856				2022-12-28	WOS:000180803200045
J	Kirkpatrick, S				Kirkpatrick, S			Rough times ahead	SCIENCE			English	Editorial Material									Hebrew Univ Jerusalem, Dept Comp Sci & Engn, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Kirkpatrick, S (corresponding author), Hebrew Univ Jerusalem, Dept Comp Sci & Engn, IL-91904 Jerusalem, Israel.	kirk@cs.huji.ac.il						Bell G, 2002, COMMUN ACM, V45, P91, DOI 10.1145/503124.503129; HILLIS D, 1985, CONNECTION MACHINE; KARDAR M, 1986, PHYS REV LETT, V56, P889, DOI 10.1103/PhysRevLett.56.889; Korniss G, 2003, SCIENCE, V299, P677, DOI 10.1126/science.1079382; Oram Andy, 2001, PEER TO PEER HARNESS, pix	5	8	8	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					668	669		10.1126/science.1081623	http://dx.doi.org/10.1126/science.1081623			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560537				2022-12-28	WOS:000180687700031
J	Feuerstein-Kadgien, B; Korn, K				Feuerstein-Kadgien, B; Korn, K			Cowpox infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Erlangen Nurnberg, D-91052 Erlangen, Germany	University of Erlangen Nuremberg	Feuerstein-Kadgien, B (corresponding author), Univ Erlangen Nurnberg, D-91052 Erlangen, Germany.			Korn, Klaus/0000-0003-1891-2107					0	2	2	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					415	415		10.1056/NEJMicm010078	http://dx.doi.org/10.1056/NEJMicm010078			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12556545				2022-12-28	WOS:000180643800007
J	Tomita, M; Murakami, M				Tomita, M; Murakami, M			High-temperature superconductor bulk magnets that can trap magnetic fields of over 17 tesla at 29 K	NATURE			English	Article							BA-CU-O; MECHANICAL-PROPERTIES; CONSTRUCTION	Large-grain high-temperature superconductors of the form RE-Ba-Cu-O (where RE is a rare-earth element) can trap magnetic fields of several tesla at low temperatures, and so can be used for permanent magnet applications(1,2). The magnitude of the trapped field is proportional to the critical current density and the volume of the superconductor(3,4). Various potential engineering applications for such magnets have emerged(5-13), and some have already been commercialized(7-10). However, the range of applications is limited by poor mechanical stability and low thermal conductivity of the bulk superconductors(14-17); RE-Ba-Cu-O magnets have been found to fracture during high-field activation, owing to magnetic pressure(14-16). Here we present a post-fabrication treatment that improves the mechanical properties as well as thermal conductivity of a bulk Y-Ba-Cu-O magnet, thereby increasing its field-trapping capacity. First, resin impregnation and wrapping the materials in carbon fibre improves the mechanical properties. Second, a small hole drilled into the centre of the magnet allows impregnation of Bi-Pb-Sn-Cd alloy into the superconductor and inclusion of an aluminium wire support, which results in a significant enhancement of thermal stability and internal mechanical strength. As a result, 17.24 T could be trapped, without fracturing, in a bulk Y-Ba-Cu-O sample of 2.65 cm diameter at 29 K.	Superconduct Res Lab, Minato Ku, Tokyo 1050023, Japan; Railway Tech Res Inst, Kokubunji, Tokyo 1858540, Japan	International Superconductivity Technology Center (ISTEC)	Tomita, M (corresponding author), Superconduct Res Lab, Minato Ku, Shibaura 1-16-25, Tokyo 1050023, Japan.	tomita@rtri.or.jp						Cardwell DA, 1998, MAT SCI ENG B-SOLID, V53, P1, DOI 10.1016/S0921-5107(97)00293-6; COLLINGS EW, 1995, ADV SUPERCONDUCTIVIT, V7, P605; Diko P, 1998, MAT SCI ENG B-SOLID, V53, P149, DOI 10.1016/S0921-5107(97)00318-8; Fuchs G, 2000, APPL PHYS LETT, V76, P2107, DOI 10.1063/1.126278; GAO L, 1994, APPL PHYS LETT, V64, P520, DOI 10.1063/1.111092; Ikuta H, 1998, SUPERCOND SCI TECH, V11, P1345, DOI 10.1088/0953-2048/11/11/001; Iwasa Y., 1994, CASE STUDIES SUPERCO; Johansen TH, 1999, PHYS REV B, V60, P9690, DOI 10.1103/PhysRevB.60.9690; Kovalev LK, 2002, SUPERCOND SCI TECH, V15, P817, DOI 10.1088/0953-2048/15/5/335; Matsunaga K, 2002, SUPERCOND SCI TECH, V15, P842, DOI 10.1088/0953-2048/15/5/341; MINAMI H, 1995, JPN J APPL PHYS 1, V34, P346, DOI 10.1143/JJAP.34.346; MIZUTANI U, IN PRESS J AM CERAM; MORITA M, 1998, P INT WORKSH SUP, P115; Murakami M, 1991, MELT PROCESSED HIGH; Nariki S, 2002, SUPERCOND SCI TECH, V15, P648, DOI 10.1088/0953-2048/15/5/302; Oka T, 2000, PHYSICA C, V335, P101, DOI 10.1016/S0921-4534(00)00152-0; REN Y, 1995, PHYSICA C, V251, P15, DOI 10.1016/0921-4534(95)00398-3; SAHO N, IN PRESS J AM CERAM; Sakai N, 2002, SUPERCOND SCI TECH, V15, P698, DOI 10.1088/0953-2048/15/5/312; SALAMA K, 2000, JOM, P17; Tajima S., 1999, ADV SUPERCONDUCTIVIT, VXI, P685; Tomita M, 2000, SUPERCOND SCI TECH, V13, P722, DOI 10.1088/0953-2048/13/6/318; Tomita M, 2002, PHYSICA C, V378, P783, DOI 10.1016/S0921-4534(02)01543-5; Wang JS, 1999, IEEE T APPL SUPERCON, V9, P904, DOI 10.1109/77.783443; WEINBERGER BR, 1991, APPL PHYS LETT, V59, P1132, DOI 10.1063/1.106367; YEH F, 1991, J APPL PHYS, V70, P4989, DOI 10.1063/1.349001; Yoo SI, 1998, MAT SCI ENG B-SOLID, V53, P203, DOI 10.1016/S0921-5107(97)00328-0	27	711	727	173	614	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2003	421	6922					517	520		10.1038/nature01350	http://dx.doi.org/10.1038/nature01350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556888				2022-12-28	WOS:000180670600040
J	Wolkin, A; Rusinek, H				Wolkin, A; Rusinek, H			A neuropathology of psychosis?	LANCET			English	Editorial Material							SCHIZOPHRENIA; BRAIN; RISK		NYU, Sch Med, Dept Radiol, New York, NY 10016 USA; NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; VA New York Harbor Healthcare Syst, Mental Hlth Serv, New York, NY USA	New York University; New York University	Rusinek, H (corresponding author), NYU, Sch Med, Dept Radiol, New York, NY 10016 USA.							Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Cho S, 1997, MAGN RESON IMAGING, V15, P1133, DOI 10.1016/S0730-725X(97)00202-6; Gilmore JH, 2001, SCHIZOPHR RES, V48, P219, DOI 10.1016/S0920-9964(00)00140-7; Harrison PJ, 1999, LANCET, V353, P3, DOI 10.1016/S0140-6736(05)74878-9; Lawrie SM, 1999, LANCET, V353, P30, DOI 10.1016/S0140-6736(98)06244-8; Lieberman JA, 2001, BIOL PSYCHIAT, V50, P884, DOI 10.1016/S0006-3223(01)01303-8; McCarley RW, 1999, BIOL PSYCHIAT, V45, P1099, DOI 10.1016/S0006-3223(99)00018-9; Sanfilipo M, 2000, ARCH GEN PSYCHIAT, V57, P471, DOI 10.1001/archpsyc.57.5.471; Sanfilipo M, 2000, SCHIZOPHRENIA BULL, V26, P201, DOI 10.1093/oxfordjournals.schbul.a033440; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Tisserand DJ, 2002, NEUROIMAGE, V17, P657, DOI 10.1006/nimg.2002.1173; WOODRUFF PWR, 1995, J NEUROL NEUROSUR PS, V58, P457, DOI 10.1136/jnnp.58.4.457	12	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					270	271		10.1016/S0140-6736(03)12361-6	http://dx.doi.org/10.1016/S0140-6736(03)12361-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559855				2022-12-28	WOS:000180643900002
J	Campillo, M; Paul, A				Campillo, M; Paul, A			Long-range correlations in the diffuse seismic coda	SCIENCE			English	Article							TIME-REVERSAL; WAVES; ATTENUATION; SCATTERING; LITHOSPHERE; SIMULATION	The late seismic coda may contain coherent information about the elastic response of Earth. We computed the correlations of the seismic codas of 101 distant earthquakes recorded at stations that were tens of kilometers apart. By stacking cross-correlation functions of codas, we found a low-frequency coherent part in the diffuse field. The extracted pulses have the polarization characteristics and group velocities expected for Rayleigh and Love waves. The set of cross-correlations has the symmetries of the surface-wave part of the Green tensor. This seismological example shows that diffuse waves produced by distant sources are sufficient to retrieve direct waves between two perfectly located points of observation. Because it relies on general properties of diffuse waves, this result has potential applications in other fields.	Univ Grenoble 1, Observ Grenoble, Lab Geophys Interne & Tectonophys, F-38041 Grenoble, France; CNRS, F-38041 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Campillo, M (corresponding author), Univ Grenoble 1, Observ Grenoble, Lab Geophys Interne & Tectonophys, BP 53, F-38041 Grenoble, France.	Michel.Campillo@obs.ujf-grenoble.fr	Campillo, Michel/AAC-5666-2019; Campillo, Michel/K-6231-2012; Paul, Anne/N-3949-2014	Campillo, Michel/0000-0001-6971-4499; Campillo, Michel/0000-0001-6971-4499; Paul, Anne/0000-0002-5973-1786				ABUBAKIROV IR, 1990, PHYS EARTH PLANET IN, V64, P52, DOI 10.1016/0031-9201(90)90005-I; AKI K, 1975, J GEOPHYS RES, V80, P3322, DOI 10.1029/JB080i023p03322; AKI K, 1980, PHYS EARTH PLANET IN, V21, P50, DOI 10.1016/0031-9201(80)90019-9; AKKERMANS E, 1988, J PHYS-PARIS, V49, P77, DOI 10.1051/jphys:0198800490107700; Apresyan L.A., 1996, RAD TRANSFER STAT WA; Campillo M., 1996, GEOFIS INTERN, V35, P361; Derode A, 1999, J APPL PHYS, V85, P6343, DOI 10.1063/1.370136; DERODE A, 1995, PHYS REV LETT, V75, P4206, DOI 10.1103/PhysRevLett.75.4206; Draeger C, 1999, J ACOUST SOC AM, V105, P611, DOI 10.1121/1.426251; Hennino R, 2001, PHYS REV LETT, V86, P3447, DOI 10.1103/PhysRevLett.86.3447; HOSHIBA M, 1991, PHYS EARTH PLANET IN, V67, P123, DOI 10.1016/0031-9201(91)90066-Q; Lobkis OI, 2001, J ACOUST SOC AM, V110, P3011, DOI 10.1121/1.1417528; Margerin L, 1999, GEOPHYS J INT, V138, P343, DOI 10.1046/j.1365-246X.1999.00897.x; ROUX P, IN PRESS J ACOUST SO; Ryzhik L, 1996, WAVE MOTION, V24, P327, DOI 10.1016/S0165-2125(96)00021-2; Sato H., 1998, SEISMIC WAVE PROPAGA; Shapiro NM, 1998, GEOPHYS RES LETT, V25, P101, DOI 10.1029/97GL03492; WEAVER RL, 1990, J MECH PHYS SOLIDS, V38, P55, DOI 10.1016/0022-5096(90)90021-U; Weaver RL, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.134301; WEAVER RL, 1982, J ACOUST SOC AM, V71, P1608, DOI 10.1121/1.387816; WU RS, 1988, PURE APPL GEOPHYS, V128, P49, DOI 10.1007/BF01772590	21	898	952	6	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					547	549		10.1126/science.1078551	http://dx.doi.org/10.1126/science.1078551			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543969				2022-12-28	WOS:000180559800043
J	Yen, HCS; Gordon, C; Chang, EC				Yen, HCS; Gordon, C; Chang, EC			Schizosaccharomyces pombe Int6 and Ras homologs regulate cell division and mitotic fidelity via the proteasome	CELL			English	Article							MAMMARY-TUMOR VIRUS; FISSION YEAST INT6; COP9 SIGNALOSOME; 26S PROTEASOME; TRANSLATION INITIATION; GENE; PROTEIN; SUBUNIT; LOCALIZATION; COMPLEXES	Yin6 is a yeast homolog of Int6, which is implicated in tumorigenesis. We show that Yin6 binds to and regulates proteasome activity. Overexpression of Yin6 strengthens proteasome function while inactivation weakens and causes the accumulation of polyubiquitinated proteins including securin/Cut2 and cyclin/Cdc13. Yin6 regulates the proteasome by preferentially interacting with Rpn5, a conserved proteasome subunit, and affecting its localization/assembly. We showed previously that Yin6 cooperates with Ras1 to mediate chromosome segregation; here, we demonstrate that Ras1 similarly regulates the proteasome via Rpn5. In yeast, human Int6 binds Rpn5 and regulates its localization. We propose that human Int6, either alone or cooperatively with Ras, influences proteasome activities via Rpn5. Inactivating Int6 can lead to accumulation of mitotic regulators affecting cell division and mitotic fidelity.	Baylor Coll Med, Dept Mol & Cellular Biol, Breast Canc Ctr, Houston, TX 77030 USA; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Baylor College of Medicine; University of Edinburgh	Chang, EC (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Breast Canc Ctr, 1 Baylor Plaza, Houston, TX 77030 USA.	echang@breastcenter.tmc.edu	Yen, Hsueh-Chi Sherry/AAA-3907-2021	Yen, Hsueh-Chi Sherry/0000-0003-3511-4414	NCI NIH HHS [R01-CA90464] Funding Source: Medline; OAPP OPHS HHS [RPG-97-137-01-MGO] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090464] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OAPP OPHS HHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams J, 2002, TRENDS MOL MED, V8, pS49, DOI 10.1016/S1471-4914(02)02315-8; Akiyoshi Y, 2001, J BIOL CHEM, V276, P10056, DOI 10.1074/jbc.M010188200; Alves KH, 2002, FEBS LETT, V527, P15, DOI 10.1016/S0014-5793(02)03147-2; AMSTERDAM A, 1993, P NATL ACAD SCI USA, V90, P99, DOI 10.1073/pnas.90.1.99; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; AYSCOUGH K, 1994, YEAST, V10, P1, DOI 10.1002/yea.320100102; BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Bandyopadhyay A, 2000, MOL BIOL CELL, V11, P4005, DOI 10.1091/mbc.11.11.4005; BASELGA J, 2000, CANCER CELL, V1, P31; Berry LD, 1999, MOL CELL BIOL, V19, P2535; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Chen CR, 1999, P NATL ACAD SCI USA, V96, P517, DOI 10.1073/pnas.96.2.517; Chen CR, 2000, MOL BIOL CELL, V11, P4067, DOI 10.1091/mbc.11.12.4067; Criekinge W. V., 1999, BIOL P ONLINE, V2, P1; Desbois C, 1996, SCIENCE, V273, P951, DOI 10.1126/science.273.5277.951; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; FUKUI Y, 1988, MOL GEN GENET, V215, P26, DOI 10.1007/BF00331298; FUKUI Y, 1986, CELL, V44, P329, DOI 10.1016/0092-8674(86)90767-1; Gachet Y, 2001, NATURE, V412, P352, DOI 10.1038/35085604; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Gohring UJ, 1999, TUMOR BIOL, V20, P173, DOI 10.1159/000030061; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; Grishchuk EL, 1998, GENETICS, V149, P1251; Guo JJ, 2000, J VIROL, V74, P1892, DOI 10.1128/JVI.74.4.1892-1899.2000; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hemelaar J, 2001, J VIROL, V75, P11106, DOI 10.1128/JVI.75.22.11106-11115.2001; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; KIARIS H, 1995, INT J ONCOL, V7, P413; Kim TH, 2001, TRENDS PLANT SCI, V6, P379, DOI 10.1016/S1360-1385(01)02015-5; Lafarga M, 2002, GLIA, V38, P313, DOI 10.1002/glia.10075; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Leclercq G, 2002, J STEROID BIOCHEM, V80, P259, DOI 10.1016/S0960-0760(02)00026-2; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liu SQ, 2002, P NATL ACAD SCI USA, V99, P3770, DOI 10.1073/pnas.052710299; Lonning Per Eystein, 2002, Int J Clin Oncol, V7, P265, DOI 10.1007/s101470200038; LUCA FC, 1989, J CELL BIOL, V109, P1895, DOI 10.1083/jcb.109.5.1895; MARCHETTI A, 1995, J VIROL, V69, P1932, DOI 10.1128/JVI.69.3.1932-1938.1995; Marchetti A, 2001, INT J ONCOL, V18, P175; Miyazaki S, 1997, GENOMICS, V46, P155, DOI 10.1006/geno.1997.4996; NADINDAVIS SA, 1986, EMBO J, V5, P2963, DOI 10.1002/j.1460-2075.1986.tb04593.x; Pajonk F, 2001, RADIAT RES, V156, P447, DOI 10.1667/0033-7587(2001)156[0447:TPICBA]2.0.CO;2; PALMER A, 1994, EUR J CELL BIOL, V64, P163; Rasmussen SB, 2001, ONCOGENE, V20, P5291, DOI 10.1038/sj.onc.1204624; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Rodenhuis S, 1992, Semin Cancer Biol, V3, P241; Saez C, 1999, ONCOGENE, V18, P5473, DOI 10.1038/sj.onc.1202914; Saito A, 1997, GENE, V203, P241, DOI 10.1016/S0378-1119(97)00524-6; Schondorf T, 1999, ONCOL REP, V6, P1029; Schwechheimer C, 2001, TRENDS CELL BIOL, V11, P420, DOI 10.1016/S0962-8924(01)02091-8; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Tatebe H, 2000, CURR BIOL, V10, P1329, DOI 10.1016/S0960-9822(00)00773-9; Tekmal R.R., 1997, FRONT BIOSCI, V2, P519; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wilkinson CRM, 1998, EMBO J, V17, P6465, DOI 10.1093/emboj/17.22.6465; Wilkinson CRM, 1997, J BIOL CHEM, V272, P25768, DOI 10.1074/jbc.272.41.25768; Wilkinson CRM, 2000, J BIOL CHEM, V275, P15182, DOI 10.1074/jbc.275.20.15182; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yahalom A, 2001, J BIOL CHEM, V276, P334, DOI 10.1074/jbc.M006721200; Yen HCS, 2000, P NATL ACAD SCI USA, V97, P14370, DOI 10.1073/pnas.97.26.14370; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	66	72	74	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 24	2003	112	2					207	217		10.1016/S0092-8674(03)00043-6	http://dx.doi.org/10.1016/S0092-8674(03)00043-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553909	Bronze			2022-12-28	WOS:000181191600010
J	Barkana, R; Loeb, A				Barkana, R; Loeb, A			Spectral signature of cosmological infall of gas around the first quasars	NATURE			English	Article							LY-ALPHA EMISSION; REIONIZATION; Z-SIMILAR-TO-6; CLUSTERS; DENSITY; LINES	Recent observations have shown that, only a billion years after the Big Bang, the Universe was already lit up by bright quasars(1) fuelled by the infall of gas onto supermassive black holes. The masses of these early black holes are inferred from their luminosities to be >10(9) solar masses. (M-circle dot), which is a difficult theoretical challenge to explain. Like nearby quasars, the early objects could have formed in the central cores of massive host galaxies. The formation of these hosts could be explained if, like local large galaxies, they were assembled gravitationally inside massive (>10(12) M-circle dot) haloes of dark matter(2). There has hitherto been no observational evidence for the presence of these massive hosts or their surrounding haloes. Here we show that the cosmic gas surrounding each halo must respond to its strong gravitational pull, where absorption by the infalling hydrogen produces a distinct spectral signature. That signature can be seen in recent data(3,4).	Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; Harvard Univ, Dept Astron, Cambridge, MA 02138 USA	Tel Aviv University; Harvard University	Barkana, R (corresponding author), Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel.	barkana@wisc.tau.ac.il; loeb@ias.edu		Barkana, Rennan/0000-0002-1557-693X				Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; Abel T, 1999, ASTROPHYS J, V520, pL13, DOI 10.1086/312136; BAJTLIK S, 1988, ASTROPHYS J, V327, P570, DOI 10.1086/166217; Barkana R, 2002, NEW ASTRON, V7, P85, DOI 10.1016/S1384-1076(01)00091-4; Barkana R, 2001, PHYS REP, V349, P126, DOI 10.1016/s0370-1573(01)00019-9; Becker RH, 2001, ASTRON J, V122, P2850, DOI 10.1086/324231; BERTSCHINGER E, 1985, ASTROPHYS J SUPPL S, V58, P39, DOI 10.1086/191028; BROTHERTON MS, 1994, ASTROPHYS J, V423, P131, DOI 10.1086/173794; Fan XH, 2002, ASTRON J, V123, P1247, DOI 10.1086/339030; Fan XH, 2001, ASTRON J, V122, P2833, DOI 10.1086/324111; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; GUNN JE, 1965, ASTROPHYS J, V142, P1633, DOI 10.1086/148444; Haiman Z, 2002, ASTROPHYS J, V576, pL1, DOI 10.1086/343101; Haiman Z, 2001, ASTROPHYS J, V556, P87, DOI 10.1086/321567; KESHET U, IN PRESS ASTROPHYS J; Loeb A, 1999, ASTROPHYS J, V524, P527, DOI 10.1086/307844; Loeb A, 2000, NATURE, V405, P156, DOI 10.1038/35012018; LOEB A, 1995, ASTROPHYS J, V448, P17, DOI 10.1086/175938; Miralda-Escude J, 1998, ASTROPHYS J, V501, P15, DOI 10.1086/305799; Miralda-Escude J, 2000, ASTROPHYS J, V530, P1, DOI 10.1086/308330; Pentericci L, 2002, ASTRON J, V123, P2151, DOI 10.1086/340077; Scharf CA, 2002, ASTROPHYS J, V580, P154, DOI 10.1086/343035; Telfer RC, 2002, ASTROPHYS J, V565, P773, DOI 10.1086/324689; Tremaine S, 2002, ASTROPHYS J, V574, P740, DOI 10.1086/341002; Vanden Berk DE, 2001, ASTRON J, V122, P549, DOI 10.1086/321167; Wyithe JSB, 2002, NATURE, V417, P923, DOI 10.1038/nature00794; WYITHE JSB, IN PRESS ASTROPHYS J; Yuan W, 1998, ASTRON ASTROPHYS, V330, P108; Zheng W, 2000, ASTRON J, V120, P1607, DOI 10.1086/301570	30	51	51	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					341	343		10.1038/nature01330	http://dx.doi.org/10.1038/nature01330			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540893	Green Accepted			2022-12-28	WOS:000180533000033
J	Dennis, C				Dennis, C			Bushfires annihilate Australian observatory	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					302	302		10.1038/421302b	http://dx.doi.org/10.1038/421302b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540862	Bronze			2022-12-28	WOS:000180533000005
J	Evans, JP; Zane, L; Francescato, S; Pilastro, A				Evans, JP; Zane, L; Francescato, S; Pilastro, A			Directional postcopulatory sexual selection revealed by artificial insemination	NATURE			English	Article							SPERM PRECEDENCE; POECILIA-RETICULATA; TRINIDADIAN GUPPY; FEMALE CHOICE; FLOUR BEETLES; PATTERNS; PATERNITY; BENEFITS; MALES	Postcopulatory sexual selection comprises both sperm competition, where the sperm from different males compete for fertilization(1), and cryptic female choice, where females bias sperm use in favour of particular males(2). Despite intense current interest in both processes as potential agents of directional sexual selection(3), few studies have attributed the success of attractive males to events that occur exclusively after insemination. This is because the interactions between pre- and post-insemination episodes of sexual selection can be important sources of variation in paternity(4). The use of artificial insemination overcomes this difficulty because it controls for variation in male fertilization success attributable to the female's perception of male quality, as well as effects due to mating order and the relative contribution of sperm from competing males(5). Here, we adopt this technique and show that in guppies, when equal numbers of sperm from two males compete for fertilization, relatively colourful individuals achieve greater parentage than their less ornamented counterparts. This finding indicates that precopulatory female mating preferences can be reinforced exclusively through postcopulatory processes occurring at a physiological level. Our analysis also revealed that relatively small individuals were advantaged in sperm competition, suggesting a possible trade-off between sperm competitive ability and body growth.	Univ Padua, Dept Biol, I-35131 Padua, Italy	University of Padua	Evans, JP (corresponding author), Univ Padua, Dept Biol, Via U Bassi 58-B, I-35131 Padua, Italy.		Pilastro, Andrea/G-3868-2011; Zane, Lorenzo/G-6249-2010; Evans, Jonathan/A-1992-2011	Pilastro, Andrea/0000-0001-9803-6308; Zane, Lorenzo/0000-0002-6963-2132; 				Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Birkhead TR, 2000, EVOLUTION, V54, P1057; Birkhead TR, 1998, SPERM COMPETITION SE; Blount JD, 2001, ECOL LETT, V4, P393, DOI 10.1046/j.1461-0248.2001.00255.x; Constantz G.D., 1989, P33; Dziuk PJ, 1996, ANIM REPROD SCI, V43, P65, DOI 10.1016/0378-4320(95)01463-2; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Edvardsson M, 2000, P ROY SOC B-BIOL SCI, V267, P559, DOI 10.1098/rspb.2000.1037; ENDLER JA, 1983, ENVIRON BIOL FISH, V9, P173, DOI 10.1007/BF00690861; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; Evans JP, 2000, P NATL ACAD SCI USA, V97, P10074, DOI 10.1073/pnas.180207297; Evans JP, 2001, P ROY SOC B-BIOL SCI, V268, P719, DOI 10.1098/rspb.2000.1577; Harvey IF, 2000, P ROY SOC B-BIOL SCI, V267, P2537, DOI 10.1098/rspb.2000.1317; HOUDE AE, 1987, EVOLUTION, V41, P1, DOI 10.1111/j.1558-5646.1987.tb05766.x; HOUDE AE, 1997, SEX COLOR MALE CHOIC; JAMES WH, 1975, GENET RES, V26, P45, DOI 10.1017/S0016672300015834; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Krackow S, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P112, DOI 10.1017/CBO9780511542053.006; LEWIS SM, 1994, BEHAV ECOL, V5, P219; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Matthews IM, 1997, P ROY SOC B-BIOL SCI, V264, P695, DOI 10.1098/rspb.1997.0099; Neems RM, 1998, BEHAV ECOL, V9, P279, DOI 10.1093/beheco/9.3.279; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; Pilastro A, 2002, P ROY SOC B-BIOL SCI, V269, P1325, DOI 10.1098/rspb.2002.2017; Pizzari T, 2000, NATURE, V405, P787, DOI 10.1038/35015558; REYNOLDS JD, 1992, P ROY SOC B-BIOL SCI, V250, P57, DOI 10.1098/rspb.1992.0130; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; Simmons L.W., 2001, SPERM COMPETITION IT; WILLIAMS DA, 1982, J R STAT SOC C-APPL, V31, P144; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010	30	214	221	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					360	363		10.1038/nature01367	http://dx.doi.org/10.1038/nature01367			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540898				2022-12-28	WOS:000180533000039
J	Heiling, AM; Herberstein, ME; Chittka, L				Heiling, AM; Herberstein, ME; Chittka, L			Pollinator attraction - Crab-spiders manipulate flower signals	NATURE			English	Article							COLOR-PERCEPTION; ULTRAVIOLET; CAMOUFLAGE; BEES		Univ Vienna, Inst Zool, A-1090 Vienna, Austria; Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; Univ London, Queen Mary Coll, Sch Biol Sci, London E1 4NS, England	University of Vienna; Macquarie University; University of London; Queen Mary University London	Heiling, AM (corresponding author), Univ Vienna, Inst Zool, A-1090 Vienna, Austria.	astrid.heiling@univie.ac.at	Chittka, Lars/C-3110-2012; Herberstein, Marie/D-2042-2011	Chittka, Lars/0000-0001-8153-1732; Herberstein, Marie/0000-0001-5071-2952				Bennett ATD, 1997, P NATL ACAD SCI USA, V94, P8618, DOI 10.1073/pnas.94.16.8618; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; Chittka L, 2001, ENTOMOL GEN, V25, P181; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Giurfa M, 1997, J COMP PHYSIOL A, V180, P235, DOI 10.1007/s003590050044; Lunau K, 1996, J COMP PHYSIOL A, V178, P477, DOI 10.1007/BF00190178; Thery M, 2002, NATURE, V415, P133, DOI 10.1038/415133a	8	145	154	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					334	334		10.1038/421334a	http://dx.doi.org/10.1038/421334a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540891	Bronze			2022-12-28	WOS:000180533000031
J	Kemper, C; Chan, AC; Green, JM; Brett, KA; Murphy, KM; Atkinson, JP				Kemper, C; Chan, AC; Green, JM; Brett, KA; Murphy, KM; Atkinson, JP			Activation of human CD4(+) cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype	NATURE			English	Article							COFACTOR PROTEIN CD46; SELF-TOLERANCE; MEASLES-VIRUS; RECEPTOR; COMPLEMENT; ELIMINATION; MOLECULE; IMMUNITY; THYMUS; MCP	The immune system must distinguish not only between self and non-self, but also between innocuous and pathological foreign antigens to prevent unnecessary or self-destructive immune responses. Unresponsiveness to harmless antigens is established through central and peripheral processes(1). Whereas clonal deletion and anergy are mechanisms of peripheral tolerance(2,3), active suppression by T-regulatory 1 (Tr1) cells has emerged as an essential factor in the control of autoreactive cells(4). Tr1 cells are CD4(+) T lymphocytes that are defined by their production of interleukin 10 (IL-10)(5) and suppression of T-helper cells(6); however, the physiological conditions underlying Tr1 differentiation are unknown. Here we show that co-engagement of CD3 and the complement regulator CD46 in the presence of IL-2 induces a Tr1-specific cytokine phenotype in human CD4(+) T cells. These CD3/CD46-stimulated IL-10-producing CD4(+) cells proliferate strongly, suppress activation of bystander T cells and acquire a memory phenotype. Our findings identify an endogenous receptor-mediated event that drives Tr1 differentiation and suggest that the complement system has a previously unappreciated role in T-cell-mediated immunity and tolerance.	Washington Univ, Sch Med, Div Rheumatol, St Louis, MO 63110 USA; Genentech Inc, San Francisco, CA 94080 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Grad Program Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Pathol & Immunol, St Louis, MO 63110 USA; Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Roche Holding; Genentech; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute	Atkinson, JP (corresponding author), Washington Univ, Sch Med, Div Rheumatol, St Louis, MO 63110 USA.		Kemper, Claudia/A-3673-2008; Kemper, Claudia/B-1502-2015	Green, Jonathan/0000-0002-7449-4387; Atkinson, John/0000-0002-2514-3441; Kemper, Claudia/0000-0003-4196-1417				Astier A, 2000, J IMMUNOL, V164, P6091, DOI 10.4049/jimmunol.164.12.6091; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; COLE JL, 1985, P NATL ACAD SCI USA, V82, P859, DOI 10.1073/pnas.82.3.859; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kallstrom H, 1998, J BIOL CHEM, V273, P21777, DOI 10.1074/jbc.273.34.21777; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Karp CL, 1996, SCIENCE, V273, P228, DOI 10.1126/science.273.5272.228; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Krych-Goldberg M, 1999, J BIOL CHEM, V274, P31160, DOI 10.1074/jbc.274.44.31160; LeDouarin N, 1996, IMMUNOL REV, V149, P35; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Liszewski MK, 2000, J BIOL CHEM, V275, P37692, DOI 10.1074/jbc.M004650200; Marie JC, 2002, NAT IMMUNOL, V3, P659, DOI 10.1038/ni810; McGuirk P, 2002, TRENDS IMMUNOL, V23, P450, DOI 10.1016/S1471-4906(02)02288-3; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Nielsen CH, 2000, IMMUNOLOGY, V100, P4, DOI 10.1046/j.1365-2567.2000.00009.x; OKADA N, 1995, P NATL ACAD SCI USA, V92, P2489, DOI 10.1073/pnas.92.7.2489; Prodeus AP, 1998, IMMUNITY, V9, P721, DOI 10.1016/S1074-7613(00)80669-X; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; Roncarolo MG, 2000, CURR OPIN IMMUNOL, V12, P676, DOI 10.1016/S0952-7915(00)00162-X; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shevach EM, 2001, IMMUNOL REV, V182, P58, DOI 10.1034/j.1600-065X.2001.1820104.x; Van Parijs L, 1998, SCIENCE, V280, P243; Wang GX, 2000, J IMMUNOL, V164, P1839, DOI 10.4049/jimmunol.164.4.1839	30	453	480	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					388	392		10.1038/nature01315	http://dx.doi.org/10.1038/nature01315			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540904				2022-12-28	WOS:000180533000046
J	Maddox, B				Maddox, B			The double helix and the 'wronged heroine'	NATURE			English	Article								In 1962, James Watson, Francis Crick and Maurice Wilkins received the Nobel prize for the discovery of the structure of DNA. Notably absent from the podium was Rosalind Franklin, whose X-ray photographs of DNA contributed directly to the discovery of the double helix. Franklin's premature death, combined with misogynist treatment by the male scientific establishment, cast her as a feminist icon. This myth overshadowed her intellectual strength and independence both as a scientist and as an individual.			Maddox, B (corresponding author), 9 Pitt St, London W8 4NX, England.		Mathur, Avijit/D-2786-2015	Mathur, Avijit/0000-0003-1798-7000				FRANKLIN RE, 1953, ACTA CRYSTALLOGR, V6, P673, DOI 10.1107/S0365110X53001939; FRANKLIN RE, 1953, ACTA CRYSTALLOGR, V6, P678, DOI 10.1107/S0365110X53001940; FRANKLIN RE, 1953, NATURE, V171, P740, DOI 10.1038/171740a0; KLUG A, 1974, NATURE, V248, P787, DOI 10.1038/248787a0; KLUG A, 1968, NATURE, V219, P808, DOI 10.1038/219808a0; KLUG A, 1968, NATURE, V0219, P00843; SAYRE A., 1975, R FRANKLIN DNA; Watson J.D., 1968, DOUBLE HELIX PERSONA	8	36	38	7	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					407	408		10.1038/nature01399	http://dx.doi.org/10.1038/nature01399			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540909	Bronze			2022-12-28	WOS:000180533000050
J	Mal, NK; Fujiwara, M; Tanaka, Y				Mal, NK; Fujiwara, M; Tanaka, Y			Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica	NATURE			English	Article							MCM-41; POLYMERIZATION; MONOLAYERS; SIEVES	Since the discovery(1) of MCM-41 more than ten years ago, many investigations have explored the suitability of hexagonal mesoporous silicas for potential practical applications(2-4). These range from catalysis(5,6) and optically active materials(7,8) to polymerization science(9-12), separation technology(3,13,14) and drug delivery(15-18), with recent successes in the fabrication of hybrid mesoporous organosilicas(19-21) expected to open up further application possibilities. Because the pore voids of this class of materials exhibit relatively narrow pore size distributions in the range of 2-4 nm in diameter, mesoporous silicas can selectively include organic compounds and release them continuously at a later stage. The functionalization of MCM-41 pore voids with photoactive derivatives(22-25) provides influence over the material's absorption behaviour, but full control over the release process remains difficult. Here we show that the uptake, storage and release of organic molecules in MCM-41 can be regulated through the photocontrolled and reversible intermolecular dimerization 26,27 of coumarin derivatives attached to the pore outlets. Successful functionalization requires uncalcined MCM-41 still filled with the template molecules that directed the formation of its pores, to ensure that coumarin derivatives attach preferentially to the pore outlets, rather than their inside walls. We find that this feature and the one-dimensional, isolated nature of the individual pores allow for efficient and reversible photocontrol over guest access to the material's interior.	Natl Inst Adv Ind Sci & Technol AIST Kansai, Kansai Ctr, Osaka 5638577, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Fujiwara, M (corresponding author), Natl Inst Adv Ind Sci & Technol AIST Kansai, Kansai Ctr, Osaka 5638577, Japan.	m-fujiwara@aist.go.jp	Fujiwara, Masahiro/B-6605-2018	Fujiwara, Masahiro/0000-0002-4285-9564				Ahola M, 2000, INT J PHARM, V195, P219, DOI 10.1016/S0378-5173(99)00403-2; Alvaro M, 2002, CHEM COMMUN, P2012, DOI 10.1039/b205883a; Arcos D, 2001, BIOMATERIALS, V22, P701, DOI 10.1016/S0142-9612(00)00233-7; Asefa T, 1999, NATURE, V402, P867, DOI 10.1038/47229; Berezin MY, 2001, PHYS CHEM CHEM PHYS, V3, P2184; CHUJO Y, 1990, MACROMOLECULES, V23, P2693, DOI 10.1021/ma00212a017; Corma A, 1997, CHEM REV, V97, P2373, DOI 10.1021/cr960406n; Czuryszkiewicz T, 2002, J NON-CRYST SOLIDS, V306, P1, DOI 10.1016/S0022-3093(02)01060-8; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Feng X, 1997, SCIENCE, V276, P923, DOI 10.1126/science.276.5314.923; Fujiwara M, 2000, CHEM COMMUN, P1523, DOI 10.1039/b004842i; Ganschow M, 2000, ANGEW CHEM INT EDIT, V39, P161; Hoffmann K, 2000, MICROPOR MESOPOR MAT, V41, P99, DOI 10.1016/S1387-1811(00)00277-8; Inagaki S, 2002, NATURE, V416, P304, DOI 10.1038/416304a; Kageyama K, 1999, SCIENCE, V285, P2113, DOI 10.1126/science.285.5436.2113; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Kruk M, 2002, J AM CHEM SOC, V124, P768, DOI 10.1021/ja0170854; Li WJ, 1997, J AM CHEM SOC, V119, P7211, DOI 10.1021/ja970633m; Lim MH, 1999, CHEM MATER, V11, P3285, DOI 10.1021/cm990369r; MASCHMEYER T, 1995, NATURE, V378, P159, DOI 10.1038/378159a0; Mercier L, 1997, ADV MATER, V9, P500, DOI 10.1002/adma.19970090611; Nguyen TQ, 2000, SCIENCE, V288, P652, DOI 10.1126/science.288.5466.652; Schomburg C, 2001, J MATER CHEM, V11, P2014, DOI 10.1039/b101516h; Spange S, 2001, CHEM-EUR J, V7, P3722, DOI 10.1002/1521-3765(20010903)7:17<3722::AID-CHEM3722>3.0.CO;2-J; Stein A, 2000, ADV MATER, V12, P1403, DOI 10.1002/1521-4095(200010)12:19<1403::AID-ADMA1403>3.0.CO;2-X; Vallet-Regi M, 2001, CHEM MATER, V13, P308, DOI 10.1021/cm0011559; Wirnsberger G, 2000, ADV MATER, V12, P1450, DOI 10.1002/1521-4095(200010)12:19<1450::AID-ADMA1450>3.0.CO;2-4; WU CG, 1994, SCIENCE, V264, P1757, DOI 10.1126/science.264.5166.1757; Ying JY, 1999, ANGEW CHEM INT EDIT, V38, P56, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<56::AID-ANIE56>3.0.CO;2-E; Zhao XS, 1999, CHEM COMMUN, P1391; Zhou WZ, 1998, SCIENCE, V280, P705, DOI 10.1126/science.280.5364.705	31	971	1010	8	446	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					350	353		10.1038/nature01362	http://dx.doi.org/10.1038/nature01362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	637UW	12540896				2022-12-28	WOS:000180533000036
J	Marth, T; Raoult, D				Marth, T; Raoult, D			Whipple's disease	LANCET			English	Review							TROPHERYMA-WHIPPELII DNA; POLYMERASE-CHAIN-REACTION; CENTRAL-NERVOUS-SYSTEM; Q-FEVER ENDOCARDITIS; TERM FOLLOW-UP; INTESTINAL-MUCOSA; PERIPHERAL-BLOOD; DIAGNOSIS; BACTERIUM; SEQUENCE	Whipple's disease, or intestinal lipodystrophy, is a systemic infectious disorder affecting mostly middle-aged white men. Patients present with weight loss, arthralgia, diarrhoea, and abdominal pain. The disease is commonly diagnosed by small-bowel biopsy; the appearance of the sample is characterised by inclusions in the lamina propria staining with periodic-acid-Schiff, which represent the causative bacteria. Tropheryma whipplei has been classified as an actinomycete and has been propagated in vitro, which allows the possibility of improving diagnostic strategies, for example through antibody-based detection of the bacillus on duodenal tissue or in circulating monocytes. Cell-mediated immunity in active and inactive Whipple's disease has subtle defects that might predispose some individuals to symptomatic infection with this bacillus, which probably occurs ubiquitously. Although most patients respond well to empirical antibiotic treatment, some with relapsing disease have a poor outlook. The recent findings and concerted research might allow development of new strategies for diagnosis,. treatment, and monitoring of patients with Whipple's disease.	Stiftung Deutsch Klin Diagnost, Div Gastroenterol, D-65191 Wiesbaden, Germany; Fac Med Marseille, CNRS UMR 6020, IFR 48, Unite Rickettsies, F-13385 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Marth, T (corresponding author), Stiftung Deutsch Klin Diagnost, Div Gastroenterol, Aukammallee 33, D-65191 Wiesbaden, Germany.		RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				ADLER CH, 1990, ANN INTERN MED, V112, P467, DOI 10.7326/0003-4819-76-3-112-6-467; Bai J. C., 1996, Acta Gastroenterologica Latinoamericana, V26, P85; BAI JC, 1991, AM J GASTROENTEROL, V86, P992; BASSOTTI G, 1991, AM J GASTROENTEROL, V86, P371; BHAGAVAN BS, 1981, HUM PATHOL, V12, P930, DOI 10.1016/S0046-8177(81)80199-2; BLACKSCHAFFER B, 1949, P SOC EXP BIOL MED, V72, P225; BOSTWICK DG, 1981, NEW ENGL J MED, V305, P995, DOI 10.1056/NEJM198110223051708; Bruhlmann P, 2000, RHEUMATOLOGY, V39, P1427, DOI 10.1093/rheumatology/39.12.1427; CANOSO JJ, 1978, J RHEUMATOL, V5, P79; CAPRON JP, 1975, LILLE MED, V9, P842; CERF M, 1970, PRESSE MED, V78, P2127; CHEARS WC, 1961, GASTROENTEROLOGY, V41, P129; COHEN AS, 1960, P SOC EXP BIOL MED, V105, P411; DESHOUGUES JR, 1976, REV RHUM, V43, P565; Dobbins 3rd WO, 1987, WHIPPLES DIS; DOBBINS WO, 1981, DIGEST DIS SCI, V26, P247, DOI 10.1007/BF01391638; DOBBINS WO, 1967, AM J PATHOL, V51, P225; DOBBINS WO, 1995, PRINCIPLES PRACTICE, P1030; Drancourt M, 2001, J CLIN MICROBIOL, V39, P2425, DOI 10.1128/JCM.39.7.2425-2430.2001; DUBOULAY CEH, 1982, HUM PATHOL, V13, P925, DOI 10.1016/S0046-8177(82)80053-1; Dutly F, 2001, CLIN MICROBIOL REV, V14, P561, DOI 10.1128/CMR.14.3.561-583.2001; Dutly F, 2000, INFECTION, V28, P219, DOI 10.1007/s150100070039; Dykman DD, 1999, DIGEST DIS SCI, V44, P2542, DOI 10.1023/A:1026607726745; Eck M, 1997, HUM PATHOL, V28, P1424, DOI 10.1016/S0046-8177(97)90234-3; ECTOERS N, 1992, GASTROENTEROLOGY, V106, pA676; ECTORS N, 1992, HISTOPATHOLOGY, V21, P1; Ehrbar HU, 1999, LANCET, V353, P2214, DOI 10.1016/S0140-6736(99)01776-6; ELSBORG L, 1975, ACTA MED SCAND, V198, P141; ENZINGER FM, 1963, VIRCHOWS ARCH A, V336, P238, DOI 10.1007/BF00957912; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fenollar F, 2001, CLIN DIAGN LAB IMMUN, V8, P1, DOI 10.1128/CDLI.8.1.1-8.2001; Fenollar F, 2001, Expert Rev Mol Diagn, V1, P299, DOI 10.1586/14737159.1.3.299; Fenollar F, 2001, CLIN INFECT DIS, V33, P1309, DOI 10.1086/322666; Fenollar F, 2002, J CLIN MICROBIOL, V40, P1119, DOI 10.1128/JCM.40.3.1119-1120.2002; FEURLE GE, 1979, NEW ENGL J MED, V300, P907, DOI 10.1056/NEJM197904193001607; FEURLE GE, 1979, EUR J CLIN INVEST, V9, P385, DOI 10.1111/j.1365-2362.1979.tb00901.x; FEURLE GE, 1994, DIGEST DIS SCI, V39, P1642, DOI 10.1007/BF02087770; FLEMING JL, 1988, MAYO CLIN PROC, V63, P539, DOI 10.1016/S0025-6196(12)64884-8; GEBOES K, 1992, ACTA GASTRO-ENT BELG, V55, P209; Geissdorfer W, 2001, INFECTION, V29, P44, DOI 10.1007/s15010-001-0135-9; Ghigo E, 2002, INFECT IMMUN, V70, P1501, DOI 10.1128/IAI.70.3.1501-1506.2002; Gisbertz I A, 2001, Eur J Intern Med, V12, P525, DOI 10.1016/S0953-6205(01)00165-0; GROLL A, 1972, GASTROENTEROLOGY, V63, P943; GROSS JB, 1959, GASTROENTEROLOGY, V36, P65; Gross M, 1999, ITAL J GASTROENTEROL, V31, P70; Gruner U, 2001, Z GASTROENTEROL, V39, P305, DOI 10.1055/s-2001-12865; Gubler JGH, 1999, ANN INTERN MED, V131, P112, DOI 10.7326/0003-4819-131-2-199907200-00007; HENDRIX JP, 1950, ARCH INTERN MED, V85, P91, DOI 10.1001/archinte.1950.00230070113006; Hinrikson HP, 1999, J CLIN MICROBIOL, V37, P152, DOI 10.1128/JCM.37.1.152-156.1999; Hinrikson HP, 1999, INT J SYST BACTERIOL, V49, P1701, DOI 10.1099/00207713-49-4-1701; Hinrikson HP, 2000, J CLIN MICROBIOL, V38, P595, DOI 10.1128/JCM.38.2.595-599.2000; KEINATH RD, 1985, GASTROENTEROLOGY, V88, P1867, DOI 10.1016/0016-5085(85)90012-5; KENT SP, 1980, ARCH PATHOL LAB MED, V104, P544; KEREN DF, 1981, CRC CR REV CL LAB SC, V14, P75, DOI 10.3109/10408368109106451; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; La Scola B, 1998, J INFECT DIS, V178, P278, DOI 10.1086/517453; La Scola B, 2001, INT J SYST EVOL MICR, V51, P1471, DOI 10.1099/00207713-51-4-1471; Le Bodic L, 1977, Gastroenterol Clin Biol, V1, P9; Liang ZX, 2002, CLIN DIAGN LAB IMMUN, V9, P156, DOI 10.1128/CDLI.9.1.156-159.2002; LOPATIN RN, 1982, J CLIN GASTROENTEROL, V4, P223, DOI 10.1097/00004836-198206000-00006; Louis ED, 1996, ANN NEUROL, V40, P561, DOI 10.1002/ana.410400404; LOWSKY R, 1994, NEW ENGL J MED, V331, P1343, DOI 10.1056/NEJM199411173312004; LUKACS G, 1978, ACTA HEPATO-GASTRO, V25, P238; Maiwald M, 1996, INT J SYST BACTERIOL, V46, P1078, DOI 10.1099/00207713-46-4-1078; MAIWALD M, 1995, J CLIN MICROBIOL, V33, P1354, DOI 10.1128/JCM.33.5.1354-1356.1995; Maiwald M, 1998, APPL ENVIRON MICROB, V64, P760; Maiwald M, 2001, ANN INTERN MED, V134, P115, DOI 10.7326/0003-4819-134-2-200101160-00011; MAIZEL H, 1970, MEDICINE, V49, P175, DOI 10.1097/00005792-197005000-00001; Marth T, 1996, LANCET, V348, P66, DOI 10.1016/S0140-6736(05)64400-5; MARTH T, 1994, CLIN IMMUNOL IMMUNOP, V72, P217, DOI 10.1006/clin.1994.1134; Marth T, 2001, Curr Allergy Asthma Rep, V1, P566, DOI 10.1007/s11882-001-0066-7; Marth T, 2002, GASTROENTEROLOGY, V123, P1468, DOI 10.1053/gast.2002.36583; Marth T, 1997, GASTROENTEROLOGY, V113, P442, DOI 10.1053/gast.1997.v113.pm9247462; Marth T, 1996, Semin Gastrointest Dis, V7, P41; MARTH T, 1999, PRINCIPLES PRACTICE, P1170; Marth T, 1993, THESIS U BONN; MAURIN M, 1992, J INFECT DIS, V166, P1097, DOI 10.1093/infdis/166.5.1097; MAXWELL JD, 1968, LANCET, V1, P887; MEIERWILLERSEN HJ, 1993, DEUT MED WOCHENSCHR, V118, P854, DOI 10.1055/s-2008-1059397; MIKSCHE LW, 1974, ACTA HEPATO-GASTRO, V21, P307; Misbah SA, 2000, J CLIN PATHOL, V53, P750, DOI 10.1136/jcp.53.10.750; Misbah SA, 1997, QJM-MON J ASSOC PHYS, V90, P765; MULLER N, 2001, ACTA ENDOSC, V31, P243; O'Duffy JD, 1999, ARTHRITIS RHEUM, V42, P812, DOI 10.1002/1529-0131(199904)42:4<812::AID-ANR27>3.0.CO;2-S; Olivieri I, 2001, J RHEUMATOL, V28, P1294; PAULLEY JW, 1952, GASTROENTEROLOGY, V22, P128; PUITE RH, 1955, AM J MED, V19, P383, DOI 10.1016/0002-9343(55)90127-3; Ramzan NN, 1997, ANN INTERN MED, V126, P520, DOI 10.7326/0003-4819-126-7-199704010-00004; Raoult D, 2000, NEW ENGL J MED, V342, P620, DOI 10.1056/NEJM200003023420903; Raoult D, 1999, ARCH INTERN MED, V159, P167, DOI 10.1001/archinte.159.2.167; Raoult D, 2001, NEW ENGL J MED, V345, P548, DOI 10.1056/NEJM200108163450716; Raoult D, 2001, JAMA-J AM MED ASSOC, V285, P1039, DOI 10.1001/jama.285.8.1039; Raoult D, 1999, ANN INTERN MED, V131, P144, DOI 10.7326/0003-4819-131-2-199907200-00012; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; RODARTE JR, 1972, ARCH INTERN MED, V129, P479, DOI 10.1001/archinte.129.3.479; Schneider T, 1998, INFECTION, V26, P178, DOI 10.1007/BF02771847; Schneider T, 1998, ANN INTERN MED, V129, P875, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00006; Schnider PJ, 1996, EUR J GASTROEN HEPAT, V8, P899; Schoedon G, 1997, J INFECT DIS, V176, P672, DOI 10.1086/514089; SIERACKI JC, 1959, ARCH PATHOL, V67, P81; SILVA MT, 1985, J GEN MICROBIOL, V131, P1001; Street S, 1999, LANCET, V354, P1178, DOI 10.1016/S0140-6736(99)03065-2; STROM RL, 1983, NEW ENGL J MED, V309, P1323; Suzer T, 1999, SCAND J INFECT DIS, V31, P411, DOI 10.1080/00365549950163897; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRIER JS, 1965, GASTROENTEROLOGY, V48, P684; Verhagen WIM, 1996, CLIN NEUROL NEUROSUR, V98, P299, DOI 10.1016/0303-8467(96)00035-2; von Herbay A, 2001, PATHOLOGE, V22, P82, DOI 10.1007/s002920000435; vonHerbay A, 1997, SCAND J GASTROENTERO, V32, P52, DOI 10.3109/00365529709025063; vonHerbay A, 1996, VIRCHOWS ARCH, V429, P335; vonHerbay A, 1997, GASTROENTEROLOGY, V113, P434, DOI 10.1053/gast.1997.v113.pm9247461; vonHerbay A, 1996, GASTROENTEROLOGY, V110, P1735, DOI 10.1053/gast.1996.v110.pm8964398; WANG HH, 1986, NEW ENGL J MED, V314, P1577; Whipple GH, 1907, B JOHNS HOPKINS HOSP, V18, P382; WILSON KH, 1991, LANCET, V338, P474, DOI 10.1016/0140-6736(91)90545-Z; YARDLEY JH, 1961, B JOHNS HOPKINS HOSP, V109, P80	116	162	167	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					239	246		10.1016/S0140-6736(03)12274-X	http://dx.doi.org/10.1016/S0140-6736(03)12274-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547551				2022-12-28	WOS:000180535400026
J	Rohde, JU; In, JH; Lim, MH; Brennessel, WW; Bukowski, MR; Stubna, A; Munck, E; Nam, W; Que, L				Rohde, JU; In, JH; Lim, MH; Brennessel, WW; Bukowski, MR; Stubna, A; Munck, E; Nam, W; Que, L			Crystallographic and spectroscopic characterization of a nonheme Fe(IV)=O complex	SCIENCE			English	Article							FE-2(MU-O)(2) DIAMOND CORE; PEROXIDASE COMPOUND-I; METHANE MONOOXYGENASE; CRYSTAL-STRUCTURE; MECHANISM; HYDROXYLATION; INTERMEDIATE; LIGAND; METALLOPORPHYRINS; ACTIVATION	Following the heme paradigm, it is often proposed that dioxygen activation by nonheme monoiron enzymes involves an iron(IV)=oxo intermediate that is responsible for the substrate oxidation step. Such a transient species has now been obtained from a synthetic complex with a nonheme macrocyclic ligand and characterized spectroscopically. Its high-resolution crystal structure reveals an iron-oxygen bond length of 1.646(3) angstroms, demonstrating that a terminal iron(IV)=oxo unit can exist in a nonporphyrin ligand environment and [ending credence to proposed mechanisms of nonheme iron catalysis.	Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Met Biocatalysis, Minneapolis, MN 55455 USA; Ewha Womans Univ, Dept Chem, Seoul 120750, South Korea; Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea; Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Ewha Womans University; Ewha Womans University; Carnegie Mellon University	Munck, E (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.		Lim, Mi Hee/D-1913-2018	Nam, Wonwoo/0000-0001-8592-4867; Bukowski, Michael/0000-0001-8381-4429	NIGMS NIH HHS [GM-38767, GM-33162, GM-22701] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033162, R01GM033162, R01GM038767, R01GM022701] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Basch H, 1999, J AM CHEM SOC, V121, P7249, DOI 10.1021/ja9906296; CHANCE M, 1986, BIOCHEMISTRY-US, V25, P1266, DOI 10.1021/bi00354a011; CHE CM, 1985, J CHEM SOC CHEM COMM, P546, DOI 10.1039/c39850000546; CHIN DH, 1980, J AM CHEM SOC, V102, P5945, DOI 10.1021/ja00538a059; Costas M, 2001, J AM CHEM SOC, V123, P12931, DOI 10.1021/ja017204f; DEBRUNNER PG, 1989, IRON PORPHYRINS, V3, P199; EDWARDS SL, 1987, BIOCHEMISTRY-US, V26, P1503, DOI 10.1021/bi00380a002; FULOP V, 1994, STRUCTURE, V2, P210; Grapperhaus CA, 2000, INORG CHEM, V39, P5306, DOI 10.1021/ic0005238; Groves John T., 1995, P3; Hata M, 2001, J AM CHEM SOC, V123, P6410, DOI 10.1021/ja000908p; HOPPE R, 1982, ACTA CRYSTALLOGR B, V38, P2237; Hsu HF, 1999, J AM CHEM SOC, V121, P5230, DOI 10.1021/ja983666q; Kellner DG, 2002, J BIOL CHEM, V277, P9641, DOI 10.1074/jbc.C100745200; KITAGAWA T, 1994, COORDIN CHEM REV, V135, P685, DOI 10.1016/0010-8545(94)80081-2; KOSTKA KL, 1993, J AM CHEM SOC, V115, P6746, DOI 10.1021/ja00068a035; Lange SJ, 1999, J AM CHEM SOC, V121, P6330, DOI 10.1021/ja990233u; Lee D, 2002, J AM CHEM SOC, V124, P3993, DOI 10.1021/ja012251t; MacBeth CE, 2000, SCIENCE, V289, P938, DOI 10.1126/science.289.5481.938; Miyake H, 2001, INORG CHEM, V40, P3534, DOI 10.1021/ic000935g; NAM WW, 1991, J AM CHEM SOC, V113, P7052, DOI 10.1021/ja00018a062; Ogliaro F, 2000, J AM CHEM SOC, V122, P8977, DOI 10.1021/ja991878x; OOSTERHUIS WT, 1973, J CHEM PHYS, V58, P4757, DOI 10.1063/1.1679055; PENNERHAHN JE, 1986, J AM CHEM SOC, V108, P7819, DOI 10.1021/ja00284a054; Que L, 1996, CHEM REV, V96, P2607, DOI 10.1021/cr960039f; SCHAPPACHER M, 1985, J AM CHEM SOC, V107, P3736, DOI 10.1021/ja00298a065; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Schunemann V, 2000, FEBS LETT, V479, P149, DOI 10.1016/S0014-5793(00)01886-X; Siegbahn PEM, 2001, J BIOL INORG CHEM, V6, P27, DOI 10.1007/s007750000184; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Watanabe Y, 2000, STRUCT BOND, V97, P61; Wolter T, 2000, J INORG BIOCHEM, V78, P117, DOI 10.1016/S0162-0134(99)00217-2; Zheng H, 2000, J AM CHEM SOC, V122, P3789, DOI 10.1021/ja9936722	34	737	741	10	299	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1037	1039		10.1126/science.299.5609.1037	http://dx.doi.org/10.1126/science.299.5609.1037			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586936				2022-12-28	WOS:000180960000038
J	Riggs, BL; Hartmann, LC				Riggs, BL; Hartmann, LC			Drug therapy: Selective estrogen-receptor modulators - Mechanisms of action and application to clinical practice	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BONE-MINERAL DENSITY; HORMONE REPLACEMENT THERAPY; SURGICAL ADJUVANT BREAST; ONCOLOGY TECHNOLOGY-ASSESSMENT; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; FIRST-LINE THERAPY; POSTMENOPAUSAL WOMEN; RANDOMIZED-TRIAL; VERTEBRAL FRACTURES		Mayo Clin & Mayo Fdn, Dept Internal Med, Div Endocrinol & Metab, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Oncol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Riggs, BL (corresponding author), Mayo Clin & Mayo Fdn, Dept Internal Med, Div Endocrinol & Metab, 200 1st St SW,N 6 Plummer, Rochester, MN 55905 USA.				NATIONAL CANCER INSTITUTE [R01CA080181, P30CA015083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027065] Funding Source: NIH RePORTER; NCI NIH HHS [CA80181, CA15083] Funding Source: Medline; NIAMS NIH HHS [AR27065] Funding Source: Medline; NIA NIH HHS [AG04775] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abrams JA, 2001, J NATL CANCER I, V93, P662, DOI 10.1093/jnci/93.9.662; *ATLAS TRIAL, 2003, NIH CLIN TRIAL; Barrett-Connor E, 2002, JAMA-J AM MED ASSOC, V287, P847, DOI 10.1001/jama.287.7.847; Barrett-Connor E, 1999, J CLIN ENDOCR METAB, V84, P1848, DOI 10.1210/jc.84.6.1848; Baum M, 2002, LANCET, V359, P2131; Bjarnason NH, 2001, ATHEROSCLEROSIS, V154, P97, DOI 10.1016/S0021-9150(00)00470-6; Bonneterre J, 2000, J CLIN ONCOL, V18, P3748, DOI 10.1200/JCO.2000.18.22.3748; Bord S, 2001, J CLIN ENDOCR METAB, V86, P2309, DOI 10.1210/jc.86.5.2309; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Buzdar AU, 1998, CLIN CANCER RES, V4, P527; Chlebowski RT, 2002, J CLIN ONCOL, V20, P3328, DOI 10.1200/JCO.2002.06.029; Clarke M, 1998, LANCET, V351, P1451; Clarkson TB, 1998, J CLIN ENDOCR METAB, V83, P721, DOI 10.1210/jc.83.3.721; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Couse JF, 1999, ENDOCR REV, V20, P459; Cox DA, 2000, OSTEOPOROSIS INT, V11, pS207; Cummings SR, 1999, JAMA-J AM MED ASSOC, V282, P2124; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Cuzick J, 1996, IARC SCI PUBL, P95; Cuzick J, 2002, LANCET, V360, P817; Daly E, 1996, LANCET, V348, P977, DOI 10.1016/S0140-6736(96)07113-9; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Earl H, 1997, Clin Oncol (R Coll Radiol), V9, P141, DOI 10.1016/S0936-6555(97)80067-2; Eastell R, 1998, NEW ENGL J MED, V338, P736, DOI 10.1056/NEJM199803123381107; Ellis PA, 1997, INT J CANCER, V72, P608, DOI 10.1002/(SICI)1097-0215(19970807)72:4<608::AID-IJC10>3.0.CO;2-7; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P2124; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fisher B, 2001, JNCI-J NATL CANCER I, V93, P684, DOI 10.1093/jnci/93.9.684; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fogelman I, 2000, J CLIN ENDOCR METAB, V85, P1895, DOI 10.1210/jc.85.5.1895; Goss PE, 2001, J CLIN ONCOL, V19, P881, DOI 10.1200/JCO.2001.19.3.881; GRADY D, 1995, OBSTET GYNECOL, V85, P304, DOI 10.1016/0029-7844(94)00383-O; Grady D, 2001, OBSTET GYNECOL, V97, P116, DOI 10.1016/S0029-7844(00)01115-7; GREY AB, 1995, AM J MED, V99, P636, DOI 10.1016/S0002-9343(99)80251-4; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Gustafsson JA, 1999, J ENDOCRINOL, V163, P379, DOI 10.1677/joe.0.1630379; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; HAYES DF, 1995, J CLIN ONCOL, V13, P2556, DOI 10.1200/JCO.1995.13.10.2556; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Heshmati HM, 2002, J BONE MINER RES, V17, P172, DOI 10.1359/jbmr.2002.17.1.172; Hlatky MA, 2002, JAMA-J AM MED ASSOC, V287, P591, DOI 10.1001/jama.287.5.591; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Hortobagyi GN, 1998, NEW ENGL J MED, V339, P974, DOI 10.1056/NEJM199810013391407; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Johnston CC, 2000, ARCH INTERN MED, V160, P3444, DOI 10.1001/archinte.160.22.3444; Jordan VC, 2001, CANCER RES, V61, P5683; JORDAN VC, 1987, BREAST CANCER RES TR, V10, P31, DOI 10.1007/BF01806132; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; Kauffman RF, 2000, J CARDIOVASC PHARM, V36, P459, DOI 10.1097/00005344-200010000-00007; Keating NL, 1999, ANN INTERN MED, V130, P545, DOI 10.7326/0003-4819-130-7-199904060-00002; King MC, 2001, JAMA-J AM MED ASSOC, V286, P2251, DOI 10.1001/jama.286.18.2251; Kristensen B, 1996, BREAST CANCER RES TR, V39, P321, DOI 10.1007/BF01806160; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; LaCroix AZ, 1997, LANCET, V350, P1042, DOI 10.1016/S0140-6736(97)22041-6; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; LINDBERG MK, IN PRESS MOL ENDOCRI; LOVE RR, 1994, ARCH INTERN MED, V154, P2585, DOI 10.1001/archinte.154.22.2585; LOVE RR, 1992, NEW ENGL J MED, V326, P852, DOI 10.1056/NEJM199203263261302; LOVE RR, 1991, ANN INTERN MED, V115, P860, DOI 10.7326/0003-4819-115-11-860; Lufkin EG, 1998, J BONE MINER RES, V13, P1747, DOI 10.1359/jbmr.1998.13.11.1747; Marttunen MB, 1998, J CLIN ENDOCR METAB, V83, P1158, DOI 10.1210/jc.83.4.1158; McDonnell DP, 1999, TRENDS ENDOCRIN MET, V10, P301, DOI 10.1016/S1043-2760(99)00177-0; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; Mosca L, 2001, AM J CARDIOL, V88, P392, DOI 10.1016/S0002-9149(01)01685-X; MULNARD RA, 2000, JAMA-J AM MED ASSOC, V284, P2597; Mulnard RI, 2000, JAMA-J AM MED ASSOC, V283, P1007, DOI 10.1001/jama.283.8.1007; Munster PN, 2001, J CLIN ONCOL, V19, P2002; Nabholtz JM, 2000, J CLIN ONCOL, V18, P3758, DOI 10.1200/JCO.2000.18.22.3758; *NIH, 2000, ADJ THER BREAST CANC, V17; Norris JD, 1999, SCIENCE, V285, P744, DOI 10.1126/science.285.5428.744; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Paige LA, 1999, P NATL ACAD SCI USA, V96, P3999, DOI 10.1073/pnas.96.7.3999; Pavo I, 2000, EUR J PHARMACOL, V410, P101, DOI 10.1016/S0014-2999(00)00865-7; Pettersson K, 2000, ONCOGENE, V19, P4970, DOI 10.1038/sj.onc.1203828; Pike ACW, 2001, STRUCTURE, V9, P145, DOI 10.1016/S0969-2126(01)00568-8; Powles T, 1996, J CLIN ONCOL, V14, P78, DOI 10.1200/JCO.1996.14.1.78; Powles T, 1998, LANCET, V352, P98; Pyrhonen S, 1997, BRIT J CANCER, V76, P270, DOI 10.1038/bjc.1997.375; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Riggs BL, 2002, J BONE MINER RES, V17, P11, DOI 10.1359/jbmr.2002.17.1.11; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Saarto T, 1996, J CLIN ONCOL, V14, P429, DOI 10.1200/JCO.1996.14.2.429; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657; TURKEN S, 1989, J NATL CANCER I, V81, P1086, DOI 10.1093/jnci/81.14.1086; TURNER RT, 1988, ENDOCRINOLOGY, V122, P1146, DOI 10.1210/endo-122-3-1146; Veronesi U, 1998, LANCET, V352, P93; Walsh BW, 1998, JAMA-J AM MED ASSOC, V279, P1445, DOI 10.1001/jama.279.18.1445; Walsh BW, 2000, J CLIN ENDOCR METAB, V85, P214, DOI 10.1210/jc.85.1.214; Wenger NK, 1997, BMJ-BRIT MED J, V315, P1085, DOI 10.1136/bmj.315.7115.1085; Wickerham DL, 2001, SEMIN ONCOL, V28, P253, DOI 10.1053/sonc.2001.23491; Winer EP, 2002, J CLIN ONCOL, V20, P3317, DOI 10.1200/JCO.2002.06.020; *WRIT GROUP PEPI T, 1995, JAMA-J AM MED ASSOC, V274, P1676; Wu X, 1999, BRAIN RES, V847, P98, DOI 10.1016/S0006-8993(99)02062-4; Yaffe K, 2001, NEW ENGL J MED, V344, P1207, DOI 10.1056/NEJM200104193441604; Zandi PP, 2002, JAMA-J AM MED ASSOC, V288, P2123, DOI 10.1001/jama.288.17.2123	104	685	713	3	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2003	348	7					618	629		10.1056/NEJMra022219	http://dx.doi.org/10.1056/NEJMra022219			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644HY	12584371				2022-12-28	WOS:000180912900008
J	Maughan, TS; James, RD; Kerr, DJ; Ledermann, JA; Seymour, MT; Topham, C; McArdle, C; Cain, D; Stephens, RJ				Maughan, TS; James, RD; Kerr, DJ; Ledermann, JA; Seymour, MT; Topham, C; McArdle, C; Cain, D; Stephens, RJ		Med Res Council Colorectal Canc Gr	Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial	LANCET			English	Article							ADVANCED BREAST-CANCER; CELL LUNG-CANCER; METASTATIC CARCINOMA; FAVORABLE-PROGNOSIS; HODGKINS-DISEASE; LEUCOVORIN; CYCLES; 5-FLUOROURACIL; CISPLATIN; DURATION	Background Policies of UK clinicians regarding the duration of chemotherapy for patients with advanced colorectal cancer are not consistent. We aimed to compare effectiveness of continuous and intermittent chemotherapy in such patients. Methods Patients who responded or had stable disease after receiving 12 weeks of the regimens described by de Gramont and Lokich, or raltitrexed chemotherapy, were randomised to either intermittent (a break in chemotherapy, re-starting on the same drug on progression), or continuous chemotherapy until progression. Findings 354 patients (178 intermittent, 176 continuous) were enrolled from 42 UK centres. At randomisation, 41% of participants had part or complete response; 59% were stable. Only 66 (37%) patients allocated to intermittent treatment restarted as planned, after a median of 130 days. Median time on treatment after restarting was 84 days. Patients in the continuous group remained on treatment for a median of a further 92 days. Similar proportions of patients in both groups received second-line therapy. Patients on intermittent chemotherapy had significantly fewer toxic effects and serious adverse events than those in the continuous group. There was no clear evidence of a difference in overall survival (hazard ratio 0.87 favouring intermittent, 95% CI 0.69-1.09, p=0.23). Interpretation Our findings provided no clear evidence of a benefit in continuing therapy indefinitely until disease progression. They showed that it is safe to stop chemotherapy after 12 weeks and re-start the same treatment on progression in patients with chemosensitive advanced colorectal cancer.	Velindre Hosp, Dept Oncol, Cardiff, S Glam, Wales; Maidstone Hlth Author, Kent Canc Ctr, Maidstone, Kent, England; Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England; UCL Hosp, Dept Oncol, London, England; Cookridge Hosp, Canc Res UK Clin Ctr, Leeds LS16 6QB, W Yorkshire, England; Royal Surrey Cty Hosp, St Lukes Canc Ctr, Guildford, Surrey, England; Royal Infirm, Univ Dept Surg, Glasgow G31 2ER, Lanark, Scotland; MRC, Clin Trials Unit, Canc Div, London, England	Velindre Hospital; Radcliffe Infirmary; University College London Hospitals NHS Foundation Trust; University of London; University College London; Cancer Research UK; Cookridge Hospital; University of Leeds; Royal Surrey County Hospital; Royal Infirmary of Edinburgh; University of Glasgow; Medical Research Council Clinical Trials Unit	Stephens, RJ (corresponding author), MRC, Clin Trials Unit, Div Canc, 222 Euston Rd, London NW1 2DA, England.	rs@ctu.mrc.ac.uk	Maughan, Timothy/D-5032-2011	Seymour, Matthew/0000-0002-2441-9629				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; ABE O, 1992, LANCET, V339, P71; Bastit P, 2000, J CLIN ONCOL, V18, P3115, DOI 10.1200/JCO.2000.18.17.3115; Beith JM, 1996, EUR J CANCER, V32A, P438, DOI 10.1016/0959-8049(95)00608-7; BERTELSEN K, 1993, GYNECOL ONCOL, V49, P30, DOI 10.1006/gyno.1993.1081; BUCCHERI GF, 1989, CANCER, V63, P428, DOI 10.1002/1097-0142(19890201)63:3<428::AID-CNCR2820630305>3.0.CO;2-V; Childhood A, 1996, LANCET, V347, P1783, DOI DOI 10.1016/S0140-6736(96)91615-3; COATES A, 1987, NEW ENGL J MED, V317, P1490, DOI 10.1056/NEJM198712103172402; Cunningham D, 1996, ANN ONCOL, V7, P961, DOI 10.1093/oxfordjournals.annonc.a010800; deGramont A, 1997, J CLIN ONCOL, V15, P808, DOI 10.1200/JCO.1997.15.2.808; EINHORN LH, 1989, J CLIN ONCOL, V7, P387, DOI 10.1200/JCO.1989.7.3.387; EJLERTSEN B, 1993, EUR J CANCER, V29A, P527, DOI 10.1016/S0959-8049(05)80145-5; Elonen E, 1998, LEUKEMIA, V12, P1041, DOI 10.1038/sj.leu.2401068; FISHER RI, 1979, ANN INTERN MED, V90, P761, DOI 10.7326/0003-4819-90-5-761; Giacchetti S, 1999, ANN ONCOL, V10, P663, DOI 10.1023/A:1008347829017; Gregory RK, 1997, EUR J CANCER, V33, P2194, DOI 10.1016/S0959-8049(97)00396-1; HAKES TB, 1992, GYNECOL ONCOL, V45, P284, DOI 10.1016/0090-8258(92)90305-3; HARRIS AL, 1990, LANCET, V335, P186, DOI 10.1016/0140-6736(90)90277-C; Ito K, 2000, ANTICANCER RES, V20, P4681; LOKICH JJ, 1991, CANCER, V67, P14, DOI 10.1002/1097-0142(19910101)67:1<14::AID-CNCR2820670104>3.0.CO;2-M; Maughan TS, 2002, LANCET, V359, P1555, DOI 10.1016/S0140-6736(02)08514-8; MUSS HB, 1991, NEW ENGL J MED, V325, P1342, DOI 10.1056/NEJM199111073251904; OCONNELL MJ, 1996, P AN M AM SOC CLIN, V15, P209; PACCAGNELLA A, 1983, EUR J CANCER CLIN ON, V19, P1345, DOI 10.1016/0277-5379(93)90002-M; Pavlovsky S, 1997, J CLIN ONCOL, V15, P2652, DOI 10.1200/JCO.1997.15.7.2652; Seymour M T, 1997, Clin Oncol (R Coll Radiol), V9, P248, DOI 10.1016/S0936-6555(97)80010-6; Seymour MT, 1996, J CLIN ONCOL, V14, P2280, DOI 10.1200/JCO.1996.14.8.2280; SMALLEY RV, 1976, CANCER RES, V36, P3911; SPIRO SG, 1990, THORAX, V45, P1, DOI 10.1136/thx.45.1.1; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	30	156	161	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					457	464		10.1016/S0140-6736(03)12461-0	http://dx.doi.org/10.1016/S0140-6736(03)12461-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583944				2022-12-28	WOS:000180900600009
J	Salter, D; McMillan, D; Richards, M; Talbot, T; Hodges, J; Bentovim, A; Hastings, R; Stevenson, J; Skuse, D				Salter, D; McMillan, D; Richards, M; Talbot, T; Hodges, J; Bentovim, A; Hastings, R; Stevenson, J; Skuse, D			Development of sexually abusive behaviour in sexually victimised males: a longitudinal study	LANCET			English	Article							SEX OFFENDERS; CHILDHOOD; CHILDREN; VICTIMIZATION; PERPETRATORS; RESILIENCE; SAMPLE	Background Sexual maltreatment is one of the most common forms of child abuse. To identify risk factors for sexually abusive behaviour by adults, we prospectively assessed childhood experiences and personal characteristics of male child victims who became abusers in later life. Methods In a longitudinal study (7-19 years duration), we included 224 former male victims of sexual abuse. Risk factors contemporaneous with the abuse, and putative protective influences, were identified from social service and clinical records. Evidence of later criminal acts was obtained from a nationwide search of official records. Findings Of the 224 former victims, 26 had subsequently committed sexual offences (victim-abusers), in almost all cases with children, mainly outside their families. Risk factors during childhood for later offending included material neglect (odds ratio 3.4, 95% CI 1.2-9.7), lack of supervision (3.0, 1.1-8.3), and sexual abuse by a female person (3.0, 1.1-8.7). Victim-abusers had more frequently witnessed serious intrafamilial violence (3.1, 1.0-10.0). Six (29%) of 21 victim-abusers on whom we had relevant data had been cruel to animals (7.9, 2.0-31.4). No single putative protective factor, nor a composite protective index, significantly reduced the risk of paedophilic behaviour. Interpretation Most male victims of child sexual abuse do not become paedophiles, but particular experiences and patterns of childhood behaviour are associated with an increased risk of victims becoming abusers in later life. Our findings have implications for the design of selective interventions with a vulnerable subgroup of male victims, aimed at reducing the risk of paedophilic behaviour in later life.	Inst Child Hlth, Behav & Brain Sci Unit, London WC1N 1EH, England; Univ Southampton, Dept Psychol, Southampton SO9 5NH, Hants, England	University of London; University College London; University of Southampton	Skuse, D (corresponding author), Inst Child Hlth, Behav & Brain Sci Unit, 30 Guilford St, London WC1N 1EH, England.	dskuse@ich.ucl.ac.uk	Hastings, Richard P/D-9657-2013	Hastings, Richard P/0000-0002-0495-8270				Alexander M A, 1999, Sex Abuse, V11, P101; Bailey S, 2001, BRIT J PSYCHIAT, V179, P496, DOI 10.1192/bjp.179.6.496; BENTOVIM A, 1988, CHILD SEXUAL ABUSE F, P1; Bolton Frank G, 1989, MALES RISK OTHER SID; Briggs F, 1996, CHILD ABUSE NEGLECT, V20, P221, DOI 10.1016/S0145-2134(95)00145-X; Butler SM, 2002, J AM ACAD CHILD PSY, V41, P83, DOI 10.1097/00004583-200201000-00015; CARMEN E, 1984, AM J PSYCHIAT, V141, P378; Cawson P., 2000, CHILD MALTREATMENT U; Craissati J, 1996, CHILD ABUSE NEGLECT, V20, P1067, DOI 10.1016/0145-2134(96)00095-6; Dhawan S., 1996, SEX ABUSE-J RES TR, V8, P7, DOI DOI 10.1177/107906329600800102; Dolan M, 1996, MED SCI LAW, V36, P343, DOI 10.1177/002580249603600414; Dufour MH, 2000, CHILD ABUSE NEGLECT, V24, P781, DOI 10.1016/S0145-2134(00)00141-1; FINKELHOR D, 1995, CHILD ABUSE NEGLECT, V19, P141, DOI 10.1016/0145-2134(94)00112-8; Glasser M, 2001, BRIT J PSYCHIAT, V179, P482, DOI 10.1192/bjp.179.6.482; Hilton MR, 1996, BRIT J PSYCHIAT, V169, P408, DOI 10.1192/bjp.169.4.408; Hummel P, 2000, J ADOLESCENCE, V23, P305, DOI 10.1006/jado.2000.0316; KENDALLTACKETT KA, 1993, PSYCHOL BULL, V113, P164, DOI 10.1037/0033-2909.113.1.164; Langstrom N, 2000, J ADOLESCENCE, V23, P319, DOI 10.1006/jado.2000.0317; MacMillan HL, 2001, AM J PSYCHIAT, V158, P1878, DOI 10.1176/appi.ajp.158.11.1878; Nelson EC, 2002, ARCH GEN PSYCHIAT, V59, P139, DOI 10.1001/archpsyc.59.2.139; Rind B, 1998, PSYCHOL BULL, V124, P22, DOI 10.1037/0033-2909.124.1.22; Romans SE, 1996, AUST NZ J PSYCHIAT, V30, P319, DOI 10.3109/00048679609064993; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; Ryan G, 1996, J AM ACAD CHILD PSY, V35, P17, DOI 10.1097/00004583-199601000-00008; Skuse D, 1998, BRIT MED J, V317, P175, DOI 10.1136/bmj.317.7152.175; WATKINS B, 1992, J CHILD PSYCHOL PSYC, V33, P197, DOI 10.1111/j.1469-7610.1992.tb00862.x; WIDOM CS, 1994, CHILD ABUSE NEGLECT, V18, P303, DOI 10.1016/0145-2134(94)90033-7; Zgourides G, 1997, INT J OFFENDER THER, V41, P272, DOI 10.1177/0306624X97413006	28	164	164	3	71	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					471	476		10.1016/S0140-6736(03)12466-X	http://dx.doi.org/10.1016/S0140-6736(03)12466-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	644CP	12583946				2022-12-28	WOS:000180900600011
J	McMahon, RJ				McMahon, RJ			Chemical reactions involving quantum tunneling	SCIENCE			English	Editorial Material							RESONANCE		Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	McMahon, RJ (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	mcmahon@chem.wisc.edu	McMahon, Robert J./AAR-3868-2020					Antoniou D, 2002, EUR J BIOCHEM, V269, P3103, DOI 10.1046/j.1432-1033.2002.03021.x; Bell R, 1980, TUNNEL EFFECT CHEM; Benderskii V.A., 1994, ADV CHEM PHYS, V<bold>88</bold>, DOI 10.1002/9780470141472; Bettens FL, 2000, J AM CHEM SOC, V122, P5856, DOI 10.1021/ja000042n; BRUNTON G, 1976, J AM CHEM SOC, V98, P6803, DOI 10.1021/ja00438a005; BUCHWALTER SL, 1979, J AM CHEM SOC, V101, P4688, DOI 10.1021/ja00510a042; CARPENTER BK, 1983, J AM CHEM SOC, V105, P1700, DOI 10.1021/ja00344a073; FREI H, 1981, J PHYS CHEM-US, V85, P3355, DOI 10.1021/j150622a030; Gao JL, 2002, ANNU REV PHYS CHEM, V53, P467, DOI 10.1146/annurev.physchem.53.091301.150114; Hammes-Schiffer S, 2002, BIOCHEMISTRY-US, V41, P13335, DOI 10.1021/bi0267137; Hammes-Schiffer S, 2001, ACCOUNTS CHEM RES, V34, P273, DOI 10.1021/ar9901117; Hiraoka K, 2001, SCIENCE, V292, P869, DOI 10.1126/science.1060837; Knapp MJ, 2002, EUR J BIOCHEM, V269, P3113, DOI 10.1046/j.1432-1033.2002.03022.x; MILLER DJ, 1981, J AM CHEM SOC, V103, P3519, DOI 10.1021/ja00402a043; WONCHOBA SE, 1995, PHYS REV B, V51, P9985, DOI 10.1103/PhysRevB.51.9985; Zuev PS, 2003, SCIENCE, V299, P867, DOI 10.1126/science.1079294	16	77	78	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					833	834		10.1126/science.1080715	http://dx.doi.org/10.1126/science.1080715			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574607				2022-12-28	WOS:000180830900028
J	Garner, D; Weston, V				Garner, D; Weston, V			Effectiveness of vaccination for Haemophilus influenzae type b	LANCET			English	Article							CONJUGATE	Several cases of invasive Haemophilus influenzae type b (Hib) infection have been identified in children previously vaccinated against this disease. We have reviewed all cases of Hib in Nottingham, UK, since the conjugated vaccine was introduced into the primary course of childhood immunisations in 1992. Our results show a worrying increase in the frequency of Hib in Nottingham, which is much the same as the national trends. We believe that the medical profession should be aware of the return of Hib, and that we now need to review the need for a booster vaccination for what was thought to be a disease of the past.	Univ Nottingham Hosp, Queens Med Ctr, Dept Microbiol, Nottingham NG7 2UH, England; Univ Nottingham Hosp, Queens Med Ctr, Publ Hlth Lab, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Garner, D (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Dept Microbiol, Nottingham NG7 2UH, England.							Eskola J, 1999, LANCET, V354, P2063, DOI 10.1016/S0140-6736(99)04377-9; Heath PT, 2000, CLIN INFECT DIS, V31, P973, DOI 10.1086/318132; MCVERNON J, 2000, 15 BRIT PAED SURV UN, P23; *PUBL HLTH LAB SER, 2002, CDR WEEKLY      0124, P3	4	29	31	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					395	396		10.1016/S0140-6736(03)12385-9	http://dx.doi.org/10.1016/S0140-6736(03)12385-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573380				2022-12-28	WOS:000180787000016
J	Festenstein, R; Pagakis, SN; Hiragami, K; Lyon, D; Verreault, A; Sekkali, B; Kioussis, D				Festenstein, R; Pagakis, SN; Hiragami, K; Lyon, D; Verreault, A; Sekkali, B; Kioussis, D			Modulation of heterochromatin protein 1 dynamics in primary mammalian cells	SCIENCE			English	Article							POSITION-EFFECT VARIEGATION; LIVING HUMAN-CELLS; RAPID EXCHANGE; HISTONE H3; CHROMATIN STRUCTURE; TRANSGENIC MICE; HP1 PROTEINS; LYSINE 9; DROSOPHILA; EXPRESSION	Heterochromatin protein 1 (HP1beta), a key component of condensed DNA, is strongly implicated in gene silencing and centromeric cohesion. Heterochromatin has been considered a static structure, stabilizing crucial aspects of nuclear organization and prohibiting access to transcription factors. We demonstrate here, by fluorescence recovery after photobleaching, that a green fluorescent protein-HP1beta fusion protein is highly mobile within both the euchromatin and heterochromatin of ex vivo resting murine T cells. Moreover, T cell activation greatly increased this mobility, indicating that such a process may facilitate (hetero)chromatin remodeling and permit access of epigenetic modifiers and transcription factors to the many genes that are consequently derepressed.	Imperial Coll Sch Med, Div Med, CSC Gene Control Mech & Dis Grp, London W12 0NN, England; Natl Inst Med Res, Confocal & Image Anal Lab, London NW7 1AA, England; London Res Inst, Canc Res UK, Chromosome Dynam Lab, Potters Bar EN6 3LD, Herts, England; Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England	Imperial College London; MRC National Institute for Medical Research; Cancer Research UK; MRC National Institute for Medical Research	Festenstein, R (corresponding author), Imperial Coll Sch Med, Div Med, CSC Gene Control Mech & Dis Grp, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.							Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Briggs SD, 2002, NAT GENET, V30, P241, DOI 10.1038/ng0302-241; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; EISSENBERG JC, 1992, GENETICS, V131, P345; Festenstein R, 1999, NAT GENET, V23, P457, DOI 10.1038/70579; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; McMorrow T, 2000, EMBO J, V19, P4986, DOI 10.1093/emboj/19.18.4986; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Minc E., 2001, Methods in Cell Science, V23, P171, DOI 10.1023/A:1013168323754; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Muller HJ, 1930, J GENET, V22, P299, DOI 10.1007/BF02984195; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Paro R, 2000, NATURE, V406, P579, DOI 10.1038/35020675; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; WREGGETT KA, 1994, CYTOGENET CELL GENET, V66, P99, DOI 10.1159/000133676; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	30	234	239	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					719	721		10.1126/science.1078694	http://dx.doi.org/10.1126/science.1078694			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560554				2022-12-28	WOS:000180687700051
J	Ciesla, FJ; Lauretta, DS; Cohen, BA; Hood, LL				Ciesla, FJ; Lauretta, DS; Cohen, BA; Hood, LL			A nebular origin for chondritic fine-grained phyllosilicates	SCIENCE			English	Article							SOLAR NEBULA; CHONDRULE FORMATION; WATER; PARTICLES; EVOLUTION; MODEL	Hydrated minerals occur in accretionary rims around chondrules in CM chondrites. Previous models suggested that these phyllosilicates did not form by gas-solid reactions in the canonical solar nebula. We propose that chondrule-forming shock waves in icy regions of the nebula produced conditions that allowed rapid mineral hydration. The time scales for phyllosilicate formation are similar to the time it takes for a shocked system to cool from the temperature of phyllosilicate stability to that of water ice condensation. This scenario allows for simultaneous formation of chondrules and their fine-grained accretionary rims.	Univ Arizona, Dept Planetary Sci, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	University of Arizona; University of Hawaii System	Ciesla, FJ (corresponding author), Univ Arizona, Dept Planetary Sci, Lunar & Planetary Lab, 1629 E Univ Blvd, Tucson, AZ 85721 USA.	fciesla@lpl.arizona.edu	COHEN, BARBARA/AAV-8199-2021	Cohen, Barbara/0000-0001-5896-5903				Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Bischoff A, 1998, METEORIT PLANET SCI, V33, P1113, DOI 10.1111/j.1945-5100.1998.tb01716.x; Ciesla FJ, 2002, ICARUS, V158, P281, DOI 10.1006/icar.2002.6895; Cohen BA, 2000, ICARUS, V145, P369, DOI 10.1006/icar.2000.6329; Connolly HC, 1998, GEOCHIM COSMOCHIM AC, V62, P2725, DOI 10.1016/S0016-7037(98)00176-8; Connolly HC, 1998, SCIENCE, V280, P62, DOI 10.1126/science.280.5360.62; CONNOLLY HC, 1994, NATURE, V371, P136, DOI 10.1038/371136a0; Cuzzi JN, 2001, ASTROPHYS J, V546, P496, DOI 10.1086/318233; Cyr KE, 1998, ICARUS, V135, P537, DOI 10.1006/icar.1998.5959; Desch SJ, 2002, METEORIT PLANET SCI, V37, P183, DOI 10.1111/j.1945-5100.2002.tb01104.x; Fegley B.J., 1989, FORMATION EVOLUTION, P171; GRIMM RE, 1989, ICARUS, V82, P244, DOI 10.1016/0019-1035(89)90038-9; Hewins R. H., 1996, CHONDRULES PROTOPLAN, P197; Iida A, 2001, ICARUS, V153, P430, DOI 10.1006/icar.2001.6682; Lauretta DS, 2000, GEOCHIM COSMOCHIM AC, V64, P3263, DOI 10.1016/S0016-7037(00)00425-7; Lauretta DS, 2001, GEOCHIM COSMOCHIM AC, V65, P1337, DOI 10.1016/S0016-7037(00)00615-3; LEE MR, 1993, METEORITICS, V28, P53, DOI 10.1111/j.1945-5100.1993.tb00248.x; LODDERS K, 1998, PLANETARY SCI COMPAN, V80, P80; METZLER K, 1992, GEOCHIM COSMOCHIM AC, V56, P2873, DOI 10.1016/0016-7037(92)90365-P; PRINN RG, 1987, ANNU REV EARTH PL SC, V15, P171; Rasmussen MG, 1998, CAN MINERAL, V36, P147; Sears DWG, 1998, METEORIT PLANET SCI, V33, P1157, DOI 10.1111/j.1945-5100.1998.tb01720.x; STEVENSON DJ, 1988, ICARUS, V75, P146, DOI 10.1016/0019-1035(88)90133-9; Supulver KD, 2000, ICARUS, V146, P525, DOI 10.1006/icar.2000.6418; Wegner W.W., 1983, AM J SCI, V283-A, P151; WEIDENSCHILLING SJ, 1988, METEORITES EARLY SOL, P348	26	113	113	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					549	552		10.1126/science.1079427	http://dx.doi.org/10.1126/science.1079427			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543970				2022-12-28	WOS:000180559800044
J	Hendler, J				Hendler, J			Communication - Science and the Semantic Web	SCIENCE			English	Editorial Material									Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Hendler, J (corresponding author), Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA.		Cranefield, Stephen J S/A-6605-2008	Cranefield, Stephen J S/0000-0001-5638-1648; Hendler, James/0000-0003-3056-1960				*AM MED INF ASS, AM MED INF ASS S ONT; BERNERSLEE T, 2001, SCI AM           MAY; Foster I., 2001, INT J SUPERCOMPUT AP, V15; Harris NL, 1999, J CLIN ONCOL, V17, P3835, DOI 10.1200/JCO.1999.17.12.3835; LEMAY G, 1984, P NATL ACAD SCI-BIOL, V81, P38, DOI 10.1073/pnas.81.1.38; *SCI SEM WEB, 2002, SCI SEM WEB SWS WORK; *WHO, 1997, CLIN ADV COMM M WARR; 2002, EUR 2002 C HELD OXF; ANATOMY GRID ENABLIN	9	70	74	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					520	521		10.1126/science.1078874	http://dx.doi.org/10.1126/science.1078874			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543958				2022-12-28	WOS:000180559800031
J	Hutson, MS; Tokutake, Y; Chang, MS; Bloor, JW; Venakides, S; Kiehart, DP; Edwards, GS				Hutson, MS; Tokutake, Y; Chang, MS; Bloor, JW; Venakides, S; Kiehart, DP; Edwards, GS			Forces for morphogenesis investigated with laser microsurgery and quantitative modeling	SCIENCE			English	Article							DROSOPHILA DORSAL CLOSURE; DYNAMIC ANALYSIS; AMNIOSEROSA; ADHESION; BIOLOGY; REVEAL; EMBRYO; CELLS	We investigated the forces that connect the genetic program of development to morphogenesis in Drosophila. We focused on dorsal closure, a powerful model system for development and wound healing. We found that the bulk of progress toward closure is driven by contractility in supracellular "purse strings" and in the amnioserosa, whereas adhesion-mediated zipping coordinates the forces produced by the purse strings and is essential only for the end stages. We applied quantitative modeling to show that these forces, generated in distinct cells, are coordinated in space and synchronized in time. Modeling of wild-type and mutant phenotypes is predictive; although closure in myospheroid mutants ultimately fails when the cell sheets rip themselves apart, our analysis indicates that beta(PS) integrin has an earlier, important role in zipping.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Duke Univ, Dept Math, Durham, NC 27708 USA; Duke Univ, Dept Phys, Durham, NC 27708 USA; Duke Univ, Free Electron Laser Lab, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Duke University	Kiehart, DP (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	dkiehart@duke.edu; edwards@fel.duke.edu	Chang, Ming-Shien/F-7922-2012	Chang, Ming-Shien/0000-0002-6385-0374	NIGMS NIH HHS [GM61240, GM33830] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033830, R01GM061240] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agnes F, 1999, CR ACAD SCI III-VIE, V322, P5, DOI 10.1016/S0764-4469(99)80012-2; Bloor JW, 2002, DEVELOPMENT, V129, P3173; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Chen HH, 2000, J BIOMECH ENG-T ASME, V122, P394, DOI 10.1115/1.1286563; Davidson LA, 1999, DEV BIOL, V209, P221, DOI 10.1006/dbio.1999.9249; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; FOE VE, 1989, DEVELOPMENT, V107, P1; Harden N, 2002, DIFFERENTIATION, V70, P181, DOI 10.1046/j.1432-0436.2002.700408.x; Harden N, 2002, J CELL SCI, V115, P2119; Jacinto A, 2002, CURR BIOL, V12, P1245, DOI 10.1016/S0960-9822(02)00955-7; Jacinto A, 2002, DEV CELL, V3, P9, DOI 10.1016/S1534-5807(02)00208-3; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Kiehart DP, 1999, CURR BIOL, V9, pR602, DOI 10.1016/S0960-9822(99)80384-4; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; MACKRELL AJ, 1988, P NATL ACAD SCI USA, V85, P2633, DOI 10.1073/pnas.85.8.2633; Magie CR, 1999, DEVELOPMENT, V126, P5353; Martinez Arias Alfonso, 1993, P517; Meinhardt H, 2002, NATURE, V419, P261, DOI 10.1038/419261a; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Reed BH, 2001, CURR BIOL, V11, P1098, DOI 10.1016/S0960-9822(01)00318-9; Stronach BE, 2001, DEVELOPMENT, V128, P2905; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29	22	373	374	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					145	149		10.1126/science.1079552	http://dx.doi.org/10.1126/science.1079552			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12574496				2022-12-28	WOS:000181988900053
J	Desnick, RJ; Brady, R; Barranger, J; Collins, AJ; Germain, DP; Goldman, M; Grabowski, G; Packman, S; Wilcox, WR				Desnick, RJ; Brady, R; Barranger, J; Collins, AJ; Germain, DP; Goldman, M; Grabowski, G; Packman, S; Wilcox, WR			Fabry disease, an under-recognized multisystemic disorder: Expert recommendations for diagnosis, management, and enzyme replacement therapy	ANNALS OF INTERNAL MEDICINE			English	Article							PREVIOUSLY UNTREATED PATIENTS; RECOMBINANT FACTOR-VIII; ALPHA-GALACTOSIDASE; GAUCHER-DISEASE; CLINICAL MANIFESTATIONS; ATYPICAL VARIANT; RENAL-DISEASE; COMPLICATIONS; DEFICIENCY; STORAGE	Fabry disease (alpha-galactosidase A deficiency) is an X-linked recessive lysosomal storage disorder. Although the disease presents in childhood and culminates in cardiac, cerebrovascular, and end-stage renal disease, diagnosis is often delayed or missed. This paper reviews the key signs and symptoms of Fabry disease and provides expert recommendations for diagnosis, follow-up, medical management, and the use of enzyme replacement therapy. Recommendations are based on reviews of the literature on Fabry disease, results of recent clinical trials, and expertise of the authors, all of whom have extensive clinical experience with Fabry disease and lysosomal storage disorders and represent subspecialties involved in treatment. All males and female carriers affected with Fabry disease should be followed closely, regardless of symptoms or treatment status. Clinical trials have shown that recombinant human alpha-galactosidase A replacement therapy-the only disease-specific therapy currently available for Fabry disease-is safe and can reverse substrate storage in the lysosome, the pathophysiologic basis of the disease. Enzyme replacement therapy in all males with Fabry disease (including those with end-stage renal disease) and female carriers with substantial disease manifestations should be initiated as early as possible. Additional experience is needed before more specific recommendations can be made on optimal dosing regimens for reversal; maintenance; and prevention of disease manifestations in affected males, symptomatic carrier females, children, and patients with compromised renal function.	CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; NINDS, NIH, Bethesda, MD 20892 USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA; Univ Minnesota, Minneapolis, MN USA; Hop Europeen Georges Pompidou, Clin Genet Unit, Paris, France; Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Minnesota System; University of Minnesota Twin Cities; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Cincinnati Children's Hospital Medical Center; University of California System; University of California San Francisco; Cedars Sinai Medical Center	Desnick, RJ (corresponding author), CUNY Mt Sinai Sch Med, Dept Human Genet, Box 1498,5th Ave & 100th St, New York, NY 10029 USA.	rjd.fabry@mssn.edu	GERMAIN, Dominique P./AAD-6747-2020	GERMAIN, Dominique/0000-0002-8355-007X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002982] Funding Source: NIH RePORTER; NIDDK NIH HHS [5 R37 DK34045] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2014, METABOLIC MOL BASES; Argoff CE, 1998, NUCL MED COMMUN, V19, P887, DOI 10.1097/00006231-199809000-00009; Ashton-Prolla P, 2000, J INVEST MED, V48, P227; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; BRADY RO, 1971, SCIENCE, V172, P174, DOI 10.1126/science.172.3979.174; Brady RO, 2000, JAMA-J AM MED ASSOC, V284, P2771, DOI 10.1001/jama.284.21.2771; Branton MH, 2002, MEDICINE, V81, P122, DOI 10.1097/00005792-200203000-00003; Brown LK, 1997, AM J RESP CRIT CARE, V155, P1004, DOI 10.1164/ajrccm.155.3.9116979; COLOMBI A, 1967, HELV MED ACTA, V34, P67; DeGraba T, 2000, ANN NEUROL, V47, P229, DOI 10.1002/1531-8249(200002)47:2<229::AID-ANA13>3.3.CO;2-K; DESNICK RJ, 1972, SURGERY, V72, P203; Desnick RJ, 2002, AM J HUM GENET, V71, P417; DESNICK RJ, 1973, J LAB CLIN MED, V81, P157; ELLEDER M, 1990, VIRCHOWS ARCH A, V417, P449, DOI 10.1007/BF01606034; Eng CM, 2001, AM J HUM GENET, V68, P711, DOI 10.1086/318809; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Germain Dominique P., 2002, Journal de la Societe de Biologie, V196, P183; Germain DP, 2001, CONTRIB NEPHROL, V136, P234; GOLDMAN ME, 1986, J AM COLL CARDIOL, V7, P1157, DOI 10.1016/S0735-1097(86)80238-8; Goodeve AC, 2000, THROMB HAEMOSTASIS, V83, P844; Grabowski GA, 1998, BLOOD REV, V12, P115, DOI 10.1016/S0268-960X(98)90023-6; Grunfeld JP, 2001, J INHERIT METAB DIS, V24, P71, DOI 10.1023/A:1012475908718; Grunfeld JP, 2001, J INHERIT METAB DIS, V24, P65, DOI 10.1023/A:1012471807810; Ioannou YA, 2001, AM J HUM GENET, V68, P14, DOI 10.1086/316953; KINT J A, 1970, Science (Washington D C), V167, P1268, DOI 10.1126/science.167.3922.1268; KRAMER W, 1985, INT J CARDIOL, V7, P72, DOI 10.1016/0167-5273(85)90179-2; Ledvinova J, 1997, BBA-LIPID LIPID MET, V1345, P180, DOI 10.1016/S0005-2760(96)00175-0; LEE K, 2003, GLYCOBIOLOGY; LENOIR G, 1977, ARCH FR PEDIATR, V34, P704; Linhart A, 2000, AM HEART J, V139, P1101, DOI 10.1067/mhj.2000.105105; Linhart A, 2001, J INHERIT METAB DIS, V24, P75, DOI 10.1023/A:1012428009627; Linthorst G. E., 2002, Journal of Inherited Metabolic Disease, V25, P115; LOCKMAN LA, 1973, NEUROLOGY, V23, P871, DOI 10.1212/WNL.23.8.871; LUSHER JM, 1993, NEW ENGL J MED, V328, P453, DOI 10.1056/NEJM199302183280701; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; MAYES JS, 1981, CLIN CHIM ACTA, V112, P247, DOI 10.1016/0009-8981(81)90384-3; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Mistry Pramod K., 1999, Journal of Hepatology, V30, P1; Mitsias P, 1996, ANN NEUROL, V40, P8, DOI 10.1002/ana.410400105; Moore DF, 2002, BMC NEUROL, V2, DOI 10.1186/1471-2377-2-4; Moore DF, 2002, STROKE, V33, P525, DOI 10.1161/hs0202.102601; Moore DF, 2001, CIRCULATION, V104, P1506, DOI 10.1161/hc3801.096352; MORGAN SH, 1988, BRIT MED J, V297, P872, DOI 10.1136/bmj.297.6653.872; MORGAN SH, 1990, Q J MED, V75, P491; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; ROSENTHAL DI, 1995, PEDIATRICS, V96, P629; Sachdev B, 2002, CIRCULATION, V105, P1407, DOI 10.1161/01.CIR.0000012626.81324.38; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; SWEELEY CC, 1963, J BIOL CHEM, V238, P3148; Thurberg BL, 2002, KIDNEY INT, V62, P1933, DOI 10.1046/j.1523-1755.2002.00675.x; Tsakiris D, 1996, NEPHROL DIAL TRANSPL, V11, P4; VanLoo A, 1996, AM J NEPHROL, V16, P352, DOI 10.1159/000169023; VONSCHEIDT W, 1991, NEW ENGL J MED, V324, P395, DOI 10.1056/NEJM199102073240607; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; WHERRETT JR, 1973, J BIOL CHEM, V248, P3046; Yoshitama T, 2001, AM J CARDIOL, V87, P71, DOI 10.1016/S0002-9149(00)01275-3	58	496	543	0	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2003	138	4					338	346		10.7326/0003-4819-138-4-200302180-00014	http://dx.doi.org/10.7326/0003-4819-138-4-200302180-00014			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DK	12585833				2022-12-28	WOS:000181019400019
J	Shiratori, Y; Shiina, S; Teratani, T; Imamura, M; Obi, S; Sato, S; Koike, Y; Yoshida, H; Omata, M				Shiratori, Y; Shiina, S; Teratani, T; Imamura, M; Obi, S; Sato, S; Koike, Y; Yoshida, H; Omata, M			Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus	ANNALS OF INTERNAL MEDICINE			English	Article							PERCUTANEOUS ETHANOL INJECTION; CIRRHOTIC-PATIENTS; RISK-FACTORS; INTRAHEPATIC RECURRENCE; LIVER-TRANSPLANTATION; NONCIRRHOTIC PATIENTS; INITIAL TREATMENT; RANDOMIZED TRIAL; RIBAVIRIN; EFFICACY	Background: Even after the surgical or medical treatment of hepatocellular carcinoma, tumors frequently develop at new foci, leading to a poor prognosis. Objective: To assess whether combined tumor ablation and interferon therapy can reduce the occurrence of new foci of hepatocellular carcinoma, thereby improving survival rate. Design: Randomized, controlled study. Setting: University hospital. Patients: 74 patients with compensated cirrhosis, three or fewer nodules of hepatocellular carcinoma, and low hepatitis C virus RNA loads (less than or equal to2 x 10(6) copies/mL). Intervention: After all patients had complete ablation of lesions by percutaneous ethanol injection therapy, 49 patients were assigned to receive 6 million U of interferon three times weekly for 48 weeks and 25 did not receive treatment. Measurements: Abdominal ultrasonography, computed tomography, and determination of blood biochemical measures. Results: Of the 49 patients treated with interferon, 21 showed a sustained biochemical response and 14 showed a sustained virologic response. The rate of first recurrence of new foci of hepatocellular carcinoma was similar in patients treated with interferon and untreated patients; however, the rates of second or third recurrence seemed to be lower in the interferon group than in the untreated group. Patients treated with interferon had a survival rate of 68% at 5 years and 53% at 7 years; untreated patients had a survival rate of 48% at 5 years and 23% at 7 years. Conclusion: After tumor ablation by ethanol injection, interferon therapy may enhance patient survival in selected patients with chronic hepatitis C.	Univ Tokyo, Fac Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo	Shiratori, Y (corresponding author), Univ Tokyo, Fac Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.	shirato@cc.okayama-u.ac.jp						BELGHITI J, 1991, ANN SURG, V214, P114, DOI 10.1097/00000658-199108000-00004; Brunetto MR, 1998, LANCET, V351, P1535; COLOMBO M, 1991, NEW ENGL J MED, V325, P675, DOI 10.1056/NEJM199109053251002; Davis GL, 1998, NEW ENGL J MED, V339, P1493, DOI 10.1056/NEJM199811193392102; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; FARMER DG, 1994, ANN SURG, V219, P236, DOI 10.1097/00000658-199403000-00003; Figueras J, 1997, HEPATOLOGY, V25, P1485, DOI 10.1002/hep.510250629; Freedman L S, 1982, Stat Med, V1, P121, DOI 10.1002/sim.4780010204; Heathcote EJ, 2000, NEW ENGL J MED, V343, P1673, DOI 10.1056/NEJM200012073432302; Hoofnagle JH, 1997, NEW ENGL J MED, V336, P347, DOI 10.1056/NEJM199701303360507; JOUET P, 1994, GASTROENTEROLOGY, V106, P686, DOI 10.1016/0016-5085(94)90703-X; Kasahara A, 1998, HEPATOLOGY, V27, P1394, DOI 10.1002/hep.510270529; KATO N, 1993, HEPATOLOGY, V18, P16, DOI 10.1002/hep.1840180104; Koike Y, 2000, HEPATOLOGY, V32, P1216, DOI 10.1053/jhep.2000.20237; Lau DTY, 1998, HEPATOLOGY, V28, P1121, DOI 10.1002/hep.510280430; LEE MJ, 1995, AM J ROENTGENOL, V164, P215, DOI 10.2214/ajr.164.1.7998542; Livraghi T, 1999, RADIOLOGY, V210, P655, DOI 10.1148/radiology.210.3.r99fe40655; LIVRAGHI T, 1995, RADIOLOGY, V197, P101, DOI 10.1148/radiology.197.1.7568806; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; OKADA S, 1994, GASTROENTEROLOGY, V106, P1618, DOI 10.1016/0016-5085(94)90419-7; OKAMOTO H, 1992, VIROLOGY, V188, P331, DOI 10.1016/0042-6822(92)90762-E; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pompili M, 1997, CANCER, V79, P1501, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1501::AID-CNCR9>3.0.CO;2-D; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Sangro B, 1998, SURGERY, V124, P575, DOI 10.1067/msy.1998.90359; Sato S, 2001, J HEPATOL, V35, P225, DOI 10.1016/S0168-8278(01)00083-6; Schalm SW, 1999, GASTROENTEROLOGY, V117, P408, DOI 10.1053/gast.1999.0029900408; SHIINA S, 1993, AM J ROENTGENOL, V160, P1023, DOI 10.2214/ajr.160.5.7682378; Shiratori Y, 1999, HEPATOLOGY, V29, P1573, DOI 10.1002/hep.510290529; SHIRATORI Y, 1995, HEPATOLOGY, V22, P1027, DOI 10.1002/hep.1840220403; Shiratori Y, 1997, GASTROENTEROLOGY, V113, P558, DOI 10.1053/gast.1997.v113.pm9247476; Shiratori Y, 2000, ANN INTERN MED, V132, P517, DOI 10.7326/0003-4819-132-7-200004040-00002; Shiratori Y, 2000, LIVER, V20, P271, DOI 10.1034/j.1600-0676.2000.020004271.x; TAKANO S, 1995, HEPATOLOGY, V21, P650; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; WANLESS IR, 1995, HEPATOLOGY, V22, P983, DOI 10.1002/hep.1840220341; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003	40	217	227	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2003	138	4					299	306		10.7326/0003-4819-138-4-200302180-00008	http://dx.doi.org/10.7326/0003-4819-138-4-200302180-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DK	12585827				2022-12-28	WOS:000181019400003
J	Mitchell, CE; Power, AG				Mitchell, CE; Power, AG			Release of invasive plants from fungal and viral pathogens	NATURE			English	Article							DISEASES	Invasive plant species both threaten native biodiversity and are economically costly(1-5), but only a few naturalized species become pests(2,4). Here we report broad, quantitative support for two long-standing hypotheses that explain why only some naturalized species have large impacts. The enemy release hypothesis argues that invaders' impacts result from reduced natural enemy attack(2,4,6-10). The biotic resistance hypothesis argues that interactions with native species, including natural enemies, limit invaders' impacts(6-8). We tested these hypotheses for viruses and for rust, smut and powdery mildew fungi that infect 473 plant species naturalized to the United States from Europe. On average, 84% fewer fungi and 24% fewer virus species infect each plant species in its naturalized range than in its native range. In addition, invasive plant species that are more completely released from pathogens are more widely reported as harmful invaders of both agricultural and natural ecosystems. Together, these results strongly support the enemy release hypothesis. Among noxious agricultural weeds, species accumulating more pathogens in their naturalized range are less widely noxious, supporting the biotic resistance hypothesis. Our results indicate that invasive plants' impacts may be a function of both release from and accumulation of natural enemies, including pathogens.	Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	Cornell University	Mitchell, CE (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.		Mitchell, Charles E/I-3709-2014	Mitchell, Charles E/0000-0002-1633-1993				AGRIOS GN, 1997, PLANT PATHOLOGY; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; [Anonymous], 1861, ORIGIN SPECIES MEANS; Braun U., 1995, POWDERY MILDEWS ERYS; Charudattan R, 2001, BIOCONTROL, V46, P229, DOI 10.1023/A:1011477531101; CLAY K, 1995, CAN J BOT, V73, pS42, DOI 10.1139/b95-223; Elton C. S., 1958, ECOLOGY INVASIONS; Farr D. F., 1989, Fungi on plants and plant products in the United States.; Gaumann E, 1959, ROSTPILZE MITTELEURO; HOKKANEN H, 1985, AGR ECOSYST ENVIRON, V14, P63, DOI 10.1016/0167-8809(85)90085-4; Holm L. G., 1977, WORLDS WORST WEEDS D; Julien M. H., 1998, BIOL CONTROL WEEDS W; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Liebman M., 2001, ECOLOGICAL MANAGEMEN, P375; Mabberly DJ., 1997, PLANT BOOK PORTABLE; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Maron JL, 2001, OIKOS, V95, P361, DOI 10.1034/j.1600-0706.2001.950301.x; Naylor R. L., 1997, Nature's services: societal dependence on natural ecosystems., P151; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Pimentel D., 2002, BIOL INVASIONS EC EN; TORCHIN ME, IN PRESS NATURE; Tutin T.G., 1968, FLORA EUROPAEA, V2, P368; *US C OFF TECHN AS, 1993, OTAF565 US C; Van der Putten WH, 2002, NATURE, V417, P32, DOI 10.1038/417032a; VuYnky K., 1994, EUROPEAN SMUT FUNGI; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Williamson M., 1996, BIOL INVASIONS; Wilson M, 1966, BRIT RUST FUNGI	30	841	894	10	391	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					625	627		10.1038/nature01317	http://dx.doi.org/10.1038/nature01317			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571594				2022-12-28	WOS:000180803200040
J	Marshall, SW; Mueller, FO; Kirby, DP; Yang, JZ				Marshall, SW; Mueller, FO; Kirby, DP; Yang, JZ			Evaluation of safety balls and faceguards for prevention of injuries in youth baseball	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LITTLE-LEAGUE BASEBALL; CHEST IMPACTS; SUDDEN-DEATH; RISK; STANDARD; HEAD	Context Safety balls and faceguards are widely used in youth baseball, but their effectiveness in reducing injury is unknown. Objective To evaluate the association of the use of faceguards and safety balls and injuries in youth baseball. Design, Setting, and Participants Ecological study using a national database of compensated insurance claims maintained by Little League Baseball Incorporated, combined with data on the number of participants in Little League and data from a census of protective equipment usage for youth aged 5 to 18 years participating in Little League Baseball in the United States during 1997-1999. Main Outcome Measures Rate of injury and injury rate ratio comparing users with nonusers of protective equipment. Results A total of 6744240 player-seasons of follow-up and 4233 compensated injury claims were available for analysis. The absolute incidence of compensated injury per 100000 player-seasons was 28.02 (95% confidence interval [CI], 26.76-29.29) for ball-related injury and 2.71 (95% CI, 2.32-3.11) for facial injury. Overall, use of safety balls was associated with a reduced risk of ball-related injury (adjusted rate ratio, 0.77; 95% CI, 0.64-0.93). This reduction was essentially due to 1 type of safety ball, known as the reduced-impact ball (adjusted rate ratio, 0.72; 95% CI, 0.57-0.91). Use of faceguards reduced the risk of facial injury (adjusted rate ratio, 0.65; 95% CI, 0.43-0.98). Metal and plastic guards appeared to be equally effective. Safety balls appeared to be more effective in the minor division (ages 7-12 years) than in the regular division (ages 9-12 years). Conclusions Reduced-impact balls and faceguards were associated with a reduced risk of injury in youth baseball. These findings support increased usage of these items; however, it should be noted that the absolute incidence of injury in youth baseball is low and that these equipment items do not prevent all injuries.	Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Orthoped, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; Little League Baseball Inc, Williamsport, PA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Marshall, SW (corresponding author), Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Injury Prevent Res Ctr, CB 7435 McGavran Greenberg Hall, Chapel Hill, NC 27599 USA.	smarshall@unc.edu	Yang, Jingzhen/N-4786-2014	Marshall, Stephen/0000-0002-2664-9233				Andrews JR, 1998, J ORTHOP SPORT PHYS, V27, P187, DOI 10.2519/jospt.1998.27.3.187; *BAS SOFTB COUNC, 1996, BAS REP PART AM NAT; Bryk A. S., 1992, HIERARCHICAL LINEAR, P1; Burns, 1994, BASEBALL ILLUSTRATED; Crisco JJ, 1997, MED SCI SPORT EXER, V29, P26, DOI 10.1097/00005768-199701000-00005; Danis R P, 2000, Inj Prev, V6, P232, DOI 10.1136/ip.6.3.232; Greenland S, 1983, Stat Med, V2, P243, DOI 10.1002/sim.4780020219; GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P350; HALE CJ, 1979, PHYSICIAN SPORTSMED, V7, P58; HART EJ, 1992, PEDIATRICS, V89, P520; HODGSON V, 1993, COMPARISON EFFECT RI; JANDA DH, 1988, JAMA-J AM MED ASSOC, V259, P1848, DOI 10.1001/jama.259.12.1848; Janda DH, 1998, J TRAUMA, V44, P298, DOI 10.1097/00005373-199802000-00011; KYLE SB, 1996, CONS PROD SAF COMM Y; LANGFORD IH, 2001, WILEY SER PROB STAT, P45; Link MS, 2002, PEDIATRICS, V109, P873, DOI 10.1542/peds.109.5.873; Link MS, 1998, NEW ENGL J MED, V338, P1805, DOI 10.1056/NEJM199806183382504; MANTEL N, 1959, J NATL CANCER I, V22, P719; MCCULLOCH CE, 2001, GEN LINEAR MIXED MOD, P223; MORGENSTERN H, 2000, ENCY EPIDEMIOLOGIC M, P315; MORGENSTERN H, 1998, MODERN EPIDEMIOLOGY, P459; Mueller FO, 2001, PHYSICIAN SPORTSMED, V29, P41, DOI 10.3810/psm.2001.07.874; MUELLER FO, 1998, SURVEY SAFETY EQUIPM; Pasternack JS, 1996, PEDIATRICS, V98, P445; RADER BG, 1992, BASEBALL HIST AM GAM; ROBINS J, 1986, AM J EPIDEMIOL, V124, P719, DOI 10.1093/oxfordjournals.aje.a114447; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; Rothman K.J., 1998, MODERN EPIDEMIOLOGY, Vsecond, P329; SENDRE RA, 1994, AM J SPORT MED, V22, P450, DOI 10.1177/036354659402200403; VIANO DC, 1993, CLIN J SPORT MED, V4, P217; Vinger PF, 1999, ARCH OPHTHALMOL-CHIC, V117, P354, DOI 10.1001/archopht.117.3.354; VINGER PF, 1996, INT S SAF BAS SOFTB; Washington RL, 2001, PEDIATRICS, V107, P782, DOI 10.1542/peds.107.4.782; Yen KL, 2000, PEDIATR EMERG CARE, V16, P215, DOI 10.1097/00006565-200006000-00021	34	42	42	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2003	289	5					568	574		10.1001/jama.289.5.568	http://dx.doi.org/10.1001/jama.289.5.568			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CV	12578489	Bronze			2022-12-28	WOS:000180787500027
J	Palmer, K; Backman, L; Winblad, B; Fratiglioni, L				Palmer, K; Backman, L; Winblad, B; Fratiglioni, L			Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							MILD COGNITIVE IMPAIRMENT; OLD ADULTS; SAMPLE; PREDICT; WILL; AD	Objectives To evaluate a simple three step procedure to identify people in the general population who are in the preclinical phase of Alzheimer's disease and dementia. Design Three year population based cohort study. Setting Kunasholmen cohort, Stockholm, Sweden. Participants 1435 people aged 75-95 years without dementia. Assessments Single question asking about memory complaints, assessment by mini-mental state examination, and neuropsychological testing. Main outcome measure Alzheimer's disease and dementia at three year follow up. Results None of the three instruments was sufficiently predictive of Alzheimer's disease and dementia when administered separately. After participants had been screened for memory complaints and global cognitive impairment, specific tests of word recall and verbal fluency had positive predictive values for dementia of 85-100% (95% confidence interval range from 62% to 100%). However, only 18% of future dementia cases were identified in the preclinical phase by this three step procedure. Memory complaints were the most sensitive indicator of Alzheimer's disease and dementia in the whole population, but only half the future dementia cases reported memory problems three years before diagnosis. Conclusion This three step procedure, which simulates what might occur in clinical practice, has a high positive predictive value for dementia, although only a small number of future cases can be identified.	Karolinska Inst, Aging Res Ctr, Div Geriatr Epidemiol & Med, S-11382 Stockholm, Sweden; Stockholm Gerontol Res Ctr, S-11382 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Palmer, K (corresponding author), Karolinska Inst, Aging Res Ctr, Div Geriatr Epidemiol & Med, Box 6401, S-11382 Stockholm, Sweden.		Palmer, Katie/A-1430-2016	Palmer, Katie/0000-0001-8783-016X				Andreasen N, 2001, ARCH NEUROL-CHICAGO, V58, P373, DOI 10.1001/archneur.58.3.373; BACKMAN L, 1994, J ABNORM PSYCHOL, V103, P361; BACKMAN L, IN PRESS NEW FRONTIE; BACKMAN L, NEW FRONTIERS COGNIT; Berger AK, 1999, NEUROLOGY, V53, P1998, DOI 10.1212/WNL.53.9.1998; Bozoki A, 2001, ARCH NEUROL-CHICAGO, V58, P411, DOI 10.1001/archneur.58.3.411; Chen P, 2000, NEUROLOGY, V55, P1847, DOI 10.1212/WNL.55.12.1847; CHRISTENSEN AL, 1984, LURIAS NEUROPSYCHOLO; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRATIGLIONI L, 1991, NEUROLOGY, V41, P1886, DOI 10.1212/WNL.41.12.1886; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Hogan DB, 2000, CAN J NEUROL SCI, V27, P18, DOI 10.1017/S0317167100051921; Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; Levy R, 1994, Int Psychogeriatr, V6, P63, DOI 10.1017/S1041610294001626; Neri M, 1998, DEMENT GERIATR COGN, V9, P56, DOI 10.1159/000017023; Palmer K, 2002, AM J PSYCHIAT, V159, P436, DOI 10.1176/appi.ajp.159.3.436; Petersen R C, 2000, Neurologia, V15, P93; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Ritchie K, 2001, NEUROLOGY, V56, P37, DOI 10.1212/WNL.56.1.37; Ritchie K, 2000, COMPR PSYCHIAT, V41, P61, DOI 10.1016/S0010-440X(00)80010-3; Small BJ, 1997, PSYCHOL AGING, V12, P309, DOI 10.1037/0882-7974.12.2.309; Small BJ, 2000, ARCH NEUROL-CHICAGO, V57, P839, DOI 10.1001/archneur.57.6.839; Wechsler D., 2010, WAIS R MANUAL, VUK 4th Edn	25	117	123	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					245	247		10.1136/bmj.326.7383.245	http://dx.doi.org/10.1136/bmj.326.7383.245			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	644FY	12560271	Bronze, Green Published			2022-12-28	WOS:000180908300014
J	Smith, O				Smith, O			Weathering the big chill	SCIENCE			English	Editorial Material																		Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; HOFFMEISTER KM, 2002, BLOOD, V100	2	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					530	530		10.1126/science.299.5606.530	http://dx.doi.org/10.1126/science.299.5606.530			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543964				2022-12-28	WOS:000180559800037
J	McCarty, M				McCarty, M			Discovering genes are made of DNA	NATURE			English	Article								Maclyn McCarty is the sole surviving member of the team that made the remarkable discovery that DNA is the material of inheritance. This preceded by a decade the discovery of the structure of DNA itself. Here he shares his personal perspective of those times and the impact of the double helix.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	McCarty, M (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.							Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; MCCARTY M, 1946, J GEN PHYSIOL, V29, P123, DOI 10.1085/jgp.29.3.123; MCCARTY M, 1946, J EXP MED, V83, P89, DOI 10.1084/jem.83.2.89	3	10	12	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					406	406		10.1038/nature01398	http://dx.doi.org/10.1038/nature01398			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540908	Bronze			2022-12-28	WOS:000180533000049
J	Woywodt, A; Streiber, F; de Groot, K; Regelsberger, H; Haller, H; Haubitz, M				Woywodt, A; Streiber, F; de Groot, K; Regelsberger, H; Haller, H; Haubitz, M			Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis	LANCET			English	Article							TISSUE FACTOR; WEGENERS-GRANULOMATOSIS; ANTIBODY; PROTEINASE-3; EXPRESSION; INDUCTION	Background Histological findings in small-vessel vasculitis associated with antineutrophil cytoplasmic antibodies (ANCAs) suggest that damaged endothelial cells undergo necrosis and detachment from the basement membrane. We postulated that isolation of these cells from peripheral blood might provide a novel marker of the disease and elucidate pathogenetic events. Methods 18 patients with active ANCA-associated vasculitis, 20 patients in remission, 20 healthy controls, 12 patients with infection, and 12 patients with glomerular disease not associated with ANCA were studied. Endothelial cells were isolated from peripheral blood by use of Dynabeads coated with antibodies against CD146, and were stained for von Willebrand factor (vWF), CD31, and Ulex Europaeus lectin 1 (UEA-1). Tissue-factor immunocytochemistry and assays for markers of apoptosis and necrosis were also done. Findings Few circulating endothelial cells were seen in healthy controls (0-20 cells/mL, median 5 cells/mL), patients with infection (0-16 cells/mL, median 8 cells/mL), and patients with non-ANCA glomerulonephritis (0-21 cells/mL, median 4 cells/mL). By contrast, large numbers of circulating endothelial cells were detected in patients with active vasculitis (20-5700 cells/mL, median 136 cells/mL, p<0.0001 when compared with healthy controls). Cell numbers fell substantially during 6 months of successful immunosuppressive treatment among those with active disease. Patients in remission had moderately raised cell numbers (0.60 cells/mL, median 16 cells/mL). 84% of cells obtained from patients with active disease stained positive for annexin/propidium iodide and 86% stained tissue factor positive, indicating a necrotic and procoagulant phenotype. Interpretation Circulating endothelial cells are a novel marker of active ANCA-associated small-vessel vasculitis. The clinical use of this tool and the pathogenic mechanisms leading to these findings require further investigation.	Hannover Med Sch, Dept Med, Div Nephrol, D-30625 Hannover, Germany	Hannover Medical School	Woywodt, A (corresponding author), Hannover Med Sch, Dept Med, Div Nephrol, D-30625 Hannover, Germany.	Woywodt.Alexander@MH-Hannover.de	Woywodt, Alexander/ABD-2711-2020	Woywodt, Alexander/0000-0002-3825-6955				Bardin N, 1996, TISSUE ANTIGENS, V48, P531, DOI 10.1111/j.1399-0039.1996.tb02666.x; Barker RN, 2002, CLIN EXP IMMUNOL, V127, P220, DOI 10.1046/j.1365-2249.2002.01774.x; Bombeli T, 1997, BLOOD, V89, P2429, DOI 10.1182/blood.V89.7.2429; BOUVIER CA, 1970, THROMB DIATH HAEMOST, P163; Contrino J, 1997, CIRCULATION, V96, P605; DAGATI V, 1986, AM J KIDNEY DIS, V7, P95, DOI 10.1016/S0272-6386(86)80062-2; DAVIES DJ, 1982, BMJ-BRIT MED J, V285, P606, DOI 10.1136/bmj.285.6342.606; Dignat-George F, 2000, EUR J HAEMATOL, V65, P215, DOI 10.1034/j.1600-0609.2000.065004215.x; Girard T, 2001, RHEUMATOLOGY, V40, P147, DOI 10.1093/rheumatology/40.2.147; Gobel U, 1996, AM J KIDNEY DIS, V28, P186, DOI 10.1016/S0272-6386(96)90300-5; Haubitz M, 2001, CLIN EXP IMMUNOL, V126, P584, DOI 10.1046/j.1365-2249.2001.01587.x; Hergesell O, 1996, THROMB HAEMOSTASIS, V75, P892; Jennette JC, 1997, NEW ENGL J MED, V337, P1512, DOI 10.1056/NEJM199711203372106; Jennette JC, 1998, HEPTINSTALLSPATHOLOG, P1059; KERR GS, 1993, ARTHRITIS RHEUM, V36, P365, DOI 10.1002/art.1780360312; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; LUQMANI RA, 1994, Q J MED, V87, P671; MOLL T, 1995, J BIOL CHEM, V270, P3849, DOI 10.1074/jbc.270.8.3849; Mutin M, 1999, BLOOD, V93, P2951; Pendergraft WF, 2000, KIDNEY INT, V57, P1981, DOI 10.1046/j.1523-1755.2000.00048.x; Preston GA, 2001, KIDNEY INT, V59, P1981, DOI 10.1046/j.1523-1755.2001.0590051981.x; SBARBATI R, 1991, BLOOD, V77, P764; Semeraro N, 1997, THROMB HAEMOSTASIS, V78, P759; Sibelius U, 1998, J EXP MED, V187, P497, DOI 10.1084/jem.187.4.497; Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203	25	244	264	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2003	361	9353					206	210		10.1016/S0140-6736(03)12269-6	http://dx.doi.org/10.1016/S0140-6736(03)12269-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547543				2022-12-28	WOS:000180535400009
J	Alexander, EK; Hurwitz, S; Heering, JP; Benson, CB; Frates, MC; Doubilet, PM; Cibas, ES; Larsen, PR; Marqusee, E				Alexander, EK; Hurwitz, S; Heering, JP; Benson, CB; Frates, MC; Doubilet, PM; Cibas, ES; Larsen, PR; Marqusee, E			Natural history of benign solid and cystic thyroid nodules	ANNALS OF INTERNAL MEDICINE			English	Article							TERM FOLLOW-UP; SUPPRESSIVE THERAPY; LEVOTHYROXINE; ULTRASOUND; THYROXINE; GOITER	Background: Thyroid nodules are common and most often benign. The natural history of benign thyroid nodules, however, is unclear. Objective: To determine the natural history of cytologically benign thyroid nodules using ultrasonography. Design: Retrospective case series. Setting: Single tertiary care clinic. Participants: All patients referred to the Brigham and Women's Hospital Thyroid Nodule Clinic, Boston, Massachusetts, who had benign cytologic results on ultrasonography-guided fine-needle aspiration of a thyroid nodule between 1995 and 2000 and returned for a requested follow-up examination 1 month to 5 years later. Measurements: Nodule dimensions were measured at both visits, and growth was defined as an increase in calculated volume of 15% or greater. These results were correlated with the time between examinations, age, sex, baseline serum thyroid-stimulating hormone concentration, and cystic content of each nodule. Results: Nodule volume increased over time (P < 0.001). The estimated proportion of nodules with an increase in volume of 15% or greater after 5 years was 89%. Nodules with greater cystic content were less likely to grow than solid nodules (P = 0.01). Seventy-four of the 330 nodules were reaspirated on the second visit. Despite an average increase in volume of 69%, only 1 of 74 reaspirated nodules was malignant. Conclusion: Most solid, benign thyroid nodules grow. Therefore, an increase in nodule volume alone is not a reliable predictor of malignancy.	Brigham & Womens Hosp, Div Endocrine, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Alexander, EK (corresponding author), Brigham & Womens Hosp, Div Endocrine, 221 Longwood Ave,2nd Floor, Boston, MA 02115 USA.	ekalexander@partners.org	Doubilet, Peter/AAY-7351-2021		NHLBI NIH HHS [HL-07609] Funding Source: Medline; NIDDK NIH HHS [DK-07529] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007529] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERGHOUT A, 1990, LANCET, V336, P193, DOI 10.1016/0140-6736(90)91730-X; BRANDER A, 1992, J CLIN ULTRASOUND, V20, P37, DOI 10.1002/jcu.1870200107; Brander AEE, 2000, RADIOLOGY, V215, P801, DOI 10.1148/radiology.215.3.r00jn07801; BRUNN J, 1981, DEUT MED WOCHENSCHR, V106, P1338, DOI 10.1055/s-2008-1070506; CHEUNG PSY, 1989, WORLD J SURG, V13, P818, DOI 10.1007/BF01658447; Danese D, 1998, THYROID, V8, P15, DOI 10.1089/thy.1998.8.15; Daniels Gilbert H., 1996, Comprehensive Therapy, V22, P239; Erdogan MF, 1998, THYROID, V8, P1087, DOI 10.1089/thy.1998.8.1087; GHARIB H, 1987, NEW ENGL J MED, V317, P70, DOI 10.1056/NEJM198707093170202; GRANT CS, 1989, SURGERY, V106, P980; KUMA K, 1994, WORLD J SURG, V18, P495, DOI 10.1007/BF00353745; KUMA K, 1992, WORLD J SURG, V16, P583, DOI 10.1007/BF02067327; LAROSA GL, 1995, ANN INTERN MED, V122, P1, DOI 10.7326/0003-4819-122-1-199501010-00001; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MAZZAFERRI EL, 1993, NEW ENGL J MED, V328, P553; Papini E, 1998, J CLIN ENDOCR METAB, V83, P780, DOI 10.1210/jc.83.3.780; REVERTER JL, 1992, CLIN ENDOCRINOL, V36, P25, DOI 10.1111/j.1365-2265.1992.tb02898.x; RIDGWAY EC, 2000, WERNER INGBARS THYRO, P949; Singer PA, 1996, ARCH INTERN MED, V156, P2165, DOI 10.1001/archinte.156.19.2165; TANNIRANDORN P, 2001, 83 M END SOC DENV CO	20	191	204	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2003	138	4					315	318		10.7326/0003-4819-138-4-200302180-00010	http://dx.doi.org/10.7326/0003-4819-138-4-200302180-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DK	12585829				2022-12-28	WOS:000181019400005
J	MacKie, RM; Bray, CA; Leman, JA				MacKie, RM; Bray, CA; Leman, JA			Effect of public education aimed at early diagnosis of malignant melanoma: cohort comparison study	BRITISH MEDICAL JOURNAL			English	Article							CAMPAIGN		Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland; Greater Glasgow NHS Board, Glasgow G3 8YZ, Lanark, Scotland; Western Infirm & Associated Hosp, Dept Dermatol, Glasgow G11 6NU, Lanark, Scotland	University of Glasgow	MacKie, RM (corresponding author), Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland.		Kelly, Caroline/AAZ-4146-2021	Kelly, Caroline/0000-0002-5330-7888				DOHERTY VR, 1986, BRIT MED J, V292, P987, DOI 10.1136/bmj.292.6526.987; DOHERTY VR, 1988, BRIT MED J, V297, P388, DOI 10.1136/bmj.297.6645.388; MacKie RM, 2002, LANCET, V360, P587, DOI 10.1016/S0140-6736(02)09779-9; MACKIE RM, 1992, BRIT MED J, V304, P1012, DOI 10.1136/bmj.304.6833.1012; WHITEHEAD SM, 1989, BRIT J CANCER, V60, P421, DOI 10.1038/bjc.1989.298	5	20	20	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2003	326	7385					367	367		10.1136/bmj.326.7385.367	http://dx.doi.org/10.1136/bmj.326.7385.367			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648RZ	12586670	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000181165500020
J	Rymer, J; Wilson, R; Ballard, K				Rymer, J; Wilson, R; Ballard, K			Making decisions about hormone replacement therapy	BRITISH MEDICAL JOURNAL			English	Review							CORONARY HEART-DISEASE; POSTMENOPAUSAL WOMEN; ENDOMETRIAL CANCER; VENOUS THROMBOEMBOLISM; ESTROGEN REPLACEMENT; RISK; METAANALYSIS; POPULATION; PREVENTION; MENOPAUSE		Guys & St Thomas Hosp Trust, Guys Kings & St Thomass Sch Med, London SE1 7EH, England; Queens Univ, Dept Family Med, Kingston, ON, Canada; Univ London Kings Coll, Guys Kings & St Thomass Sch Med, Dept Gen & Primary Care, London SE11 6SP, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Queens University - Canada; University of London; King's College London	Rymer, J (corresponding author), St Thomas Hosp, Dept Obstet & Gynaecol, London SE1 7EH, England.							ABRAHAM S, 1995, MATURITAS, V21, P91, DOI 10.1016/0378-5122(94)00881-7; Avis NE, 2001, SOC SCI MED, V52, P345, DOI 10.1016/S0277-9536(00)00147-7; Ballard K, 2002, BRIT J GEN PRACT, V52, P835; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Beresford SAA, 1997, LANCET, V349, P458, DOI 10.1016/S0140-6736(96)07365-5; Cooper C, 1996, OSTEOPOROSIS NEW PER, P1; Daly E, 1996, LANCET, V348, P977, DOI 10.1016/S0140-6736(96)07113-9; ERIKSEN PS, 1992, EUR J OBSTET GYN R B, V44, P137, DOI 10.1016/0028-2243(92)90059-8; Fletcher SW, 2002, JAMA-J AM MED ASSOC, V288, P366, DOI 10.1001/jama.288.3.366; Gold EB, 2000, AM J EPIDEMIOL, V152, P463, DOI 10.1093/aje/152.5.463; Grady D, 2000, ANN INTERN MED, V132, P689, DOI 10.7326/0003-4819-132-9-200005020-00002; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; GRADY D, 1995, OBSTET GYNECOL, V85, P304, DOI 10.1016/0029-7844(94)00383-O; Griffiths F, 1999, SOC SCI MED, V49, P469, DOI 10.1016/S0277-9536(99)00141-0; Grodstein F, 1999, AM J MED, V106, P574, DOI 10.1016/S0002-9343(99)00063-7; GRODSTEIN F, 1995, PROG CARDIOVASC DIS, V38, P199, DOI 10.1016/S0033-0620(95)80012-3; Hulley S, 2002, JAMA-J AM MED ASSOC, V288, P58, DOI 10.1001/jama.288.1.58; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Hunter MS, 1997, SOC SCI MED, V45, P1541, DOI 10.1016/S0277-9536(97)00091-9; Hunter MS, 1999, MATURITAS, V33, P37, DOI 10.1016/S0378-5122(99)00041-9; Jick H, 1996, LANCET, V348, P981, DOI 10.1016/S0140-6736(96)07114-0; Kuh D, 2000, BRIT J OBSTET GYNAEC, V107, P731, DOI 10.1111/j.1471-0528.2000.tb13333.x; Kuh DL, 1997, BRIT J OBSTET GYNAEC, V104, P923, DOI 10.1111/j.1471-0528.1997.tb14352.x; Lacey JV, 2002, JAMA-J AM MED ASSOC, V288, P334, DOI 10.1001/jama.288.3.334; Lock M, 1994, ENCOUNTERS AGEING MY; Porter M, 1996, BRIT J OBSTET GYNAEC, V103, P1025, DOI 10.1111/j.1471-0528.1996.tb09555.x; Raudaskoski T, 2002, BJOG-INT J OBSTET GY, V109, P136, DOI 10.1016/S1470-0328(02)01167-9; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; RYMER J, 2002, BRIT MED J, V321, P1516; Sturdee DW, 2000, BRIT J OBSTET GYNAEC, V107, P1392, DOI 10.1111/j.1471-0528.2000.tb11654.x; Torgerson DJ, 2001, JAMA-J AM MED ASSOC, V285, P2891, DOI 10.1001/jama.285.22.2891; Weiderpass E, 1999, J NATL CANCER I, V91, P1131, DOI 10.1093/jnci/91.13.1131; Wells M, 2002, BMJ-BRIT MED J, V325, P239, DOI 10.1136/bmj.325.7358.239; ZETHRACUS N, 1999, BRIT J OBSTET GYNAEC, V104, P1191	34	62	63	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2003	326	7384					322	326		10.1136/bmj.326.7384.322	http://dx.doi.org/10.1136/bmj.326.7384.322			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645UD	12574048	Green Published			2022-12-28	WOS:000180997000022
J	Sherman, SI				Sherman, SI			Thyroid carcinoma	LANCET			English	Review							FINE-NEEDLE-ASPIRATION; ENDOCRINE NEOPLASIA TYPE-2; RECOMBINANT HUMAN TSH; QUALITY-OF-LIFE; PROGNOSTIC-FACTORS; SERUM THYROGLOBULIN; RADIOACTIVE IODINE; FOLLOW-UP; MULTIVARIATE-ANALYSIS; ANAPLASTIC CARCINOMA	Thyroid carcinomas are fairly uncommon and include disease types that range from indolent localised papillary carcinomas to the fulminant and lethal anaplastic disease. Several attempts to formulate a consensus about treatment of thyroid carcinoma have resulted in published guidelines for diagnosis and initial disease management. Multimodality treatments are widely recommended, although there is little evidence from prospective trials to support this approach. Surgical resection to achieve local disease control remains the cornerstone of primary treatment for most thyroid cancers, and is often followed by adjuvant radioiodine treatment for papillary and follicular types of disease. Thyroid hormone replacement therapy is used not only to rectify postsurgical hypothyroidism, but also because there is evidence to suggest that high doses that suppress thyroid stimulating hormone prevent disease recurrence in patients with papillary or follicular carcinomas. Treatment for progressive metastatic disease is often of limited benefit, and there is a pressing need for novel approaches in treatment of patients at high risk of disease-related death. In families with inherited thyroid cancer syndromes, early diagnosis and intervention based on genetic testing might prevent poor disease outcomes. Care should be carefully coordinated by members of an experienced multidisciplinary team, and patients should be provided with education about diagnosis, prognosis, and treatment options to allow them to make informed contributions to decisions about their care.	Univ Texas, MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Sherman, SI (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, 1515 Holcombe Blvd, Houston, TX 77030 USA.	sisherma@mdanderson.org	Weber, Theresia/H-2436-2013; Lamonica, Dominick/W-3229-2019; Kloos, Richard/Q-9963-2019	Sherman, Steven/0000-0002-3079-5153				ABDELMOUMENE N, 1994, BRIT J CANCER, V69, P1141, DOI 10.1038/bjc.1994.224; Ain KB, 2000, THYROID, V10, P587, DOI 10.1089/thy.2000.10.587; Alsanea O, 2000, SURGERY, V128, P1043, DOI 10.1067/msy.2000.110848; ANTONELLI A, 1995, THYROID, V5, P25, DOI 10.1089/thy.1995.5.25; *ASS DIR AN SURG P, 2000, AM J CLIN PATHOL, V11, P684; Bal C, 1996, CANCER, V77, P2574, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2574::AID-CNCR22>3.0.CO;2-O; Ball Douglas W., 1996, P946; Baloch ZW, 2002, DIAGN CYTOPATHOL, V26, P41, DOI 10.1002/dc.10043; Bartolazzi A, 2001, LANCET, V357, P1644, DOI 10.1016/S0140-6736(00)04817-0; Bauer DC, 2001, ANN INTERN MED, V134, P561, DOI 10.7326/0003-4819-134-7-200104030-00009; BEIERWALTES WH, 1982, J NUCL MED, V23, P561; BEIERWALTES WH, 1984, J NUCL MED, V25, P1287; Bennedbaek FN, 1999, CLIN ENDOCRINOL, V50, P357, DOI 10.1046/j.1365-2265.1999.00663.x; Bernier MO, 2001, J CLIN ENDOCR METAB, V86, P1568, DOI 10.1210/jc.86.4.1568; Bin OY, 2002, CLIN ENDOCRINOL, V56, P341, DOI 10.1046/j.1365-2265.2002.01475.x; Biondi B, 2000, J CLIN ENDOCR METAB, V85, P4701, DOI 10.1210/jc.85.12.4701; Brandi ML, 2001, J CLIN ENDOCR METAB, V86, P5658, DOI 10.1210/jc.86.12.5658; Brierley J, 1996, THYROID, V6, P305, DOI 10.1089/thy.1996.6.305; Brierley J, 1998, ENDOCRIN UPDAT, V2, P285; Brierley JD, 1997, CANCER, V79, P2414; Brierley JD, 1999, SEMIN SURG ONCOL, V16, P42, DOI 10.1002/(SICI)1098-2388(199901/02)16:1<42::AID-SSU8>3.0.CO;2-4; British Thyroid Association & Royal College of Physicians, 2002, GUID MAN THYR CANC A; Burguera B, 2000, ENDOCRIN METAB CLIN, V29, P187, DOI 10.1016/S0889-8529(05)70123-7; Burman KD, 1996, ENDOCRIN METAB CLIN, V25, P49, DOI 10.1016/S0889-8529(05)70312-1; BYAR DP, 1979, EUR J CANCER, V15, P1033, DOI 10.1016/0014-2964(79)90291-3; Cady B, 1998, Surg Oncol Clin N Am, V7, P633; CADY B, 1988, SURGERY, V104, P947; Cases JA, 2000, SEMIN NUCL MED, V30, P81, DOI 10.1053/nm.2000.4598; CATZ B, 1959, CANCER, V12, P371, DOI 10.1002/1097-0142(195903/04)12:2<371::AID-CNCR2820120221>3.0.CO;2-P; Ceccarelli C, 2001, J CLIN ENDOCR METAB, V86, P3512, DOI 10.1210/jc.86.8.3512; Chen AY, 2001, CANCER-AM CANCER SOC, V92, P225, DOI 10.1002/1097-0142(20010715)92:2<225::AID-CNCR1313>3.0.CO;2-B; Chi D D, 1998, Surg Oncol Clin N Am, V7, P681; Chiu AC, 1997, J CLIN ENDOCR METAB, V82, P3637, DOI 10.1210/jc.82.11.3637; Cooper DS, 1998, THYROID, V8, P737, DOI 10.1089/thy.1998.8.737; Cramer H, 2000, CANCER CYTOPATHOL, V90, P325, DOI 10.1002/1097-0142(20001225)90:6<325::AID-CNCR1>3.0.CO;2-U; DEGROOT LJ, 1994, WORLD J SURG, V18, P123, DOI 10.1007/BF00348202; DEGROOT LJ, 1990, J CLIN ENDOCR METAB, V71, P414, DOI 10.1210/jcem-71-2-414; deVathaire F, 1997, BRIT J CANCER, V75, P734, DOI 10.1038/bjc.1997.130; DINNEEN SF, 1995, J CLIN ENDOCR METAB, V80, P2041, DOI 10.1210/jc.80.7.2041; Dottorini ME, 1996, CANCER, V77, P1556, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1556::AID-CNCR20>3.0.CO;2-Y; Elisei R, 1998, CANCER, V83, P2185, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2185::AID-CNCR18>3.0.CO;2-4; Evans DB, 1999, SEMIN SURG ONCOL, V16, P50; EZZAT S, 1994, ARCH INTERN MED, V154, P1838; Fagin J., 1998, THYROID CANC; Farahati J, 1996, CANCER, V77, P172, DOI 10.1002/(SICI)1097-0142(19960101)77:1<172::AID-CNCR28>3.0.CO;2-1; FIGGE J, 1999, THYROID CANC COMPREH, P85; Fleming JB, 1999, ANN SURG, V230, P697, DOI 10.1097/00000658-199911000-00013; Franceschi M, 1996, J NUCL MED, V37, P446; Freyer G, 2001, ANN ONCOL, V12, P1461, DOI 10.1023/A:1012593410510; Frilling A, 2000, SURGERY, V128, P1067, DOI 10.1067/msy.2000.110771; Fugazzola L., 1994, International Journal of Biological Markers, V9, P21; Furhang EE, 1999, J NUCL MED, V40, P131; Gagel RF, 1998, ENDOCRIN UPDAT, V2, P85; GHARIB H, 1993, ANN INTERN MED, V118, P282, DOI 10.7326/0003-4819-118-4-199302150-00007; Gillenwater AM, 1999, SEMIN SURG ONCOL, V16, P19, DOI 10.1002/(SICI)1098-2388(199901/02)16:1<19::AID-SSU5>3.0.CO;2-W; Gilliland FD, 1997, CANCER-AM CANCER SOC, V79, P564, DOI 10.1002/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO;2-0; GOLDMAN JM, 1980, J CLIN ENDOCR METAB, V50, P734, DOI 10.1210/jcem-50-4-734; GRANT CS, 1995, SURG CLIN N AM, V75, P395, DOI 10.1016/S0039-6109(16)46629-6; Grebe S K, 1996, Surg Oncol Clin N Am, V5, P43; Grigsby PW, 1999, CANCER, V85, P945, DOI 10.1002/(SICI)1097-0142(19990215)85:4<945::AID-CNCR24>3.0.CO;2-I; Hahm JR, 2001, THYROID, V11, P73, DOI 10.1089/10507250150500694; Haigh PI, 2001, CANCER-AM CANCER SOC, V91, P2335, DOI 10.1002/1097-0142(20010615)91:12<2335::AID-CNCR1266>3.3.CO;2-T; Hansford JR, 2000, J MED GENET, V37, P817, DOI 10.1136/jmg.37.11.817; Haugen BR, 1999, SEMIN SURG ONCOL, V16, P34, DOI 10.1002/(SICI)1098-2388(199901/02)16:1<34::AID-SSU7>3.0.CO;2-2; Haugen BR, 1999, J CLIN ENDOCR METAB, V84, P3877, DOI 10.1210/jc.84.11.3877; Hay ID, 1998, SURGERY, V124, P958, DOI 10.1067/msy.1998.91825; HAY ID, 1993, SURGERY, V114, P1050; HAY ID, 1987, SURGERY, V102, P1088; Hermanek P, 1992, TNM CLASSIFICATION M; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Horvit PK, 1997, J CLIN ENDOCR METAB, V82, P335, DOI 10.1210/jc.82.2.335; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Hyer SL, 2000, EUR J SURG ONCOL, V26, P686, DOI 10.1053/ejso.2000.0981; JUNOR EJ, 1992, EUR J SURG ONCOL, V18, P83; KATOH R, 1992, CANCER-AM CANCER SOC, V70, P1585, DOI 10.1002/1097-0142(19920915)70:6<1585::AID-CNCR2820700623>3.0.CO;2-Z; KIM JH, 1987, CANCER, V60, P2372, DOI 10.1002/1097-0142(19871115)60:10<2372::AID-CNCR2820601004>3.0.CO;2-1; Krisnamurthy S, 2001, CANCER CYTOPATHOL, V93, P199, DOI 10.1002/cncr.9029; Kroll TG, 2000, SCIENCE, V289, P1357, DOI 10.1126/science.289.5483.1357; Kumar H, 2001, CLIN ENDOCRINOL, V54, P719, DOI 10.1046/j.1365-2265.2001.01288.x; Ladenson PW, 1999, THYROID, V9, P429, DOI 10.1089/thy.1999.9.429; LAKSHMANAN M, 1988, CLIN NUCL MED, V13, P866, DOI 10.1097/00003072-198812000-00003; LOGUE JP, 1994, BRIT J RADIOL, V67, P1127, DOI 10.1259/0007-1285-67-803-1127; Machens A, 2001, J CLIN ENDOCR METAB, V86, P1104, DOI 10.1210/jc.86.3.1104; MALDONADO MR, 1999, 72 ANN M AM THYR ASS; Mandel SJ, 2001, CLIN NUCL MED, V26, P6, DOI 10.1097/00003072-200101000-00002; MARIOTTI S, 1995, J CLIN ENDOCR METAB, V80, P468, DOI 10.1210/jc.80.2.468; MAXON HR, 1992, J NUCL MED, V33, P1132; Maxon HR, 1997, THYROID, V7, P183, DOI 10.1089/thy.1997.7.183; MAXON HR, 1990, ENDOCRIN METAB CLIN, V19, P685, DOI 10.1016/S0889-8529(18)30317-7; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; Mazzaferri EL, 2002, J CLIN ENDOCR METAB, V87, P1490, DOI 10.1210/jc.87.4.1490; McIver B, 2001, SURGERY, V130, P1028, DOI 10.1067/msy.2001.118266; McKay JD, 2001, AM J HUM GENET, V69, P440, DOI 10.1086/321979; *MIN FJA, 2002, MOL ENDOCRINOL, V16, P903; Moley JF, 1998, J INTERN MED, V243, P521; Moretti F, 1997, ONCOGENE, V14, P729, DOI 10.1038/sj.onc.1200887; MULLERGARTNER HW, 1988, CANCER, V61, P976, DOI 10.1002/1097-0142(19880301)61:5<976::AID-CNCR2820610520>3.0.CO;2-U; Muratet JP, 1998, J NUCL MED, V39, P1546; Musholt TJ, 2000, WORLD J SURG, V24, P1409, DOI 10.1007/s002680010233; Niccoli-Sire P, 2001, J CLIN ENDOCR METAB, V86, P3746, DOI 10.1210/jc.86.8.3746; NIEDERLE B, 1986, SURGERY, V100, P1088; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; ORIORDAIN DS, 1994, SURGERY, V116, P1017; Orlandi F, 2001, ENDOCR-RELAT CANCER, V8, P135, DOI 10.1677/erc.0.0080135; OZATA M, 1994, J CLIN ENDOCR METAB, V79, P98, DOI 10.1210/jc.79.1.98; PACINI F, 1994, J NUCL MED, V35, P1418; Pacini F, 1997, J CLIN ENDOCR METAB, V82, P3563, DOI 10.1210/jc.82.11.3563; PACINI F, 1991, AM J CLIN PATHOL, V95, P300, DOI 10.1093/ajcp/95.3.300; Pacini F., 1999, Journal of Endocrinological Investigation, V22, P25; Passler C, 1999, LANGENBECK ARCH SURG, V384, P284, DOI 10.1007/s004230050205; Pierie JPEN, 2002, ANN SURG ONCOL, V9, P57, DOI 10.1245/aso.2002.9.1.57; PONDER BAJ, 1988, LANCET, V1, P397; Pujol P, 1996, J CLIN ENDOCR METAB, V81, P4318, DOI 10.1210/jc.81.12.4318; Ravetto C, 2000, CANCER CYTOPATHOL, V90, P357, DOI 10.1002/1097-0142(20001225)90:6<357::AID-CNCR6>3.0.CO;2-4; Redding AH, 2000, THYROID, V10, P919, DOI 10.1089/thy.2000.10.919; Reynolds JC, 1997, THYROID, V7, P281, DOI 10.1089/thy.1997.7.281; Ringel MD, 1998, J CLIN ENDOCR METAB, V83, P4435, DOI 10.1210/jc.83.12.4435; Roach JC, 2002, ARCH OTOLARYNGOL, V128, P263, DOI 10.1001/archotol.128.3.263; SAAD MF, 1983, J CLIN ENDOCR METAB, V57, P124, DOI 10.1210/jcem-57-1-124; SAAD MF, 1984, MEDICINE, V63, P319, DOI 10.1097/00005792-198411000-00001; Saavedra HI, 2000, ONCOGENE, V19, P3948, DOI 10.1038/sj.onc.1203723; SAMAAN NA, 1992, J CLIN ENDOCR METAB, V75, P714, DOI 10.1210/jc.75.3.714; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; SCHLUMBERGER M, 1986, J CLIN ENDOCR METAB, V63, P960; Schlumberger M, 1998, EUR J ENDOCRINOL, V138, P249, DOI 10.1530/eje.0.1380249; Schlumberger M, 2000, EUR J ENDOCRINOL, V143, P557, DOI 10.1530/eje.0.1430557; Scopsi L, 1996, CANCER, V78, P2173, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2173::AID-CNCR20>3.0.CO;2-V; Shaha AR, 1997, ANN SURG ONCOL, V4, P328, DOI 10.1007/BF02303583; Sherman SI, 1998, CANCER-AM CANCER SOC, V83, P1012; Sherman SI, 1998, J GEN INTERN MED, V13, P60, DOI 10.1046/j.1525-1497.1998.00044.x; SHERMAN SI, 1994, J CLIN ENDOCR METAB, V78, P629, DOI 10.1210/jc.78.3.629; SHERMAN SI, 2001, NCCN PRACTICE GUIDEL; SHERMAN SI, 1999, THYROID CANC COMPREH, P319; SHERMAN SI, IN PRESS HORMONE REP; Sherrill C, 1999, ADAPT PHYS ACT Q, V16, P1, DOI 10.1123/apaq.16.1.1; Shiga T, 2001, J NUCL MED, V42, P414; SILVERBERG SG, 1970, CANCER-AM CANCER SOC, V25, P792, DOI 10.1002/1097-0142(197004)25:4<792::AID-CNCR2820250408>3.0.CO;2-P; Simon D, 1996, WORLD J SURG, V20, P860, DOI 10.1007/s002689900131; Singer PA, 1996, ARCH INTERN MED, V156, P2165, DOI 10.1001/archinte.156.19.2165; Sisson JC, 1996, CANCER, V78, P2184, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2184::AID-CNCR21>3.0.CO;2-U; Specht MC, 2001, SURGERY, V130, P936, DOI 10.1067/msy.2001.118381a; Spencer CA, 1999, THYROID, V9, P435, DOI 10.1089/thy.1999.9.435; Spencer CA, 1996, CLIN CHEM, V42, P164; Spencer CA, 1998, J CLIN ENDOCR METAB, V83, P1121, DOI 10.1210/jc.83.4.1121; STALL GM, 1990, ANN INTERN MED, V113, P265, DOI 10.7326/0003-4819-113-4-265; Sugitani I, 2001, WORLD J SURG, V25, P617, DOI 10.1007/s002680020166; Takano T, 2001, BRIT J CANCER, V85, P102, DOI 10.1054/bjoc.2001.1904; TAKASHIMA S, 1990, AM J ROENTGENOL, V154, P1079, DOI 10.2214/ajr.154.5.2108546; Tan GH, 1997, ANN INTERN MED, V126, P226, DOI 10.7326/0003-4819-126-3-199702010-00009; *TASK FORC TC, 2001, ENDOCR PR, V7, P203; Taylor T, 1998, ANN INTERN MED, V129, P622, DOI 10.7326/0003-4819-129-8-199810150-00007; Teppo L, 1998, EUR J CANCER, V34, P2248, DOI 10.1016/S0959-8049(98)00337-2; TISELL LE, 1986, SURGERY, V99, P60; Tsang TW, 1998, CANCER-AM CANCER SOC, V82, P375; Tuttle RM, 1998, THYROID, V8, P377, DOI 10.1089/thy.1998.8.377; TYLER DS, 1994, SURGERY, V116, P1054; Udelsman R, 2001, ANN SURG, V233, P716, DOI 10.1097/00000658-200105000-00016; VANHEERDEN JA, 1990, ANN SURG, V212, P395, DOI 10.1097/00000658-199010000-00002; Vassilopoulou-Sellin R, 1999, CANCER, V85, P696, DOI 10.1002/(SICI)1097-0142(19990201)85:3<696::AID-CNCR20>3.0.CO;2-4; Vassilopoulou-Sellin R, 1998, HEAD NECK-J SCI SPEC, V20, P549, DOI 10.1002/(SICI)1097-0347(199809)20:6<549::AID-HED10>3.0.CO;2-R; VassilopoulouSellin R, 1996, CANCER-AM CANCER SOC, V78, P493, DOI 10.1002/(SICI)1097-0142(19960801)78:3<493::AID-CNCR17>3.0.CO;2-U; VENKATESH YSS, 1990, CANCER-AM CANCER SOC, V66, P321, DOI 10.1002/1097-0142(19900715)66:2<321::AID-CNCR2820660221>3.0.CO;2-A; Vini L, 2002, POSTGRAD MED J, V78, P92, DOI 10.1136/pmj.78.916.92; Wartofsky, 1999, THYROID CANC COMPREH, P77; Wells SA, 1998, EXP CLIN ENDOCR DIAB, V106, P29, DOI 10.1055/s-0029-1211946; Wohllk N, 1996, J CLIN ENDOCR METAB, V81, P3740, DOI 10.1210/jc.81.10.3740; WONG JB, 1990, ENDOCRIN METAB CLIN, V19, P741, DOI 10.1016/S0889-8529(18)30319-0; Xu GP, 2001, J CLIN ENDOCR METAB, V86, P1769, DOI 10.1210/jc.86.4.1769	168	792	833	2	69	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					501	511		10.1016/S0140-6736(03)12488-9	http://dx.doi.org/10.1016/S0140-6736(03)12488-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583960				2022-12-28	WOS:000180900600024
J	Stewart, JR				Stewart, JR			Comment on "Buffered tree population changes in a quaternary refugium: Evolutionary implications"	SCIENCE			English	Editorial Material							POSTGLACIAL COLONIZATION; PHYLOGEOGRAPHY; EUROPE		UCL, Dept Anthropol, London WC1E 6BT, England; UCL, AHRB Ctr Evolutionary Anal Cultural Behav, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Stewart, JR (corresponding author), UCL, Dept Anthropol, Gower St, London WC1E 6BT, England.	ucsajrs@ucl.ac.uk	Stewart, John R./C-1075-2011	Stewart, John R./0000-0002-3506-5264				BENNETT KD, 1997, EVOLUTION ECOLOGY; Bilton DT, 1998, P ROY SOC B-BIOL SCI, V265, P1219, DOI 10.1098/rspb.1998.0423; COOPE GR, 1979, DIVERSITY INSECT FAU; Garcia-Marin JL, 1999, HEREDITY, V82, P46, DOI 10.1038/sj.hdy.6884470; Hanfling B, 2002, MOL ECOL, V11, P1717, DOI 10.1046/j.1365-294X.2002.01563.x; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Kullman L, 2002, J BIOGEOGR, V29, P1117, DOI 10.1046/j.1365-2699.2002.00743.x; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; STEWART JR, MCDONALD I MONOGRAPH; STUART AJ, 1995, GEOLOGICAL SOC SPECI, V96; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TREVICK SA, 2002, MOL ECOL, V11, P1717; Trewick SA, 2002, MOL ECOL, V11, P2003, DOI 10.1046/j.1365-294X.2002.01583.x; Tyler T, 2002, J BIOGEOGR, V29, P919, DOI 10.1046/j.1365-2699.2002.00698.x; Tyrberg T., 1998, PLEISTOCENE BIRDS PA; Tzedakis PC, 2002, SCIENCE, V297, P2044, DOI 10.1126/science.1073083	19	23	24	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					825	825						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574604				2022-12-28	WOS:000180830900024
J	Spicer, RA; Harris, NBW; Widdowson, M; Herman, AB; Guo, SX; Valdes, PJ; Wolfe, JA; Kelley, SP				Spicer, RA; Harris, NBW; Widdowson, M; Herman, AB; Guo, SX; Valdes, PJ; Wolfe, JA; Kelley, SP			Constant elevation of southern Tibet over the past 15 million years	NATURE			English	Article							EAST-WEST EXTENSION; ASIAN MONSOON; LATE MIOCENE; MYR AGO; PLATEAU; UPLIFT; PALEOALTITUDES; LITHOSPHERE; COLLISION; VOLCANISM	The uplift of the Tibetan plateau, an area that is 2,000 km wide, to an altitude of about 5,000 m has been shown to modify global climate(1-3) and to influence monsoon intensity(4-8). Mechanical and thermal models for homogeneous thickening of the lithosphere make specific predictions about uplift rates of the Tibetan plateau(9,10), but the precise history of the uplift of the plateau has yet to be confirmed by observations. Here we present well-preserved fossil leaf assemblages from the Namling basin, southern Tibet, dated to similar to15 Myr ago, which allow us to reconstruct the temperatures within the basin at that time. Using a numerical general circulation model to estimate moist static energy at the location of the fossil leaves, we reconstruct the elevation of the Namling basin 15 Myr ago to be 4,689 +/- 895 m or 4,638 +/- 847 m, depending on the reference data used. This is comparable to the present-day altitude of 4,600 m. We conclude that the elevation of the southern Tibetan plateau probably has remained unchanged for the past 15 Myr.	Open Univ, Dept Earth Sci, Milton Keynes MK7 6AA, Bucks, England; Russian Acad Sci, Inst Geol, Moscow 119017, Russia; Acad Sinica, Nanjing Inst Geol & Palaeontol, Nanjing 210008, Peoples R China; Univ Reading, Dept Meteorol, Reading RG6 6BB, Berks, England; Univ Arizona, Dept Geosci, Desert Lab, Tucson, AZ 85721 USA	Open University - UK; Geological Institute, Russian Academy of Sciences; Russian Academy of Sciences; Chinese Academy of Sciences; University of Reading; University of Arizona	Spicer, RA (corresponding author), Open Univ, Dept Earth Sci, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.		Kelley, Simon/AAR-7075-2020; Harris, Nigel/AID-6373-2022; Harris, Nigel/GPS-7318-2022; Harris, Nigel B. W./AHE-8802-2022; Valdes, Paul/C-4129-2013; Herman, Alexei/AAH-3545-2019; Harris, Nigel/GQO-8889-2022; Valdes, Paul/T-2004-2019	Kelley, Simon/0000-0002-1756-0480; Harris, Nigel/0000-0001-9387-2585; Harris, Nigel/0000-0001-9387-2585; Harris, Nigel/0000-0001-9387-2585; Valdes, Paul/0000-0002-1902-3283; Spicer, Robert/0000-0003-1076-2693				An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Blisniuk PM, 2001, NATURE, V412, P628, DOI 10.1038/35088045; BURBANK DW, 1993, NATURE, V364, P48, DOI 10.1038/364048a0; COLEMAN M, 1995, NATURE, V374, P49, DOI 10.1038/374049a0; ENGLAND P, 1989, J GEOPHYS RES-SOLID, V94, P17561, DOI 10.1029/JB094iB12p17561; FOREST CE, 1995, NATURE, V374, P347, DOI 10.1038/374347a0; HARRISON TM, 1995, TECTONICS, V14, P658, DOI 10.1029/95TC00608; Ishida S., 1969, MEMOIRS FS KYOTO U S, V37, P1; Kroon D., 1991, Proceedings of the Ocean Drilling Program Scientific Results, V117, P257, DOI 10.2973/odp.proc.sr.117.126.1991; KUTZBACH JE, 1989, J GEOPHYS RES-ATMOS, V94, P18393, DOI 10.1029/JD094iD15p18393; Matsuo H., 1963, TERTIARY FLORAS JAPA, P219; MEYER HW, 1992, PALAEOGEOGR PALAEOCL, V99, P71, DOI 10.1016/0031-0182(92)90008-S; MOLNAR P, 1993, REV GEOPHYS, V31, P357, DOI 10.1029/93RG02030; Murphy MA, 1997, GEOLOGY, V25, P719, DOI 10.1130/0091-7613(1997)025<0719:DTIACA>2.3.CO;2; PLATT JP, 1994, AM J SCI, V294, P307, DOI 10.2475/ajs.294.3.307; Qiang XK, 2001, EARTH PLANET SC LETT, V187, P83, DOI 10.1016/S0012-821X(01)00281-3; QUADE J, 1989, NATURE, V342, P163, DOI 10.1038/342163a0; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Rowley DB, 1996, EARTH PLANET SC LETT, V145, P1, DOI 10.1016/S0012-821X(96)00201-4; Rowley DB, 2001, EARTH PLANET SC LETT, V188, P253, DOI 10.1016/S0012-821X(01)00324-7; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; Turner S, 1996, J PETROL, V37, P45, DOI 10.1093/petrology/37.1.45; Williams H, 2001, GEOLOGY, V29, P339, DOI 10.1130/0091-7613(2001)029<0339:AACODI>2.0.CO;2; Wolfe JA, 1998, GEOL SOC AM BULL, V110, P664, DOI 10.1130/0016-7606(1998)110<0664:PEOEAO>2.3.CO;2; WOLFE JA, 1993, US GEOL SURV B, V2040, P71	25	517	628	10	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					622	624		10.1038/nature01356	http://dx.doi.org/10.1038/nature01356			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571593				2022-12-28	WOS:000180803200039
J	Weinshilboum, R				Weinshilboum, R			Genomic medicine - Inheritance and drug response.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CATECHOL-O-METHYLTRANSFERASE; S-MEPHENYTOIN METABOLISM; THIOPURINE METHYLTRANSFERASE; GENETIC-POLYMORPHISM; DIHYDROPYRIMIDINE DEHYDROGENASE; CYTOCHROME-P450 CYP2C9; FAMILIAL PYRIMIDINEMIA; CLINICAL CONSEQUENCES; DOSE REQUIREMENT; HUMAN-SERUM		Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Mol Pharmacol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Expt Therapeut & Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Weinshilboum, R (corresponding author), Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Mol Pharmacol & Expt Therapeut, 200 1st St SW, Rochester, MN 55905 USA.	weinshilboum.richard@mayo.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061388, R01GM028157, R01GM035720] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM28157, UO1 GM61388, R01 GM35720] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; Aklillu E, 1996, J PHARMACOL EXP THER, V278, P441; BALIAN JD, 1995, CLIN PHARMACOL THER, V57, P662, DOI 10.1016/0009-9236(95)90229-5; BERTILSSON, 1994, CLIN PHARMACOL THER, V55, P648; BERTILSSON L, 1992, CLIN PHARMACOL THER, V51, P388, DOI 10.1038/clpt.1992.38; BLUM M, 1990, DNA CELL BIOL, V9, P193, DOI 10.1089/dna.1990.9.193; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Brandolese R, 2001, CLIN PHARMACOL THER, V70, P391, DOI 10.1067/mcp.2001.118868; Collie-Duguid ESR, 1999, PHARMACOGENETICS, V9, P37, DOI 10.1097/00008571-199902000-00006; Dalen P, 1998, CLIN PHARMACOL THER, V63, P444, DOI 10.1016/S0009-9236(98)90040-6; DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419; DIASIO RB, 1988, J CLIN INVEST, V81, P47, DOI 10.1172/JCI113308; DRAYER DE, 1977, CLIN PHARMACOL THER, V22, P251; DUFOUR AP, 1964, SCIENCE, V145, P391, DOI 10.1126/science.145.3630.391; EICHELBAUM M, 1979, EUR J CLIN PHARMACOL, V16, P183, DOI 10.1007/BF00562059; EVANS DAP, 1960, BRIT MED J, V2, P485, DOI 10.1136/bmj.2.5197.485; EVANS DAP, 1993, GENETIC FACTORS DRUG; EVANS DAP, 1992, INT ENCY PHARM THERA, V43, P95; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Furuta T, 1998, ANN INTERN MED, V129, P1027, DOI 10.7326/0003-4819-129-12-199812150-00006; GONZALEZ F J, 1988, Genomics, V2, P174, DOI 10.1016/0888-7543(88)90100-0; Hall D, 1999, PHARMACOGENETICS, V9, P591, DOI 10.1097/01213011-199910000-00006; Ingelman-Sundberg M, 2001, PHARMACOGENETICS, V11, P553, DOI 10.1097/00008571-200110000-00002; Iyer L, 1999, CLIN PHARMACOL THER, V65, P576, DOI 10.1016/S0009-9236(99)70078-0; Iyer L., 2002, Pharmacogenomics Journal, V2, P43, DOI 10.1038/sj.tpj.6500072; JOHANSSON I, 1993, P NATL ACAD SCI USA, V90, P11825, DOI 10.1073/pnas.90.24.11825; KALOW W, 1957, J PHARMACOL EXP THER, V120, P203; KALOW W, 1959, ANN HUM GENET, V23, P239, DOI 10.1111/j.1469-1809.1959.tb01467.x; KALOW W, 1990, LIFE SCI, V47, P1385, DOI 10.1016/0024-3205(90)90517-U; Kalow Werner, 1963, PHARMACOGENETICS HER; KIMURA S, 1989, AM J HUM GENET, V45, P889; KROEMER HK, 1995, LIFE SCI, V56, P2285, DOI 10.1016/0024-3205(95)00223-S; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lampe JW, 1999, PHARMACOGENETICS, V9, P341, DOI 10.1097/00008571-199906000-00009; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LENNARD L, 1992, EUR J CLIN PHARMACOL, V43, P329, DOI 10.1007/BF02220605; LENNARD L, 1990, LANCET, V336, P225, DOI 10.1016/0140-6736(90)91745-V; LENNARD L, 1989, CLIN PHARMACOL THER, V46, P149, DOI 10.1038/clpt.1989.119; LIN HJ, 1993, AM J HUM GENET, V52, P827; Lockridge O., 1992, PHARMACOGENETICS DRU, P15; Loebstein R, 2001, CLIN PHARMACOL THER, V70, P159, DOI 10.1067/mcp.2001.117444; MAHGOUB A, 1977, LANCET, V2, P584, DOI 10.1016/S0140-6736(77)91430-1; MCGUIRE MC, 1989, P NATL ACAD SCI USA, V86, P953, DOI 10.1073/pnas.86.3.953; McLeod HL, 1998, PHARMACOGENETICS, V8, P455, DOI 10.1097/00008571-199812000-00001; MORTIMER O, 1990, CLIN PHARMACOL THER, V47, P27, DOI 10.1038/clpt.1990.4; NAKAMURA K, 1985, CLIN PHARMACOL THER, V38, P402, DOI 10.1038/clpt.1985.194; Raida M, 2001, CLIN CANCER RES, V7, P2832; REIDENBERG MM, 1975, CLIN PHARMACOL THER, V17, P722; REILLY DK, 1980, CLIN PHARMACOL THER, V28, P278, DOI 10.1038/clpt.1980.161; REMY CN, 1963, J BIOL CHEM, V238, P1078; Ross EM, 2001, GOODMAN GILMANS PHAR, P31; Sindrup SH, 1995, PHARMACOGENETICS, V5, P335, DOI 10.1097/00008571-199512000-00001; Stubbins MJ, 1996, PHARMACOGENETICS, V6, P429, DOI 10.1097/00008571-199610000-00007; Szumlanski C, 1996, DNA CELL BIOL, V15, P17, DOI 10.1089/dna.1996.15.17; Tai HL, 1996, AM J HUM GENET, V58, P694; Tai HL, 1997, P NATL ACAD SCI USA, V94, P6444, DOI 10.1073/pnas.94.12.6444; Tanigawara Y, 1999, CLIN PHARMACOL THER, V66, P528, DOI 10.1016/S0009-9236(99)70017-2; TIMBRELL JA, 1980, CLIN PHARMACOL THER, V28, P350, DOI 10.1038/clpt.1980.173; TUCHMAN M, 1985, NEW ENGL J MED, V313, P245, DOI 10.1056/NEJM198507253130407; Tybring G, 1997, CLIN PHARMACOL THER, V62, P129, DOI 10.1016/S0009-9236(97)90060-6; van der Weide J, 2001, PHARMACOGENETICS, V11, P287, DOI 10.1097/00008571-200106000-00002; Venter JC, 2001, SCIENCE, V292, P1838; WEBER WW, 1997, PHARMACOGENETICS; WEINSHILBOUM RM, 1977, AM J HUM GENET, V29, P125; Weinshilboum RM, 1999, ANNU REV PHARMACOL, V39, P19, DOI 10.1146/annurev.pharmtox.39.1.19; WEINSHILBOUM RM, 1980, AM J HUM GENET, V32, P651; WILKINSON GR, 2001, GOODMAN GILMANS PHAR, P3; WOODSON LC, 1983, BIOCHEM PHARMACOL, V32, P819, DOI 10.1016/0006-2952(83)90582-8	68	672	727	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2003	348	6					529	537		10.1056/NEJMra020021	http://dx.doi.org/10.1056/NEJMra020021			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642JY	12571261	Bronze			2022-12-28	WOS:000180801400007
J	Farmer, P; Fawzi, MCS; Nevil, P				Farmer, P; Fawzi, MCS; Nevil, P			Unjust embargo of aid for Haiti	LANCET			English	Editorial Material							ECONOMIC SANCTIONS; HEALTH; IMPACT		Zanmi Lasante, Cange, Haiti; Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Farmer, P (corresponding author), Zanmi Lasante, Cange, Haiti.	paul_farmer@hms.harvard.edu						Ali HM, 2000, LANCET, V355, P1851, DOI 10.1016/S0140-6736(00)02289-3; Barry M, 2000, ANN INTERN MED, V132, P151, DOI 10.7326/0003-4819-132-2-200001180-00010; BLACK ME, 1993, BRIT MED J, V307, P1135, DOI 10.1136/bmj.307.6912.1135; *CDCP, 1994, MMWR-MORBID MORTAL W, V43, P845; *CENTR INT AG, WORLD FACTB 2002; *CENTR INT AG, WORLD FACTB 2001; CHELALA C, 1994, BRIT MED J, V309, P525, DOI 10.1136/bmj.309.6953.525; CHEN L, 1993, WORKING PAPER SERIES, V9307; Daponte BO, 2000, AM J PUBLIC HEALTH, V90, P546, DOI 10.2105/AJPH.90.4.546; FARMER P, 2002, USES HAITI; Farmer P., 1999, INFECT INEQUALITIES; FARMER PE, 1996, CURRENT ISSUES PUBLI, V2, P143; Galbraith JK, 2002, DAEDALUS-US, V131, P11; Garfield R, 1995, B NEW YORK ACAD MED, V72, P454; Gibbons E, 1999, AM J PUBLIC HEALTH, V89, P1499, DOI 10.2105/AJPH.89.10.1499; HANCOCK G, 1989, LORDS POVERTY FREE W; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kim J. Y., 2000, DYING GROWTH GLOBAL; LAWLESS R, 1992, HAITIS BAD PRESS, P56; *NAT LAB COMM, HAIT COUP SWEATSH RE; *PAN AM HLTH ORG W, 1993, HAIT AID URG SANT; STEPHENSON J, JAMA, V284, P556; Wilkinson R., 1997, UNHEALTHY SOC AFFLIC	23	20	20	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2003	361	9355					420	423		10.1016/S0140-6736(03)12380-X	http://dx.doi.org/10.1016/S0140-6736(03)12380-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573389				2022-12-28	WOS:000180787000024
J	Thorne, C; Fiore, S; Rudin, C				Thorne, C; Fiore, S; Rudin, C			Antiretroviral therapy during pregnancy and the risk of an adverse outcome	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									Inst Child Hlth, London WC1N 1EH, England; Univ Childrens Hosp, CH-4008 Basel, Switzerland	University of London; University College London	Thorne, C (corresponding author), Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.		Thorne, Claire/C-5943-2008; SHCS, MoCHIV/G-4081-2011	Thorne, Claire/0000-0003-0389-1956; Mofenson, Lynne/0000-0002-2818-9808				Aebi C, 2000, AIDS, V14, P2913, DOI 10.1097/00002030-200012220-00013; Martinez-Valverde I, 2000, ARCH LATINOAM NUTR, V50, P5; Newell ML, 2002, AIDS, V16, pS1; Tuomala RE, 2002, NEW ENGL J MED, V346, P1863, DOI 10.1056/NEJMoa991159	4	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					471	471						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12556551				2022-12-28	WOS:000180643800022
J	Pirrotta, V				Pirrotta, V			Puffing with PARP	SCIENCE			English	Editorial Material							NF-KAPPA-B; POLY(ADP-RIBOSE) POLYMERASE; TRANSCRIPTION; REPAIR		Univ Geneva, Dept Zool, CH-1211 Geneva, Switzerland	University of Geneva	Pirrotta, V (corresponding author), Univ Geneva, Dept Zool, CH-1211 Geneva, Switzerland.							D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dantzer F, 1999, BIOCHIMIE, V81, P69, DOI 10.1016/S0300-9084(99)80040-6; Kameoka M, 2000, BIOCHEM J, V346, P641, DOI 10.1042/0264-6021:3460641; KORGE G, 1990, DEV BIOL, V138, P324, DOI 10.1016/0012-1606(90)90200-3; Oei SL, 1998, BIOCHEMISTRY-US, V37, P1465, DOI 10.1021/bi9727390; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; Ziegler M, 2001, BIOESSAYS, V23, P543, DOI 10.1002/bies.1074	11	16	17	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					528	529		10.1126/science.1081520	http://dx.doi.org/10.1126/science.1081520			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543962				2022-12-28	WOS:000180559800035
J	Zeyl, C; Vanderford, T; Carter, M				Zeyl, C; Vanderford, T; Carter, M			An evolutionary advantage of haploidy in large yeast populations	SCIENCE			English	Article							LIFE-CYCLES; DIPLOIDY; ADAPTATION	Although seed plants and multicellular animals are predominantly diploid, the prominence of diploidy varies greatly among eukaryote life cycles, and no general evolutionary advantage of diploidy has been demonstrated. By doubling the copy number of each gene, diploidy may increase the rate at which adaptive mutations are produced. However, models suggest that this does not necessarily accelerate adaptation by diploid populations. We tested model predictions regarding rates of adaptation using asexual yeast populations. Adaptive mutations were on average partially recessive. As predicted, diploidy slowed adaptation by large populations but not by small populations.	Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA	Wake Forest University	Zeyl, C (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA.							BELL G, 1982, MASTERPIECE NATURE E; DYKHUIZEN DE, 1990, ANNU REV ECOL SYST, V21, P373, DOI 10.1146/annurev.ecolsys.21.1.373; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Hiraoka M, 2000, GENETICS, V156, P1531; JENKINS CD, 1995, EVOLUTION, V49, P512, DOI [10.1111/j.1558-5646.1995.tb02283.x, 10.2307/2410275]; KONDRASHOV AS, 1991, NATURE, V351, P314, DOI 10.1038/351314a0; ORR HA, 1994, GENETICS, V136, P1475; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; OTTO S, 1994, THEORIES EVOLUTION H, P69; OTTO SP, 1992, GENETICS, V131, P745; PAQUIN C, 1983, NATURE, V302, P495, DOI 10.1038/302495a0; PERROT V, 1991, NATURE, V351, P315, DOI 10.1038/351315a0; VALERO M, 1992, TRENDS ECOL EVOL, V7, P25, DOI 10.1016/0169-5347(92)90195-H	13	104	107	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					555	558		10.1126/science.1078417	http://dx.doi.org/10.1126/science.1078417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543972				2022-12-28	WOS:000180559800046
J	Hood, L; Galas, D				Hood, L; Galas, D			The digital code of DNA	NATURE			English	Article							PROTEIN-SYNTHESIS; HUMAN-GENOME; SEQUENCE; NETWORK	The discovery of the structure of DNA transformed biology profoundly, catalysing the sequencing of the human genome and engendering a new view of biology as an information science. Two features of DNA structure account for much of its remarkable impact on science: its digital nature and its complementarity, whereby one strand of the helix binds perfectly with its partner. DNA has two types of digital information - the genes that encode proteins, which are the molecular machines of life, and the gene regulatory networks that specify the behaviour of the genes.	Inst Syst Biol, Seattle, WA 98105 USA; Keck Grad Inst Appl Sci, Claremont, CA 91711 USA	Institute for Systems Biology (ISB); Claremont Colleges; Keck Graduate Institute; Keck Graduate Institute of Applied Life Sciences	Hood, L (corresponding author), Inst Syst Biol, 4225 Roosevelt Way NE, Seattle, WA 98105 USA.	lhood@systemsbiology.org; david_galas@kgi.edu						Ader R, 2001, PSYCHONEUROIMMUNOLOG, P3; Baliga NS, 2002, P NATL ACAD SCI USA, V99, P14913, DOI 10.1073/pnas.192558999; BRENNER S, 1961, NATURE, V190, P576, DOI 10.1038/190576a0; COLLINS F, 1993, SCIENCE, V262, P43, DOI 10.1126/science.8211127; Cotton R, 2001, E LS; CRICK FH, 1961, NATURE, V192, P1227, DOI 10.1038/1921227a0; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; HORVATH SJ, 1987, METHOD ENZYMOL, V154, P314; HUNKAPILLER MW, 1980, SCIENCE, V207, P523, DOI 10.1126/science.7352258; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; KENT SBH, 1984, PEPTIDES, V5, P185; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; NIRENBERG M, 1961, P NATL ACAD SCI USA, V47, P1588, DOI 10.1073/pnas.47.10.1588; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, NATURE, V265, P678; SANGER F, 1975, J MOL BIOL, V94, P444; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0	20	154	161	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					444	448		10.1038/nature01410	http://dx.doi.org/10.1038/nature01410			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540920	Bronze			2022-12-28	WOS:000180533000061
J	Weimerskirch, H; Chastel, O; Barbraud, C; Tostain, O				Weimerskirch, H; Chastel, O; Barbraud, C; Tostain, O			Frigatebirds ride high on thermals - This bird's bizarre physique and sparse hunting grounds account for its languid lifestyle.	NATURE			English	Article									CNRS, UPR 1934, Ctr Etud Biol Chize, F-79360 Villiersen Bois, France; Assoc Aratai, F-97357 Remire Montjoly, Guyane, France; DIREN, F-97328 Cayenne, Guyane, French Guiana	Centre National de la Recherche Scientifique (CNRS)	Weimerskirch, H (corresponding author), CNRS, UPR 1934, Ctr Etud Biol Chize, F-79360 Villiersen Bois, France.	henriw@cebc.cnrs.fr	Barbraud, Christophe/A-5870-2012; Weimerskirch, Henri/F-5562-2013; Weimerskirch, Henri/K-7306-2019; Herberstein, Marie E./D-2042-2011	Barbraud, Christophe/0000-0003-0146-212X; Weimerskirch, Henri/0000-0002-0457-586X; Herberstein, Marie E./0000-0001-5071-2952				Alerstam T, 1990, BIRD MIGRATION; AUGSTEIN E, 1980, METEOROLOGY TROPICAL; Ballance L. T., 1999, P INT ORN C, P2057; DIAMOND AW, 1973, CONDOR, V75, P200, DOI 10.2307/1365868; GOULD PJ, 1974, PELAGIC STUDIES SEAB, P6; LACK D, 1956, SWIFTSIN TOWER; NELSON J B, 1975, Living Bird, V14, P113; Orta J., 1992, P362; PENNYCUICK CJ, 1983, J EXP BIOL, V102, P307; Weimerskirch H, 2001, BIOL MARINE BIRDS, P115	10	79	87	6	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					333	334		10.1038/421333a	http://dx.doi.org/10.1038/421333a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540890				2022-12-28	WOS:000180533000030
J	Ramsay, ME; Andrews, NJ; Trotter, CL; Kaczmarski, EB; Miller, E				Ramsay, ME; Andrews, NJ; Trotter, CL; Kaczmarski, EB; Miller, E			Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis	BRITISH MEDICAL JOURNAL			English	Article									Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England; Manchester Publ Hlth Lab, Meningococcal Reference Unit, Publ Hlth Lab Serv, Manchester M20 2LR, Lancs, England	Public Health England	Ramsay, ME (corresponding author), Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England.		Trotter, Caroline L/H-5077-2013; Ramsay, Mary Elizabeth/S-8281-2016	Trotter, Caroline/0000-0003-4000-2708; Ramsay, Mary Elizabeth/0000-0002-7156-7640				Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; Trotter C L, 2002, Commun Dis Public Health, V5, P220; Trotter CL, 2002, BRIT MED J, V324, P809, DOI 10.1136/bmj.324.7341.809	5	306	320	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2003	326	7385					365	366		10.1136/bmj.326.7385.365	http://dx.doi.org/10.1136/bmj.326.7385.365			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648RZ	12586669	Bronze, Green Published			2022-12-28	WOS:000181165500019
J	Young, B; Dixon-Woods, M; Windridge, KC; Heney, D				Young, B; Dixon-Woods, M; Windridge, KC; Heney, D			Managing communication with young people who have a potentially life threatening chronic illness: qualitative study of patients and parents	BRITISH MEDICAL JOURNAL			English	Article							CANCER-PATIENTS; INFORMATION; CHILDREN; PREFERENCES; INTERVIEW	Objectives To examine young people's and parents' accounts of communication about cancer in childhood. Design Semistructured interviews analysed using the constant comparative method. Setting Paediatric oncology unit. Participants 13 families, comprising 19 parents (13 mothers, six fathers) and 13 patients aged 8-17 years. The patients had cancer or brain tumour. Results Most parents described acting in an executive-like capacity, managing what and how their children were told about their illness, particularly at the time of diagnosis. Their accounts were shaped by concerns to manage their identity as strong and optimistic parents and to protect their child's wellbeing. The patients identified elements of their parents' role that both facilitated and constrained their communication, and while they welcomed their parents' involvement, some expressed unease with the constraining aspects of their parents' role. Some young people described feeling marginalised in consultations and pointed to difficulties they experienced in encounters with some doctors. Conclusions There are difficulties in managing communication with young people who have a chronic, life threatening illness. Health professionals need to be aware of how the social positioning of young people (relative to adults) and the executive role of parents can contribute to the marginalisation of young people and hamper the development of successful relationships between themselves and young patients.	Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England; Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England; Univ Leicester, Leicester Gen Hosp, Dept Gen Practice & Primary Hlth Care, Leicester LE5 4PW, Leics, England; Leicester Royal Infirm, Childrens Hosp, Leicester LE1 5WW, Leics, England	University of Hull; University of Leicester; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University of Leicester	Young, B (corresponding author), Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England.		Young, Bridget/A-2184-2014	Dixon-Woods, Mary/0000-0002-5915-0041; Young, Bridget/0000-0001-6041-9901				Alderson P., 1993, CHILDRENS CONSENT SU; Barnes J, 2000, BRIT MED J, V321, P479, DOI 10.1136/bmj.321.7259.479; BLUEBONDLANGNER.M, 1978, PRIVATE WORLDS DYING; British Medical Association, 2001, CONS RIGHTS CHOIC HL; CASSILETH BR, 1980, ANN INTERN MED, V92, P832, DOI 10.7326/0003-4819-92-6-832; CLAFLIN CJ, 1991, J PEDIATR PSYCHOL, V16, P169, DOI 10.1093/jpepsy/16.2.169; DAVIS A, 1982, CHILDREN CLIN; Dixon-Woods M, 1999, BRIT MED J, V319, P778, DOI 10.1136/bmj.319.7212.778; FALLOWFIELD L, 1995, PSYCHO-ONCOLOGY, V4, P197, DOI 10.1002/pon.2960040305; GAHAN C, 1998, DOING QUALITATIVE AN; Glaser B.G., 1965, AWARENESS DYING; Goffman Erving, 1959, MISE SCENE VIE QUOTI; Green J, 1998, BMJ-BRIT MED J, V316, P1064; James A., 1990, CONSTRUCTING RECONST; JAMES N, 1989, SOV REV, V37, P118; Leydon GM, 2000, BMJ-BRIT MED J, V320, P909, DOI 10.1136/bmj.320.7239.909; Mayall Berry., 1996, CHILDREN HLTH SOCIAL; SCOTT JT, 2002, COCHRANE LIB; STEWART TJ, 1981, J FAM PRACTICE, V13, P827; STRONG PM, 1979, CEREMONIAL ORDER CLI; Tates K, 2001, SOC SCI MED, V52, P839, DOI 10.1016/S0277-9536(00)00193-3; TIMMERMANS S, 1994, SOCIOL HEALTH ILL, V16, P322, DOI 10.1111/1467-9566.ep11348751; van Dulmen AM, 1998, PEDIATRICS, V102, P563, DOI 10.1542/peds.102.3.563	23	173	176	1	21	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2003	326	7384					305	308B		10.1136/bmj.326.7384.305	http://dx.doi.org/10.1136/bmj.326.7384.305			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645UD	12574042	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000180997000016
J	Allada, R				Allada, R			Circadian clocks: A tale of two feedback loops	CELL			English	Editorial Material							VRILLE; TRANSCRIPTION; EXPRESSION	Circadian clocks in a wide range of organisms are thought to consist of two interdependent transcriptional feedback loops. In Drosophila, the first loop has been well characterized and controls rhythmic period expression. In this issue of Cell, Cryan et al. (2003) define a role for a transcriptional activator and a repressor in the second feedback loop.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Allada, R (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.							Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Kim EY, 2002, NEURON, V34, P69, DOI 10.1016/S0896-6273(02)00639-6; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013	10	43	44	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 7	2003	112	3					284	286		10.1016/S0092-8674(03)00076-X	http://dx.doi.org/10.1016/S0092-8674(03)00076-X			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581517	Bronze			2022-12-28	WOS:000181252200012
J	Qaim, M; Zilberman, D				Qaim, M; Zilberman, D			Yield effects of genetically modified crops in developing countries	SCIENCE			English	Article								Onfarm field trials carried out with Bacillus thuringiensis (Bt) cotton in different states of India show that the technology substantially reduces pest damage and increases yields. The yield gains are much higher than what has been reported for other countries where genetically modified crops were used mostly to replace and enhance chemical pest control. In many developing countries, small-scale farmers especially suffer big pest-related yield losses because of technical and economic constraints. Pest-resistant genetically modified crops can contribute to increased yields and agricultural growth in those situations, as the case of Bt cotton in India demonstrates.	Univ Bonn, Ctr Dev Res, D-53113 Bonn, Germany; Univ Calif Berkeley, Dept Agr & Resource Econ, Berkeley, CA 94720 USA	University of Bonn; University of California System; University of California Berkeley	Qaim, M (corresponding author), Univ Bonn, Ctr Dev Res, Walter Flex Str 3, D-53113 Bonn, Germany.	mqaim@uni-bonn.de	Qaim, Matin/P-4489-2016	Qaim, Matin/0000-0003-4143-0763				ALTIERI MA, 2001, 1 FOOD 1; Carpenter J, 2002, COMP ENV IMPACTS BIO; Committee on the Future Role of Pesticides in U.S. Agriculture, 2000, FUT ROL PEST US AGR; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Greenplate JT, 1999, J ECON ENTOMOL, V92, P1377, DOI 10.1093/jee/92.6.1377; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; *IND COUNC AGR RES, 2002, ALL IND COORD COTT I, P97; *ISAAA, 2002, BT COTT IND; *ISCI, 1999, HDB COTTON IND; ISMAEL Y, 2002, AGBIOFORUM, V5, P4; Jayaraman KS, 2002, NAT BIOTECHNOL, V20, P415, DOI 10.1038/nbt0502-415; Lauer J, 1999, J PROD AGRIC, V12, P373, DOI 10.2134/jpa1999.0373; Moffat AS, 1999, SCIENCE, V285, P370, DOI 10.1126/science.285.5426.370; Oerke EC., 1994, CROP PRODUCTION CROP; Paarlberg RobertL., 2001, POLITICS PRECAUTION; PINSTRUPANDERSE.P, 2001, SEEDS CONTENTION WOR; Pray CE, 2002, PLANT J, V31, P423, DOI 10.1046/j.1365-313X.2002.01401.x; Puri S.N., 1999, HDB COTTON INDIA, P233; QAIM M, 2002, 6 INT C INT CONS AGR; Qaim M., 2000, AGR BIOTECHNOLOGY DE; RUTTAN VW, 1999, AGBIOFORUM, V2, P54; *UK SOIL ASS, 2002, SEEDS DOUBT N AM FAR, P11; WIDAWSKY D, 1998, AGR EC, V19, P205; WOSSINK GAA, 1998, EC AGROCHEMICALS INT; ZILBERMAN D, 1991, SCIENCE, V253, P518, DOI 10.1126/science.253.5019.518	25	376	417	1	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					900	902		10.1126/science.1080609	http://dx.doi.org/10.1126/science.1080609			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574633				2022-12-28	WOS:000180830900055
J	Rich, P				Rich, P			The cost of living	NATURE			English	Editorial Material									UCL, Dept Biol, London WC1E 6BT, England	University of London; University College London	Rich, P (corresponding author), UCL, Dept Biol, Gower St, London WC1E 6BT, England.							Gilbert G.N., 1984, OPENING PANDORAS BOX; Kiberstis PA, 1999, SCIENCE, V283, P1475; PREBBLE J, 2003, WANDERING GARDENS MI; 1997, CATALOGUE PAPERS COR	4	78	80	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					583	583		10.1038/421583a	http://dx.doi.org/10.1038/421583a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571574	Bronze			2022-12-28	WOS:000180803200021
J	Dwyer, JR; Uman, MA; Rassoul, HK; Al-Dayeh, M; Caraway, L; Jerauld, J; Rakov, VA; Jordan, DM; Rambo, KJ; Corbin, V; Wright, B				Dwyer, JR; Uman, MA; Rassoul, HK; Al-Dayeh, M; Caraway, L; Jerauld, J; Rakov, VA; Jordan, DM; Rambo, KJ; Corbin, V; Wright, B			Energetic radiation produced during rocket-triggered lightning	SCIENCE			English	Article							X-RAYS; THUNDERSTORM; FLASHES	Using a Nal(TI) scintillation detector designed to operate in electrically noisy environments, we observed intense bursts of energetic radiation (>>10 kilo-electron volts) during the dart leader phase of rocket-triggered lightning, just before and possibly at the very start of 31 out of the 37 return strokes measured. The bursts had typical durations of less than 100 microseconds and deposited many tens of megaelectron volts into the detector. These results provide strong evidence that the production of runaway electrons is an important process during lightning.	Florida Inst Technol, Dept Phys & Space Sci, Melbourne, FL 32901 USA; Univ Florida, Dept Elect & Comp Engn, Gainesville, FL 32611 USA	Florida Institute of Technology; State University System of Florida; University of Florida	Dwyer, JR (corresponding author), Florida Inst Technol, Dept Phys & Space Sci, Melbourne, FL 32901 USA.		Rakov, Vladimir/A-8775-2009	Rakov, Vladimir/0000-0002-4582-9483; Rassoul, Hamid Kyan Sam/0000-0003-0681-7276				Clay J, 1939, REV MOD PHYS, V11, P0158, DOI 10.1103/RevModPhys.11.158; Eack KB, 1996, J GEOPHYS RES-ATMOS, V101, P29637, DOI 10.1029/96JD01705; Eack KB, 1996, GEOPHYS RES LETT, V23, P2915, DOI 10.1029/96GL02570; Eack KB, 2000, GEOPHYS RES LETT, V27, P185, DOI 10.1029/1999GL010849; Feng H., 2002, GEOPHYS RES LETT, V29, P6; FISHMAN GJ, 1994, SCIENCE, V264, P1313, DOI 10.1126/science.264.5163.1313; FOOTE RS, 1964, NATURAL RAD ENV, P757; GUREVICH AV, 1992, PHYS LETT A, V165, P463, DOI 10.1016/0375-9601(92)90348-P; MCCARTHY M, 1985, GEOPHYS RES LETT, V12, P393, DOI 10.1029/GL012i006p00393; Moore CB, 2001, GEOPHYS RES LETT, V28, P2141, DOI 10.1029/2001GL013140; Nemiroff RJ, 1997, J GEOPHYS RES-SPACE, V102, P9659, DOI 10.1029/96JA03107; PARKS GK, 1981, GEOPHYS RES LETT, V8, P1176, DOI 10.1029/GL008i011p01176; Suszcynsky DM, 1996, J GEOPHYS RES-ATMOS, V101, P23505, DOI 10.1029/96JD02134; Wilson CTR, 1925, P CAMB PHILOS SOC, V22, P534, DOI 10.1017/S0305004100003236	14	133	137	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					694	697		10.1126/science.1078940	http://dx.doi.org/10.1126/science.1078940			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560549				2022-12-28	WOS:000180687700043
J	Yankovskaya, V; Horsefield, R; Tornroth, S; Luna-Chavez, C; Miyoshi, H; Leger, C; Byrne, B; Cecchini, G; Iwata, S				Yankovskaya, V; Horsefield, R; Tornroth, S; Luna-Chavez, C; Miyoshi, H; Leger, C; Byrne, B; Cecchini, G; Iwata, S			Architecture of succinate dehydrogenase and reactive oxygen species generation	SCIENCE			English	Article							COLI FUMARATE REDUCTASE; QUINONE BINDING-SITES; ESCHERICHIA-COLI; COMPLEX-II; HEREDITARY PARAGANGLIOMA; RESPIRATORY-CHAIN; 2FE-2S CLUSTER; MUTATIONS; GENE; REPLACEMENT	The structure of Escherichia coli succinate dehydrogenase (SQR), analogous to the mitochondrial respiratory complex II, has been determined, revealing the electron transport pathway from the electron donor, succinate, to the terminal electron acceptor, ubiquinone. It was found that the SQR redox centers are arranged in a manner that aids the prevention of reactive oxygen species (ROS) formation at the flavin adenine dinucleotide. This is likely to be the main reason SQR is expressed during aerobic respiration rather than the related enzyme fumarate reductase, which produces high levels of ROS. Furthermore, symptoms of genetic disorders associated with mitochondrial SQR mutations may be a result of ROS formation resulting from impaired electron transport in the enzyme.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AY, England; Vet Adm Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA; Uppsala Univ, Dept Biochem, S-75123 Uppsala, Sweden; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan; Univ Oxford, Inorgan Chem Lab, Oxford OX1 3QR, England; Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AZ, England	Imperial College London; US Department of Veterans Affairs; Veterans Health Administration (VHA); Uppsala University; University of California System; University of California San Francisco; Kyoto University; University of Oxford; Imperial College London	Cecchini, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AY, England.	ceccini@itsa.ucsf.edu; s.iwata@ic.ac.uk	Léger, Christophe/C-7230-2016; Horsefield, Rob/B-1378-2010; Törnroth-Horsefield, Susanna/B-2702-2010	Léger, Christophe/0000-0002-8871-6059; Tornroth-Horsefield, Susanna/0000-0002-9435-8243; Byrne, Bernadette/0000-0001-9598-9832	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061606] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61606] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKRELL BAC, 1989, ARCH BIOCHEM BIOPHYS, V268, P26, DOI 10.1016/0003-9861(89)90561-4; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2002, J MED GENET, V39, P617, DOI 10.1136/jmg.39.9.617; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; GUEST JR, 1981, J GEN MICROBIOL, V122, P171; Hagen WR, 2000, J BIOL INORG CHEM, V5, P527, DOI 10.1007/s007750050013; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hagerhall C, 1999, J BIOL CHEM, V274, P26157, DOI 10.1074/jbc.274.37.26157; Hederstedt L, 1999, SCIENCE, V284, P1941, DOI 10.1126/science.284.5422.1941; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Kita K, 2002, BBA-BIOENERGETICS, V1553, P123, DOI 10.1016/S0005-2728(01)00237-7; KROGER A, 1992, ARCH MICROBIOL, V158, P311, DOI 10.1007/BF00245358; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; Maklashina E, 2001, J BIOL CHEM, V276, P18968, DOI 10.1074/jbc.M011270200; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Rustin P, 2002, BBA-BIOENERGETICS, V1553, P117, DOI 10.1016/S0005-2728(01)00228-6; RUZICKA FJ, 1975, P NATL ACAD SCI USA, V72, P2886, DOI 10.1073/pnas.72.8.2886; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; VANHELLEMOND JJ, 1994, BIOCHEM J, V304, P321, DOI 10.1042/bj3040321; WERTH MT, 1992, FEBS LETT, V299, P1, DOI 10.1016/0014-5793(92)80086-V; Yankovskaya V, 1996, J BIOL CHEM, V271, P21020, DOI 10.1074/jbc.271.35.21020; YU L, 1987, J BIOL CHEM, V262, P1137	31	652	686	19	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					700	704		10.1126/science.1079605	http://dx.doi.org/10.1126/science.1079605			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560550				2022-12-28	WOS:000180687700045
J	Greig, D; Travisano, M				Greig, D; Travisano, M			Haploid superiority	SCIENCE			English	Editorial Material									Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Houston System; University of Houston	Greig, D (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.		Travisano, Michael/AAI-4809-2020; Greig, Duncan/AAW-3139-2020	Greig, Duncan/0000-0002-8907-0253				CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Haldane J. B. S., 1924, Trans Phil Soc Cambridge U K, V23, P19; ORR HA, 1994, GENETICS, V136, P1475; SIMMONS MJ, 1977, ANNU REV GENET, V11, P49, DOI 10.1146/annurev.ge.11.120177.000405; WRIGHT S, 1988, AM NAT, V131, P115, DOI 10.1086/284777; Zeyl C, 2003, SCIENCE, V299, P555, DOI 10.1126/science.1078417	7	8	8	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					524	525						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543960				2022-12-28	WOS:000180559800033
J	Orlicky, S; Tang, XJ; Willems, A; Tyers, M; Sicheri, F				Orlicky, S; Tang, XJ; Willems, A; Tyers, M; Sicheri, F			Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase	CELL			English	Article							CYCLIN-E; MULTISITE PHOSPHORYLATION; PROTEOLYSIS; COMPLEX; DEGRADATION; PROTEINS; INSIGHTS; RECOGNITION; TARGETS; NOTCH	Cell cycle progression depends on precise elimination of cyclins and cyclin-dependent kinase (CDK) inhibitors by the ubiquitin system. Elimination of the CDK inhibitor Sic1 by the SCFCdc4 ubiquitin ligase at the onset of S phase requires phosphorylation of Sic1 on at least six of its nine Cdc4-phosphodegron (CPD) sites. A 2.7 Angstrom X-ray crystal structure of a Skp1-Cdc4 complex bound to a high-affinity CPD phosphopeptide from human cyclin E reveals a core CPD motif, Leu-Leu-pThr-Pro, bound to an eight-bladed WD40 propeller domain in Cdc4. The low affinity of each CPD motif in Sic1 reflects structural discordance with one or more elements of the Cdc4 binding site. Reengineering of Cdc4 to reduce selection against Sic1 sequences allows ubiquitination of lower phosphorylated forms of Sic1. These features account for the observed phosphorylation threshold in Sic1 recognition and suggest an equilibrium binding mode between a single receptor site in Cdc4 and multiple low-affinity CPD sites in Sic1.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Tyers, M (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	tyers@mshri.on.ca; sicheri@mshri.on.ca	Sicheri, Frank/F-8856-2013; Tyers, Michael/ABE-3194-2021	Orlicky, Stephen/0000-0002-8172-2042				Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Endicott JA, 1999, CURR OPIN STRUC BIOL, V9, P738, DOI 10.1016/S0959-440X(99)00038-X; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Harper JW, 2001, CURR BIOL, V11, pR431, DOI 10.1016/S0960-9822(01)00253-6; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hsiung YG, 2001, MOL CELL BIOL, V21, P2506, DOI 10.1128/MCB.21.7.2506-2520.2001; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Meimoun A, 2000, MOL BIOL CELL, V11, P915, DOI 10.1091/mbc.11.3.915; MILLER R, 1994, J APPL CRYSTALLOGR, V27, P613, DOI 10.1107/S0021889894000191; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Selkoe DJ, 2001, P NATL ACAD SCI USA, V98, P11039, DOI 10.1073/pnas.211352598; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spruck CH, 2002, CANCER RES, V62, P4535; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	48	418	427	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 24	2003	112	2					243	256		10.1016/S0092-8674(03)00034-5	http://dx.doi.org/10.1016/S0092-8674(03)00034-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553912	Bronze			2022-12-28	WOS:000181191600013
J	Blakemore, C; Dawkins, R; Noble, D; Yudkin, M				Blakemore, C; Dawkins, R; Noble, D; Yudkin, M			Is a scientific boycott ever justified? Practical guidance is needed to uphold the universality of science.	NATURE			English	Editorial Material									Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Univ Oxford, Univ Museum, Oxford OX1 3PT, England; Univ Oxford, Dept Biochem, Oxford OX1 3PT, England	University of Oxford; University of Oxford; University of Oxford	Blakemore, C (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.			Blakemore, Colin/0000-0003-2659-7899				2002, NATURE, V417, P690	1	1	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					314	314		10.1038/421314a	http://dx.doi.org/10.1038/421314a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540875				2022-12-28	WOS:000180533000018
J	Chanteau, S; Rahalison, L; Ralafiarisoa, L; Foulon, J; Ratsitorahina, M; Ratsifasoamanana, L; Carniel, E; Nato, A				Chanteau, S; Rahalison, L; Ralafiarisoa, L; Foulon, J; Ratsitorahina, M; Ratsifasoamanana, L; Carniel, E; Nato, A			Development and testing of a rapid diagnostic test for bubonic and pneumonic plague	LANCET			English	Article							IMMUNOCHROMATOGRAPHIC ASSAY; MADAGASCAR; ANTIGEN	Background Plague is often fatal without prompt and appropriate treatment. It affects mainly poor and remote populations. Late diagnosis is one of the major causes of human death and spread of the disease, since it limits the effectiveness of control measures. We aimed to develop and assess a rapid diagnostic test (RDT) for plague. Methods We developed a test that used monoclonal antibodies to the F1 antigen of Yersinia pestis. Sensitivity and specificity were assessed with a range of bacterial cultures and clinical samples, and compared with findings from available ELISA and bacteriological tests for plague. Samples from patients thought to have plague were tested with the RDT in the laboratory and by health workers in 26 pilot sites in Madagascar. Findings The RDT detected concentrations of F1 antigen as low as 0.5 ng/mL in up to 15 min, and had a shelf life of 21 days at 60degreesC. Its sensitivity and specificity were both 100%. RDT detected 41.6% and 31% more positive clinical specimens than did bacteriological methods and ELISA, respectively. The agreement rate between tests done at remote centres and in the laboratory was 89.8%. With the combination of bacteriological methods and F1 ELISA as reference standard, the positive and negative predictive values of the ROT were 90.6% and 86.7%, respectively. Interpretation Our RDT is a specific, sensitive, and reliable test that can easily be done by health workers at the patient's bedside, for the rapid diagnosis of pneumonic and bubonic plague. This test will be of key importance for the control of plague in endemic countries.	WHO, Collaborating Ctr Plague, Inst Pasteur Madagascar, Antananarivo, Madagascar; Minist Hlth, Plague Natl Control Programme, Antananarivo, Madagascar; WHO, Collaborating Ctr Yersinia, Inst Pasteur, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; World Health Organization	Chanteau, S (corresponding author), CERMES, POB 10 887, Niamey, Niger.							BAKER EE, 1952, J IMMUNOL, V68, P131; Bellamy RJ, 2001, QJM-MON J ASSOC PHYS, V94, P227, DOI 10.1093/qjmed/94.4.227; BIMBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Boisier P, 2002, EMERG INFECT DIS, V8, P311, DOI 10.3201/eid0803.010250; BRUBAKER R R, 1970, Infection and Immunity, V1, P446; Chanteau S, 2000, MICROBES INFECT, V2, P25, DOI 10.1016/S1286-4579(00)00289-6; Chanteau S, 1998, EMERG INFECT DIS, V4, P101, DOI 10.3201/eid0401.980114; Chanteau S, 1998, T ROY SOC TROP MED H, V92, P572, DOI 10.1016/S0035-9203(98)90923-3; Chanteau S, 2000, INT J MED MICROBIOL, V290, P279; CHEN TH, 1966, B WORLD HEALTH ORGAN, V34, P911; Cole RA, 1996, TUBERCLE LUNG DIS, V77, P363, DOI 10.1016/S0962-8479(96)90103-3; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Makler MT, 1998, ANN TROP MED PARASIT, V92, P419, DOI 10.1080/00034989859401; Paek SH, 2000, METHODS, V22, P53, DOI 10.1006/meth.2000.1036; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; PHALIPON A, 1992, INFECT IMMUN, V60, P1919, DOI 10.1128/IAI.60.5.1919-1926.1992; Rahalison L, 2000, J CLIN MICROBIOL, V38, P260; Ratsitorahina M, 2000, LANCET, V355, P111, DOI 10.1016/S0140-6736(99)05163-6; Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7; *WHO, 2000, WKLY EPIDEMIOL REC, V75, P337; WILLIAMS JE, 1986, B WORLD HEALTH ORGAN, V64, P745	21	129	149	1	17	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					211	216		10.1016/S0140-6736(03)12270-2	http://dx.doi.org/10.1016/S0140-6736(03)12270-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547544				2022-12-28	WOS:000180535400010
J	Hoy, D; Toole, MJ; Morgan, D; Morgan, C				Hoy, D; Toole, MJ; Morgan, D; Morgan, C			Low back pain in rural Tibet	LANCET			English	Article								In a baseline assessment of 30 rural villages surrounding Shigatse City, Tibet, many people, especially women, identified low back pain as a serious health problem. Consequently, we aimed to establish the prevalence of such pain and to develop appropriate interventions. We did a cross-sectional study of the prevalence of low back pain and related functional disability using two-stage random cluster sampling. We included 499 adults aged at least 15 years from 19 villages. The point prevalence of low back pain was 34.1% (95% CI 27.9-40.3% [170 people]); the 12-month prevalence was 41.9% (35.5-48.3% [209 people]). 100 (20%) villagers had substantial functional disability associated with low back pain. Low back pain is likely to be an important and under recognised problem in rural societies like Tibet.	Ctr Int Hlth, Burnet Inst, Melbourne, Vic 3001, Australia	Burnet Institute	Hoy, D (corresponding author), Ctr Int Hlth, Burnet Inst, POB 2284, Melbourne, Vic 3001, Australia.		Morgan, Chris/L-1613-2019	Morgan, Chris/0000-0003-0931-5474				Anderson R T, 1984, Med Anthropol, V8, P46; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; TOROPTSOVA NV, 1995, SPINE, V20, P328, DOI 10.1097/00007632-199502000-00012; WIGLEY RD, 1994, J RHEUMATOL, V21, P1484	4	51	52	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					225	226		10.1016/S0140-6736(03)12254-4	http://dx.doi.org/10.1016/S0140-6736(03)12254-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547548				2022-12-28	WOS:000180535400014
J	Berkley, JA; Ross, A; Mwangi, I; Osier, FHA; Mohammed, M; Shebbe, M; Lowe, BS; Marsh, K; Newton, CRJC				Berkley, JA; Ross, A; Mwangi, I; Osier, FHA; Mohammed, M; Shebbe, M; Lowe, BS; Marsh, K; Newton, CRJC			Prognostic indicators of early and late death in children admitted to district hospital in Kenya: cohort study	BRITISH MEDICAL JOURNAL			English	Article							AFRICAN CHILDREN; RISK-FACTORS; MENINGOCOCCAL DISEASE; DEVELOPING-COUNTRIES; CLINICAL SIGNS; HEALTH-CARE; MALARIA; MORTALITY; PNEUMONIA; ADMISSION	Objectives To identify clinical indicators of immediate, early, and late mortality in children at admission to a sub-Saharan district hospital and to develop prognostic scores. Design Prospective cohort study. Setting One district hospital in Kenya. Participants Children aged over 90 days admitted to hospital from 1 July 1998 to 30 June 2001. Main outcome measures Prognostic indicators of mortality. Results Of 8091 children admitted up to 1 June 2000, 436 (5%) died. Sixty (14%) died within four hours after admission (immediate), 193 (44%) after 4-48 hours (early), and 183 (42%) after 48 hours (late). There were marked differences in the clinical features associated with immediate, early, and late death. Seven indicators (neurological status, respiratory distress (subcostal indrawing or deep breathing), nutritional status (wasting or kwashiorkor), severe anaemia, jaundice, axillary temperature, and length of history) were included in simplified prognostic scores. Data from 4802 children admitted from 1 July 2000 to 30 June 2001 were used to validate the scores. For simplified prognostic scores the areas under the receiver operating characteristic curves were 0.93 (95% confidence interval 0.92 to 0.94), 0.82 (0.80 to 0.83), and 0.82 (0.81 to 0.84) for immediate, early, and late death, respectively. Conclusion In children admitted to a sub-Saharan hospital, the prognostic indicators of early and late deaths differ but a small number of simple clinical signs predict outcome well.	KEMRI Ctr Geog Med Res Coast, Kilifi, Kenya		Berkley, JA (corresponding author), KEMRI Ctr Geog Med Res Coast, POB 230, Kilifi, Kenya.		Newton, Charles/C-6222-2009; Newton, Charles/V-7872-2019; Newton, Charles RJC/B-7578-2014	Newton, Charles/0000-0002-6999-5507; Newton, Charles RJC/0000-0002-6999-5507; Berkley, James/0000-0002-1236-849X; Osier, Faith/0000-0001-7133-5375	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; [Anonymous], 1999, WORLD HLTH REPORT 19; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Bhutta ZA, 1997, J TROP PEDIATRICS, V43, P330, DOI 10.1093/tropej/43.6.330; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; Collins S, 2000, JAMA-J AM MED ASSOC, V284, P621, DOI 10.1001/jama.284.5.621; Dramaix M, 1996, AM J EPIDEMIOL, V143, P1235, DOI 10.1093/oxfordjournals.aje.a008711; ENGLISH M, 1995, ARCH DIS CHILD, V72, P334, DOI 10.1136/adc.72.4.334; Gove S, 1999, ARCH DIS CHILD, V81, P473, DOI 10.1136/adc.81.6.473; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Man WDC, 1998, TROP MED INT HEALTH, V3, P678, DOI 10.1046/j.1365-3156.1998.00283.x; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Molyneux E, 2001, LANCET, V357, P86, DOI 10.1016/S0140-6736(00)03536-4; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; SACHDEV HPS, 1991, J PEDIATR GASTR NUTR, V12, P76, DOI 10.1097/00005176-199101000-00016; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Sehgal V, 1997, Indian Pediatr, V34, P213; SHANN F, 1989, PEDIATR INFECT DIS J, V8, P852, DOI 10.1097/00006454-198912000-00005; Snow RW, 2000, TROP MED INT HEALTH, V5, P377, DOI 10.1046/j.1365-3156.2000.00568.x; SPIEGELHALTER DJ, 1984, J R STAT SOC A STAT, V147, P35, DOI 10.2307/2981737; Straus SE, 2000, JAMA-J AM MED ASSOC, V283, P1853, DOI 10.1001/jama.283.14.1853; Thorburn K, 2001, ARCH DIS CHILD, V85, P382, DOI 10.1136/adc.85.5.382; World Health Organization, 2000, MAN CHILD SER INF SE	24	96	97	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2003	326	7385					361	364		10.1136/bmj.326.7385.361	http://dx.doi.org/10.1136/bmj.326.7385.361			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648RZ	12586667	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000181165500017
J	Piperno, DR; Stothert, KE				Piperno, DR; Stothert, KE			Phytolith evidence for early Holocene Cucurbita domestication in Southwest Ecuador	SCIENCE			English	Article								Cucurbita (squash and gourd) phytoliths recovered from two early Holocene archaeological sites in southwestern Ecuador and directly dated to 10,130 to 9320 carbon-14 years before the present (about 12,000 to 10,000 calendar years ago) are identified as derived from domesticated plants because they are considerably larger than those from modern wild taxa. The beginnings of plant husbandry appear to have been preceded by the exploitation of a wild species of Cucurbita during the terminal Pleistocene. These data provide evidence for an independent emergence of plant food production in lowland South America that was contemporaneous with or slightly before that in highland Mesoamerica.	Univ Texas, Ctr Archaeol Res, San Antonio, TX 78249 USA; Smithsonian Trop Res Inst, Balboa, Panama	University of Texas System; Smithsonian Institution; Smithsonian Tropical Research Institute	Piperno, DR (corresponding author), Smithsonian Trop Res Inst, Balboa, Panama.							Andres T. C, 2002, CUCURBITACEAE 2002, P95; BOZARTH SR, 1987, AM ANTIQUITY, V52, P607, DOI 10.2307/281602; Flannery K., 1986, GUILA NAQUITZ ARCHAI; HARLAN JR, 1971, SCIENCE, V174, P468, DOI 10.1126/science.174.4008.468; LATHRAP DW, 1975, ANCIENT ECUADOR CULT; NEE M, 1990, ECON BOT, V44, P56, DOI 10.1007/BF02860475; PEARSALL DM, 1996, DUMB OAKS C EC FORM, P213; Piperno D.R., 1998, ORIGINS AGR LOWLAND; Piperno D.R., 1988, PHYTOLITH ANAL ARCHA; Piperno DR, 2000, J ARCHAEOL SCI, V27, P193, DOI 10.1006/jasc.1999.0443; Piperno DR, 2002, P NATL ACAD SCI USA, V99, P10923, DOI 10.1073/pnas.152275499; Sanjur OI, 2002, P NATL ACAD SCI USA, V99, P535, DOI 10.1073/pnas.012577299; Sauer Carl O., 1952, AGR ORIGINS DISPERSA; Smith BD, 1997, SCIENCE, V276, P932, DOI 10.1126/science.276.5314.932; STOTHERT KE, 1985, AM ANTIQUITY, V50, P613, DOI 10.2307/280325; STOTHERT KE, IN PRESS QUAT INT	16	156	173	3	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1054	1057		10.1126/science.1080365	http://dx.doi.org/10.1126/science.1080365			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	645DB	12586940				2022-12-28	WOS:000180960000044
J	Waitzkin, H				Waitzkin, H			Report of the WHO Commission on Macroeconomics and Health: a summary and critique	LANCET			English	Editorial Material							WORLD-TRADE ORGANIZATION; MANAGED CARE		Univ New Mexico, Dept Family & Community Med, Albuquerque, NM 87131 USA	University of New Mexico	Waitzkin, H (corresponding author), Univ New Mexico, Dept Family & Community Med, 2400 Tucker Ave NE, Albuquerque, NM 87131 USA.	waitzkin@unm.edu			NLM NIH HHS [1G08 LM06688] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [G08LM006688] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Almeida C, 2001, LANCET, V357, P1692, DOI 10.1016/S0140-6736(00)04825-X; [Anonymous], 2001, MACR HLTH INV HLTH E; Attaran A, 2001, JAMA-J AM MED ASSOC, V286, P1886, DOI 10.1001/jama.286.15.1886; Birn AE, 1999, SOC SCI MED, V49, P1197, DOI 10.1016/S0277-9536(99)00160-4; Cueto Marcos, 1994, MISSIONARIES SCI ROC; Feachem RGA, 2002, BMJ-BRIT MED J, V324, P135, DOI 10.1136/bmj.324.7330.135; FINNEGAN W, 2002, NEW YORKER      0408, P43; Horton R, 2002, LANCET, V359, P1605, DOI 10.1016/S0140-6736(02)08523-9; Iriart C, 2001, SOC SCI MED, V52, P1243, DOI 10.1016/S0277-9536(00)00243-4; Laurell AC, 1996, INT J HEALTH SERV, V26, P1, DOI 10.2190/PBX9-N89E-4QFE-046V; Navarro V, 2000, LANCET, V356, P1598, DOI 10.1016/S0140-6736(00)03139-1; Pollock AM, 2000, LANCET, V356, P1995, DOI 10.1016/S0140-6736(00)03317-1; Price D, 1999, LANCET, V354, P1889, DOI 10.1016/S0140-6736(99)11060-2; Rao M., 1999, DISINVESTING HLTH WO; Singh Kavaljit, 2000, TAMING GLOBAL FINANC; Stocker K, 1999, NEW ENGL J MED, V340, P1131, DOI 10.1056/NEJM199904083401425; Turshen M., 1999, PRIVATIZING HLTH SER; World Bank, 2001, WORLD DEV REP 2000 2; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 2000, WORLD HLTH REP 2000; 2002, LANCET, V360, P885	21	45	48	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					523	526		10.1016/S0140-6736(03)12491-9	http://dx.doi.org/10.1016/S0140-6736(03)12491-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583963				2022-12-28	WOS:000180900600027
J	Deres, K; Schroder, CH; Paessens, A; Goldmann, S; Hacker, HJ; Weber, O; Kramer, T; Niewohner, U; Pleiss, U; Stoltefuss, J; Graef, E; Koletzki, D; Masantschek, RNA; Reimann, A; Jaeger, R; Gross, R; Beckermann, B; Schlemmer, KH; Haebich, D; Rubsamen-Waigmann, H				Deres, K; Schroder, CH; Paessens, A; Goldmann, S; Hacker, HJ; Weber, O; Kramer, T; Niewohner, U; Pleiss, U; Stoltefuss, J; Graef, E; Koletzki, D; Masantschek, RNA; Reimann, A; Jaeger, R; Gross, R; Beckermann, B; Schlemmer, KH; Haebich, D; Rubsamen-Waigmann, H			Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids	SCIENCE			English	Article							DNA-SYNTHESIS	Chronic hepatitis B virus (HBV) infection is a major cause of liver disease. Only interferon-alpha and the nucleosidic inhibitors of the viral polymerase, 3TC and adefovir, are approved for therapy. However, these therapies are limited by the side effects of interferon and the substantial resistance of the virus to nucleosidic inhibitors. Potent new antiviral compounds suitable for monotherapy or combination therapy are highly desired. We describe non-nucleosidic inhibitors of HBV nucleocapsid maturation that possess in vitro and in vivo antiviral activity. These inhibitors have potential for future therapeutic regimens to combat chronic HBV infection.	Bayer Res Ctr, Dept Virol, Wuppertal, Germany; Bayer Res Ctr, Chem, Wuppertal, Germany; Bayer Res Ctr, Isotope Chem, Wuppertal, Germany; Bayer Res Ctr, Preclin Pharmakokinet, Wuppertal, Germany; Bayer Res Ctr, Toxicol, Wuppertal, Germany; Bayer Res Ctr, Safety Pharmacol, Wuppertal, Germany; Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany; Bayer Corp, Div Pharmaceut, West Haven, CT 06516 USA	Bayer AG; Bayer AG; Bayer AG; Bayer AG; Bayer AG; Bayer AG; Helmholtz Association; German Cancer Research Center (DKFZ); Bayer AG	Deres, K (corresponding author), Bayer Res Ctr, Dept Virol, Wuppertal, Germany.							Delaney WE, 2001, ANTIVIR CHEM CHEMOTH, V12, P1; Deres K, 1999, INFECTION, V27, pS45, DOI 10.1007/BF02561672; Doyle ML, 1997, CURR OPIN BIOTECH, V8, P31, DOI 10.1016/S0958-1669(97)80154-1; Fischer KR, 2001, DRUG RESIST UPDATE, V4, P118, DOI 10.1054/drup.2001.0190; King RW, 1998, ANTIMICROB AGENTS CH, V42, P3179, DOI 10.1128/AAC.42.12.3179; LAMBERTS C, 1993, J VIROL, V67, P3756, DOI 10.1128/JVI.67.7.3756-3762.1993; Nassal M, 1996, CURR TOP MICROBIOL, V214, P297; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Weber O, 2002, ANTIVIR RES, V54, P69, DOI 10.1016/S0166-3542(01)00216-9	10	417	486	7	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					893	896		10.1126/science.1077215	http://dx.doi.org/10.1126/science.1077215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574631				2022-12-28	WOS:000180830900053
J	Li, J; Li, X; Zhai, HJ; Wang, LS				Li, J; Li, X; Zhai, HJ; Wang, LS			Au-20: A tetrahedral cluster	SCIENCE			English	Article							ION MOBILITY MEASUREMENTS; PHOTOELECTRON-SPECTROSCOPY; GOLD CLUSTERS; METAL-CLUSTERS; TRANSITION; OXIDATION; ANIONS; SIZE; C-60	Photoelectron spectroscopy revealed that a 20-atom gold cluster has an extremely large energy gap, which is even greater than that of C-60, and an electron affinity comparable with that of C-60. This observation suggests that the AU(20) cluster should be highly stable and chemically inert. Using relativistic density functional calculations, we found that AU(20) possesses a tetrahedral structure, which is a fragment of the face-centered cubic lattice of bulk gold with a small structural relaxation. AU(20) is thus a unique molecule with atomic packing similar to that of bulk gold but with very different properties.	Pacific NW Natl Lab, WR Wiley Environm Mol Sci Lab, Richland, WA 99352 USA; Washington State Univ, Dept Phys, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Washington State University	Wang, LS (corresponding author), Pacific NW Natl Lab, WR Wiley Environm Mol Sci Lab, POB 999, Richland, WA 99352 USA.	ls.wang@pnl.gov	Zhai, Hua-Jin/E-8715-2011; Li, Jun/E-5334-2011	Zhai, Hua-Jin/0000-0002-1592-0534; Li, Jun/0000-0002-8456-3980				Bonacic-Koutecky V, 2002, J CHEM PHYS, V117, P3120, DOI 10.1063/1.1492800; Boyen HG, 2002, SCIENCE, V297, P1533, DOI 10.1126/science.1076248; Chen SW, 1998, SCIENCE, V280, P2098, DOI 10.1126/science.280.5372.2098; DEHEER WA, 1993, REV MOD PHYS, V65, P611, DOI 10.1103/RevModPhys.65.611; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; Furche F, 2002, J CHEM PHYS, V117, P6982, DOI 10.1063/1.1507582; Garzon IL, 1998, PHYS REV LETT, V81, P1600, DOI 10.1103/PhysRevLett.81.1600; Gilb S, 2002, J CHEM PHYS, V116, P4094, DOI 10.1063/1.1445121; GUNNARSSON O, 1995, PHYS REV LETT, V74, P1875, DOI 10.1103/PhysRevLett.74.1875; Haberlen OD, 1997, J CHEM PHYS, V106, P5189, DOI 10.1063/1.473518; Hakkinen H, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.033401; Hayat M.A., 1989, COLLOIDAL GOLD PRINC; Heiz U, 2000, J PHYS D APPL PHYS, V33, pR85, DOI 10.1088/0022-3727/33/11/201; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Li X, 2002, ANGEW CHEM INT EDIT, V41, P4786, DOI 10.1002/anie.200290048; Lopez N, 2002, J AM CHEM SOC, V124, P11262, DOI 10.1021/ja026998a; Luedtke WD, 1996, J PHYS CHEM-US, V100, P13323, DOI 10.1021/jp961721g; Nilius N, 2002, SCIENCE, V297, P1853, DOI 10.1126/science.1075242; PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244; Prinzbach H, 2000, NATURE, V407, P60, DOI 10.1038/35024037; Pyykko P, 2002, ANGEW CHEM INT EDIT, V41, P2174, DOI 10.1002/1521-3773(20020617)41:12<2174::AID-ANIE2174>3.0.CO;2-8; Sanchez A, 1999, J PHYS CHEM A, V103, P9573, DOI 10.1021/jp9935992; TARLOR KJ, 1992, J CHEM PHYS, V96, P3319; Templeton AC, 2000, ACCOUNTS CHEM RES, V33, P27, DOI 10.1021/ar9602664; Valden M, 1998, SCIENCE, V281, P1647, DOI 10.1126/science.281.5383.1647; van Gisbergen SJA, 1999, COMPUT PHYS COMMUN, V118, P119, DOI 10.1016/S0010-4655(99)00187-3; VANLENTHE E, 1993, J CHEM PHYS, V99, P4597, DOI 10.1063/1.466059; Wang J, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.064406; Wang L. S., 2000, CLUSTERS NANOSTRUCTU, P293; WANG LS, 1995, J CHEM PHYS, V102, P9480, DOI 10.1063/1.468817; Wang LS, 1999, REV SCI INSTRUM, V70, P1957, DOI 10.1063/1.1149694; Wang XB, 1999, J CHEM PHYS, V110, P8217, DOI 10.1063/1.478732; Whetten RL, 1999, ACCOUNTS CHEM RES, V32, P397, DOI 10.1021/ar970239t; Wilson NT, 2000, EUR PHYS J D, V12, P161, DOI 10.1007/s100530070053	35	1007	1018	25	421	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					864	867		10.1126/science.1079879	http://dx.doi.org/10.1126/science.1079879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574622				2022-12-28	WOS:000180830900044
J	Pi-Sunyer, X				Pi-Sunyer, X			A clinical view of the obesity problem	SCIENCE			English	Editorial Material							WEIGHT-LOSS; LONG-TERM; MAINTENANCE		Columbia Univ, St Lukes Roosevelt Hosp, Obes Res Ctr, New York, NY 10025 USA	Columbia University; Mount Sinai St. Luke's; Mount Sinai West	Pi-Sunyer, X (corresponding author), Columbia Univ, St Lukes Roosevelt Hosp, Obes Res Ctr, New York, NY 10025 USA.							KEYS A, 1950, BIOL HUMAN STARVATIO, P827; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; Klem ML, 1997, AM J CLIN NUTR, V66, P239, DOI 10.1093/ajcn/66.2.239; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; PiSunyer FX, 1996, CLIN THER, V18, P1006, DOI 10.1016/S0149-2918(96)80057-9; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; PISUNYER FX, 1993, ANN INTERN MED, V119, P722, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00019; PRENTICE AM, 1995, BRIT MED J, V311, P437, DOI 10.1136/bmj.311.7002.437; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; WADDEN TA, 1994, J CONSULT CLIN PSYCH, V62, P165, DOI 10.1037/0022-006X.62.1.165; WEIGLE DS, 1994, FASEB J, V8, P302, DOI 10.1096/fasebj.8.3.8143936; Wing R. R., 1998, HDB OBESITY, P855; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323	13	85	91	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					859	860		10.1126/science.1082319	http://dx.doi.org/10.1126/science.1082319			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574620				2022-12-28	WOS:000180830900041
J	Xiao, B; Jing, C; Wilson, JR; Walker, PA; Vasisht, N; Kelly, G; Howell, S; Taylor, IA; Blackburn, GM; Gamblin, SJ				Xiao, B; Jing, C; Wilson, JR; Walker, PA; Vasisht, N; Kelly, G; Howell, S; Taylor, IA; Blackburn, GM; Gamblin, SJ			Structure and catalytic mechanism of the human histone methyltransferase SET7/9	NATURE			English	Article							CHROMATIN-STRUCTURE; DOMAIN; METHYLATION; ACETYLATION; SITE	Acetylation(1,2), phosphorylation(3) and methylation(4) of the amino-terminal tails of histones are thought to be involved in the regulation of chromatin structure and function(5-7). With just one exception(8,9), the enzymes identified in the methylation of specific lysine residues on histones (histone methyltransferases) belong to the SET family(10). The high-resolution crystal structure of a ternary complex of human SET7/9 with a histone peptide and cofactor reveals that the peptide substrate and cofactor bind on opposite surfaces of the enzyme. The target lysine accesses the active site of the enzyme and the S-adenosyl-L-methionine (AdoMet) cofactor by inserting its side chain into a narrow channel that runs through the enzyme, connecting the two surfaces. Here we show from the structure and from solution studies that SET7/9, unlike most other SET proteins, is exclusively a mono-methylase. The structure indicates the molecular basis of the specificity of the enzyme for the histone target, and allows us to propose a model for the methylation reaction that accounts for the role of many of the residues that are invariant across the SET family.	Natl Inst Med Res, Struct Biol Grp, London NW7 1AA, England; Univ Sheffield, Dept Chem, Krebs Inst, Sheffield S3 7HF, S Yorkshire, England	MRC National Institute for Medical Research; University of Sheffield	Gamblin, SJ (corresponding author), Natl Inst Med Res, Struct Biol Grp, Mill Hill, London NW7 1AA, England.	sgambli@nimr.mrc.ac.uk	Wilson, Jon R/B-7362-2019	Wilson, Jon R/0000-0002-5157-5432; Gamblin, Steve/0000-0001-5331-639X				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; Jacobs SA, 2002, NAT STRUCT BIOL, V9, P833, DOI 10.1038/nsb861; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Min JR, 2002, NAT STRUCT BIOL, V9, P828, DOI 10.1038/nsb860; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Spotswood HT, 2002, J CLIN INVEST, V110, P577, DOI 10.1172/JCI200216547; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6	20	299	310	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2003	421	6923					652	656		10.1038/nature01378	http://dx.doi.org/10.1038/nature01378			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12540855	Green Accepted			2022-12-28	WOS:000180803200047
J	Forster, AJ; Murff, HJ; Peterson, JF; Gandhi, TK; Bates, DW				Forster, AJ; Murff, HJ; Peterson, JF; Gandhi, TK; Bates, DW			The incidence and severity of adverse events affecting patients after discharge from the hospital	ANNALS OF INTERNAL MEDICINE			English	Article							DRUG EVENTS; CARE; PREVENTABILITY; INFECTIONS; QUALITY	Background: Studies of hospitalized patients identify safety as a significant problem, but few data are available regarding injuries occurring after discharge. Patients may be vulnerable during this transition period. Objective: To describe the incidence, severity, preventability, and "ameliorability" of adverse events affecting patients after discharge from the hospital and to develop strategies for improving patient safety during this interval. Design: Prospective cohort study. Setting: A tertiary care academic hospital. Patients: 400 consecutive patients discharged home from the general medical service. Measurements: The three main outcomes were adverse events, defined as injuries occurring as a result of medical management; preventable adverse events, defined as adverse events judged to have been caused by an error; and ameliorable adverse events, defined as adverse events whose severity could have been decreased. Posthospital course was determined by performing a medical record review and a structured telephone interview approximately 3 weeks after each patient's discharge. Outcomes were determined by independent physician reviews. Results: Seventy-six patients had adverse events after discharge (19% [95% Cl, 15% to 23%]). Of these, 23 had preventable adverse events (6% [Cl, 4% to 9%]) and 24 held ameliorable adverse events (6% [Cl, 4% to 9%]). Three percent of injuries were serious laboratory abnormalities, 65% were symptoms, 30% were symptoms associated with a nonpermanent disability, and 3% were permanent disabilities. Adverse drug events were the most common type of adverse event (66% [Cl, 55% to 76%]), followed by procedure-related injuries (17% [Cl, 86% to 26%]). Of the 25 adverse events resulting in at least a nonpermanent disability, 12 were preventable (48% [Cl, 28% to 68%]) and 6 were ameliorable (24% [Cl, 7% to 41%]). Conclusion: Adverse events occurred frequently in the peridischarge period, and many could potentially have been prevented or ameliorated with simple strategies.	Univ Ottawa, Ottawa, ON K1N 6N5, Canada; Harvard Univ, Sch Med, Boston, MA USA	University of Ottawa; Harvard University; Harvard Medical School	Bates, DW (corresponding author), Brigham & Womens Hosp, Div Gen Med, 75 Francis St,PBB-A3, Boston, MA 02115 USA.	dbates@partners.org	Bates, David/AAE-7283-2019					BATES DW, 1993, J GEN INTERN MED, V8, P289, DOI 10.1007/BF02600138; Benbassat J, 2000, ARCH INTERN MED, V160, P1074, DOI 10.1001/archinte.160.8.1074; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; CAPLAN RA, 1991, JAMA-J AM MED ASSOC, V265, P1957, DOI 10.1001/jama.265.15.1957; Cook RI, 2000, BRIT MED J, V320, P791, DOI 10.1136/bmj.320.7237.791; Delgado-Rodriguez M, 2001, INFECT CONT HOSP EP, V22, P24, DOI 10.1086/501820; Gandhi TK, 2000, J GEN INTERN MED, V15, P149, DOI 10.1046/j.1525-1497.2000.04199.x; Hayward RA, 2001, JAMA-J AM MED ASSOC, V286, P415, DOI 10.1001/jama.286.4.415; *I MED, 2000, ERR HUM BUILD SAF HL; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kelley MA, 1999, ANN INTERN MED, V130, P373, DOI 10.7326/0003-4819-130-4-199902161-00009; KOSECOFF J, 1990, JAMA-J AM MED ASSOC, V264, P1980, DOI 10.1001/jama.264.15.1980; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Mitchell DH, 1999, AUST NZ J SURG, V69, P117, DOI 10.1046/j.1440-1622.1999.01500.x; PARKES J, 2000, COCHRANE DATABASE SY; SANAZARO PJ, 1991, JAMA-J AM MED ASSOC, V265, P1977, DOI 10.1001/jama.265.15.1977; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003	18	1203	1226	1	46	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					161	167		10.7326/0003-4819-138-3-200302040-00007	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558354				2022-12-28	WOS:000181018600001
J	Sandy, LG; Schroeder, SA				Sandy, LG; Schroeder, SA			Primary care in a new era: Disillusion and dissolution?	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-CARE; UNITED-STATES; HOSPITALIST; MEDICINE; PREVALENCE; WORKFORCE; OUTCOMES; COSTS	The current dilemmas in primary care stem from 1) the unintended consequences of forces thought to promote primary care and 2) the "disruptive technologies of care" that attack the very function and concept of primary care itself. This paper suggests that these forces, in combination with "tiering" in the health insurance market, could lead to the dissolution of primary care as a single concept, to be replaced by alignment of clinicians by economic niche. Evidence already exists in the marketplace for both tiering of health insurance benefits and corresponding practice changes within primary care. In the future, primary care for the top tier will cater to the affluent as "full-service brokers" and will be delivered by a wide variety of clinicians. The middle tier will continue to grapple with tensions created by patient demand and bureaucratic systems but will remain most closely aligned to primary care as a concept. The lower tier will become increasingly concerned with community health and social justice. Each primary care specialty will adapt in a unique way to a tiered world, with general internal medicine facing the most challenges. Given this forecast for the future, those concerned about primary care should focus less on workforce issues and more on macro health care financing and organization issues (such as Medicare reform); appropriate training models; and the development of a conception of primary care that emphasizes values and ethos, not just function.	Robert Wood Johnson Fdn, Princeton, NJ 08543 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Robert Wood Johnson Foundation (RWJF); University of California System; University of California San Francisco	Sandy, LG (corresponding author), Robert Wood Johnson Fdn, Route 1 & Coll Rd E,POB 2316, Princeton, NJ 08543 USA.	lsandy@rwjf.org						*AM MED ASS, 2000, PHYS SOC STAT; *ASS AM MED COLL, 1984, MED SCH GRAD QUEST A; *ASS AM MED COLL, 1997, MED SCH GRAD QUEST A; Auerbach AD, 2000, AM J MED, V109, P648, DOI 10.1016/S0002-9343(00)00597-0; Chen J, 2000, AM J MED, V108, P460, DOI 10.1016/S0002-9343(00)00331-4; Christensen CM, 2000, HARVARD BUS REV, V78, P102; COOKSON JP, 2001, COUNC EC IMP HLTH SY; Cooper RA, 1998, JAMA-J AM MED ASSOC, V280, P788, DOI 10.1001/jama.280.9.788; *COUNC GRAD MED ED, 14 COUNC GRADMED ED; *CTR MED MED SERV, 2000 MED MAN CAR ENR; *CTR MED MED SERV, 1997, MED MAN CAR ENR REP; *CTR MED MED SERV, 2001, MED MAN CAR CONTR MM; *CTR STUD HLTH SYS, 1998, COMM TRACK STUD PHYS; Donaldson M, 1996, PRIMARY CARE AM HLTH; FIRSHEIN J, 2001, IMPROVE HLTH HLTH CA, P77; Gabel J, 1999, HEALTH AFFAIR, V18, P144, DOI 10.1377/hlthaff.18.3.144; GINSBERG P, 1999, TRACKING HLTH CARE C; GREENE J, 2001, AM MED NEWS     0409; GROSEL C, 2000, HLTH HLTH CARE 2010; Hogan C, 2000, HEALTH AFFAIR, V19, P217, DOI 10.1377/hlthaff.19.6.217; Lurie JD, 1999, AM J MED, V106, P441, DOI 10.1016/S0002-9343(99)00045-5; Manton KG, 2001, P NATL ACAD SCI USA, V98, P6354, DOI 10.1073/pnas.111152298; Moore G, 2003, ANN INTERN MED, V138, P244, DOI 10.7326/0003-4819-138-3-200302040-00032; MUNDINGER MO, 1994, NEW ENGL J MED, V330, P211, DOI 10.1056/NEJM199401203300314; Oberlander J, 2000, HEALTH AFFAIR, V19, P84, DOI 10.1377/hlthaff.19.5.84; Reinhardt U E, 1996, Baxter Health Policy Rev, V2, P63; REISCHAUER RD, 1998, MEDICARE PREPARING C; Rothman AA, 2003, ANN INTERN MED, V138, P256, DOI 10.7326/0003-4819-138-3-200302040-00034; Safran DG, 2003, ANN INTERN MED, V138, P248, DOI 10.7326/0003-4819-138-3-200302040-00033; SCHROEDER SA, 1978, MED CARE, V16, P289, DOI 10.1097/00005650-197804000-00002; Schroeder SA, 1999, ANN INTERN MED, V130, P382, DOI 10.7326/0003-4819-130-4-199902161-00011; Showstack J A, 1979, Inquiry, V16, P230; Solomon DH, 1997, ANN INTERN MED, V127, P52, DOI 10.7326/0003-4819-127-1-199707010-00009; SWARTZ K, 2001, COUNC EC IMP HLTH SY; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487; Wachter RM, 1996, NEW ENGL J MED, V335, P514, DOI 10.1056/NEJM199608153350713; Yedidia MJ, 2000, JAMA-J AM MED ASSOC, V284, P1093, DOI 10.1001/jama.284.9.1093	37	35	35	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					262	267		10.7326/0003-4819-138-3-200302040-00035	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00035			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558377				2022-12-28	WOS:000181018600027
J	Fairburn, CG; Harrison, PJ				Fairburn, CG; Harrison, PJ			Eating disorders	LANCET			English	Review							COGNITIVE-BEHAVIORAL-APPROACH; ENVIRONMENTAL RISK-FACTORS; POPULATION-BASED TWIN; ANOREXIA-NERVOSA; BULIMIA-NERVOSA; SELF-HELP; INTERPERSONAL PSYCHOTHERAPY; CONTROLLED FAMILY; FOLLOW-UP; MAJOR DEPRESSION	Eating disorders are an important cause of physical and psychosocial morbidity in adolescent girls and young adult women. They are much less frequent in men. Eating disorders are divided into three diagnostic categories: anorexia nervosa, bulimia nervosa, and the atypical eating disorders. However, the disorders have many features in common and patients frequently move between them, so for the purposes of this Seminar we have adopted a transdiagnostic perspective. The cause of eating disorders is complex and badly understood. There is a genetic predisposition, and certain specific environmental risk factors have been implicated. Research into treatment has focused on bulimia nervosa, and evidence-based management of this disorder is possible. A specific form of cognitive behaviour therapy is the most effective treatment, although few patients seem to receive it in practice. Treatment of anorexia nervosa and atypical eating disorders has received remarkably little research attention.	Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England	University of Oxford	Fairburn, CG (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	credo@medicine.ox.ac.uk	Fairburn, Christopher/AAM-9792-2020; Fairburn, Christopher/AAG-6234-2019	Fairburn, Christopher/0000-0002-9673-9795; Harrison, Paul/0000-0002-6719-1126				Agras WS, 2000, ARCH GEN PSYCHIAT, V57, P459, DOI 10.1001/archpsyc.57.5.459; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Andersen AE, 2001, PSYCHIAT CLIN N AM, V24, P271, DOI 10.1016/S0193-953X(05)70223-9; Barry DT, 2002, INT J EAT DISORDER, V31, P63, DOI 10.1002/eat.1112; Bell L, 2002, Eat Weight Disord, V7, P168; BEUMONT PJV, 2002, EATING DISORDERS OBE, P162; BRYANTWAUGH R, 2002, EATING DISORDERS OBE, P210; Bulik C M, 2001, Obes Rev, V2, P107, DOI 10.1046/j.1467-789x.2001.00030.x; Bulik CM, 2000, INT J EAT DISORDER, V27, P1; Bulik CM, 1998, BIOL PSYCHIAT, V44, P1210, DOI 10.1016/S0006-3223(98)00280-7; Bulik CM, 1998, COMPR PSYCHIAT, V39, P206, DOI 10.1016/S0010-440X(98)90062-1; Bulik CM, 1997, J NERV MENT DIS, V185, P704, DOI 10.1097/00005053-199711000-00009; BUSHNELL JA, 1990, PSYCHOL MED, V20, P671, DOI 10.1017/S0033291700017190; Cachelin FM, 1999, INT J EAT DISORDER, V25, P45, DOI 10.1002/(SICI)1098-108X(199901)25:1<45::AID-EAT6>3.3.CO;2-V; Carter JC, 1998, J CONSULT CLIN PSYCH, V66, P616, DOI 10.1037/0022-006X.66.4.616; CARTER JC, IN PRESS AM J PSYCHI; Collier DA, 1997, LANCET, V350, P412, DOI 10.1016/S0140-6736(05)64135-9; COLLINGS S, 1994, BRIT J PSYCHIAT, V164, P80, DOI 10.1192/bjp.164.1.80; CONNORS ME, 1996, DEV PSYCHOPATHOL, P285; Cowen PJ, 1996, PSYCHOL MED, V26, P1155, DOI 10.1017/S003329170003587X; Crow S, 1999, INT J EAT DISORDER, V25, P39, DOI 10.1002/(SICI)1098-108X(199901)25:1<39::AID-EAT5>3.0.CO;2-W; Dansky BS, 2000, INT J EAT DISORDER, V27, P180, DOI 10.1002/(SICI)1098-108X(200003)27:2<180::AID-EAT6>3.0.CO;2-Z; DAVIS R, 1990, J CONSULT CLIN PSYCH, V58, P882, DOI 10.1037/0022-006X.58.6.882; Deng HW, 2002, AM J HUM GENET, V70, P1138, DOI 10.1086/339934; Devlin B, 2002, HUM MOL GENET, V11, P689, DOI 10.1093/hmg/11.6.689; Dingemans AE, 2002, INT J OBESITY, V26, P299, DOI 10.1038/sj.ijo.0801949; Eddy KT, 2002, INT J EAT DISORDER, V31, P191, DOI 10.1002/eat.10016; Eisler I., 2002, EATING DISORDERS OBE, P314; FAIRBURN C, 1981, PSYCHOL MED, V11, P707, DOI 10.1017/S0033291700041209; Fairburn C., 1997, OX MED PUBL, P209; Fairburn C. G., 2002, EAT DISORD OBES COMP, V2, P171; Fairburn CG, 2000, ARCH GEN PSYCHIAT, V57, P659, DOI 10.1001/archpsyc.57.7.659; FAIRBURN CG, 1993, ARCH GEN PSYCHIAT, V50, P419; FAIRBURN CG, 1982, BRIT MED J, V284, P1153, DOI 10.1136/bmj.284.6323.1153; Fairburn CG, 1999, ARCH GEN PSYCHIAT, V56, P468, DOI 10.1001/archpsyc.56.5.468; Fairburn CG, 1998, ARCH GEN PSYCHIAT, V55, P425, DOI 10.1001/archpsyc.55.5.425; Fairburn CG, 1997, ARCH GEN PSYCHIAT, V54, P509; Fairburn CG, 1996, AM J PSYCHIAT, V153, P386; FAIRBURN CG, 1995, ARCH GEN PSYCHIAT, V52, P304; Fairburn CG, 1999, BEHAV RES THER, V37, P1, DOI 10.1016/S0005-7967(98)00102-8; Fairburn CG, 1999, INT J EAT DISORDER, V26, P349, DOI 10.1002/(SICI)1098-108X(199912)26:4<349::AID-EAT1>3.0.CO;2-B; FAIRBURN CG, IN PRESS BEHAV RES T; FAIRBURN CG, IN PRESS J CONSULT C; Fairburn Christopher G., 1993, P361; Fairburn Christopher G., 1997, P278; Fichter MM, 1997, INT J EAT DISORDER, V22, P361, DOI 10.1002/(SICI)1098-108X(199712)22:4&lt;361::AID-EAT2&gt;3.0.CO;2-K; FOMBONNE E, 1995, BRIT J PSYCHIAT, V166, P462, DOI 10.1192/bjp.166.4.462; Frank GK, 2002, BIOL PSYCHIAT, V52, P896, DOI 10.1016/S0006-3223(02)01378-1; Franko DL, 2000, OBSTET GYNECOL, V95, P942, DOI 10.1016/S0029-7844(00)00792-4; Franko DL, 2001, AM J PSYCHIAT, V158, P1461, DOI 10.1176/appi.ajp.158.9.1461; Garfinkel PE, 1996, BRIT J PSYCHIAT, V168, P500, DOI 10.1192/bjp.168.4.500; GARNER DM, 1982, COGNITIVE THER RES, V6, P123, DOI 10.1007/BF01183887; GOLDFEIN JA, 1993, INT J EAT DISORDER, V14, P427, DOI 10.1002/1098-108X(199312)14:4&lt;427::AID-EAT2260140405&gt;3.0.CO;2-H; Goldner Elliot M., 1997, P450; GOODWIN GM, 1987, PSYCHOL MED, V17, P839, DOI 10.1017/S0033291700000635; Gorwood P, 2002, MOL PSYCHIATR, V7, P90, DOI 10.1038/sj/mp/4000938; Gowers SG, 2000, BRIT J PSYCHIAT, V176, P138, DOI 10.1192/bjp.176.2.138; Grice DE, 2002, AM J HUM GENET, V70, P787, DOI 10.1086/339250; Grilo C. M., 2002, EATING DISORDERS OBE, P178, DOI DOI 10.1007/S11113-008-9073-X; Grinspoon S, 2002, J CLIN ENDOCR METAB, V87, P2883, DOI 10.1210/jc.87.6.2883; Grinspoon S, 2000, ANN INTERN MED, V133, P790, DOI 10.7326/0003-4819-133-10-200011210-00011; HERZOG DB, 1993, INT J EAT DISORDER, V14, P261, DOI 10.1002/1098-108X(199311)14:3&lt;261::AID-EAT2260140304&gt;3.0.CO;2-N; Herzog DB, 1999, J AM ACAD CHILD PSY, V38, P829, DOI 10.1097/00004583-199907000-00012; Hinney A, 2000, EUR J PHARMACOL, V410, P147, DOI 10.1016/S0014-2999(00)00812-8; Hoek Hans Wijbrand, 1993, International Review of Psychiatry, V5, P61, DOI 10.3109/09540269309028295; HOLDERNESS HC, 1994, INT J EAT DISORDER, V16, P1, DOI 10.1002/1098-108X(199407)16:1<1::AID-EAT2260160102>3.0.CO;2-T; KAYE W, 1999, NEUROBIOLOGICAL FDN, P891; Kaye WH, 1996, ALCOHOL CLIN EXP RES, V20, P878, DOI 10.1111/j.1530-0277.1996.tb05266.x; Kaye WH, 2001, AM J PSYCHIAT, V158, P1152, DOI 10.1176/appi.ajp.158.7.1152; Kaye WH, 2001, BIOL PSYCHIAT, V49, P644, DOI 10.1016/S0006-3223(00)01013-1; KENDLER KS, 1991, AM J PSYCHIAT, V148, P1627; KENDLER KS, 1995, ARCH GEN PSYCHIAT, V52, P374; KLIBANSKI A, 1995, J CLIN ENDOCR METAB, V80, P898, DOI 10.1210/jc.80.3.898; Klump KL, 2001, PSYCHOL MED, V31, P737, DOI 10.1017/S0033291701003725; Kortegaard LS, 2001, PSYCHOL MED, V31, P361, DOI 10.1017/S0033291701003087; Lennkh C, 1999, J PSYCHIATR RES, V33, P349, DOI 10.1016/S0022-3956(99)00002-3; Lilenfeld LR, 1998, ARCH GEN PSYCHIAT, V55, P603, DOI 10.1001/archpsyc.55.7.603; Lilenfeld LR, 1998, W S CLIN NEUROBIOL, V4, P169; Lock J, 2013, TREATMENT MANUAL ANO, V2nd; Loeb KL, 2000, BEHAV RES THER, V38, P259, DOI 10.1016/S0005-7967(99)00041-8; LUCAS AR, 1991, AM J PSYCHIAT, V148, P917; Lucas AR, 1999, INT J EAT DISORDER, V26, P397; Meads C, 2001, EUR EAT DISORD REV, V9, P229, DOI 10.1002/erv.406; Millar HR, 1998, PSYCHIAT B, V22, P751, DOI DOI 10.1192/pb.22.12.751; Milosevic A, 1999, EUR EAT DISORD REV, V7, P103, DOI 10.1002/(SICI)1099-0968(199905)7:2<103::AID-ERV238>3.0.CO;2-7; MITCHELL JE, 1983, PSYCHOL MED, V13, P273, DOI 10.1017/S0033291700050881; Mitchell JE, 2001, EATING DISORDERS: INNOVATIVE DIRECTIONS IN RESEARCH AND PRACTICE, P197, DOI 10.1037/10403-010; Mitchell JE, 2002, INT J EAT DISORDER, V32, P271, DOI 10.1002/eat.10092; MITCHELL JE, 1987, INT J EAT DISORDER, V6, P557, DOI 10.1002/1098-108X(198707)6:4<557::AID-EAT2260060413>3.0.CO;2-Z; MITCHELL JE, 1985, AM J PSYCHIAT, V142, P482; Mitchell JE, 2001, J CLIN PSYCHOPHARM, V21, P298, DOI 10.1097/00004714-200106000-00008; MITCHELL JE, 1990, ARCH GEN PSYCHIAT, V47, P149; Mussell MP, 2000, INT J EAT DISORDER, V27, P230, DOI 10.1002/(SICI)1098-108X(200003)27:2<230::AID-EAT11>3.0.CO;2-0; Nakash-Eisikovits O, 2002, HARVARD REV PSYCHIAT, V10, P193, DOI 10.1093/hrp/10.4.193; Nielsen S, 2001, PSYCHIAT CLIN N AM, V24, P201, DOI 10.1016/S0193-953X(05)70217-3; Nielsen S, 1998, J PSYCHOSOM RES, V44, P413, DOI 10.1016/S0022-3999(97)00267-5; Palmer RL, 2002, BRIT J PSYCHIAT, V181, P230, DOI 10.1192/bjp.181.3.230; Patel P, 2002, CLIN CHILD FAM PSYCH, V5, P1, DOI 10.1023/A:1014524207660; Paul T, 2002, AM J PSYCHIAT, V159, P408, DOI 10.1176/appi.ajp.159.3.408; Pawluck DE, 1998, INT J EAT DISORDER, V23, P347, DOI 10.1002/(SICI)1098-108X(199805)23:4&lt;347::AID-EAT1&gt;3.0.CO;2-I; Pomeroy C, 2002, MED COMPLICATIONS PS MED COMPLICATIONS PS; RASTAM M, 1989, BRIT J PSYCHIAT, V155, P642; Ricca V, 2001, Eat Weight Disord, V6, P157; ROSEN JC, 1986, INT J EAT DISORDER, V5, P255, DOI 10.1002/1098-108X(198602)5:2<255::AID-EAT2260050206>3.0.CO;2-D; ROSSITER EM, 1990, INT J EAT DISORDER, V9, P513, DOI 10.1002/1098-108X(199009)9:5&lt;513::AID-EAT2260090506&gt;3.0.CO;2-T; RUSSELL GFM, 1987, ARCH GEN PSYCHIAT, V44, P1047; Russell GFM, 2001, PSYCHIAT CLIN N AM, V24, P337, DOI 10.1016/S0193-953X(05)70229-X; SHARP CW, 1993, BRIT J PSYCHIAT, V162, P452, DOI 10.1192/bjp.162.4.452; SLADE P, 1982, BRIT J CLIN PSYCHOL, V21, P167, DOI 10.1111/j.2044-8260.1982.tb00549.x; SOUNDY TJ, 1995, PSYCHOL MED, V25, P1065, DOI 10.1017/S0033291700037557; Steinhausen HC, 2002, AM J PSYCHIAT, V159, P1284, DOI 10.1176/appi.ajp.159.8.1284; Strober M, 2000, AM J PSYCHIAT, V157, P393, DOI 10.1176/appi.ajp.157.3.393; STROBER M, 1990, INT J EAT DISORDER, V9, P239, DOI 10.1002/1098-108X(199005)9:3&lt;239::AID-EAT2260090302&gt;3.0.CO;2-7; Stunkard A. J., 2002, Handbook of obesity treatment, P107; Sullivan PF, 1996, INT J EAT DISORDER, V20, P253, DOI 10.1002/(SICI)1098-108X(199611)20:3<253::AID-EAT4>3.0.CO;2-N; Sullivan PF, 1998, AM J PSYCHIAT, V155, P939, DOI 10.1176/ajp.155.7.939; Treasure J, 1996, BRIT J PSYCHIAT, V168, P94, DOI 10.1192/bjp.168.1.94; TREASURE J, 2002, CLIN EVIDENCE MENTAL, P13; Treasure J., 1989, CHILD YOUTH PSYCHIAT, P59; Turnbull S, 1996, BRIT J PSYCHIAT, V169, P705, DOI 10.1192/bjp.169.6.705; TURNER H, IN PRESS EUR EAT DIS; Van Hoeken D, 1998, W S CLIN NEUROBIOL, V4, P97; Vestergaard P, 2002, INT J EAT DISORDER, V32, P301, DOI 10.1002/eat.10101; Vitousek K, 1998, CLIN PSYCHOL REV, V18, P391, DOI 10.1016/S0272-7358(98)00012-9; Wade T, 1999, PSYCHOL MED, V29, P925, DOI 10.1017/S0033291799008740; Wade TD, 2000, AM J PSYCHIAT, V157, P469, DOI 10.1176/appi.ajp.157.3.469; Walsh B. Timothy, 1997, P25; Walsh BT, 1997, AM J PSYCHIAT, V154, P523; WEISSMAN MM, 2000, COMPREHENSIVE GUIDE; Welch SL, 1996, BRIT J PSYCHIAT, V169, P451, DOI 10.1192/bjp.169.4.451; Whittal ML, 1999, BEHAV THER, V30, P117, DOI 10.1016/S0005-7894(99)80049-5; Wilfley DE, 2002, ARCH GEN PSYCHIAT, V59, P713, DOI 10.1001/archpsyc.59.8.713; Wilson G. T., 2002, GUIDE TREATMENTS WOR, P559; Wilson GT, 1998, CLIN PSYCHOL-SCI PR, V5, P363, DOI 10.1111/j.1468-2850.1998.tb00156.x; Wilson GT, 1998, INT J EAT DISORDER, V24, P13, DOI 10.1002/(SICI)1098-108X(199807)24:1<13::AID-EAT2>3.0.CO;2-3; Wiseman CV, 2001, INT J EAT DISORDER, V30, P69, DOI 10.1002/eat.1055; Wolfe BE, 2001, INT J EAT DISORDER, V30, P288, DOI 10.1002/eat.1086; Wolfert A, 2002, Eat Weight Disord, V7, P72; YANOVSKI SZ, 1992, AM J CLIN NUTR, V56, P975, DOI 10.1093/ajcn/56.6.975; Zipfel S, 2002, INT J EAT DISORDER, V31, P105, DOI 10.1002/eat.10009	140	1049	1077	7	569	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2003	361	9355					407	416		10.1016/S0140-6736(03)12378-1	http://dx.doi.org/10.1016/S0140-6736(03)12378-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	642CP	12573387				2022-12-28	WOS:000180787000022
J	Hammarstrom, P; Wiseman, RL; Powers, ET; Kelly, JW				Hammarstrom, P; Wiseman, RL; Powers, ET; Kelly, JW			Prevention of transthyretin amyloid disease by changing protein misfolding energetics	SCIENCE			English	Article							ALZHEIMERS-DISEASE; FIBRIL FORMATION; INHIBITORS	Genetic evidence suggests that inhibition of amyloid fibril formation by small molecules should be effective against amyloid diseases. Known amyloid inhibitors appear to function by shifting the aggregation equilibrium away from the amyloid state. Here, we describe a series of transthyretin amyloidosis inhibitors that functioned by increasing the kinetic barrier associated with misfolding, preventing amyloidogenesis by stabilizing the native state. The trans-suppressor mutation, threonine 119 --> methionine 119, which is known to ameliorate familial amyloid disease, also functioned through kinetic stabilization, implying that this small-molecule strategy should be effective in treating amyloid diseases.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Kelly, JW (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jkelly@scripps.edu		Powers, Evan/0000-0001-8185-8487	NIDDK NIH HHS [DK 46335] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK046335, R37DK046335, R01DK046335] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Coehlo T., 1996, NEUROMUSCUL DISORD, V6, P27; Coelho Teresa, 1993, Journal of Rheumatology, V20, P179; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Hammarstrom P, 2001, SCIENCE, V293, P2459, DOI 10.1126/science.1062245; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Hammarstrom P, 2001, BIOCHEMISTRY-US, V40, P11453, DOI 10.1021/bi010673+; Jacobson D R, 1991, Adv Hum Genet, V20, P69; Jiang X, 2001, P NATL ACAD SCI USA, V98, P14943, DOI 10.1073/pnas.261419998; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Oza VB, 2002, J MED CHEM, V45, P321, DOI 10.1021/jm010257n; Peterson SA, 1998, P NATL ACAD SCI USA, V95, P12956, DOI 10.1073/pnas.95.22.12956; Purkey HE, 2001, P NATL ACAD SCI USA, V98, P5566, DOI 10.1073/pnas.091431798; PURKEY HE, UNPUB; Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769; SCHLOSS JV, 1988, ACCOUNTS CHEM RES, V21, P348, DOI 10.1021/ar00153a005; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	28	416	430	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					713	716		10.1126/science.1079589	http://dx.doi.org/10.1126/science.1079589			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560553				2022-12-28	WOS:000180687700049
J	Korniss, G; Novotny, MA; Guclu, H; Toroczkai, Z; Rikvold, PA				Korniss, G; Novotny, MA; Guclu, H; Toroczkai, Z; Rikvold, PA			Suppressing roughness of virtual times in parallel discrete-event simulations	SCIENCE			English	Article							NONEQUILIBRIUM SURFACE GROWTH; SMALL-WORLD NETWORKS; SYSTEMS; ALGORITHMS; MODELS	In a parallel discrete-event simulation (PDES) scheme, tasks are distributed among processing elements (PEs) whose progress is controlled by a synchronization scheme. For lattice systems with short-range interactions, the progress of the conservative PDES scheme is governed by the Kardar-Parisi-Zhang equation from the theory of nonequilibrium surface growth. Although the simulated (virtual) times of the PEs progress at a nonzero rate, their standard deviation (spread) diverges with the number of PEs, hindering efficient data collection. We show that weak random interactions among the PEs can make this spread nondivergent. The PEs then progress at a nonzero, near-uniform rate without requiring global synchronizations.	Rensselaer Polytech Inst, Dept Phys Appl Phys & Astron, Troy, NY 12180 USA; Mississippi State Univ, Dept Phys & Astron, Mississippi State, MS 39762 USA; Mississippi State Univ, ERC Ctr Computat Sci, Mississippi State, MS 39762 USA; Los Alamos Natl Lab, Div Theoret, Complex Syst Grp, Los Alamos, NM 87545 USA; Florida State Univ, Ctr Mat Res & Technol, Dept Phys, Tallahassee, FL 32306 USA; Florida State Univ, Sch Computat Sci & Informat Technol, Tallahassee, FL 32306 USA	Rensselaer Polytechnic Institute; Mississippi State University; Mississippi State University; United States Department of Energy (DOE); Los Alamos National Laboratory; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Korniss, G (corresponding author), Rensselaer Polytech Inst, Dept Phys Appl Phys & Astron, 110 8th St, Troy, NY 12180 USA.		Toroczkai, Zoltan/AAC-8446-2019; Korniss, Gyorgy/A-7360-2011; Rikvold, Per Arne/I-7668-2019; Guclu, Hasan/B-7080-2008; Toroczkai, Zoltan/A-3421-2008	Toroczkai, Zoltan/0000-0002-6602-2849; Rikvold, Per Arne/0000-0001-8665-7932; Guclu, Hasan/0000-0003-3582-9460; Toroczkai, Zoltan/0000-0002-6602-2849; Novotny, Mark/0000-0002-1410-5597				BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Barabasi A.-L., 1995, FRACTAL CONCEPTS SUR; Barrat A, 2000, EUR PHYS J B, V13, P547, DOI 10.1007/s100510050067; CHANDY KM, 1981, COMMUN ACM, V24, P198, DOI 10.1145/358598.358613; DEELMAN E, 1996, P 1996 WINT SIM C, P1191; FUJIMOTO RM, 1990, COMMUN ACM, V33, P30, DOI 10.1145/84537.84545; Gitterman M, 2000, J PHYS A-MATH GEN, V33, P8373, DOI 10.1088/0305-4470/33/47/304; Greenberg A. G., 1996, Performance Evaluation Review, V24, P91, DOI 10.1145/233008.233028; GREENBERG AG, 1994, P 8 WORKSH PAR DISTR, P187; HALPINHEALY T, 1995, PHYS REP, V254, P215, DOI 10.1016/0370-1573(94)00087-J; JEFFERSON DR, 1985, ACM T PROGR LANG SYS, V7, P404, DOI 10.1145/3916.3988; KARDAR M, 1986, PHYS REV LETT, V56, P889, DOI 10.1103/PhysRevLett.56.889; Kim BJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.056135; Korniss G, 1999, J COMPUT PHYS, V153, P488, DOI 10.1006/jcph.1999.6291; Korniss G, 2000, PHYS REV LETT, V84, P1351, DOI 10.1103/PhysRevLett.84.1351; Korniss G, 2001, SPRINGER PROC PHYS, V86, P183; Korniss G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.016120; Lubachevsky B. D., 1987, Complex Systems, V1, P1099; Lubachevsky BD, 2000, BELL LABS TECH J, V5, P134, DOI 10.1002/bltj.2227; LUBACHEVSKY BD, 1988, J COMPUT PHYS, V75, P103, DOI 10.1016/0021-9991(88)90101-5; Newman MEJ, 2000, J STAT PHYS, V101, P819, DOI 10.1023/A:1026485807148; Nicol D., 1994, Annals of Operations Research, V53, P249, DOI 10.1007/BF02136831; NICOL DM, 1988, P SCS MULT DISTR SIM, V19, P141; Sloot PMA, 2001, COMPUT PHYS COMMUN, V142, P76, DOI 10.1016/S0010-4655(01)00325-3; Toroczkai Z, 2000, PHYS REV E, V62, P276, DOI 10.1103/PhysRevE.62.276; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	26	114	116	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					677	679		10.1126/science.1079382	http://dx.doi.org/10.1126/science.1079382			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560543	Green Submitted			2022-12-28	WOS:000180687700037
J	BenEzra, D				BenEzra, D			In-vitro fertilisation and retinoblastoma	LANCET			English	Editorial Material							CHILDREN BORN; FERTILIZATION; RISK; CANCER		Hadassah Hebrew Univ Hosp, Paediat Ophthalmol Unit, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	BenEzra, D (corresponding author), Hadassah Hebrew Univ Hosp, Paediat Ophthalmol Unit, IL-91120 Jerusalem, Israel.							Anteby I, 2001, ARCH OPHTHALMOL-CHIC, V119, P1525; BenEzra D, 1976, J Pediatr Ophthalmol, V13, P340; Bruinsma F, 2000, HUM REPROD, V15, P604, DOI 10.1093/humrep/15.3.604; Cruysberg JRM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1773; de Jong-van den Berg L T, 1992, Int J Risk Saf Med, V3, P99, DOI 10.3233/JRS-1992-3205; Edirisinghe WR, 1997, HUM REPROD, V12, P2784, DOI 10.1093/humrep/12.12.2784; Klip H, 2001, HUM REPROD, V16, P2451, DOI 10.1093/humrep/16.11.2451; KRAMER S, 1987, JNCI-J NATL CANCER I, V78, P797; Michalek AM, 1996, AM J EPIDEMIOL, V143, P996; Roman E, 1997, BRIT J CANCER, V76, P406, DOI 10.1038/bjc.1997.399; VANSTEENSELMOLL HA, 1985, INT J EPIDEMIOL, V14, P555, DOI 10.1093/ije/14.4.555; Voullaire L, 2002, MOL HUM REPROD, V8, P1035, DOI 10.1093/molehr/8.11.1035; Winston RML, 2002, NAT CELL BIOL, V4, pS14, DOI 10.1038/ncb-nm-fertilityS14	13	17	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					273	274		10.1016/S0140-6736(03)12364-1	http://dx.doi.org/10.1016/S0140-6736(03)12364-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559858				2022-12-28	WOS:000180643900005
J	Cuzick, J; Powles, T; Veronesi, U; Forbes, J; Edwards, R; Ashley, S; Boyle, P				Cuzick, J; Powles, T; Veronesi, U; Forbes, J; Edwards, R; Ashley, S; Boyle, P			Overview of the main outcomes in breast-cancer prevention trials	LANCET			English	Article							TAMOXIFEN; WOMEN	Background Early findings on the use of tamoxifen or raloxifene as prophylaxis against breast cancer have been mixed; we update available data and overview the combined results. Methods All five randomised prevention trials comparing tamoxifen or raloxifene with placebo were included. Relevant data on contralateral breast tumours and side-effects were included from an overview of adjuvant trials of tamoxifen versus control. Findings The tamoxifen prevention trials showed a 38% (95% CI 28-46; p<0.0001) reduction in breast-cancer incidence. There was no effect for breast cancers negative for oestrogen receptor (ER; hazard ratio 1.22 [0.89-1.67]; p=0.21), but ER-positive cancers were decreased by 48% (36-58; p<0.0001) in the tamoxifen prevention trials. Age had no apparent effect. Rates of endometrial cancer were increased in all tamoxifen prevention trials (consensus relative risk 2.4 [1.5-4.0]; p=0.0005) and the adjuvant trials (relative risk 3.4 [1.8-6.4]; p=0.0002); no increase has been seen so far with raloxifene. Venous thromboembolic events were increased in all tamoxifen studies (relative risk 1.9 [1.4-2.6] in the prevention trials; p<0.0001) and with raloxifene. Overall, there was no effect on non-breast-cancer mortality; the only cause showing a mortality increase was pulmonary embolism (six vs two). Interpretation The evidence now clearly shows that tamoxifen can reduce the risk of ER-positive breast cancer. New approaches are needed to prevent ER-negative breast cancer and to reduce the side-effects of tamoxifen. Newer agents such as raloxifene and the aromatase inhibitors need to be evaluated. Although tamoxifen cannot yet be recommended as a preventive agent (except possibly in women at very high risk with a low risk of side-effects), continued follow-up of the current trials is essential for identification of a subgroup of high-risk, healthy women for whom the risk-benefit ratio is sufficiently positive.	Canc Res UK, London, England; Royal Marsden Hosp, Inst Canc Res, London SW3 6JJ, England; European Inst Oncol, Milan, Italy; Australia New Zealand Trials Grp, Newcastle, NSW, Australia	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; IRCCS European Institute of Oncology (IEO)	Cuzick, J (corresponding author), Wolfson Inst Prevent Med, Canc Res UK Dept Epidemiol Math & Stat, Charterhouse Sq, London EC1M 6BQ, England.		Boyle, Peter/A-4380-2014	Boyle, Peter/0000-0001-6251-0610				Baum M, 2002, LANCET, V359, P2131; Camerini T, 2001, J CLIN ONCOL, V19, P1664, DOI 10.1200/JCO.2001.19.6.1664; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Clarke M, 1998, LANCET, V351, P1451; Cuzick J, 2002, LANCET, V360, P817; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Powles T, 1998, LANCET, V352, P98; Veronesi U, 1998, LANCET, V352, P93; Veronesi U, 2002, LANCET, V359, P1122, DOI 10.1016/S0140-6736(02)08159-X	9	685	733	0	31	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					296	300		10.1016/S0140-6736(03)12342-2	http://dx.doi.org/10.1016/S0140-6736(03)12342-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559863				2022-12-28	WOS:000180643900010
J	Coblyn, JS; McCluskey, RT; King, ME; Costenbader, KH				Coblyn, JS; McCluskey, RT; King, ME; Costenbader, KH			Case 3-2003: A 36-year-old man with renal failure, hypertension, and neurologic abnormalities - Classic polyarteritis nodosa associated with hepatitis B infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RHEUMATOLOGY 1990 CRITERIA; MICROSCOPIC POLYANGIITIS; MIXED CRYOGLOBULINEMIA; CLINICAL ASPECTS; VASCULITIS; CLASSIFICATION; INVOLVEMENT; ARTERITIS		Brigham & Womens Hosp, Dept Med, Div Rheumatol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Coblyn, JS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol, 75 Francis St, Boston, MA 02115 USA.							BRYANT GL, 1986, SEMIN ARTHRITIS RHEU, V15, P297, DOI 10.1016/0049-0172(86)90025-9; DAMICO G, 1995, AM J KIDNEY DIS, V25, P361, DOI 10.1016/0272-6386(95)90095-0; DAMICO G, 1989, KIDNEY INT, V35, P1004, DOI 10.1038/ki.1989.84; DUNA GF, 1995, RHEUM DIS CLIN N AM, V21, P949; EVANS JM, 1995, ANN INTERN MED, V122, P502, DOI 10.7326/0003-4819-122-7-199504010-00004; GOREVIC PD, 1980, AM J MED, V69, P287, DOI 10.1016/0002-9343(80)90390-3; Guillevin L, 1998, ARTHRITIS RHEUM, V41, P2100, DOI 10.1002/1529-0131(199812)41:12<2100::AID-ART3>3.3.CO;2-A; HUNDER GC, 1997, PRIMER RHEUMATIC DIS, P294; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1065; Jennette JC, 1997, NEW ENGL J MED, V337, P1512, DOI 10.1056/NEJM199711203372106; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; JOHNSON RJ, 1990, KIDNEY INT, V37, P663, DOI 10.1038/ki.1990.32; KERR GS, 1994, ANN INTERN MED, V120, P919, DOI 10.7326/0003-4819-120-11-199406010-00004; Kirkland GS, 1997, CLIN NEPHROL, V47, P176; LHOTE F, 1995, RHEUM DIS CLIN N AM, V21, P911; LIGHTFOOT RW, 1990, ARTHRITIS RHEUM, V33, P1088; MICHEL BA, 1992, J RHEUMATOL, V19, P721; Niles JL, 1996, ARCH INTERN MED, V156, P440, DOI 10.1001/archinte.156.4.440; Niles John L., 1995, P95; Provenzale JM, 1996, AM J NEURORADIOL, V17, P1119	20	3	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2003	348	4					333	342		10.1056/NEJMcpc020116	http://dx.doi.org/10.1056/NEJMcpc020116			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637JD	12540647				2022-12-28	WOS:000180507200009
J	Gupta, AK; Anderson, DM; Overpeck, JT				Gupta, AK; Anderson, DM; Overpeck, JT			Abrupt changes in the Asian southwest monsoon during the Holocene and their links to the North Atlantic Ocean	NATURE			English	Article							LATE QUATERNARY; ARABIAN-SEA; SUMMER MONSOON; CLIMATE; VARIABILITY; RECORD; OMAN; FORAMINIFERA; GREENLAND; SURFACE	During the last ice age, the Indian Ocean southwest monsoon exhibited abrupt changes that were closely correlated with millennial-scale climate events in the North Atlantic region(1-3), suggesting a mechanistic link. In the Holocene epoch, which had a more stable climate, the amplitude of abrupt changes in North Atlantic climate was much smaller, and it has been unclear whether these changes are related to monsoon variability. Here we present a continuous record of centennial-scale monsoon variability throughout the Holocene from rapidly accumulating and minimally bioturbated sediments in the anoxic Arabian Sea. Our monsoon proxy record reveals several intervals of weak summer monsoon that coincide with cold periods documented in the North Atlantic region(4)-including the most recent climate changes from the Medieval Warm Period to the Little Ice Age and then to the present. We therefore suggest that the link between North Atlantic climate and the Asian monsoon is a persistent aspect of global climate.	Indian Inst Technol, Dept Geol & Geophys, Kharagpur 721302, W Bengal, India; NOAA, Paleoclimatol Program, Boulder, CO 80305 USA; Univ Arizona, Ctr Study Planet Earth, Tucson, AZ 85721 USA; Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; National Oceanic Atmospheric Admin (NOAA) - USA; University of Arizona; University of Arizona	Gupta, AK (corresponding author), Indian Inst Technol, Dept Geol & Geophys, Kharagpur 721302, W Bengal, India.		anderson, david/E-6416-2011	Gupta, Anil/0000-0003-0536-3911				Alley RB, 1997, GEOLOGY, V25, P483, DOI 10.1130/0091-7613(1997)025<0483:HCIAPW>2.3.CO;2; Altabet MA, 2002, NATURE, V415, P159, DOI 10.1038/415159a; ANDERSON DM, 1993, PALEOCEANOGRAPHY, V8, P193, DOI 10.1029/93PA00256; Anderson DM, 2002, SCIENCE, V297, P596, DOI 10.1126/science.1072881; BARNETT TP, 1989, J ATMOS SCI, V46, P661, DOI 10.1175/1520-0469(1989)046<0661:TEOESC>2.0.CO;2; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; CLEMENS S, 1991, NATURE, V353, P720, DOI 10.1038/353720a0; CURRY WB, 1992, UPWELLING SYSTEMS EV, P93; Gupta AK, 2001, GEOPHYS RES LETT, V28, P4131, DOI 10.1029/2001GL013315; Houghton J. T., 2001, CLIMATE CHANGE 2001; Janowiak JE, 1999, J CLIMATE, V12, P3335, DOI 10.1175/1520-0442(1999)012<3335:COAGSR>2.0.CO;2; Jennings AE, 1996, HOLOCENE, V6, P179, DOI 10.1177/095968369600600205; Keigwin LD, 1996, SCIENCE, V274, P1504, DOI 10.1126/science.274.5292.1504; MANABE S, 1993, NATURE, V364, P215, DOI 10.1038/364215a0; MEEHL GA, 1994, J CLIMATE, V7, P1033, DOI 10.1175/1520-0442(1994)007<1033:IOTLSI>2.0.CO;2; Naidu PD, 1996, PALEOCEANOGRAPHY, V11, P129, DOI 10.1029/95PA03198; Neff U, 2001, NATURE, V411, P290, DOI 10.1038/35077048; Overpeck J, 1996, CLIM DYNAM, V12, P213, DOI 10.1007/BF00211619; Prell W.L., 1984, CLIMATE PROCESSES CL, V29, P48; PRELL WL, 1986, NATURE, V323, P526, DOI 10.1038/323526a0; REYNOLDS RW, 1995, J CLIMATE, V8, P1571, DOI 10.1175/1520-0442(1995)008<1571:AHRGSS>2.0.CO;2; RIND D, 1993, QUATERNARY SCI REV, V12, P357, DOI 10.1016/S0277-3791(05)80002-2; Schulz H, 1998, NATURE, V393, P54, DOI 10.1038/31750; Shindell DT, 2001, SCIENCE, V294, P2149, DOI 10.1126/science.1064363; SIROCKO F, 1999, MECH GLOBAL CLIMATE, P113; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; TRENBERTH K, 1989, NCARTN388PLUSSTR, P1; Wang LJ, 1999, GEOPHYS RES LETT, V26, P2889, DOI 10.1029/1999GL900443	30	820	900	3	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					354	357		10.1038/nature01340	http://dx.doi.org/10.1038/nature01340			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540924				2022-12-28	WOS:000180533000037
J	Younis, N; Broadbent, DM; Vora, JP; Harding, SP				Younis, N; Broadbent, DM; Vora, JP; Harding, SP			Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study	LANCET			English	Article							PROGRESSION; POPULATION; PREVALENCE; DISEASE; RISK; AGE; OPHTHALMOSCOPY; DIAGNOSIS; BLINDNESS; MELLITUS	Background Incidence data on which to base targets and protocols for screening for sight-threatening diabetic retinopathy are few. We aimed to investigate yearly and cumulative incidence of any retinopathy, maculopathy, and sight-threatening diabetic retinopathy in patients with type 2 diabetes in an established systematic programme and to calculate optimum screening intervals according to retinopathy grade at baseline. Methods We investigated all patients with type 2 diabetes registered with enrolled general practices (except those who were attending an ophthalmologist) who had retinopathy data available at baseline and at least one further screening event. To screen patients, we used non-stereoscopic three-field mydriatic photography and modified Wisconsin grading. Sight-threatening diabetic retinopathy was defined as moderate preproliferative retinopathy or worse, or clinically significant maculopathy in either or both eyes. Findings Results were obtained from 20 570 screening events. Yearly incidence of sight-threatening diabetic retinopathy in patients without retinopathy at baseline was 0.3% (95% CI 0.1-0.5) in the first year, rising to 1.8% (1.2-2.5) in the fifth year; cumulative incidence at 5 years was 3.9% (2.8-5.0). Rates of progression to sight-threatening diabetic retinopathy in year 1 by baseline status were: background 5.0% (3.5-6.5), and mild preproliferative 15% (10.2-19.8). For a 95% probability of remaining free of sight-threatening diabetic retinopathy, mean screening intervals by baseline status were: no retinopathy 5.4 years (95% CI 4.7-6.3), background 1.0 years (0.7-1.3), and mild preproliferative 0.3 years (0.2-0.5). Interpretation A 3-year screening interval could be safely adopted for patients with no retinopathy, but yearly or more frequent screening is needed for patients with higher grades of retinopathy.	Royal Liverpool Univ Hosp, Dept Endocrinol & Diabet, Liverpool, Merseyside, England; Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Younis, N (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Dept Endocrinol & Diabet, Walton Hosp Site,Rice Lane, Liverpool L9 1AE, Merseyside, England.	naveedy@tinyonline.co.uk		Harding, Simon/0000-0003-4676-1158				Aiello LP, 1998, DIABETES CARE, V21, P157; *AM AC OPHTH, 1992, COMPR AD EYE EV PREF; [Anonymous], 1976, Am J Ophthalmol, V81, P383; [Anonymous], 1991, Ophthalmology, V98, P786; [Anonymous], 1991, Diabet Med, V8, P263; Bachmann MO, 1998, J EPIDEMIOL COMMUN H, V52, P45, DOI 10.1136/jech.52.1.45; Broadbent DM, 1999, EYE, V13, P160, DOI 10.1038/eye.1999.43; BROADBENT DM, 2000, DIABETIC MED, V17, pP69; DWYER MS, 1985, DIABETES CARE, V8, P316, DOI 10.2337/diacare.8.4.316; Garvican L, 2000, DIABETIC MED, V17, P627, DOI 10.1046/j.1464-5491.2000.00353.x; HARDING SP, 1995, BMJ-BRIT MED J, V311, P1131, DOI 10.1136/bmj.311.7013.1131; Henricsson M, 1996, ACTA OPHTHALMOL SCAN, V74, P528; Henricsson M, 1996, ACTA OPHTHALMOL SCAN, V74, P523; Henricsson M, 1999, ACTA OPHTHALMOL SCAN, V77, P218, DOI 10.1034/j.1600-0420.1999.770221.x; James M, 2000, BRIT MED J, V320, P1627, DOI 10.1136/bmj.320.7250.1627; KLEIN R, 1989, ARCH OPHTHALMOL-CHIC, V107, P244, DOI 10.1001/archopht.1989.01070010250031; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1464; KLEIN R, 1985, OPHTHALMOLOGY, V92, P485; KLEIN R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1217, DOI 10.1001/archopht.1994.01090210105023; KOHNER EM, 1983, DIABETES, V32, P1010; Kohner EM, 2001, DIABETIC MED, V18, P178; KRISTINSSON JK, 1994, ACTA OPHTHALMOL, V72, P341; LEE ET, 1992, DIABETES CARE, V15, P1620, DOI 10.2337/diacare.15.11.1620; *NAT DEP LAB HHS E, 1988, NAT EYE HLTH ED PROG, P100; NIELSEN NV, 1984, ACTA OPHTHALMOL, V62, P266; *ROYAL COLLOPHTH, 1997, GUID DIAB RET; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Taylor R, 1998, DIABETIC MED, V15, P344; TEUSCHER A, 1988, DIABETES CARE, V11, P246, DOI 10.2337/diacare.11.3.246; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vijan S, 2000, JAMA-J AM MED ASSOC, V283, P889, DOI 10.1001/jama.283.7.889	34	209	218	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2003	361	9353					195	200		10.1016/S0140-6736(03)12267-2	http://dx.doi.org/10.1016/S0140-6736(03)12267-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547541				2022-12-28	WOS:000180535400007
J	Wedlich-Soldner, R; Altschuler, SJ; Wu, LF; Li, R				Wedlich-Soldner, R; Altschuler, SJ; Wu, LF; Li, R			Spontaneous cell polarization through actomyosin-based delivery of the Cdc42 GTPase	SCIENCE			English	Article							EXCHANGE FACTOR CDC24; SACCHAROMYCES-CEREVISIAE; VESICULAR TRANSPORT; ACTIN CYTOSKELETON; SECRETORY VESICLES; PLASMA-MEMBRANE; YEAST; POLARITY; GROWTH; GENE	Cell polarization can occur in the absence of any spatial cues. To investigate the mechanism of spontaneous cell polarization, we used an assay in yeast where expression of an activated form of Cdc42, a Rho-type guanosine triphosphatase (GTPase) required for cell polarization, could generate cell polarity without any recourse to a preestablished physical cue. The polar distribution of Cdc42 in this assay required targeted secretion directed by the actin cytoskeleton. A mathematical simulation showed that a stable polarity axis could be generated through a positive feedback loop in which a stochastic increase in the local concentration of activated Cdc42 on the plasma membrane enhanced the probability of actin polymerization and increased the probability of further Cdc42 accumulation to that site.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Li, R (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	rong_li@hms.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057063] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM057063] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; Arkowitz RA, 1999, TRENDS CELL BIOL, V9, P20, DOI 10.1016/S0962-8924(98)01412-3; Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Gulli MP, 2001, GENE DEV, V15, P365, DOI 10.1101/gad.876901; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; Kirschner M, 2000, CELL, V100, P79, DOI 10.1016/S0092-8674(00)81685-2; Lechler T, 2001, J CELL BIOL, V155, P261, DOI 10.1083/jcb.200104094; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; NELSON WJ, 1992, SCIENCE, V258, P948, DOI 10.1126/science.1439806; Nern A, 2000, J CELL BIOL, V148, P1115, DOI 10.1083/jcb.148.6.1115; NOVICK P, 1993, CIBA F SYMP, V176, P218; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Pruyne D, 2000, J CELL SCI, V113, P365; Pruyne D, 2000, J CELL SCI, V113, P571; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Richman TJ, 2002, EUKARYOT CELL, V1, P458, DOI 10.1128/EC.1.3.458-468.2002; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Seeley TD, 2002, BIOL BULL-US, V202, P314, DOI 10.2307/1543484; Shimada Y, 2000, NAT CELL BIOL, V2, P117, DOI 10.1038/35000073; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; WEDLICHSOLDNER R, UNPUB; ZIMAN M, 1991, MOL CELL BIOL, V11, P3537, DOI 10.1128/MCB.11.7.3537	30	309	314	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2003	299	5610					1231	1235		10.1126/science.1080944	http://dx.doi.org/10.1126/science.1080944			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12560471				2022-12-28	WOS:000181065500040
J	Krum, H; Roecker, EB; Mohacsi, P; Rouleau, JL; Tendera, M; Coats, AJS; Katus, HA; Fowler, MB; Packer, M				Krum, H; Roecker, EB; Mohacsi, P; Rouleau, JL; Tendera, M; Coats, AJS; Katus, HA; Fowler, MB; Packer, M		COPERNICUS Study Grp	Effects of initiating carvedilol in patients with severe chronic heart failure - Results from the COPERNICUS study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED INTERVENTION TRIAL; LEFT-VENTRICULAR FUNCTION; BETA-BLOCKER INITIATION; METOPROLOL; TOLERABILITY; GUIDELINES; MANAGEMENT; MORTALITY; SURVIVAL	Context beta-Blockers remain underused despite their established utility for improving outcome in heart failure. Concerns that initiation of treatment produces few immediate benefits and may have important risks may be deterring widespread use. Objective To evaluate the early effects of the beta-blocker carvedilol in patients with severe heart failure. Design, Setting, and Patients Randomized, double-blind, placebo-controlled trial conducted from October 28, 1997, to March 20, 2000, at 334 hospital centers in 21 countries among 2289 patients with symptoms of heart failure at rest or with minimal exertion who were clinically euvolemic and had a left ventricular ejection fraction of less than 25%. Intervention Patients were randomly assigned to receive carvedilol, with start dosage of at 3.125 mg twice daily with uptitration to a target dosage of 25 mg twice daily (n=1156), or placebo (n=1133), in addition to their usual medications for heart failure. Main Outcome Measures Death, hospitalization, or permanent withdrawal from study drug, as well as adverse events during the first 8 weeks of treatment. Results The carvedilol group experienced no increase in cardiovascular risk but instead had fewer patients who died (19 vs 25; hazard ratio [HR], 0.75; 95% confidence interval [CI], 0.41-1.35); who died or were hospitalized (134 vs 153; HR, 0.85; 95% CI, 0.67-1.07); or who died, were hospitalized, or were permanently withdrawn from treatment (162 vs 188; HR, 0.83; 95% CI, 0.68-1.03). These effects were similar in direction and magnitude to those observed during the entire study, and were apparent particularly in the 624 patients with recent or recurrent decompensation or a very depressed left ventricular ejection fraction. Differences in favor of carvedilol became apparent as early as 14 to 21 days following initiation of treatment. Worsening heart failure was the only serious adverse event with a frequency greater than 2% and was reported with similar frequency in the placebo and carvedilol groups (6.4% vs 5.1%). Conclusions These data suggest that, in clinically euvolemic patients, the relation of benefit to risk during initiation of treatment with carvedilol is similar to that seen during long-term therapy with the drug. Our findings should provide the reassurance needed to encourage the high levels of use that are warranted by the results of long-term clinical trials.	Monash Univ, Melbourne, Vic 3004, Australia; Univ Wisconsin, Madison, WI USA; Univ Hosp Bern, CH-3010 Bern, Switzerland; L Warynski Silesian Med Acad, Katowice, Poland; Univ Hlth Network, Toronto, ON, Canada; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Royal Brompton Hosp, London SW3 6LY, England; Univ Klinikum Luebeck, Lubeck, Germany; Stanford Univ, Med Ctr, Stanford, CA 94305 USA; Columbia Univ, Coll Phys & Surg, New York, NY USA	Monash University; University of Wisconsin System; University of Wisconsin Madison; University of Bern; University Hospital of Bern; Medical University Silesia; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Royal Brompton Hospital; University of Lubeck; Stanford University; Columbia University	Krum, H (corresponding author), Monash Univ, Alfred Hosp, Dept Med & Epidemiol & Prevent Med, Natl Hlth & Med Res Council Ctr Clin Res Excellen, Melbourne, Vic 3181, Australia.	henry.krum@med.monash.edu.au	Tendera, Michal/AAA-1875-2022; Coats, Andrew J Stewart/E-4451-2012	Coats, Andrew J Stewart/0000-0002-2771-4260; Tendera, Michal/0000-0002-0812-6113				Anderson JL, 2000, CIRCULATION, V102, P779; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; Cirillo W, 2000, CIRCULATION, V101, P378, DOI 10.1161/01.CIR.101.4.378; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Colucci WS, 1996, CIRCULATION, V94, P2800, DOI 10.1161/01.CIR.94.11.2800; COX DR, 1972, J R STAT SOC B, V34, P187; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; Eichhorn EJ, 1997, AM J CARDIOL, V79, P794; EPSTEIN SE, 1966, ANN INTERN MED, V65, P20, DOI 10.7326/0003-4819-65-1-20; GAFFNEY TE, 1963, AM J MED, V34, P320, DOI 10.1016/0002-9343(63)90118-9; Gottlieb SS, 2002, CIRCULATION, V105, P1182, DOI 10.1161/hc1002.105180; Gottlieb SS, 2000, CIRCULATION, V102, P778; HALL SA, 1995, J AM COLL CARDIOL, V25, P1154, DOI 10.1016/0735-1097(94)00543-Y; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Hjalmarson A, 1999, LANCET, V353, P2001; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Krum H, 2001, MED J AUSTRALIA, V174, P439, DOI 10.5694/j.1326-5377.2001.tb143369.x; Lechat P, 2000, EUR HEART J, V21, P297; Lechat P, 1999, LANCET, V353, P9; MacMahon S, 1997, LANCET, V349, P375; Packer M, 1996, CIRCULATION, V94, P2793, DOI 10.1161/01.CIR.94.11.2793; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Packer M, 1999, AM J CARDIOL, V83, p1A; Packer Milton, 2001, American Journal of Medicine, V110, p81S; SACKNERBERNSTEI.J, 1995, CIRCULATION S1, V92, P395; WAAGSTEIN F, 1989, CIRCULATION, V80, P551, DOI 10.1161/01.CIR.80.3.551	28	213	221	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2003	289	6					712	718		10.1001/jama.289.6.712	http://dx.doi.org/10.1001/jama.289.6.712			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643WP	12585949	Bronze			2022-12-28	WOS:000180886000025
J	Thacker, SB; Stroup, DF				Thacker, SB; Stroup, DF			Revisiting the use of the electronic fetal monitor	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED TRIAL; HEART		Ctr Dis Control & Prevent, Epidemiol Program Off, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Thacker, SB (corresponding author), Ctr Dis Control & Prevent, Epidemiol Program Off, Atlanta, GA 30333 USA.	sbt1@cdc.gov						Canadian Task Force on the Periodic Health Examination, 1994, CAN GUID CLIN PREV H; MACDONALD D, 1985, AM J OBSTET GYNECOL, V152, P524, DOI 10.1016/0002-9378(85)90619-2; Mires G, 2001, BRIT MED J, V322, P1457, DOI 10.1136/bmj.322.7300.1457; Thacker SB, 1997, BIRTH-ISS PERINAT C, V24, P58; THACKER SB, 2001, COCHRANE LIB; *US PREV SERV TASK, 1989, SCREEN FET DISTR INT, P233	6	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					445	446		10.1016/S0140-6736(03)12465-8	http://dx.doi.org/10.1016/S0140-6736(03)12465-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583938				2022-12-28	WOS:000180900600003
J	Drake, JF; Swisdak, M; Cattell, C; Shay, MA; Rogers, BN; Zeiler, A				Drake, JF; Swisdak, M; Cattell, C; Shay, MA; Rogers, BN; Zeiler, A			Formation of electron holes and particle energization during magnetic reconnection	SCIENCE			English	Article							GENERATION MECHANISM; SOLITARY WAVES; ACCELERATION	Three-dimensional particle simulations of magnetic reconnection reveal the development of turbulence driven by intense electron beams that form near the magnetic x-line and separatrices. The turbulence collapses into localized three-dimensional nonlinear structures in which the electron density is depleted. The predicted structure of these electron holes compares favorably with satellite observations at Earth's magnetopause. The birth and death of these electron holes and their associated intense electric fields lead to strong electron scattering and energization, whose understanding is critical to explaining why magnetic explosions in space release energy so quickly and produce such a large number of energetic electrons.	Univ Maryland, College Pk, MD 20742 USA; Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA; EURATOM, Max Planck Inst Plasmaphys, Ctr Interdisciplinary Plasma Sci, D-85748 Garching, Germany	University System of Maryland; University of Maryland College Park; University of Minnesota System; University of Minnesota Twin Cities; Dartmouth College; Euratom; Max Planck Society	Drake, JF (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	drake@plasma.umd.edu	Drake, James/P-9477-2017; Swisdak, Michael/R-1352-2017; Shay, Michael A/G-5476-2013	Drake, James/0000-0002-9150-1841; Swisdak, Michael/0000-0002-5435-3544; Cattell, Cynthia/0000-0002-3805-320X				BISKAMP D, 1986, PHYS FLUIDS, V29, P1520, DOI 10.1063/1.865670; BUJARBARUA S, 1981, J PLASMA PHYS, V25, P515, DOI 10.1017/S0022377800026295; BUNEMAN O, 1959, PHYS REV, V115, P503, DOI 10.1103/PhysRev.115.503; Cattell C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014046; Cattell CA, 1999, GEOPHYS RES LETT, V26, P425, DOI 10.1029/1998GL900304; Franz JR, 1998, GEOPHYS RES LETT, V25, P1277, DOI 10.1029/98GL50870; Galeev A.A., 1984, BASIC PLASMA PHYS, VII, P271; LIN RP, 1971, SOL PHYS, V17, P412, DOI 10.1007/BF00150045; Matsumoto H, 1999, GEOPHYS RES LETT, V26, P421, DOI 10.1029/1999GL900005; Mikhailovskii A. B, 1974, THEORY PLASMA INSTAB, V2; Mozer FS, 1997, PHYS REV LETT, V79, P1281, DOI 10.1103/PhysRevLett.79.1281; Ness W.N., 1964, NASA SPECIAL PUBLICA, P425; Newman DL, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.255001; Oieroset M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.195001; Omura Y, 1996, J GEOPHYS RES-SPACE, V101, P2685, DOI 10.1029/95JA03145; PARKER EN, 1957, J GEOPHYS RES, V62, P509, DOI 10.1029/JZ062i004p00509; PORKOLAB M, 1978, REV MOD PHYS, V50, P745, DOI 10.1103/RevModPhys.50.745; Pottelette R, 2001, J GEOPHYS RES-SPACE, V106, P8465, DOI 10.1029/2000JA000098; SATO T, 1979, PHYS FLUIDS, V22, P1189, DOI 10.1063/1.862721; Shimada N, 2000, ASTROPHYS J, V543, pL67, DOI 10.1086/318161; Sweet P. A., 1958, ELECTROMAGNETIC PHEN, P123; SWISDAK M, IN PRESS J GEOPHYS R; TEMERIN M, 1982, PHYS REV LETT, V48, P1175, DOI 10.1103/PhysRevLett.48.1175; Zeiler A, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000287	24	346	347	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					873	877		10.1126/science.1080333	http://dx.doi.org/10.1126/science.1080333			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574625				2022-12-28	WOS:000180830900047
J	Berg, AO; Allan, JD; Frame, P; Homer, CJ; Johnson, MS; Klein, JD; Lieu, TA; Orleans, CT; Peipert, JF; Pender, NJ; Sin, AL; Teutsch, SM; Westhoff, C; Woolf, SH				Berg, AO; Allan, JD; Frame, P; Homer, CJ; Johnson, MS; Klein, JD; Lieu, TA; Orleans, CT; Peipert, JF; Pender, NJ; Sin, AL; Teutsch, SM; Westhoff, C; Woolf, SH		US Preventive Serv Task Force	Screening for type 2 diabetes mellitus in adults: Recommendations and rationale	ANNALS OF INTERNAL MEDICINE			English	Article								This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendations on screening for type 2 diabetes in adults and updates the 1996 recommendations on this topic. The complete USPSTF recommendation and rationale statement on this topic, which includes a brief review of the supporting evidence, is available through the USPSTF Web site (www.preventiveservices.ahrq.gov) and the National Guideline Clearinghouse (www.guideline.gov) and in print through the Agency for Healthcare Research and Quality (AHRQ) Publications Clearinghouse (call 800-358-9295 or e-mail ahrqpubs@ahrq.gov). The complete information on which this statement is based, including evidence tables and references, is available in the accompanying article in this issue and in the summary of the evidence and systematic evidence review on this topic on the Web sites already mentioned. The summary of the evidence is also available in print through the AHRQ Publications Clearinghouse.	Univ Washington, Seattle, WA 98195 USA; Univ Maryland, Baltimore, MD 21201 USA; TriCty Family Med, Cohocton, NY USA; Univ Rochester, Sch Med, Rochester, NY 14642 USA; Natl Initiat Childrens Healthcare Qual, Boston, MA USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; Harvard Pilgrim Hlth Care, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Robert Wood Johnson Fdn, Princeton, NJ 08540 USA; Women & Infants Hosp Rhode Isl, Providence, RI 02908 USA; Univ Michigan, Ann Arbor, MI 48109 USA; CUNY Mt Sinai Sch Med, New York, NY 10029 USA; Merck & Co Inc, West Point, PA USA; Columbia Univ, New York, NY 10032 USA; Virginia Commonwealth Univ, Fairfax, VA USA	University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland Baltimore; University of Rochester; Rutgers State University New Brunswick; Rutgers State University Medical Center; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Robert Wood Johnson Foundation (RWJF); Women & Infants Hospital Rhode Island; University of Michigan System; University of Michigan; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Merck & Company; Columbia University; Virginia Commonwealth University	Berg, AO (corresponding author), Univ Washington, Seattle, WA 98195 USA.							*AM COLL OBST GYN, 2002, GUID WOM HLTH CAR, P210; [Anonymous], 2002, DIABETES CARE, V25, pS21, DOI DOI 10.2337/DIACARE.25.2007.S21; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75	3	68	68	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					212	214		10.7326/0003-4819-138-3-200302040-00014	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00014			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558361				2022-12-28	WOS:000181018600008
J	Harris, R; Donahue, K; Rathore, SS; Frame, P; Woolf, SH; Lohr, KN				Harris, R; Donahue, K; Rathore, SS; Frame, P; Woolf, SH; Lohr, KN			Screening adults for type 2 diabetes: A review of the evidence for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							IMPAIRED GLUCOSE-TOLERANCE; CORONARY-HEART-DISEASE; FASTING PLASMA-GLUCOSE; SCANDINAVIAN-SIMVASTATIN-SURVIVAL; CONVERTING-ENZYME-INHIBITION; NUTRITION-EXAMINATION-SURVEY; AVERAGE CHOLESTEROL LEVELS; INTENSIVE GLYCEMIC CONTROL; LOWER-EXTREMITY AMPUTATION; BLOOD-PRESSURE CONTROL	Background: Type 2 diabetes mellitus is associated with a heavy burden of suffering. Screening for diabetes is controversial. Purpose: To examine the evidence that screening and earlier treatment are effective in reducing morbidity and mortality associated with diabetes. Data Sources: MEDLINE, the Cochrane Library, reviews, and experts, all of which addressed key questions about screening. Study Selection: Studies that provided information about the existence and length of an asymptomatic phase of diabetes; studies that addressed the accuracy and reliability of screening tests; and randomized, controlled trials with health outcomes for various treatment strategies were selected. Data Extraction: Two reviewers abstracted relevant information using standardized abstraction forms and graded articles according to U.S. Preventive Services Task Force criteria. Data Synthesis: No randomized, controlled trial of screening for diabetes has been performed. Type 2 diabetes mellitus includes an asymptomatic preclinical phase; the length of this phase is unknown. Screening tests can detect diabetes in its preclinical phase. Over the 10 to 15 years after clinical diagnosis, tight glycemic control probably reduces the risk for blindness and end-stage renal disease, and aggressive control of hypertension, lipid therapy, and aspirin use reduce cardiovascular events. The magnitude of the benefit is larger for cardiovascular risk reduction than for tight glycemic control. The additional benefit of starting these treatments in the preclinical phase, after detection by screening, is uncertain but is probably also greater for cardiovascular risk reduction. Conclusions: The interventions that are most clearly beneficial during the preclinical phase are those that affect the risk for cardiovascular disease. The magnitude of additional benefit of initiating tight glycemic control during the preclinical phase is uncertain but probably small.					Donahue, Katrina/E-7486-2012	Donahue, Katrina/0000-0003-4075-2875				ABRAIRA C, 1995, DIABETES CARE, V18, P1113, DOI 10.2337/diacare.18.8.1113; Abraira C, 1997, ARCH INTERN MED, V157, P181, DOI 10.1001/archinte.157.2.181; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; *AM ASS CLIN END, 2002, ENDOCR PRACT S1, V8, P5; *AM DIAB ASS, 2001, DIABETES CARE, V24, pS 21; *AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS62; *AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS5; [Anonymous], 2000, LANCET, V355, P253, DOI DOI 10.1016/S0140-6736(99)12323-7; Azad N, 1999, J DIABETES COMPLICAT, V13, P307, DOI 10.1016/S1056-8727(99)00062-8; Balkau B, 1999, DIABETES CARE, V22, P696, DOI 10.2337/diacare.22.5.696; BALKAU B, 1991, DIABETOLOGIA, V34, P201, DOI 10.1007/BF00418279; Barr RG, 2002, ANN INTERN MED, V137, P263, DOI 10.7326/0003-4819-137-4-200208200-00011; Barzilay JI, 2001, DIABETES CARE, V24, P1233, DOI 10.2337/diacare.24.7.1233; Bjornholt JV, 1999, DIABETES CARE, V22, P45, DOI 10.2337/diacare.22.1.45; BLUNT BA, 1991, DIABETES CARE, V14, P989, DOI 10.2337/diacare.14.11.989; Bonora E, 2001, DIABETES CARE, V24, P2023, DOI 10.2337/diacare.24.12.2023; BOURN DM, 1992, DIABETIC MED, V9, P744, DOI 10.1111/j.1464-5491.1992.tb01884.x; Boyle JP, 2001, DIABETES CARE, V24, P1936, DOI 10.2337/diacare.24.11.1936; BRADFORD RH, 1994, AM J CARDIOL, V74, P667, DOI 10.1016/0002-9149(94)90307-7; Bray GA, 1999, DIABETES CARE, V22, P623; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; Burke JP, 1998, DIABETES CARE, V21, P1266, DOI 10.2337/diacare.21.8.1266; Carter JS, 1996, ANN INTERN MED, V125, P221, DOI 10.7326/0003-4819-125-3-199608010-00011; Chan JCN, 2000, KIDNEY INT, V57, P590, DOI 10.1046/j.1523-1755.2000.t01-1-00879.x; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Clark CM, 2000, JAMA-J AM MED ASSOC, V284, P363, DOI 10.1001/jama.284.3.363; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Colwell JA, 1997, DIABETES CARE, V20, P1767, DOI 10.2337/diacare.20.11.1767; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Davidson MB, 1999, JAMA-J AM MED ASSOC, V281, P1203, DOI 10.1001/jama.281.13.1203; DAVIDSON MB, 2001, BMJ US, V1, P297; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Dyson PA, 1997, METABOLISM, V46, P50, DOI 10.1016/S0026-0495(97)90318-8; Edelman D, 2002, DIABETES CARE, V25, P1022, DOI 10.2337/diacare.25.6.1022; Elkeles RS, 1998, DIABETES CARE, V21, P641, DOI 10.2337/diacare.21.4.641; Emanuele N, 1996, DIABETES CARE, V19, P1375, DOI 10.2337/diacare.19.12.1375; Engelgau MM, 2000, DIABETES CARE, V23, P1563, DOI 10.2337/diacare.23.10.1563; ENGELGAU MM, 1995, DIABETES CARE, V18, P1606, DOI 10.2337/diacare.18.12.1606; ERIKSSON KF, 1990, DIABETOLOGIA, V33, P526, DOI 10.1007/BF00404139; Eschwege E, 2001, DIABETES CARE, V24, P1941, DOI 10.2337/diacare.24.11.1941; Estacio RO, 2000, DIABETES CARE, V23, pB54; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Ewart RM, 2001, BMJ-BRIT MED J, V323, P854, DOI 10.1136/bmj.323.7317.854; FERRIS FL, 1992, JAMA-J AM MED ASSOC, V268, P1292; Fogari R, 1999, J HUM HYPERTENS, V13, P47, DOI 10.1038/sj.jhh.1000732; Fonseca VA, 2000, ANN INTERN MED, V133, P154, DOI 10.7326/0003-4819-133-2-200007180-00015; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; Gavin JR, 1997, DIABETES CARE, V20, P1183; GEISS LS, 1999, DIABETES SURVEILLANC; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Goyder E, 1998, BMJ-BRIT MED J, V317, P1644, DOI 10.1136/bmj.317.7173.1644; HAFFNER SM, 1990, JAMA-J AM MED ASSOC, V263, P2893, DOI 10.1001/jama.263.21.2893; Haffner SM, 1999, ARCH INTERN MED, V159, P2661, DOI 10.1001/archinte.159.22.2661; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HARRIS MI, 1994, DIABETES CARE, V17, P440, DOI 10.2337/diacare.17.5.440; Harris MI, 1998, DIABETES CARE, V21, P331, DOI 10.2337/diacare.21.3.331; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Harris MI, 1997, DIABETES CARE, V20, P1859, DOI 10.2337/diacare.20.12.1859; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; HARRIS R, 2002, 19 AG HEALTHC RES QU; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; Hostetter TH, 2001, NEW ENGL J MED, V345, P910, DOI 10.1056/NEJM200109203451209; ISRAILI ZH, 1992, ANN INTERN MED, V117, P234, DOI 10.7326/0003-4819-117-3-234; JARRETT RJ, 1986, DIABETIC MED, V3, P261, DOI 10.1111/j.1464-5491.1986.tb00758.x; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; KLEIN R, 1995, DIABETES AM, P293; KNATTERUD GL, 1978, JAMA-J AM MED ASSOC, V240, P37, DOI 10.1001/jama.240.1.37; KNATTERUD GL, 1971, J AMER MED ASSOC, V217, P777, DOI 10.1001/jama.217.6.777; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; KOSKINEN P, 1992, DIABETES CARE, V15, P820, DOI 10.2337/diacare.15.7.820; Levin SR, 2000, DIABETES CARE, V23, P1478, DOI 10.2337/diacare.23.10.1478; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Lindholm LH, 2000, J HYPERTENS, V18, P1671, DOI 10.1097/00004872-200018110-00020; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; LITZELMAN DK, 1993, ANN INTERN MED, V119, P36, DOI 10.7326/0003-4819-119-1-199307010-00006; LOVELL HG, COCHRANE DATABASE SY; Marshall KG, 1999, CAN MED ASSOC J, V160, P1592; McCabe CJ, 1998, DIABETIC MED, V15, P80, DOI 10.1002/(SICI)1096-9136(199801)15:1<80::AID-DIA517>3.0.CO;2-K; MCPHILLIPS JB, 1990, AM J EPIDEMIOL, V131, P443, DOI 10.1093/oxfordjournals.aje.a115519; Meigs JB, 1998, ANN INTERN MED, V128, P524, DOI 10.7326/0003-4819-128-7-199804010-00002; Mooy JM, 1996, DIABETOLOGIA, V39, P298, DOI 10.1007/BF00418345; *NAT DIAB DAT GROU, 1995, DIAB AM, P401; *NAT DIAB DAT GROU, 1995, DIAB AM, P429; *NAT DIAB DAT GROU, 1995, DIAB AM, P339; *NAT I DIAB DIG KI, 1995, DIAB AM NAT DIAB DAT, P349; Neal B, 2000, LANCET, V356, P1955; Niskanen L, 2001, DIABETES CARE, V24, P2091, DOI 10.2337/diacare.24.12.2091; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; OLEFSKY JM, 1974, DIABETES, V23, P449, DOI 10.2337/diab.23.5.449; Ollerton RL, 1999, DIABETES CARE, V22, P394, DOI 10.2337/diacare.22.3.394; Pahor M, 2000, DIABETES CARE, V23, P888, DOI 10.2337/diacare.23.7.888; Pahor M, 2000, LANCET, V356, P1949, DOI 10.1016/S0140-6736(00)03306-7; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Patout CA, 2000, DIABETES CARE, V23, P1339, DOI 10.2337/diacare.23.9.1339; PEDERSEN TR, 1994, LANCET, V344, P1383; PERNEGER TV, 1994, ANN INTERN MED, V121, P912, DOI 10.7326/0003-4819-121-12-199412150-00002; Peters AL, 1996, JAMA-J AM MED ASSOC, V276, P1246, DOI 10.1001/jama.276.15.1246; PIERCE LR, 1990, JAMA-J AM MED ASSOC, V264, P71, DOI 10.1001/jama.264.1.71; Pignone MP, 2001, AM J PREV MED, V20, P77, DOI 10.1016/S0749-3797(01)00255-0; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Ray NF, 1998, DIABETES CARE, V21, P296; Resnick HE, 2000, DIABETES CARE, V23, P176, DOI 10.2337/diacare.23.2.176; Resnick HE, 1999, ARCH INTERN MED, V159, P2470, DOI 10.1001/archinte.159.20.2470; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Rohlfing CL, 2000, DIABETES CARE, V23, P187, DOI 10.2337/diacare.23.2.187; Rolka DB, 2001, DIABETES CARE, V24, P1899, DOI 10.2337/diacare.24.11.1899; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sacks FM, 2002, CIRCULATION, V105, P1424, DOI 10.1161/01.CIR.0000012918.84068.43; Saito I, 2000, ANN INTERN MED, V133, P81, DOI 10.7326/0003-4819-133-2-200007180-00007; Saydah SH, 2001, DIABETES CARE, V24, P447, DOI 10.2337/diacare.24.3.447; Schnack C, 1996, DIABETOLOGIA, V39, P1611, DOI 10.1007/s001250050623; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Shichiri M, 2000, DIABETES CARE, V23, pB21; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; SWAI ABM, 1991, DIABETES, V40, P516, DOI 10.2337/diabetes.40.4.516; Tatti P, 1998, DIABETES CARE, V21, P597, DOI 10.2337/diacare.21.4.597; Testa MA, 1998, DIABETES CARE, V21, pC44, DOI 10.2337/diacare.21.3.C44; Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UK Prospective Diabetes Study Grp, 1999, DIABETES CARE, V22, P1125; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Wareham NJ, 2001, BMJ-BRIT MED J, V322, P986, DOI 10.1136/bmj.322.7292.986; Warram JH, 1996, DIABETIC MED, V13, pS40; YUDKIN JS, 1990, BRIT MED J, V301, P397, DOI 10.1136/bmj.301.6749.397	138	87	88	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					215	229		10.7326/0003-4819-138-3-200302040-00015	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00015			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558362				2022-12-28	WOS:000181018600009
J	Levene, MJ; Korlach, J; Turner, SW; Foquet, M; Craighead, HG; Webb, WW				Levene, MJ; Korlach, J; Turner, SW; Foquet, M; Craighead, HG; Webb, WW			Zero-mode waveguides for single-molecule analysis at high concentrations	SCIENCE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; INHIBITED SPONTANEOUS EMISSION; TOTAL INTERNAL-REFLECTION; CROSS-CORRELATION; DNA; DYNAMICS; MICROSCOPY	Optical approaches for observing the dynamics of single molecules have required pico- to nanomolar concentrations of fluorophore in order to isolate individual molecules. However, many biologically relevant processes occur at micromolar ligand concentrations, necessitating a reduction in the conventional observation volume by three orders of magnitude. We show that arrays of zero-mode waveguides consisting of subwavelength holes in a metal film provide a simple and highly parallel means for studying single-molecule dynamics at micromolar concentrations with microsecond temporal resolution. We present observations of DNA polymerase activity as an example of the effectiveness of zero-mode waveguides for performing single-molecule experiments at high concentrations.	Cornell Univ, Grad Program Biochem Mol & Cell Biol, Ithaca, NY 14853 USA	Cornell University	Webb, WW (corresponding author), Cornell Univ, Grad Program Biochem Mol & Cell Biol, Clark Hall, Ithaca, NY 14853 USA.		Webb, Watt W./B-5905-2011		NCRR NIH HHS [P41-RR04224] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004224] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Auroux PA, 2002, ANAL CHEM, V74, P2637, DOI 10.1021/ac020239t; BARAK LS, 1981, J CELL BIOL, V90, P595, DOI 10.1083/jcb.90.3.595; BETZIG E, 1993, SCIENCE, V262, P1422, DOI 10.1126/science.262.5138.1422; Castro A, 1997, ANAL CHEM, V69, P3915, DOI 10.1021/ac970389h; Craighead HG, 2000, SCIENCE, V290, P1532, DOI 10.1126/science.290.5496.1532; de Lange F, 2001, J CELL SCI, V114, P4153; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Jackson J.D., 1999, CLASSICAL ELECTRODYN; Keller RA, 2002, ANAL CHEM, V74, p316a, DOI 10.1021/ac022035i; KLEPPNER D, 1981, PHYS REV LETT, V47, P233, DOI 10.1103/PhysRevLett.47.233; KOPPEL DE, 1974, PHYS REV A, V10, P1938, DOI 10.1103/PhysRevA.10.1938; KORLACH J, 2000, Patent No. 0070073; Lerch HP, 2002, P NATL ACAD SCI USA, V99, P15410, DOI 10.1073/pnas.232376799; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Medina MA, 2002, BIOESSAYS, V24, P758, DOI 10.1002/bies.10118; Mertz J, 1995, OPT LETT, V20, P2532, DOI 10.1364/OL.20.002532; Meyer-Almes FJ, 2000, BIOCHEMISTRY-US, V39, P13261, DOI 10.1021/bi000057y; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; PURCELL EM, 1946, PHYS REV, V69, P681; Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435; RICKA J, 1989, PHYS REV A, V39, P2646, DOI 10.1103/PhysRevA.39.2646; Rippe K, 2000, BIOCHEMISTRY-US, V39, P2131, DOI 10.1021/bi9922190; Schomburg D, 2001, SPRINGER HDB ENZYMES; Starr TE, 2001, BIOPHYS J, V80, P1575, DOI 10.1016/S0006-3495(01)76130-9; THOMPSON NL, 1981, BIOPHYS J, V33, P435, DOI 10.1016/S0006-3495(81)84905-3; Woolley AT, 2000, NAT BIOTECHNOL, V18, P760, DOI 10.1038/77760; Xie XS, 1999, J BIOL CHEM, V274, P15967, DOI 10.1074/jbc.274.23.15967; Xu, 2002, T FLUOR SP, P471; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059	30	1016	1452	10	280	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					682	686		10.1126/science.1079700	http://dx.doi.org/10.1126/science.1079700			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560545				2022-12-28	WOS:000180687700039
J	Yethiraj, A; van Blaaderen, A				Yethiraj, A; van Blaaderen, A			A colloidal model system with an interaction tunable from hard sphere to soft and dipolar	NATURE			English	Article							PHASE-DIAGRAM; CRYSTALLIZATION KINETICS; MONODISPERSE; FLUORESCENT; SUSPENSIONS; NUCLEATION; SIMULATION; DYNAMICS; GROWTH	Monodisperse colloidal suspensions of micrometre-sized spheres are playing an increasingly important role as model systems to study, in real space, a variety of phenomena in condensed matter physics-such as glass transitions and crystal nucleation(1-4). But to date, no quantitative real-space studies have been performed on crystal melting, or have investigated systems with long-range repulsive potentials. Here we demonstrate a charge- and sterically stabilized colloidal suspension-poly(methyl methacrylate) spheres in a mixture of cycloheptyl (or cyclohexyl) bromide and decalin-where both the repulsive range and the anisotropy of the interparticle interaction potential can be controlled. This combination of two independent tuning parameters gives rise to a rich phase behaviour, with several unusual colloidal (liquid) crystalline phases, which we explore in real space by confocal microscopy. The softness of the interaction is tuned in this colloidal suspension by varying the solvent salt concentration; the anisotropic (dipolar) contribution to the interaction potential can be independently controlled with an external electric field ranging from a small perturbation to the point where it completely determines the phase behaviour. We also demonstrate that the electric field can be used as a pseudo-thermodynamic temperature switch to enable real-space studies of melting transitions. We expect studies of this colloidal model system to contribute to our understanding of, for example, electro- and magneto-rheological fluids.	Univ Utrecht, Debye Inst, NL-3584 CC Utrecht, Netherlands; FOM, Inst Atom & Mol Phys, NL-1098 SJ Amsterdam, Netherlands	Utrecht University; AMOLF	Yethiraj, A (corresponding author), Univ Utrecht, Debye Inst, Padualaan 5, NL-3584 CC Utrecht, Netherlands.	yethiraj@chem.ubc.ca; A.vanBlaaderen@phys.uu.nl	van Blaaderen, Alfons/B-6304-2009; Yethiraj, Anand/L-4325-2014; van Blaaderen, Alfons/ABB-1370-2020	van Blaaderen, Alfons/0000-0003-3090-2753; Yethiraj, Anand/0000-0003-1293-2801; van Blaaderen, Alfons/0000-0003-3090-2753				ANTL L, 1986, COLLOID SURFACE, V17, P67, DOI 10.1016/0166-6622(86)80187-1; Bosma G, 2002, J COLLOID INTERF SCI, V245, P292, DOI 10.1006/jcis.2001.7986; Dassanayake U, 2000, J CHEM PHYS, V112, P3851, DOI 10.1063/1.480933; DEHOOG EHA, 2000, PHYS REV E, V64; DHONT JKG, 1992, J COLLOID INTERF SCI, V152, P386, DOI 10.1016/0021-9797(92)90041-J; El Azhar F, 2000, J CHEM PHYS, V112, P5121, DOI 10.1063/1.481068; Gasser U, 2001, SCIENCE, V292, P258, DOI 10.1126/science.1058457; Gast AP, 1998, PHYS TODAY, V51, P24, DOI 10.1063/1.882495; GRIER DG, 1994, J CHEM PHYS, V100, P9088, DOI 10.1063/1.466662; HALSEY TC, 1990, PHYS REV LETT, V65, P2820, DOI 10.1103/PhysRevLett.65.2820; Harland JL, 1997, PHYS REV E, V55, P3054, DOI 10.1103/PhysRevE.55.3054; Holtz JH, 1997, NATURE, V389, P829, DOI 10.1038/39834; Kegel WK, 2000, SCIENCE, V287, P290, DOI 10.1126/science.287.5451.290; MARTIN JE, 1992, PHYS REV LETT, V69, P1524, DOI 10.1103/PhysRevLett.69.1524; Martin JE, 1998, J CHEM PHYS, V108, P3765, DOI 10.1063/1.475781; MONOVOUKAS Y, 1989, J COLLOID INTERF SCI, V128, P533, DOI 10.1016/0021-9797(89)90368-8; OBRIEN RW, 1978, J CHEM SOC FARAD T 2, V74, P1607, DOI 10.1039/f29787401607; Palberg T, 1999, J PHYS-CONDENS MAT, V11, pR323, DOI 10.1088/0953-8984/11/28/201; Parthasarathy M, 1996, MAT SCI ENG R, V17, P57, DOI 10.1016/0927-796X(96)00191-X; Pham KN, 2002, SCIENCE, V296, P104, DOI 10.1126/science.1068238; Pronk S, 1999, J CHEM PHYS, V110, P4589, DOI 10.1063/1.478339; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; ROBBINS MO, 1988, J CHEM PHYS, V88, P3286, DOI 10.1063/1.453924; Russel WB, 1997, LANGMUIR, V13, P3871, DOI 10.1021/la970062b; Russel WB, 1999, COLLOIDAL DISPERSION; SIROTA EB, 1989, PHYS REV LETT, V62, P1524, DOI 10.1103/PhysRevLett.62.1524; TAO R, 1994, PHYS REV LETT, V73, P205, DOI 10.1103/PhysRevLett.73.205; VANBLAADEREN A, 1995, SCIENCE, V270, P1177, DOI 10.1126/science.270.5239.1177; VANBLAADEREN A, 1992, LANGMUIR, V8, P2921, DOI 10.1021/la00048a013; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627	30	763	772	5	341	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2003	421	6922					513	517		10.1038/nature01328	http://dx.doi.org/10.1038/nature01328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556887				2022-12-28	WOS:000180670600039
J	Friedman, MA; den Besten, H; Attaran, A				Friedman, MA; den Besten, H; Attaran, A			Out-licensing: a practical approach for improvement of access to medicines in poor countries	LANCET			English	Editorial Material									Harvard Univ, John F Kennedy Sch Govt, Carr Ctr Human Rights Policy, Cambridge, MA 02138 USA; Int Dispensary Assoc, Amsterdam, Netherlands; Pharmacia Corp, Peapack, NJ USA	Harvard University; Pfizer	Attaran, A (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Carr Ctr Human Rights Policy, 79 JFK St, Cambridge, MA 02138 USA.	amir_attaran@harvard.edu						ACHMAT Z, 2002, 14 INT AIDS C BARC; ACHMAT Z, 2001, GUARDIAN        1201; *ACT UP, 2002, ACT UP DEM BREAK PAT; *AIDS HEALTHC FDN, 2002, US LARG AIDS ORG CAL; Attaran A, 2001, JAMA-J AM MED ASSOC, V286, P1886, DOI 10.1001/jama.286.15.1886; BAKER BK, 2001, TRIPS REFORM VOLUNTA; BOOKER S, 2001, NATION          0709; BOSELEY S, 2002, GUARDIAN        1004; *BRIST MYERS SQUIB, 2001, BRIST SQUIBB ANN ACC; COHEN M, 2001, ASS PRESS WORLD 0516; *CONS PROJ TECHN H, 2001, JOINT STAT WTO WHO D; *HLTH GAP, 2002, WHAT IS HLTH GAP; *MED SANS FRONT, 2002, DURB BARC OV TREATM; *MERCK, 2000, HIV AIDS DEV WORLD M; Murray CJL, 1996, GLOBAL BURDEN DIS CO; PEARL D, 2001, WALL STREET J   0216; *PFIZER, 2002, ALL BUILD 1ST LARG S; *TREATM ACT CAMP, 2002, DEF CAMP QUEST ANSW; *UNAIDS, 2002, 12 M GEN MAY 28; WALDHOLZ M, 2002, WALL STREET J   0627; *WHO COMM MACR HLT, 2002, MACR HLTH INV HLTH E; *WHO WORLD TRADE O, 2002, WORKSH DIFF PRIC FIN; World Health Organization, 2002, SEL US ESS MED REP W; 2002, OXFAM IMPLAUSIBLE DE; 2002, REUTERS MED NEW 1115	25	16	16	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2003	361	9354					341	344		10.1016/S0140-6736(03)12331-8	http://dx.doi.org/10.1016/S0140-6736(03)12331-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559883				2022-12-28	WOS:000180643900029
J	Poremba, A; Saunders, RC; Crane, AM; Cook, M; Sokoloff, L; Mishkin, M				Poremba, A; Saunders, RC; Crane, AM; Cook, M; Sokoloff, L; Mishkin, M			Functional mapping of the primate auditory system	SCIENCE			English	Article							CEREBRAL GLUCOSE-UTILIZATION; CORTEX; ORGANIZATION; AREAS; LOCALIZATION; AFFERENTS; PATHWAYS; NEURONS; MONKEYS; STREAMS	Cerebral auditory areas were delineated in the awake, passively listening, rhesus monkey by comparing the rates of glucose utilization in an intact hemisphere and in an acoustically isolated contralateral hemisphere of the same animal. The auditory system defined in this way occupied large portions of cerebral tissue, an extent probably second only to that of the visual system. Cortically, the activated areas included the entire superior temporal gyrus and large portions of the parietal, prefrontal, and limbic lobes. Several auditory areas overlapped with previously identified visual areas, suggesting that the auditory system, like the visual system, contains separate pathways for processing stimulus quality, location, and motion.	Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; Univ Iowa, Neurosci Program, Iowa City, IA 52242 USA; NIMH, Neuropsychol Lab, Bethesda, MD 20892 USA; Univ Texas, Ctr Perceptual Syst, Austin, TX 78712 USA; NIMH, Cerebral Metab Lab, Bethesda, MD 20892 USA	University of Iowa; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Texas System; University of Texas Austin; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Poremba, A (corresponding author), Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA.	amy-poremba@uiowa.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH001101, Z01MH001101, Z01MH000882] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Bell AH, 2001, CAN J EXP PSYCHOL, V55, P123, DOI 10.1037/h0087359; Bonin G, 1947, NEOCORTEX MACACA MUL; BOUSSAOUD D, 1990, J COMP NEUROL, V296, P462, DOI 10.1002/cne.902960311; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BURTON H, 1982, J COMP NEUROL, V210, P109, DOI 10.1002/cne.902100203; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Fernandez-Ruiz J, 2001, P NATL ACAD SCI USA, V98, P4196, DOI 10.1073/pnas.061022098; Fuster J.M., 1989, PREFRONTAL CORTEX; Galuske RAW, 2000, SCIENCE, V289, P1946, DOI 10.1126/science.289.5486.1946; Griffiths TD, 2000, HUM BRAIN MAPP, V9, P72, DOI 10.1002/(SICI)1097-0193(200002)9:2<72::AID-HBM2>3.0.CO;2-9; IMIG TJ, 1977, BRAIN RES, V138, P241, DOI 10.1016/0006-8993(77)90743-0; JONES EG, 1970, BRAIN, V93, P37, DOI 10.1093/brain/93.1.37; JULIANO SL, 1981, J NEUROPHYSIOL, V46, P1260, DOI 10.1152/jn.1981.46.6.1260; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kaas JH, 2001, CURR OPIN NEUROBIOL, V11, P498, DOI 10.1016/S0959-4388(00)00240-3; KENNEDY C, 1978, ANN NEUROL, V4, P293, DOI 10.1002/ana.410040402; Kosaki H, 1997, J COMP NEUROL, V386, P304; LEINONEN L, 1980, EXP BRAIN RES, V39, P203; MACKO KA, 1982, SCIENCE, V218, P394, DOI 10.1126/science.7123241; MACKO KA, 1985, BRAIN IMAGING BRAIN; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Mazzoni P, 1996, J NEUROPHYSIOL, V75, P1233, DOI 10.1152/jn.1996.75.3.1233; NEWMAN JD, 1976, EXP BRAIN RES, V25, P169; PANDYA DN, 1995, REV NEUROL, V151, P486; Petrides M, 1999, EUR J NEUROSCI, V11, P1011, DOI 10.1046/j.1460-9568.1999.00518.x; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, AUDIOL NEURO-OTOL, V3, P86, DOI 10.1159/000013784; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Romanski LM, 2002, NAT NEUROSCI, V5, P15, DOI 10.1038/nn781; SAVAKI HE, 1993, J NEUROSCI, V13, P2772; Saykin AJ, 1999, BRAIN, V122, P1963, DOI 10.1093/brain/122.10.1963; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Stein BE, 1998, EXP BRAIN RES, V123, P124, DOI 10.1007/s002210050553; Teder-Salejarvi WA, 2002, COGNITIVE BRAIN RES, V14, P106, DOI 10.1016/S0926-6410(02)00065-4; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; WALLACE MT, 1993, PROG BRAIN RES, V112, P301; Wise RJS, 2001, BRAIN, V124, P83, DOI 10.1093/brain/124.1.83; Woolsey C. N., 1982, CORTICAL SENSORY ORG, V3, P231	45	170	172	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					568	572		10.1126/science.1078900	http://dx.doi.org/10.1126/science.1078900			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543977				2022-12-28	WOS:000180559800051
J	Qiu, XH; Nazin, GV; Ho, W				Qiu, XH; Nazin, GV; Ho, W			Vibrationally resolved fluorescence excited with submolecular precision	SCIENCE			English	Article							SCANNING-TUNNELING-MICROSCOPY; PHOTON-EMISSION; LIGHT-EMISSION; SPECTROSCOPY; RESOLUTION; SPECTRA; MODES	Tunneling electrons from a scanning tunneling microscope (STM) were used to excite photon emission from individual porphyrin molecules adsorbed on an ultrathin alumina film grown on a NiAl(110) surface. Vibrational features were observed in the light-emission spectra that depended sensitively on the different molecular conformations and corresponding electronic states obtained by scanning tunneling spectroscopy. The high spatial resolution of the STM enabled the demonstration of variations in light-emission spectra from different parts of the molecule. These experiments realize the feasibility of fluorescence spectroscopy with the STM and enable the integration of optical spectroscopy with a nanoprobe for the investigation of single molecules.	Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Ho, W (corresponding author), Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA.	wilsonho@uci.edu	Nazin, George/GQH-5396-2022					Aizpurua J, 2000, PHYS REV B, V62, P2065, DOI 10.1103/PhysRevB.62.2065; Aizpurua J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.156803; Alvarado SF, 1997, PHYS REV B, V56, P1269, DOI 10.1103/PhysRevB.56.1269; Barnes WL, 1998, J MOD OPTIC, V45, P661, DOI 10.1080/09500349808230614; Baumer M, 1999, PROG SURF SCI, V61, P127, DOI 10.1016/S0079-6816(99)00012-X; BERNDT R, 1995, PHYS REV LETT, V74, P102, DOI 10.1103/PhysRevLett.74.102; BERNDT R, 1993, PHYS REV LETT, V71, P3493, DOI 10.1103/PhysRevLett.71.3493; BERNDT R, 1993, PHYS REV B, V48, P4746, DOI 10.1103/PhysRevB.48.4746; BERNDT R, 1991, PHYS REV LETT, V67, P3796, DOI 10.1103/PhysRevLett.67.3796; BERNDT R, 1993, SCIENCE, V262, P1425, DOI 10.1126/science.262.5138.1425; COOMBS JH, 1988, J MICROSC-OXFORD, V152, P325, DOI 10.1111/j.1365-2818.1988.tb01393.x; Downes A, 1998, PHYS REV LETT, V81, P1857, DOI 10.1103/PhysRevLett.81.1857; Hoffmann G, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.212107; Hoffmann G, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.176803; HU SZ, 1995, J PHYS CHEM-US, V99, P9694, DOI 10.1021/j100024a009; JOHANSSON P, 1990, PHYS REV B, V42, P9210, DOI 10.1103/PhysRevB.42.9210; LI XY, 1989, J AM CHEM SOC, V111, P7012, DOI 10.1021/ja00200a018; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Marques HM, 2002, COORDIN CHEM REV, V225, P123, DOI 10.1016/S0010-8545(01)00411-8; MASLOV VG, 1990, IZV AN SSSR FIZ+, V54, P465; Meguro K, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165405; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Nilius N, 2000, PHYS REV LETT, V84, P3994, DOI 10.1103/PhysRevLett.84.3994; PERSSON BNJ, 1992, PHYS REV LETT, V68, P3224, DOI 10.1103/PhysRevLett.68.3224; Shelnutt JA, 1998, CHEM SOC REV, V27, P31; Stipe BC, 1999, REV SCI INSTRUM, V70, P137, DOI 10.1063/1.1149555; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; UEHARA Y, 1992, JPN J APPL PHYS 1, V31, P2465, DOI 10.1143/JJAP.31.2465; Uehara Y, 1999, PHYS REV LETT, V83, P2445, DOI 10.1103/PhysRevLett.83.2445; Uehara Y, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.075413; Uehara Y, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.155408; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Xie XS, 1998, ANNU REV PHYS CHEM, V49, P441, DOI 10.1146/annurev.physchem.49.1.441	33	485	487	4	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					542	546		10.1126/science.1078675	http://dx.doi.org/10.1126/science.1078675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543968				2022-12-28	WOS:000180559800042
J	Trainor, P				Trainor, P			The bills of qucks and duails	SCIENCE			English	Editorial Material							NEURAL CREST		Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Trainor, P (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.			Trainor, Paul/0000-0003-2774-3624				ANDRES G., 1949, GENETICA, V24, P387, DOI 10.1007/BF01487210; ANDRES G, 1946, REV SUISSE ZOOL, V53, P502; [Anonymous], 1861, ORIGIN SPECIES MEANS; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; GRANT BR, 1993, P ROY SOC B-BIOL SCI, V251, P111, DOI 10.1098/rspb.1993.0016; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Le Douarin NM, 1999, NEURAL CREST, V2; Lucas A. M., 1972, USDA HDB, V362; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; Schneider RA, 2003, SCIENCE, V299, P565, DOI 10.1126/science.1077827; Trainor P, 2000, NAT CELL BIOL, V2, P96, DOI 10.1038/35000051; Wagner G., 1959, Roux Archiv fuer Entwicklungsmechanik Organismen, V151, P136; WAGNER GERHART, 1949, REV SUISSE ZOOL, V56, P519	13	6	6	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					523	524		10.1126/science.1081521	http://dx.doi.org/10.1126/science.1081521			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543959				2022-12-28	WOS:000180559800032
J	Dennis, DT; Chu, MC				Dennis, DT; Chu, MC			A major new test for plague	LANCET			English	Editorial Material									Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Natl Ctr Infect Dis, Ft Collins, CO 80522 USA	Centers for Disease Control & Prevention - USA	Dennis, DT (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Natl Ctr Infect Dis, Ft Collins, CO 80522 USA.	dtd1@cdc.gov						[Anonymous], 2000, Wkly Epidemiol Rec, V75, P338; BIBEL DJ, 1976, BACTERIOL REV, V40, P633, DOI 10.1128/MMBR.40.3.633-651.1976; Boisier P, 2002, EMERG INFECT DIS, V8, P311, DOI 10.3201/eid0803.010250; CAMPBELL GL, 1995, ANN INTERN MED, V122, P151, DOI 10.7326/0003-4819-122-2-199501150-00014; Chanteau S, 1998, EMERG INFECT DIS, V4, P101, DOI 10.3201/eid0401.980114; Feodorova VA, 2000, J MED MICROBIOL, V49, P261, DOI 10.1099/0022-1317-49-3-261; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Ratsitorahina M, 2000, LANCET, V355, P111, DOI 10.1016/S0140-6736(99)05163-6	8	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2003	361	9353					191	192		10.1016/S0140-6736(03)12320-3	http://dx.doi.org/10.1016/S0140-6736(03)12320-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547537				2022-12-28	WOS:000180535400003
J	Horton, R				Horton, R			WHO's next Director-General: time to decide	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Horton, R (corresponding author), Lancet, London NW1 7BY, England.							Binka F, 2002, LANCET, V360, P1797, DOI 10.1016/S0140-6736(02)11841-1	1	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					194	194		10.1016/S0140-6736(03)12321-5	http://dx.doi.org/10.1016/S0140-6736(03)12321-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547540				2022-12-28	WOS:000180535400006
J	Thompson, JK; Peterson, MR; Freeman, RD				Thompson, JK; Peterson, MR; Freeman, RD			Single-neuron activity and tissue oxygenation in the cerebral cortex	SCIENCE			English	Article							SENSORY STIMULATION; BLOOD OXYGENATION; FUNCTIONAL MRI; BRAIN; ACTIVATION; SIGNAL; FMRI; COLUMNS	Blood oxygen level-dependent functional magnetic resonance imaging uses alterations in brain hemodynamics to infer changes in neural activity. Are these hemodynamic changes regulated at a spatial scale capable of resolving functional columns within the cerebral cortex? To address this question, we made simultaneous measurements of tissue oxygenation and single-cell neural activity within the visual cortex. Results showed that increases in neuronal spike rate were accompanied by immediate decreases in tissue oxygenation. We used this decrease in tissue oxygenation to predict the orientation selectivity and ocular dominance of neighboring neurons. Our results establish a coupling between neural activity and oxidative metabolism and suggest that high-resolution functional magnetic resonance imaging may be used to localize neural activity at a columnar level.	Univ Calif Berkeley, Helen WIllis Neurosci Inst, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Freeman, RD (corresponding author), Univ Calif Berkeley, Helen WIllis Neurosci Inst, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA.				NEI NIH HHS [EY01175, T32 EY 07043-24, EY03176] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY003176, R01EY001175, T32EY007043] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Cannestra AF, 2001, CEREB CORTEX, V11, P773, DOI 10.1093/cercor/11.8.773; Disbrow EA, 2000, P NATL ACAD SCI USA, V97, P9718, DOI 10.1073/pnas.170205497; FATT I, 1976, POLAROGRAPHIC OXYGEN, P197; Grinvald A, 2000, NAT NEUROSCI, V3, P105, DOI 10.1038/72045; Kanaiwa H, 1995, SURG NEUROL, V44, P172, DOI 10.1016/0090-3019(95)00126-3; Kim DS, 2000, NAT NEUROSCI, V3, P164, DOI 10.1038/72109; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lindauer U, 2001, NEUROIMAGE, V13, P988, DOI 10.1006/nimg.2000.0709; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Marota JJA, 1999, MAGNET RESON MED, V41, P247, DOI 10.1002/(SICI)1522-2594(199902)41:2<247::AID-MRM6>3.0.CO;2-U; Mayhew J, 1999, NEUROIMAGE, V10, P304, DOI 10.1006/nimg.1999.0460; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Silva AC, 2000, J CEREBR BLOOD F MET, V20, P201, DOI 10.1097/00004647-200001000-00025; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; Yacoub E, 2001, NMR BIOMED, V14, P408, DOI 10.1002/nbm.715; Zheng Y, 2002, NEUROIMAGE, V16, P617, DOI 10.1006/nimg.2002.1078	21	252	253	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1070	1072		10.1126/science.1079220	http://dx.doi.org/10.1126/science.1079220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586942				2022-12-28	WOS:000180960000049
J	Solomon, CG; Dluhy, RG				Solomon, CG; Dluhy, RG			Rethinking postmenopausal hormone therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Solomon, CG (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.								0	44	49	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2003	348	7					579	580		10.1056/NEJMp030006	http://dx.doi.org/10.1056/NEJMp030006			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644HY	12584364				2022-12-28	WOS:000180912900001
J	Davidson, AJ; Zon, LI				Davidson, AJ; Zon, LI			Love, honor, and protect (your liver)	SCIENCE			English	Editorial Material							GROWTH-FACTOR; CELLS		Childrens Hosp, Howard Hughes Med Inst, Dept Med, Div Hematol Oncol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Davidson, AJ (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Dept Med, Div Hematol Oncol, Boston, MA 02115 USA.							Bahary N, 2001, SCIENCE, V294, P530, DOI 10.1126/science.1066282; Cotran R. S., 1999, ROBBINS PATHOLOGIC B, V6th; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Ishikawa K, 1999, BIOCHEM BIOPH RES CO, V254, P587, DOI 10.1006/bbrc.1998.9984; Jeffers M, 1996, MOL CELL BIOL, V16, P1115; Kaido T, 1997, FEBS LETT, V411, P378, DOI 10.1016/S0014-5793(97)00744-8; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889	9	13	14	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					835	837		10.1126/science.1082006	http://dx.doi.org/10.1126/science.1082006			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574609				2022-12-28	WOS:000180830900030
J	Moller, PR; Nielsen, JG; Fossen, I				Moller, PR; Nielsen, JG; Fossen, I			Fish migration: Patagonian toothfish found off Greenland - This catch is evidence of transequatorial migration by a cold-water Antarctic fish	NATURE			English	Article									Univ Copenhagen, Zool Museum, DK-2100 Copenhagen O, Denmark; More Res, Sect Fisheries, N-6021 Alesund, Norway	University of Copenhagen	Moller, PR (corresponding author), Univ Copenhagen, Zool Museum, DK-2100 Copenhagen O, Denmark.		Møller, Peter/A-8807-2013	Møller, Peter/0000-0002-0177-0977				AGNEW D, 2002, IUCN SSC WILDLIFE TR; ANDRIASHEV AP, 1991, POLAR BIOL, V11, P213; [Anonymous], 1953, ZOOGEOGRAPHY SEA; Balushkin AV, 2000, J ICHTHYOL S1, V40, pS74; Dewitt H.H., 1990, P279; DIETRICH G, 1968, ATLAS OCEANOGRAPHIE; Eastman J.T., 1990, P34; Hilbish TJ, 2000, MAR BIOL, V136, P69, DOI 10.1007/s002270050010; Wienecke B, 2002, FISH RES, V54, P253, DOI 10.1016/S0165-7836(00)00307-6; WILLIAMS R, 2002, J SCI COMMITTEE COMM, V9, P33	10	29	31	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					599	599		10.1038/421599a	http://dx.doi.org/10.1038/421599a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571586				2022-12-28	WOS:000180803200031
J	Munoz, N; Bosch, FX; de Sanjose, S; Herrero, R; Castellsague, X; Shah, KV; Snijders, PJF; Meijer, CJLM				Munoz, N; Bosch, FX; de Sanjose, S; Herrero, R; Castellsague, X; Shah, KV; Snijders, PJF; Meijer, CJLM		Int Agcy Res Canc Multicenter Cerv	Epidemiologic classification of human papillomavirus types associated with cervical cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK-FACTORS; INFECTION; PCR; IDENTIFICATION; HYBRIDIZATION; NEOPLASIA	Background: Infection with human papilloma virus (HPV) is the main cause of cervical cancer, but the risk associated with the various HPV types has not been adequately assessed. Methods: We pooled data from 11 case-control studies from nine countries involving 1918 women with histologically confirmed squamous-cell cervical cancer and 1928 control women. A common protocol and questionnaire were used. Information on risk factors was obtained by personal interviews, and cervical cells were collected for detection of HPV DNA and typing in a central laboratory by polymerase-chain-reaction-based assays (with MY09/MY11 and GP5+/6+ primers). Results: HPV DNA was detected in 1739 of the 1918 patients with cervical cancer (90.7 percent) and in 259 of the 1928 control women (13.4 percent). With the GP5+/6+ primer, HPV DNA was detected in 96.6 percent of the patients and 15.6 percent of the controls. The most common HPV types in patients, in descending order of frequency, were types 16, 18, 45, 31, 33, 52, 58, and 35. Among control women, types 16, 18, 45, 31, 6, 58, 35, and 33 were the most common. For studies using the GP5+/6+ primer, the pooled odds ratio for cervical cancer associated with the presence of any HPV was 158.2 (95 percent confidence interval, 113.4 to 220.6). The odds ratios were over 45 for the most common and least common HPV types. Fifteen HPV types were classified as high-risk types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82); 3 were classified as probable high-risk types (26, 53, and 66); and 12 were classified as low-risk types (6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81, and CP6108). There was good agreement between our epidemiologic classification and the classification based on phylogenetic grouping. Conclusions: In addition to HPV types 16 and 18, types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82 should be considered carcinogenic, or high-risk, types, and types 26, 53, and 66 should be considered probably carcinogenic.	Int Agcy Res Canc, F-69372 Lyon, France; Hosp Llobregat, Epidemiol & Canc Registrat Unit, Inst Catalad Oncol, Barcelona, Spain; Costa Rican Fdn Hlth Sci, San Jose, Costa Rica; Johns Hopkins Univ, Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands	World Health Organization; International Agency for Research on Cancer (IARC); Catalan Institute of Oncology; University of Barcelona; Johns Hopkins University; Vrije Universiteit Amsterdam	Munoz, N (corresponding author), Hosp Duran & Reynals, Inst Catalad Oncol, Serv Epidemiol & Registre Canc, Epidemiol & Canc Registrat Unit, Av Gran Via,S-N Km 2 7, Barcelona 08907, Spain.	cris@ico.scs.es	de Sanjosé Llongueras, Silvia/H-6339-2014; Eluf-Neto, Jose/B-2522-2009; JOSÉ, FRANCESC XAVIER BOSCH/J-6339-2012; Pique, Xavier Castellsagué/N-5795-2014	Eluf-Neto, Jose/0000-0001-7504-2115; JOSÉ, FRANCESC XAVIER BOSCH/0000-0002-7172-3412; Pique, Xavier Castellsagué/0000-0002-0802-3595				Bayo S, 2002, INT J EPIDEMIOL, V31, P202, DOI 10.1093/ije/31.1.202; BOSCH FX, 1993, CANCER EPIDEM BIOMAR, V2, P415; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Breslow N. E., 1980, IARC SCI PUBLICATION, V32; Chaouki N, 1998, INT J CANCER, V75, P546, DOI 10.1002/(SICI)1097-0215(19980209)75:4&lt;546::AID-IJC9&gt;3.0.CO;2-T; Chichareon S, 1998, J NATL CANCER I, V90, P50, DOI 10.1093/jnci/90.1.50; Davies P, 2001, BEST PRACT RES CL OB, V15, P677, DOI 10.1053/beog.2001.0214; de Sanjose S, 1999, DIAGN MOL PATHOL, V8, P26, DOI 10.1097/00019606-199903000-00005; De Villiers E-M, 2001, PAPILLOMAVIRUS REP, V12, P57; DURST M, 1987, ONCOGENE, V1, P251; ELUFNETO J, 1994, BRIT J CANCER, V69, P114, DOI 10.1038/bjc.1994.18; Ferlay J, 2001, GLOBOCAN 2000 CANC I; Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020, DOI 10.1128/JCM.36.10.3020-3027.1998; Herrero R, 2000, JNCI-J NATL CANCER I, V92, P464, DOI 10.1093/jnci/92.6.464; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; *INT AG RES CANC, 1995, IARC MON EV CARC RIS, V64; JACOBS MV, 1995, J CLIN MICROBIOL, V33, P901, DOI 10.1128/JCM.33.4.901-905.1995; Kjaer SK, 1996, INT J CANCER, V65, P601, DOI 10.1002/(SICI)1097-0215(19960301)65:5<601::AID-IJC8>3.0.CO;2-6; Kleter B, 1999, J CLIN MICROBIOL, V37, P2508, DOI 10.1128/JCM.37.8.2508-2517.1999; MANOS MM, 1989, CANCER CEL, V7, P209; McDougall J K, 1994, Curr Top Microbiol Immunol, V186, P101; MUNOZ N, 1992, INT J CANCER, V52, P743, DOI 10.1002/ijc.2910520513; Myers G, 1997, HUMAN PAPILLOMAVIRUS; Ngelangel C, 1998, JNCI-J NATL CANCER I, V90, P43, DOI 10.1093/jnci/90.1.43; Rolon PA, 2000, INT J CANCER, V85, P486, DOI 10.1002/(SICI)1097-0215(20000215)85:4&lt;486::AID-IJC7&gt;3.0.CO;2-S; Santos C, 2001, BRIT J CANCER, V85, P966, DOI 10.1054/bjoc.2001.1948; SCHIFFMAN MH, 1993, JNCI-J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958; STOREY A, 1988, EMBO J, V7, P1815, DOI 10.1002/j.1460-2075.1988.tb03013.x; van den Brule AJC, 2002, J CLIN MICROBIOL, V40, P779, DOI 10.1128/JCM.40.3.779-787.2002; VANRANST M, 1992, J GEN VIROL, V73, P2653, DOI 10.1099/0022-1317-73-10-2653; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	31	4368	4782	11	486	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2003	348	6					518	527		10.1056/NEJMoa021641	http://dx.doi.org/10.1056/NEJMoa021641			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642JY	12571259	Green Published			2022-12-28	WOS:000180801400005
J	Safran, DG				Safran, DG			Defining the future of primary care: What can we learn from patients?	ANNALS OF INTERNAL MEDICINE			English	Article							FEE-FOR-SERVICE; HEALTH MAINTENANCE ORGANIZATIONS; MEDICAL OUTCOMES; PERFORMANCE; QUALITY; PHYSICIANS; SATISFACTION; MALPRACTICE; PREPAID; COMMUNICATION	From the earliest definitions of the term primary care to the most recent, all have stressed that primary care is predicated on a sustained relationship between patients and the clinicians who care for them. Primary care differentiates itself from other areas of medicine by attending to the whole person, in the context of the patient's personal and medical history and life circumstances, rather than focusing on a particular disease, organ, or system. Finally, the primary care physician plays a distinctive role in integrating the care that patients receive from within and outside of the primary care setting. Data obtained from patients over the past 15 years demonstrate that most Americans have a physician whom they consider to be their primary physician. This was the case well before the rules of managed care plans required patients to align themselves with a particular primary care physician and to allow that physician to coordinate all of their medical care. However, information from patients indicates that despite primary care relationships that endure over several years, the ideals of whole-person, integrated care are largely unmet in patients' primary care experiences. Moreover, considerable evidence indicates that the quality of primary care relationships has eroded over the past several years. This article highlights the relative strengths and weaknesses of primary care, as experienced and reported by patients, and posits three areas that must be addressed for primary care to live up to the ideals of sustained partnerships providing whole-person, integrated care. These three areas involve the use of teams in medicine, the establishment of meaningful primary care partnerships, and integration of care in a delivery system that patients experience as increasingly fragmented.	Tufts Univ, New England Med Ctr, Hlth Inst, Div Clin Care Res, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Safran, DG (corresponding author), Tufts Univ, New England Med Ctr, Hlth Inst, Div Clin Care Res, 750 Washington St,NEMC 345, Boston, MA 02111 USA.				AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS008841, R01HS009622] Funding Source: NIH RePORTER; AHRQ HHS [R01 HS08841, R01 HS09622] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AG HLTH CAR POL R, 1987, PUBL AG HLTH CAR POL; AIKEN LH, 1979, NEW ENGL J MED, V300, P1363, DOI 10.1056/NEJM197906143002404; ALPERT J, 1973, ED PHYSICIANS PRIMAR; *AM ASS HLTH PLANS, 1999, HLTH PLANS EMPL SPON; Anderson G, 2001, HEALTH AFFAIR, V20, P146, DOI 10.1377/hlthaff.20.6.146; Bazzoli GJ, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.6.188; BECKMAN HB, 1994, ARCH INTERN MED, V154, P1365, DOI 10.1001/archinte.154.12.1365; Campbell SM, 2001, BMJ-BRIT MED J, V323, P784, DOI 10.1136/bmj.323.7316.784; CLEMENT DG, 1994, HMOS ELDERLY; DAVIES AR, 1986, HEALTH SERV RES, V21, P429; Davis J. A., 1992, NORC GEN SOCIAL SURV; DiMatteo M R, 1994, JAMA, V271, P83, DOI 10.1001/jama.271.1.79; DIMATTEO MR, 1993, HEALTH PSYCHOL, V12, P93, DOI 10.1037/0278-6133.12.2.93; DiMatteo MR, 1994, JAMA-J AM MED ASSOC, V271, P83; Fargason C A Jr, 1992, QRB Qual Rev Bull, V18, P157; FRANCIS V, 1969, NEW ENGL J MED, V280, P535, DOI 10.1056/NEJM196903062801004; Gabel J, 2001, HEALTH AFFAIR, V20, P180, DOI 10.1377/hlthaff.20.5.180; Gittell JH, 2000, MED CARE, V38, P807, DOI 10.1097/00005650-200008000-00005; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; Hargraves JL, 2001, MED CARE, V39, P635; HICKSON GB, 1994, JAMA-J AM MED ASSOC, V272, P1583, DOI 10.1001/jama.272.20.1583; *HLTH CAR FIN ADM, NAT BREAK MAN CAR EN; *HLTH CAR FIN ADM, 2001, MED 2000 35 YEARS IM; *HLTH CAR FIN ADM, MAN CAR TRENDS MED S; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 1996, PRIM CAR AM HLTH NEW; Institute of Medicine, 1978, REP STUD MANP POL PR; Levinson W, 1997, JAMA-J AM MED ASSOC, V277, P553, DOI 10.1001/jama.277.7.553; Longest B, 2000, HLTH CARE MANAGEMENT, P210; MILLER RH, 1994, JAMA-J AM MED ASSOC, V271, P1512, DOI 10.1001/jama.271.19.1512; MILLIS JS, 1966, MILLIS COMMISSION RE; Murphy J, 2001, J FAM PRACTICE, V50, P123; Murray A, 2000, ARCH FAM MED, V9, P327, DOI 10.1001/archfami.9.4.327; MURRAY JP, 1988, J FAM PRACTICE, V26, P576; Pascoe G C, 1983, Eval Program Plann, V6, P185, DOI 10.1016/0149-7189(83)90002-2; Rosenblatt RA, 1998, JAMA-J AM MED ASSOC, V279, P1364, DOI 10.1001/jama.279.17.1364; ROSSITER LF, 1989, JAMA-J AM MED ASSOC, V262, P57, DOI 10.1001/jama.262.1.57; Rothman AA, 2003, ANN INTERN MED, V138, P256, DOI 10.7326/0003-4819-138-3-200302040-00034; RUBIN HR, 1993, JAMA-J AM MED ASSOC, V270, P835, DOI 10.1001/jama.270.7.835; Rundall T., 2000, HLTH CARE MANAG ORG, V4th, P154; Safran DG, 1998, MED CARE, V36, P728, DOI 10.1097/00005650-199805000-00012; Safran DG, 2001, J FAM PRACTICE, V50, P130; Safran DG, 2000, ARCH INTERN MED, V160, P69, DOI 10.1001/archinte.160.1.69; Safran DG, 2000, J GEN INTERN MED, V15, P116; SAFRAN DG, 1994, JAMA-J AM MED ASSOC, V271, P1579, DOI 10.1001/jama.271.20.1579; Safran DG, 2002, J GEN INTERN MED, V17, P210; Safran DG, 2002, ARCH INTERN MED, V162, P757, DOI 10.1001/archinte.162.7.757; SAFRAN DG, 1994, DEFINING PRIMARY CAR; SAFRAN DG, 1999, ASS HLTH SERV RES PO; Shortell S. M., 2000, REMAKING HLTH CARE A; SHORTELL SM, 1994, MED CARE, V32, P508, DOI 10.1097/00005650-199405000-00009; SOX HC, 1981, ANN INTERN MED, V95, P680, DOI 10.7326/0003-4819-95-6-680; Starfield B., 1992, PRIMARY CARE CONCEPT; Taira DA, 1997, JAMA-J AM MED ASSOC, V278, P1412, DOI 10.1001/jama.278.17.1412; *US C OFF TECHN AS, 1988, OTAH386 US C, P231; Vladeck BC, 2001, HEALTH AFFAIR, V20, P175, DOI 10.1377/hlthaff.20.6.175; WARE JE, 1986, LANCET, V1, P1017; Ware JE, 1976, NTIS PUBLICATION, VI; Weinick R M, 1998, Stat Bull Metrop Insur Co, V79, P11; Wilson IB, 2002, J GEN INTERN MED, V17, P218; Zaslavsky AM, 2001, HEALTH CARE FINANC R, V22, P109	62	141	141	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					248	255		10.7326/0003-4819-138-3-200302040-00033	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00033			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558375				2022-12-28	WOS:000181018600025
J	Hall, LML; Jung, RT; Leese, GP				Hall, LML; Jung, RT; Leese, GP			Controlled trial of effect of documented cardiovascular risk scores on prescribing	BRITISH MEDICAL JOURNAL			English	Article							DISEASE		Ninewells Hosp, Ctr Diabet, Dundee DD1 9SY, Scotland	University of Dundee	Leese, GP (corresponding author), Ninewells Hosp, Ctr Diabet, Dundee DD1 9SY, Scotland.							Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Jackson R, 2000, BMJ-BRIT MED J, V320, P709, DOI 10.1136/bmj.320.7236.709; Kotseva K, 2001, LANCET, V357, P995, DOI 10.1016/S0140-6736(00)04235-5; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703	5	67	67	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					251	252		10.1136/bmj.326.7383.251	http://dx.doi.org/10.1136/bmj.326.7383.251			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560273	Green Published, Bronze			2022-12-28	WOS:000180908300016
J	Behin, A; Hoang-Xuan, K; Carpentier, AF; Delattre, JY				Behin, A; Hoang-Xuan, K; Carpentier, AF; Delattre, JY			Primary brain tumours in adults	LANCET			English	Review							NERVOUS-SYSTEM LYMPHOMA; PRIMARY CNS LYMPHOMA; NON-HODGKINS-LYMPHOMA; RECURSIVE PARTITIONING ANALYSIS; LOW-GRADE OLIGODENDROGLIOMA; HIGH-DOSE METHOTREXATE; ONCOLOGY-GROUP RTOG; PHASE-II TRIAL; MALIGNANT GLIOMA; RADIATION-THERAPY	The most frequent primary brain tumours in adults are gliomas and primary CNS lymphomas. In gliomas, molecular genetic analysis plays an increasing part in classification and treatment planning, a feature well illustrated by the chemosensitive oligodendrogliomas. Unfortunately, management of glioblastoma is still mainly palliative. Incidence of primary CNS lymphoma has increased strikingly in the past 20 years; substantial progress has been achieved in patients who are immunocompetent with the addition of methotrexate-based chemotherapy to radiotherapy, but the potential neurotoxic effects of this combination in elderly patients is worrisome.	GH Pitie Salpetriere, Federat Neurol Mazarin, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Delattre, JY (corresponding author), GH Pitie Salpetriere, Federat Neurol Mazarin, F-75013 Paris, France.	jean-yves.delattre@psl.ap-hop-paris.fr	Hoang-Xuan, Khe/O-7527-2017	Carpentier, Antoine/0000-0003-2926-0060; Behin, Anthony/0000-0001-7179-5152				Abrey LE, 1998, J CLIN ONCOL, V16, P859, DOI 10.1200/JCO.1998.16.3.859; Abrey LE, 2000, J CLIN ONCOL, V18, P3144, DOI 10.1200/JCO.2000.18.17.3144; Afra D, 2002, LANCET, V359, P1011; BALMACEDA C, 1995, ANN NEUROL, V38, P202, DOI 10.1002/ana.410380212; Bauman G, 1999, INT J RADIAT ONCOL, V45, P923, DOI 10.1016/S0360-3016(99)00284-9; Bauman G, 1999, CAN J NEUROL SCI, V26, P18; Bessell EM, 2002, J CLIN ONCOL, V20, P231, DOI 10.1200/JCO.20.1.231; Bessell EM, 2001, INT J RADIAT ONCOL, V50, P457, DOI 10.1016/S0360-3016(01)01451-1; Blay JY, 1998, J CLIN ONCOL, V16, P864, DOI 10.1200/JCO.1998.16.3.864; BLAY JY, 1995, BLOOD, V86, P2922; Brada M, 1998, INT J RADIAT ONCOL, V40, P1157, DOI 10.1016/S0360-3016(98)00002-9; Brandes AA, 1999, AM J CLIN ONCOL-CANC, V22, P387, DOI 10.1097/00000421-199908000-00013; Burger PC, 2002, BRAIN PATHOL, V12, P257; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; CAIRNCROSS JG, 1988, ANN NEUROL, V23, P360, DOI 10.1002/ana.410230408; Camilleri-Broet S, 1998, AM J CLIN PATHOL, V110, P607, DOI 10.1093/ajcp/110.5.607; Capelle L, 2002, NEUROLOGY, V58, pA13; Chadha M, 1998, INT J RADIAT ONCOL, V40, P829, DOI 10.1016/S0360-3016(97)00891-2; Chinot OL, 2001, J CLIN ONCOL, V19, P2449, DOI 10.1200/JCO.2001.19.9.2449; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Corn BW, 1997, CANCER, V79, P2409; Cote TR, 1996, J NATL CANCER I, V88, P675, DOI 10.1093/jnci/88.10.675; DaumasDuport C, 1997, J NEURO-ONCOL, V34, P37, DOI 10.1023/A:1005707203596; DaumasDuport C, 1997, J NEURO-ONCOL, V34, P61, DOI 10.1023/A:1005759220434; DEANGELIS LM, 1992, J CLIN ONCOL, V10, P635, DOI 10.1200/JCO.1992.10.4.635; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; FINE HA, 1993, ANN INTERN MED, V119, P1093, DOI 10.7326/0003-4819-119-11-199312010-00007; Fortin D, 1999, NEUROSURGERY, V45, P1279, DOI 10.1097/00006123-199912000-00001; Freilich RJ, 1996, NEUROLOGY, V46, P435, DOI 10.1212/WNL.46.2.435; Friedman HS, 2000, J CLIN ONCOL, V18, P3522, DOI 10.1200/JCO.2000.18.20.3522; GABBAI AA, 1989, J NEUROSURG, V70, P190, DOI 10.3171/jns.1989.70.2.0190; Glantz MJ, 2000, NEUROLOGY, V54, P1886, DOI 10.1212/WNL.54.10.1886; Glass J, 1996, J NEURO-ONCOL, V30, P257; GLASS J, 1994, J NEUROSURG, V81, P188, DOI 10.3171/jns.1994.81.2.0188; Guha-Thakurta N, 1999, J NEURO-ONCOL, V43, P259, DOI 10.1023/A:1006210703827; He J, 2001, J NEUROPATH EXP NEUR, V60, P863, DOI 10.1093/jnen/60.9.863; Herrlinger U, 1999, J NEURO-ONCOL, V43, P227, DOI 10.1023/A:1006250317940; Hoang-Xuan K, 2001, NEUROLOGY, V57, P1278, DOI 10.1212/WNL.57.7.1278; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Hudes RS, 1999, INT J RADIAT ONCOL, V43, P293, DOI 10.1016/S0360-3016(98)00416-7; Ichimura K, 1996, ONCOGENE, V13, P1065; Ino Y, 2000, J NEUROSURG, V92, P983, DOI 10.3171/jns.2000.92.6.0983; Ino Y, 2001, CLIN CANCER RES, V7, P839; Karim ABMF, 2002, INT J RADIAT ONCOL, V52, P316, DOI 10.1016/S0360-3016(01)02692-X; Keles GE, 2001, J NEUROSURG, V95, P735, DOI 10.3171/jns.2001.95.5.0735; Kim L, 1996, J NEUROSURG, V85, P602, DOI 10.3171/jns.1996.85.4.0602; Kleihues P, 2000, PATHOLOGY GENETICS T; KYRITSIS AP, 1993, NEUROSURGERY, V32, P365, DOI 10.1227/00006123-199303000-00005; LACHANCE DH, 1994, NEUROLOGY, V44, P1721, DOI 10.1212/WNL.44.9.1721; Legler JM, 1999, J NATL CANCER I, V91, P2050, DOI 10.1093/jnci/91.23.2050A; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Maintz D, 1997, J NEUROPATH EXP NEUR, V56, P1098, DOI 10.1097/00005072-199710000-00003; Marie Y, 2001, LANCET, V358, P298, DOI 10.1016/S0140-6736(01)05499-X; Marras LC, 2000, CANCER, V89, P640, DOI 10.1002/1097-0142(20000801)89:3<640::AID-CNCR20>3.0.CO;2-E; Mason WP, 1996, NEUROLOGY, V46, P203, DOI 10.1212/WNL.46.1.203; Matz PG, 1999, J NEURO-ONCOL, V42, P233, DOI 10.1023/A:1006122122404; Meyers CA, 1998, J CLIN ONCOL, V16, P2522, DOI 10.1200/JCO.1998.16.7.2522; Mukand JA, 2001, AM J PHYS MED REHAB, V80, P346, DOI 10.1097/00002060-200105000-00005; Nelson DF, 1999, J NEURO-ONCOL, V43, P241, DOI 10.1023/A:1006206602918; NELSON DF, 1992, INT J RADIAT ONCOL, V23, P9, DOI 10.1016/0360-3016(92)90538-S; NEUWELT EA, 1991, J CLIN ONCOL, V9, P1580, DOI 10.1200/JCO.1991.9.9.1580; O'Brien P, 2000, J CLIN ONCOL, V18, P519, DOI 10.1200/JCO.2000.18.3.519; Olson JD, 2000, NEUROLOGY, V54, P1442, DOI 10.1212/WNL.54.7.1442; ONEILL BP, 1995, INT J RADIAT ONCOL, V33, P663, DOI 10.1016/0360-3016(95)00207-F; PETERSON K, 1993, CANCER, V72, P843, DOI 10.1002/1097-0142(19930801)72:3<843::AID-CNCR2820720333>3.0.CO;2-#; Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121; Rainov NG, 2000, HUM GENE THER, V11, P2389, DOI 10.1089/104303400750038499; REIFENBERGER J, 1994, AM J PATHOL, V145, P1175; Reni M, 1999, BRIT J CANCER, V79, P530, DOI 10.1038/sj.bjc.6690083; Ribom D, 2001, CANCER-AM CANCER SOC, V92, P1541, DOI 10.1002/1097-0142(20010915)92:6<1541::AID-CNCR1480>3.0.CO;2-D; Ricci PE, 2001, SEMIN RADIAT ONCOL, V11, P103, DOI 10.1053/srao.2001.21420; Sandor V, 1998, J CLIN ONCOL, V16, P3000, DOI 10.1200/JCO.1998.16.9.3000; Sasaki H, 2002, J NEUROPATH EXP NEUR, V61, P58, DOI 10.1093/jnen/61.1.58; Sawaya R, 1999, J NEURO-ONCOL, V42, P303, DOI 10.1023/A:1006167412835; Schlegel U, 2001, J NEUROL NEUROSUR PS, V71, P118, DOI 10.1136/jnnp.71.1.118; Schultz C, 1996, J CLIN ONCOL, V14, P556, DOI 10.1200/JCO.1996.14.2.556; Scott CB, 1998, INT J RADIAT ONCOL, V40, P51, DOI 10.1016/S0360-3016(97)00485-9; SHAPIRO WR, 1989, J NEUROSURG, V71, P1, DOI 10.3171/jns.1989.71.1.0001; Shaw E, 2002, J CLIN ONCOL, V20, P2267, DOI 10.1200/JCO.2002.09.126; Soffietti R, 1998, NEUROSURGERY, V43, P1066, DOI 10.1097/00006123-199811000-00035; Soussain C, 2001, J CLIN ONCOL, V19, P742, DOI 10.1200/JCO.2001.19.3.742; Thomas D, 2001, J CLIN ONCOL, V19, P509, DOI 10.1200/JCO.2001.19.2.509; van den Bent MJ, 1998, NEUROLOGY, V51, P1140, DOI 10.1212/WNL.51.4.1140; Vigliani MC, 1996, INT J RADIAT ONCOL, V35, P527, DOI 10.1016/0360-3016(96)00097-1; VIGLIANI MC, 1997, HDB CLIN NEUROLOGY, V23, P371; WALKER MD, 1978, J NEUROSURG, V49, P333, DOI 10.3171/jns.1978.49.3.0333; WALLNER KE, 1989, INT J RADIAT ONCOL, V16, P1405, DOI 10.1016/0360-3016(89)90941-3; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Weller M, 1997, NEUROLOGY, V48, P1704, DOI 10.1212/WNL.48.6.1704; WESTPHAL M, 1999, P ANN M AM SOC CLIN, V18, pA594; Yung WKA, 1999, J CLIN ONCOL, V17, P2762, DOI 10.1200/JCO.1999.17.9.2762; Zamboni WC, 1998, CLIN CANCER RES, V4, P783; Zhou XP, 1999, INT J CANCER, V84, P150, DOI 10.1002/(SICI)1097-0215(19990420)84:2<150::AID-IJC10>3.0.CO;2-#; Zlatescu MC, 2001, CANCER RES, V61, P6713	95	611	640	0	62	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2003	361	9354					323	331		10.1016/S0140-6736(03)12328-8	http://dx.doi.org/10.1016/S0140-6736(03)12328-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559880				2022-12-28	WOS:000180643900026
J	Hoerauf, A; Buttner, DW; Adjei, O; Pearlman, E				Hoerauf, A; Buttner, DW; Adjei, O; Pearlman, E			Science, medicine, and the future - Onchocerciasis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BACTERIAL ENDOSYMBIONTS; FILARIAL NEMATODES; BRUGIA-MALAYI; WOLBACHIA; CHEMOTHERAPY; TETRACYCLINE; IVERMECTIN; VOLVULUS; WORMS; PATHOGENESIS	Onchocerciasis, or river blindness, caused by the filaria Onchocerca volvulus, affects more than 17 million people in Africa, Latin America, and Yemen. The microfilaricidal agent ivermectin is the principal means of controlling the disease, through mass treatment. Wolbachia endosymbiotic bacteria in filarias have emerged as a new target for treatment with drugs that lead to long term sterilisation of adult female filarias. Participants at recent international meetings have agreed that anti- Wolbachia chemotherapy with doxycycline (currently for six weeks) could be used to treat infected individuals. This approach holds promise for new developments based on registered antibiotics that are affordable in resource poor settings, as extensive registration processes are not needed. Recent experimental findings also indicate that endotoxin-like molecules from Wolbachia have a role in the pathogenesis of the disease and in adverse reactions after treatment.	Bernhard Nocht Inst Trop Med, Dept Helminthol, D-20359 Hamburg, Germany; Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Ophthalmol, Cleveland, OH 44106 USA; Univ Sci & Technol, Sch Med Sci, Dept Microbiol, Kumasi, Ghana	Bernhard Nocht Institut fur Tropenmedizin; Case Western Reserve University; Case Western Reserve University; Kwame Nkrumah University Science & Technology	Hoerauf, A (corresponding author), Bernhard Nocht Inst Trop Med, Dept Helminthol, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	hoerauf@bni.uni-hamburg.de			NATIONAL EYE INSTITUTE [R01EY010320] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY010320, EY10320] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Abiose A, 2000, LANCET, V356, P1523, DOI 10.1016/S0140-6736(05)73271-2; Alley WS, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-12; [Anonymous], 1995, World Health Organ Tech Rep Ser, V852, P1; Awadzi K, 1995, TROP MED PARASITOL, V46, P213; Bandi C, 1999, INT J PARASITOL, V29, P357, DOI 10.1016/S0020-7519(98)00200-8; Bandi C, 2001, VET PARASITOL, V98, P215, DOI 10.1016/S0304-4017(01)00432-0; Benton B, 2002, ANN TROP MED PARASIT, V96, P5, DOI 10.1179/000349802125000619; Brattig NW, 2001, MICROBES INFECT, V3, P439, DOI 10.1016/S1286-4579(01)01399-5; *CART CTR, 2002, C ER OCH ATL; Cross HF, 2001, LANCET, V358, P1873, DOI 10.1016/S0140-6736(01)06899-4; DARGE K, 1991, TROP MED PARASITOL, V42, P361; Hall LR, 1999, CLIN MICROBIOL REV, V12, P445, DOI 10.1128/CMR.12.3.445; Hoerauf A, 2000, LANCET, V355, P1242, DOI 10.1016/S0140-6736(00)02095-X; Hoerauf A, 1999, J CLIN INVEST, V103, P11, DOI 10.1172/JCI4768; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Hoerauf Achim, 2001, Trends in Parasitology, V17, P566, DOI 10.1016/S1471-4922(01)02192-4; Kaifi JT, 2001, J IMMUNOL, V166, P6795, DOI 10.4049/jimmunol.166.11.6795; Keiser PB, 2002, J INFECT DIS, V185, P805, DOI 10.1086/339344; Langworthy NG, 2000, P ROY SOC B-BIOL SCI, V267, P1063, DOI 10.1098/rspb.2000.1110; PLAISIER AP, 1991, ACTA TROP, V48, P271, DOI 10.1016/0001-706X(91)90015-C; Prichard RK, 2001, TRENDS PARASITOL, V17, P445, DOI 10.1016/S1471-4922(01)01983-3; Rao R, 2002, J PARASITOL, V88, P605, DOI 10.1645/0022-3395(2002)088[0605:IVEOAO]2.0.CO;2; Richards F, 2000, LANCET, V355, P1663, DOI 10.1016/S0140-6736(00)02235-2; Richards FO, 2001, TRENDS PARASITOL, V17, P558, DOI 10.1016/S1471-4922(01)02112-2; STANDRE A, 2002, SCIENCE, V295, P1892; Taylor MJ, 2000, J EXP MED, V191, P1429, DOI 10.1084/jem.191.8.1429; Taylor MJ, 2001, CURR OPIN INFECT DIS, V14, P727, DOI 10.1097/00001432-200112000-00011; Townson S, 2000, ANN TROP MED PARASIT, V94, P801, DOI 10.1080/00034980020027988; WHO Expert Committee on Onchocerciasis, 1987, WHO TECH REP SER, V752, P1	29	56	60	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2003	326	7382					207	210B		10.1136/bmj.326.7382.207	http://dx.doi.org/10.1136/bmj.326.7382.207			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640LD	12543839	Green Published			2022-12-28	WOS:000180689600023
J	Majeed, A				Majeed, A			Ten ways to improve information technology in the NHS	BRITISH MEDICAL JOURNAL			English	Article									UCL, Sch Publ Policy, Primary Care Res Unit, London WC1H 9QU, England	University of London; University College London	Majeed, A (corresponding author), UCL, Sch Publ Policy, Primary Care Res Unit, 29-30 Tavistock Sq, London WC1H 9QU, England.	a.majeed@ucl.ac.uk		Majeed, Azeem/0000-0002-2357-9858				CROSS M, 2002, GUARDIAN        0425; De Lusignan S., 2000, BJHC&IM-British Journal of Healthcare Computing & Information Management, V17, P28; *DEP HLTH, 2002, DEL IT NHS; *DEP HLTH, 2002, DIR GEN NOW APP NAT; MAJEED A, 2002, FINDING MED INFORMAT	5	29	30	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 25	2003	326	7382					202	204		10.1136/bmj.326.7382.202	http://dx.doi.org/10.1136/bmj.326.7382.202			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640LD	12543838	Bronze			2022-12-28	WOS:000180689600020
J	Moll, AC; Imhof, SM; Cruysberg, JRM; Schouten-van Meeteren, AYN; Boers, M; van Leeuwen, FE				Moll, AC; Imhof, SM; Cruysberg, JRM; Schouten-van Meeteren, AYN; Boers, M; van Leeuwen, FE			Incidence of retinoblastoma in children born after in-vitro fertilisation	LANCET			English	Article							FERTILIZATION; CANCER	Every year, 3000 women in the Netherlands are treated with in-vitro fertilisation (IVF), and results from studies suggest that the offspring of these women do not have a heightened risk of cancer. Between November, 2000, and February, 2002, we diagnosed retinoblastoma in five patients born after IVF. To calculate the relative risk of the disease, we assumed that the proportion of children conceived by IVF in the Netherlands is between 1.0 and 1.5%, and that the five patients who we diagnosed with the disease represent all new cases in the Netherlands during that period. Relative risks for retinoblastoma were significantly raised (7.2 [95% CI 2.4-17.0], and 4.9 [1.6-11.3], for 1% and 1.5% rates, respectively). This possible association of an increased risk of retinoblastoma in a population-based study needs to be established.	Vrije Univ Amsterdam, Med Ctr, Dept Ophthalmol, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Paediat Oncol, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Clin Epidemiol & Biostat, NL-1081 HV Amsterdam, Netherlands; Univ Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands; Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen; Netherlands Cancer Institute	Moll, AC (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Ophthalmol, NL-1081 HV Amsterdam, Netherlands.	a.moll@vumc.nl	Cruysberg, Johannes R. M./D-4313-2009	Cruysberg, Johannes R. M./0000-0002-5330-0774				Anteby I, 2001, ARCH OPHTHALMOL-CHIC, V119, P1525; Bruinsma F, 2000, HUM REPROD, V15, P604, DOI 10.1093/humrep/15.3.604; Klip H, 2001, HUM REPROD, V16, P2451, DOI 10.1093/humrep/16.11.2451; Koudstaal J, 1999, Ned Tijdschr Geneeskd, V143, P2375; Moll AC, 1997, BRIT J OPHTHALMOL, V81, P559, DOI 10.1136/bjo.81.7.559	5	211	227	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2003	361	9354					309	310		10.1016/S0140-6736(03)12332-X	http://dx.doi.org/10.1016/S0140-6736(03)12332-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559867				2022-12-28	WOS:000180643900014
J	Fisher, ES; Wennberg, DE; Stukel, TA; Gottlieb, DJ; Lucas, FL; Pinder, EL				Fisher, ES; Wennberg, DE; Stukel, TA; Gottlieb, DJ; Lucas, FL; Pinder, EL			The implications of regional variations in medicare spending. Part 1: The content, quality, and accessibility of care	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; GEOGRAPHIC-VARIATION; ADMINISTRATIVE DATA; COMORBIDITY INDEX; MANAGED CARE; OF-CARE; SERVICES; EXPENDITURES; MORTALITY; ADMISSION	Background: The health implications of regional differences in Medicare spending are unknown. Objective: To determine whether regions with higher Medicare spending provide better care. Design: Cohort study. Setting: National study of Medicare beneficiaries. Patients: Patients hospitalized between 1993 and 1995 for hip fracture (n = 614 503), colorectal cancer (n = 195 429), or acute myocardial infarction (n = 159 393) and a representative sample (n = 18 190) drawn from the Medicare Current Beneficiary Survey (1992-1995). Exposure Measurement: End-of-life spending reflects the component of regional variation in Medicare spending that is unrelated to regional differences in illness. Each cohort member's exposure to different levels of spending was therefore defined by the level of end-of-life spending in his or her hospital referral region of residence (n = 306). Outcome Measurements: Content of care (for example, frequency and type of services received), quality of care (for example, use of aspirin after acute myocardial infarction, influenza immunization), and access to care (for example, having a usual source of care). Results: Average baseline health status of cohort members was similar across regions of differing spending levels, but patients in higher-spending regions received approximately 60% more care. The increased utilization was explained by more frequent physician visits, especially in the inpatient setting (rate ratios in the highest vs. the lowest quintile of hospital referral regions were 2.13 [95% CI, 2.12 to 2.14] for inpatient visits and 2.36 [CI, 2.33 to 2.39] for new inpatient consultations), more frequent tests and minor (but not major) procedures, and increased use of specialists and hospitals (rate ratio in the highest vs. the lowest quintile was 1.52 [CI, 1.50 to 1.54] for inpatient days and 1.55 [CI, 1.50 to 1.60] for intensive care unit days). Quality of care in higher-spending regions was no better on most measures and was worse for several preventive care measures. Access to care in higher-spending regions was also no better or worse. Conclusions: Regional differences in Medicare spending are largely explained by the more inpatient-based and specialist-oriented pattern of practice observed in high-spending regions. Neither quality of care nor access to care appear to be better for Medicare enrollees in higher-spending regions.	White River Junct Vet Affairs Med Ctr, White River Jct, VT 05001 USA; Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto	Fisher, ES (corresponding author), Dartmouth Coll, Sch Med, Ctr Evaluat Clin Sci, Strasenburgh Hall,HB 7251, Hanover, NH 03755 USA.	elliott.s.fisher@dartmouth.edu		Stukel, Therese/0000-0002-2951-1360	NATIONAL CANCER INSTITUTE [R01CA052192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER; NCI NIH HHS [CA52192] Funding Source: Medline; NIA NIH HHS [P01 AG019783-03, P01 AG019783, 1PO1 AG19783-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adler G S, 1994, Health Care Financ Rev, V15, P153; Cooper GS, 1999, MED CARE, V37, P706, DOI 10.1097/00005650-199907000-00010; Cooper RA, 2002, HEALTH AFFAIR, V21, P140, DOI 10.1377/hlthaff.21.1.140; CUTLER DM, 2001, HEALTH AFFAIR, V20, P11; DHoore W, 1996, J CLIN EPIDEMIOL, V49, P1429, DOI 10.1016/S0895-4356(96)00271-5; FISHER ES, 1994, NEW ENGL J MED, V331, P989, DOI 10.1056/NEJM199410133311506; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; Gornick M, 1982, Health Care Financ Rev, V3, P41; Heffler S, 2002, HEALTH AFFAIR, V21, P207, DOI 10.1377/hlthaff.21.2.207; Hellinger FJ, 1998, ARCH INTERN MED, V158, P833, DOI 10.1001/archinte.158.8.833; Huff ED, 1997, J CLIN EPIDEMIOL, V50, P1395, DOI 10.1016/S0895-4356(97)00218-7; Kessler D, 1996, Q J ECON, V111, P353, DOI 10.2307/2946682; Kessler DP, 2000, Q J ECON, V115, P577, DOI 10.1162/003355300554863; Kleinke JD, 2001, HEALTH AFFAIR, V20, P43, DOI 10.1377/hlthaff.20.5.43; KNICKMAN JR, 1984, MED CARE, V22, P971, DOI 10.1097/00005650-198411000-00001; Krakauer H, 1996, HEALTH SERV RES, V31, P191; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; MILLER RH, 1994, JAMA-J AM MED ASSOC, V271, P1512, DOI 10.1001/jama.271.19.1512; Newhouse J., 1993, FREE ALL; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; Pritchard RS, 1998, J AM GERIATR SOC, V46, P1242, DOI 10.1111/j.1532-5415.1998.tb04540.x; Reinhardt UE, 2002, HEALTH AFFAIR, V21, P165, DOI 10.1377/hlthaff.21.1.165; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1085, DOI 10.1016/0895-4356(93)90106-B; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Skinner J, 1997, NATL TAX J, V50, P413; SKINNER JS, 2001, NBER WORKING PAPERS; STARFIELD B, 1994, JAMA-J AM MED ASSOC, V272, P1903, DOI 10.1001/jama.272.24.1903; STRAUSS MJ, 1986, JAMA-J AM MED ASSOC, V255, P1143, DOI 10.1001/jama.255.9.1143; Stukel TA, 2001, STAT MED, V20, P2115, DOI 10.1002/sim.852; Taylor DH, 1999, NEW ENGL J MED, V340, P293, DOI 10.1056/NEJM199901283400408; WELCH WP, 1993, NEW ENGL J MED, V328, P621, DOI 10.1056/NEJM199303043280906; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; Wennberg J. E., 1996, DARTMOUTH ATLAS HLTH; WENNBERG JE, 1987, LANCET, V1, P1185, DOI 10.1016/s0140-6736(87)92152-0; WENNBERG JE, 2002, GEOGRAPHY DEBATE MED; Wennberg JE, 1998, DARTMOUTH ATLAS HLTH; Wennberg JE, 1999, DARTMOUTH ATLAS HLTH	39	1132	1141	6	67	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2003	138	4					273	287		10.7326/0003-4819-138-4-200302180-00006	http://dx.doi.org/10.7326/0003-4819-138-4-200302180-00006			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DK	12585825				2022-12-28	WOS:000181019400001
J	Lobell, DB; Asner, GP				Lobell, DB; Asner, GP			Climate and management contributions to recent trends in US agricultural yields	SCIENCE			English	Article							WORLD		Carnegie Inst Washington, Dept Global Ecol, Stanford, CA 94305 USA; Stanford Univ, Dept Geog & Environm Sci, Stanford, CA 94305 USA	Carnegie Institution for Science; Stanford University	Lobell, DB (corresponding author), Carnegie Inst Washington, Dept Global Ecol, Stanford, CA 94305 USA.		Zhong, Hong Lin/C-2633-2012; Asner, Gregory/G-9268-2013	Asner, Gregory/0000-0001-7893-6421; Lobell, David/0000-0002-5969-3476				Brown RA, 1997, AGR FOREST METEOROL, V83, P171, DOI 10.1016/S0168-1923(96)02352-0; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Conway G, 1999, NATURE, V402, pC55, DOI [10.1038/35011545, 10.1038/990141]; Dyson T, 1999, P NATL ACAD SCI USA, V96, P5929, DOI 10.1073/pnas.96.11.5929; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0	5	538	609	5	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1032	1032		10.1126/science.1077838	http://dx.doi.org/10.1126/science.1077838			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586935				2022-12-28	WOS:000180960000036
J	Caro, I; Zembowicz, A				Caro, I; Zembowicz, A			A 16-year-old girl with a rash and chest pain - Cutaneous eruption of acute systemic lupus erythematosus.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MANIFESTATIONS; DIAGNOSIS		Massachusetts Gen Hosp, Dept Dermatol, Dermatol Clin Invest Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Dermatopathol Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Caro, I (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Dermatol Clin Invest Unit, Boston, MA 02114 USA.							ASHERSON RA, 1991, SEMIN ARTHRITIS RHEU, V20, P285, DOI 10.1016/0049-0172(91)90029-Y; CAMISA C, 1983, J AM ACAD DERMATOL, V9, P924, DOI 10.1016/S0190-9622(83)70210-0; Chlebus E, 1998, J AM ACAD DERMATOL, V38, P405, DOI 10.1016/S0190-9622(98)70497-9; Crowson AN, 2001, J CUTAN PATHOL, V28, P1, DOI 10.1034/j.1600-0560.2001.280101.x; DELGADO EA, 1990, SEMIN ARTHRITIS RHEU, V19, P285, DOI 10.1016/0049-0172(90)90051-G; Egner W, 2000, J CLIN PATHOL, V53, P424, DOI 10.1136/jcp.53.6.424; ISDALE IC, 1956, Q J MED, V25, P377; Keane MP, 2000, THORAX, V55, P159, DOI 10.1136/thorax.55.2.159; MONTGOMERY HAMILTON, 1939, JOUR INVEST DERMAT, V2, P343; OLOUGHLIN S, 1978, ARCH DERMATOL, V114, P879, DOI 10.1001/archderm.114.6.879; Pepin M, 2001, NEW ENGL J MED, V344, P392; PROVOST TT, 1980, J INVEST DERMATOL, V75, P495, DOI 10.1111/1523-1747.ep12524310; Pyeritz RE, 2000, NEW ENGL J MED, V342, P730, DOI 10.1056/NEJM200003093421009; ROWELL NR, 1998, ROOK WILKINSON EBLIN, V3, P2437; SONTHEIMER RD, 1979, ARCH DERMATOL, V115, P1409, DOI 10.1001/archderm.115.12.1409; Sontheimer RD, 2002, DUBOIS LUPUS ERYTHEM, P573; SONTHEIMER RD, 1996, CUTANEOUS MANIFESTAT, P1; TROYER C, 1983, J AM ACAD DERMATOL, V8, P724, DOI 10.1016/S0190-9622(83)70088-5; WALLACE DB, 2002, DIRECT WRITE TECHNOL, P177; WALLACE DJ, 2002, DUBOIS LUPUS ERYTHEM, P629; Zeitouni NC, 2000, BRIT J DERMATOL, V142, P343, DOI 10.1046/j.1365-2133.2000.03306.x	21	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2003	348	7					630	637		10.1056/NEJMcpc020029	http://dx.doi.org/10.1056/NEJMcpc020029			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644HY	12584372				2022-12-28	WOS:000180912900009
J	Grodstein, F; Clarkson, TB; Manson, JE				Grodstein, F; Clarkson, TB; Manson, JE			Understanding the divergent data on postmenopausal hormone therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ESTROGEN REPLACEMENT THERAPY; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; CORONARY EVENTS; WOMEN; ATHEROSCLEROSIS; MORTALITY; RISK; INFLAMMATION		Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Grodstein, F (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA.							Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Bush TL, 1996, JAMA-J AM MED ASSOC, V276, P1389, DOI 10.1001/jama.276.17.1389; Cline JM, 1996, AM J OBSTET GYNECOL, V174, P93, DOI 10.1016/S0002-9378(96)70379-4; Collaborative Group on Hormonal Factors in Breast Cancer, 1997, LANCET, V350, P1484; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; Ettinger B, 1996, OBSTET GYNECOL, V87, P6, DOI 10.1016/0029-7844(95)00358-4; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Grodstein F, 1999, AM J MED, V106, P574, DOI 10.1016/S0002-9343(99)00063-7; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Grodstein F, 1996, NEW ENGL J MED, V335, P1406; Grodstein F, 1996, LANCET, V348, P983, DOI 10.1016/S0140-6736(96)07308-4; Grodstein F, 2001, ANN INTERN MED, V135, P1, DOI 10.7326/0003-4819-135-1-200107030-00003; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; GRODSTEIN F, 2002, THROMBOSIS THROMBOEM; Heckbert SR, 2001, ARCH INTERN MED, V161, P1709, DOI 10.1001/archinte.161.14.1709; HENDERSON BE, 1991, ARCH INTERN MED, V151, P75, DOI 10.1001/archinte.151.1.75; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Herrington DM, 2001, ARTERIOSCL THROM VAS, V21, P1955, DOI 10.1161/hq1201.100241; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Humphrey LL, 2002, ANN INTERN MED, V137, P273, DOI 10.7326/0003-4819-137-4-200208200-00012; Manson JE, 2001, NEW ENGL J MED, V345, P34, DOI 10.1056/NEJM200107053450106; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; MCGILL HC, 1979, ATHER REV, V4, P157; Mikkola TS, 2002, CARDIOVASC RES, V53, P605, DOI 10.1016/S0008-6363(01)00466-7; Petitti Diana B., 1994, Annals of Epidemiology, V4, P115; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Rimm EB, 2000, MED CLIN N AM, V84, P239, DOI 10.1016/S0025-7125(05)70216-9; Rodriguez C, 2001, AM J EPIDEMIOL, V153, P145, DOI 10.1093/aje/153.2.145; ROSENBERG L, 1993, AM J EPIDEMIOL, V137, P54, DOI 10.1093/oxfordjournals.aje.a116602; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sidney S, 1997, ANN INTERN MED, V127, P501, DOI 10.7326/0003-4819-127-7-199710010-00001; Sourander L, 1999, LANCET, V353, P330; Sourander L, 1998, LANCET, V352, P1965, DOI 10.1016/S0140-6736(98)05066-1; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; TEJADA C, 1968, LAB INVEST, V18, P509; Zanger D, 2000, J AM COLL CARDIOL, V36, P1797, DOI 10.1016/S0735-1097(00)00952-9	40	258	265	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2003	348	7					645	650		10.1056/NEJMsb022365	http://dx.doi.org/10.1056/NEJMsb022365			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644HY	12584376				2022-12-28	WOS:000180912900012
J	Phimister, EG				Phimister, EG			In search of a better HIV vaccine - The heat is on	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188	1	3	4	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2003	348	7					643	644		10.1056/NEJMcibr035051	http://dx.doi.org/10.1056/NEJMcibr035051			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644HY	12584375				2022-12-28	WOS:000180912900011
J	Buavirat, A; Page-Shafer, K; van Griensven, GJP; Mandel, JS; Evans, J; Chuaratanaphong, J; Chiamwongpat, S; Sacks, R; Moss, A				Buavirat, A; Page-Shafer, K; van Griensven, GJP; Mandel, JS; Evans, J; Chuaratanaphong, J; Chiamwongpat, S; Sacks, R; Moss, A			Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study	BRITISH MEDICAL JOURNAL			English	Article							ATTRIBUTABLE RISK; PRISON SYSTEM; TRANSMISSION; PREVENTION; BEHAVIOR; INMATES; COHORT; POLICY	Objectives To identify risks for HIV infection related to incarceration among injecting drug users in Bangkok, Thailand. Design Case-control study of sexual and parenteral exposures occurring before, during, and after the most recent incarceration. Setting Metropolitan Bangkok. Participants Non-prison based injecting drug users formerly incarcerated for at least six months in the previous five years, with documented HIV serostatus since their most recent release; 175 HIV positive cases and 172 HIV negative controls from methadone clinics. Main outcome measure Injection of heroin and methamphetamine, sharing of needles, sexual behaviour, and tattooing before, during, and after incarceration. Results In the month before detention cases were more likely than controls to have injected methamphetamine and to have borrowed needles. More cases than controls reported using drugs (60% v 45%; P=0.005) and sharing needles (50% v 31%; P<0.01) in the holding cell before incarceration. Independent risk factors for prevalent HIV infection included injection of methamphetamine before detention (adjusted odds ratio 3.3, 95% confidence interval 1.01 to 10.7), sharing needles in the holding cell (1.9, 1.2 to 3.0), being tattooed while in prison (2.1, 1.3 to 3.4), and borrowing needles after release (2.5, 1.3 to 4.4). Conclusions Injecting drug users in Bangkok are at significantly increased risk of HIV infection through sharing needles with multiple partners while in holding cells before incarceration. The time spent in holding cells is an important opportunity to provide risk reduction counselling and intervention to reduce the incidence of HIV.	Univ Calif San Francisco, Ctr AIDS Prevent Studies, Dept Med, San Francisco, CA 94105 USA; Dept Hlth, Hlth Promot Div, Bangkok 10400, Thailand; Univ Calif San Francisco, Ctr AIDS Prevent Studies, Dept Epidemiol & Biostat, San Francisco, CA 94105 USA; Minist Publ Hlth, HIV AIDS Program, Thailand MOPH US CDC Collaborat, Nonthaburi 11000, Thailand; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ministry of Public Health - Thailand; University of California System; University of California San Francisco	Page-Shafer, K (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, Dept Med, 74 New Montgomery, San Francisco, CA 94105 USA.		; van Griensven, Frits/G-4719-2013	Page, Kimberly/0000-0002-7120-1673; van Griensven, Frits/0000-0002-0971-2843	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH042459] Funding Source: NIH RePORTER; NIMH NIH HHS [5 P50 MH42459, P50 MH042459] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allwright S, 2000, BRIT MED J, V321, P78, DOI 10.1136/bmj.321.7253.78; *ASS STAT TERR HLT, 1999, WHY PUBL HLTH SHOULD, P1; BENICHOU J, 1990, BIOMETRICS, V46, P991, DOI 10.2307/2532443; Braithwaite RL, 1999, J PUBLIC HEALTH POL, V20, P459, DOI 10.2307/3343131; BREWER TF, 1988, AIDS, V2, P363, DOI 10.1097/00002030-198810000-00005; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; BUAVIRAT A, IN PRESS AIDS PUBLIC; Chesney MA, 1998, AM J PUBLIC HEALTH, V88, P113, DOI 10.2105/AJPH.88.1.113; CHOOPANYA K, 1991, AIDS, V5, P1509, DOI 10.1097/00002030-199112000-00014; Diaz RS, 1999, AIDS, V13, P1417, DOI 10.1097/00002030-199907300-00024; DOLAN K, 1995, AIDS, V9, P825, DOI 10.1097/00002030-199508000-00001; Dolan KA, 1999, MED J AUSTRALIA, V171, P14, DOI 10.5694/j.1326-5377.1999.tb123490.x; Edwards A, 1999, INT J STD AIDS, V10, P464, DOI 10.1258/0956462991914474; Entz AT, 2000, AIDS, V14, P1027, DOI 10.1097/00002030-200005260-00015; Frischer M, 1997, ADDICTION, V92, P419, DOI 10.1046/j.1360-0443.1997.9244196.x; Gaiter J, 1996, AM J PUBLIC HEALTH, V86, P1201, DOI 10.2105/AJPH.86.9.1201; Grinstead OA, 1999, HEALTH EDUC BEHAV, V26, P225, DOI 10.1177/109019819902600206; KITAYAPORN D, 1994, AIDS, V8, P1443, DOI 10.1097/00002030-199410000-00011; Kral AH, 1998, AM J PUBLIC HEALTH, V88, P108, DOI 10.2105/AJPH.88.1.108; Mahon N, 1996, AM J PUBLIC HEALTH, V86, P1211, DOI 10.2105/AJPH.86.9.1211; Sattah MV, 2002, ADDICTION, V97, P801, DOI 10.1046/j.1360-0443.2002.00131.x; Surasiengsunk S, 1998, AIDS, V12, P775, DOI 10.1097/00002030-199807000-00014; TAYLOR A, 1995, BRIT MED J, V310, P289, DOI 10.1136/bmj.310.6975.289; Vanichseni S, 2001, AIDS, V15, P397, DOI 10.1097/00002030-200102160-00013	24	87	92	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2003	326	7384					308	310A		10.1136/bmj.326.7384.308	http://dx.doi.org/10.1136/bmj.326.7384.308			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645UD	12574043	Green Published, Bronze			2022-12-28	WOS:000180997000017
J	Guarner, F; Malagelada, JR				Guarner, F; Malagelada, JR			Gut flora in health and disease	LANCET			English	Review							SEGMENTED FILAMENTOUS BACTERIA; ANTIBIOTIC-ASSOCIATED DIARRHEA; INTESTINAL EPITHELIAL-CELLS; INFLAMMATORY-BOWEL-DISEASE; CHAIN FATTY-ACIDS; 16S RIBOSOMAL-RNA; GERM-FREE MICE; LACTOBACILLUS-GG; INTRAEPITHELIAL LYMPHOCYTES; RESISTANT STARCH	The human gut is the natural habitat for a large and dynamic bacterial community, but a substantial part of these bacterial populations are still to be described. However, the relevance and effect of resident bacteria on a host's physiology and pathology has been well documented. Major functions of the gut microflora include metabolic activities that result in salvage of energy and absorbable nutrients, important trophic effects on intestinal epithelia and on immune structure and function, and protection of the colonised host against invasion by alien microbes. Gut flora might also be an essential factor in certain pathological disorders, including multisystem organ failure, colon cancer, and inflammatory bowel diseases. Nevertheless, bacteria are also useful in promotion of human health. Probiotics and prebiotics are known to have a role in prevention or treatment of some diseases.	Autonomous Univ Barcelona, Hosp Gen Valle Hebron, Digest Syst Res Unit, E-08035 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Guarner, F (corresponding author), Autonomous Univ Barcelona, Hosp Gen Valle Hebron, Digest Syst Res Unit, E-08035 Barcelona, Spain.	fguarnera@medynet.com	Guarner, Francisco/ABF-1192-2020; Eckhardt, Erik/G-1567-2010	Guarner, Francisco/0000-0002-4051-0836; 				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; ADLERBERTH I, 1991, ACTA PAEDIATR SCAND, V80, P602, DOI 10.1111/j.1651-2227.1991.tb11917.x; ALAM M, 1994, SCAND J GASTROENTERO, V29, P445, DOI 10.3109/00365529409096836; Armuzzi A, 2001, ALIMENT PHARM THER, V15, P163, DOI 10.1046/j.1365-2036.2001.00923.x; Arvola T, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.5.e64; BABA E, 1991, POULTRY SCI, V70, P1902, DOI 10.3382/ps.0701902; Ballongue J, 1997, SCAND J GASTROENTERO, V32, P41, DOI 10.1080/00365521.1997.11720716; Bengmark S, 1998, GUT, V42, P2, DOI 10.1136/gut.42.1.2; Bengmark S, 2001, CURR OPIN CLIN NUTR, V4, P571, DOI 10.1097/00075197-200111000-00019; Berg RD, 1999, ADV EXP MED BIOL, V473, P11; BERNET MF, 1994, GUT, V35, P483, DOI 10.1136/gut.35.4.483; Bingham SA, 1999, P NUTR SOC, V58, P243, DOI 10.1017/S0029665199000336; Borriello S, 1986, MICROBIAL METABOLISM, P2; Borruel N, 2002, GUT, V51, P659, DOI 10.1136/gut.51.5.659; Bouhnik Y, 1996, EUR J CLIN NUTR, V50, P269; BRANDTZAEG P, 1989, GASTROENTEROLOGY, V97, P1562, DOI 10.1016/0016-5085(89)90406-X; BRIGHENTI F, 1995, EUR J CLIN NUTR, V49, P242; Brook I, 1999, CRIT REV MICROBIOL, V25, P155, DOI 10.1080/10408419991299211; Burns A J, 2000, Curr Issues Intest Microbiol, V1, P13; Butler JE, 2000, IMMUNOLOGY, V100, P119, DOI 10.1046/j.1365-2567.2000.00013.x; Casellas F, 1998, INFLAMM BOWEL DIS, V4, P1; Cebra J J, 1998, Dev Immunol, V6, P13, DOI 10.1155/1998/68382; CONLY JM, 1994, AM J GASTROENTEROL, V89, P915; Cummings JH, 1996, BRIT J NUTR, V75, P733, DOI 10.1079/BJN19960177; CUMMINGS JH, 1987, AM J CLIN NUTR, V45, P1243, DOI 10.1093/ajcn/45.5.1243; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; D'Souza AL, 2002, BRIT MED J, V324, P1361, DOI 10.1136/bmj.324.7350.1361; de Vrese M, 2001, AM J CLIN NUTR, V73, p421S, DOI 10.1093/ajcn/73.2.421s; DUCLUZEAU R, 1993, ANN PEDIATR-PARIS, V40, P13; Englyst KN, 1999, AM J CLIN NUTR, V69, P448; Falk PG, 1998, MICROBIOL MOL BIOL R, V62, P1157, DOI 10.1128/MMBR.62.4.1157-1170.1998; Fallingborg J, 1999, DAN MED BULL, V46, P183; FRANKEL WL, 1994, GASTROENTEROLOGY, V106, P375, DOI 10.1016/0016-5085(94)90595-9; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; GarciaLafuente A, 1997, AM J PHYSIOL-GASTR L, V272, pG10, DOI 10.1152/ajpgi.1997.272.1.G10; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; GIBSON PR, 1992, J GASTROEN HEPATOL, V7, P165, DOI 10.1111/j.1440-1746.1992.tb00956.x; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; GOLDIN BR, 1984, AM J CLIN NUTR, V39, P756, DOI 10.1093/ajcn/39.5.756; Gordon JI, 1997, AM J PHYSIOL-GASTR L, V273, pG565, DOI 10.1152/ajpgi.1997.273.3.G565; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Guandalini S, 2000, J PEDIATR GASTR NUTR, V30, P54, DOI 10.1097/00005176-200001000-00018; Guarino A, 1997, J PEDIATR GASTR NUTR, V25, P516, DOI 10.1097/00005176-199711000-00005; Guarner C, 1997, SEMIN LIVER DIS, V17, P203, DOI 10.1055/s-2007-1007198; Guarner C, 1997, J HEPATOL, V26, P1372, DOI 10.1016/S0168-8278(97)80474-6; Guarner F, 1998, INT J FOOD MICROBIOL, V39, P237, DOI 10.1016/S0168-1605(97)00136-0; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Helgeland L, 1996, IMMUNOLOGY, V89, P494, DOI 10.1046/j.1365-2567.1996.d01-783.x; Hill MJ, 1997, EUR J CANCER PREV, V6, pS43, DOI 10.1097/00008469-199703001-00009; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Horie H, 1999, EUR J CANCER PREV, V8, P237, DOI 10.1097/00008469-199906000-00012; Hughes R, 2001, CARCINOGENESIS, V22, P199, DOI 10.1093/carcin/22.1.199; Jiang HQ, 2001, INFECT IMMUN, V69, P3611, DOI 10.1128/IAI.69.6.3611-3617.2001; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kimura K, 1997, APPL ENVIRON MICROB, V63, P3394, DOI 10.1128/AEM.63.9.3394-3398.1997; Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; KLAASEN HLBM, 1993, INFECT IMMUN, V61, P303, DOI 10.1128/IAI.61.1.303-306.1993; KOLARS JC, 1984, NEW ENGL J MED, V310, P1, DOI 10.1056/NEJM198401053100101; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Kruis W, 1997, ALIMENT PHARM THER, V11, P853, DOI 10.1046/j.1365-2036.1997.00225.x; Labayen I, 2001, ALIMENT PHARM THERAP, V15, P543, DOI 10.1046/j.1365-2036.2001.00952.x; LEVISON ME, 1990, INTERNAL MED, P1274; Lichtman SM, 2001, J PEDIATR GASTR NUTR, V33, P1, DOI 10.1097/00005176-200107000-00001; Lievin V, 2000, GUT, V47, P646, DOI 10.1136/gut.47.5.646; LINKAMSTER H, 1994, FEMS IMMUNOL MED MIC, V10, P55, DOI 10.1111/j.1574-695X.1994.tb00011.x; LONG SS, 1977, J PEDIATR-US, V91, P298, DOI 10.1016/S0022-3476(77)80836-6; LUNDEQUIST B, 1985, ACTA PAEDIATR SCAND, V74, P45, DOI 10.1111/j.1651-2227.1985.tb10919.x; Luo J, 2000, J NUTR, V130, P1572, DOI 10.1093/jn/130.6.1572; MACFARLANE GT, 1992, J APPL BACTERIOL, V72, P57, DOI 10.1111/j.1365-2672.1992.tb05187.x; MACFARLANE GT, 1986, J GEN MICROBIOL, V132, P1647; Macpherson A, 1996, GUT, V38, P365, DOI 10.1136/gut.38.3.365; MAJAMAA H, 1995, J PEDIATR GASTR NUTR, V20, P333, DOI 10.1097/00005176-199504000-00012; MARTEAU P, 1990, AM J CLIN NUTR, V52, P685, DOI 10.1093/ajcn/52.4.685; Marteau P, 2001, APPL ENVIRON MICROB, V67, P4939, DOI 10.1128/AEM.67.10.4939-4942.2001; MCFARLAND LV, 1995, AM J GASTROENTEROL, V90, P439; Miyazawa E, 1996, NUTR RES, V16, P603, DOI 10.1016/0271-5317(96)00038-3; MOORE WEC, 1995, APPL ENVIRON MICROB, V61, P3202, DOI 10.1128/AEM.61.9.3202-3207.1995; Moreau MC, 1996, RES IMMUNOL, V147, P49, DOI 10.1016/0923-2494(96)81548-3; MORRISSEY PJ, 1994, RES IMMUNOL, V145, P357, DOI 10.1016/S0923-2494(94)80200-9; Mourelle M, 1998, GASTROENTEROLOGY, V114, P519, DOI 10.1016/S0016-5085(98)70535-9; O'Boyle CJ, 1998, GUT, V42, P29, DOI 10.1136/gut.42.1.29; O'Mahony L, 2001, ALIMENT PHARM THER, V15, P1219, DOI 10.1046/j.1365-2036.2001.01027.x; Oberhelman RA, 1999, J PEDIATR-US, V134, P15, DOI 10.1016/S0022-3476(99)70366-5; Onoue M, 1997, CANCER LETT, V113, P179, DOI 10.1016/S0304-3835(97)04698-3; Pedone CA, 1999, INT J CLIN PRACT, V53, P179; PIRZER U, 1991, LANCET, V338, P1238, DOI 10.1016/0140-6736(91)92104-A; PoolZobel BL, 1996, NUTR CANCER, V26, P365, DOI 10.1080/01635589609514492; Rafter J, 1998, EUR J CANCER PREV, V7, pS69, DOI 10.1097/00008469-199805000-00011; RAZA S, 1995, PEDIATR INFECT DIS J, V14, P107, DOI 10.1097/00006454-199502000-00005; Reid G, 2002, MICROBES INFECT, V4, P319, DOI 10.1016/S1286-4579(02)01544-7; Rieger MA, 1999, CARCINOGENESIS, V20, P2311, DOI 10.1093/carcin/20.12.2311; ROBERFROID MB, 1995, NUTR REV, V53, P127, DOI 10.1111/j.1753-4887.1995.tb01535.x; SAAVEDRA JM, 1994, LANCET, V344, P1046, DOI 10.1016/S0140-6736(94)91708-6; Salminen S, 1998, BRIT J NUTR, V80, pS147, DOI 10.1079/BJN19980108; SCHIFFRIN EJ, 1995, J DAIRY SCI, V78, P491, DOI 10.3168/jds.S0022-0302(95)76659-0; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Sghir A, 2000, APPL ENVIRON MICROB, V66, P2263, DOI 10.1128/AEM.66.5.2263-2266.2000; Shanahan F, 2001, GASTROENTEROLOGY, V120, P622, DOI 10.1053/gast.2001.22122; Shornikova AV, 1997, ACTA PAEDIATR, V86, P460, DOI 10.1111/j.1651-2227.1997.tb08913.x; Shornikova AV, 1997, J PEDIATR GASTR NUTR, V24, P399, DOI 10.1097/00005176-199704000-00008; Siavoshian S, 2000, GUT, V46, P507, DOI 10.1136/gut.46.4.507; SILVESTER KR, 1995, AM J CLIN NUTR, V62, P403, DOI 10.1093/ajcn/62.2.403; SIMHON A, 1982, ARCH DIS CHILD, V57, P54; SIMON GL, 1984, GASTROENTEROLOGY, V86, P174; Singh J, 1997, CARCINOGENESIS, V18, P833, DOI 10.1093/carcin/18.4.833; Smith EA, 1996, J APPL BACTERIOL, V81, P288, DOI 10.1111/j.1365-2672.1996.tb04331.x; Spanhaak S, 1998, EUR J CLIN NUTR, V52, P899, DOI 10.1038/sj.ejcn.1600663; STEPHEN AM, 1980, J MED MICROBIOL, V13, P45, DOI 10.1099/00222615-13-1-45; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Sudo N, 1997, J IMMUNOL, V159, P1739; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Taguchi H, 2002, J MED MICROBIOL, V51, P336, DOI 10.1099/0022-1317-51-4-336; Tannock GW, 2001, AM J CLIN NUTR, V73, p410S, DOI 10.1093/ajcn/73.2.410s; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Teitelbaum JE, 2002, ANNU REV NUTR, V22, P107, DOI 10.1146/annurev.nutr.22.110901.145412; THORBURN A, 1993, METABOLISM, V42, P780, DOI 10.1016/0026-0495(93)90249-N; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555, DOI 10.1111/j.1348-0421.1995.tb02242.x; UMESAKI Y, 1993, IMMUNOLOGY, V79, P32; Vanderhoof JA, 1999, J PEDIATR-US, V135, P564, DOI 10.1016/S0022-3476(99)70053-3; VANDERWAAIJ D, 1989, ANNU REV MICROBIOL, V43, P69, DOI 10.1146/annurev.micro.43.1.69; vanderWaaij LA, 1996, GUT, V38, P348, DOI 10.1136/gut.38.3.348; VANLEEUWEN PAM, 1994, GUT, V35, pS28, DOI 10.1136/gut.35.1_Suppl.S28; VENTER CS, 1990, AM J GASTROENTEROL, V85, P549; VIDELA S, 1994, GUT, V35, P1090, DOI 10.1136/gut.35.8.1090; Wilson KH, 1996, APPL ENVIRON MICROB, V62, P2273, DOI 10.1128/AEM.62.7.2273-2278.1996; Wollowski I, 2001, AM J CLIN NUTR, V73, p451S, DOI 10.1093/ajcn/73.2.451s; YOSHIOKA H, 1983, PEDIATRICS, V72, P317; Younes H, 2001, BRIT J NUTR, V86, P479, DOI 10.1079/BJN2001430	132	2136	2346	25	907	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					512	519		10.1016/S0140-6736(03)12489-0	http://dx.doi.org/10.1016/S0140-6736(03)12489-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583961				2022-12-28	WOS:000180900600025
J	Cox, MM				Cox, MM			Better chemistry for better survival, through regulation	CELL			English	Editorial Material							YEAST RIBONUCLEOTIDE REDUCTASE	In this issue of Cell, Chabes et al. (2003) report on new aspects of the regulation of yeast ribonucleotide reductase, the mechanism by which dNTP levels are increased following DNA damage, and the consequences of the metabolic changes.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Cox, MM (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53706 USA.							Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chabes A, 2000, P NATL ACAD SCI USA, V97, P2474, DOI 10.1073/pnas.97.6.2474; Domkin V, 2002, J BIOL CHEM, V277, P18574, DOI 10.1074/jbc.M201553200; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; MENETSKI JP, 1989, BIOCHEMISTRY-US, V28, P5871, DOI 10.1021/bi00440a025; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Stubbe J, 2000, CURR OPIN STRUC BIOL, V10, P731, DOI 10.1016/S0959-440X(00)00153-6; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; Voegtli WC, 2001, P NATL ACAD SCI USA, V98, P10073, DOI 10.1073/pnas.181336398; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299	10	4	4	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 7	2003	112	3					286	287		10.1016/S0092-8674(03)00080-1	http://dx.doi.org/10.1016/S0092-8674(03)00080-1			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581518	Bronze			2022-12-28	WOS:000181252200013
J	Lorenz, R				Lorenz, R			Full steam ahead - Probably	SCIENCE			English	Editorial Material							ENTROPY PRODUCTION		Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	University of Arizona	Lorenz, R (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.		Lorenz, Ralph D/B-8759-2016	Lorenz, Ralph D/0000-0001-8528-4644				Bak P., 1998, HOW NATURE WORKS; Carnot S., 1824, REFLECTIONS MOTIVE P; Dewar R, 2003, J PHYS A-MATH GEN, V36, P631, DOI 10.1088/0305-4470/36/3/303; HILL A, 1990, NATURE, V348, P426, DOI 10.1038/348426a0; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Lorenz EN, 1960, DYNAMICS CLIMATE, P86; Lorenz RD, 2002, J NON-EQUIL THERMODY, V27, P229, DOI 10.1515/JNETDY.2002.013; Lorenz RD, 2001, GEOPHYS RES LETT, V28, P415, DOI 10.1029/2000GL012336; PALTRIDGE GW, 1975, Q J ROY METEOR SOC, V101, P475, DOI 10.1002/qj.49710142906; Rinaldo A, 1996, PHYS REV LETT, V76, P3364, DOI 10.1103/PhysRevLett.76.3364; Shimokawa S, 2002, Q J ROY METEOR SOC, V128, P2115, DOI 10.1256/003590002320603566; Wang GM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.050601	12	30	30	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					837	838		10.1126/science.1081280	http://dx.doi.org/10.1126/science.1081280			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574610				2022-12-28	WOS:000180830900031
J	Currie, GP; Gray, RD; McKay, J				Currie, GP; Gray, RD; McKay, J			10-minute consultation - Chronic cough	BRITISH MEDICAL JOURNAL			English	Article									Aberdeen Royal Infirm, Chest Clin C, Aberdeen AB25 2ZN, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland; Univ Glasgow, Dept Postgrad Med Gen Practice, Glasgow G12 9LX, Lanark, Scotland	University of Aberdeen; University of Dundee; University of Glasgow	Currie, GP (corresponding author), Aberdeen Royal Infirm, Chest Clin C, Aberdeen AB25 2ZN, Scotland.		Gray, Robert/HIR-3528-2022	Currie, Graeme P/0000-0002-5711-9147; Gray, Robert/0000-0002-2203-2703				Irwin RS, 2000, NEW ENGL J MED, V343, P1715, DOI 10.1056/NEJM200012073432308; SCHROEDER K, 2001, COCHRANE DB SYST REV, P1831; 1997, THORAX S1, V52, P10	3	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					261	261		10.1136/bmj.326.7383.261	http://dx.doi.org/10.1136/bmj.326.7383.261			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560280	Green Published, Bronze			2022-12-28	WOS:000180908300023
J	Hurst, SA; Mauron, A				Hurst, SA; Mauron, A			Assisted suicide and euthanasia in Switzerland: allowing a role for non-physicians	BRITISH MEDICAL JOURNAL			English	Article							VOLUNTARY EUTHANASIA		NIH, Dept Clin Bioeth, Bethesda, MD 20892 USA; Univ Geneva, Fac Med, Unite Rech & Enseignement Bioeth, Geneva, Switzerland	National Institutes of Health (NIH) - USA; University of Geneva	Hurst, SA (corresponding author), NIH, Dept Clin Bioeth, Bldg 10, Bethesda, MD 20892 USA.		Hurst, Samia A./A-9661-2008	Hurst, Samia A./0000-0002-1980-5226				*ASS DROIT MOUR DI, SOND ASS SUIC EUTH A; Bittel N, 2002, SUPPORT CARE CANCER, V10, P265, DOI 10.1007/s00520-001-0325-0; CASSANI U, 1997, MED HYG, V55, P616; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; EMANUEL EJ, 1994, ANN INTERN MED, V121, P793, DOI 10.7326/0003-4819-121-10-199411150-00010; Hunziker A, 1999, Praxis (Bern 1994), V88, P1235; Kerridge IH, 1996, J MED ETHICS, V22, P273, DOI 10.1136/jme.22.5.273; Malacrida R, 1996, SCHWEIZ MED WSCHR, V126, P2149; MAURON A, 1997, MED HYG, V55, P617; ROY DJ, 1994, EUR J PALLIAT CARE, V1, P1; Sayid Mustafa D, 1983, Boston College Int Comp Law Rev, V6, P533; Sheldon T, 2001, BRIT MED J, V322, P947, DOI 10.1136/bmj.322.7292.947; Sobel J, 2001, Rev Med Suisse Romande, V121, P163; STIEFEL F, 2001, B SWISS PHYS, V82, P1611; STRATENWERTH G, 1983, SCHWEIZERISCHES STRA; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; *SWISS AC MED SCI, 1995, MED ETH GUID MED CAR; *SWISS FED STAT OF, 2001, ANN POP STAT 2001; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; WATSON R, 2001, BRIT MED J, V323, P1024	20	112	115	3	20	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					271	273		10.1136/bmj.326.7383.271	http://dx.doi.org/10.1136/bmj.326.7383.271			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560284	Green Published			2022-12-28	WOS:000180908300027
J	Foth, BJ; Ralph, SA; Tonkin, CJ; Struck, NS; Fraunholz, M; Roos, DS; Cowman, AF; McFadden, GI				Foth, BJ; Ralph, SA; Tonkin, CJ; Struck, NS; Fraunholz, M; Roos, DS; Cowman, AF; McFadden, GI			Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum	SCIENCE			English	Article							CHLOROPLAST TRANSIT PEPTIDES; TOXOPLASMA-GONDII; SIGNAL PEPTIDES; LEADER SEQUENCE; IN-VIVO; MITOCHONDRIAL; IDENTIFICATION; PRECURSORS; PROTEINS; IMPORT	Transit peptides mediate protein targeting into plastids and are only poorly understood. We extracted amino acid features from transit peptides that target proteins to the relict plastid (apicoplast) of malaria parasites. Based on these amino acid characteristics, we identified 466 putative apicoplast proteins in the Plasmodium falciparum genome. Altering the specific charge characteristics in a model transit peptide by site-directed mutagenesis severely disrupted organellar targeting in vivo. Similarly, putative Hsp70 (DnaK) binding sites present in the transit peptide proved to be important for correct targeting.	Univ Melbourne, Sch Bot, Plant Cell Biol Res Ctr, Parkville, Vic 3010, Australia; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	University of Melbourne; University of Pennsylvania; Walter & Eliza Hall Institute	McFadden, GI (corresponding author), Univ Melbourne, Sch Bot, Plant Cell Biol Res Ctr, Parkville, Vic 3010, Australia.	gim@unimelb.edu.au	McFadden, Geoffrey McFadden I/F-7667-2014; Tonkin, Christopher/K-6534-2019; Cowman, Alan F/C-7642-2013; Ralph, Stuart/C-8590-2014	McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Tonkin, Christopher/0000-0002-7036-6222; Cowman, Alan F/0000-0001-5145-9004; Ralph, Stuart/0000-0003-0114-7808; Roos, David Siker/0000-0001-6725-4089				Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bruce BD, 2001, BBA-MOL CELL RES, V1541, P2, DOI 10.1016/S0167-4889(01)00149-5; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Heard TS, 1998, J BIOL CHEM, V273, P29389, DOI 10.1074/jbc.273.45.29389; Ivey RA, 2000, PLANT PHYSIOL, V122, P1289, DOI 10.1104/pp.122.4.1289; Ivey RA, 2000, CELL STRESS CHAPERON, V5, P62, DOI 10.1379/1466-1268(2000)005<0062:IVAIVI>2.0.CO;2; Jackson-Constan D, 2001, BBA-MOL CELL RES, V1541, P102, DOI 10.1016/S0167-4889(01)00148-3; Jarvis P, 2002, BBA-MOL CELL RES, V1590, P177, DOI 10.1016/S0167-4889(02)00176-3; Kissinger JC, 2002, NATURE, V419, P490, DOI 10.1038/419490a; Komiya T, 1998, EMBO J, V17, P3886, DOI 10.1093/emboj/17.14.3886; Ni L, 1999, J BIOL CHEM, V274, P12685, DOI 10.1074/jbc.274.18.12685; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ralph SA, 2001, DRUG RESIST UPDATE, V4, P145, DOI 10.1054/drup.2001.0205; Rial DV, 2000, EUR J BIOCHEM, V267, P6239, DOI 10.1046/j.1432-1327.2000.01707.x; Roos DS, 1999, CURR OPIN MICROBIOL, V2, P426, DOI 10.1016/S1369-5274(99)80075-7; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; van Dooren GG, 2002, J BIOL CHEM, V277, P23612, DOI 10.1074/jbc.M201748200; van Dooren GG, 2001, BBA-MOL CELL RES, V1541, P34, DOI 10.1016/S0167-4889(01)00154-9; VONHEIJNE G, 1991, FEBS LETT, V278, P1, DOI 10.1016/0014-5793(91)80069-F; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Wilson RJM, 2002, J MOL BIOL, V319, P257, DOI 10.1016/S0022-2836(02)00303-0; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Yung S, 2001, MOL BIOCHEM PARASIT, V118, P11, DOI 10.1016/S0166-6851(01)00359-0; Zhang XP, 2002, TRENDS PLANT SCI, V7, P14, DOI 10.1016/S1360-1385(01)02180-X; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	27	369	377	3	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					705	708		10.1126/science.1078599	http://dx.doi.org/10.1126/science.1078599			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560551				2022-12-28	WOS:000180687700046
J	Schlotterer, C				Schlotterer, C			Where do male genes live?	SCIENCE			English	Editorial Material									Vet Med Univ Wien, Inst Tierzucht & Genet, A-1210 Vienna, Austria	University of Veterinary Medicine Vienna	Schlotterer, C (corresponding author), Vet Med Univ Wien, Inst Tierzucht & Genet, A-1210 Vienna, Austria.	christian.schloetterer@vu-wien.ac.at	Schlötterer, Christian/Q-5264-2019; Schlötterer, Christian/G-6326-2010	Schlötterer, Christian/0000-0003-4710-6526; Schlötterer, Christian/0000-0003-4710-6526				Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927	7	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					670	671		10.1126/science.1082030	http://dx.doi.org/10.1126/science.1082030			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560539				2022-12-28	WOS:000180687700033
J	Ellis, M; Zwaan, F; Hedstrom, U; Poynton, C; Kristensen, J; Jumaa, P; Wassell, J; al-Ramadi, B				Ellis, M; Zwaan, F; Hedstrom, U; Poynton, C; Kristensen, J; Jumaa, P; Wassell, J; al-Ramadi, B			Recombinant human interleukin 11 and bacterial infection in patients with haemological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial	LANCET			English	Article							C-REACTIVE PROTEIN; GROWTH-FACTOR; CELLS; MICE	Background Bacteraemia in patients with haemological malignant disease causes substantial morbidity. Recombinant human interleukin 11 (rhIL-11) prevents gastrointestinal epithelial disintegrity and has immunomodulatory actions. Our aim was to ascertain whether or not treatment with rhIL-11 can prevent gut-associated infections. Methods We did a double-blind placebo-controlled randomised trial, to which we enrolled 40 patients with haemological malignant disease who were undergoing chemotherapy. Patients received either rhIL-11 50 mug/kg (n=20) or placebo (n=20) daily by subcutaneous injection from the day before the start of chemotherapy until resolution of neutropenia or for 2:1 days, whichever was longer. Our primary outcome measure was a reduction in bacteraemia. Analysis was by intention to treat. Findings Significantly fewer patients who received rhIL-11 rather than placebo developed bacteraemia, particularly of gastrointestinal origin: the proportion of patients with at least one positive blood culture was 0.65 and 0.25, respectively (p=0.02). The numbers of patients (placebo vs rhIL-11) for each number of distinct isolates were: no organism isolated seven versus 15, one organism nine versus four, two organisms two versus one, three organisms one versus none, and four organisms one versus none (p=0.01), suggesting a lower bacterial load in the rhIL-11 than in the placebo group. Time to first bacteraemic event was longer in patients who received rhIL-11 (p=0.03) than in those who received placebo. Interpretation rhIL-11 reduces the frequency and load of bacteraemia in patients with haemological malignant disease undergoing chemotherapy, possibly by gastrointestinal cytoprotective or immunological mechanisms.	United Arab Emirates Univ, Dept Med & Hlth Sci, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; Tawam Hosp, Al Ain, U Arab Emirates; Karolinska Inst, Huddinge Hosp, S-10401 Stockholm, Sweden; Univ Wales Coll Cardiff, Cardiff CF1 3NS, S Glam, Wales	United Arab Emirates University; Karolinska Institutet; Cardiff University	Ellis, M (corresponding author), United Arab Emirates Univ, Dept Med & Hlth Sci, Fac Med & Hlth Sci, POB 17666, Al Ain, U Arab Emirates.							Antin JH, 2002, BONE MARROW TRANSPL, V29, P373, DOI 10.1038/sj.bmt.1703394; BAUMANN H, 1991, J BIOL CHEM, V266, P20424; COX DR, 1972, J R STAT SOC B, V34, P187; Culley FJ, 1997, BIOCHEM SOC T, V25, pS286, DOI 10.1042/bst025286s; Curti A, 2001, BLOOD, V97, P2758, DOI 10.1182/blood.V97.9.2758; DU XX, 1994, BLOOD, V83, P33; FEGAN C, 1990, BONE MARROW TRANSPL, V5, P373; Gordon MS, 1996, BLOOD, V87, P3615, DOI 10.1182/blood.V87.9.3615.bloodjournal8793615; Hughes WT, 2002, CLIN INFECT DIS, V34, P730, DOI 10.1086/339215; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Mahboubi K, 2000, J IMMUNOL, V164, P3837, DOI 10.4049/jimmunol.164.7.3837; MOLD C, 1981, J EXP MED, V154, P1703, DOI 10.1084/jem.154.5.1703; Opal SM, 1999, BLOOD, V93, P3467, DOI 10.1182/blood.V93.10.3467.410k10_3467_3472; Opal SM, 2000, J INFECT DIS, V181, P754, DOI 10.1086/315247; Peterson RL, 1998, LAB INVEST, V78, P1503; Sonis ST, 2000, ORAL ONCOL, V36, P373, DOI 10.1016/S1368-8375(00)00012-9; Szalai AJ, 2000, INFECT IMMUN, V68, P5652, DOI 10.1128/IAI.68.10.5652-5656.2000; TREPICCHIO WL, 1996, J IMMUNOL, V157, P1705; Weiser JN, 1998, J EXP MED, V187, P631, DOI 10.1084/jem.187.4.631	19	39	45	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					275	280		10.1016/S0140-6736(03)12322-7	http://dx.doi.org/10.1016/S0140-6736(03)12322-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559860				2022-12-28	WOS:000180643900007
J	Roberts, SE; Goldacre, MJ				Roberts, SE; Goldacre, MJ			Case fatality rates after admission to hospital with stroke: linked database study	BRITISH MEDICAL JOURNAL			English	Article								Population based mortality for stroke has declined in most Western countries during the past few decades.' This is probably because of a decrease in both the incidence of and case fatality from stroke over this period.(2-4) Routine statistics generally do not provide long term trends in case fatality, and few studies have looked at differences in case fatality rates between hospitals.(5) We used routine hospital data, which had been linked to mortality data in the former Oxford health region of England, to study case fatality rates after admission for stroke and to compare rates between different periods and different hospitals.	Univ Oxford, Inst Hlth Sci, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England	University of Oxford	Goldacre, MJ (corresponding author), Univ Oxford, Inst Hlth Sci, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England.							BONITA R, 1993, LANCET, V342, P1470, DOI 10.1016/0140-6736(93)92938-P; Charlton J., 1997, HLTH ADULT BRITAIN 1, VVolume 2, P60; MALMGREN R, 1987, LANCET, V2, P1196; Wolfe CDA, 1999, STROKE, V30, P350, DOI 10.1161/01.STR.30.2.350; 1983, LANCET, V1, P1195	5	12	15	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 25	2003	326	7382					193	194		10.1136/bmj.326.7382.193	http://dx.doi.org/10.1136/bmj.326.7382.193			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640LD	12543834	Green Published, Bronze			2022-12-28	WOS:000180689600016
J	Alberts, B				Alberts, B			DNA replication and recombination	NATURE			English	Article							DEOXYRIBONUCLEIC-ACID; ESCHERICHIA-COLI; PROTEIN MACHINES; MUTANTS	Knowledge of the structure of DNA enabled scientists to undertake the difficult task of deciphering the detailed molecular mechanisms of two dynamic processes that are central to life: the copying of the genetic information by DNA replication, and its reassortment and repair by DNA recombination. Despite dramatic advances towards this goal over the past five decades, many challenges remain for the next generation of molecular biologists.	Natl Acad Sci, Washington, DC 20418 USA	National Academies of Sciences, Engineering & Medicine	Alberts, B (corresponding author), Natl Acad Sci, 2101 Constitut Ave, Washington, DC 20418 USA.							Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Alberts B., 2008, MOL BIOL CEL, V5th ed.; ALBERTS BM, 1984, COLD SPRING HARB SYM, V49, P1; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; BONHOEFFER F, 1965, BIOCHEM BIOPH RES CO, V20, P93; CAIRNS J, 1963, J MOL BIOL, V6, P208, DOI 10.1016/S0022-2836(63)80070-4; CRICK F H, 1958, Symp Soc Exp Biol, V12, P138; Davey MJ, 2000, CURR OPIN CHEM BIOL, V4, P581, DOI 10.1016/S1367-5931(00)00134-4; DOTY P, 1961, HARV LECT 1960; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; EPSTEIN RH, 1963, COLD SPRING HARB SYM, V28, P375, DOI 10.1101/SQB.1963.028.01.053; HUBERMAN JA, 1971, J MOL BIOL, V62, P39, DOI 10.1016/0022-2836(71)90129-X; KAVENOFF R, 1973, COLD SPRING HARB SYM, V38, P1; KOHIYAMA M, 1966, ANN I PASTEUR PARIS, V110, P465; KORNBERG A, 1960, SCIENCE, V131, P1503, DOI 10.1126/science.131.3412.1503; Kornberg A., 1992, DNA REPLICATION; MARMUR J, 1961, J MOL BIOL, V3, P585, DOI 10.1016/S0022-2836(61)80023-5; MESELSON M, 1958, P NATL ACAD SCI USA, V44, P671, DOI 10.1073/pnas.44.7.671; MORRIS CF, 1975, P NATL ACAD SCI USA, V72, P4800, DOI 10.1073/pnas.72.12.4800; *NAT RES COUNC, 2002, BIO2010 UND ED PREP; OKAZAKI R, 1968, P NATL ACAD SCI USA, V59, P598, DOI 10.1073/pnas.59.2.598; Radding C, 2001, P NATL ACAD SCI USA, V98, P8172, DOI 10.1073/pnas.161004898; RADDING CM, 1981, CELL, V25, P3, DOI 10.1016/0092-8674(81)90224-5; Trakselis MA, 2001, STRUCTURE, V9, P999, DOI 10.1016/S0969-2126(01)00676-1; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0	27	67	69	3	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					431	435		10.1038/nature01407	http://dx.doi.org/10.1038/nature01407			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540917	Bronze			2022-12-28	WOS:000180533000058
J	Kemp, M				Kemp, M			The Mona Lisa of modern science	NATURE			English	Article								No molecule in the history of science has reached the iconic status of the double helix of DNA. Its image has been imprinted on all aspects of society, from science, art, music, cinema, architecture and advertising. This review of the Mona Lisa of science examines the evolution of its form at the hands of both science and art.	Univ Oxford, Dept Hist Art, Oxford OX1 1PT, England; Wallace Kemp, Artakt, London W9 3QJ, England	University of Oxford	Kemp, M (corresponding author), Univ Oxford, Dept Hist Art, Littlegate House, Oxford OX1 1PT, England.	martin.kemp@trinity.ox.ac.uk						COEN E, 1999, ART GENES ORG GROW T; DESCHARNES H, 1998, S DALI 1904 1989; KEMP M, 2001, NATURE, V413, P778; Nelkin D, 2002, NAT REV GENET, V3, P967, DOI 10.1038/nrg950; Watson J. D., 1965, MOL BIOL GENE; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0	6	20	24	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					416	420		10.1038/nature01403	http://dx.doi.org/10.1038/nature01403			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540913	Bronze			2022-12-28	WOS:000180533000054
J	Rosenzweig, A				Rosenzweig, A			Endothelial progenitor cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Program Cardiovasc Gene Therapy, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Rosenzweig, A (corresponding author), Massachusetts Gen Hosp, Program Cardiovasc Gene Therapy, Charlestown, MA 02129 USA.		Rosenzweig, Anthony/AAD-7893-2019						0	62	70	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2003	348	7					581	582		10.1056/NEJMp020175	http://dx.doi.org/10.1056/NEJMp020175			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644HY	12584365				2022-12-28	WOS:000180912900002
J	Freeman, JW				Freeman, JW			Where we draw the line	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2003	289	6					671	672		10.1001/jama.289.6.671	http://dx.doi.org/10.1001/jama.289.6.671			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643WP	12585928				2022-12-28	WOS:000180886000001
J	Janata, K; Holzer, M; Laggner, AN; Mullner, M				Janata, K; Holzer, M; Laggner, AN; Mullner, M			Cardiac troponin T in the severity assessment of patients with pulmonary embolism: cohort study	BRITISH MEDICAL JOURNAL			English	Article							RIGHT-VENTRICULAR DYSFUNCTION		Univ Vienna, Allgemeines Krankenhaus Wien, Jkub BItfakkned, A-1090 Vienna, Austria	University of Vienna	Mullner, M (corresponding author), Univ Vienna, Allgemeines Krankenhaus Wien, Jkub BItfakkned, Wahringer Gurtel 18-20-6D, A-1090 Vienna, Austria.							Giannitsis E, 2000, CIRCULATION, V102, P211, DOI 10.1161/01.CIR.102.2.211; GROSSER KD, 1980, INTERNIST, V21, P273; Kasper W, 1997, HEART, V77, P346, DOI 10.1136/hrt.77.4.346; LUALDI JC, 1995, AM HEART J, V130, P1276, DOI 10.1016/0002-8703(95)90155-8; Meyer T, 2000, J AM COLL CARDIOL, V36, P1632, DOI 10.1016/S0735-1097(00)00905-0	5	77	85	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2003	326	7384					312	313		10.1136/bmj.326.7384.312	http://dx.doi.org/10.1136/bmj.326.7384.312			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645UD	12574045	Bronze, Green Published			2022-12-28	WOS:000180997000019
J	Chabes, A; Georgieva, B; Domkin, V; Zhao, XL; Rothstein, R; Thelander, L				Chabes, A; Georgieva, B; Domkin, V; Zhao, XL; Rothstein, R; Thelander, L			Survival of DNA damage in yeast directly depends on increased dNTP levels allowed by relaxed feedback inhibition of ribonucleotide reductase	CELL			English	Article							CELL-CYCLE; ALLOSTERIC REGULATION; CHECKPOINT PATHWAYS; MUTATOR PHENOTYPES; SMALL-SUBUNIT; CALF THYMUS; IN-VITRO; POLYMERASE; PROTEIN; KINASE	In eukaryotes, DNA damage elicits a multifaceted response that includes cell cycle arrest, transcriptional activation of DNA repair genes, and, in multicellular organisms, apoptosis. We demonstrate that in Saccharomyces cerevisiae, DNA damage leads to a 6- to 8-fold increase in dNTP levels. This increase is conferred by an unusual, relaxed dATP feedback inhibition of ribonucleotide reductase (RNR). Complete elimination of dATP feedback inhibition by mutation of the allosteric activity site in RNR results in 1.6-2 times higher dNTP pools under normal growth conditions, and the pools increase an additional 11- to 17-fold during DNA damage. The increase in dNTP pools dramatically improves survival following DNA damage, but at the same time leads to higher mutation rates' We propose that increased survival and mutation rates result from more efficient translesion DNA synthesis at elevated dNTP concentrations.	Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	Umea University; Columbia University	Chabes, A (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	chabes@cshl.org		Zhao, Xiaolan/0000-0002-8302-6905; Chabes, Andrei/0000-0003-1708-8259; Rothstein, Rodney/0000-0002-4107-9654	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080670] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKERBLOM L, 1981, P NATL ACAD SCI-BIOL, V78, P2159, DOI 10.1073/pnas.78.4.2159; CARAS IW, 1988, MOL CELL BIOL, V8, P2698, DOI 10.1128/MCB.8.7.2698; Chabes A, 2000, P NATL ACAD SCI USA, V97, P2474, DOI 10.1073/pnas.97.6.2474; Chabes A, 1999, J BIOL CHEM, V274, P36679, DOI 10.1074/jbc.274.51.36679; Domkin V, 2002, J BIOL CHEM, V277, P18574, DOI 10.1074/jbc.M201553200; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; ECKSTEIN H, 1974, Z NATURFORSCH C, VC 29, P272; ELLEDGE SJ, 1993, BIOESSAYS, V15, P333, DOI 10.1002/bies.950150507; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; ENGSTROM Y, 1979, BIOCHEMISTRY-US, V18, P2941, DOI 10.1021/bi00581a004; ERIKSSON S, 1979, BIOCHEMISTRY-US, V18, P2948, DOI 10.1021/bi00581a005; ERIKSSON S, 1981, J BIOL CHEM, V256, P193; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; GIBBS PEM, 1995, NUCLEIC ACIDS RES, V23, P1919, DOI 10.1093/nar/23.11.1919; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; Haracska L, 2000, MOL CELL BIOL, V20, P8001, DOI 10.1128/MCB.20.21.8001-8007.2000; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Johnson RE, 2001, MOL CELL BIOL, V21, P3558, DOI 10.1128/MCB.21.10.3558-3563.2001; Minko IG, 2003, J BIOL CHEM, V278, P784, DOI 10.1074/jbc.M207774200; Prakash S, 2002, GENE DEV, V16, P1872, DOI 10.1101/gad.1009802; Reichard P, 2000, J BIOL CHEM, V275, P33021, DOI 10.1074/jbc.M005337200; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; Shcherbakova PV, 1999, MOL CELL BIOL, V19, P3177; Shimizu K, 2002, J BIOL CHEM, V277, P37422, DOI 10.1074/jbc.M204476200; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114; WEINBERG G, 1981, P NATL ACAD SCI-BIOL, V78, P2447, DOI 10.1073/pnas.78.4.2447; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Zhang XL, 1996, J BACTERIOL, V178, P4115, DOI 10.1128/jb.178.14.4115-4121.1996; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299; Zhao XL, 2000, MOL CELL BIOL, V20, P9076, DOI 10.1128/MCB.20.23.9076-9083.2000; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G	43	340	346	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 7	2003	112	3					391	401		10.1016/S0092-8674(03)00075-8	http://dx.doi.org/10.1016/S0092-8674(03)00075-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581528	Bronze			2022-12-28	WOS:000181252200010
J	Hederstedt, L				Hederstedt, L			Complex II is complex too	SCIENCE			English	Editorial Material							FUMARATE REDUCTASE		Lund Univ, Dept Cell & Organism Biol, SE-22362 Lund, Sweden	Lund University	Hederstedt, L (corresponding author), Lund Univ, Dept Cell & Organism Biol, SE-22362 Lund, Sweden.			Hederstedt, Lars/0000-0002-6650-6296				Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Gennis R. B., 1996, ESCHERICHIA COLI SAL, P217; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Lancaster CRD, 2002, BBA-BIOENERGETICS, V1553, P1, DOI 10.1016/S0005-2728(01)00240-7; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	9	24	26	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					671	672		10.1126/science.1081821	http://dx.doi.org/10.1126/science.1081821			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560540				2022-12-28	WOS:000180687700034
J	Gaede, P; Vedel, P; Larsen, N; Jensen, GVH; Parving, H; Pedersen, O				Gaede, P; Vedel, P; Larsen, N; Jensen, GVH; Parving, H; Pedersen, O			Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; MORTALITY; MELLITUS; MICROALBUMINURIA; HYPERTENSION; RETINOPATHY; MEN	BACKGROUND: Cardiovascular morbidity is a major burden in patients with type 2 diabetes. In the Steno-2 Study, we compared the effect of a targeted, intensified, multifactorial intervention with that of conventional treatment on modifiable risk factors for cardiovascular disease in patients with type 2 diabetes and microalbuminuria. METHODS: The primary end point of this open, parallel trial was a composite of death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, revascularization, and amputation. Eighty patients were randomly assigned to receive conventional treatment in accordance with national guidelines and 80 to receive intensive treatment, with a stepwise implementation of behavior modification and pharmacologic therapy that targeted hyperglycemia, hypertension, dyslipidemia, and microalbuminuria, along with secondary prevention of cardiovascular disease with aspirin. RESULTS: The mean age of the patients was 55.1 years, and the mean follow-up was 7.8 years. The decline in glycosylated hemoglobin values, systolic and diastolic blood pressure, serum cholesterol and triglyceride levels measured after an overnight fast, and urinary albumin excretion rate were all significantly greater in the intensive-therapy group than in the conventional-therapy group. Patients receiving intensive therapy also had a significantly lower risk of cardiovascular disease (hazard ratio, 0.47; 95 percent confidence interval, 0.24 to 0.73), nephropathy (hazard ratio, 0.39; 95 percent confidence interval, 0.17 to 0.87), retinopathy (hazard ratio, 0.42; 95 percent confidence interval, 0.21 to 0.86), and autonomic neuropathy (hazard ratio, 0.37; 95 percent confidence interval, 0.18 to 0.79). CONCLUSIONS: A target-driven, long-term, intensified intervention aimed at multiple risk factors in patients with type 2 diabetes and microalbuminuria reduces the risk of cardiovascular and microvascular events by about 50 percent.	Steno Diabet Ctr, Copenhagen, Denmark; Herlev Cty Hosp, Herlev, Denmark; Amtssygehuset Roskilde, Roskilde, Denmark; Aarhus Univ, Fac Hlth Sci, Aarhus, Denmark	Steno Diabetes Center; Aarhus University	Pedersen, O (corresponding author), Steno Diabet Ctr, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark.	oluf@steno.dk	Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Greiver, Michelle/N-8764-2015	Pedersen, Oluf/0000-0002-3321-3972; Greiver, Michelle/0000-0001-8957-0285; Gaede, Peter/0000-0002-1457-2742				ALDINGTON SJ, 1995, DIABETOLOGIA, V38, P437, DOI 10.1007/BF00410281; BECKNIELSEN H, 1988, IKKEINSULINKRAEVENDE; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Curb JD, 1996, JAMA-J AM MED ASSOC, V276, P1886, DOI 10.1001/jama.276.23.1886; Curb JD, 1997, JAMA-J AM MED ASSOC, V277, P1356; De Giorgio L, 2000, NEW ENGL J MED, V342, P1376; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; GALL MA, 1995, DIABETES, V44, P1303, DOI 10.2337/diabetes.44.11.1303; GALL MA, 1991, DIABETOLOGIA, V34, P655, DOI 10.1007/BF00400995; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Pyorala K, 1997, DIABETES CARE, V20, P1048; Ravid M, 1996, ARCH INTERN MED, V156, P286, DOI 10.1001/archinte.156.3.286; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UK Prospect Diabet Study Grp, 1999, BMJ-BRIT MED J, V318, P29; Wingard DL., 1995, DIABETES AM, P429; Yusuf S, 2000, NEW ENGL J MED, V342, P145	28	2984	3134	5	167	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					383	393		10.1056/NEJMoa021778	http://dx.doi.org/10.1056/NEJMoa021778			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12556541				2022-12-28	WOS:000180643800003
J	Liu, JG; Daily, GC; Ehrlich, PR; Luck, GW				Liu, JG; Daily, GC; Ehrlich, PR; Luck, GW			Effects of household dynamics on resource consumption and biodiversity	NATURE			English	Article							HUMAN-POPULATION; ENERGY USE; HOTSPOTS	Human population size and growth rate are often considered important drivers of biodiversity loss(1-6), whereas household dynamics are usually neglected. Aggregate demographic statistics may mask substantial changes in the size and number of households, and their effects on biodiversity. Household dynamics influence per capita consumption(7,8) and thus biodiversity through, for example, consumption of wood for fuel(9), habitat alteration for home building and associated activities(10-12), and greenhouse gas emissions(13). Here we report that growth in household numbers globally, and particularly in countries with biodiversity hotspots (areas rich in endemic species and threatened by human activities 14), was more rapid than aggregate population growth between 1985 and 2000. Even when population size declined, the number of households increased substantially. Had the average household size (that is, the number of occupants) remained static, there would have been 155 million fewer households in hotspot countries in 2000. Reduction in average household size alone will add a projected 233 million additional households to hotspot countries during the period 2000-15. Rapid increase in household numbers, often manifested as urban sprawl, and resultant higher per capita resource consumption in smaller households(15-19) pose serious challenges to biodiversity conservation.	Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; Stanford Univ, Ctr Conservat Biol, Stanford, CA 94305 USA	Michigan State University; Stanford University	Liu, JG (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	jliu@panda.msu.edu	Liu, Jianguo/G-5211-2015; feng, tingting/A-9545-2012	Liu, Jianguo/0000-0001-6344-0087; Luck, Gary/0000-0002-7266-5568				An L, 2001, ECOL MODEL, V140, P31, DOI 10.1016/S0304-3800(01)00267-8; BONGAARTS J, 2001, END FERTILITY TRANSI; Cincotta R. P., 2000, NATURES PLACE HUMAN; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Daily G. C., 1997, Nature's services: societal dependence on natural ecosystems., P113; Dompka V, 1996, HUMAN POPULATION BIO; Durrenberger G, 2001, INT J ENVIRON POLLUT, V15, P159, DOI 10.1504/IJEP.2001.000599; Friesen LE, 1995, CONSERV BIOL, V9, P1408, DOI 10.1046/j.1523-1739.1995.09061408.x; GARDNEROUTLAW T, 1999, FOREST FUTURES POPUL; HOLDREN JP, 1974, AM SCI, V62, P282; IRONMONGER DS, 1995, ENERG ECON, V17, P301, DOI 10.1016/0140-9883(95)00032-P; KAUL S, 1992, ENERGY, V17, P405, DOI 10.1016/0360-5442(92)90114-F; Kinsella K., 2001, AGEING WORLD, DOI [10.1037/e407472005-001, DOI 10.1037/E407472005-001]; KITAGAWA EM, 1955, J AM STAT ASSOC, V50, P1168, DOI 10.2307/2281213; Kluza DA, 2000, ANIM CONSERV, V3, P15, DOI 10.1017/S1367943000000706; Lenzen M, 2001, ECOL ECON, V37, P229, DOI 10.1016/S0921-8009(00)00275-5; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; MacKellar FL, 1995, POPUL DEV REV, V21, P849, DOI 10.2307/2137777; MICHAEL RT, 1980, DEMOGRAPHY, V17, P39, DOI 10.2307/2060962; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NILON CH, 1995, LANDSCAPE URBAN PLAN, V32, P81, DOI 10.1016/0169-2046(94)00192-6; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Rutledge DT, 2001, CONSERV BIOL, V15, P475, DOI 10.1046/j.1523-1739.2001.015002475.x; SANDIFORD P, 1990, J TROP MED HYG, V93, P383; THOMPSON WC, 1989, LAW HUMAN BEHAV, V13, P185, DOI 10.1007/BF01055923; *UN CTR HUMAN SETT, 2001, CIT GLOB WORLD GLOB; Wilson E.O., 1988, P3; YOUSIF HM, 1995, INT J SUST DEV WORLD, V2, P54, DOI 10.1080/13504509509469889	28	422	456	4	192	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 30	2003	421	6922					530	533		10.1038/nature01359	http://dx.doi.org/10.1038/nature01359			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	640DB	12540852				2022-12-28	WOS:000180670600044
J	Whitehead, M; Holland, P				Whitehead, M; Holland, P			What puts children of lone parents at a health disadvantage?	LANCET			English	Editorial Material							MOTHERS; SWEDEN; INEQUALITIES; MORTALITY; TRENDS		Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England	University of Liverpool	Whitehead, M (corresponding author), Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England.			Holland, Paula/0000-0002-8324-9957				Brown GW, 1997, PSYCHOL MED, V27, P21, DOI 10.1017/S0033291796004060; Burstrom B, 1999, J EPIDEMIOL COMMUN H, V53, P750, DOI 10.1136/jech.53.12.750; GRAHAM H, 1987, SOC SCI MED, V25, P47, DOI 10.1016/0277-9536(87)90206-1; Graham H., 1987, GIVE TAKE FAMILIES S, P56; Hiscock R., 2001, HOUSING THEORY SOC, V18, P50, DOI [10.1080/140360901750424761, DOI 10.1080/14036090120617]; Hope S, 1999, SOC SCI MED, V49, P1637, DOI 10.1016/S0277-9536(99)00251-8; Lahelma E, 2002, SOC SCI MED, V54, P727, DOI 10.1016/S0277-9536(01)00105-8; Macias J, 1998, TRAINING DEV, V52, P7; Weitoft GR, 2000, LANCET, V355, P1215, DOI 10.1016/S0140-6736(00)02087-0; Whitehead M, 1999, BRIT MED J, V318, P908, DOI 10.1136/bmj.318.7188.908; Whitehead M, 2000, SOC SCI MED, V50, P255, DOI 10.1016/S0277-9536(99)00280-4	11	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					271	271		10.1016/S0140-6736(03)12362-8	http://dx.doi.org/10.1016/S0140-6736(03)12362-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	639RV	12559856				2022-12-28	WOS:000180643900003
J	Egan, MF; Kojima, M; Callicott, JH; Goldberg, TE; Kolachana, BS; Bertolino, A; Zaitsev, E; Gold, B; Goldman, D; Dean, M; Lu, B; Weinberger, DR				Egan, MF; Kojima, M; Callicott, JH; Goldberg, TE; Kolachana, BS; Bertolino, A; Zaitsev, E; Gold, B; Goldman, D; Dean, M; Lu, B; Weinberger, DR			The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function	CELL			English	Article							LONG-TERM POTENTIATION; HIGH-FREQUENCY STIMULATION; N-ACETYL ASPARTATE; NEUROTROPHIC FACTOR; SYNAPTIC TRANSMISSION; ALZHEIMERS-DISEASE; WORKING-MEMORY; RELATIVE RISK; KNOCKOUT MICE; SCHIZOPHRENIA	Brain-derived neurotrophic factor (BDNF) modulates hippocampal plasticity and hippocampal-dependent memory in cell models and in animals. We examined the effects of a valine (val) to methionine (met) substitution in the 5' pro-region of the human BDNF protein. In human subjects, the met allele was associated with poorer episodic memory, abnormal hippocampal activation assayed with fMRI, and lower hippocampal n-acetyl aspartate (NAA), assayed with MRI spectroscopy. Neurons transfected with met-BDNF-GFP showed lower depolarization-induced secretion, while constitutive secretion was unchanged. Furthermore, met-BDNF-GFP failed to localize to secretory granules or synapses. These results demonstrate a role for BDNF	NICHHD, Sect Neural Dev & Plast, NIH, DHHS, Bethesda, MD 20892 USA; NIMH, Clin Brain Disorders Branch, Bethesda, MD 20892 USA; NIAAA, Neurogenet Lab, Rockville, MD 20857 USA; NCI, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; Natl Inst AIST, Cell Dynam Res Grp, Osaka 5638577, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST)	Lu, B (corresponding author), NICHHD, Sect Neural Dev & Plast, NIH, DHHS, Bldg 49-6A67, Bethesda, MD 20892 USA.		Callicott, Joseph H/C-9102-2009; Dean, Michael/R-7501-2019; Majid, Salma/AAT-2616-2020; Callicott, Joseph H/AAE-7243-2022; Lu, Bai/A-4018-2012; Goldman, David/F-9772-2010; Dean, Michael C/G-8172-2012; BERTOLINO, ALESSANDRO/O-6352-2016	Callicott, Joseph H/0000-0003-1298-3334; Majid, Salma/0000-0002-1724-5405; Goldman, David/0000-0002-1724-5405; Dean, Michael C/0000-0003-2234-0631; BERTOLINO, ALESSANDRO/0000-0002-1251-1380; Lu, Bai/0000-0001-5418-9759	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002734, Z01MH002716, ZIAMH002734, ZIAMH002716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000302, Z01AA000303] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Bertolino A, 1996, AM J PSYCHIAT, V153, P1554; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Callicott JH, 1998, BIOL PSYCHIAT, V44, P941, DOI 10.1016/S0006-3223(98)00264-9; de Geus EJC, 2001, BEHAV GENET, V31, P489, DOI 10.1023/A:1013360909048; Egan MF, 2001, BIOL PSYCHIAT, V50, P98, DOI 10.1016/S0006-3223(01)01133-7; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Egan MF, 2000, AM J PSYCHIAT, V157, P1309, DOI 10.1176/appi.ajp.157.8.1309; Farhadi HF, 2000, J NEUROSCI, V20, P4059; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; GOODMAN LJ, 1996, MOL CELL NEUROSCI, V7, P223; Gottschalk W, 1998, J NEUROSCI, V18, P6830; Gottschalk WA, 1999, LEARN MEMORY, V6, P243; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Jenkins BG, 2000, J NEUROCHEM, V74, P2108, DOI 10.1046/j.1471-4159.2000.0742108.x; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kojima M, 2001, J NEUROSCI RES, V64, P1, DOI 10.1002/jnr.1080; Kopelman MD, 1998, BRAIN, V121, P875, DOI 10.1093/brain/121.5.875; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 1998, NEUROPHARMACOLOGY, V37, P553, DOI 10.1016/S0028-3908(98)00035-5; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Linnarsson S, 1997, EUR J NEUROSCI, V9, P2581, DOI 10.1111/j.1460-9568.1997.tb01687.x; Lu B, 2000, PROG BRAIN RES, V128, P231; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; MAIER M, 1995, PSYCHOL MED, V25, P1201, DOI 10.1017/S0033291700033171; Mattay VS, 1996, J NEUROSCI, V16, P4816; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Nakatani A, 1998, J BIOCHEM-TOKYO, V123, P707; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Plomin R, 1999, NATURE, V402, pC25, DOI 10.1038/35011520; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Roses AD, 1998, ANN NY ACAD SCI, V855, P738, DOI 10.1111/j.1749-6632.1998.tb10653.x; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Tartaglia N, 2001, J BIOL CHEM, V276, P37585, DOI 10.1074/jbc.M101683200; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000	52	2885	3000	5	256	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 24	2003	112	2					257	269		10.1016/S0092-8674(03)00035-7	http://dx.doi.org/10.1016/S0092-8674(03)00035-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553913	Bronze			2022-12-28	WOS:000181191600014
J	Bell, JI				Bell, JI			The double helix in clinical practice	NATURE			English	Article							ASSOCIATION; GENETICS; CANCER; ASTHMA	The discovery of the double helix half a century ago has so far been slow to affect medical practice, but significant transformations are likely over the next 50 years. Changes to the way medicine is practised and new doctors are trained will be required before potential benefits are realized.	Univ Oxford, Off Regius Professor Med, Oxford OX3 9DU, England	University of Oxford	Bell, JI (corresponding author), Univ Oxford, Off Regius Professor Med, Oxford OX3 9DU, England.	regius@medsci.ox.ac.uk						Abraham EP, 1941, LANCET, V2, P177; Bell J, 1998, BMJ-BRIT MED J, V316, P618, DOI 10.1136/bmj.316.7131.618; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; COOKSON WOCM, 1989, LANCET, V1, P1292; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; FISHER RA, 1958, NATURE, V182, P596, DOI 10.1038/182596a0; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; Lewis T, 1944, LANCET, V1, P619; Osler W, 1892, PRINCIPLES PRACTICE; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Shirakawa T, 2000, IMMUNOL TODAY, V21, P60, DOI 10.1016/S0167-5699(99)01492-9; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WEBER WW, 1997, PHARMACOGENETICS	15	22	26	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					414	416		10.1038/nature01402	http://dx.doi.org/10.1038/nature01402			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540912	Bronze			2022-12-28	WOS:000180533000053
J	Counihan, TJ				Counihan, TJ			Conjugal Parkinson's disease	LANCET			English	Editorial Material									Eastman Dent Ctr, Rochester, NY 14618 USA	Eastman Chemical Company; University of Rochester	Counihan, TJ (corresponding author), Eastman Dent Ctr, Rochester, NY 14618 USA.								0	3	3	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					252	252		10.1016/S0140-6736(03)12277-5	http://dx.doi.org/10.1016/S0140-6736(03)12277-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547554				2022-12-28	WOS:000180535400029
J	Murray, SA; Grant, E; Grant, A; Kendall, M				Murray, SA; Grant, E; Grant, A; Kendall, M			Dying from cancer in developed and developing countries: lessons from two qualitative interview studies of patients and their carers	BRITISH MEDICAL JOURNAL			English	Article								Objective To describe the experiences of illness and needs and use of services in two groups of patients with incurable cancer, one in a developed country and the other in a developing country. Design Scotland: longitudinal study with qualitative interviews. Kenya: cross sectional study with qualitative interviews. Settings Lothian region, Scotland, and Meru District, Kenya. Participants Scotland: 20 patients with inoperable lung cancer and their carers. Kenya: 24 patients with common advanced cancers and their main informal carers. Main outcome measures Descriptions of experiences, needs, and available services. Results 67 interviews were conducted in Scotland and 46 in Kenya. The emotional pain of facing death was the prime concern of Scottish patients and their carers, while physical pain and financial worries dominated the lives of Kenyan patients and their carers. In Scotland, free health and social services (including financial assistance) were available, but sometimes underused. In Kenya, analgesia, essential equipment, suitable food, and assistance in care were often inaccessible and unaffordable, resulting in considerable unmet physical needs. Kenyan patients thought that their psychological, social, and spiritual needs were met by their families, local community, and religious groups. Some Scottish patients thought that such non-physical needs went unmet. Conclusions In patients living in developed and developing countries there are differences not only in resources available for patients dying from cancer but also in their lived experience of illness. The expression of needs and how they are met in different cultural contexts can inform local assessment of needs and provide insights for initiatives in holistic cancer care.	Univ Edinburgh, Div Community Hlth Sci, Edinburgh EH8 9DX, Midlothian, Scotland; Chogoria Hosp, Chogoria, Meru, Kenya	University of Edinburgh	Murray, SA (corresponding author), Univ Edinburgh, Div Community Hlth Sci, Edinburgh EH8 9DX, Midlothian, Scotland.							Coffey A, 1996, MAKING SENSE QUALITA; DEBOER CN, 1989, SOC SCI MED, V28, P1007, DOI 10.1016/0277-9536(89)90383-3; Defilippi K, 2000, Int J Palliat Nurs, V6, P108; GRANT E, IN PRESS J PALLIAT C; Green J, 1998, BMJ-BRIT MED J, V316, P1230, DOI 10.1136/bmj.316.7139.1230; Haines A, 2000, BRIT MED J, V320, P1, DOI 10.1136/bmj.320.7226.1; Isichei Elizabeth, 1995, HIST CHRISTIANITY AF; Lincon Y. S., 2000, HDB QUALITATIVE RES, P163; Maslow A.H., 1954, MOTIVATION PERSONALI; Mbiti J. S., 1969, AFRICAN RELIG PHILOS; MURRAY JL, 1996, GLOBAL BURDEN DIS; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; OLWENY C, 1996, OXFORD TXB PALLIATIV; Olweny C L, 1994, J Palliat Care, V10, P17; Ramsay S, 2001, LANCET, V358, P734, DOI 10.1016/S0140-6736(01)05942-6; Scottish Executive Health Department, 2001, CANC SCEN AID PLANN; Singer PA, 2002, BMJ-BRIT MED J, V324, P1291, DOI 10.1136/bmj.324.7349.1291; Smith R, 2000, BMJ-BRIT MED J, V320, P129, DOI 10.1136/bmj.320.7228.129; WESTPHUAL VB, 1990, MONOGRAPH 6 HOME CAR; *WHO, 1979, HDB REPRESENTING RES; World Health Organization, 1990, CANC PAIN REL PALL C; World Health Organization, 2001, MACR HLTH INV HLTH E	22	98	99	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2003	326	7385					368	371		10.1136/bmj.326.7385.368	http://dx.doi.org/10.1136/bmj.326.7385.368			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648RZ	12586671	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000181165500021
J	LeCouter, J; Moritz, DR; Li, B; Phillips, GL; Liang, XH; Gerber, HP; Hillan, KJ; Ferrara, N				LeCouter, J; Moritz, DR; Li, B; Phillips, GL; Liang, XH; Gerber, HP; Hillan, KJ; Ferrara, N			Angiogenesis-independent endothelial protection of liver: Role of VEGFR-1	SCIENCE			English	Article							GROWTH-FACTOR VEGF; TYROSINE KINASE; FLT-1 VEGFR-1; RECEPTOR; CELLS; BINDING; REGENERATION; MIGRATION; MITOGEN; KDR	The vascular endothelium was once thought to function primarily in nutrient and oxygen delivery, but recent evidence suggests that it may play a broader role in tissue homeostasis. To explore the role of sinusoidal endothelial cells (LSECs) in the adult liver, we studied the effects of vascular endothelial growth factor (VEGF) receptor activation on mouse hepatocyte growth. Delivery of VEGF-A increased liver mass in mice but did not stimulate growth of hepatocytes in vitro, unless LSECs were also present in the culture. Hepatocyte growth factor (HGF) was identified as one of the LSEC-derived paracrine mediators promoting hepatocyte growth. Selective activation of VEGF receptor-1 (VEGFR-1) stimulated hepatocyte but not endothelial proliferation in vivo and reduced liver damage in mice exposed to a hepatotoxin. Thus, VEGFR-1 agonists may have therapeutic potential for preservation of organ function in certain liver disorders.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ferrara, N (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.							Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; BARUCH Y, 1995, J HEPATOL, V23, P328, DOI 10.1016/0168-8278(95)80477-3; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Gille H, 2000, EMBO J, V19, P4064, DOI 10.1093/emboj/19.15.4064; ITO N, 1994, BIOCHEM BIOPH RES CO, V198, P25, DOI 10.1006/bbrc.1994.1004; JAKEMAN LB, 1992, J CLIN INVEST, V89, P244, DOI 10.1172/JCI115568; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; Kliche S, 2001, IUBMB LIFE, V52, P61, DOI 10.1080/15216540252774784; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; LECOUTER J, UNPUB; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; MAHER JJ, 1993, J CLIN INVEST, V91, P2244, DOI 10.1172/JCI116451; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Ogawa S, 1998, J BIOL CHEM, V273, P31273, DOI 10.1074/jbc.273.47.31273; PARK JE, 1994, J BIOL CHEM, V269, P25646; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; SIMIONESCU N, 1992, ENDOTHELIAL CELL FUN; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; YAMANE A, 1994, ONCOGENE, V9, P2683; Zeng HY, 2001, J BIOL CHEM, V276, P26969, DOI 10.1074/jbc.M103213200	30	502	527	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					890	893		10.1126/science.1079562	http://dx.doi.org/10.1126/science.1079562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574630				2022-12-28	WOS:000180830900052
J	Ashby, DT; Collins, MB				Ashby, DT; Collins, MB			Aneurysm of the left anterior descending coronary artery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Cardiovasc Res Fdn, New York, NY 10022 USA; Lenox Hill Heart & Vasc Inst, New York, NY 10021 USA	Cardiovascular Research Foundation (CRF); Lenox Hill Heart & Vascular Institute of New York	Ashby, DT (corresponding author), Cardiovasc Res Fdn, New York, NY 10022 USA.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2003	348	6					E2	E2		10.1056/ENEJMicm020267	http://dx.doi.org/10.1056/ENEJMicm020267			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642JY	12571272				2022-12-28	WOS:000180801400034
J	Aspelin, P; Aubry, P; Fransson, S; Strasser, R; Willenbrock, R; Berg, KJ				Aspelin, P; Aubry, P; Fransson, S; Strasser, R; Willenbrock, R; Berg, KJ		NEPHRIC Study Investigators	Nephrotoxic effects in high-risk patients undergoing angiography.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEDIA-INDUCED NEPHROTOXICITY; ACUTE-RENAL-FAILURE; RADIOGRAPHIC-CONTRAST-AGENT; RADIOCONTRAST NEPHROPATHY; DIABETES-MELLITUS; HIGH-OSMOLALITY; PREVENTION; TRIAL; PATHOPHYSIOLOGY; INSUFFICIENCY	Background: The use of iodinated contrast medium can result in nephropathy. Whether iso-osmolar contrast medium is less nephrotoxic than low-osmolar contrast medium in high-risk patients is uncertain. Methods: We conducted a randomized, double-blind, prospective, multicenter study comparing the nephrotoxic effects of an iso-osmolar, dimeric, nonionic contrast medium, iodixanol, with those of a low-osmolar, nonionic, monomeric contrast medium, iohexol. The study involved 129 patients with diabetes with serum creatinine concentrations of 1.5 to 3.5 mg per deciliter who underwent coronary or aortofemoral angiography. The primary end point was the peak increase from base line in the creatinine concentration during the three days after angiography. Other end points were an increase in the creatinine concentration of 0.5 mg per deciliter or more, an increase of 1.0 mg per deciliter or more, and a change in the creatinine concentration from day 0 to day 7. Results: The creatinine concentration increased significantly less in patients who received iodixanol. From day 0 to day 3, the mean peak increase in creatinine was 0.13 mg per deciliter in the iodixanol group and 0.55 mg per deciliter in the iohexol group (P=0.001; the increase with iodixanol minus the increase with iohexol, -0.42 mg per deciliter [95 percent confidence interval, -0.73 to -0.22]). Two of the 64 patients in the iodixanol group (3 percent) had an increase in the creatinine concentration of 0.5 mg per deciliter or more, as compared with 17 of the 65 patients in the iohexol group (26 percent) (P=0.002; odds ratio for such an increase in the iodixanol group, 0.09 [95 percent confidence interval, 0.02 to 0.41]). No patient receiving iodixanol had an increase of 1.0 mg per deciliter or more, but 10 patients in the iohexol group (15 percent) did. The mean change in the creatinine concentration from day 0 to day 7 was 0.07 mg per deciliter in the iodixanol group and 0.24 mg per deciliter in the iohexol group (P=0.003; value in the iodixanol group minus the value in the iohexol group, -0.17 mg per deciliter [95 percent confidence interval, -0.34 to -0.07]). Conclusions: Nephropathy induced by contrast medium may be less likely to develop in high-risk patients when iodixanol is used rather than a low-osmolar, nonionic contrast medium.	Huddinge Univ Hosp, Dept Radiol, S-14186 Huddinge, Sweden; CHU Bichat, Dept Cardiol, Paris, France; Linkoping Univ Hosp, Dept Thorac Radiol, S-58185 Linkoping, Sweden; Tech Univ, Kardiol Herzzentrum, Med Klin 2, Dresden, Germany; Helios Kliniken, Franz Volhard Klin, Dept Cardiol, Berlin, Germany; Univ Oslo, Rikshosp, Lab Renal Physiol, N-0027 Oslo, Norway	Karolinska Institutet; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Linkoping University; Technische Universitat Dresden; University of Hamburg; University Medical Center Hamburg-Eppendorf; Franz-Volhard Clinical Research Center; Helios Kliniken; University of Oslo; National Hospital Norway	Aspelin, P (corresponding author), Huddinge Univ Hosp, Dept Radiol, S-14186 Huddinge, Sweden.	peter.aspelin@cfss.ki.se	Aubry, Pierre/ABF-1167-2021					Bakris GL, 1999, KIDNEY INT, V56, P206, DOI 10.1046/j.1523-1755.1999.00528.x; BARRETT BJ, 1992, KIDNEY INT, V41, P1274, DOI 10.1038/ki.1992.189; BARRETT BJ, 1994, J AM SOC NEPHROL, V5, P125; BARRETT BJ, 1993, RADIOLOGY, V188, P171, DOI 10.1148/radiology.188.1.8511292; Berg KJ, 2000, SCAND J UROL NEPHROL, V34, P317, DOI 10.1080/003655900750048341; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; Caputo C, 2002, AM J KIDNEY DIS, V39, pA14; Carraro M, 1998, EUR RADIOL, V8, P144, DOI 10.1007/s003300050356; Chalmers N, 1999, BRIT J RADIOL, V72, P701, DOI 10.1259/bjr.72.859.10624328; COCHRAN ST, 1983, AM J ROENTGENOL, V141, P1027, DOI 10.2214/ajr.141.5.1027; Davidson CJ, 2000, CIRCULATION, V101, P2172, DOI 10.1161/01.CIR.101.18.2172; Deray G, 1999, INVEST RADIOL, V34, P1, DOI 10.1097/00004424-199901000-00001; Diaz-Sandoval LJ, 2002, AM J CARDIOL, V89, P356, DOI 10.1016/S0002-9149(01)02243-3; Efron B., 1994, MONOGRAPHS STAT APPL; Erickson CW, 2002, AM J KIDNEY DIS, V39, pA16; Gerlach AT, 2000, PHARMACOTHERAPY, V20, P540, DOI 10.1592/phco.20.6.540.35154; Grynne BH, 1995, ACTA RADIOL, V36, P265, DOI 10.1177/0284185195036S39933; Heyman SN, 1999, INVEST RADIOL, V34, P685, DOI 10.1097/00004424-199911000-00004; Jakobsen JA, 1996, EUR RADIOL, V6, pS16, DOI 10.1007/BF02342567; Jakobsen JA, 1996, NEPHRON, V73, P549; Katzberg RW, 1997, RADIOLOGY, V204, P297, DOI 10.1148/radiology.204.2.9240511; Kini AS, 2002, AM J CARDIOL, V89, P999, DOI 10.1016/S0002-9149(02)02259-2; Lancelot E, 2002, INVEST RADIOL, V37, P368, DOI 10.1097/00004424-200207000-00002; LAUTIN EM, 1991, AM J ROENTGENOL, V157, P59, DOI 10.2214/ajr.157.1.2048540; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; MANSKE CL, 1990, AM J MED, V89, P615, DOI 10.1016/0002-9343(90)90180-L; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; Morcos SK, 1998, BRIT J RADIOL, V71, P357, DOI 10.1259/bjr.71.844.9659127; Morcos SK, 1999, EUR RADIOL, V9, P1602, DOI 10.1007/s003300050894; Murakami R, 1998, ACTA RADIOL, V39, P368; PARFREY PS, 1989, NEW ENGL J MED, V320, P143, DOI 10.1056/NEJM198901193200303; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; RUDNICK MR, 1995, KIDNEY INT, V47, P254, DOI 10.1038/ki.1995.32; SAFIRSTEIN R, 1997, AM J MED, V103, P368; SCHWAB SJ, 1989, NEW ENGL J MED, V320, P149, DOI 10.1056/NEJM198901193200304; Sketch M H Jr, 2001, Am J Ther, V8, P155, DOI 10.1097/00045391-200105000-00004; SOLOMON R, 1994, NEW ENGL J MED, V331, P1416, DOI 10.1056/NEJM199411243312104; TALIERCIO CP, 1991, J AM COLL CARDIOL, V17, P384, DOI 10.1016/S0735-1097(10)80103-2; Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304; Thomsen HS, 2001, EUR RADIOL, V11, P2351, DOI 10.1007/s003300101054; Turney JH, 1996, JAMA-J AM MED ASSOC, V275, P1516, DOI 10.1001/jama.275.19.1516; UEDA J, 1992, ACTA RADIOL, V33, P596; Wang A, 2000, KIDNEY INT, V57, P1675, DOI 10.1046/j.1523-1755.2000.00012.x; Wang YXJ, 2001, BRIT J RADIOL, V74, P1103, DOI 10.1259/bjr.74.888.741103; Waybill MM, 2001, J VASC INTERV RADIOL, V12, P3, DOI 10.1016/S1051-0443(07)61394-3; WEISBERG LS, 1994, KIDNEY INT, V45, P259, DOI 10.1038/ki.1994.32; 1991, AMJR AM J ROENTGENOL, V157, P895	47	771	916	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2003	348	6					491	499		10.1056/NEJMoa021833	http://dx.doi.org/10.1056/NEJMoa021833			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642JY	12571256				2022-12-28	WOS:000180801400003
J	Evans, WE; McLeod, HL				Evans, WE; McLeod, HL			Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CONVERTING ENZYME-INHIBITOR; SINGLE-NUCLEOTIDE POLYMORPHISMS; S-METHYLTRANSFERASE DEFICIENCY; APOLIPOPROTEIN-E POLYMORPHISM; LEFT-VENTRICULAR HYPERTROPHY; SEROTONIN TRANSPORTER GENE; MULTIDRUG-RESISTANCE GENE; P-GLYCOPROTEIN; BETA(2)-ADRENERGIC RECEPTOR; CORONARY ATHEROSCLEROSIS		St Jude Childrens Res Hosp, Memphis, TN 38101 USA; Univ Tennessee, Coll Pharm, Memphis, TN USA; Univ Tennessee, Coll Med, Memphis, TN USA; Washington Univ, Sch Med, St Louis, MO USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Washington University (WUSTL)	Evans, WE (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38101 USA.	william.evans@stjude.org	McLeod, Howard/ABD-8364-2021; Evans, William E./C-2069-2012	McLeod, Howard/0000-0002-9004-9232; Evans, William E./0000-0002-9333-5322	NCI NIH HHS [R37 CA36401, R01 CA78224, CA21765, CA091842] Funding Source: Medline; NIGMS NIH HHS [U01 GM61394, U01 GM63340, U01 GM61393] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078224, R37CA036401, P30CA021765, P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061394, U01GM063340, U01GM061393] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Ameyaw MM, 2001, PHARMACOGENETICS, V11, P217, DOI 10.1097/00008571-200104000-00005; Arranz MJ, 2000, LANCET, V355, P1615, DOI 10.1016/S0140-6736(00)02221-2; Ballantyne CM, 2000, J AM COLL CARDIOL, V36, P1572, DOI 10.1016/S0735-1097(00)00918-9; Basile VS, 1999, NEUROPSYCHOPHARMACOL, V21, P17, DOI 10.1016/S0893-133X(98)00114-6; Black AJ, 1998, ANN INTERN MED, V129, P716, DOI 10.7326/0003-4819-129-9-199811010-00007; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Brinkmann U, 2001, DRUG DISCOV TODAY, V6, P835, DOI 10.1016/S1359-6446(01)01892-X; Cargill M, 2000, Pharmacogenomics, V1, P27, DOI 10.1517/14622416.1.1.27; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; Choo EF, 2000, DRUG METAB DISPOS, V28, P655; Cockcroft JR, 2000, HYPERTENSION, V36, P371, DOI 10.1161/01.HYP.36.3.371; de Maat MPM, 1999, AM J CARDIOL, V83, P852, DOI 10.1016/S0002-9149(98)01073-X; Dishy V, 2001, NEW ENGL J MED, V345, P1030, DOI 10.1056/NEJMoa010819; Drazen JM, 1999, NAT GENET, V22, P168, DOI 10.1038/9680; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Eichhammer P, 2000, AM J MED GENET, V96, P187, DOI 10.1002/(SICI)1096-8628(20000403)96:2<187::AID-AJMG13>3.0.CO;2-8; Esteller M, 2000, NEW ENGL J MED, V343, P1740; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; EVANS DAP, 1960, BRIT MED J, V2, P485, DOI 10.1136/bmj.2.5197.485; Evans WE, 2001, J CLIN ONCOL, V19, P2293, DOI 10.1200/JCO.2001.19.8.2293; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Evans WE, 2001, ANNU REV GENOM HUM G, V2, P9, DOI 10.1146/annurev.genom.2.1.9; Farlow MR, 1998, NEUROLOGY, V50, P669, DOI 10.1212/WNL.50.3.669; Fellay J, 2002, LANCET, V359, P30, DOI 10.1016/S0140-6736(02)07276-8; Gerdes LU, 2000, CIRCULATION, V101, P1366, DOI 10.1161/01.CIR.101.12.1366; Herrington DM, 2002, NEW ENGL J MED, V346, P967, DOI 10.1056/NEJMoa012952; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Hitzl M, 2001, PHARMACOGENETICS, V11, P293, DOI 10.1097/00008571-200106000-00003; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; HUGHES HB, 1954, AM REV TUBERC PULM, V70, P266; Hwu HG, 1998, BIOL PSYCHIAT, V44, P483, DOI 10.1016/S0006-3223(98)00134-6; Ingelman-Sundberg M, 1999, TRENDS PHARMACOL SCI, V20, P342, DOI 10.1016/S0165-6147(99)01363-2; Israel E, 2001, INT ARCH ALLERGY IMM, V124, P183, DOI 10.1159/000053705; Issa AM, 2000, CAN J PSYCHIAT, V45, P917, DOI 10.1177/070674370004501007; Jacobsen P, 1998, KIDNEY INT, V53, P1002, DOI 10.1046/j.1523-1755.1998.00847.x; Kaiser R, 2000, MOL PSYCHIATR, V5, P418, DOI 10.1038/sj.mp.4000729; Kalow W, 1998, PHARMACOGENETICS, V8, P283; KALOW W, 1956, LANCET, V2, P576; Kim DK, 2000, NEUROREPORT, V11, P215, DOI 10.1097/00001756-200001170-00042; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Kohno M, 1999, AM J MED, V106, P544, DOI 10.1016/S0002-9343(99)00067-4; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Kuivenhoven JA, 1998, NEW ENGL J MED, V338, P86, DOI 10.1056/NEJM199801083380203; Liggett SB, 2000, AM J RESP CRIT CARE, V161, pS197, DOI 10.1164/ajrccm.161.supplement_2.a1q4-10; Lima JJ, 1999, CLIN PHARMACOL THER, V65, P519, DOI 10.1016/S0009-9236(99)70071-8; Liotta LA, 2001, JAMA-J AM MED ASSOC, V286, P2211, DOI 10.1001/jama.286.18.2211; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Marian AJ, 2000, J AM COLL CARDIOL, V35, P89, DOI 10.1016/S0735-1097(99)00535-5; Martinelli I, 1998, NEW ENGL J MED, V338, P1793, DOI 10.1056/NEJM199806183382502; Martinez FD, 1997, J CLIN INVEST, V100, P3184, DOI 10.1172/JCI119874; McDonald OG, 2002, PHARMACOGENETICS, V12, P93, DOI 10.1097/00008571-200203000-00003; McLeod HL, 2002, LANCET, V359, P78, DOI 10.1016/S0140-6736(02)07296-3; McLeod HL, 2001, ANNU REV PHARMACOL, V41, P101, DOI 10.1146/annurev.pharmtox.41.1.101; Meyer UA, 2000, LANCET, V356, P1667, DOI 10.1016/S0140-6736(00)03167-6; Michelson AD, 2000, CIRCULATION, V101, P1013, DOI 10.1161/01.CIR.101.9.1013; Mukae S, 2000, HYPERTENSION, V36, P127, DOI 10.1161/01.HYP.36.1.127; Napolitano C, 2000, J CARDIOVASC ELECTR, V11, P691, DOI 10.1111/j.1540-8167.2000.tb00033.x; NESTRUCK AC, 1987, METABOLISM, V36, P743, DOI 10.1016/0026-0495(87)90110-7; Ohmichi N, 1997, AM J HYPERTENS, V10, P951, DOI 10.1016/S0895-7061(97)00121-0; Okamura A, 1999, ANGIOLOGY, V50, P811, DOI 10.1177/000331979905001005; Ongphiphadhanakul B, 2000, CLIN ENDOCRINOL, V52, P581, DOI 10.1046/j.1365-2265.2000.00979.x; ORDOVAS JM, 1995, ATHEROSCLEROSIS, V113, P157, DOI 10.1016/0021-9150(94)05439-P; Pedro-Botet J, 2001, ATHEROSCLEROSIS, V158, P183, DOI 10.1016/S0021-9150(01)00410-5; Penno G, 1998, DIABETES, V47, P1507, DOI 10.2337/diabetes.47.9.1507; Perna A, 2000, KIDNEY INT, V57, P274, DOI 10.1046/j.1523-1755.2000.00818.x; Poirier J, 1995, P NATL ACAD SCI USA, V92, P12260, DOI 10.1073/pnas.92.26.12260; Prasad A, 2000, CIRCULATION, V102, P35, DOI 10.1161/01.CIR.102.1.35; Psaty BM, 2002, JAMA-J AM MED ASSOC, V287, P1680, DOI 10.1001/jama.287.13.1680; Rao VV, 1999, P NATL ACAD SCI USA, V96, P3900, DOI 10.1073/pnas.96.7.3900; Relling MV, 1999, JNCI-J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Relling MV, 1999, LANCET, V354, P34, DOI 10.1016/S0140-6736(98)11079-6; Richard F, 1997, LANCET, V349, P539, DOI 10.1016/S0140-6736(97)80089-X; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sakaeda T, 2001, PHARMACEUT RES, V18, P1400, DOI 10.1023/A:1012244520615; Sasaki M, 1996, J HYPERTENS, V14, P1403, DOI 10.1097/00004872-199612000-00003; Sata F, 2000, CLIN PHARMACOL THER, V67, P48, DOI 10.1067/mcp.2000.104391; Schaeffeler E, 2001, LANCET, V358, P383, DOI 10.1016/S0140-6736(01)05579-9; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Sham P, 2001, PHARMACOGENOMICS, V2, P195, DOI 10.1517/14622416.2.3.195; Siest G, 2000, CLIN CHEM LAB MED, V38, P841, DOI 10.1515/CCLM.2000.122; Smeraldi E, 1998, MOL PSYCHIATR, V3, P508, DOI 10.1038/sj.mp.4000425; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Stavroulakis GA, 2000, CARDIOVASC DRUG THER, V14, P427, DOI 10.1023/A:1007820401377; Tan S, 1997, LANCET, V350, P995, DOI 10.1016/S0140-6736(97)03211-X; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; VESELL ES, 1989, PHARMACOL THERAPEUT, V41, P535, DOI 10.1016/0163-7258(89)90130-7; WATANABE J, 1993, DIABETES RES CLIN PR, V20, P21, DOI 10.1016/0168-8227(93)90018-Z; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021; Whale R, 2000, PSYCHOPHARMACOLOGY, V150, P120, DOI 10.1007/s002130000432; Yates CR, 1997, ANN INTERN MED, V126, P608, DOI 10.7326/0003-4819-126-8-199704150-00003; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	95	1212	1343	2	151	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2003	348	6					538	549		10.1056/NEJMra020526	http://dx.doi.org/10.1056/NEJMra020526			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642JY	12571262				2022-12-28	WOS:000180801400008
J	Kay, J; Chow, WH; Chan, TM; Lo, SK; Kwok, OH; Yip, A; Fan, K; Lee, CH; Lam, WF				Kay, J; Chow, WH; Chan, TM; Lo, SK; Kwok, OH; Yip, A; Fan, K; Lee, CH; Lam, WF			Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RADIOGRAPHIC-CONTRAST-AGENT; ACETYL-L-CYSTEINE; HIGH-OSMOLALITY; FAILURE; RISK; NEPHROTOXICITY; ANGIOPLASTY; NEPHROPATHY; MEDIA; INJURY	Context The antioxidant acetylcysteine prevents acute contrast nephrotoxicity in patients with impaired renal function who undergo computed tomography scanning. However, its role. in coronary angiography is unclear. Objective To determine whether oral acetylcysteine prevents acute deterioration in renal function in patients with moderate renal insufficiency who undergo elective coronary angiography. Design and Setting Prospective, randomized, double-blind, placebo-controlled trial conducted from May 2000 to December 2001 at the Grantham Hospital at the University of Hong Kong. Participants Two hundred Chinese patients aged mean (SD) 68 (6.5) years with stable moderate renal insufficiency (creatinine clearance <60 mL/min [1.00 mL/s]) who were undergoing elective coronary angiography with or without intervention. Intervention Participants were randomly assigned to receive oral acetylcysteine (600 mg twice per day; n=102) or matching placebo tablets (n=98) on the day before and the day of angiography. All patients received low-osmolality contrast agent. Main Outcome Measures Occurrence of more than a 25% increase in serum creatinine level within 48 hours after contrast administration; change in creatinine clearance and serum creatinine level. Results Twelve control patients (12%) and 4 acetylcysteine patients (4%) developed a more than 25% increase in serum creatinine level within 48 hours after contrast administration (relative risk, 0.32; 95% confidence interval [CI], 0.10-0.96; P=.03). Serum creatinine was lower in the acetylcysteine group (1.22 mg/dL [107.8 mu mol/L]; 95% CI, 1.11-1.33 mg/dL vs 1.38 mg/dL [122.9 mu mol/L]; 95% Cl, 1.27-1.49 mg/dL; P=.006) during the first 48 hours after angiography. Acetylcysteine treatment significantly increased creatinine clearance from 44.8 mL/min (0.75 mL/s) (95% Cl, 42.7-47.6 mL/min) to 58.9 mL/min (0.98 mL/s) (95% CI, 55.6-62.3 mL/min) 2 days after the contrast administration (P<.001). The increase was not significant in the control group (from 42.1 to 44.1 mL/min [0.70 to 0.74 mL/s]; P=.15). The benefit of acetylcysteine was consistent among various patient subgroups and persistent for at least 7 days. There were no major treatment-related adverse events., Conclusion Acetylcysteine protects patients with moderate chronic renal insufficiency from contrast-induced deterioration in renal function after coronary angiographic procedures, with minimal adverse effects and at a low cost.	Grantham Hosp, Cardiac Med Unit, Aberdeen, Hong Kong, Peoples R China; Univ Hong Kong, Queen Marys Hosp, Dept Med, Div Nephrol, Hong Kong, Hong Kong, Peoples R China; Univ Sydney, Inst Int Hlth, Sydney, NSW 2006, Australia	University of Hong Kong; University of Sydney	Kay, J (corresponding author), Grantham Hosp, Cardiac Med Unit, 125 Wong Chuk Hang Rd, Aberdeen, Hong Kong, Peoples R China.	flkay@netvigator.com	Lee, Chi-Hang/L-1807-2013; Chan, Daniel Tak Mao/C-4202-2009	Lee, Chi-Hang/0000-0001-8777-2705; LO, Sing Kai/0000-0001-8401-1759				Abizaid AS, 1999, AM J CARDIOL, V83, P260, DOI 10.1016/S0002-9149(98)00833-9; Adamian MG, 2002, J AM COLL CARDIOL, V39, p1A; ARSTALL MA, 1995, CIRCULATION, V92, P2855, DOI 10.1161/01.CIR.92.10.2855; BAKRIS GL, 1990, AM J PHYSIOL, V258, pF115, DOI 10.1152/ajprenal.1990.258.1.F115; Baliga R, 1997, AM J KIDNEY DIS, V29, P465, DOI 10.1016/S0272-6386(97)90212-2; BARRETT BJ, 1994, J AM SOC NEPHROL, V5, P125; Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; COCHRAN ST, 1983, AM J ROENTGENOL, V141, P1027, DOI 10.2214/ajr.141.5.1027; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; DAVIDSON CJ, 1989, ANN INTERN MED, V110, P119, DOI 10.7326/0003-4819-110-2-119; Diaz-Sandoval LJ, 2002, AM J CARDIOL, V89, P356, DOI 10.1016/S0002-9149(01)02243-3; DiMari J, 1997, AM J PHYSIOL-RENAL, V272, pF292, DOI 10.1152/ajprenal.1997.272.3.F292; Gruberg L, 2000, J AM COLL CARDIOL, V36, P1542, DOI 10.1016/S0735-1097(00)00917-7; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; JONES AL, 1994, GUT, V35, P1290, DOI 10.1136/gut.35.9.1290; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; MOORE RD, 1992, RADIOLOGY, V182, P649, DOI 10.1148/radiology.182.3.1535876; Mouhavar EN, 2002, J AM COLL CARDIOL, V39, p1A; Pollman MJ, 1999, CIRC RES, V84, P113; PORTER GA, 1993, INVEST RADIOL, V28, pS11, DOI 10.1097/00004424-199309001-00004; Rasuli P, 1998, CAN ASSOC RADIOL J, V49, P161; RUDNICK MR, 1995, KIDNEY INT, V47, P254, DOI 10.1038/ki.1995.32; Salom MG, 1998, TRANSPLANTATION, V65, P1315, DOI 10.1097/00007890-199805270-00006; Shyu KG, 2002, J AM COLL CARDIOL, V40, P1383, DOI 10.1016/S0735-1097(02)02308-2; SOLOMON R, 1994, NEW ENGL J MED, V331, P1416, DOI 10.1056/NEJM199411243312104; STEINBERG EP, 1992, NEW ENGL J MED, V326, P425, DOI 10.1056/NEJM199202133260701; Stevens NA, 1999, J AM COLL CARDIOL, V33, P403; TALIERCIO CP, 1991, J AM COLL CARDIOL, V17, P384, DOI 10.1016/S0735-1097(10)80103-2; Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304; Vlietstra RE, 1996, AM HEART J, V132, P1049, DOI 10.1016/S0002-8703(96)90021-6; WEISBERG LS, 1994, KIDNEY INT, V45, P259, DOI 10.1038/ki.1994.32; ZHANG H, 1995, EUR SURG RES, V27, P292, DOI 10.1159/000129412	33	292	310	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2003	289	5					553	558		10.1001/jama.289.5.553	http://dx.doi.org/10.1001/jama.289.5.553			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CV	12578487	Bronze			2022-12-28	WOS:000180787500025
J	Prideaux, D				Prideaux, D			ABC of learning and teaching in medicine - Curriculum design	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Flinders Univ S Australia, Sch Med, Off Med Educ, Adelaide, SA 5001, Australia	Flinders University South Australia	Prideaux, D (corresponding author), Flinders Univ S Australia, Sch Med, Off Med Educ, Adelaide, SA 5001, Australia.			Prideaux, David/0000-0001-6695-2723				Bligh J, 2001, MED EDUC, V35, P520, DOI 10.1046/j.1365-2923.2001.00984.x; Harden RM, 2001, MED TEACH, V23, P123, DOI 10.1080/01421590120036547; LAIDLAW JM, 1990, MED TEACH, V12, P7, DOI 10.3109/01421599009010556; Prideaux D, 2000, MED EDUC, V34, P168; Print M., 1993, CURRICULUM DEV DESIG	5	151	153	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2003	326	7383					268	270		10.1136/bmj.326.7383.268	http://dx.doi.org/10.1136/bmj.326.7383.268			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560283	Green Published			2022-12-28	WOS:000180908300026
J	Spurgeon, D				Spurgeon, D			Scientists call for Canada to boost polar-shelf funding	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2003	421	6922					464	464		10.1038/421464b	http://dx.doi.org/10.1038/421464b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556855	Bronze			2022-12-28	WOS:000180670600010
J	Huopio, H; Otonkoski, T; Vauhkonen, I; Reimann, F; Ashcroft, FM; Laakso, M				Huopio, H; Otonkoski, T; Vauhkonen, I; Reimann, F; Ashcroft, FM; Laakso, M			A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1	LANCET			English	Article							K-ATP CHANNEL; INSULIN-SECRETION; SEQUENCE VARIANTS; HYPERINSULINEMIC HYPOGLYCEMIA; KNOCKOUT MICE; MELLITUS; PANCREAS; GLUCOSE; NESIDIOBLASTOSIS; DEFINITION	Background ATP-sensitive potassium (K-ATP) channels are major regulators of glucose-induced insulin secretion in pancreatic P cells. We have described a dominant heterozygous mutation-E1506K-in the sulfonylurea receptor 1 (SUR1) gene (ABCC8) in a Finnish family, which leads to congenital hyperinsulinaemia due to reduction of K-ATP-channel activity. We aimed to characterise glucose metabolism in adults heterozygous for the E1506K mutation. Methods Glucose tolerance was assessed by an oral glucose tolerance test, insulin secretion by the intravenous glucose tolerance test and hyperglycaemic clamp, and insulin sensitivity by hyperinsulinaemic euglycaemic clamp in 11 people heterozygous for the E1506K mutation and 19 controls. Findings Four people who were heterozygous for the SUR1 E1506K mutation had diabetes, five had impaired glucose tolerance, one had impaired fasting glucose, and one had normal glucose tolerance. Although glucose-induced, first-phase insulin secretion was normal in children younger than 10 years of age who were heterozygous for the SUR1 E1506K mutation (n=2; 66 and 334 pmol/L), it fell rapidly after puberty (n=3; 12-32 pmol/L), and was almost completely lost in adulthood (n=11; 12-32 pmol/L). Furthermore, these heterozygous people had a substantial reduction in maximum glucose-stimulated insulin secretion during hyperglycemic clamp (carriers without diabetes 422 pmol/L; carriers with diabetes 97 pmol/L). By contrast, insulin sensitivity (M/I value) was normal in carriers of the E1506K mutation who did not have diabetes and was reduced by 15% in those who were heterozygous with diabetes (0.07 in those without diabetes and 0.05 in those with the disorder; not significantly different from controls). Interpretation Heterozygous E1506K substitution in the SUR1 gene causes congenital hyperinsulinism in infancy, loss of insulin secretory capacity in early adulthood, and diabetes in middle-age. This variant represents a new subtype of autosomal dominant diabetes.	Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; Univ Kuopio, Dept Paediat, FIN-70211 Kuopio, Finland; Univ Helsinki, Transplantat Lab, Haartman Inst, Helsinki, Finland; Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland; Addenbrookes Hosp, Dept Clin Biochem, Cambridge, England; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	University of Eastern Finland; University of Eastern Finland; University of Helsinki; University of Helsinki; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford	Laakso, M (corresponding author), Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland.	Markku.Laakso@kuh.fi	Otonkoski, Timo/F-1189-2011	Reimann, Frank/0000-0001-9399-6377				Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; AYNSLEYGREEN A, 1981, ARCH DIS CHILD, V56, P496, DOI 10.1136/adc.56.7.496; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; DORIA A, 2000, CURR OPIN ENDOCRINOL, V7, P203; Efanova IB, 1998, J BIOL CHEM, V273, P33501, DOI 10.1074/jbc.273.50.33501; Glaser B, 1999, DIABETES, V48, P1652, DOI 10.2337/diabetes.48.8.1652; Goksel DL, 1998, HUM GENET, V103, P280, DOI 10.1007/s004390050817; Hansen T, 1998, DIABETES, V47, P598, DOI 10.2337/diabetes.47.4.598; Huopio H, 2000, J CLIN INVEST, V106, P897, DOI 10.1172/JCI9804; Inoue H, 1996, DIABETES, V45, P825, DOI 10.2337/diabetes.45.6.825; Ishiyama-Shigemoto S, 1998, DIABETIC MED, V15, P826, DOI 10.1002/(SICI)1096-9136(199810)15:10<826::AID-DIA685>3.0.CO;2-H; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Lehto M, 1997, J CLIN INVEST, V99, P582, DOI 10.1172/JCI119199; Lehto M, 1999, DIABETOLOGIA, V42, P1131, DOI 10.1007/s001250051281; LEIBOWITZ G, 1995, J CLIN ENDOCR METAB, V80, P386, DOI 10.1210/jc.80.2.386; Miki T, 1997, P NATL ACAD SCI USA, V94, P11969, DOI 10.1073/pnas.94.22.11969; Miki T, 2001, DIABETES, V50, pS48, DOI 10.2337/diabetes.50.2007.S48; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; RANKE M, 1996, TESTS BETA CELL FUNC, P448; Saltiel AR, 2000, J CLIN INVEST, V106, P163, DOI 10.1172/JCI10533; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Seino S, 2000, DIABETES, V49, P311, DOI 10.2337/diabetes.49.3.311; 't Hart LM, 1999, DIABETOLOGIA, V42, P617, DOI 10.1007/s001250051203; Vauhkonen I, 1998, J CLIN INVEST, V101, P86, DOI 10.1172/JCI716; Weisnagel SJ, 2001, DIABETES, V50, P697, DOI 10.2337/diabetes.50.3.697; *WHO, 1985, DIAB MELL, P10	28	120	129	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2003	361	9354					301	307		10.1016/S0140-6736(03)12325-2	http://dx.doi.org/10.1016/S0140-6736(03)12325-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559865				2022-12-28	WOS:000180643900012
J	Martin, RM; Sterne, JAC; Gunnell, D; Ebrahim, S; Smith, GD; Frankel, S				Martin, RM; Sterne, JAC; Gunnell, D; Ebrahim, S; Smith, GD; Frankel, S			NHS waiting lists and evidence of national or local failure: analysis of health service data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SURGERY; TIMES; STRATEGY; LESSONS; DEMAND; CARE	Objectives To investigate the national distribution of prolonged waiting for elective day case and inpatient surgery, and to examine associations of prolonged waiting with markers of NHS capacity, activity in the independent sector, and need. Setting NHS hospital trusts in England. Population People waiting for elective treatment in the specialties of general surgery; ear, nose and throat surgery; ophthalmic surgery; and trauma and orthopaedic surgery. Main outcome measure Numbers of people waiting six months or longer (prolonged waiting). Characteristics of trusts with large numbers waiting six months or longer were examined by using logistic regression. Results The distribution of numbers of people waiting for day case or elective surgery in all the specialties examined was highly positively skewed. Between 52% and 83% of patients waiting longer than six months in the specialties studied were found in one quarter of trusts, which in turn contributed 23-451% of the national throughput specific to the specialty. In general, there was little evidence to show that capacity (measured by numbers of operating theatres, dedicated day case theatres, available beds, and bed occupancy rate) or independent sector activity were associated with prolonged waiting, although exceptions were noted for individual specialties. There was consistent evidence showing an increase in prolonged waiting, with increased numbers of anaesthetists across all specialties and with increased bed occupancy rates for car, nose, and throat surgery. Markers of greater need for health care, such as deprivation score and rate of limiting long term illness, were inversely associated with prolonged waiting. Conclusion In most instances, substantial numbers of patients waiting unacceptably long periods for elective surgery were limited to a small number of hospitals. Little and inconsistent support was found for associations of prolonged waiting with markers of capacity, independent sector activity, or need in the surgical specialties examined.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol	Frankel, S (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	stephen.frankel@bristol.ac.uk	Sterne, Jonathan/Z-3106-2019; Gunnell, David/ABE-6653-2020; Davey Smith, George/A-7407-2013	Sterne, Jonathan/0000-0001-8496-6053; Gunnell, David/0000-0002-0829-6470; Davey Smith, George/0000-0002-1407-8314				Armstrong PW, 2000, STAT MED, V19, P2037, DOI 10.1002/1097-0258(20000815)19:15<2037::AID-SIM606>3.0.CO;2-R; BENSHLOMO Y, 1995, J EPIDEMIOL COMMUN H, V49, P200, DOI 10.1136/jech.49.2.200; Bosch X, 1998, BRIT MED J, V316, P885; CARRHILL RA, 1994, BRIT MED J, V309, P1046, DOI 10.1136/bmj.309.6961.1046; CLARKE A, 1992, BRIT MED J, V305, P1307, DOI 10.1136/bmj.305.6865.1307; Clover KA, 1998, MED J AUSTRALIA, V169, P464, DOI 10.5694/j.1326-5377.1998.tb123367.x; CROMWELL J, 1986, J HEALTH ECON, V5, P293, DOI 10.1016/0167-6296(86)90006-8; DeCoster C, 1999, MED CARE, V37, pJS187, DOI 10.1097/00005650-199906001-00016; *DEP HLTH, 1999, NHS WAIT TIM; *DEP HLTH, 2002, NHS PERF RAT IND; *DEP HLTH, 1999, GETT PAT TREAT WAIT; *DEP HLTH, 2000, NHS PLAN; Department of Health, 2001, NHS PERF IND CONS; Derrett S, 1999, INT J QUAL HEALTH C, V11, P47, DOI 10.1093/intqhc/11.1.47; Frankel S, 2000, BMJ-BRIT MED J, V321, P40, DOI 10.1136/bmj.321.7252.40; Frankel S, 1999, LANCET, V353, P1304, DOI 10.1016/S0140-6736(98)06451-4; FRANKEL S, 1993, RATIONING RATIONALIT; Fricker J, 1999, BRIT MED J, V318, P78, DOI 10.1136/bmj.318.7176.78; Grouden M, 1998, IRISH MED J, V91, P90; Hemingway H, 2000, LANCET, V355, P985, DOI 10.1016/S0140-6736(00)90018-7; HOPPER C, 1999, J EPIDEMIOL COMMUNIT, V53, P661; Long J. S., 1997, REGRESSION MODELS CA, P217; MORRIS RR, 1989, BRIT MED J, V297, P599; NIINIMAKI T, 1991, ACTA ORTHOP SCAND, V62, P42, DOI 10.3109/17453679109155106; Pell JP, 2000, BRIT MED J, V320, P15, DOI 10.1136/bmj.320.7226.15; POPE C, 1992, BRIT MED J, V305, P577, DOI 10.1136/bmj.305.6853.577; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; SMITH T, 1994, BRIT MED J, V309, P593, DOI 10.1136/bmj.309.6954.593; Steensen J P, 1992, Ugeskr Laeger, V154, P647	29	30	31	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2003	326	7382					188	192A		10.1136/bmj.326.7382.188	http://dx.doi.org/10.1136/bmj.326.7382.188			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640LD	12543833	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000180689600015
J	Zeineh, MM; Engel, SA; Thompson, PM; Bookheimer, SY				Zeineh, MM; Engel, SA; Thompson, PM; Bookheimer, SY			Dynamics of the hippocampus during encoding and retrieval of face-name pairs	SCIENCE			English	Article							EVENT-RELATED FMRI; SPATIAL MEMORY DEFICITS; RECOGNITION MEMORY; FUNCTIONAL MRI; PARAHIPPOCAMPAL CORTEX; PREFRONTAL CORTEX; BRAIN ACTIVITY; HUMANS; ACTIVATIONS; LESIONS	The medial temporal lobe (MTL) is critical in forming new memories, but how subregions within the MTL carry out encoding and retrieval processes in humans is unknown. Using new high-resolution functional magnetic resonance imaging (fMRI) acquisition and analysis methods, we identified mnemonic properties of different subregions within the hippocampal circuitry as human subjects learned to associate names with faces. The cornu ammonis (CA) fields 2 and 3 and the dentate gyrus were active relative to baseline only during encoding, and this activity decreased as associations were learned. Activity in the subiculum showed the same temporal decline, but primarily during retrieval. Our results demonstrate that subdivisions within the hippocampus make distinct contributions to new memory formation.	Univ Calif Los Angeles, Sch Med, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Med Scientist Training Program, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Neurol, Lab Neuroimaging, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bookheimer, SY (corresponding author), Univ Calif Los Angeles, Sch Med, Ahmanson Lovelace Brain Mapping Ctr, 660 Charles Young Dr S, Los Angeles, CA 90095 USA.		Thompson, Paul M/C-4194-2018	Thompson, Paul M/0000-0002-4720-8867; Bookheimer, Susan/0000-0002-3417-5891; Zeineh, Michael/0000-0002-6940-9096	NIA NIH HHS [AG 13308] Funding Source: Medline; NIMH NIH HHS [MH12167] Funding Source: Medline; OHS HRSA HHS [MSTP GM08042] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG013308] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OHS HRSA HHS; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Amaral DG, 1990, HUMAN NERVOUS SYSTEM, P711; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buckner RL, 1998, NEUROIMAGE, V7, P163, DOI 10.1006/nimg.1998.0328; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Clark RE, 2002, J NEUROSCI, V22, P4663, DOI 10.1523/JNEUROSCI.22-11-04663.2002; Crane J, 2002, NEUROPSYCHOLOGIA, V40, P530, DOI 10.1016/S0028-3932(01)00131-2; Donaldson DI, 2001, NEUROIMAGE, V13, P129, DOI 10.1006/nimg.2000.0664; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Lepage M, 1998, HIPPOCAMPUS, V8, P313, DOI 10.1002/(SICI)1098-1063(1998)8:4<313::AID-HIPO1>3.0.CO;2-I; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; McDermott KB, 2000, J COGNITIVE NEUROSCI, V12, P965, DOI 10.1162/08989290051137503; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; Ploner CJ, 2000, CEREB CORTEX, V10, P1211, DOI 10.1093/cercor/10.12.1211; Rolls ET, 1996, HIPPOCAMPUS, V6, P601, DOI 10.1002/(SICI)1098-1063(1996)6:6<601::AID-HIPO5>3.0.CO;2-J; Rugg MD, 1999, NEUROIMAGE, V10, P520, DOI 10.1006/nimg.1999.0488; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; Sperling RA, 2001, HUM BRAIN MAPP, V14, P129, DOI 10.1002/hbm.1047; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Thompson PM, 2000, HUM BRAIN MAPP, V9, P81, DOI 10.1002/(SICI)1097-0193(200002)9:2<81::AID-HBM3>3.0.CO;2-8; THOMPSON PM, 1998, BRAIN WARPING, P311; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Zeineh MM, 2000, NEUROIMAGE, V11, P668, DOI 10.1006/nimg.2000.0561; Zeineh MM, 2001, ANAT RECORD, V265, P111, DOI 10.1002/ar.1061	28	384	393	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					577	580		10.1126/science.1077775	http://dx.doi.org/10.1126/science.1077775			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543980				2022-12-28	WOS:000180559800054
J	Chakravarti, A; Little, P				Chakravarti, A; Little, P			Nature, nurture and human disease	NATURE			English	Article								What has been learnt about individual human biology and common diseases 50 years on from the discovery of the structure of DNA? Unfortunately the double helix has not, so far, revealed as much as one would have hoped. The primary reason is an inability to determine how nurture fits into the DNA paradigm. We argue here that the environment exerts its influence at the DNA level and so will need to be understood before the underlying causal factors of common human diseases can be fully recognized.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	Johns Hopkins University; University of New South Wales Sydney	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, 600 N Wolfe St,Jefferson St Bldg 2-109, Baltimore, MD 21287 USA.							Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Arcos-Burgos M, 2002, CLIN GENET, V61, P233, DOI 10.1034/j.1399-0004.2002.610401.x; Boyle JP, 2001, DIABETES CARE, V24, P1936, DOI 10.2337/diacare.24.11.1936; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Chakravarti A, 2001, NATURE, V409, P822, DOI 10.1038/35057281; Cox NJ, 2001, HUM MOL GENET, V10, P2301, DOI 10.1093/hmg/10.20.2301; Evans WE, 2001, ANNU REV GENOM HUM G, V2, P9, DOI 10.1146/annurev.genom.2.1.9; Jaroff Leon, 1989, Time, V133, P62; Lown KS, 1997, J CLIN INVEST, V99, P2545, DOI 10.1172/JCI119439; MacGregor AJ, 2000, TRENDS GENET, V16, P131, DOI 10.1016/S0168-9525(99)01946-0; Munger K, 2002, CANCER INVEST, V20, P71, DOI 10.1081/CNV-120000369; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Stucker I, 2002, CARCINOGENESIS, V23, P1475, DOI 10.1093/carcin/23.9.1475; Sullivan PF, 2001, AM J MED GENET, V105, P266, DOI 10.1002/ajmg.1324; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Wertz DC, 2002, NAT REV GENET, V3, P496, DOI 10.1038/nrg854; Wright A. F., 2002, Pharmacogenomics Journal, V2, P75, DOI 10.1038/sj.tpj.6500085	17	100	106	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					412	414		10.1038/nature01401	http://dx.doi.org/10.1038/nature01401			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540911	Bronze			2022-12-28	WOS:000180533000052
J	Friedberg, EC				Friedberg, EC			DNA damage and repair	NATURE			English	Article							XERODERMA-PIGMENTOSUM; DEOXYRIBONUCLEIC-ACID; COLORECTAL-CANCER; EUKARYOTES; HOMOLOG; CELLS	The aesthetic appeal of the DNA double helix initially hindered notions of DNA mutation and repair, which would necessarily interfere with its pristine state. But it has since been recognized that DNA is subject to continuous damage and the cell has an arsenal of ways of responding to such injury. Although mutations or deficiencies in repair can have catastrophic consequences, causing a range of human diseases, mutations are nonetheless fundamental to life and evolution.	Univ Texas, SW Med Ctr, Dept Pathol, Lab Mol Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Friedberg, EC (corresponding author), Univ Texas, SW Med Ctr, Dept Pathol, Lab Mol Pathol, Dallas, TX 75390 USA.	friedberg.errol@pathology.swmed.edu						AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Boveri T, 1929, ORIGIN MALIGNANT TUM; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; CRICK F, 1974, NATURE, V248, P766, DOI 10.1038/248766a0; DEWEERDK.EA, 1972, NATURE-NEW BIOL, V238, P80, DOI 10.1038/newbio238080a0; DULBECCO R, 1949, NATURE, V163, P949, DOI 10.1038/163949b0; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Freidberg E. C., 1997, CORRECTING BLUEPRINT; Friedberg EC, 2002, DNA REPAIR, V1, P855, DOI 10.1016/S1568-7864(02)00112-X; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; HANAWALT PC, 1967, SCI AM, V216, P36, DOI 10.1038/scientificamerican0267-36; Hollaender A, 1935, P SOC EXP BIOL MED, V33, P61; KELNER A, 1949, P NATL ACAD SCI USA, V35, P73, DOI 10.1073/pnas.35.2.73; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LEVINSON G, 1987, NUCLEIC ACIDS RES, V15, P5323, DOI 10.1093/nar/15.13.5323; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Masutani C, 2000, COLD SPRING HARB SYM, V65, P71, DOI 10.1101/sqb.2000.65.71; Muller H J, 1927, Science, V66, P84, DOI 10.1126/science.66.1699.84; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Pontecorvo G., 1958, TRENDS GENETIC ANAL; RASMUSSEN RE, 1964, NATURE, V203, P1360, DOI 10.1038/2031360a0; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SETLOW RB, 1964, P NATL ACAD SCI USA, V51, P226, DOI 10.1073/pnas.51.2.226; Timofeeff-Ressovsky N. W., 1935, Nachrichten von der Gesellschaft der Wissenschaften zu Gottingen, V1, P189; Vogelstein B., 1998, GENETIC BASIS HUMAN; Watson J.D., 1968, DOUBLE HELIX PERSONA; WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; ZIMMER KG, 1992, PHAGE ORIGINS MOL BI	34	656	679	1	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					436	440		10.1038/nature01408	http://dx.doi.org/10.1038/nature01408			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540918	Bronze			2022-12-28	WOS:000180533000059
J	Gatenby, RA; Maini, PK				Gatenby, RA; Maini, PK			Mathematical oncology: Cancer summed up	NATURE			English	Editorial Material							MODEL		Univ Arizona, Dept Radiol, Tucson, AZ 85724 USA; Univ Arizona, Dept Appl Math, Tucson, AZ 85724 USA; Math Inst, Ctr Math Biol, Oxford OX1 3LB, England	University of Arizona; University of Arizona; University of Oxford	Gatenby, RA (corresponding author), Univ Arizona, Dept Radiol, Tucson, AZ 85724 USA.							ADAM JA, 1996, SURVEY MODELS TUMOUR; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gatenby RA, 1996, CANCER RES, V56, P5745; Keener J., 1998, MATH PHYSL	4	151	156	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					321	321		10.1038/421321a	http://dx.doi.org/10.1038/421321a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540881	Bronze			2022-12-28	WOS:000180533000023
J	Moore, T; Armstrong, KM				Moore, T; Armstrong, KM			Selective gating of visual signals by microstimulation of frontal cortex	NATURE			English	Article							SACCADIC EYE-MOVEMENTS; SPATIAL ATTENTION; CORTICAL AREAS; MACAQUE; FIELDS; V4; REPRESENTATIONS; STIMULATION; TOPOGRAPHY; PRIMATES	Several decades of psychophysical and neurophysiological studies have established that visual signals are enhanced at the locus of attention(1-5). What remains a mystery is the mechanism that initiates biases in the strength of visual representations(6). Recent evidence argues that, during spatial attention, these biases reflect nascent saccadic eye movement commands(7,8). We examined the functional interaction of saccade preparation and visual coding by electrically stimulating sites within the frontal eye fields (FEF) and measuring its effect on the activity of neurons in extrastriate visual cortex. Here we show that visual responses in area V4 could be enhanced after brief stimulation of retinotopically corresponding sites within the FEF using currents below that needed to evoke saccades. The magnitude of the enhancement depended on the effectiveness of receptive field stimuli as well as on the presence of competing stimuli outside the receptive field. Stimulation of non-corresponding FEF representations could suppress V4 responses. The results suggest that the gain of visual signals is modified according to the strength of spatially corresponding eye movement commands.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University	Moore, T (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.							Blaser E, 1999, P NATL ACAD SCI USA, V96, P11681, DOI 10.1073/pnas.96.20.11681; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Burman DD, 1997, J NEUROPHYSIOL, V77, P2252, DOI 10.1152/jn.1997.77.5.2252; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; GODOY J, 1990, NEUROLOGY, V40, P296, DOI 10.1212/WNL.40.2.296; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Moore T, 1999, SCIENCE, V285, P1914, DOI 10.1126/science.285.5435.1914; Moore T, 1998, P NATL ACAD SCI USA, V95, P8981, DOI 10.1073/pnas.95.15.8981; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Nakamura K, 1999, J NEUROPHYSIOL, V81, P2374, DOI 10.1152/jn.1999.81.5.2374; Penfield W., 1950, CEREBRAL CORTEX MAN; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Schiller PH, 2001, PROG BRAIN RES, V134, P127; SHEPHERD M, 1986, Q J EXP PSYCHOL-A, V38, P475, DOI 10.1080/14640748608401609; SPERLING G, 1978, SCIENCE, V202, P315, DOI 10.1126/science.694536; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; VANHOOFF JAR, 1972, NONVERBAL COMMUNICAT, pCH7; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Zipser K, 1996, J NEUROSCI, V16, P7376	26	824	830	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					370	373		10.1038/nature01341	http://dx.doi.org/10.1038/nature01341			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540901				2022-12-28	WOS:000180533000042
J	Olby, R				Olby, R			Quiet debut for the double helix	NATURE			English	Article							DEOXYRIBONUCLEIC-ACID; ESCHERICHIA-COLI; DNA	Past discoveries usually become aggrandized in retrospect, especially at jubilee celebrations, and the double helix is no exception. The historical record reveals a muted response by the scientific community to the proposal of this structure in 1953. Indeed, it was only when the outlines appeared of a mechanism for DNA's involvement in protein synthesis that the biochemical community began to take a serious interest in the structure.	Univ Pittsburgh, Dept Hist & Philosophy Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Olby, R (corresponding author), Univ Pittsburgh, Dept Hist & Philosophy Sci, 1017 Cathedral Learning, Pittsburgh, PA 15260 USA.	olbyr+@pitt.edu						Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; CALDER R, 1953, NEWS CHRONIDE   0515, P1; CAMPBELL PN, 1953, NATURE, V171, P997, DOI 10.1038/171997a0; CRICK F H, 1958, Symp Soc Exp Biol, V12, P138; CRICK FH, 1961, NATURE, V192, P1227, DOI 10.1038/1921227a0; CRICK FHC, 1954, PROC R SOC LON SER-A, V223, P80, DOI 10.1098/rspa.1954.0101; DOUNCE A L, 1952, Enzymologia, V15, P251; FRANKLIN RE, 1953, NATURE, V172, P156, DOI 10.1038/172156a0; FRANKLIN RE, 1953, NATURE, V171, P740, DOI 10.1038/171740a0; Fruton JS, 1958, GEN BIOCH; HERSHEY AD, 1952, J GEN PHYSIOL, V36, P39, DOI 10.1085/jgp.36.1.39; JACOBSON B, 1953, NATURE, V172, P666, DOI 10.1038/172666a0; KORNBERG A, 1960, SCIENCE, V131, P1503, DOI 10.1126/science.131.3412.1503; KORNBERG A, 1957, S CHEM BAS HER, P605; Kornberg A., 1989, LOVE ENZYMES ODYSSEY; LEHMAN IR, 1958, J BIOL CHEM, V233, P163; MADDOX B., 2002, R FRANKLIN DARK LADY; MESELSON M, 1958, P NATL ACAD SCI USA, V44, P671, DOI 10.1073/pnas.44.7.671; NIRENBERG MW, 1961, P NATL ACAD SCI USA, V47, P1558; SINSHEIMER RL, 1957, SCIENCE, V125, P1123, DOI 10.1126/science.125.3258.1123; Watson J D, 1980, DOUBLE HELIX PERSONA; WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0; WATSON JD, 1953, COLD SPRING HARB SYM, V18, P123, DOI 10.1101/SQB.1953.018.01.020; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WILKINS MHF, 1953, NATURE, V171, P738, DOI 10.1038/171738a0; WILKINS MHF, 1953, NATURE, V172, P759, DOI 10.1038/172759b0	26	33	37	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					402	405		10.1038/nature01397	http://dx.doi.org/10.1038/nature01397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540907	Bronze			2022-12-28	WOS:000180533000048
J	Sudlow, CLM; Counsell, CE				Sudlow, CLM; Counsell, CE			Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; SECONDARY PROGRESSIVE MS; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; INTERFERON BETA-1B; GLATIRAMER ACETATE; NATURAL-HISTORY; CLINICAL-TRIALS; FINAL REPORT; RELAPSE RATE	The government plans to make interferon beta and glatiramer available to patients with multiple sclerosis through a risk sharing scheme, despite lack of evidence of cost effectiveness. Sudlow and colleagues argue that the money would be better spent on independent research.	Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; Aberdeen Royal Infirm, Dept Neurol, Aberdeen AB25 2ZN, Scotland	University of Edinburgh; University of Aberdeen	Sudlow, CLM (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	csudlow@skull.dcn.ed.ac.uk		Sudlow, Cathie/0000-0002-7725-7520	Wellcome Trust [063668] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		*ASS BRIT NEUR, 2001, GUID US BET INT GLAT; *ASS BRIT NEUR WOR, 2002, AC NEUR EM AD; BORNSTEIN MB, 1991, NEUROLOGY, V41, P533, DOI 10.1212/WNL.41.4.533; BORNSTEIN MB, 1987, NEW ENGL J MED, V317, P408, DOI 10.1056/NEJM198708133170703; CLEGG A, 2000, HLTH TECHNOLOGY ASSE, V4; Collins R, 1996, OXFORD TXB MED, V1, P21; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64.abs; Confavreux C, 1996, NEUROLOGY, V46, P1607, DOI 10.1212/WNL.46.6.1607; Department of Health, 2002, 2002004 DEP HLTH HLT; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; ELLISON GW, 1989, NEUROLOGY, V39, P1018, DOI 10.1212/WNL.39.8.1018; GHEZZI A, 1989, INT CONGR SER, V863, P345; GOODKIN DE, 1991, NEUROLOGY, V41, P20, DOI 10.1212/WNL.41.1.20; Goodkin DE, 2000, NEUROLOGY, V54, P2352; HUGHES RAC, 1988, LANCET, V2, P179; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Johnson KP, 1998, NEUROLOGY, V50, P701, DOI 10.1212/WNL.50.3.701; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; King J, 2001, NEUROLOGY, V56, P1496; KINLEN LJ, 1985, AM J MED, V78, P44, DOI 10.1016/0002-9343(85)90245-1; Kremenchutzky M, 1999, BRAIN, V122, P1941, DOI 10.1093/brain/122.10.1941; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; MERTIN J, 1982, LANCET, V2, P351; MILANESE C, 1993, J NEUROL, V240, P295, DOI 10.1007/BF00838165; *MS STUD GROUP, 1999, LANCET, V53, P679; *NAT I CLIN EXC, BET INT GLAT AC TREA; *NO YORKSH REG DRU, 2000, ASS INT GLAT TREATM; NOSEWORTHY JH, 1994, NEUROLOGY, V44, P16, DOI 10.1212/WNL.44.1.16; Rice G, 1998, ARCH NEUROL-CHICAGO, V55, P1578, DOI 10.1001/archneur.55.12.1578; Rice GP, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002002; Rudick RA, 1997, NEUROLOGY, V49, P358, DOI 10.1212/WNL.49.2.358; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; SWINBURN WR, 1973, J NEUROL NEUROSUR PS, V36, P124, DOI 10.1136/jnnp.36.1.124; Tappenden P, 2001, COST EFFECTIVENESS B; WEINSHENKER BG, 1991, BRAIN, V114, P1045, DOI 10.1093/brain/114.2.1045; YUDKIN PL, 1991, LANCET, V338, P1051, DOI 10.1016/0140-6736(91)91909-E	42	50	50	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2003	326	7385					388	392		10.1136/bmj.326.7385.388	http://dx.doi.org/10.1136/bmj.326.7385.388			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648RZ	12586677	Green Submitted, Green Published			2022-12-28	WOS:000181165500027
J	Willison, DJ; Keshavjee, K; Nair, K; Goldsmith, C; Holbrook, AM				Willison, DJ; Keshavjee, K; Nair, K; Goldsmith, C; Holbrook, AM		COMPETE investigators	Patients' consent preferences for research uses of information in electronic medical records: interview and survey data	BRITISH MEDICAL JOURNAL			English	Article								Objectives To assess patients' preferred method of consent for use of information from electronic medical records for research. Design Interviews and a structured survey of patients in practices with electronic medical records. Setting Family practices in southern Ontario, Canada. Participants 123 patients: 17 were interviewed and 106 completed a survey. Main outcome measures Patients' opinions and concerns on use of information from their medical records for research and their preferences for method of consent. Results Most interviewees were willing to allow the use of their information for research purposes, although the majority preferred that consent was sought first. The seeking of consent was considered an important element of respect for the individual. Most interviewees made little distinction between identifiable and anonymised data. Research sponsored by private insurance firms generated the greatest concern, and research sponsored by foundation the least. Sponsorship by drug companies evoked negative responses during interview and positive responses in the survey. Conclusions Patients are willing to allow information from their medical records to be used for research, but most prefer to be asked for consent either verbally or in writing.	McMaster Univ, Fac Hlth Sci, Ctr Evaluat Med, Hamilton, ON L8N 1G6, Canada	McMaster University	Willison, DJ (corresponding author), McMaster Univ, Fac Hlth Sci, Ctr Evaluat Med, 105 Main St E,P1, Hamilton, ON L8N 1G6, Canada.			Keshavjee, Karim/0000-0003-1317-7035				*CAN I HLTH RES, 2001, DISC DOC RES CIHR CO; *CAN I HLTH RES, 2001, REC INT APPL PERS IN; DeSario J., 1987, CITIZEN PARTICIPATIO; Dunkerley D, 1998, CRITICAL PUBLIC HLTH, V8, P181, DOI DOI 10.1080/09581599808402906; KOSSEIM P, 2000, COMP CAN LEG RESP PR; KOSSEIM P, 2000, COMPENDIUM CANADIAN; Mandl KD, 2001, BMJ-BRIT MED J, V322, P283, DOI 10.1136/bmj.322.7281.283; Mitchell E, 2001, BMJ-BRIT MED J, V322, P279, DOI 10.1136/bmj.322.7281.279; MORGAN R, 2001, PRIVACY COMMUNITY; *POL PLANN DIV SAS, 1998, CONS PAP PROT PERS H; Upshur REG, 2001, CAN MED ASSOC J, V165, P307; Willison D., 2001, USE ELECT MED RECORD; Woodward B, 1999, JAMA-J AM MED ASSOC, V282, P1947, DOI 10.1001/jama.282.20.1947; 1999, CANADIANS CONFIDENTI	14	71	72	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2003	326	7385					373	376		10.1136/bmj.326.7385.373	http://dx.doi.org/10.1136/bmj.326.7385.373			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648RZ	12586673	Green Published, Bronze			2022-12-28	WOS:000181165500023
J	Steinman, MA; Landefeld, CS; Gonzales, R				Steinman, MA; Landefeld, CS; Gonzales, R			Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE BRONCHITIS; PATIENTS EXPECTATIONS; EDUCATIONAL OUTREACH; PHYSICIANS BEHAVIOR; CLINICAL-PRACTICE; CONTROLLED TRIAL; DRUG COMPANIES; PERCEPTIONS; PRESCRIPTION; PRINCIPLES	Context Broad-spectrum antibiotics are commonly prescribed, but little is known about the physicians who prescribe and the patients who take these agents. Objective To identify factors associated with prescribing of broad-spectrum antibiotics by physicians caring for patients with nonpneumonic acute respiratory tract infections (ARTIs). Design, Setting, and Patients Cross-sectional study using data from the National Ambulatory Medical Care Survey between 1997 and 1999. Information was collected on a national sample of 1981 adults seen by physicians for the common cold and nonspecific upper respiratory tract infections (URTIs) (24%), acute sinusitis (24%), acute bronchitis (23%), otitis media (5%), pharyngitis, laryngitis, and tracheitis (11%), or more than 1 of the above diagnoses (13%). Main Outcome Measure Prescription of broad-spectrum antibiotics, defined for this study as quinolones; amoxicillin/clavulanate, second- and third-generation cephalosporins, and azithromycin and clarithromycin. Results, Antibiotics were prescribed to 63% of patients with an ARTI, ranging from 46% of patients with,the common cold or nonspecific URTIs to 69% of patients with acute sinusitis. Broad-spectrum agents were chosen in 54% of patients prescribed an antibiotic, including 51% of patients with the common cold and nonspecific URTIs, 53% with acute sinusitis, 62% with acute bronchitis, and 65% with otitis media. Multivariable analysis identified several clinical and nonclinical factors associated with choice of a broad-spectrum agent. After adjusting for diagnosis and chronic comorbid illnesses, the strongest independent predictors of broad-spectrum antibiotic prescribing were physician specialty (odds ratio [OR], 2.4; 95% confidence interval [CI], 1.6-3.5 for internal medicine physicians compared with general and family physicians) and geographic region (OR, 2.6; 95% CI, 1.4-4.8 for Northeast and OR, 2.4; 95% CI, 1.4-4.2 for South [both compared with West]). Other independent predictors of choosing a broad-spectrum agent included black race, lack of health insurance, and health maintenance organization membership, each of which was associated with lower rates of broad-spectrum prescribing. Patient age, sex, and urban vs rural location were not significantly associated with prescribing choice. Conclusions Broad-spectrum antibiotics are commonly prescribed for the treatment of ARTIs, especially by internists and physicians in the Northeast and South. These high rates of prescribing, wide variations in practice patterns, and the strong association of nonclinical factors with antibiotic choice suggest opportunities to improve prescribing patterns.	San Francisco VA Med Ctr, Div Geriatr, San Francisco, CA 94121 USA; San Francisco VA Med Ctr, VA Natl Qual Scholars Program, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Steinman, MA (corresponding author), San Francisco VA Med Ctr, Div Geriatr, 4150 Clement St,Box 181-G, San Francisco, CA 94121 USA.							Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Avery AJ, 1997, BRIT J GEN PRACT, V47, P810; Avorn J, 2000, ANN INTERN MED, V133, P128, DOI 10.7326/0003-4819-133-2-200007180-00012; AVORN J, 1983, NEW ENGL J MED, V308, P1457, DOI 10.1056/NEJM198306163082406; Bell RA, 1999, J FAM PRACTICE, V48, P446; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; CARRIN G, 1987, HEALTH POLICY, V7, P73, DOI 10.1016/0168-8510(87)90048-0; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P800; Chew LD, 2000, J GEN INTERN MED, V15, P478, DOI 10.1046/j.1525-1497.2000.08014.x; CHREN MM, 1989, JAMA-J AM MED ASSOC, V262, P3448, DOI 10.1001/jama.262.24.3448; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; Cockburn J, 1997, BRIT MED J, V315, P520, DOI 10.1136/bmj.315.7107.520; EPSTEIN AM, 1984, AM J MED, V77, P313, DOI 10.1016/0002-9343(84)90709-5; Gonzales R, 1998, J GEN INTERN MED, V13, P541, DOI 10.1046/j.1525-1497.1998.00165.x; Gonzales R, 2001, CLIN INFECT DIS, V33, P757, DOI 10.1086/322627; Gonzales R, 1999, J GEN INTERN MED, V14, P151, DOI 10.1046/j.1525-1497.1999.00306.x; Gonzales R, 1999, JAMA-J AM MED ASSOC, V281, P1512, DOI 10.1001/jama.281.16.1512; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; Hadley J, 1999, HEALTH SERV RES, V34, P307; Hamm RM, 1996, J FAM PRACTICE, V43, P56; Harrold LR, 1999, J GEN INTERN MED, V14, P499, DOI 10.1046/j.1525-1497.1999.08168.x; Hasty M, 1999, J GEN INTERN MED, V14, P756, DOI 10.1046/j.1525-1497.1999.04099.x; HEMMINKI E, 1975, SOC SCI MED, V9, P111, DOI 10.1016/0037-7856(75)90103-1; Hutchinson JM, 1999, CAN MED ASSOC J, V160, P1013; Hyde TB, 2001, JAMA-J AM MED ASSOC, V286, P1857, DOI 10.1001/jama.286.15.1857; Ioannidis JPA, 2001, J ANTIMICROB CHEMOTH, V48, P677, DOI 10.1093/jac/48.5.677; Lambert BL, 1997, SOC SCI MED, V45, P1767, DOI 10.1016/S0277-9536(97)00108-1; Linder JA, 2001, JAMA-J AM MED ASSOC, V286, P1181, DOI 10.1001/jama.286.10.1181; LURIE N, 1990, J GEN INTERN MED, V5, P240, DOI 10.1007/BF02600542; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; Mainous AG, 1998, ARCH PEDIAT ADOL MED, V152, P349; Mainous AG, 1997, LANCET, V350, P1077, DOI 10.1016/S0140-6736(05)70457-8; Mather J. L., 1994, Canadian Journal of Hospital Pharmacy, V47, P111; McCaig LF, 2002, JAMA-J AM MED ASSOC, V287, P3096, DOI 10.1001/jama.287.23.3096; Metlay JP, 1998, ARCH INTERN MED, V158, P1813, DOI 10.1001/archinte.158.16.1813; Metlay JP, 2002, J GEN INTERN MED, V17, P87, DOI 10.1046/j.1525-1497.2002.10711.x; *NAT CTR HLTH STAT, 2001, PUBL US MICR FIL DOC; *NAT CTR HLTH STAT, 2000, PUBL US MICR FIL DOC; *NAT CTR HLTH STAT, 1999, PUBL US MICR FIL DOC; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Piccirillo JF, 2001, JAMA-J AM MED ASSOC, V286, P1849, DOI 10.1001/jama.286.15.1849; Reschovsky J, 2001, MED CARE, V39, P254, DOI 10.1097/00005650-200103000-00006; Rosenthal MB, 2002, NEW ENGL J MED, V346, P498, DOI 10.1056/NEJMsa012075; SAFAVI KT, 1992, J GEN INTERN MED, V7, P32, DOI 10.1007/BF02599099; SCHWARTZ RK, 1989, SOC SCI MED, V28, P577, DOI 10.1016/0277-9536(89)90252-9; Snow V, 2001, ANN INTERN MED, V134, P518, DOI 10.7326/0003-4819-134-6-200103200-00020; Snow V, 2001, ANN INTERN MED, V134, P487, DOI 10.7326/0003-4819-134-6-200103200-00014; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; Soumerai SB, 2000, PHARMACOEPIDEM DR S, P483; Takata GS, 2001, PEDIATRICS, V108, P239, DOI 10.1542/peds.108.2.239; *US DEP HHS, 1988, INT CLASS DIS 9 REV; Walker S, 2000, CAN MED ASSOC J, V163, P273; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Wilkes MS, 2000, HEALTH AFFAIR, V19, P110, DOI 10.1377/hlthaff.19.2.110; ZIEGLER MG, 1995, JAMA-J AM MED ASSOC, V273, P1296, DOI 10.1001/jama.273.16.1296	58	210	214	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2003	289	6					719	725		10.1001/jama.289.6.719	http://dx.doi.org/10.1001/jama.289.6.719			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643WP	12585950	Bronze			2022-12-28	WOS:000180886000026
J	Bouvier, P				Bouvier, P			Child sexual abuse: vicious circles of fate or paths to resilience?	LANCET			English	Editorial Material									Serv Sante Jeunesse, CH-1211 Geneva 3, Switzerland		Bouvier, P (corresponding author), Serv Sante Jeunesse, CH-1211 Geneva 3, Switzerland.	paul.bouvier@etat.ge.ch		Bouvier, Paul/0000-0001-5198-9056				Aldwin C. M, 1994, STRESS COPING DEV IN, P331; Bentovim A, 2002, CHILD ABUSE NEGLECT, V26, P661, DOI 10.1016/S0145-2134(02)00340-X; Djeddah C, 2000, SOC SCI MED, V51, P905, DOI 10.1016/S0277-9536(00)00070-8; Dufour MH, 2000, CHILD ABUSE NEGLECT, V24, P781, DOI 10.1016/S0145-2134(00)00141-1; Ertem IO, 2000, LANCET, V356, P814, DOI 10.1016/S0140-6736(00)02656-8; Finkelhor D, 1995, AM J PUBLIC HEALTH, V85, P1684, DOI 10.2105/AJPH.85.12.1684; Gudjonsson GH, 2000, CHILD ABUSE NEGLECT, V24, P363, DOI 10.1016/S0145-2134(99)00150-7; Rutter ML, 1999, BRIT J PSYCHIAT, V174, P480, DOI 10.1192/bjp.174.6.480; World Health Organization, 2002, WORLD REPORT VIOLENC	10	14	16	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					446	447		10.1016/S0140-6736(03)12501-9	http://dx.doi.org/10.1016/S0140-6736(03)12501-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	644CP	12583939				2022-12-28	WOS:000180900600004
J	Impey, L; Reynolds, M; MacQuillan, K; Gates, S; Murphy, J; Sheil, O				Impey, L; Reynolds, M; MacQuillan, K; Gates, S; Murphy, J; Sheil, O			Admission cardiotocography: a randomised controlled trial	LANCET			English	Article							FETAL HEART-RATE; CEREBRAL-PALSY; LABOR; DISTRESS	Background Admission cardiotocography is widely used to identify pregnancies that might benefit from continuous electronic fetal monitoring in labour. We aimed to compare the effect on neonatal outcome of admission cardiotocography versus intermittent auscultation of the fetal heart rate. Methods 8580 women admitted to the delivery ward of a Dublin teaching hospital who were at low risk of fetal distress in labour were randomly assigned admission cardiotocography (20 min) or the unit's usual care (intermittent auscultation only, with continuous cardiotocography only if clinically indicated). The primary outcome was moderate to severe neonatal morbidity, or perinatal mortality in the absence of a major congenital malformation. Analyses were by intention to treat. Findings 44 (1.0%) women assigned admission cardiotocography did not undergo the procedure; 15 (0.4%) assigned usual care had admission cardiotocography. The primary endpoint occurred in 56 (1.3%) of 4298 women assigned admission cardiotocography and 55 (1.3%) of 4282 in the usual-care group (relative risk 1.01; 95% CI 0.70-1.47). Other indices of neonatal morbidity also showed no differences. Despite an increase in use of continuous cardiotocography (1.39; 1.33-1.45) and fetal blood sampling (1.30; 1.14-1.47) with admission cardiotocography, there were no significant differences in the rates of caesarean delivery (1.13; 0.92-1.40), instrumental delivery (1.03; 0.92-1.16), or episiotomy (1.06; 0.99-1.13). Interpretation Routine use of cardiotocography for 20 min on admission to the delivery ward does not improve neonatal outcome. No significant increase in operative delivery was apparent, probably because of liberal use of fetal blood sampling.	John Radcliffe Hosp, Womens Ctr, Oxford Fetomaternal Med Unit, Oxford OX3 9DU, England; Natl Matern Hosp, Dublin 2, Ireland; Inst Hlth Sci, Natl Perinatal Epidemiol Unit, Oxford, England	University of Oxford; National Maternity Hospital, Dublin; University of Oxford	Impey, L (corresponding author), John Radcliffe Hosp, Womens Ctr, Oxford Fetomaternal Med Unit, Level 4, Oxford OX3 9DU, England.	Lawrence.Impey@orh.nhs.uk						BLAIR E, 1988, J PEDIATR-US, V112, P515, DOI 10.1016/S0022-3476(88)80161-6; Blix E, 2001, ACTA OBSTET GYN SCAN, V80, P738, DOI 10.1034/j.1600-0412.2001.080008738.x; Golditch BD, 1998, AM J PERINAT, V15, P273, DOI 10.1055/s-2007-993941; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; Impey L, 2000, AM J OBSTET GYNECOL, V183, P438, DOI 10.1067/mob.2000.105899; Impey L, 1999, BRIT J OBSTET GYNAEC, V106, P183, DOI 10.1111/j.1471-0528.1999.tb08229.x; Impey L, 2001, BRIT J OBSTET GYNAEC, V108, P594, DOI 10.1111/j.1471-0528.2001.00145.x; INGEMARSSON I, 1986, OBSTET GYNECOL, V68, P800; MACDONALD D, 1985, AM J OBSTET GYNECOL, V152, P524, DOI 10.1016/0002-9378(85)90619-2; Mires G, 2001, BRIT MED J, V322, P1457, DOI 10.1136/bmj.322.7300.1457; *NAT I CLIN EXC, 2001, US EL FET MON INH CL; Nelson KB, 1996, NEW ENGL J MED, V334, P613, DOI 10.1056/NEJM199603073341001; PELLO LC, 1988, BRIT J OBSTET GYNAEC, V95, P1128, DOI 10.1111/j.1471-0528.1988.tb06790.x; PHELAN JP, 1994, CLIN PERINATOL, V21, P879, DOI 10.1016/S0095-5108(18)30324-5; RUTH VJ, 1988, BRIT MED J, V297, P24, DOI 10.1136/bmj.297.6640.24; *STAT OFF, 2000, 7 STAT OFF; STEER PJ, 1989, OBSTET GYNECOL, V74, P715; Swinscow TDV, 1996, STAT SQUARE ONE, V9th; THACKER SB, 2001, COCHRANE LIB	19	50	52	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					465	470		10.1016/S0140-6736(03)12464-6	http://dx.doi.org/10.1016/S0140-6736(03)12464-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583945				2022-12-28	WOS:000180900600010
J	Tassicker, R; Savulescu, J; Skene, L; Marshall, P; Fitzgerald, L; Delatycki, MB				Tassicker, R; Savulescu, J; Skene, L; Marshall, P; Fitzgerald, L; Delatycki, MB			Prenatal diagnosis requests for Huntington's disease when the father is at risk and does not want to know his genetic status: clinical, legal, and ethical viewpoints	BRITISH MEDICAL JOURNAL			English	Article									Royal Childrens Hosp, Genet Hlth Serv Victoria, Parkville, Vic 3052, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Univ Melbourne, Fac Law, Parkville, Vic 3052, Australia; Launceston Gen Hosp, Dept Psychiat, Launceston, Tas 7250, Australia	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Delatycki, MB (corresponding author), Royal Childrens Hosp, Genet Hlth Serv Victoria, Flemington Rd, Parkville, Vic 3052, Australia.		Delatycki, Martin B/A-5409-2013					Binedell J, 1998, CLIN GENET, V54, P477; Craufurd D, 1996, PRENATAL DIAG, V16, P1237, DOI 10.1002/(SICI)1097-0223(199612)16:13<1237::AID-PD98>3.0.CO;2-T; Decruyenaere M, 1996, J MED GENET, V33, P737, DOI 10.1136/jmg.33.9.737; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Myers RH, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P301; Richards F, 1997, AUST SOC WORK, V50, P61, DOI DOI 10.1080/03124079708415747; ROSE P, 1999, PRACTICAL GENETICS P; Savulescu J, 1997, J MED ETHICS, V23, P282, DOI 10.1136/jme.23.5.282; WENT L, 1994, J MED GENET, V31, P555	9	14	14	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2003	326	7384					331	333		10.1136/bmj.326.7384.331	http://dx.doi.org/10.1136/bmj.326.7384.331			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645UD	12574051	Green Published			2022-12-28	WOS:000180997000025
J	Culi, J; Mann, RS				Culi, J; Mann, RS			Boca, an endoplasmic reticulum protein required for wingless signaling and trafficking of LDL receptor family members in Drosophila	CELL			English	Article							LONG-RANGE ACTION; VITELLOGENIN RECEPTOR; GENOME SEQUENCE; VESTIGIAL GENE; IN-VIVO; POLARITY; MELANOGASTER; TRANSDUCTION; EXPRESSION; HOMOLOG	The maturation of cell surface receptors through the secretory pathway often requires chaperones that aid in protein folding and trafficking from one organelle to another. Here we describe boca, an evolutionarily conserved gene in Drosophila melanogaster, which encodes an endoplasmic reticulum protein that is specifically required for the intracellular trafficking of members of the low-density lipoprotein family of receptors (LDLRs). Two LDLRs in flies, Arrow, which is required for Wingless signal transduction, and Yolkless, which is required for yolk protein uptake during oogenesis, both require boca function. Consequently, boca is an essential component of the Wingless pathway but is more generally required for the activities of multiple LDL receptor family members.	Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University	Mann, RS (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, 701 W 168th St,HHSC 1104, New York, NY 10032 USA.		Culi, Joaquim/Y-6270-2019	Culi, Joaquim/0000-0001-6233-7379	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054510, R01GM058575] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM054510, R01 GM058575] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; BAKER NE, 1988, DEVELOPMENT, V102, P489; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Bhat KM, 1998, CELL, V95, P1027, DOI 10.1016/S0092-8674(00)81726-2; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Bu GJ, 2001, INT REV CYTOL, V209, P79; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; Chen CM, 1999, DEVELOPMENT, V126, P5441; Cheon HM, 2001, INSECT BIOCHEM MOLEC, V31, P753, DOI 10.1016/S0965-1748(01)00068-6; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Chou TB, 1996, GENETICS, V144, P1673; Ciccarese M, 2000, AM J HUM GENET, V66, P453, DOI 10.1086/302753; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; COUSO JP, 1994, DEVELOPMENT, V120, P621; Dantuma NP, 1999, J LIPID RES, V40, P973; DEAK II, 1978, DEV BIOL, V66, P422, DOI 10.1016/0012-1606(78)90249-X; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Grandea AG, 2001, TRENDS IMMUNOL, V22, P194, DOI 10.1016/S1471-4906(01)01861-0; HEITZLER P, 1993, GENETICS, V135, P105; HOLDENER BC, 1994, DEVELOPMENT, V120, P1335; Howell BW, 2001, CURR OPIN NEUROBIOL, V11, P74, DOI 10.1016/S0959-4388(00)00176-8; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Konsolaki M, 1998, GENE DEV, V12, P120, DOI 10.1101/gad.12.1.120; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Lecuit T, 1997, NATURE, V388, P139, DOI 10.1038/40563; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Milanesi L, 1999, BIOINFORMATICS, V15, P612, DOI 10.1093/bioinformatics/15.7.612; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; PANGANIBAN G, 1995, SCIENCE, V270, P1363, DOI 10.1126/science.270.5240.1363; PEIFER M, 1991, DEVELOPMENT, V111, P1029; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; PHILLIPS RG, 1993, DEVELOPMENT, V118, P427; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rulifson EJ, 1996, NATURE, V384, P72, DOI 10.1038/384072a0; SCHONBAUM CP, 1995, P NATL ACAD SCI USA, V92, P1485, DOI 10.1073/pnas.92.5.1485; Schonbaum CP, 2000, MOL BIOL CELL, V11, P511, DOI 10.1091/mbc.11.2.511; Sen J, 2000, DEVELOPMENT, V127, P5541; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Uden E, 1999, NEUROSCIENCE, V88, P687, DOI 10.1016/S0306-4522(98)00272-3; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Wines ME, 2001, GENOMICS, V72, P88, DOI 10.1006/geno.2000.6466; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	57	117	129	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 7	2003	112	3					343	354		10.1016/S0092-8674(02)01279-5	http://dx.doi.org/10.1016/S0092-8674(02)01279-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581524	Bronze			2022-12-28	WOS:000181252200006
J	Hill, JO; Wyatt, HR; Reed, GW; Peters, JC				Hill, JO; Wyatt, HR; Reed, GW; Peters, JC			Obesity and the environment: Where do we go from here?	SCIENCE			English	Editorial Material							ENERGY-EXPENDITURE; COST		Univ Colorado, Hlth Sci Ctr, Ctr Human Nutr, Denver, CO 80262 USA; Univ Massachusetts, Sch Med, Dept Med, Div Prevent & Behav Med, Worcester, MA 01655 USA; Procter & Gamble Co, Cincinnati, OH 45252 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Massachusetts System; University of Massachusetts Worcester; Procter & Gamble	Hill, JO (corresponding author), Univ Colorado, Hlth Sci Ctr, Ctr Human Nutr, 4200 E 9th Ave, Denver, CO 80262 USA.	james.hill@uchsc.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042549, P30DK048520, R01DK042549] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK42549, DK48520] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2001, SURG GEN CALL ACT PR; Bell AC, 2001, INT J OBESITY, V25, P1079, DOI 10.1038/sj.ijo.0801651; Blundell JE, 1998, INT J OBESITY, V22, pS22; DONNELLY JD, IN PRESS ARCH INTERN; Economos CD, 2001, NUTR REV, V59, pS40; FRENCH SA, 2001, ANNU REV PUBL HEALTH, V22, P63, DOI DOI 10.1146/ANNUREV.PUBLHEALTH.22.1.309; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Gleick J., 1999, ACCELERATION JUST EV; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; HORTON TJ, 1995, AM J CLIN NUTR, V62, P19, DOI 10.1093/ajcn/62.1.19; Kortt MA, 1998, CLIN THER, V20, P772, DOI 10.1016/S0149-2918(98)80140-9; Lewis CE, 2001, CIRCULATION, V104, P787; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; PinhasHamiel O, 1996, J PEDIATR-US, V128, P608, DOI 10.1016/S0022-3476(96)80124-7; Reich R., 2001, FUTURE SUCCESS; Sturm R, 2002, HEALTH AFFAIR, V21, P245, DOI 10.1377/hlthaff.21.2.245; TREMBLAY A, 1992, AM J CLIN NUTR, V56, P857, DOI 10.1093/ajcn/56.5.857; Wadden T. A., 2002, Handbook of obesity treatment, P144; Wolf AM, 1998, OBES RES, V6, P97, DOI 10.1002/j.1550-8528.1998.tb00322.x	19	1521	1548	3	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					853	855		10.1126/science.1079857	http://dx.doi.org/10.1126/science.1079857			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574618				2022-12-28	WOS:000180830900039
J	Mazmanian, SK; Skaar, EP; Gaspar, AH; Humayun, M; Gornicki, P; Jelenska, J; Joachmiak, A; Missiakas, DM; Schneewind, O				Mazmanian, SK; Skaar, EP; Gaspar, AH; Humayun, M; Gornicki, P; Jelenska, J; Joachmiak, A; Missiakas, DM; Schneewind, O			Passage of heme-iron across the envelope of Staphylococcus aureus	SCIENCE			English	Article							GRAM-POSITIVE BACTERIA; SURFACE-PROTEINS; CELL-WALL; PENICILLIN; HEMOGLOBIN; VIRULENCE; SORTASE; ANCHOR; FUR	The cell wall envelope of Gram-positive pathogens functions as a scaffold for the attachment of virulence factors and as a sieve that prevents diffusion of molecules. Here the isd genes (iron-regulated surface determinant) of Staphylococcus aureus were found to encode factors responsible for hemoglobin binding and passage of heme-iron to the cytoplasm, where it acts as an essential nutrient. Heme-iron passage required two sortases that tether Isd proteins to unique locations within the cell wall. Thus, Isd appears to act as an import apparatus that uses cell wall-anchored proteins to relay heme-iron across the bacterial envelope.	Univ Chicago, Comm Microbiol, Chicago, IL 60637 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Argonne Natl Lab, Biosci Div, Struct Biol Ctr, Argonne, IL 60439 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Schneewind, O (corresponding author), Univ Chicago, Comm Microbiol, 920 E 58th St, Chicago, IL 60637 USA.		Humayun, Munir/A-1247-2007	Humayun, Munir/0000-0001-8516-9435	NIAID NIH HHS [AI5474, AI38897] Funding Source: Medline; NIGMS NIH HHS [GM58266] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058266] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERNHEIMER AW, 1968, J BACTERIOL, V96, P487, DOI 10.1128/JB.96.2.487-491.1968; BHAKDI S, 1984, PHILOS T R SOC B, V306, P311, DOI 10.1098/rstb.1984.0092; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Cabanes D, 2002, TRENDS MICROBIOL, V10, P238, DOI 10.1016/S0966-842X(02)02342-9; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Drazek ES, 2000, MOL MICROBIOL, V36, P68, DOI 10.1046/j.1365-2958.2000.01818.x; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; GHUYSEN JM, 1968, BACTERIOL REV, V32, P425, DOI 10.1128/MMBR.32.4_Pt_2.425-464.1968; Giesbrecht P, 1998, MICROBIOL MOL BIOL R, V62, P1371, DOI 10.1128/MMBR.62.4.1371-1414.1998; Horsburgh MJ, 2001, J BACTERIOL, V183, P468, DOI 10.1128/JB.183.2.468-475.2001; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Navarre WW, 1998, J BIOL CHEM, V273, P29135, DOI 10.1074/jbc.273.44.29135; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; PERUTZ MF, 1979, ANNU REV BIOCHEM, V48, P327, DOI 10.1146/annurev.bi.48.070179.001551; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Sebulsky MT, 2000, J BACTERIOL, V182, P4394, DOI 10.1128/JB.182.16.4394-4400.2000; STROMINGER JL, 1967, SCIENCE, V156, P213, DOI 10.1126/science.156.3772.213	23	461	495	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					906	909		10.1126/science.1081147	http://dx.doi.org/10.1126/science.1081147			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574635				2022-12-28	WOS:000180830900057
J	Rhodes, KV; Levinson, W				Rhodes, KV; Levinson, W			Interventions for intimate partner violence against women - Clinical applications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DOMESTIC VIOLENCE; EMERGENCY; HEALTH; RISK; ABUSE; PREVALENCE; VICTIMS; SCREEN; MODEL; MEN	Sufficient evidence regarding the effectiveness of physician screening, counseling, and referral for intimate partner violence is lacking. However, even in the absence of sufficient evidence, many medical organizations recommend that physicians make efforts to identify and refer patients who have experienced abuse. This article presents 3 cases that illustrate the interaction between patients experiencing violence in intimate relationships and physicians and other members of the health care team. Suggestions for care are based on guidelines and evidence where available. Resources to assist physicians with referral to appropriate services also are provided.	Univ Chicago, Dept Med, Sect Emergency Med, Hlth Serv Res Grp, Chicago, IL 60637 USA; Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada	University of Chicago; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Rhodes, KV (corresponding author), Univ Chicago, Dept Med, Sect Emergency Med, Hlth Serv Res Grp, 5841 S Maryland Ave,MC 5068, Chicago, IL 60637 USA.	krhodes@medicine.bsd.uchicago.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS011096] Funding Source: NIH RePORTER; AHRQ HHS [HS11096-02] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ABBOTT J, 1995, JAMA-J AM MED ASSOC, V273, P1763, DOI 10.1001/jama.273.22.1763; *AM AC FAM PHYS, 2003, VIOL POS PAP AAFP PO; *AM COLL EM PHYS, 1999, 400286 AM COLL EM PH; American College of Obstetricians and Gynecologists, 1995, AM FAM PHYSICIAN, V52, P2391; American Heart Association, 2000, CIRCULATION, V102, P122; [Anonymous], 1995, Am Fam Physician, V52, P2387; Bays JA, 1998, PEDIATRICS, V101, P1091; BROWN R, 1992, JAMA-J AM MED ASSOC, V267, P3184; Campbell JC, 2001, ACAD EMERG MED, V8, P131, DOI 10.1111/j.1553-2712.2001.tb01277.x; *CDCP, 1994, MMWR-MORBID MORTAL W, V43, P132; *COL U L HARR ASS, 1993, HLTH AM WOM; *COMM FUND COMM WO, 1996, VIOL WOM US COMPR BA; Drossman DA, 1996, GASTROENTEROLOGY, V110, P999, DOI 10.1053/gast.1996.v110.pm8613034; Dunford FW, 2000, J CONSULT CLIN PSYCH, V68, P468, DOI 10.1037//0022-006X.68.3.468; Dutton D G, 1992, Violence Vict, V7, P29; Elliott B A, 1995, Arch Fam Med, V4, P113; Elliott L, 2002, J GEN INTERN MED, V17, P112, DOI 10.1046/j.1525-1497.2002.10233.x; Ferris LE, 1997, JAMA-J AM MED ASSOC, V278, P851, DOI 10.1001/jama.278.10.851; Fleming MF, 2000, MED CARE, V38, P7, DOI 10.1097/00005650-200001000-00003; Frasier PY, 2001, PATIENT EDUC COUNS, V43, P211, DOI 10.1016/S0738-3991(00)00152-X; GANLEY A, 1996, IMPROVING HLTH CARE, P89; Gazmararian JA, 1996, JAMA-J AM MED ASSOC, V275, P1915, DOI 10.1001/jama.275.24.1915; Gerbert B, 1999, WOMEN HEALTH, V29, P115, DOI 10.1300/J013v29n03_08; GOLDBERG WG, 1984, JAMA-J AM MED ASSOC, V251, P3259, DOI 10.1001/jama.251.24.3259; Herrera VM, 2001, CHILD ABUSE NEGLECT, V25, P1037, DOI 10.1016/S0145-2134(01)00255-1; Holt VL, 2002, JAMA-J AM MED ASSOC, V288, P589, DOI 10.1001/jama.288.5.589; *JOINT COMM, 1993, AIDS ALERT, V8, P152; KANTOR K, 1990, PHYSICAL VIOLENCE AM, P151; KOTTKE TE, 1990, MAYO CLIN PROC, V65, P899, DOI 10.1016/S0025-6196(12)62582-8; Koziol-McLain J, 2001, AM J PREV MED, V21, P93, DOI 10.1016/S0749-3797(01)00325-7; Krasnoff M, 2002, ANN EMERG MED, V40, P485, DOI 10.1067/mem.2002.128872; Kyriacou DN, 1999, NEW ENGL J MED, V341, P1892, DOI 10.1056/NEJM199912163412505; MACMILLAN HL, 2001, SYSTEMATIC REV RECOM; Mechem CC, 1999, ACAD EMERG MED, V6, P786, DOI 10.1111/j.1553-2712.1999.tb01207.x; Muelleman RL, 1998, ACAD EMERG MED, V5, P866, DOI 10.1111/j.1553-2712.1998.tb02815.x; Muelleman RL, 1998, AM J EMERG MED, V16, P128, DOI 10.1016/S0735-6757(98)90028-6; O'Farrell TJ, 2000, J SUBST ABUSE TREAT, V18, P51, DOI 10.1016/S0740-5472(99)00026-4; PROCHASKA JO, 1994, HEALTH PSYCHOL, V13, P39, DOI 10.1037/0278-6133.13.1.39; Ramsay J, 2002, BRIT MED J, V325, P314, DOI 10.1136/bmj.325.7359.314; Rhodes KV, 2001, ANN EMERG MED, V37, P284, DOI 10.1067/mem.2001.110818; Rittmayer J, 1999, QUAL HEALTH RES, V9, P166, DOI 10.1177/104973299129121767; Roberts S J, 1996, Nurse Pract, V21, P49; ROBERTS SJ, 1996, NURSE PRACT, V21, P45; ROBERTS SJ, 1996, NURSE PRACT, V21, P49; Rodriguez MA, 1996, ARCH FAM MED, V5, P153, DOI 10.1001/archfami.5.3.153; Rosenberg HJ, 2000, INT J PSYCHIAT MED, V30, P247, DOI 10.2190/J8M8-YDTE-46CB-GYDK; Salber PR, 1998, ACAD EMERG MED, V5, P849, DOI 10.1111/j.1553-2712.1998.tb02810.x; SUGG NK, 1992, JAMA-J AM MED ASSOC, V267, P3157, DOI 10.1001/jama.267.23.3157; Sullivan CM, 1999, J CONSULT CLIN PSYCH, V67, P43, DOI 10.1037/0022-006X.67.1.43; Titus K, 1996, JAMA-J AM MED ASSOC, V275, P1863, DOI 10.1001/jama.275.24.1863; TJADEN P, 2000, FULL REPORT PREVANEN; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Wathen CN, 2003, JAMA-J AM MED ASSOC, V289, P589, DOI 10.1001/jama.289.5.589; WEISS E, 2000, SURVIVING DOMESTIC V; Williams-Evans S A, 2000, J Cult Divers, V7, P48; Zink T, 1997, Minn Med, V80, P26; ZINK T, 1997, MINN MED, V80, P29; 2000, MMMR MORB MORTAL WKL, V49, P114	58	78	79	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2003	289	5					601	605		10.1001/jama.289.5.601	http://dx.doi.org/10.1001/jama.289.5.601			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	642CV	12578493	Bronze			2022-12-28	WOS:000180787500031
J	Allen, SA; Spaulding, AC; Osei, AM; Taylor, LE; Cabral, AM; Rich, JD				Allen, SA; Spaulding, AC; Osei, AM; Taylor, LE; Cabral, AM; Rich, JD			Treatment of chronic hepatitis C in a state correctional facility	ANNALS OF INTERNAL MEDICINE			English	Article							ANTIVIRAL TREATMENT; INFECTION	Background: Approximately 1 in 4 of the nearly 2 million individuals in state and federal correctional facilities are infected with hepatitis C virus (HCV). Currently, there are few reports of treatment outcomes of this common infection in this setting. Objective: To describe HCV therapy in the incarcerated setting. Design: Retrospective, descriptive observational study. Setting: Rhode Island Department of Corrections, Cranston, Rhode island. Patients: 93 inmates with chronic HCV infection. Intervention: Interferon-alpha with ribavirin. Measurements: HCV RNA levels 6 months after treatment. Results: Response rates are similar to previously published rates achieved in the community; 63% (50 of 79) of patients achieved viral clearance after 6 months of therapy, and 46% (26 of 57) achieved sustained response 6 months after treatment. Conclusion: The incarcerated population (which is disproportionately affected by addiction and psychiatric illness) can be effectively treated for HCV infection with interferon and ribavirin. The correctional setting may provide an opportunity to safely treat patients with these two challenging comorbid conditions.	Miriam Hosp, Providence, RI 02906 USA; Rhode Isl Dept Correct, Cranston, RI USA; Brown Univ, Sch Med, Providence, RI 02912 USA	Lifespan Health Rhode Island; Miriam Hospital; Brown University	Rich, JD (corresponding author), Miriam Hosp, 164 Summit Ave, Providence, RI 02906 USA.	jrich@lifespan.org	Allen, Scott/D-2403-2015	Allen, Scott/0000-0001-8815-4714; Taylor, Lynn/0000-0002-0472-8125	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER; NIAID NIH HHS [P30-AI-42853] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; [Anonymous], 1997, HEPATOLOGY, V26, pS2; Falck-Ytter Y, 2002, ANN INTERN MED, V136, P288, DOI 10.7326/0003-4819-136-4-200202190-00008; Fontana RJ, 2000, DIGEST DIS, V18, P107, DOI 10.1159/000051384; HAMMET TM, 2002, NAT HIV PREV C ATL G; MACALINO GE, 2002, 1999 NAT HIV PREV C; *NIH, 2002, CONS DEV C STAT MAN; Reindollar Robert W., 1999, American Journal of Medicine, V107, p100S; Rich JD, 2001, AM J PUBLIC HEALTH, V91, P699, DOI 10.2105/AJPH.91.5.699; Spaulding A, 1999, PREV MED, V28, P92, DOI 10.1006/pmed.1998.0418; Wong JB, 2000, ANN INTERN MED, V133, P665, DOI 10.7326/0003-4819-133-9-200011070-00008; Wong JB, 1998, JAMA-J AM MED ASSOC, V280, P2088, DOI 10.1001/jama.280.24.2088; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301	13	98	99	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					187	190		10.7326/0003-4819-138-3-200302040-00010	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558357				2022-12-28	WOS:000181018600004
J	Carney, PA; Miglioretti, DL; Yankaskas, BC; Kerlikowske, K; Rosenberg, R; Rutter, CM; Geller, BM; Abraham, LA; Taplin, SH; Dignan, M; Cutter, G; Ballard-Barbash, R				Carney, PA; Miglioretti, DL; Yankaskas, BC; Kerlikowske, K; Rosenberg, R; Rutter, CM; Geller, BM; Abraham, LA; Taplin, SH; Dignan, M; Cutter, G; Ballard-Barbash, R			Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER RISK; SENSITIVITY; ESTROGEN; WOMEN; ASSOCIATION; SPECIFICITY; PROGESTIN; HISTORY; TRIAL	Background: The relationships among breast density, age, and use of hormone replacement therapy (HRT) in breast cancer detection have not been fully evaluated. Objective: To determine how breast density, age, and use of HRT individually and in combination affect the accuracy of screening mammography. Design: Prospective cohort study. Setting: 7 population-based mammography registries in North Carolina; New Mexico; New Hampshire; Vermont; Colorado; Seattle, Washington; and San Francisco, California. Participants: 329 495 women 40 to 89 years of age who had 463 372 screening mammograms from 1996 to 1998; 2223 women received a diagnosis of breast cancer. Measurements: Breast density, age, HRT use, rate of breast cancer occurrence, and sensitivity and specificity of screening mammography. Results: Adjusted sensitivity ranged from 62.9% in women with extremely dense breasts to 87.0% in women with almost entirely fatty breasts; adjusted sensitivity increased with age from 68.6% in women 40 to 44 years of age to 83.3% in women 80 to 89 years of age. Adjusted specificity increased from 89.1% in women with extremely dense breasts to 96.9% in women with almost entirely fatty breasts. In women who did not use HRT, adjusted specificity increased from 91.4% in women 40 to 44 years of age to 94.4% in women 80 to 89 years of age. In women who used HRT, adjusted specificity was about 91.7% for all ages. Conclusions: Mammographic breast density and age are important predictors of the accuracy of screening mammography. Although HRT use is not an independent predictor of accuracy, it probably affects accuracy by increasing breast density.	Dartmouth Coll, Sch Med, Dept Community & Family Med, Lebanon, NH 03756 USA; Grp Hlth Cooperat Puget Sound, Seattle, WA 98121 USA; Univ N Carolina, Chapel Hill, NC 27599 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA; Univ New Mexico, Albuquerque, NM 87131 USA; Univ Vermont, Burlington, VT 05405 USA; AMC Canc Res Ctr, Denver, CO USA; NCI, Bethesda, MD 20892 USA	Dartmouth College; Group Health Cooperative; University of North Carolina; University of North Carolina Chapel Hill; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of New Mexico; University of Vermont; AMC Cancer Research Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Carney, PA (corresponding author), Dartmouth Coll, Sch Med, Dept Community & Family Med, 1 Med Ctr Dr,HB 7925, Lebanon, NH 03756 USA.	Patricia.A.Carney@dartmouth.edu	Rutter, Carolyn/AAZ-3677-2021; SALAZAR, ANTONIO/A-5806-2013; Cutter, Gary/AAY-5392-2021	SALAZAR, ANTONIO/0000-0003-2639-2340; Cutter, Gary/0000-0002-8455-980X	NATIONAL CANCER INSTITUTE [U01CA070013, U01CA063736, U01CA063731, U01CA086076, R01CA080888, U01CA069976, U01CA086082, U01CA070040, U01CA063740] Funding Source: NIH RePORTER; NCI NIH HHS [UO1CA70013, UO1CA63736, UO1CA70040, UO1CA63731, UO1CA63740, UO1CA69976, UO1CA86076, UO1CA86082, R01 CA80888] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		American College of Radiology (ACR), 1998, ILL BREAST IM REP DA; [Anonymous], 1994, AHCPR PUBL, V94-0592; Baines CJ, 1997, CANCER-AM CANCER SOC, V80, P720; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; Byrne C, 1997, J NATL CANCER I, V89, P531, DOI 10.1093/jnci/89.8.531; Carney PA, 2000, AM J EPIDEMIOL, V152, P371, DOI 10.1093/aje/152.4.371; COVENEY EC, 1994, CLIN RADIOL, V49, P123, DOI 10.1016/S0009-9260(05)83454-3; Ernster V L, 1997, J Natl Cancer Inst Monogr, P151; Harvey SC, 1996, AM J ROENTGENOL, V167, P394, DOI 10.2214/ajr.167.2.8686614; HOUN F, 1995, RADIOL CLIN N AM, V33, P1059; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; Lam PB, 2000, CANCER, V89, P369, DOI 10.1002/1097-0142(20000715)89:2&lt;369::AID-CNCR23&gt;3.0.CO;2-J; Laya MB, 1996, J NATL CANCER I, V88, P643, DOI 10.1093/jnci/88.10.643; Leung W, 1997, SURGERY, V122, P669, DOI 10.1016/S0039-6060(97)90072-6; Litherland JC, 1997, CLIN RADIOL, V52, P276, DOI 10.1016/S0009-9260(97)80053-0; Mandelson MT, 2000, J NATL CANCER I, V92, P1081, DOI 10.1093/jnci/92.13.1081; MORRISON AS, 1988, JNCI-J NATL CANCER I, V80, P1540, DOI 10.1093/jnci/80.19.1540; Pankow JS, 1997, J NATL CANCER I, V89, P549, DOI 10.1093/jnci/89.8.549; Persson I, 1997, J CLIN ONCOL, V15, P3201, DOI 10.1200/JCO.1997.15.10.3201; Rosenberg RD, 2000, ACAD RADIOL, V7, P1058, DOI 10.1016/S1076-6332(00)80057-4; Rosenberg RD, 1998, RADIOLOGY, V209, P511, DOI 10.1148/radiology.209.2.9807581; SAFTLAS AF, 1991, CANCER, V67, P2833, DOI 10.1002/1097-0142(19910601)67:11<2833::AID-CNCR2820671121>3.0.CO;2-U; Shapiro S, 1997, J Natl Cancer Inst Monogr, P27; STEINBERG KK, 1991, JAMA-J AM MED ASSOC, V265, P1985, DOI 10.1001/jama.265.15.1985; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; Taplin SH, 2002, RADIOLOGY, V222, P529, DOI 10.1148/radiol.2222010647; Thurfjell EL, 1997, RADIOLOGY, V203, P339, DOI 10.1148/radiology.203.2.9114085; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; White E, 1998, J NATL CANCER I, V90, P906, DOI 10.1093/jnci/90.12.906; Yankaskas BC, 2001, AM J ROENTGENOL, V177, P543, DOI 10.2214/ajr.177.3.1770543	33	781	803	0	36	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					168	175		10.7326/0003-4819-138-3-200302040-00008	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558355				2022-12-28	WOS:000181018600002
J	Lambert, TW; Goldacre, MJ; Turner, G				Lambert, TW; Goldacre, MJ; Turner, G			Career choices of United Kingdom medical graduates of 1999 and 2000: questionnaire surveys	BRITISH MEDICAL JOURNAL			English	Article							DOCTORS	The career choices of doctors at the end of their preregistration year have been studied for doctors who qualified in the United Kingdom in 1974, 1977, 1980, 1983, 1988, 1993 and 1996.(1-4) We report here on the graduates of 1999 and 2000.	Univ Oxford, UK Med Careers Res Grp, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England	University of Oxford	Lambert, TW (corresponding author), Univ Oxford, UK Med Careers Res Grp, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England.			Lambert, Trevor/0000-0001-9688-3036				Goldacre MJ, 1999, MED EDUC, V33, P882, DOI 10.1046/j.1365-2923.1999.00560.x; Lambert TW, 1998, BRIT MED J, V317, P1429, DOI 10.1136/bmj.317.7170.1429; Lambert TW, 1997, BRIT MED J, V314, P1591, DOI 10.1136/bmj.314.7094.1591; Lambert TW, 1996, BRIT MED J, V313, P19, DOI 10.1136/bmj.313.7048.19; Report Todd, 1968, CMND3569	5	66	67	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 25	2003	326	7382					194	195		10.1136/bmj.326.7382.194	http://dx.doi.org/10.1136/bmj.326.7382.194			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640LD	12543835	Green Published, Bronze			2022-12-28	WOS:000180689600017
J	Abe, E; Pennycook, SJ; Tsai, AP				Abe, E; Pennycook, SJ; Tsai, AP			Direct observation of a local thermal vibration anomaly in a quasicrystal	NATURE			English	Article							DECAGONAL QUASI-CRYSTALS; DIFFUSE-SCATTERING; CO; CRYSTALLOGRAPHY; ELASTICITY; CLUSTERS; PHASONS	Quasicrystals have long-range order with symmetries that are incompatible with periodicity, and are often described with reference to a higher-dimensional analogue of a periodic lattice(1-3). Within the context of this 'hyperspace' crystallography, lattice dynamics of quasicrystals can be described by a combination of lattice vibrations and atomic fluctuations-phonons and phasons(1,4). However, it is difficult to see localized fluctuations in a real-space quasicrystal structure, and so the nature of phason-related fluctuations and their contribution to thermodynamic stability are still not fully understood. Here we use atomic-resolution annular dark-field scanning transmission electron microscopy to map directly the change in thermal diffuse scattering intensity distribution in the quasicrystal, through in situ high-temperature observation of decagonal Al72Ni20Co8. We find that, at 1,100 K, a local anomaly of atomic vibrations becomes significant at specific atomic sites in the structure. The distribution of these localized vibrations is not random but well-correlated, with a quasiperiodic length scale of 2 nm. We are able to explain this feature by an anomalous temperature (Debye-Waller) factor for the Al atoms that sit at the phason-related sites defined within the framework of hyperspace crystallography. The present results therefore provide a direct observation of local thermal vibration anomalies in a solid.	Oak Ridge Natl Lab, Condensed Matter Sci Div, Oak Ridge, TN 37830 USA; Japan Sci & Technol Corp, Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; Japan Sci & Technol Corp, SORST, Tsukuba, Ibaraki 3050047, Japan	United States Department of Energy (DOE); Oak Ridge National Laboratory; Japan Science & Technology Agency (JST); National Institute for Materials Science; Japan Science & Technology Agency (JST)	Abe, E (corresponding author), Oak Ridge Natl Lab, Condensed Matter Sci Div, Oak Ridge, TN 37830 USA.		Pennycook, Stephen/AAA-1112-2019; Abe, Eiji/AAE-7129-2020	Pennycook, Stephen/0000-0002-3210-6323; Abe, Eiji/0000-0003-3999-4383				Abe E, 2000, PHYS REV LETT, V84, P4609, DOI 10.1103/PhysRevLett.84.4609; ABE H, UNPUB J PHYS; BAK P, 1985, PHYS REV LETT, V54, P1517, DOI 10.1103/PhysRevLett.54.1517; Bancel PA, 1991, QUASICRYSTALS STATE, P17; Cervellino A, 2002, ACTA CRYSTALLOGR B, V58, P8, DOI 10.1107/S0108768101018936; Coddens G, 1999, PHYS REV B, V60, P270, DOI 10.1103/PhysRevB.60.270; Colella R, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.014202; DEBOISSIEU M, 1995, PHYS REV LETT, V75, P89, DOI 10.1103/PhysRevLett.75.89; Dolinsek J, 1999, PHYS REV LETT, V82, P572, DOI 10.1103/PhysRevLett.82.572; Edagawa K, 2000, PHYS REV LETT, V85, P1674, DOI 10.1103/PhysRevLett.85.1674; Gummelt P, 1996, GEOMETRIAE DEDICATA, V62, P1, DOI 10.1007/bf00239998; Henley CL, 2002, J ALLOY COMPD, V342, P221, DOI 10.1016/S0925-8388(02)00199-8; Henley CL, 1991, QUASICRYSTALS STATE, P429; Hiraga K, 2000, PHIL MAG LETT, V80, P653, DOI 10.1080/09500830050134381; ISHII Y, 1992, PHYS REV B, V45, P5228, DOI 10.1103/PhysRevB.45.5228; JANSSEN T, 1986, ACTA CRYSTALLOGR A, V42, P261, DOI 10.1107/S0108767386099324; JARIC MV, 1988, PHYS REV B, V37, P4458, DOI 10.1103/PhysRevB.37.4458; JEONG HC, 1993, PHYS REV B, V48, P9394, DOI 10.1103/PhysRevB.48.9394; Muller DA, 2001, ULTRAMICROSCOPY, V86, P371, DOI 10.1016/S0304-3991(00)00128-5; PENNYCOOK SJ, 1992, ACTA METALL MATER, V40, pS149, DOI 10.1016/0956-7151(92)90275-J; PENNYCOOK SJ, 1991, ULTRAMICROSCOPY, V37, P14, DOI 10.1016/0304-3991(91)90004-P; Ritsch S, 1996, PHIL MAG LETT, V74, P99, DOI 10.1080/095008396180452; Saitoh K, 1997, JPN J APPL PHYS 2, V36, pL1400, DOI 10.1143/JJAP.36.L1400; SOCOLAR JES, 1986, PHYS REV B, V34, P3345, DOI 10.1103/PhysRevB.34.3345; Steinhardt PJ, 1999, NATURE, V399, P84, DOI 10.1038/20005; Takakura H, 2001, ACTA CRYSTALLOGR A, V57, P576, DOI 10.1107/S0108767301007942; WEICKENMEIER A, 1991, ACTA CRYSTALLOGR A, V47, P590, DOI 10.1107/S0108767391004804; Yamamoto A, 1996, ACTA CRYSTALLOGR A, V52, P509, DOI 10.1107/S0108767396000967; Yan Y, 1998, PHYS REV LETT, V81, P5145, DOI 10.1103/PhysRevLett.81.5145; Yan YF, 2001, PHYS REV LETT, V86, P1542, DOI 10.1103/PhysRevLett.86.1542; Zeger G, 1999, PHYS REV LETT, V82, P5273, DOI 10.1103/PhysRevLett.82.5273	31	112	112	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					347	350		10.1038/nature01337	http://dx.doi.org/10.1038/nature01337			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540895				2022-12-28	WOS:000180533000035
J	Bustamante, C; Bryant, Z; Smith, SB				Bustamante, C; Bryant, Z; Smith, SB			Ten years of tension: single-molecule DNA mechanics	NATURE			English	Article							COLI RNA-POLYMERASE; SUPERCOILED DNA; STRUCTURAL TRANSITIONS; OPTICAL TWEEZERS; STRANDED-DNA; FORCE; ELASTICITY; TRANSLOCATION; TOPOISOMERASE; TRANSCRIPTION	The basic features of DNA were elucidated during the half-century following the discovery of the double helix. But it is only during the past decade that researchers have been able to manipulate single molecules of DNA to make direct measurements of its mechanical properties. These studies have illuminated the nature of interactions between DNA and proteins, the constraints within which the cellular machinery operates, and the forces created by DNA-dependent motors.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu; zev@alice.berkeley.edu; steve@alice.berkeley.edu		Bustamante, Carlos/0000-0002-2970-0073				Alberts B., 2008, MOL BIOL CEL, V5th ed.; Allemand JF, 1998, P NATL ACAD SCI USA, V95, P14152, DOI 10.1073/pnas.95.24.14152; Bennink ML, 2001, NAT STRUCT BIOL, V8, P606, DOI 10.1038/89646; BEUCHE F, 1962, PHYSICAL PROPERTIES; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Bockelmann U, 2002, BIOPHYS J, V82, P1537, DOI 10.1016/S0006-3495(02)75506-9; Brower-Toland BD, 2002, P NATL ACAD SCI USA, V99, P1960, DOI 10.1073/pnas.022638399; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Calladine CR., 1997, UNDERSTANDING DNA; Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1; Cluzel P, 1996, SCIENCE, V271, P792, DOI 10.1126/science.271.5250.792; Crisona NJ, 2000, GENE DEV, V14, P2881, DOI 10.1101/gad.838900; Cui Y, 2000, P NATL ACAD SCI USA, V97, P127, DOI 10.1073/pnas.97.1.127; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Dekker NH, 2002, P NATL ACAD SCI USA, V99, P12126, DOI 10.1073/pnas.132378799; Dohoney KM, 2001, NATURE, V409, P370, DOI 10.1038/35053124; EssevazRoulet B, 1997, P NATL ACAD SCI USA, V94, P11935, DOI 10.1073/pnas.94.22.11935; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; GOODMAN SD, 1989, NATURE, V341, P251, DOI 10.1038/341251a0; Harada Y, 2001, NATURE, V409, P113, DOI 10.1038/35051126; Hegner M., 2000, Single Molecules, V1, P139, DOI 10.1002/1438-5171(200006)1:2<139::AID-SIMO139>3.0.CO;2-C; Koch SJ, 2002, BIOPHYS J, V83, P1098, DOI 10.1016/S0006-3495(02)75233-8; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; Landick R, 1997, CELL, V88, P741, DOI 10.1016/S0092-8674(00)81919-4; Leger JF, 1999, PHYS REV LETT, V83, P1066, DOI 10.1103/PhysRevLett.83.1066; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Maier B, 2000, P NATL ACAD SCI USA, V97, P12002, DOI 10.1073/pnas.97.22.12002; Mao CD, 1999, NATURE, V397, P144, DOI 10.1038/16437; PARVIN JD, 1995, NATURE, V373, P724, DOI 10.1038/373724a0; PAULING L, 1953, P NATL ACAD SCI USA, V39, P84, DOI 10.1073/pnas.39.2.84; PEREZMARTIN J, 1993, SCIENCE, V260, P805, DOI 10.1126/science.8387228; Sarkar A, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.051903; SCHELLMAN JA, 1974, BIOPOLYMERS, V13, P217, DOI 10.1002/bip.1974.360130115; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; STRAUSS JK, 1994, SCIENCE, V266, P1829, DOI 10.1126/science.7997878; Strick T, 2000, PROG BIOPHYS MOL BIO, V74, P115, DOI 10.1016/S0079-6107(00)00018-3; Strick TR, 2000, NATURE, V404, P901, DOI 10.1038/35009144; Strick TR, 1998, BIOPHYS J, V74, P2016, DOI 10.1016/S0006-3495(98)77908-1; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; WILKINS MHF, 1951, NATURE, V167, P759, DOI 10.1038/167759a0; Williams MC, 2002, ACCOUNTS CHEM RES, V35, P159, DOI 10.1021/ar010045k; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	50	1050	1087	7	284	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					423	427		10.1038/nature01405	http://dx.doi.org/10.1038/nature01405			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540915	Bronze			2022-12-28	WOS:000180533000056
J	Patane, D; De Gori, P; Chiarabba, C; Bonaccorso, A				Patane, D; De Gori, P; Chiarabba, C; Bonaccorso, A			Magma ascent and the pressurization of Mount Etna's volcanic system	SCIENCE			English	Article							MT-ETNA; SEISMICITY; ERUPTIONS; TOMOGRAPHY; INVERSION	After a period of deflation during the 1991-1993 flank eruption, Mount Etna underwent a rapid inflation. Seismicity and ground deformation show that since 1994, a huge volume of magma intruded beneath the volcano, producing from 1998 onward a series of eruptions at the summit and on the flank of the volcano. The last of these, started on 27 October 2002, is still in progress and can be considered one of the most explosive eruptions of the volcano in recent times. Here we show how geodetic data and seismic deformation, between 1994 and 2001, indicate a radial compression around an axial intrusion, consistent with a repressurization of Mount Etna's plumbing system at a depth of 6 to 15 kilometers, which triggered most of the seismicity and provoked the dilatation of the volcano and the recent explosive eruptive activity.	Ist Nazl Geofis & Vulcanol, Sez Catania, I-95123 Catania, Italy; Ctr Nazl Terremoti, Ist Nazl Geofis & Vulcanol, I-00143 Rome, Italy	Istituto Nazionale Geofisica e Vulcanologia (INGV); Istituto Nazionale Geofisica e Vulcanologia (INGV)	Patane, D (corresponding author), Ist Nazl Geofis & Vulcanol, Sez Catania, Piazza Roma 2, I-95123 Catania, Italy.		chiarabba, claudio/G-4780-2011; Bonaccorso, Alessandro/H-4778-2011	chiarabba, claudio/0000-0002-8111-3466; Bonaccorso, Alessandro/0000-0002-4770-6006; PATANE', Domenico/0000-0001-9410-5126				ARMIENTI P, 1989, J VOLCANOL GEOTH RES, V39, P315, DOI 10.1016/0377-0273(89)90095-4; Bonaccorso A, 1996, GEOPHYS RES LETT, V23, P451, DOI 10.1029/96GL00418; Bonaccorso A, 2001, J VOLCANOL GEOTH RES, V109, P99, DOI 10.1016/S0377-0273(00)00306-1; Bonaccorso A, 2001, TECTONOPHYSICS, V334, P61, DOI 10.1016/S0040-1951(01)00056-7; Bonaccorso A, 1996, J GEOPHYS RES-SOL EA, V101, P17467, DOI 10.1029/96JB01151; BONACCORSO A, IN PRESS PURE APPL G; BONACCORSO A, 2002, GEOPHYS RES LETT, V29; Budetta G, 1999, GEOPHYS J INT, V138, P77, DOI 10.1046/j.1365-246x.1999.00836.x; Budetta G, 1998, B VOLCANOL, V59, P311, DOI 10.1007/s004450050194; CHESTER DK, 1985, MOUNT ETNA ANATOMY V; Chiarabba C, 2000, J GEOPHYS RES-SOL EA, V105, P10923, DOI 10.1029/1999JB900427; CHIARABBA C, IN PRESS MT ETNA VOL; CORSARO R, 1998, 496 CNR I INT VULC, P27; Hughes JW, 1990, MAGMA TRANSPORT STOR, P385; Laigle M, 2000, J GEOPHYS RES-SOL EA, V105, P21633, DOI 10.1029/2000JB900190; Montone P, 1999, J GEOPHYS RES-SOL EA, V104, P25595, DOI 10.1029/1999JB900181; MORAN SC, 1994, J GEOPHYS RES-SOL EA, V99, P4341, DOI 10.1029/93JB02993; NERCESSIAN A, 1996, J VOLCANOL GEOTHERM, V70, P125; Nicolich R, 2000, TECTONOPHYSICS, V329, P121, DOI 10.1016/S0040-1951(00)00192-X; Patane D, 2001, J VOLCANOL GEOTH RES, V109, P77, DOI 10.1016/S0377-0273(00)00305-X; PATANE D, 2002, GEOPHYS RES LETT, V29; ROWAN LR, 1993, J GEOPHYS RES-SOL EA, V98, P4355, DOI 10.1029/92JB02531; Thurber C., 1993, SEISMIC TOMOGRAPHY T, P563; TOOMEY DR, 1989, J GEOPHYS RES-SOLID, V94, P17497, DOI 10.1029/JB094iB12p17497	24	170	173	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2003	299	5615					2061	2063		10.1126/science.1080653	http://dx.doi.org/10.1126/science.1080653			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12574497				2022-12-28	WOS:000181834200053
J	Bryant, VM				Bryant, VM			Invisible clues to New World plant domestication	SCIENCE			English	Editorial Material							AGRICULTURE		Texas A&M Univ, Dept Anthropol, Ctr Ecol Archaeol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Bryant, VM (corresponding author), Texas A&M Univ, Dept Anthropol, Ctr Ecol Archaeol, College Stn, TX 77843 USA.		Bryant, Vaughn M/J-5592-2019					DIMBLEBY G. W., 1957, NEW PHYTOL, V56, P12, DOI 10.1111/j.1469-8137.1957.tb07446.x; MacNeish R. S., 1967, PREHISTORY TEHUACAN, P290; PEARSALL DM, 1993, CURRENT RES PHYTOLIT, P109; Piperno D.R., 1998, ORIGINS AGR LOWLAND; Piperno D.R., 2001, PHYTOLITHARIEN, V13, P1; Piperno D.R., 1988, PHYTOLITH ANAL ARCHA; Piperno DR, 1998, J ARCHAEOL SCI, V25, P765, DOI 10.1006/jasc.1997.0258; PIPERNO DR, 1991, J WORLD PREHIST, V5, P155, DOI 10.1007/BF00974678; Piperno DR, 2003, SCIENCE, V299, P1054, DOI 10.1126/science.1080365; Pope KO, 2001, SCIENCE, V292, P1370, DOI 10.1126/science.292.5520.1370	10	10	11	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1029	1030		10.1126/science.1081624	http://dx.doi.org/10.1126/science.1081624			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586933				2022-12-28	WOS:000180960000034
J	Warren, LA; Kauffman, ME				Warren, LA; Kauffman, ME			Microbial geoengineers	SCIENCE			English	Editorial Material							ACID-MINE DRAINAGE; MICROORGANISMS		McMaster Univ, Sch Geog & Geol, Hamilton, ON L8S 4K1, Canada; Idaho Natl Engn & Environm Lab, Idaho Falls, ID 83415 USA	McMaster University; United States Department of Energy (DOE); Idaho National Laboratory	Warren, LA (corresponding author), McMaster Univ, Sch Geog & Geol, Hamilton, ON L8S 4K1, Canada.							Beliaev AS, 2002, J BACTERIOL, V184, P4612, DOI 10.1128/JB.184.16.4612-4616.2002; Bond PL, 2000, APPL ENVIRON MICROB, V66, P3842, DOI 10.1128/AEM.66.9.3842-3849.2000; Chapelle FH, 2002, NATURE, V415, P312, DOI 10.1038/415312a; Edwards KJ, 2000, SCIENCE, V287, P1796, DOI 10.1126/science.287.5459.1796; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; HAACK EA, 2002, FALL AGU M SAN FRANC; HANSEL CM, 2002, FALL AGU M SAN FRANC; MORIN G, 2002, FALL AGU M SAN FRANC; Nealson KH, 1997, REV MINERAL, V35, P5; Newman DK, 2002, SCIENCE, V296, P1071, DOI 10.1126/science.1010716; O'Day PA, 1999, REV GEOPHYS, V37, P249, DOI 10.1029/1998RG900003; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Reysenbach AL, 2002, SCIENCE, V296, P1077, DOI 10.1126/science.1072483; Takai K, 2001, APPL ENVIRON MICROB, V67, P3618, DOI 10.1128/AEM.67.8.3618-3629.2001; 2002, FALL AGU M SAN FRANC	15	11	23	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1027	+		10.1126/science.1072076	http://dx.doi.org/10.1126/science.1072076			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586932				2022-12-28	WOS:000180960000033
J	Calverley, P; Pauwels, R; Vestbo, J; Jones, P; Pride, N; Gulsvik, A; Anderson, J; Maden, C				Calverley, P; Pauwels, R; Vestbo, J; Jones, P; Pride, N; Gulsvik, A; Anderson, J; Maden, C		TRISTAN Study Grp	Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; FORMOTEROL DRY POWDER; INHALED BUDESONIDE; HEALTH-STATUS; EFFICACY; MODERATE; MILD; TOLERABILITY; THEOPHYLLINE; COMBINATION	Background Inhaled longacting beta(2) agonists improve lung function and health status in symptomatic chronic obstructive pulmonary disease (COPD), whereas inhaled corticosteroids reduce the frequency of acute episodes of symptom exacerbation and delay deterioration in health status. We postulated that a combination of these treatments would be better than each component used alone. Methods 1465 patients with COPD were recruited from outpatient departments in 25 countries. They were treated in a randomised, double-blind, parallel-group, placebo-controlled study with either 50 mug salmeterol twice daily (n=372), 500 mug fluticasone twice daily (n=374), 50 mug salmeterol and 500 mug fluticasone twice daily (n=358), or placebo (n=361) for 12 months. The primary outcome was the pretreatment forced expiratory volume in 1 s (FEV1) after 12 months treatment' and after patients had abstained from all bronchodilators for at least 6 h and from study medication for at least 12 h. Secondary outcomes were other lung function measurements, symptoms and rescue treatment use, the number of exacerbations, patient withdrawals, and disease-specific health status. We assessed adverse events, serum cortisol concentrations, skin bruising, and electrocardiograms. Analysis was as predefined in the study protocol. Findings All active treatments improved lung function, symptoms, and health status and reduced use of rescue medication and frequency of exacerbations. Combination therapy improved pretreatment FEV1 significantly more than did placebo (treatment difference 133 mL, 95% CI 105-161, p<0.0001), salmeterol (73 mL, 46-101, p<0.0001), or fluticasone alone (95 mL, 67-122, p<0.0001). Combination treatment produced a clinically significant improvement in health status and the greatest reduction in daily symptoms. All treatments were well tolerated with no difference in the frequency of adverse events, bruising, or clinically significant falls in serum cortisol concentration. Interpretation Because inhaled long-acting beta(2) agonists and corticosteroid combination treatment produces better control of symptoms and lung function, with no greater risk of side-effects than that with use of either component alone, this combination treatment should be considered for patients with COPD.	Aintree Univ Hosp NHS Fdn Trust, Ctr Clin Sci, Dept Med, Liverpool L9 7AL, Merseyside, England; Ghent Univ Hosp, Dept Pulm Dis, B-9000 Ghent, Belgium; Hvidovre Univ Hosp, Lungemed Klin, Hvidovre, Denmark; Univ London St Georges Hosp, Dept Med Physiol, London, England; Natl Heart & Lung Inst, Dept Thorac Med, Bergen, Norway; GlaxoSmithKline Res & Dev Ltd, Greenford, Middx, England	Aintree University Hospitals NHS Foundation Trust; University of Liverpool; Ghent University; Ghent University Hospital; University of Copenhagen; St Georges University London; GlaxoSmithKline	Calverley, P (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Ctr Clin Sci, Dept Med, Liverpool L9 7AL, Merseyside, England.	pmacal@liverpool.ac.uk	Vestbo, Jorgen/Y-2912-2019	Vestbo, Jorgen/0000-0001-6355-6362				Barnes PJ, 2002, EUR RESPIR J, V19, P182, DOI 10.1183/09031936.02.00283202; Barnes PJ, 2000, AM J RESP CRIT CARE, V161, P342; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Boyd G, 1997, EUR RESPIR J, V10, P815; BROWN H, 1999, REPEATED MEASURES DA, P199; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; Dahl R, 2001, AM J RESP CRIT CARE, V164, P778, DOI 10.1164/ajrccm.164.5.2007006; Di Lorenzo G, 1998, CLIN THER, V20, P1130, DOI 10.1016/S0149-2918(98)80109-4; Dowson LJ, 2001, AM J RESP CRIT CARE, V163, P936, DOI 10.1164/ajrccm.163.4.2007048; *GLOB IN CHRON OBS, 2001, NIH PUBL, V2701; HOLLANDER M, 1973, NONPARAMETRIC STAT M, P67; Johnson M, 2001, CHEST, V120, P258, DOI 10.1378/chest.120.1.258; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Jones PW, 1997, AM J RESP CRIT CARE, V155, P1283, DOI 10.1164/ajrccm.155.4.9105068; Knox AJ, 2001, EUR RESPIR J, V17, P1059, DOI 10.1183/09031936.01.00092301; Mahler DA, 1999, CHEST, V115, P957, DOI 10.1378/chest.115.4.957; Osman LM, 1997, THORAX, V52, P67; Paggiaro PL, 1998, LANCET, V351, P773, DOI 10.1016/S0140-6736(97)03471-5; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Pearson MG, 1997, THORAX, V52, pS1; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rennard SI, 2001, AM J RESP CRIT CARE, V163, P1087, DOI 10.1164/ajrccm.163.5.9903053; Rossi A, 2002, CHEST, V121, P1058, DOI 10.1378/chest.121.4.1058; Rutten-van Molken M, 1999, THORAX, V54, P995; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; SIAFAKAS NM, 1995, EUR RESPIR J, V8, P1398, DOI 10.1183/09031936.95.08081398; Taccola M, 1999, Monaldi Arch Chest Dis, V54, P302; THOMPSON AB, 1992, AM REV RESPIR DIS, V146, P389, DOI 10.1164/ajrccm/146.2.389; VANELTEREN P, 1960, B INT STATIST INST, V37, P351; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; WIJKSTRA PJ, 1994, THORAX, V49, P465, DOI 10.1136/thx.49.5.465	33	811	853	0	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					449	456		10.1016/S0140-6736(03)12459-2	http://dx.doi.org/10.1016/S0140-6736(03)12459-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583942				2022-12-28	WOS:000180900600007
J	Thies, F; Garry, JMC; Yaqoob, P; Rerkasem, K; Williams, J; Shearman, CP; Gallagher, PJ; Calder, PC; Grimble, RF				Thies, F; Garry, JMC; Yaqoob, P; Rerkasem, K; Williams, J; Shearman, CP; Gallagher, PJ; Calder, PC; Grimble, RF			Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial	LANCET			English	Article							CORONARY HEART-DISEASE; LONG-CHAIN N-3; FISH-OIL; MYOCARDIAL-INFARCTION; EICOSAPENTAENOIC ACID; RISK; MORTALITY; CONSUMPTION; DEATH; SUPPLEMENTATION	Background N-3 polyunsaturated fatty acids (PUFAs) from oily fish protect against death from cardiovascular disease. We aimed to assess the hypothesis that incorporation of n-3 and n-6 PUFAs into advanced atherosclerotic plaques increases and decreases plaque stability, respectively. Methods We did a randomised controlled trial of patients awaiting carotid endarterectomy. We randomly allocated patients control, sunflower oil (n-6), or fish-oil (n-3) capsules until surgery. Primary outcome was plaque morphology indicative of stability or instability, and outcome measures were concentrations of EPA, DHA, and linoleic acid in carotid plaques; plaque morphology; and presence of macrophages in plaques. Analysis was per protocol. Findings 188 patients were enrolled and randomised; 18 withdrew and eight were excluded. Duration of oil treatment was 7-189 days (median 42) and did not differ between groups. The proportions of EPA and DHA were higher in carotid plaque fractions in patients receiving fish oil compared with those receiving control (absolute difference 0.5 [95% CI 0.3-0.7], 0.4 [0.1-0.6], and 0.2 [0.1-0.4] g/100 g total fatty acids for EPA; and 0.3 [0.0-0.8], 0.4 [0.1-0.7], and 0.3 [0.1-0.6] g/100 g total fatty acids for DHA; in plaque phospholipids, cholesteryl esters, and triacylglycerols, respectively). Sunflower oil had little effect on the fatty acid composition of lipid fractions. Fewer plaques from patients being treated with fish oil had thin fibrous caps and signs of inflammation and more plaques had thick fibrous caps and no signs of inflammation, compared with plaques in patients in the control and sunflower oil groups (odds ratio 0.52 [95% CI 0.24-0.89] and 1.19 [1.02-1.57] vs control; 0.49 [0.23-0.90] and 1.16 [1.01-1.53] vs sunflower oil). The number of macrophages in plaques from patients receiving fish oil was lower than in the other two groups. Carotid plaque morphology and infiltration by macrophages did not differ between control and sunflower oil groups. Interpretation Atherosclerotic plaques readily incorporate n-3 PUFAs from fish-oil supplementation, inducing changes that can enhance stability of atherosclerotic plaques. By contrast, increased consumption of n-6 PUFAs does not affect carotid plaque fatty-acid composition or stability over the time course studied here. Stability of plaques could explain reductions in non-fatal and fatal cardiovascular events associated with increased n-3 PUFA intake.	Univ Southampton, Sch Med, Inst Human Nutr, Southampton SO16 7PX, Hants, England; Univ Southampton, Dept Pathol & Microbiol, Southampton SO16 7PX, Hants, England; Southampton Univ Hosp NHS Trust, Dept Vasc Surg, Southampton, Hants, England	University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	Calder, PC (corresponding author), Univ Southampton, Sch Med, Inst Human Nutr, Bassett Crescent E, Southampton SO16 7PX, Hants, England.	pcc@soton.ac.uk	Calder, Philip C/E-9739-2013	Calder, Philip C/0000-0002-6038-710X; thies, frank/0000-0002-9275-9713				Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Baumann KH, 1999, ARTERIOSCL THROM VAS, V19, P59, DOI 10.1161/01.ATV.19.1.59; *BRIT NUTR FDN, 1999, BRIEF PAP N3 FATT AC; British Nutrition Foundation, 1992, UNS FATT AC NUTR PHY; BURR ML, 1989, LANCET, V2, P757; Calder PC, 2002, P NUTR SOC, V61, P345, DOI 10.1079/PNS2002166; Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502; DAVIS HR, 1987, ARTERIOSCLEROSIS, V7, P441, DOI 10.1161/01.ATV.7.5.441; DOLECEK TA, 1992, P SOC EXP BIOL MED, V200, P177, DOI 10.3181/00379727-200-43413; FESKENS EJM, 1993, DIABETES CARE, V16, P1029, DOI 10.2337/diacare.16.7.1029; Finstad HS, 1998, BIOCHEM J, V336, P451, DOI 10.1042/bj3360451; Grimble RF, 1998, P NUTR SOC, V57, P535, DOI 10.1079/PNS19980078; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; KROMHOUT D, 1995, INT J EPIDEMIOL, V24, P340, DOI 10.1093/ije/24.2.340; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; Leaf A, 1998, Curr Opin Clin Nutr Metab Care, V1, P225, DOI 10.1097/00075197-199803000-00014; Libby P, 1996, CURR OPIN LIPIDOL, V7, P330, DOI 10.1097/00041433-199610000-00012; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; Mortensen A, 1998, BRIT J NUTR, V80, P565, DOI 10.1017/S0007114598001664; Pedersen JI, 2000, EUR J CLIN NUTR, V54, P618, DOI 10.1038/sj.ejcn.1601064; Plutzky J, 1999, AM J CARDIOL, V84, p15J; RAPP JH, 1991, ARTERIOSCLER THROMB, V11, P903, DOI 10.1161/01.ATV.11.4.903; Schumacher H, 2001, EUR J VASC ENDOVASC, V21, P494, DOI 10.1053/ejvs.2001.1362; SINGH RB, 1997, CARDIOVASC DRUG THER, V11, P85; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Sweeney B, 2001, PEDIATR SURG INT, V17, P254, DOI 10.1007/s003830100589; Tavani A, 2001, CIRCULATION, V104, P2269, DOI 10.1161/hc4401.099450; Thies F, 2001, AM J CLIN NUTR, V73, P539; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; von Schacky C, 1999, ANN INTERN MED, V130, P554, DOI 10.7326/0003-4819-130-7-199904060-00003; WALLACE JMW, 1995, ARTERIOSCL THROM VAS, V15, P185, DOI 10.1161/01.ATV.15.2.185; WEINER BH, 1986, NEW ENGL J MED, V315, P841, DOI 10.1056/NEJM198610023151401	35	569	642	2	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					477	485		10.1016/S0140-6736(03)12468-3	http://dx.doi.org/10.1016/S0140-6736(03)12468-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583947				2022-12-28	WOS:000180900600012
J	Cyran, SA; Buchsbaum, AM; Reddy, KL; Lin, MC; Glossop, NRJ; Hardin, PE; Young, MW; Storti, RV; Blau, J				Cyran, SA; Buchsbaum, AM; Reddy, KL; Lin, MC; Glossop, NRJ; Hardin, PE; Young, MW; Storti, RV; Blau, J			vrille, Pdp1, and dClock form a second feedback loop in the Drosophila circadian clock	CELL			English	Article							LEUCINE-ZIPPER PROTEINS; GENE-EXPRESSION; DOUBLE-TIME; BZIP FAMILY; DNA-BINDING; TRANSCRIPTION; PERIOD; DBP; PAR; HOMOLOG	The Drosophila circadian clock consists of two interlocked transcriptional feedback loops. In one loop, dCLOCK/CYCLE activates period expression, and PERIOD protein then inhibits dCLOCK/CYCLE activity. dClock is also rhythmically transcribed, but its regulators are unknown. vrille (vri) and Par Domain Protein 1 (Pdp1) encode related transcription factors whose expression is directly activated by dCLOCK/CYCLE. We show here that VRI and PDP1 proteins feed back and directly regulate dClock expression. Repression of dClock by VRI is separated from activation by PDP1 since VRI levels peak 3-6 hours before PDP1. Rhythmic vri transcription is required for molecular rhythms, and here we show that the clock stops in a Pdp1 null mutant identifying Pdp1 as an essential clock gene. Thus, VRI and PDP1, together with dClock itself, comprise a second feedback loop in the Drosophila clock that gives rhythmic expression of dClock, and probably of other genes, to generate accurate circadian rhythms.	NYU, Dept Biol, New York, NY 10003 USA; Univ Illinois, Dept Biochem & Mol Biol, Chicago, IL 60612 USA; Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; Rockefeller Univ, New York, NY 10021 USA	New York University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Houston System; University of Houston; Rockefeller University	Blau, J (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.	justin.blau@nyu.edu	, 机智的马小跳和机智的羊不愁/ABC-5169-2020	Hardin, Paul/0000-0002-3370-9011; Reddy, Karen/0000-0003-4548-5999	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063911, R37GM054339, R01GM054339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061423] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54339, GM063911] Funding Source: Medline; NIMH NIH HHS [MH61423] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; COWELL IG, 1992, MOL CELL BIOL, V12, P3070, DOI 10.1128/MCB.12.7.3070; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Falvey E, 1996, BIOL CHEM, V377, P797; Fonjallaz P, 1996, EMBO J, V15, P351, DOI 10.1002/j.1460-2075.1996.tb00365.x; Franken P, 2000, J NEUROSCI, V20, P617, DOI 10.1523/JNEUROSCI.20-02-00617.2000; George H, 1997, GENETICS, V146, P1345; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Kaneko M, 1997, J NEUROSCI, V17, P6745; Kim EY, 2002, NEURON, V34, P69, DOI 10.1016/S0896-6273(02)00639-6; Kloss B, 2001, NEURON, V30, P699, DOI 10.1016/S0896-6273(01)00320-8; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lin SC, 1997, DEVELOPMENT, V124, P4685; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Reddy KL, 2000, DEV BIOL, V224, P401, DOI 10.1006/dbio.2000.9797; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Rothenfluh A, 2000, CURR BIOL, V10, P1399, DOI 10.1016/S0960-9822(00)00786-7; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Suri V, 2000, J NEUROSCI, V20, P7547; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000	42	390	404	4	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 7	2003	112	3					329	341		10.1016/S0092-8674(03)00074-6	http://dx.doi.org/10.1016/S0092-8674(03)00074-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581523	Bronze			2022-12-28	WOS:000181252200005
J	Langenau, DM; Traver, D; Ferrando, AA; Kutok, JL; Aster, JC; Kanki, JP; Lin, S; Prochownik, E; Trede, NS; Zon, LI; Look, AT				Langenau, DM; Traver, D; Ferrando, AA; Kutok, JL; Aster, JC; Kanki, JP; Lin, S; Prochownik, E; Trede, NS; Zon, LI; Look, AT			Myc-induced T cell leukemia in transgenic zebrafish	SCIENCE			English	Article							NEOPLASTIC PHENOTYPE; C-MYC; MODELS; HEART	The zebrafish is an attractive model organism for studying cancer development because of its genetic accessibility. Here we describe the induction of clonally derived T cell acute lymphoblastic leukemia in transgenic zebrafish expressing mouse c-myc under control of the zebrafish Rag2 promoter. Visualization of leukemic cells expressing a chimeric transgene encoding Myc fused to green fluorescent protein (GFP) revealed that leukemias arose in the thymus, spread locally into gill arches and retro-orbital soft tissue, and then disseminated into skeletal muscle and abdominal organs. Leukemic cells homed back to the thymus in irradiated fish transplanted with GFP-labeled leukemic lymphoblasts. This transgenic model provides a platform for drug screens and for genetic screens aimed at identifying mutations that suppress or enhance c-myc-induced carcinogenesis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Childrens Hosp Pittsburgh, Div Hematol Oncol, Pittsburgh, PA 15213 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp Boston, Div Hematol Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School	Look, AT (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	thomas_look@dfci.harvard.edu	Aster, Jon C/B-6857-2009; Langenau, David/GXI-0197-2022	Langenau, David/0000-0001-6664-8318	NATIONAL CANCER INSTITUTE [P01CA068484, P30CA006516] Funding Source: NIH RePORTER; NCI NIH HHS [CA-06516, CA-68484] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams JM, 1999, ONCOGENE, V18, P5268, DOI 10.1038/sj.onc.1202997; Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; Beckwith LG, 2000, LAB INVEST, V80, P379, DOI 10.1038/labinvest.3780042; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Driever W, 1996, DEVELOPMENT, V123, P37; Haffter P, 1996, DEVELOPMENT, V123, P1; Haire RN, 2000, IMMUNOGENETICS, V51, P915, DOI 10.1007/s002510000229; Hsu K, 2001, CURR OPIN HEMATOL, V8, P245, DOI 10.1097/00062752-200107000-00011; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jessen JR, 1999, NAT GENET, V23, P15, DOI 10.1038/12609; Jessen JR, 2001, GENESIS, V29, P156, DOI 10.1002/gene.1019; LOOK AT, 1998, GENETIC BASIS HUMAN, pCH5; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Peterson RT, 2001, CURR BIOL, V11, P1481, DOI 10.1016/S0960-9822(01)00482-1; STUART GW, 1988, DEVELOPMENT, V103, P403; Thisse C, 2002, SCIENCE, V295, P457, DOI 10.1126/science.1063654; TRAVER D, UNPUB; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Wu XM, 2001, TRENDS CELL BIOL, V11, pS2, DOI 10.1016/S0962-8924(01)82000-6; Yin XY, 2001, ONCOGENE, V20, P4650, DOI 10.1038/sj.onc.1204606	24	408	442	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					887	890		10.1126/science.1080280	http://dx.doi.org/10.1126/science.1080280			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574629				2022-12-28	WOS:000180830900051
J	Weber, JE; Shofer, FS; Larkin, GL; Kalaria, AS; Hollander, JE				Weber, JE; Shofer, FS; Larkin, GL; Kalaria, AS; Hollander, JE			Validation of a brief observation period for patients with cocaine-associated chest pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION	Background: Retrospective studies of patients with cocaine-associated chest pain suggest that a strategy of discharging patients from the emergency department after a 12-hour observation period if they do not have evidence of ischemia should be associated with a very low rate of complications. Methods: We prospectively evaluated the safety of a 9-to-12-hour observation period in patients with cocaine-associated chest pain who were at low-to-intermediate risk of cardiovascular events. Consecutive patients who reported or tested positive for cocaine use and who received protocol-driven care in a chest-pain observation unit were included. Patients who had normal levels of troponin I, without new ischemic changes on electrocardiography, and who had no cardiovascular complications (dysrhythmias, acute myocardial infarction, or recurrent symptoms) during the 9-to-12-hour observation period were discharged from the unit. The main outcome was death from cardiovascular causes at 30 days. Results: Three hundred forty-four patients with cocaine-associated chest pain were evaluated. Forty-two of these patients (12 percent) were directly admitted to the hospital. The study cohort comprised the remaining 302 patients. During the 30-day follow-up period, none of the patients died of a cardiovascular event (0 percent; 95 percent confidence interval, 0 to 0.99), and only 4 of the 256 patients for whom detailed follow-up data were available had a nonfatal myocardial infarction (1.6 percent; 95 percent confidence interval, 0.1 to 3.1). All four nonfatal myocardial infarctions occurred in patients who continued to use cocaine. Conclusions: Patients with cocaine-associated chest pain who do not have evidence of ischemia or cardiovascular complications over a 9-to-12-hour period in a chest-pain observation unit have a very low risk of death or myocardial infarction during the 30 days after discharge.	Childrens Hosp Philadelphia, Dept Emergency Med, Philadelphia, PA 19104 USA; Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; Hurley Med Ctr, Dept Emergency Med, Flint, MI USA; Univ Texas, SW Med Ctr, Div Emergency Med, Dallas, TX USA; Northwestern Univ, Sch Med, Dept Emergency Med, Chicago, IL USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Michigan System; University of Michigan; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Northwestern University	Hollander, JE (corresponding author), Childrens Hosp Philadelphia, Dept Emergency Med, Ground Fl,Ravdin Bldg,3400 Spruce St, Philadelphia, PA 19104 USA.	jholland@mail.med.upenn.edu		Hollander, Judd/0000-0002-1318-2785; LARKIN, GREGORY LUKE/0000-0002-8655-7824				AMIN M, 1990, AM J CARDIOL, V66, P1434, DOI 10.1016/0002-9149(90)90529-A; BRAUNWALD E, 1989, CIRCULATION, V80, P410, DOI 10.1161/01.CIR.80.2.410; BRODY SL, 1990, AM J MED, V88, P325, DOI 10.1016/0002-9343(90)90484-U; Farkouh ME, 1998, NEW ENGL J MED, V339, P1882, DOI 10.1056/NEJM199812243392603; Feldman JA, 2000, ANN EMERG MED, V36, P469, DOI 10.1067/mem.2000.110994; FLORES ED, 1990, J AM COLL CARDIOL, V16, P74, DOI 10.1016/0735-1097(90)90459-3; GIBLER WB, 1995, ANN EMERG MED, V25, P1, DOI 10.1016/S0196-0644(95)70347-0; GITTER MJ, 1991, ANN INTERN MED, V115, P277, DOI 10.7326/0003-4819-115-4-277; Hoekstra J W, 1994, Acad Emerg Med, V1, P103; Hollander J E, 1994, Acad Emerg Med, V1, P330; HOLLANDER JE, 1995, ARCH INTERN MED, V155, P1081, DOI 10.1001/archinte.155.10.1081; HOLLANDER JE, 1995, ACAD EMERG MED, V2, P179, DOI 10.1111/j.1553-2712.1995.tb03191.x; Hollander JE, 1998, AM HEART J, V135, P245, DOI 10.1016/S0002-8703(98)70089-4; HOLLANDER JE, 1995, NEW ENGL J MED, V333, P1267, DOI 10.1056/NEJM199511093331907; Hollander Judd E., 1994, Journal of Emergency Medicine, V12, P199, DOI 10.1016/0736-4679(94)90699-8; Kontos MC, 1999, ANN EMERG MED, V33, P639; Kushman SO, 2000, AM J CARDIOL, V85, P394, DOI 10.1016/S0002-9149(99)00755-9; Lange RA, 2001, NEW ENGL J MED, V345, P351, DOI 10.1056/NEJM200108023450507; LANGE RA, 2001, NEW ENGL J MED, V345, P1432; LEE TH, 1991, NEW ENGL J MED, V324, P1239, DOI 10.1056/NEJM199105023241803; Mittleman MA, 1999, CIRCULATION, V99, P2737, DOI 10.1161/01.CIR.99.21.2737; *OFF APPL STUD, 2001, DHHS PUBL; Qureshi AI, 2001, CIRCULATION, V103, P502, DOI 10.1161/01.CIR.103.4.502; *SUBST AB MENT HLT, 2000, 1999 NAT HOUS SURV D; TOKARSKI GF, 1990, ANN EMERG MED, V19, P1088, DOI 10.1016/S0196-0644(05)81509-4; Walker NJ, 2001, ACAD EMERG MED, V8, P703, DOI 10.1111/j.1553-2712.2001.tb00188.x; Weber JE, 2000, ACAD EMERG MED, V7, P873, DOI 10.1111/j.1553-2712.2000.tb02064.x	27	86	89	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2003	348	6					510	517		10.1056/NEJMoa022206	http://dx.doi.org/10.1056/NEJMoa022206			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642JY	12571258	Bronze			2022-12-28	WOS:000180801400004
J	Keavney, B; Parish, S; Palmer, A; Clark, S; Youngman, L; Danesh, J; McKenzie, C; Delepine, M; Lathrop, M; Peto, R; Collins, R				Keavney, B; Parish, S; Palmer, A; Clark, S; Youngman, L; Danesh, J; McKenzie, C; Delepine, M; Lathrop, M; Peto, R; Collins, R		ISIS Collaborators	Large-scale evidence that the cardiotoxicity of smoking is not significantly modified by the apolipoprotein E epsilon 2/epsilon 3/epsilon 4 genotype	LANCET			English	Article							CORONARY HEART-DISEASE; MYOCARDIAL-INFARCTION; MEN	Results from two small studies, involving a total of only 174 cases, have suggested that the increased. risk of coronary heart disease conferred by cigarette smoking Is substantially affected by genotype at the apolipoprotein E (APOE) epsilon2/epsilon3/epsilon4 polymorphism. We have established APOE genotypes in 4484 patients With acute myocardial infarction diagnosed before the age of 55 years for male and 65 years for female patients, and in 5757 controls with no history of cardiovascular disease. On average, the hazard ratio for myocardial infarction was 1.17 (95% CI 1.09-1.25; p<0.00001) per stepwise change from &epsilon;3/2 to &epsilon;3/3 to &epsilon;3/4 genotype. Among individuals in this study with known cigarette smoking status, the hazard ratio for myocardial infarction in smokers versus non-smokers was 4.6 (4.2-5.1). There was, however, no significant difference between the smoker/non-smoker hazard ratios for those with different APOE genotypes (&chi;(2)(2)=0.69; p=0.7). When differences in risk between different genotypes are not extreme (as with this APOE polymorphism), reliable assessment of hypothesised gene-environment interactions will often require the study of many thousands of disease cases.	Univ Newcastle Upon Tyne, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; Univ Oxford, Clin Trial Serv Unit, Oxford, England; Univ Oxford, Epidemiol Studies Unit, Oxford, England; Univ W Indies, Trop Metab Res Unit, Kingston 7, Jamaica; Ctr Natl Genotypage, Paris, France	Newcastle University - UK; University of Oxford; University of Oxford; University West Indies Mona Jamaica; CEA	Keavney, B (corresponding author), Univ Newcastle Upon Tyne, Inst Human Genet, Int Ctr Life, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.			Keavney, Bernard/0000-0001-9573-0812				Humphries SE, 2001, LANCET, V358, P115, DOI 10.1016/S0140-6736(01)05330-2; Keavney B, 2000, LANCET, V355, P434; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; Stengard JH, 1999, CLIN GENET, V56, P367; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250	5	40	42	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					396	398		10.1016/S0140-6736(03)12386-0	http://dx.doi.org/10.1016/S0140-6736(03)12386-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573381				2022-12-28	WOS:000180787000017
J	van Leeuwen, R; Vingerling, JR; Hofman, A; de Jong, PTVM; Stricker, BH				van Leeuwen, R; Vingerling, JR; Hofman, A; de Jong, PTVM; Stricker, BH			Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement	BRITISH MEDICAL JOURNAL			English	Article							MACULAR DEGENERATION		Erasmus Med Ctr Rotterdam, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Erasmus Med Ctr Rotterdam, Dept Ophthalmol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	de Jong, PTVM (corresponding author), Netherlands Ophthalm Res Inst, KNAW, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.							Arnold JJ, 2000, BRIT MED J, V321, P741, DOI 10.1136/bmj.321.7263.741; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Hall NF, 2001, BRIT MED J, V323, P375, DOI 10.1136/bmj.323.7309.375; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; McCarty CA, 2001, MED J AUSTRALIA, V175, P340, DOI 10.5694/j.1326-5377.2001.tb143604.x	5	60	61	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					255	256		10.1136/bmj.326.7383.255	http://dx.doi.org/10.1136/bmj.326.7383.255			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560276	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000180908300019
J	Konacki, M; Torres, G; Jha, S; Sasselov, DD				Konacki, M; Torres, G; Jha, S; Sasselov, DD			An extrasolar planet that transits the disk of its parent star	NATURE			English	Article							GRAVITATIONAL LENSING EXPERIMENT; LUMINOSITY OBJECT TRANSITS; GALACTIC DISK; SEARCH	Planets orbiting other stars could in principle be found through the periodic dimming of starlight as a planet moves across-or 'transits'-the line of sight between the observer and the star. Depending on the size of the planet relative to the star, the dimming could reach a few per cent of the apparent brightness of the star. Despite many searches, no transiting planet has been discovered in this way; the one known 1,2 transiting planet-HD209458b-was first discovered using precise measurements(2,3) of the parent star's radial velocity and only subsequently detected photometrically. Here we report radial velocity measurements of the star OGLE-TR-56, which was previously found to exhibit a 1.2-day transit-like light curve 4,5 in a survey looking for gravitational microlensing events. The velocity changes that we detect correlate with the light curve, from which we conclude that they are probably induced by an object of around 0.9 Jupiter masses in an orbit only 0.023 AU from its star. We estimate the planetary radius to be around 1.3 Jupiter radii and its density to be about 0.5 g cm(-3). This object is hotter than any known planet (similar to1,900 K), but is still stable against long-term evaporation or tidal disruption.	CALTECH, Div Geol & Planteary Sci 150 21, Pasadena, CA 91125 USA; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA	California Institute of Technology; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of California System; University of California Berkeley	Konacki, M (corresponding author), CALTECH, Div Geol & Planteary Sci 150 21, Pasadena, CA 91125 USA.	maciej@gps.caltech.edu	Konacki, Maciej/A-1220-2007	Konacki, Maciej/0000-0003-3400-1610; Jha, Saurabh/0000-0001-8738-6011				Brown TM, 2001, ASTROPHYS J, V552, P699, DOI 10.1086/320580; Brown TM, 2002, PUBL ASTRON SOC PAC, V114, P826, DOI 10.1086/341717; Charbonneau D, 2000, ASTROPHYS J, V529, pL45, DOI 10.1086/312457; Charbonneau D, 2002, ASTROPHYS J, V568, P377, DOI 10.1086/338770; Cody AM, 2002, ASTROPHYS J, V569, P451, DOI 10.1086/339281; Henry GW, 2000, ASTROPHYS J, V529, pL41, DOI 10.1086/312458; HORNE K, IN PRESS SCI FRONTIE; Jha S, 2000, ASTROPHYS J, V540, pL45, DOI 10.1086/312869; Marcy GW, 1998, ANNU REV ASTRON ASTR, V36, P57, DOI 10.1146/annurev.astro.36.1.57; Mazeh T, 2000, ASTROPHYS J, V532, pL55, DOI 10.1086/312558; Queloz D, 2001, ASTRON ASTROPHYS, V379, P279, DOI 10.1051/0004-6361:20011308; Santos NC, 2002, ASTRON ASTROPHYS, V392, P215, DOI 10.1051/0004-6361:20020876; SCHNEIDER J, 2002, EXTRASOLAR PLANET EN; SEAGER S, 2002, UNPUB ASTROPHYS J; Tinney CG, 2001, ASTROPHYS J, V551, P507, DOI 10.1086/320097; Trilling DE, 1998, ASTROPHYS J, V500, P428, DOI 10.1086/305711; Udalski A, 2002, ACTA ASTRONOM, V52, P1; Udalski A, 2002, ACTA ASTRONOM, V52, P115; VOGT S, 1994, P SOC PHOTO-OPT INS, V2198, P362, DOI 10.1117/12.176725; WOLSZCZAN A, 1992, NATURE, V355, P145, DOI 10.1038/355145a0; ZUCKER S, 1994, ASTROPHYS J, V420, P806, DOI 10.1086/173605	22	292	293	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2003	421	6922					507	509		10.1038/nature01379	http://dx.doi.org/10.1038/nature01379			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556885				2022-12-28	WOS:000180670600037
J	Shu, DG; Morris, SC; Han, J; Zhang, ZF; Yasui, K; Janvier, P; Chen, L; Zhang, XL; Liu, JN; Li, Y; Liu, HQ				Shu, DG; Morris, SC; Han, J; Zhang, ZF; Yasui, K; Janvier, P; Chen, L; Zhang, XL; Liu, JN; Li, Y; Liu, HQ			Head and backbone of the Early Cambrian vertebrate Haikouichthys	NATURE			English	Article							EVOLUTION; CHINA; PERSPECTIVES; AMPHIOXUS; HAGFISHES; INSIGHTS; LAMPREYS; ORIGIN	Agnathan fish hold a key position in vertebrate evolution, especially regarding the origin of the head and neural-crest-derived tissue(1). In contrast to amphioxus(2), lampreys and other vertebrates possess a complex brain and placodes that contribute to well-developed eyes, as well as auditory and olfactory systems(3). These sensory sytems were arguably a trigger to subsequent vertebrate diversifications. However, although they are known from skeletal impressions in younger Palaeozoic agnathans(4), information about the earliest records of these systems has been largely wanting. Here we report numerous specimens of the Lower Cambrian vertebrate Haikouichthys ercaicunensis, until now only known from the holotype(5). Haikouichthys shows significant differences from other fossil agnathans: key features include a small lobate extension to the head, with eyes and possible nasal sacs, as well as what may be otic capsules. A notochord with separate vertebral elements is also identifiable. Phylogenetic analysis indicates that this fish lies within the stem-group craniates. Although Haikouichthys somewhat resembles the ammocoete larva of modern lampreys, this is because of shared general craniate characters; adult lampreys and hagfishes (the cyclostomes if monophyletic(6,7)) are probably derived in many respects.	NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China; NW Univ Xian, Dept Geol, Xian 710069, Peoples R China; China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Kumamoto Univ, Div Dev & Biohist, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; CNRS, UMR 8569, Lab Paleontol, Museum Natl Hist Nat, F-75005 Paris, France; Museum Nat Hist, Dept Palaeontol, London SW7 5BD, England	Northwest University Xi'an; Northwest University Xi'an; China University of Geosciences; University of Cambridge; Kumamoto University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Natural History Museum London	Shu, DG (corresponding author), NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China.			zhang, zhifei/0000-0003-0325-5116				Bardack D., 1971, BIOL LAMPREYS, V1, P67; Cohn MJ, 2002, NATURE, V416, P386, DOI 10.1038/416386a; COLE WC, 1982, AM J ANAT, V165, P131, DOI 10.1002/aja.1001650205; Farris J. S., 1988, HENNIG86 VERSION 1 5; Fritzsch B, 1998, OTOLARYNG HEAD NECK, V119, P182, DOI 10.1016/S0194-5998(98)70053-1; GABBOTT SE, 1995, NATURE, V374, P800, DOI 10.1038/374800a0; Gagnier P. Y., 1993, Annales de Paleontologie, V79, P119; Gagnier Pierre-Yves, 1993, Annales de Paleontologie, V79, P19; Holland LZ, 2001, J ANAT, V199, P85, DOI 10.1046/j.1469-7580.2001.19910085.x; Holland ND, 2001, BIOESSAYS, V23, P142, DOI 10.1002/1521-1878(200102)23:2<142::AID-BIES1021>3.0.CO;2-5; Janvier P, 1996, PALAEONTOLOGY, V39, P259; Janvier P, 1999, NATURE, V402, P21, DOI 10.1038/46909; Janvier P., 1996, EARLY VERTEBRATES; KLEEREKOPER H, 1972, BIOL LAMPREYS, V2, P373; Kuraku S, 1999, J MOL EVOL, V49, P729, DOI 10.1007/PL00006595; Kuratani S, 2001, PHILOS T ROY SOC B, V356, P1615, DOI 10.1098/rstb.2001.0976; Lacalli TC, 1996, PHILOS T ROY SOC B, V351, P243, DOI 10.1098/rstb.1996.0022; Lacalli TC, 2001, PHILOS T ROY SOC B, V356, P1565, DOI 10.1098/rstb.2001.0974; Mallat J, 1998, MOL BIOL EVOL, V15, P1706, DOI 10.1093/oxfordjournals.molbev.a025897; Northcutt R. Glenn, 1996, Israel Journal of Zoology, V42, P273; RAMOS TC, 1996, TREE GARDNERER VERSI; Ritchie A., 1968, Palaeontology, V11, P21; Shigetani Y, 2002, SCIENCE, V296, P1316, DOI 10.1126/science.1068310; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Shu DG, 1996, NATURE, V384, P157, DOI 10.1038/384157a0; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Shu DG, 2001, NATURE, V411, P472, DOI 10.1038/35078069; Shu DG, 2001, NATURE, V414, P419, DOI 10.1038/35106514; Zhang XL, 2001, J GEOL SOC LONDON, V158, P211, DOI 10.1144/jgs.158.2.211	29	207	228	4	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					526	529		10.1038/nature01264	http://dx.doi.org/10.1038/nature01264			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556891				2022-12-28	WOS:000180670600043
J	Jackson, PK				Jackson, PK			Ubiquitinating a phosphorylated Cdk inhibitor on the blades of the Cdc4 beta-propeller	CELL			English	Article							MULTISITE PHOSPHORYLATION; LIGASE COMPLEX; PROTEINS	Substrate binding by the SCFCdc4 ubiquitin ligase is regulated by phosphorylation. In this issue of Cell, Orlicky et al. describe the crystal structure of the Cdc4 subunit bound to a high-affinity substrate phosphopeptide. This structure provides insights into the binding interaction and how a precise mechanism involving multiple regulatory phosphorylations may be mediated by a single binding site.	Stanford Univ, Sch Med, Program Chem Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Jackson, PK (corresponding author), Stanford Univ, Sch Med, Program Chem Biol, 300 Pasteur Dr, Stanford, CA 94305 USA.			Jackson, Peter/0000-0002-1742-2539				Deshaies RJ, 2001, CELL, V107, P819, DOI 10.1016/S0092-8674(01)00620-1; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Kominami K, 1998, GENES CELLS, V3, P721, DOI 10.1046/j.1365-2443.1998.00225.x; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	10	2	2	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 24	2003	112	2					142	144		10.1016/S0092-8674(03)00041-2	http://dx.doi.org/10.1016/S0092-8674(03)00041-2			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553901	Bronze			2022-12-28	WOS:000181191600002
J	Polyansky, OL; Csaszar, AG; Shirin, SV; Zobov, NF; Barletta, P; Tennyson, J; Schwenke, DW; Knowles, PJ				Polyansky, OL; Csaszar, AG; Shirin, SV; Zobov, NF; Barletta, P; Tennyson, J; Schwenke, DW; Knowles, PJ			High-accuracy ab initio rotation-vibration transitions for water	SCIENCE			English	Article							POTENTIAL-ENERGY SURFACE; BORN-OPPENHEIMER APPROXIMATION; BASIS-SET CONVERGENCE; RELATIVISTIC CORRECTIONS; LIMIT; H-3(+)	The spectrum of water vapor is of fundamental importance for a variety of processes, including the absorption and retention of sunlight in Earth's atmosphere. Therefore, there has long been an urgent need for a robust and accurate predictive model for this spectrum. In our work on the high-resolution spectrum of water, we report first-principles calculations that approach experimental accuracy. To achieve this, we performed exceptionally large electronic structure calculations and considered a variety of effects, including quantum electrodynamics, which have routinely been neglected in studies of small many-electron molecules. The high accuracy of the resulting ab initio procedure is demonstrated for the main isotopomers of water.	UCL, Dept Phys & Astron, London WC1E 6BT, England; Eotvos Lorand Univ, Dept Theoret Chem, H-1518 Budapest 112, Hungary; Russian Acad Sci, Inst Appl Phys, Nizhnii Novgorod 603950, Russia; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Birmingham, Sch Chem Sci, Birmingham B15 2TT, W Midlands, England	University of London; University College London; Eotvos Lorand University; Russian Academy of Sciences; Institute of Applied Physics of the Russian Academy of Sciences; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Birmingham	Tennyson, J (corresponding author), UCL, Dept Phys & Astron, Gower St, London WC1E 6BT, England.	j.tennyson@ucl.ac.uk	Tennyson, Jonathan/I-2222-2012; Csaszar, Attila G/A-5241-2009; Knowles, Peter/G-2985-2010; schwenke, david w/I-3564-2013; Nikolay, Zobov/U-1709-2019	Tennyson, Jonathan/0000-0002-4994-5238; Csaszar, Attila G/0000-0001-5640-191X; Knowles, Peter/0000-0003-4657-6331; 				BUNKER PR, 1980, J MOL SPECTROSC, V80, P217, DOI 10.1016/0022-2852(80)90283-0; Callegari A, 2002, SCIENCE, V297, P993, DOI 10.1126/science.1073731; Cencek W, 1998, J CHEM PHYS, V108, P2831, DOI 10.1063/1.475702; COWAN RD, 1976, J OPT SOC AM, V66, P1010, DOI 10.1364/JOSA.66.001010; Csaszar AG, 1999, CHEM PHYS LETT, V312, P613; Csaszar AG, 1998, J CHEM PHYS, V108, P9751, DOI 10.1063/1.476449; Csaszar AG, 1998, CHEM PHYS LETT, V293, P317, DOI 10.1016/S0009-2614(98)00697-6; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; FELLER D, 1993, J CHEM PHYS, V98, P7059, DOI 10.1063/1.464749; Grant IP, 2000, INT J QUANTUM CHEM, V80, P283, DOI 10.1002/1097-461X(2000)80:3<283::AID-QUA2>3.0.CO;2-L; Halkier A, 1999, CHEM PHYS LETT, V302, P437, DOI 10.1016/S0009-2614(99)00179-7; Helgaker T, 1997, J CHEM PHYS, V106, P9639, DOI 10.1063/1.473863; Klopper W, 1999, J PHYS B-AT MOL OPT, V32, pR103, DOI 10.1088/0953-4075/32/13/201; KUTCHITSU K, COMMUNICATION; Partridge H, 1997, J CHEM PHYS, V106, P4618, DOI 10.1063/1.473987; Polyansky OL, 1997, SCIENCE, V277, P346, DOI 10.1126/science.277.5324.346; Polyansky OL, 1999, J CHEM PHYS, V110, P5056, DOI 10.1063/1.478404; Pyykkii P., 1978, ADV QUANTUM CHEM, V11, P353, DOI [DOI 10.1016/S0065-3276(08)60241-5, 10.1016/S0065-3276(08)60241-5]; Pyykko P, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.024502; Quiney HM, 1998, CHEM PHYS LETT, V290, P473, DOI 10.1016/S0009-2614(98)00568-5; Quiney HM, 2001, CHEM PHYS LETT, V344, P413, DOI 10.1016/S0009-2614(01)00784-9; Schwenke DW, 2001, J PHYS CHEM A, V105, P2352, DOI 10.1021/jp0032513; Tarczay G, 2001, MOL PHYS, V99, P1769, DOI 10.1080/00268970110073907; TENNYSON J, 1995, COMPUT PHYS COMMUN, V86, P175, DOI 10.1016/0010-4655(94)00139-S; Tennyson J, 2002, SPECTROCHIM ACTA A, V58, P663, DOI 10.1016/S1386-1425(01)00663-1; Tennyson J, 2001, J PHYS CHEM REF DATA, V30, P735, DOI 10.1063/1.1364517; Valeev EF, 2001, J CHEM PHYS, V114, P2875, DOI 10.1063/1.1346576; VALEEV EF, UNPUB; WAYNE RP, 2000, CHEM ATMOSPHERES, P50	29	271	275	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					539	542		10.1126/science.1079558	http://dx.doi.org/10.1126/science.1079558			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543967	Green Submitted			2022-12-28	WOS:000180559800041
J	Sambridge, M				Sambridge, M			An ensemble view of Earth's inner core	SCIENCE			English	Editorial Material									Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia	Australian National University	Sambridge, M (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia.		Sambridge, Malcolm/E-6902-2011	Sambridge, Malcolm/0000-0003-2858-3175				Beghein C, 2003, SCIENCE, V299, P552, DOI 10.1126/science.1078159; Davis L, 1987, GENETIC ALGORITHMS S; Ishii M, 2002, P NATL ACAD SCI USA, V99, P14026, DOI 10.1073/pnas.172508499; PRESS F, 1968, J GEOPHYS RES, V73, P5223, DOI 10.1029/JB073i016p05223; PRICE GD, 2002, EOS S, V83; Sambridge M, 1999, GEOPHYS J INT, V138, P479, DOI 10.1046/j.1365-246X.1999.00876.x; SAMBRIDGE M, 2002, REV GEOPHYS, V40; Taubes G, 1996, SCIENCE, V274, P1840	8	6	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					529	530		10.1126/science.1080685	http://dx.doi.org/10.1126/science.1080685			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543963				2022-12-28	WOS:000180559800036
J	Bunge, M; Adrian, L; Kraus, A; Opel, M; Lorenz, WG; Andreesen, JR; Gorisch, H; Lechner, U				Bunge, M; Adrian, L; Kraus, A; Opel, M; Lorenz, WG; Andreesen, JR; Gorisch, H; Lechner, U			Reductive dehalogenation of chlorinated dioxins by an anaerobic bacterium	NATURE			English	Article							DIBENZO-P-DIOXINS; MICROBIAL CONSORTIUM; ESTUARINE SEDIMENTS; DECHLORINATION; TETRACHLOROETHENE; DIVERSITY; CULTURES; PCDD/F; RIVER	Polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDDs and PCDFs) are among the most notorious environmental pollutants. Some congeners, particularly those with lateral chlorine substitutions at positions 2, 3, 7 and 8, are extremely toxic and carcinogenic to humans(1). One particularly promising mechanism for the detoxification of PCDDs and PCDFs is microbial reductive dechlorination. So far only a limited number of phylogenetically diverse anaerobic bacteria have been found that couple the reductive dehalogenation of chlorinated compounds-the substitution of a chlorine for a hydrogen atom-to energy conservation and growth in a process called dehalorespiration(2). Microbial dechlorination of PCDDs occurs in sediments and anaerobic mixed cultures from sediments, but the responsible organisms have not yet been identified or isolated. Here we show the presence of a Dehalococcoides species in four dioxin-dechlorinating enrichment cultures from a freshwater sediment highly contaminated with PCDDs and PCDFs. We also show that the previously described chlorobenzene-dehalorespiring bacterium Dehalococcoides sp. strain CBDB1 (ref. 3) is able to reductively dechlorinate selected dioxin congeners. Reductive dechlorination of 1, 2,3,7,8-pentachlorodibenzo-p-dioxin (PeCDD) demonstrates that environmentally significant dioxins are attacked by this bacterium.	Univ Halle Wittenberg, Inst Mikrobiol, D-06099 Halle Saale, Germany; Univ Halle Wittenberg, Inst Analyt & Umweltchem, D-06099 Halle Saale, Germany; Tech Univ Berlin, Inst Biotechnol, Fachgebiet Tech Biochem, D-13353 Berlin, Germany; GfA Gesell Arbeitsplatz & Umweltanalyt mbH, D-06896 Straach, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Technical University of Berlin	Bunge, M (corresponding author), Univ Halle Wittenberg, Inst Mikrobiol, D-06099 Halle Saale, Germany.		Bunge, Michael/J-6261-2012; Adrian, Lorenz/A-4443-2012	Bunge, Michael/0000-0001-7124-2750; Adrian, Lorenz/0000-0001-8205-0842				ADRIAENS P, 1994, CHEMOSPHERE, V29, P2253, DOI 10.1016/0045-6535(94)90392-1; ADRIAENS P, 1995, ENVIRON SCI TECHNOL, V29, P2252, DOI 10.1021/es00009a015; Adrian L, 2000, NATURE, V408, P580, DOI 10.1038/35046063; Albrecht ID, 1999, ENVIRON SCI TECHNOL, V33, P737, DOI 10.1021/es980791t; Ballerstedt H, 1997, ENVIRON SCI TECHNOL, V31, P1749, DOI 10.1021/es960737h; Barkovskii AL, 1996, APPL ENVIRON MICROB, V62, P4556, DOI 10.1128/AEM.62.12.4556-4562.1996; BEURSKENS JEM, 1995, ENVIRON TOXICOL CHEM, V14, P939, DOI 10.1002/etc.5620140603; BEURSKENS JEM, 1993, ENVIRON TOXICOL CHEM, V12, P1549, DOI 10.1002/etc.5620120905; Breitenstein A, 2001, ARCH MICROBIOL, V175, P133, DOI 10.1007/s002030000248; Brzuzy LP, 1996, ENVIRON SCI TECHNOL, V30, P1797, DOI 10.1021/es950714n; Bunge M, 2001, CHEMOSPHERE, V43, P675, DOI 10.1016/S0045-6535(00)00420-3; Cutter LA, 2001, ENVIRON MICROBIOL, V3, P699, DOI 10.1046/j.1462-2920.2001.00246.x; *DIN EN, 1997, 19483 DIN EN; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; GRIBBLE GW, 1998, ENCY ENV ANAL REMEDI, P972; Hendrickson ER, 2002, APPL ENVIRON MICROB, V68, P485, DOI 10.1128/AEM.68.2.485-495.2002; Hoekstra EJ, 1999, ENVIRON SCI TECHNOL, V33, P2543, DOI 10.1021/es9900104; Holliger C, 1998, FEMS MICROBIOL REV, V22, P383, DOI 10.1016/S0168-6445(98)00030-8; Kaiser J, 2000, SCIENCE, V288, P1941; Loffler FE, 2000, APPL ENVIRON MICROB, V66, P1369, DOI 10.1128/AEM.66.4.1369-1374.2000; Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; MEHARG AA, 1995, NATURE, V375, P353, DOI 10.1038/375353a0; Muller JF, 1999, CHEMOSPHERE, V39, P1707, DOI 10.1016/S0045-6535(99)00065-X; RAPPE C, 1999, ORGANOHALOGEN COMPD, V43, P111; von Wintzingerode F, 1999, APPL ENVIRON MICROB, V65, P283; Wu QZ, 2002, APPL ENVIRON MICROB, V68, P807, DOI 10.1128/AEM.68.2.807-812.2002; ZOLLER W, 1985, FRESEN Z ANAL CHEM, V321, P247, DOI 10.1007/BF00470365	28	264	280	10	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					357	360		10.1038/nature01237	http://dx.doi.org/10.1038/nature01237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540897				2022-12-28	WOS:000180533000038
J	Lo, YMD; Poon, LLM				Lo, YMD; Poon, LLM			The ins and outs of fetal DNA in maternal plasma	LANCET			English	Editorial Material							CELLS; BLOOD		Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; University of Hong Kong	Lo, YMD (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China.		Poon, Leo/AAP-6887-2020; Poon, Leo Lit Man/C-4382-2009; Lo, Yuk Ming Dennis/D-4468-2011	Poon, Leo Lit Man/0000-0002-9101-7953; Lo, Yuk Ming Dennis/0000-0001-8746-0293				Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Bischoff FZ, 2003, LANCET, V361, P139, DOI 10.1016/S0140-6736(03)12191-5; Chiu RWK, 2002, LANCET, V360, P998, DOI 10.1016/S0140-6736(02)11086-5; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Lambert NC, 2002, BLOOD, V100, P2845, DOI 10.1182/blood-2002-01-0295; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Nelson JL, 1998, LANCET, V351, P559, DOI 10.1016/S0140-6736(97)08357-8; Ng EKO, 2002, CLIN CHEM, V48, P1212; Poon LLM, 2000, LANCET, V356, P1819, DOI 10.1016/S0140-6736(00)03237-2; Poon LLM, 2000, CLIN CHEM, V46, P1832; Tsui NBY, 2002, CLIN CHEM, V48, P1647; van Wijk IJ, 2000, CLIN CHEM, V46, P729; Zhong XY, 2000, OBSTET GYNECOL, V96, P991, DOI 10.1016/S0029-7844(00)01065-6	15	15	16	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					193	194						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547539				2022-12-28	WOS:000180535400005
J	Eisenberg, RS				Eisenberg, RS			Science and the law - Patent swords and shields	SCIENCE			English	Editorial Material									Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Eisenberg, RS (corresponding author), Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA.		Eisenberg, Robert/P-6070-2019					Barinaga M, 1999, SCIENCE, V286, P1655; *BUR NAT AFF, 2000, DAIL REPORT EX  0623, pA41; FISK MC, 2002, NATL LAW J      0318, pA1; HANTMAN RD, 1985, J PATENT TRADEMARK, V67, P617; Mueller JM, 2001, WASH LAW REV, V76, P1; *U MINN, 1999, FACT SHEET GLAX WELL; United States Patent & Trademark Office, US COLL U UT PAT GRA	7	42	42	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1018	1019		10.1126/science.1081790	http://dx.doi.org/10.1126/science.1081790			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586927				2022-12-28	WOS:000180960000028
J	Evans, JG				Evans, JG			Drugs and falls in later life	LANCET			English	Editorial Material							RISK		Univ Oxford Green Coll, Oxford OX2 6HE, England	University of Oxford	Evans, JG (corresponding author), Univ Oxford Green Coll, Oxford OX2 6HE, England.	john.grimleyevans@geratology.oxford.ac.uk						COOK PJ, 1986, ACTA PSYCHIAT S S332, V73, P149; Ensrud KE, 2002, J AM GERIATR SOC, V50, P1629, DOI 10.1046/j.1532-5415.2002.50453.x; EVANS JG, 1990, AGE AGEING, V19, P268, DOI 10.1093/ageing/19.4.268; EVANS JG, 1992, FALLS, BALANCE AND GAIT DISORDERS IN THE ELDERLY, P39; HECKMAN GA, 2002, COCHRANE LIB; Leipzig RM, 1999, J AM GERIATR SOC, V47, P30, DOI 10.1111/j.1532-5415.1999.tb01898.x; MURPHY J, 1982, GERONTOLOGY, V28, P265, DOI 10.1159/000212543; PRUDHAM D, 1981, AGE AGEING, V10, P264; RAY WA, 1989, JAMA-J AM MED ASSOC, V262, P3303, DOI 10.1001/jama.262.23.3303; Thapa PB, 1998, NEW ENGL J MED, V339, P875, DOI 10.1056/NEJM199809243391303	10	32	36	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					448	448		10.1016/S0140-6736(03)12502-0	http://dx.doi.org/10.1016/S0140-6736(03)12502-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583941				2022-12-28	WOS:000180900600006
J	Hagege, AA; Carrion, C; Menasche, P; Vilquin, JT; Duboc, D; Marolleau, JP; Desnos, M; Bruneval, P				Hagege, AA; Carrion, C; Menasche, P; Vilquin, JT; Duboc, D; Marolleau, JP; Desnos, M; Bruneval, P			Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy	LANCET			English	Article							TRANSPLANTATION	Autologous skeletal myoblast transplantation might improve postinfarction ventricular function, but graft viability and differentiation (le, proof of concept) has not been shown. A 72-year-old man had autologous cultured myoblasts from his vastus lateralis Injected to an area of transmural inferior myocardial Infarction in non-reperfused scar tissue. He showed Improvement In symptoms and left-ventricular ejection fraction. When he died 17.5 months after the procedure, the grafted postinfarction scar showed well developed skeletal myotubes with a preserved contractile apparatus. 65% of myotubes expressed the slow myosin isoform and 33% coexpressed the slow and fast isoforms (vs 44% and 0.6%, respectively, in skeletal muscle). Myoblast grafts can survive and show a switch to slow-twitch fibres, which might allow sustained improvement in cardiac function.	Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Cardiol, Paris, France; Necker Paris Univ 5, INSERM, EMI 16, Paris, France; Hop La Pitie Salpetriere, Inst Myol, INSERM, U523, Paris, France; Hop Cochin, Dept Cardiol, F-75674 Paris, France; Hop St Louis, Cell Therapy Lab, Paris, France; Hop Europeen Georges Pompidou, Dept Cardiovasc Surg, Paris, France; Hop Europeen Georges Pompidou, Dept Pathol, Paris, France; INSERM, U430, F-75654 Paris 13, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hagege, AA (corresponding author), Hop Europeen Georges Pompidou, Dept Cardiol 1, 20 Rue Leblanc, F-75015 Paris, France.	hagege@club-internet.fr		Vilquin, Jean-Thomas/0000-0003-0050-0219; carrion, claire/0000-0003-3221-6319; HAGEGE, Albert/0000-0003-4685-6077				Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929; [No title captured]	5	206	233	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					491	492		10.1016/S0140-6736(03)12458-0	http://dx.doi.org/10.1016/S0140-6736(03)12458-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583951				2022-12-28	WOS:000180900600016
J	Partanen, J				Partanen, J			Genetic susceptibility to variant Creutzfeldt-Jakob disease	LANCET			English	Editorial Material									Finnish Red Cross Blood Transfus Serv, Dept Tissue Typing, Helsinki 00310, Finland		Partanen, J (corresponding author), Finnish Red Cross Blood Transfus Serv, Dept Tissue Typing, Helsinki 00310, Finland.	jukka.partanen@bts.redcross.fi	Partanen, Jukka/B-7207-2014	Partanen, Jukka/0000-0001-6681-4734				Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; GLYNNE PA, 2000, HLA HLTH DIS, P299; Jackson GS, 2001, NATURE, V414, P269, DOI 10.1038/35104694; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Mabbott NA, 2001, J GEN VIROL, V82, P2307, DOI 10.1099/0022-1317-82-10-2307	5	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					447	448		10.1016/S0140-6736(03)12456-7	http://dx.doi.org/10.1016/S0140-6736(03)12456-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583940				2022-12-28	WOS:000180900600005
J	Hoshino, M				Hoshino, M			Coupling across many scales	SCIENCE			English	Editorial Material							ELECTROSTATIC SOLITARY WAVES; DOUBLE-LAYERS; ELECTRONS		Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan	University of Tokyo	Hoshino, M (corresponding author), Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan.	hoshino@eps.s.u-tokyo.ac.jp	Hoshino, Masahiro/A-1837-2009	Hoshino, Masahiro/0000-0002-1818-9927				Bale SD, 1998, GEOPHYS RES LETT, V25, P2929, DOI 10.1029/98GL02111; Birn J, 2001, J GEOPHYS RES-SPACE, V106, P3715, DOI 10.1029/1999JA900449; BOSTROM R, 1988, PHYS REV LETT, V61, P82, DOI 10.1103/PhysRevLett.61.82; Carlson CW, 1998, GEOPHYS RES LETT, V25, P2017, DOI 10.1029/98GL00851; Carter TA, 2002, PHYS PLASMAS, V9, P3272, DOI 10.1063/1.1494433; Drake JF, 2003, SCIENCE, V299, P873, DOI 10.1126/science.1080333; Hoshino M, 2002, ASTROPHYS J, V572, P880, DOI 10.1086/340454; Kim KH, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014636; KOJIMA H, 1994, GEOPHYS RES LETT, V21, P2919, DOI 10.1029/94GL02111; KOYAMA K, 1995, NATURE, V378, P255, DOI 10.1038/378255a0; MATSUMOTO H, 1994, GEOPHYS RES LETT, V21, P2915, DOI 10.1029/94GL01284; McClements KG, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.255002; SAEKI K, 1979, PHYS REV LETT, V42, P501, DOI 10.1103/PhysRevLett.42.501; Shinohara I, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.095001; TEMERIN M, 1982, PHYS REV LETT, V48, P1175, DOI 10.1103/PhysRevLett.48.1175	15	7	7	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					834	835		10.1126/science.1081610	http://dx.doi.org/10.1126/science.1081610			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574608				2022-12-28	WOS:000180830900029
J	Dajee, M; Lazarov, M; Zhang, JY; Cai, T; Green, CL; Russell, AJ; Marinkovich, MP; Tao, SY; Lin, Q; Kubo, Y; Khavari, PA				Dajee, M; Lazarov, M; Zhang, JY; Cai, T; Green, CL; Russell, AJ; Marinkovich, MP; Tao, SY; Lin, Q; Kubo, Y; Khavari, PA			NF-kappa B blockade and oncogenic Ras trigger invasive human epidermal neoplasia	NATURE			English	Article							SQUAMOUS-CELL CARCINOMAS; HUMAN BREAST-CANCER; SKIN; ALPHA-6-BETA-4; CARCINOGENESIS; ACTIVATION; EXPRESSION; APOPTOSIS; LAMININ-5; SUBUNITS	The nuclear factor NF-kappaB and oncogenic Ras can alter proliferation in epidermis, the most common site of human cancer(1,2). These proteins are implicated in epidermal squamous cell carcinoma in mice(3-5), however, the potential effects of altering their function are uncertain. Whereas inhibition of NF-kappaB enhances apoptosis in certain tumours(6), blockade of NF-kappaB predisposes murine skin to squamous cell carcinoma(5,7). Because therapeutics inhibiting Ras and NF-kappaB pathways are being developed to treat human cancer(8,9), it is essential to assess the effects of altering these regulators. The medical relevance of murine studies is limited, however, by differences between mouse and human skin, and by the greater ease of transforming murine cells. Here we show that in normal human epidermal cells both NF-kappaB and oncogenic Ras trigger cell-cycle arrest. Growth arrest triggered by oncogenic Ras can be bypassed by IkappaBalpha-mediated blockade of NF-kappaB, generating malignant human epidermal tissue resembling squamous cell carcinoma. Human cell tumorigenesis is dependent on laminin 5 and alpha6beta4 integrin. Thus, IkappaBalpha circumvents restraints on growth promotion induced by oncogenic Ras and can act with Ras to induce invasive human tissue neoplasia.	Stanford Univ, Sch Med, Vet Affairs Palo Alto Healthcare Syst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Khavari, PA (corresponding author), Stanford Univ, Sch Med, Vet Affairs Palo Alto Healthcare Syst, Stanford, CA 94305 USA.		Zhang, Junyi/HDN-7815-2022	Russell, Alan/0000-0001-7545-5008; Zhang, Jennifer Y./0000-0002-4485-1750				Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Dajee M, 2002, ONCOGENE, V21, P1527, DOI 10.1038/sj.onc.1205287; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; LAAROV M, 2002, NAT MED, V8, P1105; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; MARINKOVICH MP, 1999, DERMATOLOGY GEN MED, P690; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; Mercurio AM, 2001, SEMIN CANCER BIOL, V11, P129, DOI 10.1006/scbi.2000.0364; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; MITCHELL CE, 1995, ANAL BIOCHEM, V224, P148, DOI 10.1006/abio.1995.1020; Nordemar S, 2001, ANTICANCER RES, V21, P509; Pazzaglia S, 2001, MOL CARCINOGEN, V30, P111, DOI 10.1002/1098-2744(200102)30:2<111::AID-MC1019>3.0.CO;2-L; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Robbins PB, 2001, P NATL ACAD SCI USA, V98, P5193, DOI 10.1073/pnas.091484998; SAVOIA P, 1993, J INVEST DERMATOL, V101, P352, DOI 10.1111/1523-1747.ep12365531; Seitz CS, 2000, CANCER RES, V60, P4085; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Stambolic V, 1999, ONCOGENE, V18, P6094, DOI 10.1038/sj.onc.1203126; VAN AD, 1996, SCIENCE, V274, P787; van Hogerlinden M, 1999, CANCER RES, V59, P3299; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wick M, 1999, GENE, V232, P97, DOI 10.1016/S0378-1119(99)00108-0; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; YUSPA SH, 1994, CANCER RES, V54, P1178; Zimonjic D, 2001, CANCER RES, V61, P8838	30	452	465	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					639	643		10.1038/nature01283	http://dx.doi.org/10.1038/nature01283			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571598				2022-12-28	WOS:000180803200044
J	McFarland, EW; Tang, J				McFarland, EW; Tang, J			A photovoltaic device structure based on internal electron emission	NATURE			English	Article								There has been an active search for cost-effective photovoltaic devices since the development of the first solar cells in the 1950s (refs 1-3). In conventional solid-state solar cells, electron-hole pairs are created by light absorption in a semiconductor, with charge separation and collection accomplished under the influence of electric fields within the semiconductor. Here we report a multilayer photovoltaic device structure in which photon absorption instead occurs in photoreceptors deposited on the surface of an ultrathin metal-semiconductor junction Schottky diode. Photoexcited electrons are transferred to the metal and travel ballistically to-and over-the Schottky barrier, so providing the photocurrent output. Low-energy (similar to1 eV) electrons have surprisingly long ballistic path lengths in noble metals 4,5, allowing a large fraction of the electrons to be collected. Unlike conventional cells, the semiconductor in this device serves only for majority charge transport and separation. Devices fabricated using a fluorescein photoreceptor on an Au/TiO2/Ti multilayer structure had typical open-circuit photovoltages of 600-800 mV and short-circuit photocurrents of 10-18 muA cm(-2) under 100 mW cm(-2) visible band illumination: the internal quantum efficiency (electrons measured per photon absorbed) was 10 per cent. This alternative approach to photovoltaic energy conversion might provide the basis for durable low-cost solar cells using a variety of materials.	Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	McFarland, EW (corresponding author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.		McFarland, Eric/G-1763-2014					ARCHER MD, 2001, SERIES PHOTOCONVERSI, V1; CHAPIN DM, 1954, J APPL PHYS, V25, P676, DOI 10.1063/1.1721711; FRESE KW, 1992, J ELECTROCHEM SOC, V139, P3234, DOI 10.1149/1.2069059; Goetzberger A, 2000, SOL ENERG MAT SOL C, V62, P1, DOI 10.1016/S0927-0248(99)00131-2; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Green MA, 2001, PROG PHOTOVOLTAICS, V9, P49, DOI 10.1002/pip.361; Nienhaus H, 1999, PHYS REV LETT, V82, P446, DOI 10.1103/PhysRevLett.82.446; Seah M. P., 1979, Surface and Interface Analysis, V1, P2, DOI 10.1002/sia.740010103; SZE SM, 1981, PHYS SEMICONDUCTOR D, pCH14	9	355	362	3	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					616	618		10.1038/nature01316	http://dx.doi.org/10.1038/nature01316			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571591				2022-12-28	WOS:000180803200037
J	Reynolds, K; Lewis, LB; Nolen, JDL; Kinney, GL; Sathya, B; He, J				Reynolds, K; Lewis, LB; Nolen, JDL; Kinney, GL; Sathya, B; He, J			Alcohol consumption and risk of stroke - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; ISCHEMIC-STROKE; FOLLOW-UP; CARDIOVASCULAR MORTALITY; CEREBRAL INFARCTION; HEMORRHAGIC STROKE; CIGARETTE-SMOKING; HEAVY DRINKING; MODERATE; MEN	Context Observational studies suggest that heavy alcohol consumption may increase the risk of stroke while moderate consumption may decrease the risk. Objective To examine the association between alcohol consumption and relative risk of stroke. Data Sources Studies published in English-language journals were retrieved by searching MEDLINE (1966-April 2002) using Medical Subject Headings alcohol drinking, ethanol, cerebrovascular accident, cerebrovascular disorders, and intracranial embolism and thrombosis and the key word stroke; Dissertation Abstracts Online using the keywords stroke and alcohol; and bibliographies of retrieved articles. Study Selection From 122 relevant retrieved reports, 35 observational studies. (cohort or case control) in which total stroke, ischemic stroke, or hemorrhagic (intracerebral or total) stroke was an end point; the relative risk or relative odds and their variance (or data to calculate them) of stroke associated with alcohol consumption were reported; alcohol consumption was quantified; and abstainers served as the reference group. Data Extraction Information on study design, participant characteristics, level of alcohol consumption, stroke outcome, control for potential confounding factors, and risk estimates was abstracted independently by 3 investigators using a standardized protocol. Data Synthesis A random-effects model and meta-regression analysis were used to pool data from individual studies. Compared with abstainers, consumption of more than 60 g of alcohol per day was associated with an increased relative risk of total stroke, 1.64 (95% confidence interval [CI], 1.39-1.93); ischemic stroke, 1.69. (95% CI, 1.34-2.15); and hemorrhagic stroke, 2.18 (95% CI, 1.48-3.20), while consumption of less than 12 g/d was associated with a reduced relative risk of total stroke, 0.83 (95%, CI, 0.75-0.91) and ischemic stroke, 0.80 (95% CI, 0.67-0.96), and consumption of 12 to 24 g/d was associated with a reduced relative risk of ischemic stroke, 0.72 (95%, CI, 0.57-0.91). The meta-regression analysis revealed a significant nonlinear relationship between alcohol consumption and total and ischemic stroke and a linear relationship between alcohol consumption and hemorrhagic stroke. Conclusions These results indicate that heavy alcohol consumption increases the relative risk of stroke while light or moderate alcohol consumption may be protective against total and ischemic stroke.	Tulane Univ, Sch Publ Hlth & Trop Med, Hlth Sci Ctr, Dept Epidemiol, New Orleans, LA 70112 USA	Tulane University	Reynolds, K (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Hlth Sci Ctr, Dept Epidemiol, 1430 Tulane Ave SL 18, New Orleans, LA 70112 USA.	kreynol1@tulane.edu	Kinney, Gregory/ABB-2081-2021; Kinney, Gregory L/M-4867-2013; Reynolds, Kristi/AAN-1434-2021	Kinney, Gregory L/0000-0002-5218-4986; Reynolds, Kristi/0000-0001-7619-1649	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060300] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL60300] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AM HEART ASS, 2001, 2002 HEART STROK STA; Ashley MJ, 1997, CAN FAM PHYSICIAN, V43, P687; Begg C., 1994, HDB RES SYNTHESIS, P399; BEGHI E, 1992, ITAL J NEUROL SCI, V13, P209, DOI 10.1007/BF02224391; BEGHI E, 1995, STROKE, V26, P1691, DOI 10.1161/01.STR.26.9.1691; Beilin LJ, 1996, J HUM HYPERTENS, V10, pS1; BENSHLOMO Y, 1992, STROKE, V23, P1093, DOI 10.1161/01.STR.23.8.1093; Berger K, 1999, NEW ENGL J MED, V341, P1557, DOI 10.1056/NEJM199911183412101; BLACKWELDER WC, 1980, AM J MED, V68, P164, DOI 10.1016/0002-9343(80)90350-2; Caicoya M, 1999, J CLIN EPIDEMIOL, V52, P677, DOI 10.1016/S0895-4356(98)00074-2; Camargo CA, 1997, ARCH INTERN MED, V157, P79, DOI 10.1001/archinte.157.1.79; Camargo CA, 1996, CLIN CHIM ACTA, V246, P107, DOI 10.1016/0009-8981(96)06231-6; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Djousse L, 2002, STROKE, V33, P907, DOI 10.1161/hs0402.105245; DONAHUE RP, 1986, JAMA-J AM MED ASSOC, V255, P2311, DOI 10.1001/jama.255.17.2311; EICHNER ER, 1988, AM FAM PHYSICIAN, V37, P217; Gaziano JM, 2000, J AM COLL CARDIOL, V35, P96, DOI 10.1016/S0735-1097(99)00531-8; GILL JS, 1991, AM J MED, V90, P489, DOI 10.1016/0002-9343(91)80090-9; GILL JS, 1988, INT J EPIDEMIOL, V17, P542, DOI 10.1093/ije/17.3.542; GILL JS, 1986, NEW ENGL J MED, V315, P1041, DOI 10.1056/NEJM198610233151701; GOLDBERG RJ, 1994, CIRCULATION, V89, P651, DOI 10.1161/01.CIR.89.2.651; GORDON T, 1987, AM J EPIDEMIOL, V125, P263, DOI 10.1093/oxfordjournals.aje.a114525; Gorelick P B, 1992, Heart Dis Stroke, V1, P255; Gorelick PB, 1999, JAMA-J AM MED ASSOC, V281, P1112, DOI 10.1001/jama.281.12.1112; GORELICK PB, 1989, NEUROLOGY, V39, P339, DOI 10.1212/WNL.39.3.339; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Haapaniemi H, 1997, STROKE, V28, P26, DOI 10.1161/01.STR.28.1.26; Haapaniemi H, 1996, STROKE, V27, P1023, DOI 10.1161/01.STR.27.6.1023; HANSAGI H, 1995, STROKE, V26, P1768, DOI 10.1161/01.STR.26.10.1768; Hart CL, 1999, BMJ-BRIT MED J, V318, P1725, DOI 10.1136/bmj.318.7200.1725; HENRICH JB, 1989, ARCH INTERN MED, V149, P1413, DOI 10.1001/archinte.149.6.1413; HERMAN B, 1983, AM J EPIDEMIOL, V118, P514, DOI 10.1093/oxfordjournals.aje.a113657; HILLBOM M, 1995, STROKE, V26, P40, DOI 10.1161/01.STR.26.1.40; Hillbom M, 1999, STROKE, V30, P2307, DOI 10.1161/01.STR.30.11.2307; HILLBOM M, 1990, ANN MED, V22, P347, DOI 10.3109/07853899009147918; Hillbom M, 1998, ALCOHOL CLIN EXP RES, V22, p352S, DOI 10.1111/j.1530-0277.1998.tb04390.x; ISO H, 1995, STROKE, V26, P767, DOI 10.1161/01.STR.26.5.767; JAMROZIK K, 1994, STROKE, V25, P51, DOI 10.1161/01.STR.25.1.51; Jousilahti P, 2000, STROKE, V31, P1851, DOI 10.1161/01.STR.31.8.1851; JUVELA S, 1995, STROKE, V26, P1558, DOI 10.1161/01.STR.26.9.1558; KAGAN A, 1980, STROKE, V11, P14, DOI 10.1161/01.STR.11.1.14; Kissela BM, 2002, STROKE, V33, P1321, DOI 10.1161/01.STR.0000014773.57733.3E; KIYOHARA Y, 1995, STROKE, V26, P368, DOI 10.1161/01.STR.26.3.368; KLATSKY AL, 1981, ANN INTERN MED, V95, P139, DOI 10.7326/0003-4819-95-2-139; KLATSKY AL, 1989, STROKE, V20, P741, DOI 10.1161/01.STR.20.6.741; KLATSKY AL, 1990, AM J CARDIOL, V66, P1237, DOI 10.1016/0002-9149(90)91107-H; Klatsky AL, 2001, AM J CARDIOL, V88, P703, DOI 10.1016/S0002-9149(01)01824-0; Klatsky AL, 1998, NOVART FDN SYMP, V216, P2; KONO S, 1986, INT J EPIDEMIOL, V15, P527, DOI 10.1093/ije/15.4.527; Leppala JM, 1999, CIRCULATION, V100, P1209, DOI 10.1161/01.CIR.100.11.1209; MACLURE M, 1993, EPIDEMIOL REV, V15, P328, DOI 10.1093/oxfordjournals.epirev.a036124; Malarcher AM, 2001, STROKE, V32, P77, DOI 10.1161/01.STR.32.1.77; Marmot MG, 2001, INT J EPIDEMIOL, V30, P724, DOI 10.1093/ije/30.4.724; Maskarinec G, 1998, EPIDEMIOLOGY, V9, P654, DOI 10.1097/00001648-199811000-00016; Mazzaglia G, 2001, ADDICTION, V96, P1743, DOI 10.1046/j.1360-0443.2001.961217434.x; MONFORTE R, 1990, STROKE, V21, P1529, DOI 10.1161/01.STR.21.11.1529; PALMER AJ, 1995, J HYPERTENS, V13, P957, DOI 10.1097/00004872-199509000-00004; PALOMAKI H, 1993, STROKE, V24, P1828, DOI 10.1161/01.STR.24.12.1828; Papadakis JA, 2000, J R SOC PROMO HEALTH, V120, P11, DOI 10.1177/146642400012000111; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; RODGERS H, 1993, STROKE, V24, P1473, DOI 10.1161/01.STR.24.10.1473; Romelsjo A, 1999, BRIT MED J, V319, P821, DOI 10.1136/bmj.319.7213.821; Sacco RL, 1999, JAMA-J AM MED ASSOC, V281, P53, DOI 10.1001/jama.281.1.53; SHAPER AG, 1988, LANCET, V2, P1267; SHAPER AG, 1991, BRIT MED J, V302, P1111, DOI 10.1136/bmj.302.6785.1111; SHINTON R, 1993, J NEUROL NEUROSUR PS, V56, P458, DOI 10.1136/jnnp.56.5.458; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; Thrift AG, 1999, EPIDEMIOLOGY, V10, P307, DOI 10.1097/00001648-199905000-00020; Truelsen T, 1998, STROKE, V29, P2467, DOI 10.1161/01.STR.29.12.2467; TURNER C, 1990, BRIT J ADDICT, V85, P1171; WANNAMETHEE G, 1988, INT J EPIDEMIOL, V17, P307, DOI 10.1093/ije/17.2.307; Wannamethee SG, 1998, NEUROEPIDEMIOLOGY, V17, P288, DOI 10.1159/000026182; Wannamethee SG, 1996, STROKE, V27, P1033, DOI 10.1161/01.STR.27.6.1033; Warlow CP, 1998, LANCET S3, V352, pSIII1, DOI DOI 10.1016/S0140-6736(98)90086-1; Yuan JM, 1997, BRIT MED J, V314, P18, DOI 10.1136/bmj.314.7073.18; Zakhari S, 1997, ALCOHOL HEALTH RES W, V21, P21; Zodpey SP, 2000, PUBLIC HEALTH, V114, P177, DOI 10.1016/S0033-3506(00)00331-0	77	588	621	1	53	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2003	289	5					579	588		10.1001/jama.289.5.579	http://dx.doi.org/10.1001/jama.289.5.579			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CV	12578491				2022-12-28	WOS:000180787500029
J	Inadomi, JM; Sampliner, R; Lagergren, J; Lieberman, D; Fendrick, AM; Vakil, N				Inadomi, JM; Sampliner, R; Lagergren, J; Lieberman, D; Fendrick, AM; Vakil, N			Screening and surveillance for Barrett esophagus in high-risk groups: A cost-utility analysis	ANNALS OF INTERNAL MEDICINE			English	Article							HIGH-GRADE DYSPLASIA; GASTROESOPHAGEAL-REFLUX DISEASE; SPECIALIZED INTESTINAL METAPLASIA; PROSPECTIVE MULTIVARIATE-ANALYSIS; ENDOSCOPIC SURVEILLANCE; FOLLOW-UP; GASTROINTESTINAL-ENDOSCOPY; SURGICAL-TREATMENT; OVERRATED RISK; CANCER-RISK	Background: Once-in-a-lifetime screening for Barrett esophagus has been proposed for patients with gastroesophageal reflux disease (GERD) but there is little evidence of its cost-effectiveness. Objective: 1) To determine the cost-effectiveness of screening high-risk groups for Barrett esophagus and providing surveillance to patients with Barrett esophagus and dysplasia or to all patients With Barrett esophagus and 2) to compare the results with the cost-effectiveness of no screening or surveillance. Design: A decision analytic model was developed to examine no screening or surveillance and screening and surveillance for Barrett esophagus with dysplasia only or Barrett esophagus without dysplasia every 2 to 5 years. Low- or high-grade dysplasia received surveillance every 6 or 3 months, respectively. Data Sources: Published literature and the Health Care Financing Administration. Target Population: 50-year-old white men with symptoms of GERD. Time Horizon: 50 years of age until 80 years of age or death. Perspective: Third-party payer. Outcome Measure: incremental cost-effectiveness ratio. Results of Base-Case Analysis: Screening with surveillance limited to patients with Barrett esophagus with dysplasia required $10 440 per quality-adjusted life-year (QALY) saved compared to no screening or surveillance. The incremental cost-effectiveness ratio of surveillance every 5 years in patients with Barrett esophagus without dysplasia compared to surveillance of patients with Barrett esophagus with dysplasia was $596 000 per QALY saved. Results of Sensitivity Analysis: The annual incidence of adenocarcinoma must exceed 1 case per 54 patient-years of follow-up (1.9%) foe surveillance of Barrett esophagus without dysplasia every 5 years to yield an incremental cost-effectiveness ratio less than $50 000 per QALY saved. Conclusions: Screening 50-year-old men with symptoms of GERD to detect adenocarcinoma associated with Barrett esophagus is probably cost-effective. However, subsequent surveillance of patients with Barrett esophagus but no dysplasia, even at 5-year intervals, is an expensive practice.	Univ Wisconsin, Sch Med, Aurora Sinai Med Ctr, Div Gastroenterol, Milwaukee, WI 53233 USA; Univ Michigan, Vet Adm Ctr Practice Management & Outcomes Res, Ann Arbor, MI 48109 USA; Consortium Hlth Outcomes Innovat & Cost Effective, Ann Arbor, MI USA; SO Arizona Vet Affairs Healthcare Syst, Tucson, AZ USA; Univ Arizona, Tucson, AZ 85724 USA; Karolinska Inst, S-10521 Stockholm, Sweden; Karolinska Hosp, S-10401 Stockholm, Sweden; Oregon Hlth & Sci Univ, Portland, OR 97201 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Southern Arizona Veterans Affairs Health Care System; University of Arizona; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Oregon Health & Science University	Vakil, N (corresponding author), Univ Wisconsin, Sch Med, Aurora Sinai Med Ctr, Div Gastroenterol, 945 N 12th St,Room 4040, Milwaukee, WI 53233 USA.	nvakil@wisc.edu	Inadomi, John/A-6221-2014	Inadomi, John/0000-0001-6776-8661; Lagergren, Jesper/0000-0002-5143-5448				ACHKAR E, 1988, AM J GASTROENTEROL, V83, P291; BECK JR, 1983, MED DECIS MAKING, V3, P419, DOI 10.1177/0272989X8300300403; BONELLI L, 1993, ENDOSCOPY, V25, P652, DOI 10.1055/s-2007-1010425; CAMERON AJ, 1985, NEW ENGL J MED, V313, P857, DOI 10.1056/NEJM198510033131404; CAMERON AJ, 1992, GASTROENTEROLOGY, V103, P1241, DOI 10.1016/0016-5085(92)91510-B; Caygill CPJ, 1999, EUR J GASTROEN HEPAT, V11, P1355, DOI 10.1097/00042737-199912000-00003; Caygill CPJ, 1999, EUR J CANCER PREV, V8, P539, DOI 10.1097/00008469-199912000-00010; Corley DA, 2002, GASTROENTEROLOGY, V122, P633, DOI 10.1053/gast.2002.31879; DEMEESTER TR, 1988, J THORAC CARDIOV SUR, V95, P42; DENT J, 1991, J GASTROEN HEPATOL, V6, P1, DOI 10.1111/j.1440-1746.1991.tb01137.x; Drewitz DJ, 1997, AM J GASTROENTEROL, V92, P212; EARLAM R, 1980, BRIT J SURG, V67, P381, DOI 10.1002/bjs.1800670602; Ellis FH, 1997, J THORAC CARDIOV SUR, V113, P836, DOI 10.1016/S0022-5223(97)70256-3; ELLIS FH, 1983, ANN SURG, V198, P531, DOI 10.1097/00000658-198310000-00013; Eloubeidi MA, 1999, AM J GASTROENTEROL, V94, P2033; Eloubeidi MA, 2001, J CLIN GASTROENTEROL, V33, P306, DOI 10.1097/00004836-200110000-00010; Eloubeidi MA, 2000, AM J GASTROENTEROL, V95, P1881; GALANDIUK S, 1986, ANN SURG, V203, P101, DOI 10.1097/00000658-198601000-00016; Gorelick AB, 2001, J CLIN GASTROENTEROL, V33, P210, DOI 10.1097/00004836-200109000-00008; HABRGAMA A, 1989, WORLD J SURG, V13, P193, DOI 10.1007/BF01658399; HAMEETEMAN W, 1989, GASTROENTEROLOGY, V96, P1249, DOI 10.1016/S0016-5085(89)80011-3; Hirota WK, 1999, GASTROENTEROLOGY, V116, P277, DOI 10.1016/S0016-5085(99)70123-X; Johnston MH, 1996, AM J GASTROENTEROL, V91, P1507; Katz D, 1998, AM J GASTROENTEROL, V93, P536; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; MENKEPLUYMERS MBE, 1992, GUT, V33, P1454, DOI 10.1136/gut.33.11.1454; *NAT CTR HLTH STAT, 2001, VIT STAT US 2000; Nguyen NT, 2000, SURGERY, V127, P284, DOI 10.1067/msy.2000.103489; O'Connor JB, 1999, AM J GASTROENTEROL, V94, P2037; PERA M, 1992, ANN THORAC SURG, V54, P199, DOI 10.1016/0003-4975(92)91370-O; PETERS JH, 1994, J THORAC CARDIOV SUR, V108, P813, DOI 10.1016/S0022-5223(94)70178-4; Provenzale D, 1999, AM J GASTROENTEROL, V94, P2043; PROVENZALE D, 1994, AM J GASTROENTEROL, V89, P670; ROBERTSON CS, 1988, BRIT J SURG, V75, P760, DOI 10.1002/bjs.1800750813; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Sampliner RE, 2002, AM J GASTROENTEROL, V97, P1888; Schnell TG, 2001, GASTROENTEROLOGY, V120, P1607, DOI 10.1053/gast.2001.25065; Schoenfeld P, 1998, AM J GASTROENTEROL, V93, P906; Shaheen N, 2002, JAMA-J AM MED ASSOC, V287, P1972, DOI 10.1001/jama.287.15.1972; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; Sharma P, 1997, AM J GASTROENTEROL, V92, P2012; Sharma P, 2001, GASTROENTEROLOGY, V120, pA16, DOI 10.1016/S0016-5085(01)80081-0; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; SILVIS SE, 1976, JAMA-J AM MED ASSOC, V235, P928, DOI 10.1001/jama.235.9.928; SKINNER DB, 1983, J THORAC CARDIOV SUR, V85, P59; Soni A, 2000, AM J GASTROENTEROL, V95, P2086; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; SPECHLER SJ, 1984, GASTROENTEROLOGY, V87, P927; Spechler SJ, 2001, JAMA-J AM MED ASSOC, V285, P2331, DOI 10.1001/jama.285.18.2331; Streitz JM, 1998, AM J GASTROENTEROL, V93, P911; STREITZ JM, 1993, J THORAC CARDIOV SUR, V105, P383; van Sandick JW, 1998, GUT, V43, P216, DOI 10.1136/gut.43.2.216; VANDERVEEN AH, 1989, GUT, V30, P14, DOI 10.1136/gut.30.1.14; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Weston AP, 2000, AM J GASTROENTEROL, V95, P1888; Weston AP, 1996, AM J GASTROENTEROL, V91, P981; Weston AP, 1999, AM J GASTROENTEROL, V94, P3413, DOI 10.1111/j.1572-0241.1999.01602.x; Weston AP, 1999, AM J GASTROENTEROL, V94, P3420, DOI 10.1016/S0002-9270(99)00662-0; WILLIAMSON WA, 1991, ARCH INTERN MED, V151, P2212, DOI 10.1001/archinte.151.11.2212; Winters C, 1987, GASTROENTEROLOGY, V92, P118, DOI 10.1016/0016-5085(87)90847-X; WOLFE WG, 1993, J THORAC CARDIOV SUR, V105, P749; Wright TA, 1996, GUT, V39, P574, DOI 10.1136/gut.39.4.574; WU YK, 1979, ANN SURG, V190, P361	63	296	302	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					176	186		10.7326/0003-4819-138-3-200302040-00009	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00009			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558356				2022-12-28	WOS:000181018600003
J	Jensen, M				Jensen, M			Another loss in the privatisation war: PubScience	LANCET			English	Editorial Material									Natl Acad, Washington, DC USA	National Academies of Sciences, Engineering & Medicine	Jensen, M (corresponding author), Natl Acad, Washington, DC USA.								0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					274	274		10.1016/S0140-6736(03)12365-3	http://dx.doi.org/10.1016/S0140-6736(03)12365-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559859				2022-12-28	WOS:000180643900006
J	Lightowler, JV; Wedzicha, JA; Elliott, MW; Ram, FSF				Lightowler, JV; Wedzicha, JA; Elliott, MW; Ram, FSF			Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STANDARD MEDICAL THERAPY; MECHANICAL VENTILATION; NOSOCOMIAL PNEUMONIA; LUNG-DISEASE; SUPPORT; TRIAL; RISK	Objectives To determine the effectiveness of non-invasive positive pressure ventilation (NPPV) in the management of respiratory failure secondary to acute exacerbation of chronic obstructive pulmonary disease. Design Systematic review of randomised controlled trials that compared NPPV and usual medical care with usual medical care alone in patients admitted to hospital with respiratory failure resulting from an exacerbation of chronic obstructive pulmonary disease and with PaCO2 > 6 kPa. Results The eight studies included in the review showed that, compared with usual care alone, NPPV as an adjunct to usual care was associated with a lower mortality (relative risk 0.41 (95% confidence interval 0.26 to 0.64)), a lower need for intubation (relative risk 0.42 (0.31 to 0.59)), lower likelihood of treatment failure (relative risk 0.51 (0.38 to 0.67)), and greater improvements at 1 hour in pH (weighted mean difference 0.03 (0.02 to 0.04)), PaCO2 (weighted mean difference - 0.40 kPa (- 0.78 to - 0.03)), and respiratory rate (weighted mean difference - 3.08 breaths per minute (- 4.26 to - 1.89)). NPPV resulted in fewer complications associated with treatment (relative risk 0.32 (0.18 to 0.56)) and shorter duration of stay in hospital (weighted mean difference - 3.24 days (- 4.42 to - 2.06)). Conclusions NPPV should be the first line intervention in addition to usual medical care to manage respiratory failure secondary to an acute exacerbation of chronic obstructive pulmonary disease in all suitable patients. NPPV should be tried early in the course of respiratory failure and before severe acidosis, to reduce mortality, avoid endotracheal intubation, and decrease treatment failure.	Univ London St Georges Hosp, Sch Med, Dept Med Physiol, London SW17 0RE, England; St James Univ Hosp, Dept Resp Med, Leeds LS9 7TF, W Yorkshire, England; St Bartholomews Sch, London EC1A 7BE, England; Royal London Sch Med & Dent, London EC1A 7BE, England	St Georges University London; Saint James's University Hospital; University of London; Queen Mary University London; University of London; Queen Mary University London	Ram, FSF (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Med Physiol, London SW17 0RE, England.	fram@sghms.ac.uk		Ram, Felix Simon Francis/0000-0002-5437-4089				Avdeev S N, 1998, Anesteziol Reanimatol, P45; AVDEEV SN, 1998, ANESTEZIOL REANIMATO; Barbe F, 1996, EUR RESPIR J, V9, P1240, DOI 10.1183/09031936.96.09061240; Baudouin S, 2002, THORAX, V57, P192; BOTT J, 1993, LANCET, V341, P1555, DOI 10.1016/0140-6736(93)90696-E; BROCHARD L, 1994, AM J RESP CRIT CARE, V150, P896, DOI 10.1164/ajrccm.150.4.7921460; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; BROCHARD L, 1990, NEW ENGL J MED, V323, P1523, DOI 10.1056/NEJM199011293232204; Celikel T, 1998, CHEST, V114, P1636, DOI 10.1378/chest.114.6.1636; Dikensoy O, 2002, INT J CLIN PRACT, V56, P85; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; FAGON JY, 1993, AM J MED, V94, P281, DOI 10.1016/0002-9343(93)90060-3; FOGLIO C, 1992, CHEST, V101, P1533, DOI 10.1378/chest.101.6.1533; Guerin C, 1997, INTENS CARE MED, V23, P1024, DOI 10.1007/s001340050452; HOO GWS, 1994, CRIT CARE MED, V22, P1253, DOI 10.1097/00003246-199408000-00009; JEFFREY AA, 1992, THORAX, V47, P34, DOI 10.1136/thx.47.1.34; Kramer B, 1999, ANN INTERN MED, V130, P1027, DOI 10.7326/0003-4819-130-12-199906150-00025; KRAMER N, 1995, AM J RESP CRIT CARE, V151, P1799, DOI 10.1164/ajrccm.151.6.7767523; MEDURI GU, 1989, CHEST, V95, P865, DOI 10.1378/chest.95.4.865; Moretti M, 2000, THORAX, V55, P819, DOI 10.1136/thorax.55.10.819; Nourdine K, 1999, INTENS CARE MED, V25, P567, DOI 10.1007/s001340050904; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0	22	512	550	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2003	326	7382					185	187		10.1136/bmj.326.7382.185	http://dx.doi.org/10.1136/bmj.326.7382.185			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640LD	12543832	Green Published, Bronze			2022-12-28	WOS:000180689600014
J	Pinhu, L; Whitehead, T; Evans, T; Griffiths, M				Pinhu, L; Whitehead, T; Evans, T; Griffiths, M			Ventilator-associated lung injury	LANCET			English	Review							RESPIRATORY-DISTRESS SYNDROME; HIGH AIRWAY PRESSURE; HYALINE-MEMBRANE FORMATION; ALVEOLAR EPITHELIAL-CELLS; SURFACTANT-DEPLETED LUNG; END-EXPIRATORY PRESSURE; NECROSIS-FACTOR-ALPHA; ISOLATED RAT LUNGS; MECHANICAL VENTILATION; TIDAL VOLUME	Mechanical ventilation is indispensable in support of patients with respiratory failure who are critically ill. However, use of this technique has adverse effects, including increased risk of pneumonia, impaired cardiac performance, and difficulties associated with sedation and paralysis. Moreover, application of pressure to the lung, whether positive or negative, can cause damage known as ventilator-associated lung injury (VALI). Despite difficulties in distinguishing the effects of mechanical ventilation from those of the underlying disorder, VALI greatly assists patients with the most severe form of lung injury, acute respiratory distress syndrome (ARDS). Moreover, modification of mechanical ventilation so that VALI is kept to a minimum improves survival of patients with ARDS. Here, we outline the effects of mechanical ventilation on injured lungs and explore the underlying mechanisms.	Royal Brompton Hosp, Adult Intens Care Unit, London SW3 6NP, England; Imperial Coll Sch Med, Dept Intens Care Med, London, England; Imperial Coll Sch Med, Crit Care Unit, London, England; Imperial Coll Sch Med, Natl Heart & Lung Inst, London, England; Royal Brompton Hosp, Dept Resp Med, London SW3 6LY, England	Royal Brompton Hospital; Imperial College London; Imperial College London; Imperial College London; Royal Brompton Hospital	Griffiths, M (corresponding author), Royal Brompton Hosp, Adult Intens Care Unit, London SW3 6NP, England.			Griffiths, Mark/0000-0002-1615-1896				ADAMSON IYR, 1991, EXP LUNG RES, V17, P821, DOI 10.3109/01902149109062880; AMATO MBP, 1995, AM J RESP CRIT CARE, V152, P1835, DOI 10.1164/ajrccm.152.6.8520744; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; *ARDS CLIN NETW, 2002, ASSESSMENT LOW TIDAL; ARGIRAS EP, 1987, BRIT J ANAESTH, V59, P1278, DOI 10.1093/bja/59.10.1278; ARTIGAS A, 2002, EUROPEAN RESP MONOGR, P1; BREUSS JM, 1993, J HISTOCHEM CYTOCHEM, V41, P1521, DOI 10.1177/41.10.8245410; Broccard AF, 1998, AM J RESP CRIT CARE, V157, P1935, DOI 10.1164/ajrccm.157.6.9612006; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; Brower RG, 1999, CRIT CARE MED, V27, P1492, DOI 10.1097/00003246-199908000-00015; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carmichael LC, 1996, J CRIT CARE, V11, P9, DOI 10.1016/S0883-9441(96)90015-5; CHEN BM, 1995, SCIENCE, V269, P1578, DOI 10.1126/science.7667637; Cheng JJ, 1996, HYPERTENSION, V28, P386, DOI 10.1161/01.HYP.28.3.386; Chiumello D, 1999, AM J RESP CRIT CARE, V160, P109, DOI 10.1164/ajrccm.160.1.9803046; CORBRIDGE TC, 1990, AM REV RESPIR DIS, V142, P311, DOI 10.1164/ajrccm/142.2.311; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; DREYFUSS D, 1985, AM REV RESPIR DIS, V132, P880; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; Dries DJ, 2002, CRIT CARE MED, V30, P1159, DOI 10.1097/00003246-200205000-00036; Eisner MD, 2002, AM J RESP CRIT CARE, V165, P978, DOI 10.1164/ajrccm.165.7.2109059; FEIHL F, 1994, AM J RESP CRIT CARE, V150, P1722, DOI 10.1164/ajrccm.150.6.7952641; FELDHERR CM, 1990, J CELL BIOL, V111, P1, DOI 10.1083/jcb.111.1.1; FU ZX, 1992, J APPL PHYSIOL, V73, P123, DOI 10.1152/jappl.1992.73.1.123; GATTINONI L, 1987, AM REV RESPIR DIS, V136, P730, DOI 10.1164/ajrccm/136.3.730; Grembowicz KP, 1999, MOL BIOL CELL, V10, P1247, DOI 10.1091/mbc.10.4.1247; Gunther A, 1996, AM J RESP CRIT CARE, V153, P176; GUNTHER A, 2002, EUROPEAN RESP SOC MO, P119; Guo YH, 2001, AM J PHYSIOL-LUNG C, V280, pL191, DOI 10.1152/ajplung.2001.280.2.L191; Harris RS, 2000, AM J RESP CRIT CARE, V161, P432; Held HD, 2001, AM J RESP CRIT CARE, V163, P711, DOI 10.1164/ajrccm.163.3.2003001; HERNANDEZ LA, 1989, J APPL PHYSIOL, V66, P2364, DOI 10.1152/jappl.1989.66.5.2364; HICKLING KG, 1990, INTENS CARE MED, V16, P372, DOI 10.1007/BF01735174; IMAI Y, 1994, AM J RESP CRIT CARE, V150, P1550, DOI 10.1164/ajrccm.150.6.7952613; Imai Y, 1999, J APPL PHYSIOL, V87, P510, DOI 10.1152/jappl.1999.87.2.510; Imanaka H, 2001, ANESTH ANALG, V92, P428; Jalali S, 2001, P NATL ACAD SCI USA, V98, P1042, DOI 10.1073/pnas.031562998; KAWANO T, 1987, J APPL PHYSIOL, V62, P27, DOI 10.1152/jappl.1987.62.1.27; Ko KS, 2001, J BIOL CHEM, V276, P35967, DOI 10.1074/jbc.M104106200; LIU MY, 1994, J CELL PHYSIOL, V161, P501, DOI 10.1002/jcp.1041610313; Liu MY, 1996, J BIOL CHEM, V271, P7066, DOI 10.1074/jbc.271.12.7066; LIU MY, 1995, AM J PHYSIOL-LUNG C, V269, pL178, DOI 10.1152/ajplung.1995.269.2.L178; Liu MY, 1999, AM J PHYSIOL-LUNG C, V277, pL667, DOI 10.1152/ajplung.1999.277.4.L667; LOICK HM, 1993, J APPL PHYSIOL, V75, P301, DOI 10.1152/jappl.1993.75.1.301; Maggiore S M, 2001, Minerva Anestesiol, V67, P228; MATHIEUCOSTELLO OA, 1994, CHEST, V105, pS102, DOI 10.1378/chest.105.3_Supplement.102S; Matsuoka H, 2002, AM J PHYSIOL-LUNG C, V283, pL103, DOI 10.1152/ajplung.00187.2001; MATSUOKA T, 1994, J APPL PHYSIOL, V76, P539, DOI 10.1152/jappl.1994.76.2.539; MEAD J, 1970, J APPL PHYSIOL, V28, P596, DOI 10.1152/jappl.1970.28.5.596; Meyer CJ, 2000, NAT CELL BIOL, V2, P666, DOI 10.1038/35023621; Mourgeon E, 2000, AM J PHYSIOL-LUNG C, V279, pL699, DOI 10.1152/ajplung.2000.279.4.L699; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Murphy DB, 2000, AM J RESP CRIT CARE, V162, P27, DOI 10.1164/ajrccm.162.1.9908110; MUSCEDERE JG, 1994, AM J RESP CRIT CARE, V149, P1327, DOI 10.1164/ajrccm.149.5.8173774; Nahum A, 1997, CRIT CARE MED, V25, P1733, DOI 10.1097/00003246-199710000-00026; Nakamura T, 2001, J APPL PHYSIOL, V91, P811, DOI 10.1152/jappl.2001.91.2.811; NARIMANBEKOV IO, 1995, EXP LUNG RES, V21, P239, DOI 10.3109/01902149509068830; NAURECKAS ET, 1994, J APPL PHYSIOL, V76, P1372, DOI 10.1152/jappl.1994.76.3.1372; PARK J, 2000, AM J RESP CRIT CARE, V161, pA47; Parker JC, 1998, J APPL PHYSIOL, V84, P1113, DOI 10.1152/jappl.1998.84.4.1113; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; Pugin J, 1998, AM J PHYSIOL-LUNG C, V275, pL1040, DOI 10.1152/ajplung.1998.275.6.L1040; Pugin J, 1999, CRIT CARE MED, V27, P304, DOI 10.1097/00003246-199902000-00036; Quinn D, 1999, CHEST, V116, p89S, DOI 10.1378/chest.116.suppl_1.89S; RAGHU G, 1985, AM REV RESPIR DIS, V131, P281, DOI 10.1164/ajrccm/138.3.703; Ranieri VM, 2000, JAMA-J AM MED ASSOC, V284, P43, DOI 10.1001/jama.284.1.43; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Ricard JD, 2001, AM J RESP CRIT CARE, V163, P1176, DOI 10.1164/ajrccm.163.5.2006053; ROUBY JJ, 1993, INTENS CARE MED, V19, P383, DOI 10.1007/BF01724877; ROUPIE E, 1995, AM J RESP CRIT CARE, V152, P121, DOI 10.1164/ajrccm.152.1.7599810; Sanchez-Esteban J, 2001, J APPL PHYSIOL, V91, P589, DOI 10.1152/jappl.2001.91.2.589; SANDHAR BK, 1988, INTENS CARE MED, V14, P538, DOI 10.1007/BF00263527; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; Shyy JYJ, 1997, CURR OPIN CELL BIOL, V9, P707, DOI 10.1016/S0955-0674(97)80125-1; SLUTSKY AS, 1993, CHEST, V104, P1833, DOI 10.1378/chest.104.6.1833; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Tschumperlin DJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1173, DOI 10.1152/ajplung.1998.275.6.L1173; TSUKIMOTO K, 1991, J APPL PHYSIOL, V71, P573, DOI 10.1152/jappl.1991.71.2.573; TSUNO K, 1991, AM REV RESPIR DIS, V143, P1115, DOI 10.1164/ajrccm/143.5_Pt_1.1115; Uhal BD, 1997, AM J PHYSIOL-LUNG C, V272, pL1031, DOI 10.1152/ajplung.1997.272.6.L1031; Verbrugge SJC, 1999, ANESTHESIOLOGY, V91, P1834, DOI 10.1097/00000542-199912000-00038; Vlahakis NE, 2000, J APPL PHYSIOL, V89, P2490, DOI 10.1152/jappl.2000.89.6.2490; Vlahakis NE, 1999, AM J PHYSIOL-LUNG C, V277, pL167, DOI 10.1152/ajplung.1999.277.1.L167; von Bethmann AN, 1998, AM J RESP CRIT CARE, V157, P263, DOI 10.1164/ajrccm.157.1.9608052; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; Ward NS, 2002, CRIT CARE MED, V30, P963, DOI 10.1097/00003246-200205000-00002; Weg JG, 1998, NEW ENGL J MED, V338, P341, DOI 10.1056/NEJM199802053380601; Wirtz HR, 2000, RESP PHYSIOL, V119, P1, DOI 10.1016/S0034-5687(99)00092-4; WIRTZ HRW, 1990, SCIENCE, V250, P1266, DOI 10.1126/science.2173861; WOO SW, 1972, J APPL PHYSIOL, V33, P14, DOI 10.1152/jappl.1972.33.1.14	91	258	295	2	20	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					332	340		10.1016/S0140-6736(03)12329-X	http://dx.doi.org/10.1016/S0140-6736(03)12329-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559881				2022-12-28	WOS:000180643900027
J	Sosic, D; Richardson, JA; Yu, K; Ornitz, DM; Olson, EN				Sosic, D; Richardson, JA; Yu, K; Ornitz, DM; Olson, EN			Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappa B activity	CELL			English	Article							TRANSCRIPTION FACTORS; DROSOPHILA EMBRYO; BHLH PROTEIN; INFLAMMATORY DISEASES; MESODERMAL CELLS; ZYGOTIC GENE; ACTIVATION; CACHEXIA; PATTERN; ENHANCER	During Drosophila embryogenesis, the dorsal transcription factor activates the expression of twist, a transcription factor required for mesoderm formation. We show here that the mammalian twist proteins, twist-1 and -2, are induced by a cytokine signaling pathway that requires the dorsal-related protein RelA, a member of the NF-kappaB family of transcription factors. Twist-1 and -2 repress cytokine gene expression through interaction with RelA. Mice homozygous for a twist-2 null allele or doubly heterozygous for twist-1 and -2 alleles show elevated expression of proinflammatory cytokines, resulting in perinatal death from cachexia. These findings reveal an evolutionarily conserved signaling circuit in which twist proteins regulate cytokine signaling by establishing a negative feedback loop that represses the NF-kappaB-dependent cytokine pathway.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL)	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.			Ornitz, David/0000-0003-1592-7629	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039952] Funding Source: NIH RePORTER; NICHD NIH HHS [HD39952] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; Castanon I, 2001, DEVELOPMENT, V128, P3145; Charite J, 2001, GENE DEV, V15, P3039, DOI 10.1101/gad.931701; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; CHENG J, 1992, GENE DEV, V6, P1444, DOI 10.1101/gad.6.8.1444; Cripps RM, 1998, GENE DEV, V12, P422, DOI 10.1101/gad.12.3.422; DEKOSSODO S, 1995, J INVEST DERMATOL, V104, P318, DOI 10.1111/1523-1747.ep12665361; Fearon KCH, 2002, INT J CARDIOL, V85, P73, DOI 10.1016/S0167-5273(02)00235-8; Govind S, 1999, ONCOGENE, V18, P6875, DOI 10.1038/sj.onc.1203223; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; IP TY, 1992, GENE DEV, V6, P1518; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; JIANG J, 1992, EMBO J, V11, P3147, DOI 10.1002/j.1460-2075.1992.tb05387.x; JIANG J, 1993, EMBO J, V12, P3201, DOI 10.1002/j.1460-2075.1993.tb05989.x; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; KHABAR KSA, 1995, IMMUNOL LETT, V46, P107, DOI 10.1016/0165-2478(95)00026-2; Khush RS, 2001, TRENDS IMMUNOL, V22, P260, DOI 10.1016/S1471-4906(01)01887-7; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; Ling PR, 1996, AM J PHYSIOL-ENDOC M, V270, pE305, DOI 10.1152/ajpendo.1996.270.2.E305; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Misra S, 1998, DEVELOPMENT, V125, P1261; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; PAN D, 1992, EMBO J, V11, P1837, DOI 10.1002/j.1460-2075.1992.tb05235.x; Protonotariou E, 1999, EARLY HUM DEV, V56, P31, DOI 10.1016/S0378-3782(99)00029-8; SADOWSKI I, 1992, GENE, V118, P137, DOI 10.1016/0378-1119(92)90261-M; Sheehan D.C., 1980, THEORY PRACTICE HIST; Shirokawa JM, 1997, MOL CELL BIOL, V17, P3345, DOI 10.1128/MCB.17.6.3345; Sosic D, 1997, DEV BIOL, V185, P229, DOI 10.1006/dbio.1997.8561; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; STJOHNSTON D, 1992, CELL, V68, P201; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; THISSE B, 1987, GENE DEV, V1, P709, DOI 10.1101/gad.1.7.709; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; TRACEY KJ, 1988, J EXP MED, V167, P1211, DOI 10.1084/jem.167.3.1211; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I; WURST W, 1993, GENE TARGETING PRACT	43	339	373	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 24	2003	112	2					169	180		10.1016/S0092-8674(03)00002-3	http://dx.doi.org/10.1016/S0092-8674(03)00002-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553906	Bronze			2022-12-28	WOS:000181191600007
J	Hoag, H				Hoag, H			Transgenic salmon still out in the cold in United States	NATURE			English	News Item																		Reichhardt T, 2000, NATURE, V406, P10, DOI 10.1038/35017657	1	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					304	304		10.1038/421304b	http://dx.doi.org/10.1038/421304b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540865	Bronze			2022-12-28	WOS:000180533000010
J	Paabo, S				Paabo, S			The mosaic that is our genome	NATURE			English	Article							MODERN HUMAN ORIGINS; HUMAN-EVOLUTION; DNA-SEQUENCES; MITOCHONDRIAL-DNA; NEANDERTHAL DNA; MODERN HUMANS; X-CHROMOSOME; REGION; DIVERSITY; RECOMBINATION	The discovery of the basis of genetic variation has opened inroads to understanding our history as a species. It has revealed the remarkable genetic similarity we share with other individuals as well as with our closest primate relatives. To understand what make us unique, both as individuals and as a species, we need to consider the genome as a mosaic of discrete segments, each with its own unique history and relatedness to different contemporary and ancestral individuals.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	Max Planck Society	Paabo, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.	paabo@eva.mpg.de						BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L., 1993, HIST GEOGRAPHY HUMAN; Chen FC, 2001, J HERED, V92, P481, DOI 10.1093/jhered/92.6.481; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Deinard A, 1999, J HUM EVOL, V36, P687, DOI 10.1006/jhev.1999.0298; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Mayr E., 1963, ANIMAL SPECIES EVOLU; MIYAMOTO MM, 1987, SCIENCE, V238, P369, DOI 10.1126/science.3116671; Nei M., 1987, MOL EVOLUTIONARY GEN; Nordborg M, 1998, AM J HUM GENET, V63, P1237, DOI 10.1086/302052; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Paabo S, 1999, TRENDS CELL BIOL, V9, pM13, DOI 10.1016/S0968-0004(99)01497-8; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Risch N., 2002, GENOME BIOL, V3; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Takahata N, 2001, MOL BIOL EVOL, V18, P172, DOI 10.1093/oxfordjournals.molbev.a003791; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Tomasello M, 1997, PRIMATE COGNITION; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; WILSON AC, 1969, P NATL ACAD SCI USA, V63, P1088, DOI 10.1073/pnas.63.4.1088; Yu N, 2002, GENETICS, V161, P269; Yu N, 2000, GENETICS, V155, P1481	42	95	101	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					409	412		10.1038/nature01400	http://dx.doi.org/10.1038/nature01400			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540910	Bronze			2022-12-28	WOS:000180533000051
J	Friederich, PW; Herny, CP; Messelink, EJ; Geerdink, MG; Keller, T; Kurth, KH; Buller, HR; Levi, M				Friederich, PW; Herny, CP; Messelink, EJ; Geerdink, MG; Keller, T; Kurth, KH; Buller, HR; Levi, M			Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled andomised trial	LANCET			English	Article							TISSUE FACTOR; AUTOLOGOUS BLOOD; FACTOR-X; HEMOPHILIA-A; TRANSFUSION; DONATION; HEMODILUTION; PROTHROMBIN; INHIBITION; MECHANISM	Background Recombinant activated factor VII (factor VIIa) has prohaemostatic effects in bleeding patients with coagulation abnormalities. We aimed to test the hypothesis that recombinant factor VIIa could reduce perioperative blood loss in patients with normal coagulation systems. Therefore, we assessed safety and efficacy of this drug in patients undergoing retropubic prostatectomy, which is often associated with major blood loss and need for transfusion. Methods In a double-blind, randomised placebo-controlled trial, we recorded blood loss and transfusion requirements in 36 patients undergoing retropubic prostatectomy, who were randomised to receive an intravenous bolus of recombinant factor VIIa (20 mug/kg or 40 mug/kg) or placebo in the early operative phase. Findings Median perioperative blood loss was 1235 mL (IQR 1025-1407) and 1089 mL (928-1320) in groups given recombinant factor VIIa 20 mug/kg and 40 mug/kg, respectively, compared with 2688 mL (1707-3565) in the placebo group (p=0.001). Seven of twelve placebo-treated patients were transfused, whereas no patients who received 40 mug/kg recombinant factor VIIa needed transfusion. The odds ratio for receiving any blood product in patients treated with recombinant factor VIIa compared with control patients was 0 (95% CI 0.00-0.33) No adverse events arose. Interpretation An injection of recombinant factor VIIa can reduce perioperative blood loss and eliminate the need for transfusion in patients undergoing major surgery.	Univ Amsterdam, Acad Med Ctr, Dept Vasc Med Internal Med, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Anaesthesiol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Urol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Levi, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med F4, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.m.levi@amc.uva.nl	Levi, Marcel/AAZ-8559-2020					Aledort LM, 2000, THROMB HAEMOSTASIS, V83, P637; ANDRIOLE GL, 1994, J UROLOGY, V152, P1858, DOI 10.1016/S0022-5347(17)32400-X; Bernstein DE, 1997, GASTROENTEROLOGY, V113, P1930, DOI 10.1016/S0016-5085(97)70013-1; Chun TY, 1997, UROLOGY, V50, P727, DOI 10.1016/S0090-4295(97)00481-0; de Wolf JT, 1999, TRANSFUSION, V39, p87S; DODD RY, 1992, NEW ENGL J MED, V327, P419, DOI 10.1056/NEJM199208063270610; Friederich PW, 2001, CIRCULATION, V103, P2555; Friederich PW, 2001, AM J HEMATOL, V66, P292, DOI 10.1002/ajh.1060; Gaylis FD, 1998, J UROLOGY, V159, P167, DOI 10.1016/S0022-5347(01)64045-X; GOAD JR, 1995, J UROLOGY, V154, P2103, DOI 10.1016/S0022-5347(01)66706-5; Goh M, 1997, UROLOGY, V49, P569, DOI 10.1016/S0090-4295(96)00548-1; Hedner U, 2000, BLOOD COAGUL FIBRIN, V11, pS107, DOI 10.1097/00001721-200004001-00020; HOFFMAN M, 1994, BLOOD, V83, P38; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Kristensen J, 1996, HAEMOSTASIS, V26, P159; Lusher JM, 1998, HAEMOPHILIA, V4, P790; Mann KG, 1999, THROMB HAEMOSTASIS, V82, P165; MILLIN T, 1970, UROLOGY, V3, P2507; Monroe DM, 1998, BLOOD COAGUL FIBRIN, V9, pS15; Nash PA, 1996, BRIT J UROL, V77, P856, DOI 10.1046/j.1464-410X.1996.00615.x; NESS PM, 1992, TRANSFUSION, V32, P226, DOI 10.1046/j.1537-2995.1992.32392213805.x; OEFELEIN MG, 1995, J UROLOGY, V154, P442, DOI 10.1016/S0022-5347(01)67070-8; Peters M, 1998, THROMB HAEMOSTASIS, V80, P352; RAO LVM, 1990, BLOOD, V75, P1069; RAPAPORT SI, 1995, THROMB HAEMOSTASIS, V74, P7; TENCATE H, 1993, J CLIN INVEST, V92, P1207, DOI 10.1172/JCI116691; van't Veer C, 2000, BLOOD, V95, P1330, DOI 10.1182/blood.V95.4.1330.004k28_1330_1335; White B, 1999, BRIT J HAEMATOL, V107, P677	28	305	318	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2003	361	9353					201	205		10.1016/S0140-6736(03)12268-4	http://dx.doi.org/10.1016/S0140-6736(03)12268-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547542				2022-12-28	WOS:000180535400008
J	van Strijen, MJL; de Monye, W; Schiereck, J; Kieft, GJ; Prins, MH; Huisman, MV; Pattynama, PMT				van Strijen, MJL; de Monye, W; Schiereck, J; Kieft, GJ; Prins, MH; Huisman, MV; Pattynama, PMT		Adv New Technologies Evaluating	Single-detector helical computed tomography as the primary diagnostic test in suspected pulmonary embolism: A multicenter clinical management study of 510 patients	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP VENOUS THROMBOSIS; PERFUSION LUNG-SCAN; NEGATIVE SPIRAL CT; COMPRESSION ULTRASONOGRAPHY; VEIN THROMBOSIS; VALIDITY; ANGIOGRAPHY; SCINTIGRAPHY; THROMBOEMBOLISM; PROBABILITY	Background: Helical computed tomography (CT) is a readily available tool for diagnosing pulmonary embolism (PE); however, its role in the management of patients with clinically suspected PE has not been fully established. Objective: To determine the effectiveness and safety of using helical CT of the pulmonary arteries as the primary diagnostic test in patients with suspected PE. Design: Multicenter, prospective clinical outcome study. Setting: Two academic hospitals and one large teaching hospital in the Netherlands. Patients: 510 consecutive inpatients and outpatients with clinically suspected PE followed for 3 months. Interventions: Patients underwent helical CT of the pulmonary arteries within 24 hours after presenting with signs and symptoms of PE. If CT results were normal or inconclusive, compression ultrasonography was performed on the same day as CT and repeated on days 4 and 7 if findings on the first compression ultrasonography were normal. When CT or compression ultrasonography results were positive for thromboembolism, anticoagulation was started. Anticoagulation was not started when results of CT were negative for PE or indicated an alternative diagnosis that explained the clinical signs and symptoms, or when results on serial compression ultrasonography were normal. Measurements: Patients received instructions to report any symptoms or signs of PE or deep venous thrombosis (DVT) during the 3-month follow-up period. The authors performed compression ultrasonography or phlebography for suspected DVT and pulmonary angiography for suspected PE. Results: Computed tomography identified PE in 124 of 510 patients (24.3%) and an alternative diagnosis in 130 patients (25.5%); CT scans were normal in 248 patients (48.6%). The CT scan could not be interpreted in 8 patients (1.6%) and was not obtained in 2. Compression ultrasonography revealed DVT in 2 patients at the first examination; findings on repeated compression ultrasonography at days 4 and 7 were normal. Mortality in the patients with normal helical CT scans was 4.1% (10 of 246 patients). No patients in this group died of fatal PE, 1 patient developed nonfatal PE, and venous thromboembolism occurred in 0.4% of these patients (95% CI, 0% to 2.2%). In the patients with alternative diagnoses, 1 patient had DVT on objective testing during follow-up. Mortality in this group was 21.5% (28 of 130 patients); in 1 of these patients, PE could not be confidently ruled out as a contributing cause of death. Venous thromboembolism occurred in 1.5% of these patients (CI, 0.2% to 5.6%). Conclusions: In patients with suspected PE, helical CT can be used safely as the primary diagnostic test to rule out PE. Serial compression ultrasonography has limited additional value.	Leiden Univ, Med Ctr, Dept Gen Internal Med, NL-2300 RC Leiden, Netherlands; Leyenburg Ziekenhuis, The Hague, Netherlands; Utrecht Med Ctr, Utrecht, Netherlands; Erasmus MC, Rotterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC	Huisman, MV (corresponding author), Leiden Univ, Med Ctr, Dept Gen Internal Med, Room B3Q-84,POB 9600, NL-2300 RC Leiden, Netherlands.	m.v.huisman@lumc.nl						Baile EM, 2000, AM J RESP CRIT CARE, V161, P1010, DOI 10.1164/ajrccm.161.3.9904067; Birdwell BG, 1998, ANN INTERN MED, V128, P1, DOI 10.7326/0003-4819-128-1-199801010-00001; Cham MD, 2000, RADIOLOGY, V216, P744, DOI 10.1148/radiology.216.3.r00se44744; Cogo A, 1998, BRIT MED J, V316, P17, DOI 10.1136/bmj.316.7124.17; COGO A, 1993, ARCH INTERN MED, V153, P2777, DOI 10.1001/archinte.153.24.2777; de Monye W, 2001, SEMIN THROMB HEMOST, V27, P33; Ferretti GR, 1997, RADIOLOGY, V205, P453, DOI 10.1148/radiology.205.2.9356628; Garg K, 1999, AM J ROENTGENOL, V172, P1627, DOI 10.2214/ajr.172.6.10350303; Ghaye B, 2001, RADIOLOGY, V219, P629, DOI 10.1148/radiology.219.3.r01jn32629; Goodman LR, 2000, RADIOLOGY, V215, P535, DOI 10.1148/radiology.215.2.r00ma23535; Gottsater A, 2001, EUR RADIOL, V11, P65, DOI 10.1007/s003300000539; HENRY JW, 1995, CHEST, V107, P1375, DOI 10.1378/chest.107.5.1375; HULL R, 1981, CIRCULATION, V64, P622, DOI 10.1161/01.CIR.64.3.622; HULL RD, 1990, CHEST, V97, P23, DOI 10.1378/chest.97.1.23; Lomis NNT, 1999, J VASC INTERV RADIOL, V10, P707, DOI 10.1016/S1051-0443(99)70104-1; Loud PA, 2001, RADIOLOGY, V219, P498, DOI 10.1148/radiology.219.2.r01ma26498; Mac Gillavry MR, 2000, THROMB HAEMOSTASIS, V84, P973; Mullins MD, 2000, ARCH INTERN MED, V160, P293, DOI 10.1001/archinte.160.3.293; Ost D, 2001, AM J MED, V110, P16, DOI 10.1016/S0002-9343(00)00641-0; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Rathbun SW, 2000, ANN INTERN MED, V132, P227, DOI 10.7326/0003-4819-132-3-200002010-00009; Remy-Jardin M, 2000, AM J ROENTGENOL, V175, P407, DOI 10.2214/ajr.175.2.1750407; REMYJARDIN M, 1992, RADIOLOGY, V185, P381, DOI 10.1148/radiology.185.2.1410342; van Erkel AR, 1998, ACAD RADIOL, V5, pS321, DOI 10.1016/S1076-6332(98)80344-9; van Rossum AB, 1998, EUR RADIOL, V8, P90, DOI 10.1007/s003300050345; van Rossum AB, 1998, EUR RADIOL, V8, P1160, DOI 10.1007/s003300050526; VANBEEK EJR, 1995, CHEST, V108, P170, DOI 10.1378/chest.108.1.170; VANBEEK EJR, 2001, HEMOSTASIS THROMBOSI, P1303; vanErkel AR, 1996, RADIOLOGY, V201, P29, DOI 10.1148/radiology.201.1.8816516; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; WORSLEY DF, 1994, ARCH INTERN MED, V154, P2737, DOI 10.1001/archinte.1994.00420230134016	31	182	182	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2003	138	4					307	314		10.7326/0003-4819-138-4-200302180-00009	http://dx.doi.org/10.7326/0003-4819-138-4-200302180-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DK	12585828				2022-12-28	WOS:000181019400004
J	Ayus, JC; Levine, R; Arieff, AI				Ayus, JC; Levine, R; Arieff, AI			Fatal dysnatraemia caused by elective colonoscopy	BRITISH MEDICAL JOURNAL			English	Review							COLORECTAL-CANCER; HYPONATREMIC ENCEPHALOPATHY; PREVENTION; COLON		Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78284 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA	University of Texas System; University of Texas Health San Antonio; Baylor College of Medicine; University of California System; University of California San Francisco	Ayus, JC (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78284 USA.							AYUS JC, 1993, ENDOCRIN METAB CLIN, V22, P425; Ayus JC, 1999, JAMA-J AM MED ASSOC, V281, P2299, DOI 10.1001/jama.281.24.2299; COHEN SM, 1994, DIS COLON RECTUM, V37, P689, DOI 10.1007/BF02054413; *DEP HLTH HUM SERV, 1997, VIT HLTH STAT DET DI, P125; Detsky AS, 2001, NEW ENGL J MED, V345, P607, DOI 10.1056/NEJM200108233450809; HAMPTON KK, 1991, CLIN SCI, V81, P257, DOI 10.1042/cs0810257; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; NICKL NJ, 2001, MASSY GLASSOCKS TXB, P1330; PHILLIPS PA, 1984, NEW ENGL J MED, V311, P753, DOI 10.1056/NEJM198409203111202; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; SIFTON DW, 2001, PHYSICIANS DESK REFE, P990; SNYDER NA, 1987, ANN INTERN MED, V107, P309, DOI 10.7326/0003-4819-107-2-309; Verbalis JG, 2001, DIS KIDNEY URINARY T, P2511; WAYE JD, 1992, J CLIN GASTROENTEROL, V15, P347, DOI 10.1097/00004836-199212000-00018	16	58	60	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2003	326	7385					382	384		10.1136/bmj.326.7385.382	http://dx.doi.org/10.1136/bmj.326.7385.382			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648RZ	12586675	Green Published			2022-12-28	WOS:000181165500025
J	Powrie, F; Maloy, KJ				Powrie, F; Maloy, KJ			Regulating the regulators	SCIENCE			English	Editorial Material							T-CELLS		Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Powrie, F (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.		Sahoo, Professor M.S./AAA-6537-2022	Sahoo, Professor M.S./0000-0002-8236-323X; Maloy, Kevin/0000-0001-5795-7688				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kullberg MC, 2002, J EXP MED, V196, P505, DOI 10.1084/jem.20020556; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; RAMSDELL F, COMMUNICATION; Sing A, 2002, J EXP MED, V196, P1017, DOI 10.1084/jem.20020908	12	104	108	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1030	1031		10.1126/science.1082031	http://dx.doi.org/10.1126/science.1082031			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586934				2022-12-28	WOS:000180960000035
J	Walsh, JP; Arora, A; Cohen, WM				Walsh, JP; Arora, A; Cohen, WM			Science and the law - Working through the patent problem	SCIENCE			English	Editorial Material									Univ Illinois, Dept Sociol, Chicago, IL 60607 USA; Univ Tokyo, Res Ctr Adv Econ Engn, Tokyo, Japan; Carnegie Mellon Univ, Heinz Sch Policy & Management, Pittsburgh, PA 15213 USA; Duke Univ, Fuqua Sch Business, Durham, NC 27708 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Tokyo; Carnegie Mellon University; Duke University	Walsh, JP (corresponding author), Univ Illinois, Dept Sociol, Chicago, IL 60607 USA.		arora, ashish/M-1720-2013	arora, ashish/0000-0001-5097-8646				Arora A., 2001, MARKETS TECHNOLOGY; Arora A., 2003, 9431 NAT BUR EC RES; Barton JH, 2000, SCIENCE, V287, P1933, DOI 10.1126/science.287.5460.1933; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; COHEN WM, 2000, 7552 NAT BUR EC; EISENBERG R, 2001, EXPANDING BOUNDARIES; Eisenberg RS, 2003, SCIENCE, V299, P1018, DOI 10.1126/science.1081790; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; LEVIN RC, 1987, BROOKINGS PAPERS EC, V3, P783, DOI DOI 10.2307/2534454; MAEBIUS S, 2001, NATL LAW J, V24, pC3; Marshall E, 2000, SCIENCE, V288, P255, DOI 10.1126/science.288.5464.255; MERGES RP, 1990, COLUMBIA LAW REV, V90, P839, DOI 10.2307/1122920; NAT'L RESEARCH COUNCIL, 1997, INT PROP RIGHTS RES; National Institutes of Health, 1999, FED REG, V64, P72090; SCOTCHMER S, 1991, J ECON PERSPECT, V5, P29, DOI 10.1257/jep.5.1.29; Uzzi B, 1996, AM SOCIOL REV, V61, P674, DOI 10.2307/2096399; WALSH JP, IN PRESS PATENTS KNO; Whyte W. F., 1984, LEARNING FIELD	18	94	95	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1021	1021		10.1126/science.299.5609.1021	http://dx.doi.org/10.1126/science.299.5609.1021			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	645DB	12586928				2022-12-28	WOS:000180960000029
J	Wing, LMH; Reid, CM; Ryan, P; Beilin, LJ; Brown, MA; Jennings, GLR; Johnston, CI; McNeil, JJ; Macdonald, GJ; Marley, JE; Morgan, TO; West, MJ; Nelson, M; Bruce, A; Beckinsale, P; Thompson, J; McMurchie, M; Fraser, G; Gleave, D; Cope, V; DeLooze, F; Moore, S; Dibben, C; Newbury, J; Miles, H; McDermott, B; Willson, K; Bear, C; West, M; Harrap, S; Johnston, C; Beilin, L; Ryan, P; Wing, L; Reid, C; Beilin, L; Brown, M; Ryan, P; Wing, L; Reid, C; Jennings, G; Fletcher, P; Feneley, M; Dewar, E; Wing, L; Reid, C; McNeil, J; Wing, L; Marley, J; Reid, C; Johnston, C; Jennings, G; Wing, L; Reid, C; Marley, J; Moss, J; Webb, P; Glasziou, P; Boyle, F; Primrose, J; Wing, L; Reid, C; Steven, I; Piterman, L; De Looze, F; Dickinson, J; Gambrill, J; Joseph, P; Reid, C; Hunt, D; Donnan, G; Wing, L; Morgan, T; Chalmers, J; Whitworth, J; MacMahon, S; Silagy, C				Wing, LMH; Reid, CM; Ryan, P; Beilin, LJ; Brown, MA; Jennings, GLR; Johnston, CI; McNeil, JJ; Macdonald, GJ; Marley, JE; Morgan, TO; West, MJ; Nelson, M; Bruce, A; Beckinsale, P; Thompson, J; McMurchie, M; Fraser, G; Gleave, D; Cope, V; DeLooze, F; Moore, S; Dibben, C; Newbury, J; Miles, H; McDermott, B; Willson, K; Bear, C; West, M; Harrap, S; Johnston, C; Beilin, L; Ryan, P; Wing, L; Reid, C; Beilin, L; Brown, M; Ryan, P; Wing, L; Reid, C; Jennings, G; Fletcher, P; Feneley, M; Dewar, E; Wing, L; Reid, C; McNeil, J; Wing, L; Marley, J; Reid, C; Johnston, C; Jennings, G; Wing, L; Reid, C; Marley, J; Moss, J; Webb, P; Glasziou, P; Boyle, F; Primrose, J; Wing, L; Reid, C; Steven, I; Piterman, L; De Looze, F; Dickinson, J; Gambrill, J; Joseph, P; Reid, C; Hunt, D; Donnan, G; Wing, L; Morgan, T; Chalmers, J; Whitworth, J; MacMahon, S; Silagy, C		Second Australian Natl Blood Press	A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR MORBIDITY; RANDOMIZED-TRIAL; SWEDISH TRIAL; OLD PATIENTS; MORTALITY; CAPTOPRIL; INTERVENTION; NEPHROPATHY; PREVENTION; TIME	BACKGROUND: Treatment of hypertension with diuretics, beta-blockers, or both leads to improved outcomes. It has been postulated that agents that inhibit the renin-angiotensin system confer benefit beyond the reduction of blood pressure alone. We compared the outcomes in older subjects with hypertension who were treated with angiotensin-converting-enzyme (ACE) inhibitors with the outcomes in those treated with diuretic agents. METHODS: We conducted a prospective, randomized, open-label study with blinded assessment of end points in 6083 subjects with hypertension who were 65 to 84 years of age and received health care at 1594 family practices. Subjects were followed for a median of 4.1 years, and the total numbers of cardiovascular events in the two treatment groups were compared with the use of multivariate proportional-hazards models. RESULTS: At base line, the treatment groups were well matched in terms of age, sex, and blood pressure. By the end of the study, blood pressure had decreased to a similar extent in both groups (a decrease of 26/12 mm Hg). There were 695 cardiovascular events or deaths from any cause in the ACE-inhibitor group (56.1 per 1000 patient-years) and 736 cardiovascular events or deaths from any cause in the diuretic group (59.8 per 1000 patient-years; the hazard ratio for a cardiovascular event or death with ACE-inhibitor treatment was 0.89 [95 percent confidence interval, 0.79 to 1.00]; P=0.05). Among male subjects, the hazard ratio was 0.83 (95 percent confidence interval, 0.71 to 0.97; P=0.02); among female subjects, the hazard ratio was 1.00 (95 percent confidence interval, 0.83 to 1.21; P=0.98); the P value for the interaction between sex and treatment-group assignment was 0.15. The rates of nonfatal cardiovascular events and myocardial infarctions decreased with ACE-inhibitor treatment, whereas a similar number of strokes occurred in each group (although there were more fatal strokes in the ACE-inhibitor group). CONCLUSIONS: Initiation of antihypertensive treatment involving ACE inhibitors in older subjects, particularly men, appears to lead to better outcomes than treatment with diuretic agents, despite similar reductions of blood pressure.	Baker Heart Res Inst, Melbourne, Vic 8008, Australia; Flinders Univ S Australia, Sch Med, Adelaide, SA 5001, Australia; Univ Adelaide, Dept Publ Hlth, Adelaide, SA, Australia; Univ Western Australia, Dept Med, Perth, WA 6009, Australia; Univ New S Wales, Dept Nephrol, Sydney, NSW, Australia; Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; Merck Sharp & Dohme Ltd, Sydney, NSW, Australia; Univ Newcastle, Fac Hlth, Newcastle, NSW 2308, Australia; Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia; Univ Queensland, Dept Med, Brisbane, Qld 4000, Australia	Baker Heart and Diabetes Institute; Flinders University South Australia; University of Adelaide; University of Western Australia; University of New South Wales Sydney; Monash University; Merck & Company; University of Newcastle; University of Melbourne; University of Queensland	Reid, CM (corresponding author), Baker Heart Res Inst, POB 6492,St Kilda Rd Cent, Melbourne, Vic 8008, Australia.	chris.reid@baker.edu.au	Jennings, Garry/B-3914-2009; Glasziou, Paul/A-7832-2008; Reid, Christopher M/AAP-8135-2021; DONNAN, GEOFFREY A/A-9947-2008; Marley, John/F-1239-2010; west, malcolm J/C-9425-2009; McNeil, John/L-6440-2019	Glasziou, Paul/0000-0001-7564-073X; west, malcolm J/0000-0002-7629-5277; McNeil, John/0000-0002-1049-5129; Reid, Christopher/0000-0001-9173-3944; Jennings, Garry/0000-0002-7865-5483				Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1980, LANCET, V1, P1261; *AUSTR COMP OUTC T, 1997, CLIN EXP PHARM PHYSL, V24, P188; *AUSTR I HLTH WELF, 2001, CARD DIS SER, V14; *BRIT HYP SOC, 1993, BRIT MED J; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; Brown MJ, 2000, LANCET, V356, P514; CANBERRA A, 2001, 13 AIHW CVD; Chalmers J, 1999, J HYPERTENS, V17, P151; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; DAHLOF B, 1992, AM J HYPERTENS, V5, P95, DOI 10.1093/ajh/5.2.95; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; *DECL HELS, 1990, B PAN AM HLTH ORG, V24, P606; Effects of treatment on morbidity in hypertension, 1970, JAMA-J AM MED ASSOC, V213, P1143, DOI DOI 10.1001/JAMA.213.7.1143; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; GAVRAS H, 1974, PROG CARDIOVASC DIS, V17, P39, DOI 10.1016/0033-0620(74)90037-1; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; Hlubocka Z, 2002, J HUM HYPERTENS, V16, P557, DOI 10.1038/sj.jhh.1001403; LEWIS EJ, 1994, NEW ENGL J MED, V330, P152; Li QH, 1997, STAT MED, V16, P925; MARRE M, 1988, BMJ-BRIT MED J, V297, P1092, DOI 10.1136/bmj.297.6656.1092; MATHIESEN ER, 1991, BMJ-BRIT MED J, V303, P81, DOI 10.1136/bmj.303.6794.81; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; Neal B, 2000, LANCET, V356, P1955; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; POLLARE T, 1989, NEW ENGL J MED, V321, P868, DOI 10.1056/NEJM198909283211305; Reid CM, 2001, CLINICAL TRIALS IN HYPERTENSION, P587; Reid CM, 1998, MED J AUSTRALIA, V169, P349, DOI 10.5694/j.1326-5377.1998.tb126798.x; Reid CM, 2001, CLIN EXP PHARMACOL P, V28, P663, DOI 10.1046/j.1440-1681.2001.03501.x; RUTHERFORD JD, 1994, CIRCULATION, V90, P1731, DOI 10.1161/01.CIR.90.4.1731; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Stearne MR, 1998, BRIT MED J, V317, P713; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; WEIDMANN P, 1985, J HYPERTENS, V3, P297, DOI 10.1097/00004872-198508000-00001; WHO Int Soc Hyperten Blood Press Lower, 1998, J HYPERTENS, V16, P127; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S., 1992, NEW ENGL J MED, V327, P685, DOI [DOI 10.1056/NEJM199209033271003, 10.1056/NEJM199209033271003.Erratumin]	46	811	852	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2003	348	7					583	592		10.1056/NEJMoa021716	http://dx.doi.org/10.1056/NEJMoa021716			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644HY	12584366	Bronze, Green Published			2022-12-28	WOS:000180912900003
J	Pepys, MB; Bybee, A; Booth, DR; Bishop, MT; Will, RG; Little, AM; Prokupek, B; Madrigal, JA				Pepys, MB; Bybee, A; Booth, DR; Bishop, MT; Will, RG; Little, AM; Prokupek, B; Madrigal, JA			MHC typing in variant Creutzfeldt-Jakob disease	LANCET			English	Article								Identification of factors that cause susceptibility to, and clinical expression of, variant Creutzfeldt-Jakob disease (vCJD) is essential for future management of the disease. We established MHC genotypes of 76 individuals with vCJD and 131 controls, and analysed MHC phenotypes in relation to age of onset of vCJD and its duration from presentation to death. There were no significant differences between vCJD and control populations in frequencies of any MHC types, nor were there associations between MHC type and age of onset or duration of vCJD disease. Our results do not support the idea of an association between MHC types and either susceptibility to, or expression of, vCJD.	UCL Royal Free & Univ Coll Med Sch, Dept Med, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England; Univ Edinburgh, Western Gen Hosp, Natl CJD Surveillance Unit, Edinburgh, Midlothian, Scotland; UCL Royal Free Hosp, Anthony Nolan Res Inst & Histocompatibil Labs, London NW3 2QG, England	University of London; University College London; UCL Medical School; University of Edinburgh; University of London; University College London	Pepys, MB (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Med, Ctr Amyloidosis & Acute Phase Prot, Rowland Hill St, London NW3 2PF, England.	m.pepys@rfc.ucl.ac.uk		Madrigal, Alejandro/0000-0001-8359-9917				Arguello JR, 1998, BONE MARROW TRANSPL, V22, P527, DOI 10.1038/sj.bmt.1701383; Arguello JR, 1998, NAT GENET, V18, P192, DOI 10.1038/ng0298-192; Jackson GS, 2001, NATURE, V414, P269, DOI 10.1038/35104694; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; McDermott AB, 1997, TISSUE ANTIGENS, V50, P8, DOI 10.1111/j.1399-0039.1997.tb02827.x	5	20	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					487	489		10.1016/S0140-6736(03)12455-5	http://dx.doi.org/10.1016/S0140-6736(03)12455-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583949				2022-12-28	WOS:000180900600014
J	Linke, H				Linke, H			Coherent power booster	SCIENCE			English	Editorial Material							BROWNIAN MOTORS		Univ Oregon, Dept Phys, Eugene, OR 97403 USA; Univ Oregon, Inst Mat Sci, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Linke, H (corresponding author), Univ Oregon, Dept Phys, Eugene, OR 97403 USA.	linke@uoregon.edu	Linke, Heiner/A-5825-2010	Linke, Heiner/0000-0003-4451-4006				Astumian RD, 2002, PHYS TODAY, V55, P33, DOI 10.1063/1.1535005; Atkins P., 1984, 2 LAW SCI AM BOOKS; HARRIS SE, 1997, PHYS TODAY, V36; Humphrey TE, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.116801; Lloyd S, 1997, PHYS REV A, V56, P3374, DOI 10.1103/PhysRevA.56.3374; Nieuwenhuizen TM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.036102; RAMSEY NF, 1956, PHYS REV, V103, P20, DOI 10.1103/PhysRev.103.20; Reimann P, 2002, PHYS REP, V361, P57, DOI 10.1016/S0370-1573(01)00081-3; SCOVIL HED, 1959, PHYS REV LETT, V2, P262, DOI 10.1103/PhysRevLett.2.262; Scully MO, 2003, SCIENCE, V299, P862, DOI 10.1126/science.1078955; Scully MO, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.050602; Zubairy MS, 2002, AIP CONF PROC, V643, P92; 2002, 2001 ANN REP, P29	13	2	3	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					841	842		10.1126/science.1080886	http://dx.doi.org/10.1126/science.1080886			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574613				2022-12-28	WOS:000180830900034
J	Mackey, D; Belkhadir, Y; Alonso, JM; Ecker, JR; Dangl, JL				Mackey, D; Belkhadir, Y; Alonso, JM; Ecker, JR; Dangl, JL			Arabidopsis RIN4 is a target of the type III virulence effector AvrRpt2 and modulates RPS2-mediated resistance	CELL			English	Article							NUCLEOTIDE-BINDING SITE; SYRINGAE PV. TOMATO; DISEASE-RESISTANCE; GENE-PRODUCT; SECRETION SYSTEM; AVIRULENCE GENE; PLANT-PATHOGENS; BACTERIAL; PROTEIN; THALIANA	Type III pili deliver effector proteins (virulence factors) from bacterial pathogens to host cells. Plants express disease resistance (R) proteins that respond specifically to a particular type III effector by activating immune responses. We demonstrated previously that two unrelated type III effectors from Pseudomonas syringae target and modify the Arabidopsis RIN4 protein. Here, we show that AvrRpt2, a third, unrelated type III effector, also targets RIN4 and induces its post-transcriptional disappearance. This effect is independent of the presence of RPS2, the Arabidopsis R protein that senses AvrRpt2. RIN4 overexpression inhibits multiple phenotypes associated with AvrRpt2 function. Conversely, disruption of RIN4 results in RPS2-dependent lethality. RPS2 and RIN4 physically associate in the plant. We suggest that RIN4 is the target of the AvrRpt2 virulence function, and that perturbation of RIN4 activates RPS2. Thus, RIN4 is a point of convergence for the activity of at least three unrelated P. syringae type III effectors.	Univ N Carolina, Curriculum Genet, Dept Biol, Chapel Hill, NC 27599 USA; Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA; Univ N Carolina, Curriculum Genet, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; Salk Institute	Dangl, JL (corresponding author), Univ N Carolina, Curriculum Genet, Dept Biol, Coker Hall CB 3280, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu	Ecker, Joseph R/B-9144-2008; Alonso, Jose M/K-6826-2014; Belkhadir, Youssef/GXM-6743-2022	Ecker, Joseph R/0000-0001-5799-5895; Alonso, Jose M/0000-0001-7087-1571; Belkhadir, Youssef/0000-0001-7149-7139				Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Bonas U, 2002, CURR OPIN MICROBIOL, V5, P44, DOI 10.1016/S1369-5274(02)00284-9; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Chang JH, 2000, MOL PLANT MICROBE IN, V13, P568, DOI 10.1094/MPMI.2000.13.5.568; Chen ZY, 2000, MOL PLANT MICROBE IN, V13, P1312, DOI 10.1094/MPMI.2000.13.12.1312; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collins N, 1999, PLANT CELL, V11, P1365, DOI 10.1105/tpc.11.7.1365; Collmer A, 2000, P NATL ACAD SCI USA, V97, P8770, DOI 10.1073/pnas.97.16.8770; Collmer A, 2002, TRENDS MICROBIOL, V10, P462, DOI 10.1016/S0966-842X(02)02451-4; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gassmann W, 1999, PLANT J, V20, P265, DOI 10.1046/j.1365-313X.1999.t01-1-00600.x; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; KEARNEY B, 1990, NATURE, V346, P385, DOI 10.1038/346385a0; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Lawrence G, 1995, TRENDS MICROBIOL, V3, P475, DOI 10.1016/S0966-842X(00)89014-9; LAWRENCE GJ, 1981, PHYTOPATHOLOGY, V71, P12, DOI 10.1094/Phyto-71-12; Leister RT, 2000, PLANT J, V22, P345, DOI 10.1046/j.1365-313x.2000.00744.x; LORANG JM, 1994, MOL PLANT MICROBE IN, V7, P508, DOI 10.1094/MPMI-7-0508; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Nimchuk Z, 2001, CURR OPIN PLANT BIOL, V4, P288, DOI 10.1016/S1369-5266(00)00175-8; Oldroyd GED, 1998, P NATL ACAD SCI USA, V95, P10300, DOI 10.1073/pnas.95.17.10300; ORLANDI EW, 1992, PHYSIOL MOL PLANT P, V40, P173, DOI 10.1016/0885-5765(92)90058-4; Puri N, 1997, MOL PLANT MICROBE IN, V10, P247, DOI 10.1094/MPMI.1997.10.2.247; RITTER C, 1995, MOL PLANT MICROBE IN, V8, P444, DOI 10.1094/MPMI-8-0444; Ritter C, 1996, PLANT CELL, V8, P251, DOI 10.1105/tpc.8.2.251; Schneider DS, 2002, CELL, V109, P537, DOI 10.1016/S0092-8674(02)00764-X; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Stokes TL, 2002, GENE DEV, V16, P171, DOI 10.1101/gad.952102; Tao Y, 2000, PLANT CELL, V12, P2541, DOI 10.1105/tpc.12.12.2541; Tornero P, 2001, PLANT J, V28, P475, DOI 10.1046/j.1365-313X.2001.01136.x; Tsiamis G, 2000, EMBO J, V19, P3204, DOI 10.1093/emboj/19.13.3204; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Warren RF, 1998, PLANT CELL, V10, P1439, DOI 10.1105/tpc.10.9.1439	45	708	739	4	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 7	2003	112	3					379	389		10.1016/S0092-8674(03)00040-0	http://dx.doi.org/10.1016/S0092-8674(03)00040-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581527	Bronze			2022-12-28	WOS:000181252200009
J	Rothman, AA; Wagner, EH				Rothman, AA; Wagner, EH			Chronic illness management: What is the role of primary care?	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; DEPENDENT DIABETES-MELLITUS; IMPROVING PRIMARY-CARE; DISEASE MANAGEMENT; RANDOMIZED-TRIAL; HEALTH-SERVICES; DEPRESSION; OUTCOMES; IMPACT; GENERALISTS	An estimated 99 million Americans live with a chronic illness. Meeting the needs of this population is one of the major challenges facing the U.S. health care system today and in the future. Dozens of studies, surveys, and audits have revealed that sizable proportions of chronically ill patients have not received effective therapy and do not have optimal disease control. The consistent findings of generally substandard care for many chronic conditions have spurred proposals that care be shifted to specialists or disease management programs. Published evidence to date does not indicate any clear superiority of these alternatives to primary care. The defining features of primary care (that is, continuity, coordination, and comprehensiveness) are well suited to care of chronic illness. A rapidly growing body of health services research points to the design of the care system, not the specialty of the physician, as the primary determinant of chronic care quality. The future of primary care in the United States may depend on its ability to successfully redesign care systems that can meet the needs of a growing population of chronically ill patients.	Univ Calif San Francisco, San Francisco, CA 94118 USA; Grp Hlth Cooperat Puget Sound, Seattle, WA 98121 USA	University of California System; University of California San Francisco; Group Health Cooperative	Rothman, AA (corresponding author), Univ Calif San Francisco, 3333 Calif St,Suite 265, San Francisco, CA 94118 USA.		Showstack, Jonathan/L-6556-2013	Showstack, Jonathan/0000-0002-1367-419X				Bodenheimer T, 2000, BRIT MED J, V320, P563, DOI 10.1136/bmj.320.7234.563; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Bonomi AE, 2002, HEALTH SERV RES, V37, P791, DOI 10.1111/1475-6773.00049; Callahan CM, 2001, MED CARE, V39, P772, DOI 10.1097/00005650-200108000-00004; CHERRY DK, 2001, STAT DOHC NATL AMBUL; DONDALDSON MS, 1996, PRIMARY CARE AM HLTH; Donohoe MT, 1998, ARCH INTERN MED, V158, P1596, DOI 10.1001/archinte.158.15.1596; Gittell JH, 2000, MED CARE, V38, P807, DOI 10.1097/00005650-200008000-00005; Greenfield S, 2002, ANN INTERN MED, V136, P111, DOI 10.7326/0003-4819-136-2-200201150-00008; GREENFIELD S, 1995, JAMA-J AM MED ASSOC, V274, P1436; Greenfield S, 1999, J GEN INTERN MED, V14, P516, DOI 10.1046/j.1525-1497.1999.05059.x; Harrold LR, 1999, J GEN INTERN MED, V14, P499, DOI 10.1046/j.1525-1497.1999.08168.x; Hiss RG, 1996, ANN INTERN MED, V124, P146, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00012; Ho M, 1997, DIABETES CARE, V20, P472, DOI 10.2337/diacare.20.4.472; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Hoffman C, 1996, JAMA-J AM MED ASSOC, V276, P1473, DOI 10.1001/jama.276.18.1473; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; Katon W, 2000, MED CARE, V38, P552, DOI 10.1097/00005650-200006000-00002; Katon W, 1999, ARCH GEN PSYCHIAT, V56, P1109, DOI 10.1001/archpsyc.56.12.1109; Lafata JE, 2001, MED CARE, V39, P491; LURIE N, 1993, NEW ENGL J MED, V329, P478, DOI 10.1056/NEJM199308123290707; MacLean CH, 2000, JAMA-J AM MED ASSOC, V284, P984, DOI 10.1001/jama.284.8.984; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; McCulloch D K, 1998, Eff Clin Pract, V1, P12; MCCULLOCH DK, 2000, DIS MANAGEMENT, V3, P73; Moore G, 2003, ANN INTERN MED, V138, P244, DOI 10.7326/0003-4819-138-3-200302040-00032; Nash DB, 1997, ANN INTERN MED, V127, P72, DOI 10.7326/0003-4819-127-1-199707010-00012; Nelson K, 2002, MED CARE, V40, P283, DOI 10.1097/00005650-200204000-00004; Norris SL, 2002, AM J PREV MED, V22, P15, DOI 10.1016/S0749-3797(02)00423-3; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Piette JD, 2001, DIABETES CARE, V24, P202, DOI 10.2337/diacare.24.2.202; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Rosenblatt RA, 1998, JAMA-J AM MED ASSOC, V279, P1364, DOI 10.1001/jama.279.17.1364; ROTHMAN ALA, 2000, INTERDISCIPLINARY HL, P187; Safran DG, 2003, ANN INTERN MED, V138, P248, DOI 10.7326/0003-4819-138-3-200302040-00033; Shortell SM, 2000, MED CARE, V38, P207, DOI 10.1097/00005650-200002000-00010; Showstack J, 2003, ANN INTERN MED, V138, P268, DOI 10.7326/0003-4819-138-3-200302040-00036; Simon GE, 2000, BRIT MED J, V320, P550, DOI 10.1136/bmj.320.7234.550; Solberg LI, 1997, ANN BEHAV MED, V19, P271, DOI 10.1007/BF02892291; Starfield B, 1998, PRIMARY CARE BALANCI; Taplin S H, 1994, J Am Board Fam Pract, V7, P375; Verlato G, 1996, DIABETES CARE, V19, P211, DOI 10.2337/diacare.19.3.211; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Von Korff M, 2001, J Fam Pract, V50, pE1; Wagner E H, 1999, Manag Care Q, V7, P56; Wagner E H, 2001, Jt Comm J Qual Improv, V27, P63; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; WAGNER EH, 1995, PATIENT EDUC COUNS, V26, P225, DOI 10.1016/0738-3991(95)00761-N; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569; Wanger EH, 1998, ANN INTERN MED, V129, P654, DOI 10.7326/0003-4819-129-8-199810150-00015; WEINBERGER M, 1993, ARTHRITIS RHEUM, V36, P243, DOI 10.1002/art.1780360216; Willison DJ, 1998, ARCH INTERN MED, V158, P1778, DOI 10.1001/archinte.158.16.1778; Yawn B, 2001, DIABETES CARE, V24, P1390, DOI 10.2337/diacare.24.8.1390	56	332	334	1	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					256	261		10.7326/0003-4819-138-3-200302040-00034	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00034			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558376				2022-12-28	WOS:000181018600026
J	Wetzel, MS; Kaptchuk, TJ; Haramati, A; Eisenberg, DM				Wetzel, MS; Kaptchuk, TJ; Haramati, A; Eisenberg, DM			Complementary and alternative medical therapies: Implications for medical education	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; JOHNS WORT; SCHOOLS; TRENDS; CARE	Increased use of complementary and alternative medicine (CAM) has made it imperative that these topics be included in medical education from the preclinical years through residency and beyond. There has been progress in this direction in recent years, with a steady increase in the number of medical schools that include CAM therapies in their curricula. There remains, however, a lack of clear goals and concrete suggestions for implementing these changes. This article examines the questions that arise when medical educators consider how to incorporate CAM therapies as an integral part of the medical curriculum. It offers practical suggestions for finding time in an already packed curriculum, getting started, including faculty and students in the process, and sustaining the initiative with the necessary administrative and institutional support.	Harvard Univ, Sch Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Georgetown Univ, Sch Med, Washington, DC 20057 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Georgetown University	Wetzel, MS (corresponding author), Harvard Univ, Sch Med, 10 Shattuck St,Suite 612, Boston, MA 02115 USA.		Haramati, Aviad/ABB-1587-2020		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U24AR043441] Funding Source: NIH RePORTER; NIAMS NIH HHS [U24 AR 43441] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		*AM ASS MED COLL, 1998, LEARN OBJ MED STUD E, V6, P8; *AM MED ASS COUNC, 1997, ENC MED STUD ED COMP; Angell M, 1998, NEW ENGL J MED, V339, P839, DOI 10.1056/NEJM199809173391210; Barzansky B, 2000, JAMA-J AM MED ASSOC, V284, P1114, DOI 10.1001/jama.284.9.1114; Berman BM, 2001, BRIT MED J, V322, P121, DOI 10.1136/bmj.322.7279.121; Carlston M, 1997, Fam Med, V29, P559; Caspi O, 2000, ARCH INTERN MED, V160, P3193, DOI 10.1001/archinte.160.21.3193; Coulter I, 1998, ALTERN THER HEALTH M, V4, P64; DESAINTONGE DMC, 1994, LANCET, V344, P995, DOI 10.1016/S0140-6736(94)91647-0; Eisenberg DM, 1997, ANN INTERN MED, V127, P61, DOI 10.7326/0003-4819-127-1-199707010-00010; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Fontanarosa PB, 1998, JAMA-J AM MED ASSOC, V280, P1618, DOI 10.1001/jama.280.18.1618; Frenkel M, 2001, ACAD MED, V76, P251, DOI 10.1097/00001888-200103000-00012; *HARV MED SCH CTR, 2000, WOM HLTH 10 CURR THE, V2, P1; *HARV MED SCH OFF, 2000, NEW HMS DIV PROB COM; JENSEN CB, 1997, ALTERN COMPLEMENT TH, V3, P276; Kligler B, 2000, FAM MED, V32, P30; Laken M P, 1995, J Altern Complement Med, V1, P93, DOI 10.1089/acm.1995.1.93; Marshall E, 2000, SCIENCE, V288, P1571, DOI 10.1126/science.288.5471.1571; MUEHSAM PA, 2000, GEA CORRESPONDENT, V13, P8; MUEHSAM PA, 1999, GEA CORRESPONDENT, V12, P13; *NAT CTR COMPL ALT, 1999, REQ PROP CAM ED GRAN; Nortier JL, 2000, NEW ENGL J MED, V342, P1686, DOI 10.1056/NEJM200006083422301; OH VMS, 1994, BRIT MED J, V309, P69, DOI 10.1136/bmj.309.6947.69; Pelletier KR, 1999, AM J HEALTH PROMOT, V14, P125, DOI 10.4278/0890-1171-14.2.125; Piscitelli SC, 2000, LANCET, V355, P547, DOI 10.1016/S0140-6736(99)05712-8; Ruschitzka F, 2000, LANCET, V355, P548, DOI 10.1016/S0140-6736(99)05467-7; SLOAN DA, 1995, ANN SURG, V222, P735, DOI 10.1097/00000658-199512000-00007; Wetzel MS, 1998, JAMA-J AM MED ASSOC, V280, P784, DOI 10.1001/jama.280.9.784	30	106	109	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					191	196		10.7326/0003-4819-138-3-200302040-00011	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00011			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558358				2022-12-28	WOS:000181018600005
J	Hoerling, M; Kumar, A				Hoerling, M; Kumar, A			The perfect ocean for drought	SCIENCE			English	Article							MODEL ASSESSMENT; TELECONNECTIONS; TRENDS; ENSO	The 1998-2002 droughts spanning the United States, southern Europe, and Southwest Asia were linked through a common oceanic influence. Cold sea surface temperatures (SSTs) in the eastern tropical Pacific and warm SSTs in the western tropical Pacific and Indian oceans were remarkably persistent during this period. Climate models show that the climate signals forced separately by these regions acted synergistically, each contributing to widespread mid-latitude drying: an ideal. scenario for spatially expansive, synchronized drought. The warmth of the Indian and west Pacific oceans was unprecedented and consistent with greenhouse gas forcing. Some implications are drawn for future drought.	NOAA, Climate Diagnost Ctr, Boulder, CO 80305 USA; NOAA, Climate Predict Ctr, Camp Springs, MD 20746 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Hoerling, M (corresponding author), NOAA, Climate Diagnost Ctr, Boulder, CO 80305 USA.	Martin.P.Hoerling@noaa.gov	, AK/B-6517-2008					Barlow M, 2002, J CLIMATE, V15, P697, DOI 10.1175/1520-0442(2002)015&lt;0697:DICASA&gt;2.0.CO;2; Bell GD, 2000, B AM METEOROL SOC, V81, pS1, DOI 10.1175/1520-0477(2000)81[s1:CAF]2.0.CO;2; Branstator G, 2002, J CLIMATE, V15, P1893, DOI 10.1175/1520-0442(2002)015<1893:CTTJSW>2.0.CO;2; COLE JE, IN PRESS GEOPHYS RES; IPCC, 2001, ADV CLIM CHANG RES; Kiladis GN, 1989, J CLIMATE, V2, P1069, DOI 10.1175/1520-0442(1989)002<1069:GCAAWE>2.0.CO;2; Knutson TR, 1999, J GEOPHYS RES-ATMOS, V104, P30981, DOI 10.1029/1999JD900965; Knutson TR, 1998, J CLIMATE, V11, P2273, DOI 10.1175/1520-0442(1998)011<2273:MAODVA>2.0.CO;2; Lawrimore JH, 2001, B AM METEOROL SOC, V82, pS1, DOI 10.1175/0003-0007-82.6.S1; Markgraf V., 2000, EL NINO SO OSCILLATI, P465; Philander S, 1990, EL NINO LA NINA SO O; Portner H.-O., 2022, CLIMATE CHANGE 2022, P3; Rajagopalan B, 1997, J CLIMATE, V10, P2351, DOI 10.1175/1520-0442(1997)010<2351:AEOAAV>2.0.CO;2; Ropelewski CF, 1989, J CLIMATE, V2, P268, DOI 10.1175/1520-0442(1989)002<0268:PPAWTH>2.0.CO;2; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; Timmermann A, 1999, J ATMOS SCI, V56, P2313, DOI 10.1175/1520-0469(1999)056<2313:DTNROE>2.0.CO;2; Trenberth KE, 1998, J GEOPHYS RES-OCEANS, V103, P14291, DOI 10.1029/97JC01444; Waple AM, 2002, B AM METEOROL SOC, V83, pS1	19	505	519	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					691	694		10.1126/science.1079053	http://dx.doi.org/10.1126/science.1079053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560548				2022-12-28	WOS:000180687700042
J	Grady-Weliky, TA				Grady-Weliky, TA			Premenstrual dysphoric disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL; PHASE SERTRALINE TREATMENT; DOUBLE-BLIND; LUTEAL-PHASE; CONTROLLED CROSSOVER; SYMPTOMS; ALPRAZOLAM; EFFICACY; FLUOXETINE		Univ Rochester, Sch Med & Dent, Dept Psychiat, Rochester, NY 14642 USA	University of Rochester	Grady-Weliky, TA (corresponding author), Univ Rochester, Sch Med, 601 Elmwood Ave,Box 601, Rochester, NY 14642 USA.	tana_gradyweliky@urmc.rochester.edu						American College of Obstetricians and Gynecologists, 2000, ACOG PRACT B; [Anonymous], 2000, DIAGN STAT MAN MENT, P771; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; BERGER CP, 1994, OBSTET GYNECOL, V84, P379; Blake F, 1998, J PSYCHOSOM RES, V45, P307, DOI 10.1016/S0022-3999(98)00042-7; BROWN CS, 1994, OBSTET GYNECOL, V84, P779; Campbell EM, 1997, J REPROD MED, V42, P637; CHRISTENSEN AP, 1995, J AFFECT DISORDERS, V33, P57, DOI 10.1016/0165-0327(94)00073-I; ENDICOTT J, 1998, J AM MED WOMEN ASSOC, V53, P170; ERIKSSON E, 1995, NEUROPSYCHOPHARMACOL, V12, P167, DOI 10.1038/sj.npp.1380251; Freeman EW, 1996, J CLIN PSYCHIAT, V57, P56; Freeman EW, 1999, ARCH GEN PSYCHIAT, V56, P932, DOI 10.1001/archpsyc.56.10.932; FREEMAN EW, 1995, JAMA-J AM MED ASSOC, V274, P51, DOI 10.1001/jama.274.1.51; Freeman EW, 1997, PSYCHOPHARMACOL BULL, V33, P303; Freeman EW, 2001, J WOMEN HEALTH GEN-B, V10, P561, DOI 10.1089/15246090152543148; FREEMAN EW, 1994, J CLIN PSYCHOPHARM, V14, P180; Halbreich U, 1997, J CLIN PSYCHIAT, V58, P399, DOI 10.4088/JCP.v58n0905; HAMMARBACK S, 1988, ACTA OBSTET GYN SCAN, V67, P159, DOI 10.3109/00016348809004191; HARRISON WM, 1990, ARCH GEN PSYCHIAT, V47, P270; HARRISON WM, 1989, J CLIN PSYCHIAT, V50, P136; Hylan TR, 1999, J WOMEN HEALTH GEN-B, V8, P1043, DOI 10.1089/jwh.1.1999.8.1043; Jermain DM, 1999, ARCH FAM MED, V8, P328, DOI 10.1001/archfami.8.4.328; KIRKBY RJ, 1994, J CONSULT CLIN PSYCH, V62, P1026, DOI 10.1037/0022-006X.62.5.1026; MORSE CA, 1991, J BEHAV MED, V14, P469, DOI 10.1007/BF00845105; MORTOLA JF, 1990, OBSTET GYNECOL, V76, P302; Pearlstein TB, 2000, J CLIN PSYCHIAT, V61, P101, DOI 10.4088/JCP.v61n0205; Pearlstein TB, 1997, J CLIN PSYCHOPHARM, V17, P261, DOI 10.1097/00004714-199708000-00004; PEARLSTEIN TB, 1994, J CLIN PSYCHIAT, V55, P332; SCHMIDT PJ, 1993, ARCH GEN PSYCHIAT, V50, P467; Schmidt PJ, 1998, NEW ENGL J MED, V338, P209, DOI 10.1056/NEJM199801223380401; SMITH S, 1987, OBSTET GYNECOL, V70, P37; Steiner M, 1997, PSYCHOPHARMACOL BULL, V33, P771; STEINER M, 1995, NEW ENGL J MED, V332, P1529, DOI 10.1056/NEJM199506083322301; SUNDBLAD C, 1992, ACTA PSYCHIAT SCAND, V85, P39, DOI 10.1111/j.1600-0447.1992.tb01440.x; Sundblad C, 1997, EUR NEUROPSYCHOPHARM, V7, P201, DOI 10.1016/S0924-977X(97)00404-5; SUNDBLAD C, 1993, NEUROPSYCHOPHARMACOL, V9, P133, DOI 10.1038/npp.1993.52; Thys-Jacobs S, 1998, AM J OBSTET GYNECOL, V179, P444, DOI 10.1016/S0002-9378(98)70377-1; THYSJACOBS S, 1995, PSYCHOPHARMACOL BULL, V31, P389; VEENINGA AT, 1990, PSYCHOPHARMACOLOGY, V102, P414, DOI 10.1007/BF02244113; Wang MD, 1995, ACTA OBSTET GYN SCAN, V74, P803, DOI 10.3109/00016349509021201; Wikander I, 1998, J CLIN PSYCHOPHARM, V18, P390, DOI 10.1097/00004714-199810000-00007; Wyatt K, 2001, BMJ-BRIT MED J, V323, P776, DOI 10.1136/bmj.323.7316.776; Wyatt KM, 1999, BMJ-BRIT MED J, V318, P1375, DOI 10.1136/bmj.318.7195.1375; Yonkers KA, 1997, JAMA-J AM MED ASSOC, V278, P983, DOI 10.1001/jama.278.12.983; Young SA, 1998, J CLIN PSYCHIAT, V59, P76, DOI 10.4088/JCP.v59n0206	45	59	67	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					433	438		10.1056/NEJMcp012067	http://dx.doi.org/10.1056/NEJMcp012067			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12556546				2022-12-28	WOS:000180643800010
J	Ottino, JM				Ottino, JM			Is a picture worth 1,000 words? Exciting new illustration technologies should be used with care	NATURE			English	Editorial Material									Northwestern Univ, Robert R McCormick Sch Engn & Appl Sci, Evanston, IL 60208 USA	Northwestern University	Ottino, JM (corresponding author), Northwestern Univ, Robert R McCormick Sch Engn & Appl Sci, Evanston, IL 60208 USA.		Ottino, Julio/B-6682-2009					Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; BECKER LE, 2002, UNPUB J FLUID MECH; Frankel F, 2002, ENVISIONING SCI DESI; Hadamard Jacques., 1945, PSYCHOL INVENTION MA; Holton G, 1996, DAEDALUS, V125, P183; MISELL DL, 1978, PRACTICAL METHODS EL, V7; POINCARE H, 1982, FDN SCI; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903	8	28	29	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					474	476		10.1038/421474a	http://dx.doi.org/10.1038/421474a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556864				2022-12-28	WOS:000180670600018
J	Glaser, B				Glaser, B			Dominant SUR1 mutation causing autosomal dominant type 2 diabetes	LANCET			English	Editorial Material							HYPERINSULINISM; MELLITUS; SULFONYLUREA; INSULIN; APOPTOSIS; INFANCY		Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Internal Med, Endocrinol & Metab Serv, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Glaser, B (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Internal Med, Endocrinol & Metab Serv, IL-91120 Jerusalem, Israel.		Glaser, Benjamin/F-8411-2017	Glaser, Benjamin/0000-0003-4711-5000				de Lonlay-Debeney P, 1999, NEW ENGL J MED, V340, P1169, DOI 10.1056/NEJM199904153401505; Efanova IB, 1998, J BIOL CHEM, V273, P33501, DOI 10.1074/jbc.273.50.33501; FAJANS SS, 1994, LIFE SCI, V55, P413, DOI 10.1016/0024-3205(94)90052-3; Ferrannini E, 1998, ENDOCR REV, V19, P477, DOI 10.1210/edrv.19.4.0336; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Grimberg A, 2001, DIABETES, V50, P322, DOI 10.2337/diabetes.50.2.322; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Huopio H, 2002, DIABETES CARE, V25, P101, DOI 10.2337/diacare.25.1.101; Huopio H, 2000, J CLIN INVEST, V106, P897, DOI 10.1172/JCI9804; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; LEIBOWITZ G, 1995, J CLIN ENDOCR METAB, V80, P386, DOI 10.1210/jc.80.2.386; Malecki MT, 1999, NAT GENET, V23, P323, DOI 10.1038/15500; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Velho G, 2002, HORM RES, V57, P29, DOI 10.1159/000053309	14	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					272	273		10.1016/S0140-6736(03)12363-X	http://dx.doi.org/10.1016/S0140-6736(03)12363-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559857				2022-12-28	WOS:000180643900004
J	Weitoft, GR; Hjern, A; Haglund, B; Rosen, M				Weitoft, GR; Hjern, A; Haglund, B; Rosen, M			Mortality, severe morbidity, and injury in children living with single parents in Sweden: a population-based study	LANCET			English	Article							LONE MOTHERS; HEALTH INEQUALITIES; BIRTH COHORT; SOCIAL-CLASS; DIVORCE; ADULTHOOD; CHILDHOOD; DISTRESS	Background Growing up with one parent has become increasingly common, and seems to entail disadvantages in terms of socioeconomic circumstances and health. We aimed to investigate differences in mortality, severe morbidity, and injury between children living in households with one adult and those living in households with two adults. Methods In this population-based study, we assessed overall and cause-specific mortality between 1991 and 1998 and risk of admission between 1991 and 1999 for 65 085 children with single parents and 921257 children with two parents. We estimated relative risks by Poisson regression, adjusted for factors that might be presumed to select people into single parenthood, and for other factors, mainly resulting from single parenthood, that might have affected the relation between type of parenting and risk. Findings Children with single parents showed increased risks of psychiatric disease, suicide or suicide attempt, injury, and addiction. After adjustment for confounding factors, such as socioeconomic status and parents' addiction or mental disease, children in single-parent households had increased risks compared with those in two-parent households for psychiatric disease in childhood (relative risk for girls 2.1 [95% CI 1.9-2.3] and boys 2.5 [2.3-2.8]), suicide attempt (girls 2.0 [1.9-2.2], boys 2.3 [2.1-2.6]), alcohol-related disease (girls 2.4 [2.2-2.7], boys 2.2 [2.0-2.4]), and narcotics-related disease (girls 3.2 [2.7-3.7], boys 4.0 [3.5-4.5]). Boys in single-parent families were more likely to develop psychiatric disease and narcotics-related disease than were girls, and they also had a raised risk of all-cause mortality. Conclusions Growing up in a single-parent family has disadvantages to the health of the child. Lack of household resources plays a major part in increased risks. However, even when a wide range of demographic and socioeconomic circumstances are included in multivariate models, children of single parents still have increased risks of mortality, severe morbidity, and injury.	Swedish Natl Board Hlth & Welf, Ctr Epidemiol, S-10630 Stockholm, Sweden; Umea Univ, Dept Publ Hlth & Clin Med, S-90187 Umea, Sweden; Karolinska Inst, Huddinge Univ Hosp, Dept Clin Sci, S-10401 Stockholm, Sweden	National Board of Health & Welfare; Umea University; Karolinska Institutet	Weitoft, GR (corresponding author), Swedish Natl Board Hlth & Welf, Ctr Epidemiol, S-10630 Stockholm, Sweden.			Hjern, Anders/0000-0002-1645-2058				AMATO PR, 1991, PSYCHOL BULL, V110, P26, DOI 10.1037/0033-2909.110.1.26; Benzeval M, 1998, SOC SCI MED, V46, P1337, DOI 10.1016/S0277-9536(97)10083-1; BLUM HM, 1988, J AM ACAD CHILD PSY, V27, P214, DOI 10.1097/00004583-198803000-00014; EDWARDS JN, 1987, J FAM ISSUES, V8, P355, DOI 10.1177/019251387008004003; Fleming DM, 1998, BRIT MED J, V316, P1572, DOI 10.1136/bmj.316.7144.1572; GAHLER M, 1998, THESIS SWEDISH I SOC; Hansagi H, 2000, EUR J PUBLIC HEALTH, V10, P86, DOI 10.1093/eurpub/10.2.86; Hetherington E. M., 1982, NONTRADITIONAL FAMIL, P233; Hobson Barbara, 1997, LONE MOTHERS EUROPEA, P121; Hope S, 1999, SOC SCI MED, V49, P1637, DOI 10.1016/S0277-9536(99)00251-8; JUDGE K, 1993, BRIT MED J, V306, P677, DOI 10.1136/bmj.306.6879.677; KRANTZ SE, 1988, FEMINISM CHILDREN NE, P249; Lipman EL, 2002, J AM ACAD CHILD PSY, V41, P75, DOI 10.1097/00004583-200201000-00014; LUNDBERG O, 1993, SOC SCI MED, V36, P1047, DOI 10.1016/0277-9536(93)90122-K; MACINTYRE S, 1992, SOC SCI MED, V35, P453, DOI 10.1016/0277-9536(92)90338-Q; Makikyro T, 1998, FAM PROCESS, V37, P335, DOI 10.1111/j.1545-5300.1998.00335.x; MASTEKAASA A, 1994, J FAM ISSUES, V15, P208, DOI 10.1177/0192513X94015002004; NEIGHBORS B, 1992, ADOLESCENCE, V27, P639; NYMAN H, 1998, THESIS GOTEBORG U; OSTBERG V, 1996, THESIS SWEDISH I SOC; Pensola TH, 2000, J EPIDEMIOL COMMUN H, V54, P525, DOI 10.1136/jech.54.7.525; Power C, 1997, LANCET, V350, P1584, DOI 10.1016/S0140-6736(97)07474-6; Sauvola A, 2001, EUR J PUBLIC HEALTH, V11, P284, DOI 10.1093/eurpub/11.3.284; *STAT SWED, 2000, BARN DER FAM 1999 CH; VAGERO D, 1994, LANCET, V343, P1224, DOI 10.1016/S0140-6736(94)92432-5; VOYDANOFF P, 1990, J MARRIAGE FAM, V52, P1099, DOI 10.2307/353321; WADSWORTH J, 1983, J EPIDEMIOL COMMUN H, V37, P100, DOI 10.1136/jech.37.2.100; WALLERSTEIN JS, 1979, SOC WORK, V24, P468, DOI 10.1093/sw/24.6.468; WALLERSTEIN JS, 1991, J AM ACAD CHILD PSY, V30, P349, DOI 10.1097/00004583-199105000-00001; Weitoft GR, 2000, LANCET, V355, P1215, DOI 10.1016/S0140-6736(00)02087-0; Weitoft GR, 2002, INT J EPIDEMIOL, V31, P573, DOI 10.1093/ije/31.3.573; Whitehead M, 2000, SOC SCI MED, V50, P255, DOI 10.1016/S0277-9536(99)00280-4; ZASLOW MJ, 1988, AM J ORTHOPSYCHIAT, V58, P355, DOI 10.1111/j.1939-0025.1988.tb01597.x	33	220	223	3	20	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					289	295		10.1016/S0140-6736(03)12324-0	http://dx.doi.org/10.1016/S0140-6736(03)12324-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	639RV	12559862				2022-12-28	WOS:000180643900009
J	Wang, JW; Wong, AM; Flores, J; Vosshall, LB; Axel, R				Wang, JW; Wong, AM; Flores, J; Vosshall, LB; Axel, R			Two-photon calcium imaging reveals an odor-evoked map of activity in the fly brain	CELL			English	Article							RAT OLFACTORY-BULB; ANTENNAL LOBE; DROSOPHILA-MELANOGASTER; PYRAMIDAL NEURONS; DENDRITIC SPINES; REPRESENTATIONS; RECEPTORS; ORGANIZATION; INFORMATION; EXPRESSION	An understanding of the logic of odor perception requires a functional analysis of odor-evoked patterns of activity in neural assemblies in the brain. We have developed a sensitive imaging system in the Drosophila brain that couples two-photon microscopy with the specific expression of the calcium-sensitive fluorescent protein, G-CaMP. At natural odor concentration, each odor elicits a distinct and sparse spatial pattern of activity in the antennal lobe that is conserved in different flies. Patterns of glomerular activity are similar upon imaging of sensory and projection neurons, suggesting the faithful transmission of sensory input to higher brain centers. Finally, we demonstrate that the response pattern of a given glomerulus is a function of the specificity of a single odorant receptor. The development of this imaging system affords an opportunity to monitor activity in defined neurons throughout the fly brain with high sensitivity and excellent spatial resolution.	Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10021 USA	Columbia University; Rockefeller University	Axel, R (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, 701 W 168th St, New York, NY 10032 USA.		Wang, Jing W/C-3885-2008	Wang, Jing W/0000-0001-6291-5802; Vosshall, Leslie/0000-0002-6060-8099; Axel, Richard/0000-0002-3141-4076	NIMH NIH HHS [MH 50733] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; BRAND AH, 1993, DEVELOPMENT, V118, P401; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Delaney K, 2001, EUR J NEUROSCI, V13, P1658, DOI 10.1046/j.1460-9568.2001.01545.x; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; DETHIER VG, 1952, J GEN PHYSIOL, V35, P823, DOI 10.1085/jgp.35.6.823; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUTHRIE KM, 1995, CHEM SENSES, V20, P271, DOI 10.1093/chemse/20.2.271; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; JOURDAN F, 1980, BRAIN RES, V188, P139, DOI 10.1016/0006-8993(80)90563-6; KAUER JS, 1987, BRAIN RES, V418, P255, DOI 10.1016/0006-8993(87)90093-X; Laissue PP, 1999, J COMP NEUROL, V405, P543; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; LAURENT G, 1994, J NEUROSCI, V14, P2993; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Meister M, 2001, J NEUROSCI, V21, P1351; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; SINGLETON K, 1994, DEV BIOL, V161, P154, DOI 10.1006/dbio.1994.1017; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wang JW, 2001, J NEUROPHYSIOL, V85, P977, DOI 10.1152/jn.2001.85.2.977; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	56	598	612	5	87	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 24	2003	112	2					271	282		10.1016/S0092-8674(03)00004-7	http://dx.doi.org/10.1016/S0092-8674(03)00004-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553914	Bronze			2022-12-28	WOS:000181191600015
J	Sanchez, I; Mahlke, C; Yuan, JY				Sanchez, I; Mahlke, C; Yuan, JY			Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders	NATURE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; HUNTINGTONS-DISEASE; PROTEIN AGGREGATION; TERMINAL FRAGMENTS; MUTANT HUNTINGTIN; HEAT-SHOCK; CAG REPEAT; CONGO RED; TOXICITY; INHIBITION	The expansion of a CAG repeat coding for polyglutamine in otherwise unrelated gene products is central to eight neurodegenerative disorders including Huntington's disease(1). It has been well documented that expanded polyglutamine fragments, cleaved from their respective full-length proteins, form microscopically visible aggregates in affected individuals and in transgenic mice(2-7). The contribution of polyglutamine oligomers to neurodegeneration, however, is controversial. The azo-dye Congo red binds preferentially to beta-sheets containing amyloid fibrils(8,9) and can specifically inhibit oligomerization(10) and disrupt preformed oligomers. Here we show that inhibition of polyglutamine oligomerization by Congo red prevents ATP depletion and caspase activation, preserves normal cellular protein synthesis and degradation functions, and promotes the clearance of expanded polyglutamine repeats in vivo and in vitro. Infusion of Congo red into a transgenic mouse model of Huntington's disease, well after the onset of symptoms, promotes the clearance of expanded repeats in vivo and exerts marked protective effects on survival, weight loss and motor function. We conclude that oligomerization is a crucial determinant in the biochemical properties of expanded polyglutamine that are central to their chronic cytotoxicity.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Sanchez, I (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, 715 Albany St, Boston, MA 02118 USA.		Sanchez, Ivelisse/E-3856-2010; Sánchez, Ivelisse/H-8765-2013	Sanchez, Ivelisse/0000-0002-7605-5337; Sánchez, Ivelisse/0000-0002-7605-5337				BEAL MF, 1993, TRENDS NEUROSCI, V16, P125, DOI 10.1016/0166-2236(93)90117-5; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Carter DB, 1998, NEUROBIOL AGING, V19, P37, DOI 10.1016/S0197-4580(97)00164-4; Carter RJ, 1999, J NEUROSCI, V19, P3248; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Chai YH, 1999, J NEUROSCI, V19, P10338; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; FARRER LA, 1985, CLIN GENET, V27, P62; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; Heiser V, 2000, P NATL ACAD SCI USA, V97, P6739, DOI 10.1073/pnas.110138997; Howlett DR, 1999, BIOCHEM J, V343, P419, DOI 10.1042/0264-6021:3430419; Hurlbert MS, 1999, DIABETES, V48, P649, DOI 10.2337/diabetes.48.3.649; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; KLUNK WE, 1995, NEUROBIOL AGING, V16, P541, DOI 10.1016/0197-4580(95)00058-M; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Moulder KL, 1999, J NEUROSCI, V19, P705; Onodera O, 1997, BIOCHEM BIOPH RES CO, V238, P599, DOI 10.1006/bbrc.1997.7337; PERUTZ M, 1994, PROTEIN SCI, V3, P1629, DOI 10.1002/pro.5560031002; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898	30	392	404	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					373	379		10.1038/nature01301	http://dx.doi.org/10.1038/nature01301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540902				2022-12-28	WOS:000180533000043
J	Tobalske, BW; Hedrick, TL; Dial, KP; Biewener, AA				Tobalske, BW; Hedrick, TL; Dial, KP; Biewener, AA			Comparative power curves in bird flight	NATURE			English	Article							PECTORALIS-MUSCLE; COLUMBA-LIVIA; ANIMAL FLIGHT; WIND-TUNNEL; TAKE-OFF; PERFORMANCE; OUTPUT	The relationship between mechanical power output and forward velocity in bird flight is controversial, bearing on the comparative physiology and ecology of locomotion(1,2). Applied to flying birds, aerodynamic theory predicts that mechanical power should vary as a function of forward velocity in a U-shaped curve. The only empirical test of this theory, using the black-billed magpie (Pica pica), suggests that the mechanical power curve is relatively flat over intermediate velocities(3). Here, by integrating in vivo measurements of pectoralis force and length change with quasi-steady aerodynamic models developed using data on wing and body movement, we present mechanical power curves for cockatiels (Nymphicus hollandicus) and ringed turtle-doves (Streptopelia risoria). In contrast to the curve reported for magpies(3), the power curve for cockatiels is acutely concave, whereas that for doves is intermediate in shape and shows higher mass-specific power output at most speeds. We also find that wing-beat frequency and mechanical power output do not necessarily share minima in flying birds. Thus, aspects of morphology, wing kinematics and overall style of flight can greatly affect the magnitude and shape of a species' power curve.	Univ Portland, Dept Biol, Portland, OR 97203 USA; Harvard Univ, Concord Field Stn, Bedford, MA 01738 USA; Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Portland; Harvard University; University of Montana System; University of Montana	Tobalske, BW (corresponding author), Univ Portland, Dept Biol, 5000 N Williamette Blvd, Portland, OR 97203 USA.		Biewener, Andrew/O-2989-2016; Hedrick, Tyson/GZH-3140-2022	Biewener, Andrew/0000-0003-3303-8737; Hedrick, Tyson/0000-0002-6573-9602				Askew GN, 2001, J EXP BIOL, V204, P3601; Biewener AA, 1998, J EXP BIOL, V201, P3293; Dial KP, 1997, NATURE, V390, P67, DOI 10.1038/36330; DIAL KP, 1992, J EXP ZOOL, V262, P357, DOI 10.1002/jez.1402620402; ELLINGTON CP, 1991, J EXP BIOL, V160, P71; Hedrick TL, 2002, J EXP BIOL, V205, P1389; Norberg U., 1990, VERTEBRATE FLIGHT ME; Pennycuick CJ, 1997, J EXP BIOL, V200, P1441; Pennycuick CJ, 1996, J EXP BIOL, V199, P2757; RAYNER JMV, 1979, J FLUID MECH, V91, P731, DOI 10.1017/S0022112079000422; Rayner JMV, 1999, J EXP BIOL, V202, P3449; ROSSER BWC, 1986, CAN J ZOOL, V64, P1174, DOI 10.1139/z86-176; Rosser BWC, 1996, BIOCHEM CELL BIOL, V74, P715, DOI 10.1139/o96-078; THOMAS ALR, 1993, PHILOS T ROY SOC B, V340, P361, DOI 10.1098/rstb.1993.0079; Tobalske BW, 2000, J EXP BIOL, V203, P3319; Tobalske BW, 2000, PHYSIOL BIOCHEM ZOOL, V73, P736, DOI 10.1086/318107	16	174	178	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					363	366		10.1038/nature01284	http://dx.doi.org/10.1038/nature01284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540899				2022-12-28	WOS:000180533000040
J	Kondo, R; Haniuda, M; Nakano, H; Amano, J				Kondo, R; Haniuda, M; Nakano, H; Amano, J			A loose sternotomy wire	LANCET			English	Editorial Material									Shinshu Univ, Sch Med, Dept Surg, Matsumoto, Nagano 3908621, Japan	Shinshu University	Kondo, R (corresponding author), Shinshu Univ, Sch Med, Dept Surg, Matsumoto, Nagano 3908621, Japan.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					223	223		10.1016/S0140-6736(03)12272-6	http://dx.doi.org/10.1016/S0140-6736(03)12272-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547546	Bronze			2022-12-28	WOS:000180535400012
J	Todd, JF; Stanley, SA; Roufosse, CA; Bishop, AE; Khoo, B; Bloom, SR; Meeran, K				Todd, JF; Stanley, SA; Roufosse, CA; Bishop, AE; Khoo, B; Bloom, SR; Meeran, K			A tumour that secretes glucagon-like peptide-1 and somatostatin in a patient with reactive hypoglycaemia and diabetes	LANCET			English	Article							HYPOGLYCEMIA	Glucagon-like peptide 1 (GLIP-1), an insulinotropic hormone normally synthesised in the intestinal mucosa and released in response to a meal, is essential for normal glucose homoeostasis. There is much interest in the use of GLP-1. to treat diabetes, since the risk of hypoglycaemia is thought to be low. We report an instance of a 45-year-old woman with a GLP-1 and somatostatin secreting neuroendocrine tumour who presented with reactive hypoglycaemia and hyperglycaemia, but who was subsequently cured by surgery. This case, of a neuroendocrine tumour secreting GLP-1 and causing reactive hypoglycaemia, indicates a potential adverse effect of GLP-1 therapy for diabetes.	Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Endocrine Unit, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Dept Histopathol, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Sch Med, Tissue Engn Ctr, London, England	Imperial College London; Imperial College London; Imperial College London	Todd, JF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Endocrine Unit, London W12 0NN, England.		Roufosse, Candice/N-1747-2019; Khoo, Bernard/B-1247-2009; Roufosse, Candice/J-1774-2017	Roufosse, Candice/0000-0002-6490-4290; Khoo, Bernard/0000-0002-4223-9736; Roufosse, Candice/0000-0002-6490-4290				ASHTON MA, 1995, HISTOPATHOLOGY, V27, P463, DOI 10.1111/j.1365-2559.1995.tb00311.x; Edwards CMB, 1998, CLIN SCI, V95, P719, DOI 10.1042/cs0950719; HAMID QA, 1986, HISTOPATHOLOGY, V10, P119, DOI 10.1111/j.1365-2559.1986.tb02468.x; KREYMANN B, 1987, LANCET, V2, P1300; MORGELLO S, 1988, CANCER, V61, P800, DOI 10.1002/1097-0142(19880215)61:4<800::AID-CNCR2820610426>3.0.CO;2-3	5	38	42	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					228	230		10.1016/S0140-6736(03)12256-8	http://dx.doi.org/10.1016/S0140-6736(03)12256-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547550				2022-12-28	WOS:000180535400016
J	Byock, I; Miles, SH				Byock, I; Miles, SH			Hospice benefits and phase I cancer trials	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INFORMED-CONSENT; CARE; LIFE; PAIN; END	Medicare denies hospice coverage to patients with terminal illnesses who enroll as participants in phase I studies, which assess the toxicity and dosing of potential treatments for incurable diseases. Federal regulations require patients to forgo curative therapies, and they interpret phase I agents as treatment for the terminal condition for which hospice care was elected. Thus, by enrolling as a participant in a phase I trial, a patient otherwise eligible for hospice is rendered ineligible. Private insurers have similar provisions for children and adults younger than 65 years of age. Such exclusions are not defensible on ethical or clinical grounds. Policymakers, insurers, and institutional review boards all have a role in resolving this problem.	Univ Montana, Pract Eth Ctr, Missoula, MT 59812 USA	University of Montana System; University of Montana	Byock, I (corresponding author), Univ Montana, Pract Eth Ctr, 1000 E Beckwith Ave, Missoula, MT 59812 USA.	ibyock@aol.com						AARON HJ, 1999, EXTENDING MEDICARE R; [Anonymous], 1998, Bull Am Coll Surg, V83, P46; Bernabei R, 1998, JAMA-J AM MED ASSOC, V279, P1877, DOI 10.1001/jama.279.23.1877; Breitbart W, 1996, PAIN, V65, P243, DOI 10.1016/0304-3959(95)00217-0; Byock I, 2000, CA-CANCER J CLIN, V50, P123, DOI 10.3322/canjclin.50.2.123; CASSEL CK, 1999, PRINCIPLES CARE PATI; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; DAUGHERTY C, 1995, J CLIN ONCOL, V13, P1062, DOI 10.1200/JCO.1995.13.5.1062; DAUGHERTY CK, 1995, ANN ONCOL, V6, P321, DOI 10.1093/oxfordjournals.annonc.a059178; Field MJ, 1997, APPROACHING DEATH IM; Foley KM, 2001, IMPROVING PALLIATIVE; hhs, 1979, BELM REP ETH PRINC G; *HLTH CAR FIN ADM, 1999, HOSP MAN; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Horng S, 2002, NEW ENGL J MED, V347, P2134, DOI 10.1056/NEJMsa021182; JANISCH L, 1994, CANCER-AM CANCER SOC, V74, P1965, DOI 10.1002/1097-0142(19941001)74:7<1965::AID-CNCR2820740723>3.0.CO;2-1; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KODISH E, 1992, J CLIN ONCOL, V10, P1810, DOI 10.1200/JCO.1992.10.11.1810; Lo B, 1999, ANN INTERN MED, V130, P772, DOI 10.7326/0003-4819-130-9-199905040-00018; Mahoney J J, 1998, J Palliat Med, V1, P139, DOI 10.1089/jpm.1998.1.139; Miller M, 2000, HASTINGS CENT REP, V30, P34, DOI 10.2307/3527646; MYERS F, 2002, 38 ANN M AM SOC CLIN; *NAT ARCH REC ADM, 2000, WEEKLY COMPILATION P, V36, P1311; *NCI, 2002, INV HDB MAN PART CLI; Nelson RM, 2000, PEDIATRICS, V106, P351; Oliverio R, 1998, Holist Nurs Pract, V13, P1; Schaeffer MH, 1996, AM J MED, V100, P261, DOI 10.1016/S0002-9343(97)89483-1; Schnipper L, 1998, J CLIN ONCOL, V16, P1986; *US GAO, 2002, PUBL US GAO; Wolfe J, 2000, NEW ENGL J MED, V342, P326, DOI 10.1056/NEJM200002033420506	30	17	17	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2003	138	4					335	337		10.7326/0003-4819-138-4-200302180-00013	http://dx.doi.org/10.7326/0003-4819-138-4-200302180-00013			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DK	12585832				2022-12-28	WOS:000181019400018
J	Rousseau, N; McColl, E; Newton, J; Grimshaw, J; Eccles, M				Rousseau, N; McColl, E; Newton, J; Grimshaw, J; Eccles, M			Practice based, longitudinal, qualitative interview study of computerised evidence based guidelines in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DECISION-SUPPORT-SYSTEMS; EVALUATING INFORMATICS APPLICATIONS; MANAGEMENT	Objective To understand the factors influencing the adoption of a computerised clinical decision support system for two chronic diseases in general practice. Design Practice based, longitudinal, qualitative interview study. Setting Five general practices in north east England. Participants 13 respondents (two practice managers, three nurses, and eight general practitioners) gave a total of 19 semistructured interviews. 40 people in practices included in the randomised controlled trial (34 doctors, three nurses) and interview study (three doctors, one previously interviewed) gave feedback. Results Negative comments about the decision support system significantly outweighed the positive or neutral comments. Three main areas of concern among clinicians emerged: timing of the guideline trigger, ease of use of the system, and helpfulness of the content. Respondents did not feel that the system fitted well within the general practice context. Experience of "on-demand" information sources, which were generally more positively viewed, informed the comments about the system. Some general practitioners suggested that nurses might find the guideline content more clinically useful and might be more prepared to use a computerised decision support system, but lack of feedback from nurses who had experienced the system limited the ability to assess this. Conclusions Significant barriers exist to the use of complex clinical decision support systems for chronic disease by general practitioners. Key issues include the relevance and accuracy of messages and the flexibility to respond to other factors influencing decision making in primary care.	Newcastle Univ, Ctr Hlth Serv Res, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England; Northumbria Univ, Dept Sociol, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB9 1FX, Scotland	Newcastle University - UK; Northumbria University; University of Aberdeen	Eccles, M (corresponding author), Newcastle Univ, Ctr Hlth Serv Res, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England.	martin.eccles@ncl.ac.uk	Greiver, Michelle/N-8764-2015; Eccles, Martin P/AAD-4029-2020; Grimshaw, Jeremy/D-8726-2013; McColl, Elaine/V-9906-2019	Greiver, Michelle/0000-0001-8957-0285; McColl, Elaine/0000-0001-8300-3204; Rousseau, Nikki/0000-0001-8826-3515; Grimshaw, Jeremy/0000-0001-8015-8243				Berg M, 1997, SOC SCI MED, V44, P1081, DOI 10.1016/S0277-9536(96)00235-3; Berg M, 1999, INT J MED INFORM, V56, P51, DOI 10.1016/S1386-5056(99)00041-6; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Eccles M, 2001, FAM PRACT, V18, P223, DOI 10.1093/fampra/18.2.223; Eccles M, 2001, FAM PRACT, V18, P217, DOI 10.1093/fampra/18.2.217; Eccles M, 2000, FAM PRACT, V17, P180, DOI 10.1093/fampra/17.2.180; Eccles M, 2002, BMJ-BRIT MED J, V325, P941, DOI 10.1136/bmj.325.7370.941; ECCLES M, 2002, BMJ; ECCLES M, 2002, EVALUATION COMPUTERI; ELSON RB, 1995, PRIMARY CARE, V22, P365; Freeman AC, 2001, BRIT MED J, V323, P1100, DOI 10.1136/bmj.323.7321.1100; Grimshaw J, 1995, Qual Health Care, V4, P55, DOI 10.1136/qshc.4.1.55; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; Kaplan B, 2001, INT J MED INFORM, V64, P15, DOI 10.1016/S1386-5056(01)00183-6; Kaplan B, 2001, INT J MED INFORM, V64, P39, DOI 10.1016/S1386-5056(01)00184-8; Kitson A, 1998, QUAL HEALTH CARE, V7, P149, DOI 10.1136/qshc.7.3.149; Litzelman DK, 1996, J GEN INTERN MED, V11, P497, DOI 10.1007/BF02599049; LOMAS J, 1994, DISSEMINATING RES CH; McColl A, 1998, BRIT MED J, V316, P361, DOI 10.1136/bmj.316.7128.361; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; ROUSSEAU N, 1999, CHANGING PROFESSIONA, P99; Seale C., 1999, QUALITY QUALITATIVE; Yin R. K., 1994, CASE STUDY RES DESIG	23	131	134	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2003	326	7384					314	318B		10.1136/bmj.326.7384.314	http://dx.doi.org/10.1136/bmj.326.7384.314			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645UD	12574046	Green Published, Bronze			2022-12-28	WOS:000180997000020
J	Baltuska, A; Udem, T; Uiberacker, M; Hentschel, M; Goulielmakis, E; Gohle, C; Holzwarth, R; Yakovlev, VS; Scrinzi, A; Hansch, TW; Krausz, F				Baltuska, A; Udem, T; Uiberacker, M; Hentschel, M; Goulielmakis, E; Gohle, C; Holzwarth, R; Yakovlev, VS; Scrinzi, A; Hansch, TW; Krausz, F			Attosecond control of electronic processes by intense light fields	NATURE			English	Article							ULTRASHORT-PULSE GENERATION; ORDER HARMONIC-GENERATION; CYCLE LASER-PULSES; NONLINEAR OPTICS; PHASE-CONTROL; IONIZATION; FRONTIERS	The amplitude and frequency of laser light can be routinely measured and controlled on a femtosecond (10(-15) s) timescale(1). However, in pulses comprising just a few wave cycles, the amplitude envelope and carrier frequency are not sufficient to characterize and control laser radiation, because evolution of the light field is also influenced by a shift of the carrier wave with respect to the pulse peak(2). This so-called carrier-envelope phase has been predicted(3-9) and observed(10) to affect strong-field phenomena, but random shot-to-shot shifts have prevented the reproducible guiding of atomic processes using the electric field of light. Here we report the generation of intense, few-cycle laser pulses with a stable carrier envelope phase that permit the triggering and steering of microscopic motion with an ultimate precision limited only by quantum mechanical uncertainty. Using these reproducible light waveforms, we create light-induced atomic currents in ionized matter; the motion of the electronic wave packets can be controlled on timescales shorter than 250 attoseconds (250 x 10(-18) s). This enables us to control the attosecond temporal structure of coherent soft X-ray emission produced by the atomic currents-these X-ray photons provide a sensitive and intuitive tool for determining the carrier-envelope phase.	Vienna Univ Technol, Inst Photon, A-1040 Vienna, Austria; Max Planck Inst Quantum Opt, D-85748 Garching, Germany	Technische Universitat Wien; Max Planck Society	Krausz, F (corresponding author), Vienna Univ Technol, Inst Photon, Gusshausstr 27, A-1040 Vienna, Austria.	ferenc.krausz@tuwien.ac.at	Goulielmakis, Eleftherios/F-1693-2011; Baltuska, ANDRIUS/ABE-2033-2020; Goulielmakis, Eleftherios/AAZ-1052-2020	Goulielmakis, Eleftherios/0000-0003-3386-0245; Baltuska, Andrius/0000-0002-5267-0626				Apolonski A, 2000, PHYS REV LETT, V85, P740, DOI 10.1103/PhysRevLett.85.740; Baltuska A, 2002, OPT LETT, V27, P1241, DOI 10.1364/OL.27.001241; Brabec T, 2000, REV MOD PHYS, V72, P545, DOI 10.1103/RevModPhys.72.545; Christov IP, 1999, OPT LETT, V24, P1425, DOI 10.1364/OL.24.001425; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Cormier E, 1998, EUR PHYS J D, V2, P15, DOI 10.1007/s100530050104; de Bohan A, 1998, PHYS REV LETT, V81, P1837, DOI 10.1103/PhysRevLett.81.1837; Dietrich P, 2000, OPT LETT, V25, P16, DOI 10.1364/OL.25.000016; Drescher M, 2002, NATURE, V419, P803, DOI 10.1038/nature01143; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Itatani J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.173903; Jones DJ, 2000, SCIENCE, V288, P635, DOI 10.1126/science.288.5466.635; Kakehata M, 2001, OPT LETT, V26, P1436, DOI 10.1364/OL.26.001436; Kitzler M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.173904; Krausz F, 1998, OPT PHOTONICS NEWS, V9, P46, DOI 10.1364/OPN.9.7.000046; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; Milosevic N, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.093905; NIIKURA H, IN PRESS NATURE; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413; Paulus GG, 2001, NATURE, V414, P182, DOI 10.1038/35102520; Priori E, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.063801; Sartania S, 1997, OPT LETT, V22, P1562, DOI 10.1364/OL.22.001562; SCHAFER KJ, 1993, PHYS REV LETT, V70, P1599, DOI 10.1103/PhysRevLett.70.1599; Steinmeyer G, 1999, SCIENCE, V286, P1507, DOI 10.1126/science.286.5444.1507; Telle HR, 1999, APPL PHYS B-LASERS O, V69, P327, DOI 10.1007/s003400050813; Tempea G, 1999, J OPT SOC AM B, V16, P669, DOI 10.1364/JOSAB.16.000669; Udem T., 1997, THESIS LUDWIG MAXIMI; Xu L, 1996, OPT LETT, V21, P2008, DOI 10.1364/OL.21.002008; YAKOVLEV VS, UNPUB PHYS REV LETT	30	1313	1352	3	333	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2003	421	6923					611	615		10.1038/nature01414	http://dx.doi.org/10.1038/nature01414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571590				2022-12-28	WOS:000180803200036
J	Chapman, T				Chapman, T			Lab automation and robotics - Automation on the move	NATURE			English	Article																			0	75	75	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					661	+		10.1038/421661a	http://dx.doi.org/10.1038/421661a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571603	Bronze			2022-12-28	WOS:000180803200049
J	Hope, MD				Hope, MD			Pain and forgetting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Hope, MD (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.								0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2003	289	5					617	617		10.1001/jama.289.5.617	http://dx.doi.org/10.1001/jama.289.5.617			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CV	12578502	Bronze			2022-12-28	WOS:000180787500036
J	Bernstein, R; Dowd, CF; Gress, DR				Bernstein, R; Dowd, CF; Gress, DR			Rapidly reversible dementia	LANCET			English	Editorial Material							DURAL ARTERIOVENOUS-MALFORMATIONS		Univ Calif San Francisco, Med Ctr, Neurovasc Serv, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bernstein, R (corresponding author), Univ Calif San Francisco, Med Ctr, Neurovasc Serv, 505 Parnassus Ave, San Francisco, CA 94143 USA.							AMINOFF MJ, 1974, J NEUROL SCI, V23, P255, DOI 10.1016/0022-510X(74)90229-9; AWAD IA, 1990, J NEUROSURG, V72, P839, DOI 10.3171/jns.1990.72.6.0839; Hurst RW, 1998, AM J NEURORADIOL, V19, P1267; LASJAUNIAS P, 1986, J NEUROSURG, V64, P724, DOI 10.3171/jns.1986.64.5.0724; SIMON TDL, 1984, J NEUROSURG, V60, P238	5	12	12	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					392	392		10.1016/S0140-6736(03)12394-X	http://dx.doi.org/10.1016/S0140-6736(03)12394-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573378				2022-12-28	WOS:000180787000014
J	Bonetti, A				Bonetti, A			Hepatic artery infusion for liver metastases from colorectal cancer	LANCET			English	Editorial Material							5-FLUOROURACIL; LEUCOVORIN		ASL 21 Reg Veneto Osped Legnago, Dept Oncol, I-37045 Legnago, VR, Italy	ULSS 9 Scaligera; Ospedale Mater Salutis di Legnago	Bonetti, A (corresponding author), ASL 21 Reg Veneto Osped Legnago, Dept Oncol, I-37045 Legnago, VR, Italy.		Bonetti, Andrea/AAL-6623-2020	BONETTI, Andrea/0000-0003-2329-6628				ACKERMAN NB, 1974, SURGERY, V75, P589; Buyse M, 1996, J NATL CANCER I, V88, P252; ENSMINGER WD, 1978, CANCER RES, V38, P3784; Estey E, 1997, CLIN CANCER RES, V3, P2591; Giacchetti S, 1999, ANN ONCOL, V10, P663, DOI 10.1023/A:1008347829017; GROTHEY A, 2002, P AN M AM SOC CLIN, V21, P512; Kemeny N, 2001, J CLIN ONCOL, V19, P2687, DOI 10.1200/JCO.2001.19.10.2687; Lorenz M, 2000, J CLIN ONCOL, V18, P243, DOI 10.1200/JCO.2000.18.2.243; Midgley R, 1999, LANCET, V353, P391, DOI 10.1016/S0140-6736(98)07127-X; SALTZ LB, 2000, P ASCO, V19, P242; THERNEAU TM, 1993, CONTROL CLIN TRIALS, V14, P98, DOI 10.1016/0197-2456(93)90013-4	11	11	12	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					358	359		10.1016/S0140-6736(03)12439-7	http://dx.doi.org/10.1016/S0140-6736(03)12439-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573366				2022-12-28	WOS:000180787000002
J	Hesketh, T				Hesketh, T			Getting married in China: pass the medical first	BRITISH MEDICAL JOURNAL			English	Article							BETA-THALASSEMIA TRAIT; PREVENTION; PREVALENCE; SMOKING		Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England	University of London; University College London	Hesketh, T (corresponding author), Inst Child Hlth, Ctr Int Child Hlth, 30 Guilford St, London WC1N 1EH, England.			Hesketh, Therese/0000-0002-7564-9221	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; FANG XS, 1991, CHINESE J VIROLOGY, V7, pS350; Hesketh T, 2001, AM J PUBLIC HEALTH, V91, P1653, DOI 10.2105/AJPH.91.10.1653; Hu Z, 1991, Zhonghua Liu Xing Bing Xue Za Zhi, V12, P222; Kaplan F, 1998, GENET TEST, V2, P271, DOI 10.1089/gte.1998.2.271; Keskin A, 2000, ACTA HAEMATOL-BASEL, V104, P31, DOI 10.1159/000041066; Wu M T, 1990, Gaoxiong Yi Xue Ke Xue Za Zhi, V6, P594; Xu XM, 1996, HUM GENET, V98, P199, DOI 10.1007/s004390050190; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Yao GB, 1996, GUT, V38, pS39, DOI 10.1136/gut.38.Suppl_2.S39; ZENG YT, 1987, J MED GENET, V24, P578, DOI 10.1136/jmg.24.10.578; 2002, PRESENT AIDS EPIDEMI	12	33	35	1	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					277	279		10.1136/bmj.326.7383.277	http://dx.doi.org/10.1136/bmj.326.7383.277			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560286	Green Published			2022-12-28	WOS:000180908300029
J	Sharp, D				Sharp, D			Acrylamide in food	LANCET			English	Editorial Material							CANCER		Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							Becalski A, 2003, J AGR FOOD CHEM, V51, P802, DOI 10.1021/jf020889y; Food and Agriculture Organization World Health Organization, 2002, CONS HLTH IMPL ACR F; Godin AC, 2002, VET REC, V151, P724; Hagmar L, 2001, SCAND J WORK ENV HEA, V27, P219, DOI 10.5271/sjweh.608; *HLTH CONS PROT DI, 2002, OP SCI COMM FOOD NEW; JACKSON L, FORMATION ACRYLAMIDE; Marsh GM, 1999, OCCUP ENVIRON MED, V56, P181, DOI 10.1136/oem.56.3.181; Mottram DS, 2002, NATURE, V419, P448, DOI 10.1038/419448a; Paulsson B, 2001, CARCINOGENESIS, V22, P817, DOI 10.1093/carcin/22.5.817; Reynolds T, 2002, J NATL CANCER I, V94, P876; ROSEN JD, ACRYLAMIDE FOOD IS I; Shaw I, 2003, LANCET, V361, P434, DOI 10.1016/S0140-6736(03)12413-0; Stadler RH, 2002, NATURE, V419, P449, DOI 10.1038/419449a; *SWED GOV, 1998, SWED GOV OFF REP MIL, P137; Tareke E, 2000, CHEM RES TOXICOL, V13, P517, DOI 10.1021/tx9901938; Tareke E, 2002, J AGR FOOD CHEM, V50, P4998, DOI 10.1021/jf020302f; WHO INT AGCY RES CANC, 1994, IARC MONOG EVAL CARC, V60, P389; 2002, PUBL M ASS ACR US FO; 2002, REUTERS HLTH    0930	19	37	46	3	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2003	361	9355					361	362		10.1016/S0140-6736(03)12442-7	http://dx.doi.org/10.1016/S0140-6736(03)12442-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573369				2022-12-28	WOS:000180787000005
J	Herting, E; Stichtenoth, G; Robertson, B				Herting, E; Stichtenoth, G; Robertson, B			Syringes with rubber-coated plungers and inactivation of surfactant	LANCET			English	Article								Injectable drugs are generally administered to newborns with 1 mL syringes. During in-vitro measurements of surface tension with a pulsating bubble surfactometer, we noticed that surfactant was inactivated after repeated aspiration into a 1 mL syringe with a rubber-coated plunger. Inactivation did not take place, however, when we used rubber-free two-part syringes with polyethylene pistons. Results of further studies showed that the silicone fluid used to lubricate the rubber surface of the syringe was inactivating the surfactant. Our findings suggest that contact with rubber surfaces should be avoided in the handling of surfactant material for biophysical assessment or clinical use.	Univ Gottingen, Dept Paediat, D-37075 Gottingen, Germany; Karolinska Hosp, Dept Surg Sci, Lab Survactant Res, S-10401 Stockholm, Sweden	University of Gottingen; Karolinska Institutet; Karolinska University Hospital	Herting, E (corresponding author), Univ Gottingen, Dept Paediat, Robert Koch Str 40, D-37075 Gottingen, Germany.							Herting E, 2001, PEDIATR RES, V50, P44, DOI 10.1203/00006450-200107000-00010; JOBE AH, 1993, NEW ENGL J MED, V328, P861; Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278; Loff S, 2000, J PEDIATR SURG, V35, P1775, DOI 10.1053/jpsu.2000.19249; Mooibroek H, 2000, APPL MICROBIOL BIOT, V53, P355, DOI 10.1007/s002530051627	5	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					311	313		10.1016/S0140-6736(03)12334-3	http://dx.doi.org/10.1016/S0140-6736(03)12334-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559869				2022-12-28	WOS:000180643900016
J	Schneider, RA; Helms, JA				Schneider, RA; Helms, JA			The cellular and molecular origins of beak morphology	SCIENCE			English	Article							NEURAL CREST; SONIC HEDGEHOG; CRANIOFACIAL MORPHOGENESIS; EXPRESSION; MESODERM; REGION; EMBRYO; FGF8	Cellular and molecular mechanisms underlying differences in beak morphology likely involve interactions among multiple embryonic populations. We exchanged neural crest cells destined to participate in beak morphogenesis between two anatomically distinct species. Quail neural crest cells produced quail beaks in duck hosts and duck neural crest produced duck bills in quail hosts. These transformations involved morphological changes to non neural crest host beak tissues. To achieve these changes, donor neural crest cells executed autonomous molecular programs and regulated gene expression in adjacent host tissues. Thus, neural crest cells are a source of molecular information that generates interspecific variation in beak morphology.	Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Helms, JA (corresponding author), Univ Calif San Francisco, Dept Orthopaed Surg, 533 Parnassus Ave,Suite U-453, San Francisco, CA 94143 USA.			Helms, Jill/0000-0002-0463-396X; Schneider, Richard/0000-0002-2626-3111	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD073263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007236, R29DE012462, R03DE014795, K02DE000421] Funding Source: NIH RePORTER; NICHD NIH HHS [N01-HD-7-3263] Funding Source: Medline; NIDCR NIH HHS [K02 DE 00421, R03 DE014795-01, R03 DE014795, T32 DE07236, R29 DE12462-03] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ahlgren SC, 1999, CURR BIOL, V9, P1304, DOI 10.1016/S0960-9822(00)80052-4; ANDRES G., 1949, GENETICA, V24, P387, DOI 10.1007/BF01487210; Barlow AJ, 1999, DEV DYNAM, V214, P291, DOI 10.1002/(SICI)1097-0177(199904)214:4<291::AID-AJA2>3.0.CO;2-E; Coppinger Raymond, 1995, P21; Couly G, 2002, DEVELOPMENT, V129, P1061; COULY GF, 1993, DEVELOPMENT, V117, P409; Darwin C, 1962, ORIGIN SPECIES; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harrison RG, 1933, AM NAT, V67, P306, DOI 10.1086/280493; Helms JA, 1997, DEV BIOL, V187, P25, DOI 10.1006/dbio.1997.8589; Hu D, 1999, DEVELOPMENT, V126, P4873; Kontges G, 1996, DEVELOPMENT, V122, P3229; LUCAS AM, 1972, AGR HDB USDA, V362; MINA M, 1995, DEV DYNAM, V202, P195, DOI 10.1002/aja.1002020211; NODEN DM, 1978, DEV BIOL, V67, P296, DOI 10.1016/0012-1606(78)90201-4; Piotrowski T, 2000, DEV BIOL, V225, P339, DOI 10.1006/dbio.2000.9842; Schneider RA, 2001, DEVELOPMENT, V128, P2755; Schneider RA, 1999, DEV BIOL, V208, P441, DOI 10.1006/dbio.1999.9213; Shigetani Y, 2000, DEV BIOL, V228, P73, DOI 10.1006/dbio.2000.9932; SOHAL GS, 1976, BRAIN RES, V113, P35, DOI 10.1016/0006-8993(76)90004-4; TRAINOR PA, 1995, DEVELOPMENT, V121, P2569; Wagner G., 1959, Roux Archiv fuer Entwicklungsmechanik Organismen, V151, P136	22	224	227	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					565	568		10.1126/science.1077827	http://dx.doi.org/10.1126/science.1077827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543976				2022-12-28	WOS:000180559800050
J	Helms, M; Vastrup, P; Gerner-Smidt, P; Molbak, K				Helms, M; Vastrup, P; Gerner-Smidt, P; Molbak, K			Short and long term mortality associated with foodborne bacterial gastrointestinal infections: registry based study	BRITISH MEDICAL JOURNAL			English	Article							CHARLSON COMORBIDITY INDEX; ADMINISTRATIVE DATA; UNITED-STATES; SALMONELLA; MORBIDITY	Objectives To determine the excess mortality associated with infections with Salmonella, Campylobacter, Yersinia enterocolitica, and Shigella and to examine the effect of pre-existing illness. Design Registry based, matched cohort study. Setting Denmark. Participants 48 857 people with gastrointestinal infections plus 487 138 controls from the general population. Main outcome measure One year mortality among patients with gastrointestinal infections compared with controls after adjustment for comorbidity. Results 1071 (2.2%) people with gastrointestinal infections died within one year after infection compared with 3636 (0.7%) controls. The relative mortality within one year was 3.1 times higher in patients than in controls. The relative mortality within 30 days of infection was high in all four bacterial groups. Furthermore, there was excess mortality one to six months after infection with Yersinia enterocolitica (relative risk 2.53, 95% confidence interval 1.38 to 4.62) and from six months to one year after infection with Campylobacter (1.35, 1.02 to 1.80) and Salmonella (1.53,1.31 to 1.79). Conclusions Infections with all these bacteria were associated with an increased short term risk of death, even after pre-existing illnesses were taken into account. Salmonella, Campylobacter, and Yersinia enterocolitica infections were also associated with increased long term mortality.	Statens Serum Inst, Dept Gastrointestinal Infect, DK-2300 Copenhagen S, Denmark; Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark	Statens Serum Institut; Aarhus University; Statens Serum Institut	Molbak, K (corresponding author), Statens Serum Inst, Dept Gastrointestinal Infect, DK-2300 Copenhagen S, Denmark.			Molbak, Kare/0000-0002-3100-4990				Altekruse SF, 1997, EMERG INFECT DIS, V3, P285, DOI 10.3201/eid0303.970304; Banatvala N, 1999, EPIDEMIOL INFECT, V122, P201, DOI 10.1017/S0950268899002162; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cleves MA, 1997, J CLIN EPIDEMIOL, V50, P903, DOI 10.1016/S0895-4356(97)00091-7; COHEN ML, 1986, SCIENCE, V234, P964, DOI 10.1126/science.3535069; de Wit MAS, 2000, EUR J EPIDEMIOL, V16, P713, DOI 10.1023/A:1026754218713; DHoore W, 1996, J CLIN EPIDEMIOL, V49, P1429, DOI 10.1016/S0895-4356(96)00271-5; DHOORE W, 1993, METHOD INFORM MED, V32, P382; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; FANG FC, 1991, MEDICINE, V70, P198, DOI 10.1097/00005792-199105000-00004; Helms M, 2002, EMERG INFECT DIS, V8, P490, DOI 10.3201/eid0805.010267; Lester A, 1995, Ugeskr Laeger, V157, P20; LESTER A, 1990, Ugeskrift for Laeger, V152, P529; MAUSKOPF JA, 1991, RISK ANAL, V11, P619, DOI 10.1111/j.1539-6924.1991.tb00651.x; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mosbech J, 1995, Ugeskr Laeger, V157, P3741; Potter Morris E., 1997, World Health Statistics Quarterly, V50, P24; RYAN CA, 1987, JAMA-J AM MED ASSOC, V258, P3269, DOI 10.1001/jama.258.22.3269; Todd Ewen C. D., 1997, World Health Statistics Quarterly, V50, P30	19	160	162	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2003	326	7385					357	359		10.1136/bmj.326.7385.357	http://dx.doi.org/10.1136/bmj.326.7385.357			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648RZ	12586666	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000181165500015
J	Ment, LR; Vohr, B; Allan, W; Katz, KH; Schneider, KC; Westerveld, M; Duncan, CC; Makuch, RW				Ment, LR; Vohr, B; Allan, W; Katz, KH; Schneider, KC; Westerveld, M; Duncan, CC; Makuch, RW			Change in cognitive function over time in very low-birth-weight infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MULTICENTER RANDOMIZED TRIAL; HEMORRHAGE PREVENTION TRIAL; LOW-DOSE INDOMETHACIN; AGE 8 YEARS; INTRAVENTRICULAR HEMORRHAGE; PRETERM INFANTS; DEVELOPMENT PROGRAM; EARLY INTERVENTION; PREMATURE-INFANTS; GESTATIONAL-AGE	Context Preterm very low-birth-weight (VLBW) infants have a high prevalence of neurodevelopmental disability when evaluated during the first several years of life. However, recent experimental data suggest that the developing brain may recover from or compensate for injury. Objective To determine if there is cognitive improvement throughout early and middle childhood following VLBW birth. Design, Setting, and Participants Follow-up data of 296 infants born weighing 600 to 1250 g who participated in a prospective, randomized, placebo-controlled intraventricular hemorrhage (IVH) prevention study performed at 3 northeastern US hospitals between September 1989 and August 1992 and who were serially evaluated at 36, 54, 72, and 96 months of corrected age (CA). Main Outcome Measures The age-normed Peabody Picture Vocabulary Test-Revised (PPVT-R) score and measures of intelligence. Results Overall,,the median PPVT-R score increased from 88 at 36 months of CA to 99 at 96 months of CA; when data from 36 and 96 months of CA were compared, 45% of children gained 10 points or more and 12.5% showed a 5- to 9-point increase in test scores. Similar findings were noted for full-scale and verbal IQ scores. Multivariate analyses demonstrated that increasing age, residence in a 2-parent household, and higher levels of maternal education were all significantly associated with higher PPVT-R scores (for each, P<.001). In addition, early intervention led to greater increases over time in PPVT-R scores among children whose mothers had less than a high school education compared with those with a high school education level or greater (P=.03 by test for interaction). Although most children showed improvement in PPVT-R scores with increasing CA, children with early-onset IVH and subsequent significant central nervous system injury had the lowest PPVT-R scores initially and the scores declined over time (P=.009 by test for interaction). Conclusions The majority of VLBW children had improvement in verbal and IQ test scores over time. Only children with early-onset IVH followed by significant central nervous system injury had low PPVT-R scores that declined over time.	Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA; Brown Univ, Sch Med, Dept Pediat, Providence, RI 02912 USA; Maine Med Ctr, Dept Neurol, Portland, ME 04102 USA	Yale University; Yale University; Yale University; Yale University; Brown University; Maine Medical Center	Ment, LR (corresponding author), Yale Univ, Sch Med, Dept Pediat, 333 Cedar St, New Haven, CT 06520 USA.				NCRR NIH HHS [RR 06022] Funding Source: Medline; NINDS NIH HHS [NS 27116] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027116] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allan WC, 1997, ARCH PEDIAT ADOL MED, V151, P580, DOI 10.1001/archpedi.1997.02170430046010; BROOKSGUNN J, 1994, JAMA-J AM MED ASSOC, V272, P1257, DOI 10.1001/jama.272.16.1257; CONSTANTINE NA, 1987, J PEDIATR-US, V110, P921, DOI 10.1016/S0022-3476(87)80416-X; CROWLEY PA, 1995, AM J OBSTET GYNECOL, V173, P322, DOI 10.1016/0002-9378(95)90222-8; Dessens AB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e77; Dunn L. M., 1981, PPVT PEABODY PICTURE; Hack M, 2000, ARCH PEDIAT ADOL MED, V154, P725, DOI 10.1001/archpedi.154.7.725; Hack M, 1999, EARLY HUM DEV, V53, P193, DOI 10.1016/S0378-3782(98)00052-8; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; HACK M, 1995, AM J OBSTET GYNECOL, V172, P457, DOI 10.1016/0002-9378(95)90557-X; HACK M, 1994, NEW ENGL J MED, V331, P753, DOI 10.1056/NEJM199409223311201; Horwood LJ, 1998, ARCH DIS CHILD-FETAL, V79, pF12, DOI 10.1136/fn.79.1.F12; Johnston M V, 2001, Adv Pediatr, V48, P1; LEVINE SC, 1987, DEV MED CHILD NEUROL, V29, P27; McCarton CM, 1997, JAMA-J AM MED ASSOC, V277, P126, DOI 10.1001/jama.277.2.126; McCormick MC, 1996, PEDIATRICS, V97, P18; MENT LR, 1994, J PEDIATR-US, V124, P951, DOI 10.1016/S0022-3476(05)83191-9; Ment LR, 2000, PEDIATRICS, V105, P485, DOI 10.1542/peds.105.3.485; Ment LR, 2002, NEUROLOGY, V58, P1726, DOI 10.1212/WNL.58.12.1726; Ment LR, 1996, PEDIATRICS, V98, P714; MENT LR, 1994, PEDIATRICS, V93, P543; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Petrou S, 2001, CHILD CARE HLTH DEV, V27, P97, DOI 10.1046/j.1365-2214.2001.00203.x; Pinto-Martin JA, 1999, DEV MED CHILD NEUROL, V41, P826, DOI 10.1017/S0012162299001644; Roth S, 2001, EARLY HUM DEV, V65, P81, DOI 10.1016/S0378-3782(01)00173-6; SAIGAL S, 1991, J PEDIATR-US, V118, P751, DOI 10.1016/S0022-3476(05)80043-5; SAIGAL S, 1995, J PEDIATR-US, V126, pS61, DOI 10.1016/S0022-3476(95)70009-9; Saigal S, 2001, PEDIATRICS, V108, P407, DOI 10.1542/peds.108.2.407; Salokorpi T, 2001, ACTA PAEDIATR, V90, P218, DOI 10.1080/080352501300049505; Singer LT, 2001, J DEV BEHAV PEDIATR, V22, P19, DOI 10.1097/00004703-200102000-00003; Soll Roger F., 1992, P325; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; Taylor HG, 2000, DEV NEUROPSYCHOL, V17, P289, DOI 10.1207/S15326942DN1703_2; TERMAN LM, 1973, STANFORDBINET SCALE; VERLOOVEVANHORICK SP, 1994, PEDIATRICS, V93, P576; Vohr B, 1999, SEMIN PERINATOL, V23, P212, DOI 10.1016/S0146-0005(99)80065-2; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; Wechsler D., 2014, WECHSLER PRESCHOOL P; Wechsler D., 1991, WISC 3 WECHSLER INTE; Weiss B, 1997, MENT RETARD DEV D R, V3, P246, DOI 10.1002/(SICI)1098-2779(1997)3:3<246::AID-MRDD5>3.0.CO;2-N; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	42	237	244	0	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2003	289	6					705	711		10.1001/jama.289.6.705	http://dx.doi.org/10.1001/jama.289.6.705			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643WP	12585948	Bronze			2022-12-28	WOS:000180886000024
J	Singri, N; Ahya, SN; Levin, ML				Singri, N; Ahya, SN; Levin, ML			Acute renal failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONTROLLED TRIAL; AMPHOTERICIN-B; CLINICAL-TRIAL; FUROSEMIDE; DOPAMINE; NEPHROTOXICITY; MULTICENTER		Northwestern Univ, Feinberg Sch Med, Dept Med, Div Nephrol Hypertens, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Ahya, SN (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Nephrol Hypertens, Olson Pavil,4-500,710 N Fairbanks St, Chicago, IL 60611 USA.							Abraham SC, 2001, AM J SURG PATHOL, V25, P637, DOI 10.1097/00000478-200105000-00011; Acker CG, 2000, KIDNEY INT, V57, P293, DOI 10.1046/j.1523-1755.2000.00827.x; Allgren RL, 1997, NEW ENGL J MED, V336, P828, DOI 10.1056/NEJM199703203361203; Bates DW, 2001, KIDNEY INT, V60, P1452, DOI 10.1046/j.1523-1755.2001.00948.x; Bellomo R, 2000, LANCET, V356, P2139; Briguori C, 2002, J AM COLL CARDIOL, V40, P298, DOI 10.1016/S0735-1097(02)01958-7; Brivet FG, 1996, CRIT CARE MED, V24, P192, DOI 10.1097/00003246-199602000-00003; BROWN CB, 1981, CLIN NEPHROL, V15, P90; Chang CH, 2001, AM J NEPHROL, V21, P441, DOI 10.1159/000046647; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Diaz-Sandoval LJ, 2002, AM J CARDIOL, V89, P356, DOI 10.1016/S0002-9149(01)02243-3; Harbarth S, 2001, AM J MED, V111, P528, DOI 10.1016/S0002-9343(01)00928-7; Hirschberg R, 1999, KIDNEY INT, V55, P2423, DOI 10.1046/j.1523-1755.1999.00463.x; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; KAUFMAN J, 1991, AM J KIDNEY DIS, V17, P191, DOI 10.1016/S0272-6386(12)81128-0; Kay J, 2003, JAMA-J AM MED ASSOC, V289, P553, DOI 10.1001/jama.289.5.553; Kellum JA, 2001, CRIT CARE MED, V29, P1526, DOI 10.1097/00003246-200108000-00005; Kini AS, 2002, AM J CARDIOL, V89, P999, DOI 10.1016/S0002-9149(02)02259-2; KLEINKNECHT D, 1976, NEPHRON, V17, P51, DOI 10.1159/000180710; Koreny M, 2002, AM J MED, V112, P115, DOI 10.1016/S0002-9343(01)01070-1; Lassnigg A, 2000, J AM SOC NEPHROL, V11, P97, DOI 10.1681/ASN.V11197; Madyoon H, 2001, CATHETER CARDIO INTE, V53, P341, DOI 10.1002/ccd.1178; Mehta RL, 2002, JAMA-J AM MED ASSOC, V288, P2547, DOI 10.1001/jama.288.20.2547; Mehta RL, 1996, AM J KIDNEY DIS, V28, pS74, DOI 10.1016/S0272-6386(96)90083-9; Mehta RL, 2001, KIDNEY INT, V60, P1154, DOI 10.1046/j.1523-1755.2001.0600031154.x; MILLER TR, 1978, ANN INTERN MED, V89, P47, DOI 10.7326/0003-4819-89-1-47; Mueller C, 2002, ARCH INTERN MED, V162, P329, DOI 10.1001/archinte.162.3.329; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; O'Neill WC, 2000, AM J KIDNEY DIS, V35, P1021, DOI 10.1016/S0272-6386(00)70036-9; PRINS JM, 1993, LANCET, V341, P335, DOI 10.1016/0140-6736(93)90137-6; Schiffl H, 2002, NEW ENGL J MED, V346, P305, DOI 10.1056/NEJMoa010877; SOLOMON R, 1994, NEW ENGL J MED, V331, P1416, DOI 10.1056/NEJM199411243312104; Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304; Tumlin JA, 2002, AM HEART J, V143, P894, DOI 10.1067/mhj.2002.122118; VandenBerghe G, 1996, CRIT CARE MED, V24, P1580, DOI 10.1097/00003246-199609000-00024; Wang A, 2000, KIDNEY INT, V57, P1675, DOI 10.1046/j.1523-1755.2000.00012.x	36	124	139	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2003	289	6					747	751		10.1001/jama.289.6.747	http://dx.doi.org/10.1001/jama.289.6.747			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643WP	12585954				2022-12-28	WOS:000180886000030
J	Meier, C; Trittibach, P; Guglielmetti, M; Staub, JJ; Muller, B				Meier, C; Trittibach, P; Guglielmetti, M; Staub, JJ; Muller, B			Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article									Univ Basel Hosp, Dept Med, Div Endocrinol, CH-4031 Basel, Switzerland	University of Basel	Meier, C (corresponding author), Univ Basel Hosp, Dept Med, Div Endocrinol, CH-4031 Basel, Switzerland.		Mueller, Beat/G-2662-2012					Canaris GJ, 1997, J GEN INTERN MED, V12, P544, DOI 10.1046/j.1525-1497.1997.07109.x; FRANKLYN JA, 1993, CLIN ENDOCRINOL, V38, P453, DOI 10.1111/j.1365-2265.1993.tb00339.x; RIDGWAY EC, 1980, CLIN ENDOCRINOL, V13, P479, DOI 10.1111/j.1365-2265.1980.tb03414.x; STAUB JJ, 1992, AM J MED, V92, P631, DOI 10.1016/0002-9343(92)90782-7; Zulewski H, 1997, J CLIN ENDOCR METAB, V82, P771, DOI 10.1210/jc.82.3.771	5	30	32	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2003	326	7384					311	312		10.1136/bmj.326.7384.311	http://dx.doi.org/10.1136/bmj.326.7384.311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645UD	12574044	Bronze, Green Published			2022-12-28	WOS:000180997000018
J	Fisher, AT; Davis, EE; Hutnak, M; Spiess, V; Zuhlsdorff, L; Cherkaoui, A; Christiansen, L; Edwards, K; Macdonald, R; Villinger, H; Mottl, MJ; Wheat, CG; Becker, K				Fisher, AT; Davis, EE; Hutnak, M; Spiess, V; Zuhlsdorff, L; Cherkaoui, A; Christiansen, L; Edwards, K; Macdonald, R; Villinger, H; Mottl, MJ; Wheat, CG; Becker, K			Hydrothermal recharge and discharge across 50 km guided by seamounts on a young ridge flank	NATURE			English	Article							DE-FUCA RIDGE; OCEANIC-CRUST; HEAT-FLOW; CHEMICAL-COMPOSITION; CASCADIA BASIN; EASTERN FLANK; BABY-BARE; CIRCULATION; FLUXES; PERMEABILITY	Hydrothermal circulation within the sea floor, through lithosphere older than one million years (Myr), is responsible for 30% of the energy released from plate cooling, and for 70% of the global heat flow anomaly (the difference between observed thermal output and that predicted by conductive cooling models)(1,2). Hydrothermal fluids remove significant amounts of heat from the oceanic lithosphere for plates typically up to about 65 Myr old(3,4). But in view of the relatively impermeable sediments that cover most ridge flanks(5), it has been difficult to explain how these fluids transport heat from the crust to the ocean. Here we present results of swath mapping, heat flow, geochemistry and seismic surveys from the young eastern flank of the Juan de Fuca ridge, which show that isolated basement outcrops penetrating through thick sediments guide hydrothermal discharge and recharge between sites separated by more than 50 km. Our analyses reveal distinct thermal patterns at the sea floor adjacent to recharging and discharging outcrops. We find that such a circulation through basement outcrops can be sustained in a setting of pressure differences and crustal properties as reported in independent observations and modelling studies.	Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Inst Geophys & Planetary Phys, Santa Cruz, CA 95064 USA; Geol Survey Canada, Pacific Geosci Ctr, Sidney, BC V8L 4B2, Canada; Univ Bremen, Dept Earth Sci, D-28359 Bremen, Germany; Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; Univ Hawaii, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; Univ Alaska, Global Undersea Res Unit, Fairbanks, AK 99775 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; University of Bremen; Johns Hopkins University; University of Miami; University of Hawaii System; University of Alaska System; University of Alaska Fairbanks	Fisher, AT (corresponding author), Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA.		Fisher, Andrew/A-1113-2016; Spiess, Volkhard/E-4376-2010	Spiess, Volkhard/0000-0001-5019-5844; Wheat, Charles/0000-0001-8858-1310				BAKER PA, 1991, EARTH PLANET SC LETT, V105, P522, DOI 10.1016/0012-821X(91)90189-O; Becker NC, 2000, J GEOPHYS RES-SOL EA, V105, P23557, DOI 10.1029/2000JB900204; Bethke CM, 2002, GEOLOGY, V30, P107, DOI 10.1130/0091-7613(2002)030<0107:POGA>2.0.CO;2; BREDEHOEFT JD, 1965, WATER RESOUR RES, V1, P325, DOI 10.1029/WR001i002p00325; Davis EE, 2000, J GEOPHYS RES-SOL EA, V105, P13423, DOI 10.1029/2000JB900084; Davis EE, 2002, EARTH PLANET SC LETT, V204, P231, DOI 10.1016/S0012-821X(02)00982-2; Davis EE, 1999, J GEOPHYS RES-SOL EA, V104, P17675, DOI 10.1029/1999JB900124; DAVIS EE, 1992, CAN J EARTH SCI, V29, P925, DOI 10.1139/e92-078; DAVIS EE, 1997, P ODP INIT REP; Elderfield H, 1996, ANNU REV EARTH PL SC, V24, P191, DOI 10.1146/annurev.earth.24.1.191; Elderfield H, 1999, EARTH PLANET SC LETT, V172, P151, DOI 10.1016/S0012-821X(99)00191-0; Fisher AT, 2000, NATURE, V403, P71, DOI 10.1038/47463; Fisher AT, 1997, GEOPHYS RES LETT, V24, P1311, DOI 10.1029/97GL01286; Giambalvo ER, 2000, J GEOPHYS RES-SOL EA, V105, P913, DOI 10.1029/1999JB900360; JACOBSON RS, 1992, REV GEOPHYS, V30, P23, DOI 10.1029/91RG02811; MOTTL MJ, 1994, GEOCHIM COSMOCHIM AC, V58, P2225, DOI 10.1016/0016-7037(94)90007-8; Mottl MJ, 1998, GEOLOGY, V26, P51, DOI 10.1130/0091-7613(1998)026<0051:WSDOMO>2.3.CO;2; PARSONS B, 1977, J GEOPHYS RES, V82, P803, DOI 10.1029/JB082i005p00803; Sanford WE, 1997, GROUND WATER, V35, P357, DOI 10.1111/j.1745-6584.1997.tb00093.x; SCLATER JG, 1980, REV GEOPHYS, V18, P269, DOI 10.1029/RG018i001p00269; Shapiro AM, 2001, WATER RESOUR RES, V37, P507, DOI 10.1029/2000WR900301; STEIN CA, 1992, NATURE, V359, P123, DOI 10.1038/359123a0; THOMSON RE, 1995, J GEOPHYS RES-SOL EA, V100, P6121, DOI 10.1029/95JB00030; Villinger H, 2002, EARTH PLANET SC LETT, V202, P159, DOI 10.1016/S0012-821X(02)00759-8; Wessel P, 2001, J GEOPHYS RES-SOL EA, V106, P19431, DOI 10.1029/2000JB000083; Wheat CG, 2000, J GEOPHYS RES-SOL EA, V105, P13437, DOI 10.1029/2000JB900070; WHEAT CG, 1994, J GEOPHYS RES-SOL EA, V99, P3067, DOI 10.1029/93JB01612; Wheat CG, 2000, GEOCHIM COSMOCHIM AC, V64, P629, DOI 10.1016/S0016-7037(99)00347-6; Williams D.L., 1974, GEOLOGY, V2, P327, DOI [2.0.CO;2, DOI 10.1130/0091-7613%281974%292%3C327%3AHLFTEN%3E2.0.CO%3B2]	29	176	180	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					618	621		10.1038/nature01352	http://dx.doi.org/10.1038/nature01352			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571592				2022-12-28	WOS:000180803200038
J	Niven, JE; Vahasoyrinki, M; Kauranen, M; Hardie, RC; Juusola, M; Weckstrom, M				Niven, JE; Vahasoyrinki, M; Kauranen, M; Hardie, RC; Juusola, M; Weckstrom, M			The contribution of Shaker K+ channels to the information capacity of Drosophila photoreceptors	NATURE			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; POTASSIUM CHANNELS; CONDUCTANCE; PROPAGATION; DENDRITES; DIVERSITY; MEMBRANE; MUTANTS	An array of rapidly inactivating voltage-gated K+ channels is distributed throughout the nervous systems of vertebrates and invertebrates(1-5). Although these channels are thought to regulate the excitability of neurons by attenuating voltage signals, their specific functions are often poorly understood. We studied the role of the prototypical inactivating K+ conductance, Shaker(6,7), in Drosophila photoreceptors(8,9) by recording intracellularly from wild-type and Shaker mutant photoreceptors. Here we show that loss of the Shaker K+ conductance produces a marked reductionin the signal-to-noise ratio of photoreceptors, generating a 50% decrease in the information capacity of these cells in fully light-adapted conditions. By combining experiments with modelling, we show that the inactivation of Shaker K+ channels amplifies voltage signals and enables photoreceptors to use their voltage range more effectively. Loss of the Shaker conductance attenuated the voltage signal and induced a compensatory decrease in impedance. Our results demonstrate the importance of the Shaker K+ conductance for neural coding precision and as a mechanism for selectively amplifying graded signals in neurons, and highlight the effect of compensatory mechanisms on neuronal information processing.	Univ Cambridge, Physiol Lab, Cambridge CB2 3EG, England; Univ Oulu, Dept Phys Sci, Div Biophys, Oulu, Finland; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge; University of Oulu; University of Cambridge	Juusola, M (corresponding author), Univ Cambridge, Physiol Lab, Downing St, Cambridge CB2 3EG, England.	mj216@cus.cam.ac.uk	Juusola, Mikko/E-6948-2011; Niven, Jeremy E/A-5883-2011	Hardie, Roger/0000-0001-5531-3264; Juusola, Mikko/0000-0002-4428-5330				Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; HARDIE RC, 1991, NEURON, V6, P477, DOI 10.1016/0896-6273(91)90255-X; HARDIE RC, 1991, J NEUROSCI, V11, P3079; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HEVERS W, 1995, NEURON, V14, P845, DOI 10.1016/0896-6273(95)90228-7; Hille B., 2001, IONIC CHANNELS EXCIT, P814; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Johnston D., 1995, FDN CELLULAR NEUROPH; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; KAPLAN WD, 1969, GENETICS, V61, P399; KOUVALAINEN E, 1994, VISUAL NEUROSCI, V11, P1221, DOI 10.1017/S095252380000701X; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LAURENT G, 1990, J NEUROSCI, V10, P2268; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; SALKOFF L, 1981, NATURE, V293, P228, DOI 10.1038/293228a0; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WECKSTROM M, 1995, TRENDS NEUROSCI, V18, P17, DOI 10.1016/0166-2236(95)93945-T	30	67	67	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2003	421	6923					630	634		10.1038/nature01384	http://dx.doi.org/10.1038/nature01384			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571596				2022-12-28	WOS:000180803200042
J	Doiron, B; Chacron, MJ; Maler, L; Longtin, A; Bastian, J				Doiron, B; Chacron, MJ; Maler, L; Longtin, A; Bastian, J			Inhibitory feedback required for network oscillatory responses to communication but not prey stimuli	NATURE			English	Article							WEAKLY ELECTRIC FISH; LATERAL-LINE LOBE; ENCODING NEURAL ASSEMBLIES; CORTICOTHALAMIC FEEDBACK; SENSORY SEARCHLIGHT; VISUAL-CORTEX; SYNCHRONIZATION; NEURONS; CELLS; MECHANISMS	Stimulus-induced oscillations occur in visual(1,2), olfactory(3-6) and somatosensory(7) systems. Several experimental(2,3,5) and theoretical(8-13) studies have shown how such oscillations can be generated by inhibitory connections between neurons. But the effects of realistic spatiotemporal sensory input on oscillatory network dynamics and the overall functional roles of such oscillations in sensory processing are poorly understood. Weakly electric fish must detect electric field modulations produced by both prey (spatially localized)(14) and communication (spatially diffuse)(15) signals. Here we show, through in vivo recordings, that sensory pyramidal neurons in these animals produce an oscillatory response to communication-like stimuli, but not to prey-like stimuli. On the basis of well-characterized circuitry(16), we construct a network model of pyramidal neurons that predicts that diffuse delayed inhibitory feedback is required to achieve oscillatory behaviour only in response to communication-like stimuli. This prediction is experimentally verified by reversible blockade of feedback inhibition that removes oscillatory behaviour in the presence of communication-like stimuli. Our results show that a sensory system can use inhibitory feedback as a mechanism to 'toggle' between oscillatory and non-oscillatory firing states, each associated with a naturalistic stimulus.	Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	University of Ottawa; University of Ottawa; University of Oklahoma System; University of Oklahoma - Norman	Doiron, B (corresponding author), Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.		Longtin, Andre/D-2443-2009	Chacron, Maurice/0000-0002-3032-452X				AHISSAR E, 1990, P NATL ACAD SCI USA, V87, P8935, DOI 10.1073/pnas.87.22.8935; Bastian J, 2002, J NEUROSCI, V22, P4577, DOI 10.1523/JNEUROSCI.22-11-04577.2002; Bastian J, 2001, J NEUROPHYSIOL, V85, P10, DOI 10.1152/jn.2001.85.1.10; Berman NJ, 1998, J NEUROPHYSIOL, V80, P3197, DOI 10.1152/jn.1998.80.6.3197; Berman NJ, 1999, J EXP BIOL, V202, P1243; Berman NJ, 1997, J NEUROPHYSIOL, V78, P1869, DOI 10.1152/jn.1997.78.4.1869; Bressloff PC, 2000, NEURAL COMPUT, V12, P91, DOI 10.1162/089976600300015907; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; Dayan P, 2001, COMPUTATIONAL NEUROS; Destexhe A, 1998, J NEUROPHYSIOL, V79, P999; Doiron B, 2002, J COMPUT NEUROSCI, V12, P5, DOI 10.1023/A:1014921628797; ERNST U, 1995, PHYS REV LETT, V74, P1570, DOI 10.1103/PhysRevLett.74.1570; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gabbiani F, 1996, NATURE, V384, P564, DOI 10.1038/384564a0; Glass L., 1988, CLOCKS CHAOS RHYTHMS; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kloeden P. E., 1992, NUMERICAL SOLUTIONS; Lemon N, 2000, J NEUROPHYSIOL, V84, P1519, DOI 10.1152/jn.2000.84.3.1519; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MALER L, 1994, J COMP NEUROL, V345, P224, DOI 10.1002/cne.903450206; MALER L, 1981, J COMP NEUROL, V195, P87, DOI 10.1002/cne.901950107; Metzner W, 1999, J EXP BIOL, V202, P1365; Nelson ME, 1999, J EXP BIOL, V202, P1195; Pauluis Q, 1999, J COMPUT NEUROSCI, V6, P27, DOI 10.1023/A:1008804916112; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; van Vreeswijk C, 2001, NEURAL COMPUT, V13, P959, DOI 10.1162/08997660151134280; WANG XJ, 1993, NEUROSCIENCE, V53, P899, DOI 10.1016/0306-4522(93)90474-T; Wessel R, 1996, J NEUROPHYSIOL, V75, P2280, DOI 10.1152/jn.1996.75.6.2280	30	133	134	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					539	543		10.1038/nature01360	http://dx.doi.org/10.1038/nature01360			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556894				2022-12-28	WOS:000180670600047
J	Ma, D; Yang, CH; McNeill, H; Simon, MA; Axelrod, JD				Ma, D; Yang, CH; McNeill, H; Simon, MA; Axelrod, JD			Fidelity in planar cell polarity signalling	NATURE			English	Article							TISSUE POLARITY; DROSOPHILA EYE; CADHERIN SUPERFAMILY; GENE; ENCODES; MEMBER; PROTEIN; MORPHOGENESIS; MUTATIONS; GROWTH	The polarity of Drosophila wing hairs displays remarkable fidelity. Each of the approximately 30,000 wing epithelial cells constructs an actin-rich prehair that protrudes from its distal vertex and points distally. The distal location and orientation of the hairs is virtually error free, thus forming a nearly perfect parallel array. This process is controlled by the planar cell polarity signalling pathway(1-4). Here we show that interaction between two tiers of the planar cell polarity signalling mechanism results in the observed high fidelity. The first tier, mediated by the cadherin Fat(5), dictates global orientation by transducing a directional signal to individual cells. The second tier, orchestrated by the 7-pass transmembrane receptor Frizzled(6,7), aligns each cell's polarity with that of its neighbours through the action of an intercellular feedback loop, enabling polarity to propagate from cell to cell(8). We show that all cells need not respond correctly to the presumably subtle signal transmitted by Fat. Subsequent action of the Frizzled feedback loop is sufficient to align all the cells cooperatively. This economical system is therefore highly robust, and produces virtually error-free arrays.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Canc Res UK, London Res Inst, London WC2A 3PX, England	Stanford University; Stanford University; Cancer Research UK	Axelrod, JD (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.		McNeill, Helen/E-4579-2013	McNeill, Helen/0000-0003-1126-5154				Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Adler PN, 1997, CURR BIOL, V7, P940, DOI 10.1016/S0960-9822(06)00413-1; Adler PN, 1998, DEVELOPMENT, V125, P959; Axelrod JD, 2001, GENE DEV, V15, P1182; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Buckles GR, 2001, DEVELOPMENT, V128, P3533; Casal J, 2002, CURR BIOL, V12, P1189, DOI 10.1016/S0960-9822(02)00974-0; Chae J, 1999, DEVELOPMENT, V126, P5421; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Fanto M, 1999, NATURE, V397, P523, DOI 10.1038/17389; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Strutt DI, 2002, SEMIN CELL DEV BIOL, V13, P225, DOI 10.1016/S1084-9521(02)00041-1; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Taylor J, 1998, GENETICS, V150, P199; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VILLANO JL, 1995, DEVELOPMENT, V121, P2767; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Wolff T, 1998, DEVELOPMENT, V125, P1149; XU T, 1993, DEVELOPMENT, V117, P1223; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Zeidler MP, 1999, CURR BIOL, V9, P1363, DOI 10.1016/S0960-9822(00)80081-0; Zeidler MP, 2000, DEV BIOL, V228, P181, DOI 10.1006/dbio.2000.9940	30	256	257	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					543	547		10.1038/nature01366	http://dx.doi.org/10.1038/nature01366			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12540853				2022-12-28	WOS:000180670600048
J	Vidale, JE; Li, YG				Vidale, JE; Li, YG			Damage to the shallow Landers fault from the nearby Hector Mine earthquake	NATURE			English	Article							SEISMIC VELOCITY; CALIFORNIA; AFTERSHOCKS; ZONE; FIELD	Crustal faults have long been identified as sites where localized sliding motion occurs during earthquakes(1), which allows for the relative motion between adjacent crustal blocks. Although there is a growing awareness that we must understand the evolution of fault systems on many timescales to relate present-day crustal stresses and fault motions to geological structures formed in the past, fault-zone damage and healing have been documented quantitatively in only a few cases(2,3). We have been monitoring the healing of damage on the shallow Johnson Valley fault after its rupture in the 1992 magnitude-7.3 Landers earthquake, and here we report that this healing was interrupted in 1999 by the magnitude-7.1 Hector Mine earthquake rupture, which occurred 20-30 km away. The Hector Mine earthquake both strongly shook and permanently strained the Johnson Valley fault, adding damage discernible as a temporary reversal of the healing process. The fault has since resumed the trend of strength recovery that it showed after the Landers earthquake. These observations lead us to speculate that fault damage caused by strong seismic waves may help to explain earthquake clustering and seismicity triggering by shaking, and may be involved in friction reduction during faulting.	Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Southern California	Vidale, JE (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.		Vidale, John/H-4965-2011	Vidale, John/0000-0002-3658-818X				Baisch S, 2001, J GEOPHYS RES-SOL EA, V106, P16323, DOI 10.1029/2001JB000151; Bokelmann GHR, 2000, J GEOPHYS RES-SOL EA, V105, P23879, DOI 10.1029/2000JB900207; Bowman DD, 2001, GEOPHYS RES LETT, V28, P4039, DOI 10.1029/2001GL013022; Brodsky EE, 2000, GEOPHYS RES LETT, V27, P2741, DOI 10.1029/2000GL011534; COCHRAN E, 2001, EOS, V82; Fialko Y, 2002, SCIENCE, V297, P1858, DOI 10.1126/science.1074671; Fialko Y, 2001, GEOPHYS RES LETT, V28, P3063, DOI 10.1029/2001GL013174; Gomberg J, 2001, NATURE, V411, P462, DOI 10.1038/35078053; Hauksson E, 2002, B SEISMOL SOC AM, V92, P1154, DOI 10.1785/0120000920; HILL DP, 1993, SCIENCE, V260, P1617, DOI 10.1126/science.260.5114.1617; IKUTA R, 2002, GEOPHYS REV LETT, V29; Ji C, 2002, B SEISMOL SOC AM, V92, P1208, DOI 10.1785/0120000917; Kilb D, 2000, NATURE, V408, P570, DOI 10.1038/35046046; Knopoff L, 1996, J GEOPHYS RES-SOL EA, V101, P5779, DOI 10.1029/95JB03730; Li YG, 2001, GEOPHYS RES LETT, V28, P2999, DOI 10.1029/2001GL012922; Li YG, 2000, J GEOPHYS RES-SOL EA, V105, P6237, DOI 10.1029/1999JB900449; LI YG, IN PRESS B SEISMOL S; Marone C, 1998, ANNU REV EARTH PL SC, V26, P643, DOI 10.1146/annurev.earth.26.1.643; Price EJ, 1998, J GEOPHYS RES-SOL EA, V103, P27001, DOI 10.1029/98JB01821; RATDOMOPURBO A, 1995, GEOPHYS RES LETT, V22, P775, DOI 10.1029/95GL00302; Reid H.F., 1910, MECH EARTHQUAKE CALI, V2; Richardson E, 1999, J GEOPHYS RES-SOL EA, V104, P28859, DOI 10.1029/1999JB900320; Rockwell TK, 2000, B SEISMOL SOC AM, V90, P1200, DOI 10.1785/0119990023; RUBINSTEIN JL, 2002, EOS, V83; Schaff DP, 1998, GEOPHYS RES LETT, V25, P4549, DOI 10.1029/1998GL900192; SIEH K, 1993, SCIENCE, V260, P171, DOI 10.1126/science.260.5105.171; Stein RS, 1997, GEOPHYS J INT, V128, P594, DOI 10.1111/j.1365-246X.1997.tb05321.x; 2000, SEISMOL RES LETT, V71, P11	28	133	140	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					524	526		10.1038/nature01354	http://dx.doi.org/10.1038/nature01354			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556890				2022-12-28	WOS:000180670600042
J	Sidiki, SS; Hamilton, R; Dutton, GN				Sidiki, SS; Hamilton, R; Dutton, GN			Lesson of the week - Fear of the dark in children: is stationary night blindness the cause?	BRITISH MEDICAL JOURNAL			English	Review							TERRORS		Yorkhill NHS Trust, Dept Clin Phys, Glasgow G3 8SJ, Lanark, Scotland; Gartnavel Royal Hosp, Tennent Inst Ophthalmol, Glasgow G12 0YN, Lanark, Scotland; Yorkhill NHS Trust, Dept Ophthalmol, Glasgow G3 8SJ, Lanark, Scotland	Gartnavel Royal Hospital	Hamilton, R (corresponding author), Yorkhill NHS Trust, Dept Clin Phys, Glasgow G3 8SJ, Lanark, Scotland.		Hamilton, Ruth/H-4253-2011	Hamilton, Ruth/0000-0002-0855-9533				CARR R. E., 1966, INVEST OPHTHALMOL, V5, P497; CARR RE, 1991, PRINCIPLES PRACTICE; CARROLL FD, 1953, AMA ARCH OPHTHALMOL, V50, P35; Fitzgerald KM, 2001, AM J OPHTHALMOL, V131, P495, DOI 10.1016/S0002-9394(00)00849-7; GIEBENHAIN JE, 1984, J APPL BEHAV ANAL, V17, P121, DOI 10.1901/jaba.1984.17-121; KALES JD, 1980, ARCH GEN PSYCHIAT, V37, P1413, DOI 10.1001/archpsyc.1980.01780250099012; LASK B, 1988, BRIT MED J, V297, P592, DOI 10.1136/bmj.297.6648.592; MOORE A, 1990, PAEDIAT OPHTHALMOLOG; Nettleship Edward, 1907, T OPHTHAL SOC UK, V27, P269; Pardue MT, 1998, INVEST OPHTH VIS SCI, V39, P2443; Purvin V, 1999, SURV OPHTHALMOL, V43, P335, DOI 10.1016/S0039-6257(98)00050-2; RAYNER RJ, 1989, ARCH DIS CHILD, V64, P1151, DOI 10.1136/adc.64.8.1151; ROSNER M, 1993, AM J OPHTHALMOL, V116, P373, DOI 10.1016/S0002-9394(14)71358-3; Sandberg MA, 1998, ARCH OPHTHALMOL-CHIC, V116, P867, DOI 10.1001/archopht.116.7.867; Weems CF, 1999, J CHILD PSYCHOL PSYC, V40, P941, DOI 10.1111/1469-7610.00511	15	3	7	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 25	2003	326	7382					211	212		10.1136/bmj.326.7382.211	http://dx.doi.org/10.1136/bmj.326.7382.211			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640LD	12543840	Green Published, Green Accepted			2022-12-28	WOS:000180689600024
J	Komiyama, T; Johnson, WA; Luo, LQ; Jefferis, GSXE				Komiyama, T; Johnson, WA; Luo, LQ; Jefferis, GSXE			From lineage to wiring specificity: POU domain transcription factors control precise connections of Drosophila olfactory projection neurons	CELL			English	Article							C-ELEGANS; MOTOR-NEURONS; CELL LINEAGE; SENSORY MAP; IDENTITY; CODES; ACJ6; DIFFERENTIATION; REPRESENTATION; MELANOGASTER	Axonal selection of synaptic partners is generally believed to determine wiring specificity in the nervous system. However, we have recently found evidence for specific dendritic targeting in the olfactory system of Drosophila: second order olfactory neurons (Projection Neurons) from the anterodorsal (adPN) and lateral (IPN) lineages send their dendrites to stereotypical, intercalating but non-overlapping glomeruli. Here we show that POU domain transcription factors, Acj6 and Drifter, are expressed in adPNs and IPNs respectively, and are required for their dendritic targeting. Moreover, misexpression of Acj6 in IPNs, or Drifter in adPNs, results in dendritic targeting to glomeruli normally reserved for the other PN lineage. Thus, Acj6 and Drifter translate PN lineage information into distinct dendritic targeting specificity. Acj6 also controls stereotypical axon terminal arborization of PNs in a central target, suggesting that the connectivity of PN axons and dendrites in different brain centers is coordinately regulated.	Stanford Univ, Dept Biol Sci, Neurosci Program, Stanford, CA 94305 USA; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA	Stanford University; University of Iowa	Luo, LQ (corresponding author), Stanford Univ, Dept Biol Sci, Neurosci Program, Stanford, CA 94305 USA.	lluo@stanford.edu	Jefferis, Gregory/C-6386-2012	Komiyama, Takaki/0000-0001-9609-4600; Johnson, Wayne/0000-0002-6961-5498; Luo, Liqun/0000-0001-5467-9264; Jefferis, Gregory/0000-0002-0587-9355				ANDERSON MG, 1995, GENE DEV, V9, P123, DOI 10.1101/gad.9.1.123; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; AYER RK, 1991, P NATL ACAD SCI USA, V88, P5467, DOI 10.1073/pnas.88.12.5467; Certel K, 2000, DEVELOPMENT, V127, P3173; Certel SJ, 2000, DEVELOPMENT, V127, P2395; CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jefferis GSXE, 2002, CURR OPIN NEUROBIOL, V12, P80, DOI 10.1016/S0959-4388(02)00293-3; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; MCKENNA M, 1989, P NATL ACAD SCI USA, V86, P8118, DOI 10.1073/pnas.86.20.8118; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	34	125	125	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 24	2003	112	2					157	167		10.1016/S0092-8674(03)00030-8	http://dx.doi.org/10.1016/S0092-8674(03)00030-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553905	Bronze			2022-12-28	WOS:000181191600006
J	Snapper, SB; Rosen, FS				Snapper, SB; Rosen, FS			A family of WASPs	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Snapper, SB (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, J706,55 Blossom St, Boston, MA 02114 USA.	ssnapper@hms.harvard.edu			NHLBI NIH HHS [HL59561] Funding Source: Medline; NIAID NIH HHS [AI50950] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050950, R56AI050950] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; RISCHKNECHT F, 2001, TRENDS CELL BIOL, V11, P30; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Takenawa T, 2001, J CELL SCI, V114, P1801	5	21	22	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2003	348	4					350	351		10.1056/NEJMcibr001155	http://dx.doi.org/10.1056/NEJMcibr001155			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637JD	12540651				2022-12-28	WOS:000180507200013
J	Floel, A; Reilmann, R; Frese, A; Ludemann, P				Floel, A; Reilmann, R; Frese, A; Ludemann, P			Anticonvulsants for Creutzfeldt-Jakob disease?	LANCET			English	Editorial Material							DIAGNOSIS		Univ Munster, Dept Neurol, D-48129 Munster, Germany	University of Munster	Floel, A (corresponding author), Univ Munster, Dept Neurol, Albert Schweltzer Str 33, D-48129 Munster, Germany.		Floel, Agnes/A-9426-2017	Reilmann, Ralf/0000-0002-5904-9517				Henkel K, 2002, J NEUROL, V249, P699, DOI 10.1007/s00415-002-0695-3; Johnson RT, 1998, NEW ENGL J MED, V339, P1994, DOI 10.1056/NEJM199812313392707; Poser S, 1999, BRAIN, V122, P2345, DOI 10.1093/brain/122.12.2345; Steinhoff BJ, 1996, ARCH NEUROL-CHICAGO, V53, P162, DOI 10.1001/archneur.1996.00550020074017; Zerr I, 1998, ANN NEUROL, V43, P32, DOI 10.1002/ana.410430109	5	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					224	224		10.1016/S0140-6736(03)12273-8	http://dx.doi.org/10.1016/S0140-6736(03)12273-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547547				2022-12-28	WOS:000180535400013
J	Rooney, CM				Rooney, CM			New insights into EBV-associated post-transplant lymphoproliferative disease	LANCET			English	Editorial Material							EPSTEIN-BARR-VIRUS; CELLS; INFECTION; GENES		Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	Baylor College of Medicine	Rooney, CM (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.							GREGORY CD, 1987, EUR J IMMUNOL, V17, P1199, DOI 10.1002/eji.1830170818; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Helminen M, 1999, J INFECT DIS, V180, P496, DOI 10.1086/314883; Joseph AM, 2000, J IMMUNOL, V165, P2975, DOI 10.4049/jimmunol.165.6.2975; Kuppers R, 2002, ANN ONCOL, V13, P11, DOI 10.1093/annonc/13.S1.11; Nalesnik Michael A, 2002, Recent Results Cancer Res, V159, P9; Poppema S, 2000, SEMIN CANCER BIOL, V10, P345, DOI 10.1006/scbi.2000.0327; RICKINSON AB, 1974, INT J CANCER, V14, P704, DOI 10.1002/ijc.2910140603	8	2	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					192	193		10.1016/S0140-6736(03)12318-5	http://dx.doi.org/10.1016/S0140-6736(03)12318-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547538				2022-12-28	WOS:000180535400004
J	Barbour, DL; Wang, XQ				Barbour, DL; Wang, XQ			Contrast tuning in auditory cortex	SCIENCE			English	Article							TOPOGRAPHY; RESPONSES; NUCLEUS	The acoustic features useful for converting auditory information into perceived objects are poorly understood. Although auditory cortex neurons have been described as being narrowly tuned and preferentially responsive to narrowband signals, naturally occurring sounds are generally wideband with unique spectral energy profiles. Through the use of parametric wideband acoustic stimuli, we found that such neurons in awake marmoset monkeys respond vigorously to wideband sounds having complex spectral shapes, preferring stimuli of either high or low spectral contrast. Low contrast-preferring neurons cannot be studied thoroughly with narrowband stimuli and have not been previously described. These findings indicate that spectral contrast reflects an important stimulus decomposition in auditory cortex and may contribute to the recognition of acoustic objects.	Johns Hopkins Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Barbour, DL (corresponding author), Johns Hopkins Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, 720 Rutland Ave,424 Ross Bldg, Baltimore, MD 21205 USA.	dbarbour@bme.jhu.edu		Barbour, Dennis/0000-0003-0851-0665	NIDCD NIH HHS [R01 DC003180, DC-03180] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003180] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AITKIN LM, 1986, J COMP NEUROL, V252, P175, DOI 10.1002/cne.902520204; Barbour DL, 2002, J NEUROPHYSIOL, V88, P2684, DOI 10.1152/jn.00253.2002; CALHOUN BM, 1998, PSYCHOPHYSICAL PHYSL, P170; Dan Y, 1996, J NEUROSCI, V16, P3351; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; EHRET G, 1985, SCIENCE, V227, P1245, DOI 10.1126/science.3975613; EHRET G, 1988, BRAIN RES REV, V13, P139, DOI 10.1016/0165-0173(88)90018-5; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3524, DOI 10.1152/jn.1996.76.5.3524; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Schnupp JWH, 2001, NATURE, V414, P200, DOI 10.1038/35102568; Schreiner C.E., 1994, AUDIT NEUROSCI, V1, P39; SCHREINER CE, 1990, J NEUROPHYSIOL, V64, P1442, DOI 10.1152/jn.1990.64.5.1442; SCHREINER CE, 1992, J NEUROPHYSIOL, V68, P1487, DOI 10.1152/jn.1992.68.5.1487; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; SEIDEN HR, 1957, THESIS PRINCETON U P; SUGA N, 1988, AUDITORY FUNCTION NE, P679; Suga N., 1994, COGNITIVE NEUROSCIEN, P295; WANG X, 2003, P NATL ACAD SCI USA, V97, P11843; Young E. D., 1998, SYNAPTIC ORG BRAIN, P121; Young ED, 1998, P NATL ACAD SCI USA, V95, P933, DOI 10.1073/pnas.95.3.933; Yu JJ, 2000, P NATL ACAD SCI USA, V97, P11780, DOI 10.1073/pnas.97.22.11780	24	83	84	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2003	299	5609					1073	1075		10.1126/science.1080425	http://dx.doi.org/10.1126/science.1080425			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586943	Green Submitted, Green Accepted			2022-12-28	WOS:000180960000050
J	Mayhew, JEW				Mayhew, JEW			A measured look at neuronal oxygen consumption	SCIENCE			English	Editorial Material							IMAGING SPECTROSCOPY; INTRINSIC SIGNALS; BLOOD-FLOW		Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England	University of Sheffield	Mayhew, JEW (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England.							Ances BM, 2001, J CEREBR BLOOD F MET, V21, P511, DOI 10.1097/00004647-200105000-00005; Buxton RB, 2001, NEUROIMAGE, V13, P953, DOI 10.1006/nimg.2001.0814; ERNST T, 1994, MAGN RESON MED, V32, P146, DOI 10.1002/mrm.1910320122; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Jones M, 2001, NEUROIMAGE, V13, P1002, DOI 10.1006/nimg.2001.0808; Kim DS, 2000, NAT NEUROSCI, V3, P164, DOI 10.1038/72109; Kim SG, 2002, CURR OPIN NEUROBIOL, V12, P607, DOI 10.1016/S0959-4388(02)00355-0; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555	11	16	16	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1023	1024						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586929				2022-12-28	WOS:000180960000030
J	Redfern, A; Smart, J				Redfern, A; Smart, J			Cardiac rupture	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Southampton Gen Hosp, Southampton SO16 6YD, Hants, England	University of Southampton	Redfern, A (corresponding author), Southampton Gen Hosp, Southampton SO16 6YD, Hants, England.								0	5	5	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2003	348	7					609	609		10.1056/NEJMicm020504	http://dx.doi.org/10.1056/NEJMicm020504			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644HY	12584369				2022-12-28	WOS:000180912900006
J	Brown, GC				Brown, GC			NO says yes to mitochondria	SCIENCE			English	Editorial Material							NITRIC-OXIDE		Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge	Brown, GC (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.			Brown, Guy/0000-0002-3610-1730				Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7; Elfering SL, 2002, J BIOL CHEM, V277, P38079, DOI 10.1074/jbc.M205256200; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; HIBBS JB, 1987, J IMMUNOL, V138, P550; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Momken I, 2002, BIOCHEM J, V368, P341, DOI 10.1042/BJ20020591; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Nisoli E, 1998, BRIT J PHARMACOL, V125, P888, DOI 10.1038/sj.bjp.0702131; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3	10	58	63	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					838	839		10.1126/science.1082028	http://dx.doi.org/10.1126/science.1082028			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574611				2022-12-28	WOS:000180830900032
J	Friedman, JM				Friedman, JM			A war on obesity, not the obese	SCIENCE			English	Editorial Material							BODY-MASS INDEX; EARLY-ONSET OBESITY; DIABETES-MELLITUS; LIFE-STYLE; LEPTIN; WEIGHT; ADULTS; PREVALENCE; MUTATIONS; MORTALITY		Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Friedman, JM (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 New York Ave, New York, NY 10021 USA.	friedj@mail.rockefeller.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041096] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK41096] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison DB, 1996, INT J OBESITY, V20, P501; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Critser G., 2003, FAT LAND AM BECAME F; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Diamond, 1999, GUNS GERMS STEEL FAT; DIAMOND JM, 1992, NATURE, V357, P362, DOI 10.1038/357362a0; DOWSE GK, 1990, DIABETES, V39, P390, DOI 10.2337/diabetes.39.3.390; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; FAROOQI S, COMMUNICATION; FLEGAL K, COMMUNICATION; Flegal KM, 2000, INT J OBESITY, V24, P807, DOI 10.1038/sj.ijo.0801232; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; HOWARD BV, 1991, AM J CLIN NUTR, V53, pS1577, DOI 10.1093/ajcn/53.6.1577S; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Kumanyika Shiriki, 2002, Ethnicity and Disease, V12, P316; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Murray JE, 1997, J ECON HIST, V57, P585, DOI 10.1017/S0022050700113373; NEEL JV, 1962, AM J HUM GENET, V14, P353; RAVUSSIN E, 1995, METABOLISM, V44, P12, DOI 10.1016/0026-0495(95)90312-7; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wadden TA, 1998, J CLIN ENDOCR METAB, V83, P214, DOI 10.1210/jc.83.1.214; WEIGLE DS, 1994, FASEB J, V8, P302, DOI 10.1096/fasebj.8.3.8143936; Weiner, 1995, BEAK FINCH STORY EVO; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zimmet P, 1984, Diabetes Res, V1, P13; 2002, NY TIMES        1124	37	277	284	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					856	858		10.1126/science.1079856	http://dx.doi.org/10.1126/science.1079856			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574619				2022-12-28	WOS:000180830900040
J	Spence, JCH				Spence, JCH			Oxygen in crystals - Seeing is believing	SCIENCE			English	Editorial Material							ELECTRON-MICROSCOPY; RESOLUTION		Arizona State Univ, Dept Phys & Astron, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Spence, JCH (corresponding author), Arizona State Univ, Dept Phys & Astron, Tempe, AZ 85287 USA.							ALLPRESS JG, 1969, ACTA CRYSTALL B-STRU, VB 25, P1156, DOI 10.1107/S0567740869003669; ANDERSON JS, 1973, J CHEM SOC DALTON, P1107, DOI 10.1039/dt9730001107; Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; COENE W, 1992, PHYS REV LETT, V69, P3743, DOI 10.1103/PhysRevLett.69.3743; Copley J, 2001, NATURE, V410, P862, DOI 10.1038/35073794; GAI PL, 1997, INSITU MICROSCOPY MA; Haider M, 1998, NATURE, V392, P768, DOI 10.1038/33823; HORIUCHI S, 1993, J ELECTRON MICROSC, V42, P166; IIJIMA S, 1975, J SOLID STATE CHEM, V14, P52, DOI 10.1016/0022-4596(75)90361-8; Jia CL, 2003, SCIENCE, V299, P870, DOI 10.1126/science.1079121; NGUYEN N, 1981, J SOLID STATE CHEM, V39, P120, DOI 10.1016/0022-4596(81)90310-8; OURMAZD A, 1987, NATURE, V329, P425, DOI 10.1038/329425a0; Spence J.C.H., 2003, HIGH RESOLUTION ELEC, V3rd; Voyles PM, 2002, NATURE, V416, P826, DOI 10.1038/416826a	14	11	12	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					839	+						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574612				2022-12-28	WOS:000180830900033
J	Chan, CLH; Facer, P; Davis, JB; Smith, GD; Egerton, J; Bountra, C; Williams, NS; Anand, P				Chan, CLH; Facer, P; Davis, JB; Smith, GD; Egerton, J; Bountra, C; Williams, NS; Anand, P			Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency	LANCET			English	Article							RAT; IMMUNOREACTIVITY; DISTENSION; SENSATION; PEPTIDE; NEURONS	Background Faecal urgency and incontinence with rectal hypersensitivity is a distressing, unexplained disorder that is inadequately treated. We aimed to determine whether expression of the heat and capsaicin receptor vanilloid receptor 1 (TRPV1 or VR1) was changed in rectal sensory fibres, and to correlate nerve fibre density with sensory abnormalities. Methods We compared full-thickness rectal biopsy samples from nine patients with physiologically characterised rectal hypersensitivity with tissue samples from 12 controls. Sensory thresholds to rectal balloon distension and heating the rectal mucosa were measured before biopsy. We assessed specimens with immunohistochemistry and image analysis using specific antibodies to TRPV1; nerve growth factor (NGF) receptor tyrosine kinase A; glial cell line-derived neurotrophic factor (GDNF); neuropeptides calcitonin gene-related peptide (CGRP) and substance P; the related vanilloid receptor-like protein (VRL) 2; glial markers S-100 and glial fibrillary acid protein (GFAP); and the nerve structural marker peripherin. Findings In rectal hypersensitivity, nerve fibres immunoreactive to TRPV1 were increased in muscle, submucosal, and mucosal layers: in the mucosal layer, the median % area positive was 0.44 (range 0.30-0.59) in patients who were hypersensitive and 0.11 (0.00-0.21) in controls (p=0.0005). The numbers of peripherin-positive fibres also increased in the mucosal layer (hypersensitive 3.00 [1.80-6.50], controls 1.20 [0.39-2.10]: (p=0.0002). The increase in TRVP1 correlated significantly with the decrease in rectal heat (p=0.03) and the distension (p=0.02) sensory thresholds. The thresholds for heat and distension were also significantly correlated (p=0.0028). Expression of nerve fibres positive for GDNF (p=0.001) and tyrosine kinase A (p=0.002) was also increased, as were cell bodies of the submucosal ganglia immunoreactive to CGRP (P=0.0009). Interpretation Faecal urgency and rectal hypersensitivity could result from increased numbers of polymodal sensory nerve fibres expressing TRPV1. The triggering factor or factors remain uncertain, but drugs that target nerve terminals that express this receptor, such as topical resiniferatoxin, deserve consideration.	Hammersmith Hosp, Imperial Coll London, Div Neurosci & Psychol Med, Peripheral Neuropathy Unit, London W12 0NN, England; GlaxoSmithKline, Neurol CEDD, Harlow, Essex, England; Barts & London Queen Marys Sch Med & Dent, Acad Dept Surg, London, England	Imperial College London; GlaxoSmithKline; University of London; Queen Mary University London	Anand, P (corresponding author), Hammersmith Hosp, Imperial Coll London, Div Neurosci & Psychol Med, Peripheral Neuropathy Unit, Du Cane Rd, London W12 0NN, England.	p.anand@ic.ac.uk						Anavi-Goffer S, 2002, NEUROSCI LETT, V319, P53, DOI 10.1016/S0304-3940(01)02480-6; Avelino A, 2000, AUTON NEUROSCI-BASIC, V86, P37, DOI 10.1016/S1566-0702(00)00204-6; BREWER DB, 1990, J PATHOL, V161, P301, DOI 10.1002/path.1711610406; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CERVERO F, 1992, TRENDS NEUROSCI, V15, P374, DOI 10.1016/0166-2236(92)90182-8; CHAN CL, 2001, COLORECTAL DIS S, V3, P78; Dasgupta P, 2000, BJU INT, V85, P238, DOI 10.1046/j.1464-410x.2000.00427.x; DUTHIE HL, 1960, BRIT J SURG, V47, P585, DOI 10.1002/bjs.18004720602; FARTHING MJG, 1978, GUT, V19, P64, DOI 10.1136/gut.19.1.64; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; MAYER EA, 1994, GASTROENTEROLOGY, V107, P271, DOI 10.1016/0016-5085(94)90086-8; NAGY JI, 1982, NEUROSCIENCE, V7, P89, DOI 10.1016/0306-4522(82)90155-5; Peters RJ, 1998, J AUTONOM NERV SYST, V70, P115, DOI 10.1016/S0165-1838(98)00044-7; PILOWSKY I, 1984, GEN HOSP PSYCHIAT, V6, P123, DOI 10.1016/0163-8343(84)90070-7; Plourde V, 1997, AM J PHYSIOL-GASTR L, V273, pG191, DOI 10.1152/ajpgi.1997.273.1.G191; PRIOR A, 1992, GUT, V33, P264, DOI 10.1136/gut.33.2.264; Sloots CEJ, 2000, NEUROGASTROENT MOTIL, V12, P361; SNAITH RP, 1986, BMJ-BRIT MED J, V292, P344, DOI DOI 10.1136/BMJ.292.6516.344; Steer RA, 1999, GEN HOSP PSYCHIAT, V21, P106, DOI 10.1016/S0163-8343(98)00070-X; Su X, 1998, J NEUROPHYSIOL, V80, P2632, DOI 10.1152/jn.1998.80.5.2632; SUN WM, 1992, GUT, V33, P807, DOI 10.1136/gut.33.6.807; WALKER K, 2001, SOC NEUR ABSTR, V27; Williams NS, 2001, DIS COLON RECTUM, V44, P192, DOI 10.1007/BF02234292; WINNING AJ, 1986, CLIN SCI, V71, P519, DOI 10.1042/cs0710519; WINTER J, 1988, NEURON, V1, P973, DOI 10.1016/0896-6273(88)90154-7; Yiangou Y, 2001, LANCET, V357, P1338, DOI 10.1016/S0140-6736(00)04503-7	27	253	279	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2003	361	9355					385	391		10.1016/S0140-6736(03)12392-6	http://dx.doi.org/10.1016/S0140-6736(03)12392-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573376				2022-12-28	WOS:000180787000012
J	Abbott, A				Abbott, A			Italians riled by science reforms	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					465	465		10.1038/421465b	http://dx.doi.org/10.1038/421465b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556857	Bronze			2022-12-28	WOS:000180670600012
J	Weinberg, L; Sardesai, SH; Maskell, G; Mathew, J				Weinberg, L; Sardesai, SH; Maskell, G; Mathew, J			A mediastinal tumour	LANCET			English	Editorial Material									Royal Cornwall Hosp, Dept Anaesthet, Truro TR1 3LJ, Cornwall, England; Royal Cornwall Hosp, Dept Med, Truro TR1 3LJ, Cornwall, England; Royal Cornwall Hosp, Dept Radiol, Truro TR1 3LJ, Cornwall, England; Royal Cornwall Hosp, Dept Pathol, Truro TR1 3LJ, Cornwall, England	Royal Cornwall Hospital; Royal Cornwall Hospital; Royal Cornwall Hospital; Royal Cornwall Hospital	Weinberg, L (corresponding author), Royal Cornwall Hosp, Dept Anaesthet, Truro TR1 3LJ, Cornwall, England.			Weinberg, Laurence/0000-0001-7403-7680					0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					300	300		10.1016/S0140-6736(03)12343-4	http://dx.doi.org/10.1016/S0140-6736(03)12343-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559864				2022-12-28	WOS:000180643900011
J	Beghein, C; Trampert, J				Beghein, C; Trampert, J			Robust normal mode constraints on inner-core anisotropy from model space search	SCIENCE			English	Article							FREE OSCILLATIONS; NEIGHBORHOOD ALGORITHM; GEOPHYSICAL INVERSION; ASPHERICAL STRUCTURE; EARTH; TEMPERATURE; MULTIPLETS; IRON	A technique for searching full model space that was applied to measurements of anomalously split normal modes showed a robust pattern of P-wave and S-wave anisotropy in the inner core. The parameter describing P-wave anisotropy changes sign around a radius of 400 kilometers, whereas S-wave anisotropy is small in the upper two-thirds of the inner core and becomes negative at greater depths. Our results agree with observed travel-time anomalies of rays traveling at epicentral distances varying from 150degrees to 180degrees. The models may be explained by progressively tilted hexagonal close-packed iron in the upper half of the inner core and could suggest a different iron phase in the center.	Univ Utrecht, Fac Earth Sci, NL-3508 TA Utrecht, Netherlands	Utrecht University	Beghein, C (corresponding author), Univ Utrecht, Fac Earth Sci, POB 80021, NL-3508 TA Utrecht, Netherlands.		Beghein, Caroline/A-7516-2008; Beghein, Caroline/AAQ-6871-2021; Trampert, Jeannot/N-3240-2019; Trampert, Jeannot/B-8090-2015	Beghein, Caroline/0000-0002-3158-2213; Beghein, Caroline/0000-0002-3158-2213; Trampert, Jeannot/0000-0002-5868-9491; Trampert, Jeannot/0000-0002-5868-9491				BACKUS G, 1970, PHILOS TR R SOC S-A, V266, P123, DOI 10.1098/rsta.1970.0005; Beghein C, 2002, GEOPHYS J INT, V149, P646, DOI 10.1046/j.1365-246X.2002.01684.x; BIRCH F, 1964, J GEOPHYS RES, V69, P4377, DOI 10.1029/JZ069i020p04377; CREAGER KC, 2000, GEOPHYS MONOGR SER, V117, P89, DOI DOI 10.1029/GM117P0089; Durek JJ, 1999, GEOPHYS J INT, V139, P599, DOI 10.1046/j.1365-246x.1999.00961.x; Gessmann CK, 2002, EARTH PLANET SC LETT, V200, P63, DOI 10.1016/S0012-821X(02)00593-9; He X, 1996, J GEOPHYS RES-SOL EA, V101, P20053, DOI 10.1029/96JB01783; Ishii M, 2002, P NATL ACAD SCI USA, V99, P14026, DOI 10.1073/pnas.172508499; Li XD, 1996, J GEOPHYS RES-SOL EA, V101, P22245, DOI 10.1029/96JB01306; Lin JF, 2002, SCIENCE, V295, P313, DOI 10.1126/science.1066932; Love A.E.H., 1927, TREATISE MATH THEORY; Mao HK, 2001, SCIENCE, V292, P914, DOI 10.1126/science.1057670; Masters G, 1996, PHILOS T R SOC A, V354, P1385, DOI 10.1098/rsta.1996.0054; MASTERS G, 2000, GEOPHYS MONOGR SER, V117, P63, DOI DOI 10.1029/GM117P0063; MATSUURA M, 1982, J PHYS EARTH, V30, P451, DOI 10.4294/jpe1952.30.451; Mooney WD, 1998, J GEOPHYS RES-SOL EA, V103, P727, DOI 10.1029/97JB02122; MORELLI A, 1986, GEOPHYS RES LETT, V13, P1545, DOI 10.1029/GL013i013p01545; RESOVSKY J, 1999, UNPUB, V104, P993; Resovsky JS, 1998, J GEOPHYS RES-SOL EA, V103, P783, DOI 10.1029/97JB02482; Resovsky JS, 2002, GEOPHYS J INT, V150, P665, DOI 10.1046/j.1365-246X.2002.01727.x; Ritsema J, 1999, SCIENCE, V286, P1925, DOI 10.1126/science.286.5446.1925; RITZWOLLER M, 1988, J GEOPHYS RES-SOLID, V93, P6369, DOI 10.1029/JB093iB06p06369; Romanowicz B, 2000, J GEOPHYS RES-SOL EA, V105, P21559, DOI 10.1029/2000JB900144; Sambridge M, 1999, GEOPHYS J INT, V138, P727, DOI 10.1046/j.1365-246x.1999.00900.x; Sambridge M, 1999, GEOPHYS J INT, V138, P479, DOI 10.1046/j.1365-246X.1999.00876.x; Song XD, 1996, J GEOPHYS RES-SOL EA, V101, P16089, DOI 10.1029/96JB01152; Steinle-Neumann G, 2001, NATURE, V413, P57, DOI 10.1038/35092536; Stixrude L, 1997, J GEOPHYS RES-SOL EA, V102, P24729, DOI 10.1029/97JB02125; SU WJ, 1995, J GEOPHYS RES-SOL EA, V100, P9831, DOI 10.1029/95JB00746; SU WJ, 1994, J GEOPHYS RES-SOL EA, V99, P6945, DOI 10.1029/93JB03408; Sun XL, 2002, EARTH PLANET SC LETT, V199, P429, DOI 10.1016/S0012-821X(02)00580-0; TROMP J, 1993, NATURE, V366, P678, DOI 10.1038/366678a0; TROMP J, 1995, GEOPHYS J INT, V121, P963, DOI 10.1111/j.1365-246X.1995.tb06451.x; TROMP J, 1995, GEOPHYS RES LETT, V22, P2297, DOI 10.1029/95GL01810; Tromp J, 1995, GSA TODAY, V5, P137; WIDMER R, 1992, GEOPHYS J INT, V111, P559, DOI 10.1111/j.1365-246X.1992.tb02112.x; WOODHOUSE JH, 1986, GEOPHYS RES LETT, V13, P1549, DOI 10.1029/GL013i013p01549	37	106	109	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					552	555		10.1126/science.1078159	http://dx.doi.org/10.1126/science.1078159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543971	Green Submitted			2022-12-28	WOS:000180559800045
J	Gabrieli, JDE; Preston, AR				Gabrieli, JDE; Preston, AR			Visualizing genetic influences on human brain functions	CELL			English	Article							MEMORY; SCHIZOPHRENIA	Egan and colleagues (2003), in this issue of Cell, integrate genetics and functional brain imaging by showing that variation in the human brain-derived neurotrophic factor (BDNF) gene is associated with variation in episodic memory ability and in hippocampal neurochemistry and function.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Gabrieli, JDE (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.		Gabrieli, John/AAJ-2869-2020					Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Wilson RS, 1996, NEUROPSYCHOLOGY, V10, P459	8	5	5	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 24	2003	112	2					144	145		10.1016/S0092-8674(03)00039-4	http://dx.doi.org/10.1016/S0092-8674(03)00039-4			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553902	Bronze			2022-12-28	WOS:000181191600003
J	Burgio, GR; Gluckman, E; Locatelli, F				Burgio, GR; Gluckman, E; Locatelli, F			Ethical reappraisal of 15 years of cord-blood transplantation	LANCET			English	Review							BONE-MARROW; PREIMPLANTATION DIAGNOSIS; FANCONIS ANEMIA; LEUKEMIA; CHILDREN; BANKING; DISEASE; DONORS	Since the first successful use of cord blood as source of haemopoietic stem cells for transplantation in 1988, more than 2000 patients with malignant or non-malignant disorders have been treated with this procedure. Collection and storage of cord blood has prompted ethical considerations, mainly dealing with the issues of autonomy in making decisions about donation of cord blood, and of privacy and confidentiality in the tests required before use of placental cells for transplantation. The ethical implications of possible storage of cord-blood cells for autologous use has also been discussed. Preimplantation selection of HLA-matched embryos to obtain a donor of cells for cord-blood transplantation of a sibling with a life-threatening disease has raised the issue of the extent to which this approach complies with the principles of bioethics.	Hop St Louis, Serv Greffe Moelle, Paris, France; Univ Pavia, Policlin San Matteo, Ist Ricovero & Cura Carattere Sci, Dept Paediat, I-27100 Pavia, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; IRCCS Fondazione San Matteo; University of Pavia	Locatelli, F (corresponding author), Univ Pavia, Policlin San Matteo, Ist Ricovero & Cura Carattere Sci, Dept Paediat, Ple Golgi 2, I-27100 Pavia, Italy.							Alby N., 1987, REV MED PSYCHOSOM, V9, P15; Annas GJ, 1999, NEW ENGL J MED, V340, P1521, DOI 10.1056/NEJM199905133401923; Bauchamp TL, 1994, PRINCIPLES BIOMEDICA; BERTOLINI F, 1995, BLOOD, V85, P3361, DOI 10.1182/blood.V85.11.3361.bloodjournal85113361; BURGIO GR, 1987, LANCET, V1, P1484; Burgio GR, 2000, LANCET, V356, P1868, DOI 10.1016/S0140-6736(00)03254-2; Burgio GR, 1997, BONE MARROW TRANSPL, V19, P1163, DOI 10.1038/sj.bmt.1700825; Damewood MD, 2001, JAMA-J AM MED ASSOC, V285, P3143, DOI 10.1001/jama.285.24.3143; Dufour C, 2001, BRIT J HAEMATOL, V112, P796, DOI 10.1046/j.1365-2141.2001.02572.x; Ford AM, 1998, P NATL ACAD SCI USA, V95, P4584, DOI 10.1073/pnas.95.8.4584; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Gluckman E, 1997, NEW ENGL J MED, V337, P373, DOI 10.1056/NEJM199708073370602; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; HOROWITZ MM, 1990, BLOOD, V75, P555; *INT WORK GROUP PR, 2000, J ASSIST REPROD GEN, V17, P75; Jones HW, 1999, BEST PRACT RES CL OB, V13, P473, DOI 10.1053/beog.1999.0043; Locatelli F, 1999, BLOOD, V93, P3662; Marshall E, 1996, SCIENCE, V271, P586, DOI 10.1126/science.271.5249.586; Rocha V, 2000, NEW ENGL J MED, V342, P1846, DOI 10.1056/NEJM200006223422501; Sugarman J, 1997, JAMA-J AM MED ASSOC, V278, P938, DOI 10.1001/jama.278.11.938; Verlinsky Y, 2001, JAMA-J AM MED ASSOC, V285, P3130, DOI 10.1001/jama.285.24.3130; WAGNER JE, 1995, LANCET, V346, P214, DOI 10.1016/S0140-6736(95)91268-1	22	46	49	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					250	252		10.1016/S0140-6736(03)12276-3	http://dx.doi.org/10.1016/S0140-6736(03)12276-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547553				2022-12-28	WOS:000180535400028
J	Reissmann, S; Hochleitner, E; Wang, HF; Paschos, A; Lottspeich, F; Glass, RS; Bock, A				Reissmann, S; Hochleitner, E; Wang, HF; Paschos, A; Lottspeich, F; Glass, RS; Bock, A			Taming of a poison: Biosynthesis of the NiFe-hydrogenase cyanide ligands	SCIENCE			English	Article							MARINE	NiFe-hydrogenases have an Ni-Fe site in which the iron has one CO and two CN groups as ligands. Synthesis of the CN ligands requires the activity of two hydrogenase maturation proteins: HypF and HypE. HypF is a carbamoyltransferase that transfers the carbamoyl moiety of carbamoyladenylate to the COOH-terminal cysteine of HypE and thus forms an enzyme-thiocarbamate. HypE dehydrates the S-carbamoyl moiety in an adenosine triphosphate-dependent process to yield the enzyme thiocyanate. Chemical model reactions corroborate the feasibility of this unprecedented biosynthetic route and show that thiocyanates can donate CN to iron. This finding underscores a striking parallel between biochemistry and organometallic chemistry in the formation of an iron-cyano complex.	Univ Munich, Dept Biol 1, D-80638 Munich, Germany; Max Planck Inst Biochem, Prot Chem Abt, D-82152 Martinsried, Germany; Univ Arizona, Dept Chem, Tucson, AZ 85721 USA	University of Munich; Max Planck Society; University of Arizona	Bock, A (corresponding author), Univ Munich, Dept Biol 1, Maria Ward Str 1A, D-80638 Munich, Germany.							Blokesch M, 2002, BIOCHEM SOC T, V30, P674, DOI 10.1042/BST0300674; BURKHARDT G, 1965, J AM CHEM SOC, V87, P591, DOI 10.1021/ja01081a035; BUSETTO L, 1968, INORG CHIM ACTA, V2, P391; FREY M, 2001, HDB METALLOPROTEINS, P880; HAUSINGER RP, 1996, MECH METALLOCENTER A, P1; HOCHLEITNER E, UNPUB; JIMENEZ C, 1991, TETRAHEDRON, V47, P2097, DOI 10.1016/S0040-4020(01)96120-4; JUNGBAUER A, 1980, J ORGANOMET CHEM, V186, P361, DOI 10.1016/S0022-328X(00)82417-1; Lai CH, 1998, J AM CHEM SOC, V120, P10103, DOI 10.1021/ja982053a; Li CL, 1999, STRUCTURE, V7, P1155, DOI 10.1016/S0969-2126(99)80182-8; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Paschos A, 2001, FEBS LETT, V488, P9, DOI 10.1016/S0014-5793(00)02408-X; PASCHOS A, UNPUB; PHAM AT, 1991, TETRAHEDRON LETT, V32, P4843, DOI 10.1016/S0040-4039(00)93475-0; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; RANGANATHAN D, 1990, J ORG CHEM, V55, P2351, DOI 10.1021/jo00295a022; RIERA V, 1990, J ORGANOMET CHEM, V384, P339, DOI 10.1016/0022-328X(90)87126-X; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Simpson JS, 1998, TETRAHEDRON LETT, V39, P5819, DOI 10.1016/S0040-4039(98)01149-6; VANWAZER JR, 1996, J AM CHEM SOC, V88, P4415; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x	21	170	178	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1067	1070		10.1126/science.1080972	http://dx.doi.org/10.1126/science.1080972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586941				2022-12-28	WOS:000180960000048
J	Oto, M; Russell, AJC; McGonigal, A; Duncan, R				Oto, M; Russell, AJC; McGonigal, A; Duncan, R			Misdiagnosis of epilepsy in patients prescribed anticonvulsant drugs for other reasons	BRITISH MEDICAL JOURNAL			English	Review									So Gen Hosp, Inst Neurol Sci, W Scotland Reg Epilepsy Serv, Glasgow G51 4TF, Lanark, Scotland	University of Glasgow	Oto, M (corresponding author), So Gen Hosp, Inst Neurol Sci, W Scotland Reg Epilepsy Serv, Glasgow G51 4TF, Lanark, Scotland.		McGonigal, Aileen/V-3292-2018	McGonigal, Aileen/0000-0001-6775-5318				Barry JJ, 2000, EPILEPSIA, V41, P81, DOI 10.1111/j.1528-1157.2000.tb01509.x; BETTS T, 1990, LANCET, V336, P163, DOI 10.1016/0140-6736(90)91673-X; Francis PA, 1999, SEIZURE-EUR J EPILEP, V8, P53, DOI 10.1053/seiz.1998.0246; HOWELL SJL, 1989, Q J MED, V71, P507; LEIS AA, 1992, NEUROLOGY, V42, P95, DOI 10.1212/WNL.42.1.95; Malt UF, 2000, ACTA NEUROL SCAND, V102, P40; Smith D, 1999, QJM-INT J MED, V92, P15, DOI 10.1093/qjmed/92.1.15	7	8	8	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2003	326	7384					326	327		10.1136/bmj.326.7384.326	http://dx.doi.org/10.1136/bmj.326.7384.326			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645UD	12574049	Green Published			2022-12-28	WOS:000180997000023
J	Bower, P; Roland, M; Campbell, J; Mead, N				Bower, P; Roland, M; Campbell, J; Mead, N			Setting standards based on patients' views on access and continuity: secondary analysis of data from the general practice assessment survey	BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE; QUALITY; PRIORITIES	Objectives To examine patients' views on access and continuity in general practice to derive quality standards. Design Secondary analysis of data from general practice research studies and routine quality assessment activities undertaken by practices and primary care trusts. Setting General practice. Participants General practice patients. Results Satisfactory standards of access were next day appointments with general practitioners and a 6-10 minute wait for consultations to begin. A satisfactory level of continuity was seeing the same general practitioner "a lot of the time." Standards varied with the analytic method used and by sociodemographic group. Conclusions Standards expected by patients in primary care can be derived from linked report-assessment pairs. Patients may have expectations of access that are in excess of government targets. Patients also have high expectations of continuity of care. It is unclear the degree to which such standards are reliable or valid, how conflicts between access and continuity should be resolved, or how these standards relate to other priorities of patients such as high quality interpersonal care.	Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England; Peninsula Med Sch, Dept Gen Practice & Primary Care, Exeter EX2 5DW, Devon, England	University of Manchester; University of Exeter	Bower, P (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England.		Bower, Peter/A-1508-2011	Bower, Peter/0000-0001-9558-3349; Campbell, John/0000-0002-6752-3493				Bamford C, 1992, Qual Health Care, V1, P153, DOI 10.1136/qshc.1.3.153; Bower P, 2002, FAM PRACT, V19, P489, DOI 10.1093/fampra/19.5.489; Campbell JL, 2001, QUAL HEALTH CARE, V10, P90, DOI 10.1136/qhc.10.2.90; Campbell SM, 2001, BMJ-BRIT MED J, V323, P784, DOI 10.1136/bmj.323.7316.784; Campbell SM, 2000, SOC SCI MED, V51, P1611, DOI 10.1016/S0277-9536(00)00057-5; GROL R, 2000, PATIENTS EVALUATE GE; Gulliford Martin, 2002, J Health Serv Res Policy, V7, P186, DOI 10.1258/135581902760082517; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kearley KE, 2001, BRIT J GEN PRACT, V51, P712; Little P, 2001, BRIT MED J, V323, P908, DOI 10.1136/bmj.323.7318.908; MEAD N, 2002, THESIS U MANCHESTER; Neuberger J, 1998, BMJ-BRIT MED J, V317, P260, DOI 10.1136/bmj.317.7153.260; *NHS EX, 1998, 1 CLASS SERV QUAL NE; *NHS EX, 1999, NAT SURV NHS PAT; *PMS NAT EV TEAM, 2000, NAT EV 1 WAV NHS PER; Ramsay J, 2000, FAM PRACT, V17, P372, DOI 10.1093/fampra/17.5.372; Roland M., 2002, GEN PRACTICE ASSESSM; Salisbury C, 2002, BRIT J GEN PRACT, V52, P554; Scott A, 1999, SCOT J POLIT ECON, V46, P111, DOI 10.1111/1467-9485.00124; Scott A., 2001, EVIDENCE BASED PATIE, P66; Secretary of State for Health, 2000, NHS PLAN; SMITH CH, 1989, BRIT MED J, V299, P494, DOI 10.1136/bmj.299.6697.494; Stewart M, 2001, BRIT MED J, V322, P444, DOI 10.1136/bmj.322.7284.444; Vick S, 1998, J HEALTH ECON, V17, P587, DOI 10.1016/S0167-6296(97)00035-0; Wensing M, 1998, SOC SCI MED, V47, P1573, DOI 10.1016/S0277-9536(98)00222-6; Williamson C, 2000, QUAL HEALTH CARE, V9, P190, DOI 10.1136/qhc.9.3.190	26	57	60	1	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					258	260A		10.1136/bmj.326.7383.258	http://dx.doi.org/10.1136/bmj.326.7383.258			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560279	Bronze, Green Published			2022-12-28	WOS:000180908300022
J	Cheutin, T; McNairn, AJ; Jenuwein, T; Gilbert, DM; Singh, PB; Misteli, T				Cheutin, T; McNairn, AJ; Jenuwein, T; Gilbert, DM; Singh, PB; Misteli, T			Maintenance of stable heterochromatin domains by dynamic HP1 binding	SCIENCE			English	Article							MAMMALIAN-CELLS; HISTONE H3; LYSINE 9; CHROMATIN; PROTEINS; DROSOPHILA; YEAST; RNA	One function of heterochromatin is the epigenetic silencing by sequestration of genes into transcriptionally repressed nuclear neighborhoods. Heterochromatin protein 1 (HP1) is a major component of heterochromatin and thus is a candidate for establishing and maintaining the transcriptionally repressive heterochromatin structure. Here we demonstrate that maintenance of stable heterochromatin domains in living cells involves the transient binding and dynamic exchange of HP1 from chromatin. HP1 exchange kinetics correlate with the condensation level of chromatin and are dependent on the histone methyltransferase Suv39h. The chromodomain and the chromoshadow domain of HP1 are both required for binding to native chromatin in vivo, but they contribute differentially to binding in euchromatin and heterochromatin. These data argue against HP1 repression of transcription by formation of static, higher order oligomeric networks but support a dynamic competition model, and they demonstrate that heterochromatin is accessible to regulatory factors.	NCI, NIH, Bethesda, MD 20892 USA; SUNY Upstate Med Univ, Syracuse, NY 13210 USA; Inst Mol Pathol, A-1030 Vienna, Austria; Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.		Singh, Prim/G-1088-2014	Singh, Prim/0000-0002-9571-0974; McNairn, Adrian/0000-0003-4727-3770	NATIONAL CANCER INSTITUTE [ZIABC010309, Z01BC010309] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmad K, 2001, CELL, V104, P839, DOI 10.1016/S0092-8674(01)00281-1; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Cheng TH, 2000, GENE DEV, V14, P452; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Haaf T, 1996, EXP CELL RES, V224, P163, DOI 10.1006/excr.1996.0124; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kirschmann DA, 2000, CANCER RES, V60, P3359; Kourmouli N, 2000, EMBO J, V19, P6558, DOI 10.1093/emboj/19.23.6558; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LORENTZ A, 1994, GENE, V143, P139, DOI 10.1016/0378-1119(94)90619-X; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; NICKERSON JA, 1989, P NATL ACAD SCI USA, V86, P177, DOI 10.1073/pnas.86.1.177; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang GZ, 2000, MOL CELL BIOL, V20, P6970, DOI 10.1128/MCB.20.18.6970-6983.2000	24	486	491	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					721	725		10.1126/science.1078572	http://dx.doi.org/10.1126/science.1078572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560555				2022-12-28	WOS:000180687700052
J	Ramirez, AP				Ramirez, AP			Magic moments	NATURE			English	Editorial Material									Los Alamos Natl Lab, Mat Integrat Sci Lab, Los Alamos, NM 87545 USA; Los Alamos Natl Lab, Inst Complex Adapt Matter, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Ramirez, AP (corresponding author), Los Alamos Natl Lab, Mat Integrat Sci Lab, POB 1663, Los Alamos, NM 87545 USA.		Ramirez, Arthur/HGD-6619-2022					Harris MJ, 1997, PHYS REV LETT, V79, P2554, DOI 10.1103/PhysRevLett.79.2554; Ramirez AP., 2001, HDB MAGNETIC MAT, Vvol 13, P423, DOI DOI 10.1016/S1567-2719(01)13008-8; Wong GCL, 2000, SCIENCE, V288, P2035, DOI 10.1126/science.288.5473.2035	3	72	72	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					483	483		10.1038/421483a	http://dx.doi.org/10.1038/421483a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556870	Bronze			2022-12-28	WOS:000180670600024
J	Alder, NN; Theg, SM				Alder, NN; Theg, SM			Energetics of protein transport across biological membranes: A study of the thylakoid Delta pH-dependent/cpTat pathway	CELL			English	Article							TWIN-ARGININE MOTIF; ESCHERICHIA-COLI TRANSLOCASE; OXYGEN-EVOLVING COMPLEX; SIGNAL PEPTIDE; EXPORT PATHWAY; IN-VITRO; ELECTRON STOICHIOMETRY; ESSENTIAL COMPONENT; PRECURSOR PROTEINS; PH/TAT MACHINERY	Among the pathways for protein translocation across biological membranes, the DeltapH-dependent/Tat system is unusual in its sole reliance upon the transmembrane pH gradient to drive protein transport. The free energy cost of protein translocation via the chloroplast DeltapH-dependent/Tat pathway was measured by conducting in vitro transport assays with isolated thylakoids while concurrently monitoring energetic parameters. These experiments revealed a substrate-specific energetic barrier to cpTat-mediated transport as well as direct utilization of protons from the gradient, consistent with a H+/protein antiporter mechanism. The magnitude of proton flux was assayed by four independent approaches and averaged 7.9 x 10(4) protons released from the gradient per transported protein. This corresponds to a DeltaG(transport) of 6.9 x 10(5) W-mol protein translocated(-1), representing the utilization of an energetic equivalent of 10(4) molecules of ATP. At this cost, we estimate that the DeltapH-dependent/cpTat pathway utilizes approximately 3% of the total energy output of the chloroplast.	Univ Calif Davis, Div Biol Sci, Plant Biol Sect, Davis, CA 95616 USA	University of California System; University of California Davis	Theg, SM (corresponding author), Univ Calif Davis, Div Biol Sci, Plant Biol Sect, 1 Shields Ave, Davis, CA 95616 USA.	smtheg@ucdavis.edu		Alder, Nathan/0000-0003-4474-7803				Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Alder N ., 2002, THESIS U CALIFORNIA; Asai T, 1999, J BIOL CHEM, V274, P20075, DOI 10.1074/jbc.274.29.20075; Berghofer J, 1999, FEBS LETT, V460, P328, DOI 10.1016/S0014-5793(99)01365-4; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Berks BC, 2000, BBA-BIOENERGETICS, V1459, P325, DOI 10.1016/S0005-2728(00)00168-7; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Berry S, 1996, BBA-BIOENERGETICS, V1276, P51, DOI 10.1016/0005-2728(96)00031-X; Berry S, 1999, BBA-BIOENERGETICS, V1410, P248, DOI 10.1016/S0005-2728(99)00003-1; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Brink S, 1998, FEBS LETT, V434, P425, DOI 10.1016/S0014-5793(98)01028-X; BROCK IW, 1995, J BIOL CHEM, V270, P1657, DOI 10.1074/jbc.270.4.1657; CAPELLOS C, 1980, KINETIC SYSTEMS; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Chance B., 1967, METHODS ENZYMOL, V10, P641; Clark SA, 1997, MOL BIOL CELL, V8, P923, DOI 10.1091/mbc.8.5.923; CLINE K, 1992, J BIOL CHEM, V267, P2688; Cruz JA, 2001, BIOCHEMISTRY-US, V40, P1226, DOI 10.1021/bi0018741; DRIESSEN AJM, 1991, P NATL ACAD SCI USA, V88, P2471, DOI 10.1073/pnas.88.6.2471; DRIESSEN AJM, 1992, EMBO J, V11, P847, DOI 10.1002/j.1460-2075.1992.tb05122.x; Duong F, 1997, CELL, V91, P567, DOI 10.1016/S0092-8674(00)80444-4; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; GRZESIEK S, 1988, BIOCHIM BIOPHYS ACTA, V938, P411, DOI 10.1016/0005-2736(88)90139-3; Halbig D, 1999, EUR J BIOCHEM, V263, P543, DOI 10.1046/j.1432-1327.1999.00536.x; Herrmann JM, 2000, BBA-BIOENERGETICS, V1459, P331, DOI 10.1016/S0005-2728(00)00169-9; Holroyd C, 2001, FEBS LETT, V501, P6, DOI 10.1016/S0014-5793(01)02617-5; Hynds PJ, 1998, J BIOL CHEM, V273, P34868, DOI 10.1074/jbc.273.52.34868; JUNGE W, 1979, BIOCHIM BIOPHYS ACTA, V546, P121, DOI 10.1016/0005-2728(79)90175-0; JUNGE W, 1989, ANN NY ACAD SCI, V574, P268; KAWASAKI S, 1993, J BIOL CHEM, V268, P8193; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; Kramer DM, 1999, PHOTOSYNTH RES, V60, P151, DOI 10.1023/A:1006212014787; Leheny EA, 1998, PLANT PHYSIOL, V116, P805, DOI 10.1104/pp.116.2.805; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Lyman SK, 1997, CELL, V88, P85, DOI 10.1016/S0092-8674(00)81861-9; Ma XY, 2000, J BIOL CHEM, V275, P10016, DOI 10.1074/jbc.275.14.10016; MARTIN J, 1991, J BIOL CHEM, V266, P18051; MEISTER M, 1987, CELL, V49, P643, DOI 10.1016/0092-8674(87)90540-X; Mills J. D., 1986, Photosynthesis: energy transduction: a practical approach, P143; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Mori H, 1999, J CELL BIOL, V146, P45, DOI 10.1083/jcb.146.1.45; Mori H, 2001, FEBS LETT, V501, P65, DOI 10.1016/S0014-5793(01)02626-6; MOULD RM, 1991, J BIOL CHEM, V266, P12189; Musser SM, 2000, BIOCHEMISTRY-US, V39, P8228, DOI 10.1021/bi000115f; Musser SM, 2000, EUR J BIOCHEM, V267, P2588, DOI 10.1046/j.1432-1327.2000.01269.x; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; NISHIMURA H, 1993, LASER PART BEAMS, V11, P89, DOI 10.1017/S0263034600006947; Nishiyama K, 1999, EMBO J, V18, P1049, DOI 10.1093/emboj/18.4.1049; Nouwen N, 1996, MOL MICROBIOL, V19, P1205, DOI 10.1111/j.1365-2958.1996.tb02466.x; PROKS P, 1992, GEN PHYSL BIOPHYS, V11, P411; Rapoport TA, 1999, BIOL CHEM, V380, P1143, DOI 10.1515/BC.1999.145; Robinson C, 2001, NAT REV MOL CELL BIO, V2, P350, DOI 10.1038/35073038; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Roffey RA, 1996, PLANT PHYSIOL, V111, P1329, DOI 10.1104/pp.111.4.1329; ROTTENBERG H, 1979, BIOCHIM BIOPHYS ACTA, V549, P225, DOI 10.1016/0304-4173(79)90001-6; ROTTENBERG H, 1973, BIOPHYS J, V13, P503, DOI 10.1016/S0006-3495(73)86004-7; RUMBERG B, 1976, BIOELECTROCH BIOENER, V3, P393, DOI 10.1016/0302-4598(76)80033-5; Sacksteder CA, 2000, P NATL ACAD SCI USA, V97, P14283, DOI 10.1073/pnas.97.26.14283; Sanders C, 2001, MOL MICROBIOL, V41, P241, DOI 10.1046/j.1365-2958.2001.02514.x; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 2001, EUR J BIOCHEM, V268, P3361, DOI 10.1046/j.1432-1327.2001.02263.x; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SCHONKNECHT G, 1990, FEBS LETT, V277, P65, DOI 10.1016/0014-5793(90)80810-6; SCHULDINER S, 1972, EUR J BIOCHEM, V25, P64, DOI 10.1111/j.1432-1033.1972.tb01667.x; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; SHIOZUKA K, 1990, J BIOL CHEM, V265, P18843; SIGALAT C, 1993, BIOCHEMISTRY-US, V32, P10193, DOI 10.1021/bi00089a040; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; TANI K, 1990, J BIOL CHEM, V265, P17341; Teter SA, 1998, P NATL ACAD SCI USA, V95, P1590, DOI 10.1073/pnas.95.4.1590; THEG SM, 1989, J BIOL CHEM, V264, P6730; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; van Dalen A, 1999, J BIOL CHEM, V274, P19913, DOI 10.1074/jbc.274.28.19913; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; VREDENBERG WJ, 1976, INTACT CHLOROPLAST; Walker MB, 1999, J CELL BIOL, V147, P267, DOI 10.1083/jcb.147.2.267; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; WICKNER WT, 1994, SCIENCE, V266, P1197, DOI 10.1126/science.7973701; Yahr TL, 2001, EMBO J, V20, P2472, DOI 10.1093/emboj/20.10.2472	82	83	87	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 24	2003	112	2					231	242		10.1016/S0092-8674(03)00032-1	http://dx.doi.org/10.1016/S0092-8674(03)00032-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553911	Bronze			2022-12-28	WOS:000181191600012
J	Dalton, R				Dalton, R			Researcher uncovers truth behind wartime security slur	NATURE			English	News Item																		Munk W., 2002, OCEANOGRAPHY, V15, P7, DOI DOI 10.5670/OCEANOG.2002.02; Oreskes N, 2000, STUD HIST PHILOS M P, V31B, P309, DOI 10.1016/S1355-2198(00)00019-8	2	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					303	303		10.1038/421303b	http://dx.doi.org/10.1038/421303b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540864	Bronze			2022-12-28	WOS:000180533000008
J	Xu, X; Zhou, ZH; Wang, XL; Kuang, XW; Zhang, FC; Du, XK				Xu, X; Zhou, ZH; Wang, XL; Kuang, XW; Zhang, FC; Du, XK			Four-winged dinosaurs from China	NATURE			English	Article							EARLY EVOLUTION; ORIGIN; BIRD; ARCHAEOPTERYX; PALEONTOLOGY; FEATHERS; FLIGHT	Although the dinosaurian hypothesis of bird origins is widely accepted, debate remains about how the ancestor of birds first learned to fly. Here we provide new evidence suggesting that basal dromaeosaurid dinosaurs were four-winged animals and probably could glide, representing an intermediate stage towards the active, flapping-flight stage. The new discovery conforms to the predictions of early hypotheses that proavians passed through a tetrapteryx stage.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Tianjin Museum Nat Hist, Tianjin 300074, Peoples R China; Beijing Univ, Peoples Hosp, Dept Radiol, Beijing 100044, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Peking University	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	xing_xu@sina.com						Arnold EN, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P195; BEEBE CW, 1915, TETRAPTERYX STAGE AN; BOCK WJ, 1986, MEM CALIF ACAD SCI, V8, P57; Burgers P, 1999, NATURE, V399, P60, DOI 10.1038/19967; Burns T, 2000, HIST HUM SCI, V13, P1, DOI 10.1177/09526950022120845; Chatterjee S., 1997, THE RISE OF BIRDS; Chiappe LM, 1999, B AM MUS NAT HIST, P3; CURRIE PJ, 1985, CAN J EARTH SCI, V22, P1643, DOI 10.1139/e85-173; FEDUCCIA A, 1979, SCIENCE, V203, P1021, DOI 10.1126/science.203.4384.1021; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; HEILMANN G, 1927, ORIGIN BIRDS; Holtz Jr T. R., 2000, GAIA, V15, P5; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Jones TD, 2000, NATURE, V406, P716, DOI 10.1038/35021041; Makovicky Peter J., 1998, American Museum Novitates, V3240, P1; Norberg U.M., 1985, P293; NORBERG UM, 1985, AM NAT, V126, P303, DOI 10.1086/284419; Norberg UML, 1990, VERTEBRATE FLIGHT; Norell M, 2002, NATURE, V416, P36, DOI 10.1038/416036a; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; Norell MA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P49; Norell Mark A., 1997, American Museum Novitates, V3215, P1; Novas FE, 1997, NATURE, V387, P390, DOI 10.1038/387390a0; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; OSTROM JH, 1986, MEM CALIF ACAD SCI, V8, P73; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; Rayner J.M.V., 1985, P289; Rayner J.M.V., 1985, P279; Rowe T, 2001, NATURE, V410, P539, DOI 10.1038/35069145; Sanz JL, 1996, NATURE, V382, P442, DOI 10.1038/382442a0; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 1992, SCIENCE, V255, P845, DOI 10.1126/science.255.5046.845; SMITH PE, 1995, CAN J EARTH SCI, V32, P1426, DOI 10.1139/e95-115; SPEAKMAN JR, 1994, NATURE, V370, P514, DOI 10.1038/370514a0; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X., 2002, THESIS CHINESE ACAD; Yalden D.W., 1997, Archaeopteryx, V15, P107; Zhang FC, 2000, SCIENCE, V290, P1955, DOI 10.1126/science.290.5498.1955; Zhang Xiao-Hong, 2001, Vertebrata Palasiatica, V39, P282; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P237	46	321	364	8	261	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					335	340		10.1038/nature01342	http://dx.doi.org/10.1038/nature01342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540892	Green Published			2022-12-28	WOS:000180533000032
J	Kovacs, JA				Kovacs, JA			How iron activates O-2	SCIENCE			English	Editorial Material							STRUCTURAL-CHARACTERIZATION; ELECTRONIC-STRUCTURE; NONHEME; DIOXYGEN; PATHWAY		Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kovacs, JA (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	kovacs@chem.washington.edu	Kovacs, Julie A./G-5792-2015	Kovacs, Julie A./0000-0003-2358-1269				Chen K, 2002, J CHEM SOC DALTON, P672, DOI 10.1039/b108629d; Harris DL, 1998, J AM CHEM SOC, V120, P8941, DOI 10.1021/ja981059x; Ho RYN, 1999, CHEM COMMUN, P2161, DOI 10.1039/a905535e; Jenney FE, 1999, SCIENCE, V286, P306, DOI 10.1126/science.286.5438.306; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; MacBeth CE, 2000, SCIENCE, V289, P938, DOI 10.1126/science.289.5481.938; Neese F, 1998, J AM CHEM SOC, V120, P12829, DOI 10.1021/ja981561h; Newcomb M, 2000, J AM CHEM SOC, V122, P2677, DOI 10.1021/ja994106+; PENNERHAHN JE, 1986, J AM CHEM SOC, V108, P7819, DOI 10.1021/ja00284a054; Que L, 2000, NAT STRUCT BIOL, V7, P182, DOI 10.1038/73270; Que L, 1996, CHEM REV, V96, P2607, DOI 10.1021/cr960039f; Rohde JU, 2003, SCIENCE, V299, P1037, DOI 10.1126/science.299.5609.1037; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Shearer J, 2002, J AM CHEM SOC, V124, P11709, DOI 10.1021/ja012722b; Solomon EI, 2001, INORG CHEM, V40, P3656, DOI 10.1021/ic010348a	15	63	66	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2003	299	5609					1024	1025		10.1126/science.1081792	http://dx.doi.org/10.1126/science.1081792			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586930				2022-12-28	WOS:000180960000031
J	Norberg, A; Christopher, NC; Ramundo, ML; Bower, JR; Berman, SA				Norberg, A; Christopher, NC; Ramundo, ML; Bower, JR; Berman, SA			Contamination rates of blood cultures obtained by dedicated phlebotomy vs intravenous catheter	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-CONTROL METHODS; OCCULT BACTEREMIA; FEBRILE CHILDREN; HOSPITAL EPIDEMIOLOGY; RESOURCE UTILIZATION; PEDIATRIC EMERGENCY; INFECTION-CONTROL; DECISION-ANALYSIS; RISK; MANAGEMENT	Context Blood culture is the criterion standard for identifying children with bacteremia. However, elevated false-positive rates are common and are associated with substantial health care costs. Objective To compare contamination rates in blood culture specimens obtained from separate sites vs through newly inserted intravenous catheters. Design, Setting, and Participants Observational study conducted January 1998 through December 1999 among patients aged 18 years or younger who were seen at a US children's hospital emergency department and had a blood culture obtained as part of their care. Medical records were reviewed in all cases with a positive blood culture. Patients with indwelling vascular catheters were excluded. Intervention All phlebotomy was performed by emergency department registered nurses. During the baseline phase, blood specimens for culture were obtained simultaneously with intravenous catheter insertion. During the postintervention phase, specimens were obtained by a separate, dedicated procedure. Main Outcome Measure Contamination rate in the postintervention period compared with the baseline period. Results A total of 4108 blood cultures were evaluated, including 2108 during the baseline phase and 2000 in the postintervention phase. The false-positive blood culture rate decreased from 9.1% to 2.8% (P<.001). A statistical process control chart demonstrated a steady-state process in the baseline phase and the establishment of a significantly improved steady state in the postintervention phase. Young age was associated with increased contamination rate in both the baseline and postintervention periods. Conclusion Blood culture contamination rates were lower when specimens were drawn from a separate site compared with when they were drawn through a newly inserted intravenous catheter.	Childrens Hosp, Med Ctr, Div Emergency Med, Dept Pediat, Akron, OH 44308 USA; Childrens Hosp, Med Ctr, Div Infect Dis, Dept Pediat, Akron, OH 44308 USA; NE Ohio Univ, Coll Med, Dept Emergency Med, Rootstown, OH 44272 USA; NE Ohio Univ, Coll Med, Dept Pediat, Rootstown, OH 44272 USA	Akron Children's Hospital; Akron Children's Hospital; Northeast Ohio Medical University (NEOMED); Northeast Ohio Medical University (NEOMED)	Christopher, NC (corresponding author), Childrens Hosp, Med Ctr, Div Emergency Med, Dept Pediat, 1 Perkins Sq, Akron, OH 44308 USA.							Alpern ER, 2000, PEDIATRICS, V106, P505, DOI 10.1542/peds.106.3.505; BARAFF LJ, 1993, ANN EMERG MED, V22, P1198, DOI 10.1016/S0196-0644(05)80991-6; BATES DW, 1991, JAMA-J AM MED ASSOC, V265, P365, DOI 10.1001/jama.265.3.365; Benneyan JC, 1998, INFECT CONT HOSP EP, V19, P265; Benneyan JC, 1998, INFECT CONT HOSP EP, V19, P194; CAMPOS JM, 1989, EUR J CLIN MICROBIOL, V8, P815, DOI 10.1007/BF02185854; DOWNS SM, 1991, J PEDIATR-US, V118, P11, DOI 10.1016/S0022-3476(05)81837-2; Humble C, 1998, INFECT CONT HOSP EP, V19, P865; ISAACMAN DJ, 1990, PEDIATR INFECT DIS J, V9, P815, DOI 10.1097/00006454-199011000-00007; KORNBERG AE, 1994, PEDIATR EMERG CARE, V10, P20, DOI 10.1097/00006565-199402000-00006; KOSKA MT, 1992, HOSPITALS, V66, P62; Kuppermann N, 1999, PEDIATR CLIN N AM, V46, P1073, DOI 10.1016/S0031-3955(05)70176-0; Lee GM, 1998, ARCH PEDIAT ADOL MED, V152, P624; LIEU TA, 1991, J PEDIATR-US, V118, P21, DOI 10.1016/S0022-3476(05)81838-4; MYLOTTE JM, 1989, INFECT CONT HOSP EP, V10, P455; NELSON DS, 1992, PEDIATRICS, V90, P5; Ramsook C, 2000, INFECT CONT HOSP EP, V21, P649, DOI 10.1086/501708; Schwab R A, 1999, J Healthc Qual, V21, P38; Segal GS, 2000, ARCH PEDIAT ADOL MED, V154, P469, DOI 10.1001/archpedi.154.5.469; SMART D, 1993, ANN EMERG MED, V22, P1164, DOI 10.1016/S0196-0644(05)80983-7; Thuler LCS, 1997, PEDIATR INFECT DIS J, V16, P846, DOI 10.1097/00006454-199709000-00006; TONNESEN A, 1976, JAMA-J AM MED ASSOC, V235, P1877, DOI 10.1001/jama.235.17.1877; Weinbaum FI, 1997, J CLIN MICROBIOL, V35, P563, DOI 10.1128/JCM.35.3.563-565.1997; Yamamoto LG, 1998, AM J EMERG MED, V16, P193, DOI 10.1016/S0735-6757(98)90047-X	24	89	100	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2003	289	6					726	729		10.1001/jama.289.6.726	http://dx.doi.org/10.1001/jama.289.6.726			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643WP	12585951	Bronze			2022-12-28	WOS:000180886000027
J	Kochendoerfer, GG; Chen, SY; Mao, F; Cressman, S; Traviglia, S; Shao, HY; Hunter, CL; Low, DW; Cagle, EN; Carnevali, M; Gueriguian, V; Keogh, PJ; Porter, H; Stratton, SM; Wiedeke, MC; Wilken, J; Tang, J; Levy, JJ; Miranda, LP; Crnogorac, MM; Kalbag, S; Botti, P; Schindler-Horvat, J; Savatski, L; Adamson, JW; Kung, A; Kent, SBH; Bradburne, JA				Kochendoerfer, GG; Chen, SY; Mao, F; Cressman, S; Traviglia, S; Shao, HY; Hunter, CL; Low, DW; Cagle, EN; Carnevali, M; Gueriguian, V; Keogh, PJ; Porter, H; Stratton, SM; Wiedeke, MC; Wilken, J; Tang, J; Levy, JJ; Miranda, LP; Crnogorac, MM; Kalbag, S; Botti, P; Schindler-Horvat, J; Savatski, L; Adamson, JW; Kung, A; Kent, SBH; Bradburne, JA			Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis protein	SCIENCE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; POLYETHYLENE-GLYCOL; TRANSFER-RNAS; LIGATION; CSF	We report the design and total chemical synthesis of "synthetic erythropoiesis protein" (SEP), a 51-kilodalton protein-polymer construct consisting of a 166-amino-acid polypeptide chain and two covalently attached, branched, and monodisperse polymer moieties that are negatively charged. The ability to control the chemistry allowed us to synthesize a macromolecule of precisely defined covalent structure. SEP was homogeneous as shown by high-resolution analytical techniques, with a mass of 50,825+/-10 daltons by electrospray mass spectrometry, and with a pI of 5.0. In cell and animal assays for erythropoiesis, SEP displayed potent biological activity and had significantly prolonged duration of action in vivo. These chemical methods are a powerful tool in the rational design of protein constructs with potential therapeutic applications.	Gryphon Therapeut, San Francisco, CA 94080 USA; Blood Ctr SE Wisconsin Inc, Blood Res Inst, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin	Kochendoerfer, GG (corresponding author), Gryphon Therapeut, 250 E Grand Ave,Suite 90, San Francisco, CA 94080 USA.		Mao, Feng/B-8280-2019					Bailon P, 2001, BIOCONJUGATE CHEM, V12, P195, DOI 10.1021/bc000082g; Clark R, 1996, J BIOL CHEM, V271, P21969, DOI 10.1074/jbc.271.36.21969; Cload ST, 1996, CHEM BIOL, V3, P1033, DOI 10.1016/S1074-5521(96)90169-6; DAVIS JM, 1987, BIOCHEMISTRY-US, V26, P2633, DOI 10.1021/bi00383a034; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; Egrie JC, 2001, BRIT J CANCER, V84, P3, DOI 10.1054/bjoc.2001.1746; Eliason JF, 2001, BIODRUGS, V15, P705, DOI 10.2165/00063030-200115110-00001; FUKUDA MN, 1989, BLOOD, V73, P84; JACOBS K, 1985, NATURE, V313, P806, DOI 10.1038/313806a0; KOCHENDOERFER G, UNPUB; Kochendoerfer G G, 2001, Curr Opin Drug Discov Devel, V4, P205; KOMATSU N, 1993, BLOOD, V82, P456; LAI PH, 1986, J BIOL CHEM, V261, P3116; MAO F, UNPUB; MISAIZU T, 1995, BLOOD, V86, P4097, DOI 10.1182/blood.V86.11.4097.bloodjournal86114097; Morstyn G, 2001, ACTA HAEMATOL-BASEL, V105, P151, DOI 10.1159/000046557; Rose K, 1999, J AM CHEM SOC, V121, P7034, DOI 10.1021/ja9909879; ROSE K, 1994, J AM CHEM SOC, V116, P30, DOI 10.1021/ja00080a004; SAXENA VP, 1970, BIOCHEMISTRY-US, V9, P5015; SCHNOLZER M, 1992, SCIENCE, V256, P221, DOI 10.1126/science.1566069; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; SPIVAK JL, 1989, BLOOD, V73, P90; TSUTSUMI Y, 1994, JPN J CANCER RES, V85, P9, DOI 10.1111/j.1349-7006.1994.tb02879.x; Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9; Wang L, 2001, CHEM BIOL, V8, P883, DOI 10.1016/S1074-5521(01)00063-1; YAMASAKI M, 1994, J BIOCHEM-TOKYO, V115, P814, DOI 10.1093/oxfordjournals.jbchem.a124421	27	271	307	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					884	887		10.1126/science.1079085	http://dx.doi.org/10.1126/science.1079085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574628				2022-12-28	WOS:000180830900050
J	Mohler, PJ; Schott, JJ; Gramolini, AO; Dilly, KW; Guatimosim, S; duBell, WH; Haurogne, K; Kyndt, F; Ali, ME; Rogers, TB; Lederer, WJ; Escande, D; Le Marec, H; Bennett, V				Mohler, PJ; Schott, JJ; Gramolini, AO; Dilly, KW; Guatimosim, S; duBell, WH; Haurogne, K; Kyndt, F; Ali, ME; Rogers, TB; Lederer, WJ; Escande, D; Le Marec, H; Bennett, V			Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death	NATURE			English	Article							SODIUM-CALCIUM EXCHANGE; VENTRICULAR MYOCYTES; SPECTRIN; CHANNELS; GENE	Mutations in ion channels involved in the generation and termination of action potentials constitute a family of molecular defects that underlie fatal cardiac arrhythmias in inherited long-QT syndrome(1). We report here that a loss-of-function (E1425G) mutation in ankyrin-B (also known as ankyrin(2)), a member of a family of versatile membrane adapters(2),causes dominantly inherited type 4 long-QT cardiac arrhythmia in humans. Mice heterozygous for a null mutation in ankyrin-B are haploinsufficient and display arrhythmia similar to humans. Mutation of ankyrin-B results in disruption in the cellular organization of the sodium pump, the sodium/calcium exchanger, and inositol-1,4,5-trisphosphate receptors (all ankyrin-B-binding proteins), which reduces the targeting of these proteins to the transverse tubules as well as reducing overall protein level. Ankyrin-B mutation also leads to altered Ca2+ signalling in adult cardiomyocytes that results in extrasystoles, and provides a rationale for the arrhythmia. Thus, we identify a new mechanism for cardiac arrhythmia due to abnormal coordination of multiple functionally related ion channels and transporters.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurosci, Durham, NC 27710 USA; Hop Hotel Dieu, INSERM, U533, Lab Physiopathol & Pharmacol Cellulaires & Mol, Paris, France; Hosp G&R Laennec, Dept Cardiol, Nantes, France; Univ Maryland, Inst Biotechnol, Ctr Med Biotechnol, Baltimore, MD 21021 USA; Univ Maryland, Inst Biotechnol, Dept Physiol, Baltimore, MD 21021 USA; Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21021 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bennett, V (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.		Guatimosim, Silvia/AAN-7441-2021; Schott, jean-Jacques/F-8842-2013; Le Marec, Hervé/D-2718-2015; Lederer, William/B-1285-2010; KYNDT, Florence/D-6370-2015	Guatimosim, Silvia/0000-0001-8386-3722; Schott, jean-Jacques/0000-0002-9578-9475; Le Marec, Hervé/0000-0002-8288-8693; KYNDT, Florence/0000-0001-6651-1696; Song, Long-Sheng/0000-0002-6035-8106				Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bers DM, 2001, EXCITATION CONTRACTI; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Casimiro MC, 2001, P NATL ACAD SCI USA, V98, P2526, DOI 10.1073/pnas.041398998; duBell WH, 1996, J PHYSIOL-LONDON, V493, P793, DOI 10.1113/jphysiol.1996.sp021423; FRANK JS, 1997, MYOCARDIUM, P1; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Marks AR, 2002, J CELL PHYSIOL, V190, P1, DOI 10.1002/jcp.10031; Mohler PJ, 2002, J CELL SCI, V115, P1565; Mohler PJ, 2002, J BIOL CHEM, V277, P10599, DOI 10.1074/jbc.M110958200; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Reuter H, 2002, CIRC RES, V90, P305, DOI 10.1161/hh0302.104562; Santana LF, 1997, J PHYSIOL-LONDON, V503, P21, DOI 10.1111/j.1469-7793.1997.021bi.x; Santana LF, 1998, SCIENCE, V279, P1027, DOI 10.1126/science.279.5353.1027; SCHOTT JJ, 1995, AM J HUM GENET, V57, P1114; Towbin JA, 2001, AM J MED, V110, P385, DOI 10.1016/S0002-9343(00)00715-4; Tuvia S, 1999, J CELL BIOL, V147, P995, DOI 10.1083/jcb.147.5.995	19	716	759	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					634	639		10.1038/nature01335	http://dx.doi.org/10.1038/nature01335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571597				2022-12-28	WOS:000180803200043
J	Li, J; Precht, DH; Mortensen, PB; Olsen, J				Li, J; Precht, DH; Mortensen, PB; Olsen, J			Mortality in parents after death of a child in Denmark: a nationwide follow-up study	LANCET			English	Article							CONJUGAL BEREAVEMENT; CANCER INCIDENCE; STRESS; LIFE; EDUCATION; SMOKING; ADULTS; COHORT; SPOUSE; RISK	Background Little is known about the effect of parental bereavement on physical health. We investigated whether the death of a child increased mortality in parents. Methods We undertook a follow-up study based on national registers. From 1980 to 1996, we enrolled 21062 parents in Denmark who had a child who had died (exposed cohort), and 293 745 controls-ie, parents whose children were alive, and whose family structure matched that of the exposed cohort. Natural deaths were defined with ICD8 codes 0000-7969 and ICD10 codes A00-R99, and unnatural deaths with codes 8000-9999 and V01-Y98. We used Cox's proportional-hazards regression models to assess the mortality rate, of parents up to 18 years after bereavement. Findings We observed an increased overall mortality rate in mothers whose child had died (hazards ratio 1.43, 95% CI 1.24-1.64; p<0.0001). An excess mortality from natural causes (1.44, 1.15-1.78; p<0.0001) was noted in mothers only during the 10th-18th year of follow-up. Mothers had increased mortality rates from unnatural causes throughout follow-up, with the highest rate recorded during the first 3 years (3.84,.2.48-5.88; p<0.0001). Bereaved fathers had only an early excess mortality from unnatural causes (1.57, 1.06-2.32; p=0.04). Mothers who lost a child due to an unnatural death or an unexpected death had a hazard ratio of 1.72 (1.38-2.15; p=0.0040) and 1.67 (1.37-2.03; p=0.0037), respectively. Interpretation The death of a child is associated with an overall increased mortality from both natural and unnatural causes in mothers, and an early increased mortality from unnatural causes in fathers.	Aarhus Univ, Danish Epidemiol Sci Ctr, DK-8000 Aarhus, Denmark; Aarhus Univ, Natl Ctr Register Based Res, DK-8000 Aarhus, Denmark; Natl Inst Publ Hlth, Copenhagen, Denmark	Aarhus University; Aarhus University	Olsen, J (corresponding author), Aarhus Univ, Danish Epidemiol Sci Ctr, DK-8000 Aarhus, Denmark.		Mortensen, Preben B/D-2358-2015; Harding, Richard/G-9729-2012; li, jiong/L-6534-2014	Mortensen, Preben B/0000-0002-5230-9865; li, jiong/0000-0002-1716-8067; li, jiong/0000-0003-1125-026X				*AM PSYCH ASS, 1987, DSM3R DIAGN STAT MAN; ANDA RF, 1990, JAMA-J AM MED ASSOC, V264, P1541, DOI 10.1001/jama.264.12.1541; BATTEN PJ, 1992, AM J FOREN MED PATH, V13, P159, DOI 10.1097/00000433-199206000-00016; DYRGROVEN A, 1990, SCAND J PSYCHOL, V31, P266; Goodkin K, 2001, HDB BEREAVEMENT RES, P671; Johansen C, 1997, BRIT J CANCER, V75, P144, DOI 10.1038/bjc.1997.24; KLATSKY AL, 1993, ALCOHOL CLIN EXP RES, V17, P1156, DOI 10.1111/j.1530-0277.1993.tb05221.x; KRAUSE N, 1986, J GERONTOL, V41, P512, DOI 10.1093/geronj/41.4.512; Krupnick J.L., 1984, BEREAVEMENT REACTION, P99; Leistikow BN, 1998, PREV MED, V27, P871, DOI 10.1006/pmed.1998.0374; LEVAV I, 1981, ISRAEL J MED SCI, V17, P176; Levav I, 2000, AM J PUBLIC HEALTH, V90, P1601, DOI 10.2105/AJPH.90.10.1601; LEVAV I, 1988, NEW ENGL J MED, V319, P457, DOI 10.1056/NEJM198808253190801; LI GH, 1994, AM J PUBLIC HEALTH, V84, P1402, DOI 10.2105/AJPH.84.9.1402; Lichtenstein P, 1998, PSYCHOL MED, V28, P635, DOI 10.1017/S0033291798006692; Lusyne P, 2001, POP STUD-J DEMOG, V55, P281, DOI 10.1080/00324720127701; Martikainen P, 1996, AM J PUBLIC HEALTH, V86, P1087, DOI 10.2105/AJPH.86.8_Pt_1.1087; Martikainen P, 1998, EPIDEMIOLOGY, V9, P530, DOI 10.1097/00001648-199809000-00010; Matthews KA, 2002, ARCH INTERN MED, V162, P309, DOI 10.1001/archinte.162.3.309; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Moriarty HJ, 1996, RES NURS HEALTH, V19, P461, DOI 10.1002/(SICI)1098-240X(199612)19:6<461::AID-NUR2>3.0.CO;2-M; Parkes CM, 1998, BRIT MED J, V316, P856, DOI 10.1136/bmj.316.7134.856; REES WD, 1967, BRIT MED J, V4, P13, DOI 10.1136/bmj.4.5570.13; Roed AS, 1999, DAN MED BULL, V46, P269; Rubin Simon Shimshon, 1993, P285, DOI 10.1017/CBO9780511664076.020; SCHAEFER C, 1995, AM J EPIDEMIOL, V141, P1142, DOI 10.1093/oxfordjournals.aje.a117387; VANCE JC, 1991, MED J AUSTRALIA, V155, P292, DOI 10.5694/j.1326-5377.1991.tb142283.x; Vassilas CA, 1997, BRIT J PSYCHIAT, V170, P453, DOI 10.1192/bjp.170.5.453; 1998, FERTILITY DATABASE G	29	312	315	0	34	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					363	367		10.1016/S0140-6736(03)12387-2	http://dx.doi.org/10.1016/S0140-6736(03)12387-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	642CP	12573371				2022-12-28	WOS:000180787000007
J	McCormack, VA; Silva, ID; De Stavola, BL; Mohsen, R; Leon, DA; Lithell, HO				McCormack, VA; Silva, ID; De Stavola, BL; Mohsen, R; Leon, DA; Lithell, HO			Fetal growth and subsequent risk of breast cancer: results from long term follow up of Swedish cohort	BRITISH MEDICAL JOURNAL			English	Article							BIRTH-WEIGHT; FACTOR-I; WOMEN; HEIGHT	Objective To investigate whether size at birth and rate of fetal growth influence the risk of breast cancer in adulthood. Design Cohort identified from detailed birth records, with 97% follow up. Setting Uppsala Academic Hospital, Sweden. Participants 5358 singleton females born during 1915-29, alive and traced to the 1960 census. Main outcome measures Incidence of breast cancer before (at age < 50 years) and after (&GE; 50 years) the menopause. Results Size at birth was positively associated with rates of breast cancer in premenopausal women. In women who weighed &GE; 4000 g at birth rates of breast cancer were 3.5 times (95% confidence interval 1.3 to 9.3) those in women of similar gestational age who weighed < 3000 g at birth. Rates in women in the top fifths of the distributions of birth length and head circumference were 3.4 (1.5 to 7.9) and 4.0 (1.6 to 10.0) times those in the lowest fifths (adjusted for gestational age). The effect of birth weight disappeared after adjustment for birth length or head circumference, whereas the effects of birth length and head circumference remained significant after adjustment for birth weight. For a given size at birth, gestational age was inversely associated with risk (P=0.03 for linear trend). Adjustment for markers of adult risk factors did not affect these findings. Birth size was not associated with rates of breast cancer in postmenopausal women. Conclusions Size at birth, particularly length and head circumference, is associated with risk of breast cancer in women aged < 50 years. Fetal growth rate, as measured by birth size adjusted for gestational age, rather than size at birth may be the aetiologically relevant factor in premenopausal breast cancer.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Uppsala Univ, Dept Geriatr, S-75125 Uppsala, Sweden	University of London; London School of Hygiene & Tropical Medicine; Uppsala University	McCormack, VA (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.		Leon, David A/G-2195-2010	Leon, David A/0000-0001-9747-1762; McCormack, Valerie/0000-0001-7397-3442; De Stavola, Bianca Lucia/0000-0001-7853-0528; dos Santos Silva, Isabel/0000-0002-6596-8798				De Stavola BL, 2000, BRIT J CANCER, V83, P964, DOI 10.1054/bjoc.2000.1370; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Ekbom A, 1997, JNCI-J NATL CANCER I, V89, P71, DOI 10.1093/jnci/89.1.71; EKBOM A, 1992, LANCET, V340, P1015, DOI 10.1016/0140-6736(92)93019-J; Ekbom A, 2000, J NATL CANCER I, V92, P840, DOI 10.1093/jnci/92.10.840; GARNE JP, 1995, ACTA ONCOL, V34, P153, DOI 10.3109/02841869509093949; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Innes K, 2000, AM J EPIDEMIOL, V152, P1121, DOI 10.1093/aje/152.12.1121; LEMARCHAND L, 1988, BRIT J CANCER, V57, P437, DOI 10.1038/bjc.1988.99; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; LEON DA, 1999, FETAL PROGRAMMING IN; MARUBINI E, 1994, ANAL SURVIVAL DATA C; Michels KB, 1996, LANCET, V348, P1542, DOI 10.1016/S0140-6736(96)03102-9; Sanderson M, 2002, BRIT J CANCER, V86, P84, DOI 10.1038/sj.bjc.6600009; Sanderson M, 1996, EPIDEMIOLOGY, V7, P34, DOI 10.1097/00001648-199601000-00007; Sorensen HT, 1999, AM J EPIDEMIOL, V149, P726; Thomas HV, 1997, BRIT J CANCER, V75, P1075, DOI 10.1038/bjc.1997.183; Titus-Ernstoff L, 2002, CANCER EPIDEM BIOMAR, V11, P207; Toniolo P, 2000, INT J CANCER, V88, P828, DOI 10.1002/1097-0215(20001201)88:5<828::AID-IJC22>3.0.CO;2-8; TRICHOPOULOS D, 1990, LANCET, V335, P939, DOI 10.1016/0140-6736(90)91000-Z; Tuvemo T, 1999, PEDIATR RES, V46, P491, DOI 10.1203/00006450-199911000-00001; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514; Vatten LJ, 2002, BRIT J CANCER, V86, P89, DOI 10.1038/sj.bjc.6600011	24	107	107	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					248	251		10.1136/bmj.326.7383.248	http://dx.doi.org/10.1136/bmj.326.7383.248			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560272	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000180908300015
J	Nakagawa, T; Kitagawa, H; Yasuda, Y; Tarasov, PE; Nishida, K; Gotanda, K; Sawai, Y				Nakagawa, T; Kitagawa, H; Yasuda, Y; Tarasov, PE; Nishida, K; Gotanda, K; Sawai, Y		Yangtze River Civilization Program	Asynchronous climate changes in the North Atlantic and Japan during the last termination	SCIENCE			English	Article							GLACIAL-INTERGLACIAL TRANSITION; ICE-CORE RECORD; RADIOCARBON CALIBRATION; MEDITERRANEAN SEA; DEGLACIATION; CIRCULATION; REGION; EVENT; C-14; BP	Pollen records from the annually laminated sediment sequence in Lake Suigetsu, Japan, suggest a sequence of climate changes during the Last Termination that resembles that of the North Atlantic region but with noticeable differences in timing. An interstadial interval commenced a few centuries earlier [similar to15,000 years before the present (yr B.P.)] than the North Atlantic GI-1 (Bolling) event Conversely, the onset of a Younger Dryas (YD)-like cold reversal (112,300 to 11,250 yr B.P.) postdated the North Atlantic GS-1 (YD) event by a few centuries. Climate in the Far East during the Last Termination reflected solar insolation changes as much as Atlantic influences.	Int Res Ctr Japanese Studies, Nishikyo Ku, Kyoto 6101192, Japan; Nagoya Univ, Inst Hydrospher Atmospher, Chikusa Ku, Nagoya, Aichi 4648601, Japan; Moscow MV Lomonosov State Univ, Dept Geog, Moscow 119899, Russia; Kagoshima Univ, Fac Sci, Dept Math & Comp Sci, Kagoshima 8900065, Japan	Nagoya University; Lomonosov Moscow State University; Kagoshima University	Nakagawa, T (corresponding author), Int Res Ctr Japanese Studies, Nishikyo Ku, 3-2 Oeyama Cho, Kyoto 6101192, Japan.		Tarasov, Pavel/ABG-3993-2020; Sawai, Yuki/D-3216-2013	Tarasov, Pavel/0000-0002-7219-5009; Sawai, Yuki/0000-0001-7015-4361; Nakagawa, Takeshi/0000-0003-0831-6803				ALLEY RB, 1993, NATURE, V362, P527, DOI 10.1038/362527a0; Bard E, 1996, NATURE, V382, P241, DOI 10.1038/382241a0; Bjorck S, 1998, J QUATERNARY SCI, V13, P283, DOI 10.1002/(SICI)1099-1417(199807/08)13:4<283::AID-JQS386>3.0.CO;2-A; Blunier T, 1998, NATURE, V394, P739, DOI 10.1038/29447; Cacho I, 2001, PALEOCEANOGRAPHY, V16, P40, DOI 10.1029/2000PA000502; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Goslar T, 2000, NATURE, V403, P877, DOI 10.1038/35002547; GOSLAR T, 1995, NATURE, V377, P414, DOI 10.1038/377414a0; Gotanda K, 2002, QUATERNARY SCI REV, V21, P647, DOI 10.1016/S0277-3791(01)00046-4; GUIOT J, 1990, PALAEOGEOGR PALAEOCL, V80, P49, DOI 10.1016/0031-0182(90)90033-4; Hughen KA, 1996, NATURE, V380, P51, DOI 10.1038/380051a0; Hughen KA, 2000, SCIENCE, V290, P1951, DOI 10.1126/science.290.5498.1951; Kitagawa H, 1998, SCIENCE, V279, P1187, DOI 10.1126/science.279.5354.1187; Koutavas A, 2002, SCIENCE, V297, P226, DOI 10.1126/science.1072376; Kromer B, 1996, RADIOCARBON, V38, P607, DOI 10.1017/S0033822200030149; LEHMAN SJ, 1992, NATURE, V356, P757, DOI 10.1038/356757a0; Litt T, 2001, QUATERNARY SCI REV, V20, P1233, DOI 10.1016/S0277-3791(00)00149-9; LORIUS C, 1985, NATURE, V316, P591, DOI 10.1038/316591a0; Lowe JJ, 2001, QUATERNARY SCI REV, V20, P1175, DOI 10.1016/S0277-3791(00)00183-9; Lowe JJ, 2000, RADIOCARBON, V42, P53, DOI 10.1017/S0033822200053054; Nakagawa T, 2002, QUATERNARY SCI REV, V21, P2099, DOI 10.1016/S0277-3791(02)00014-8; Siani G, 2000, RADIOCARBON, V42, P271, DOI 10.1017/S0033822200059075; Thompson LG, 1998, SCIENCE, V282, P1858, DOI 10.1126/science.282.5395.1858; Tsukada M., 1988, VEGETATION HIST, P459	24	134	156	5	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					688	691		10.1126/science.1078235	http://dx.doi.org/10.1126/science.1078235			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560547				2022-12-28	WOS:000180687700041
J	Altman, DG; Bland, JM				Altman, DG; Bland, JM			Statistics Notes - Interaction revisited: the difference between two estimates	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HETEROGENEITY		Inst Hlth Sci, Canc Res UK Med Stat Grp, Ctr Stat Med, Oxford OX3 7LF, England; St George Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England	Cancer Research UK; University of Oxford; St Georges University London	Altman, DG (corresponding author), Inst Hlth Sci, Canc Res UK Med Stat Grp, Ctr Stat Med, Oxford OX3 7LF, England.	doug.altman@cancer.org.uk						Altman DG, 1996, BRIT MED J, V313, P486; Bland JM, 1996, BRIT MED J, V312, P700; BLAND M, IN PRESS OBSTET GYNA; Matthews JNS, 1996, BRIT MED J, V313, P808; Matthews JNS, 1996, BRIT MED J, V313, P862; Torgerson DJ, 2001, JAMA-J AM MED ASSOC, V285, P2891, DOI 10.1001/jama.285.22.2891	6	1923	1938	10	46	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2003	326	7382					219	219		10.1136/bmj.326.7382.219	http://dx.doi.org/10.1136/bmj.326.7382.219			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640LD	12543843	Green Published, Bronze			2022-12-28	WOS:000180689600027
J	Carroll, D; Corfield, A; Spicer, R; Cairns, P				Carroll, D; Corfield, A; Spicer, R; Cairns, P			Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis	LANCET			English	Article								Calprotectin has been proposed as a useful marker of inflammatory bowel disease in children. We did a pilot study to establish whether it can be used to aid diagnosis of necrotising enterocolitis in preterm infants. Patients with clinical features of necrotising enterocolitis had raised faecal calprotectin concentrations at the time of diagnosis compared with matched controls (288.4 mg/L [SD 49.1] and 98.0 mg/L [60.6], respectively; p=0.0006). Faecal calprotectin might be a useful marker of gastrointestinal mucosal inflammation in neonates.	Royal Hosp Sick Children, Dept Paediat Surg, Bristol BS2 8BJ, Avon, England	Bristol Royal Hospital For Children	Carroll, D (corresponding author), Royal Hosp Sick Children, Dept Paediat Surg, Bristol BS2 8BJ, Avon, England.							Fagerhol M. K., 1990, STIMULUS RESPONSE CO, P187; Fagerhol MK, 2000, LANCET, V356, P1783, DOI 10.1016/S0140-6736(00)03224-4; Olafsdottir E, 2002, ACTA PAEDIATR, V91, P45, DOI 10.1080/080352502753457932; Rugtveit J, 2002, J PEDIATR GASTR NUTR, V34, P323, DOI 10.1097/00005176-200203000-00022; Tibble J, 2000, GUT, V47, P506, DOI 10.1136/gut.47.4.506	5	94	100	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					310	311		10.1016/S0140-6736(03)12333-1	http://dx.doi.org/10.1016/S0140-6736(03)12333-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559868				2022-12-28	WOS:000180643900015
J	Rekart, ML; Patrick, DM; Chakraborty, B; Maginley, JJL; Jones, HD; Bajdik, CD; Pourbohloul, B; Brunham, RC				Rekart, ML; Patrick, DM; Chakraborty, B; Maginley, JJL; Jones, HD; Bajdik, CD; Pourbohloul, B; Brunham, RC			Targeted mass treatment for syphilis with oral azithromycin	LANCET			English	Article								From mid 1997 to end of 1999, there was a sexually-transmitted infectious syphilis outbreak mainly in heterosexual people in British Columbia, Canada, that was concentrated in Vancouver. The rate across the province increased from less than 0.5 to 3.4 per 100 000, and the rate in Vancouver reached 12.9 per 100 000. We aimed to eliminate the syphillis outbreak by treating people at risk of infection. In 2000, a targeted mass treatment programme provided azithromycin (1.8 g orally) to 4384 at-risk residents in this city. After the programme, syphilis frequency fell significantly for 6 months (p=0.016), but rose again in 2001. Results from curve fitting analyses showed that the number of cases in 2001 (177) was higher than expected (0.0001<p<0.0044). This rate rebound and the absence of a sustained effect suggest that targeted mass treatment for syphilis, even though feasible, should not be done routinely.	Univ British Columbia, Ctr Dis Control, Vancouver, BC V5Z 1M9, Canada; British Columbia Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada; British Columbia Canc Agcy, Canc Control Res Programme, Vancouver, BC V5Z 4E6, Canada	University of British Columbia; British Columbia Cancer Agency	Rekart, ML (corresponding author), Univ British Columbia, Ctr Dis Control, Vancouver, BC V5Z 1M9, Canada.							HIBBS JR, 1991, AM J PUBLIC HEALTH, V81, P1259, DOI 10.2105/AJPH.81.10.1259; Hook EW, 1999, ANN INTERN MED, V131, P434, DOI 10.7326/0003-4819-131-6-199909210-00007; Korenromp EL, 2000, AIDS, V14, P573, DOI 10.1097/00002030-200003310-00013; Patrick DM, 2002, SEX TRANSM INFECT, V78, pI164, DOI 10.1136/sti.78.suppl_1.i164; ROSSI MA, 1990, CAN J CARDIOL, V6, P293	5	47	48	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					313	314		10.1016/S0140-6736(03)12335-5	http://dx.doi.org/10.1016/S0140-6736(03)12335-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559870				2022-12-28	WOS:000180643900017
J	Asmis, KR; Pivonka, NL; Santambrogio, G; Brummer, M; Kaposta, C; Neumark, DM; Woste, L				Asmis, KR; Pivonka, NL; Santambrogio, G; Brummer, M; Kaposta, C; Neumark, DM; Woste, L			Gas-phase infrared spectrum of the protonated water dimer	SCIENCE			English	Article							FREE-ELECTRON LASER; VIBRATIONAL SPECTROSCOPY; MOLECULAR-DYNAMICS; MECHANISM; TRANSPORT; H5O2+	The protonated water dimer is a prototypical system for the study of proton transfer in aqueous solution. We report infrared photodissociation spectra of cooled H+(H2O)(2) [and D+(D2O2] ions, measured between 620 and 1900 wave numbers (cm(-1)). The experiment directly probes the shared proton region of the potential energy surface and reveals three strong bands below 1600 cm(-1) and one at 1740 cm(-1) (for H5O2+). From a comparison to multidimensional quantum calculations, the three lower energy bands were assigned to stretching and bending fundamentals involving the O...H+...O moiety, and the highest energy band was assigned to a terminal water bend. These results highlight the importance of intermode coupling in shared proton systems.	Free Univ Berlin, Inst Expt Phys, D-14195 Berlin, Germany; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Chem Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Free University of Berlin; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Asmis, KR (corresponding author), Free Univ Berlin, Inst Expt Phys, Arnimallee 14, D-14195 Berlin, Germany.		Santambrogio, Gabriele/B-1357-2009; Neumark, Daniel M/B-9551-2009; Asmis, Knut R./N-5408-2014	Santambrogio, Gabriele/0000-0001-5932-7049; Neumark, Daniel M/0000-0002-3762-9473; Asmis, Knut R./0000-0001-6297-5856; Stanca-Kaposta, E. Cristina/0000-0002-9441-0494				AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Asmis KR, 2002, PHYS CHEM CHEM PHYS, V4, P1101, DOI [10.1039/b111056j, 10.1039/b1111056j]; Chaban GM, 2000, J PHYS CHEM A, V104, P2772, DOI 10.1021/jp993391g; EIGEN M, 1958, PROC R SOC LON SER-A, V247, P505, DOI 10.1098/rspa.1958.0208; Grotthuss C. J. T., 1806, ANN CHIM PHYS, V58, P54; Kim J, 2002, J CHEM PHYS, V116, P737, DOI 10.1063/1.1423327; KNIPPELS GMH, 1995, PHYS REV LETT, V75, P1755, DOI 10.1103/PhysRevLett.75.1755; Lanyi JK, 2000, J PHYS CHEM B, V104, P11441, DOI 10.1021/jp0023718; LAU YK, 1982, J AM CHEM SOC, V104, P1462, DOI 10.1021/ja00370a002; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; LIBROVICH NB, 1979, CHEM PHYS, V39, P351, DOI 10.1016/0301-0104(79)80155-X; Marx D, 1999, NATURE, V397, P601, DOI 10.1038/17579; MUGUET FF, 1996, J MOL STRUC-THEOCHEM, V368, P173; MUKAMEL S, 1976, J CHEM PHYS, V65, P5204, DOI 10.1063/1.433073; OJAMAE L, 1995, INT J QUANTUM CHEM Q, V29, P657; Oomens J, 2001, J PHYS CHEM A, V105, P8302, DOI 10.1021/jp0110455; Oomens J, 2000, ASTROPHYS J, V542, P404, DOI 10.1086/309545; Pivonka NL, 2002, J CHEM PHYS, V117, P6493, DOI 10.1063/1.1506308; Pomes R, 2002, BIOPHYS J, V82, P2304, DOI 10.1016/S0006-3495(02)75576-8; Putter M, 1996, CHEM PHYS LETT, V258, P118, DOI 10.1016/0009-2614(96)00656-2; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Smondyrev AM, 2002, BIOPHYS J, V82, P1460, DOI 10.1016/S0006-3495(02)75500-8; SUDBO AS, 1979, J CHEM PHYS, V70, P912, DOI 10.1063/1.437482; Valeev EF, 1998, J CHEM PHYS, V108, P7197, DOI 10.1063/1.476137; Vener MV, 2001, J CHEM PHYS, V114, P240, DOI 10.1063/1.1330748; Vuilleumier R, 1999, J CHEM PHYS, V111, P4251, DOI 10.1063/1.479723; Wales DJ, 1999, J CHEM PHYS, V110, P10403, DOI 10.1063/1.478972; YEH LI, 1989, J CHEM PHYS, V91, P7319, DOI 10.1063/1.457305; YEH LI, 1994, J MOL SPECTROSC, V164, P473, DOI 10.1006/jmsp.1994.1090; Zundel G, 2000, ADV CHEM PHYS, V111, P1	30	355	355	5	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1375	1377		10.1126/science.1081634	http://dx.doi.org/10.1126/science.1081634			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12574498				2022-12-28	WOS:000181192300046
J	Kato, Y; Myers, RC; Driscoll, DC; Gossard, AC; Levy, J; Awschalom, DD				Kato, Y; Myers, RC; Driscoll, DC; Gossard, AC; Levy, J; Awschalom, DD			Gigahertz electron spin manipulation using voltage-controlled g-tensor modulation	SCIENCE			English	Article							QUANTUM-WELLS; POLARIZATION; RESONANCE; COHERENCE; GAAS	We present a scheme that enables gigahertz-bandwidth three-dimensional control of electron spins in a semiconductor heterostructure with the use of a single voltage signal. Microwave modulation of the Lande g tensor produces frequency-modulated electron spin precession. Driving at the Larmor frequency results in g-tensor modulation resonance, which is functionally equivalent to electron spin resonance but without the use of time-dependent magnetic fields. These results provide proof of the concept that quantum spin information can be locally manipulated with the use of high-speed electrical circuits.	Univ Calif Santa Barbara, Ctr Spintron & Quantum Computat, Santa Barbara, CA 93106 USA; Univ Pittsburgh, Ctr Oxide Semicond Mat Quantum Computat, Pittsburgh, PA 15260 USA	University of California System; University of California Santa Barbara; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Awschalom, DD (corresponding author), Univ Calif Santa Barbara, Ctr Spintron & Quantum Computat, Santa Barbara, CA 93106 USA.		Myers, Roberto/B-4431-2008; Kato, Yuichiro K./B-5051-2008; Levy, Jeremy/A-2081-2009	Myers, Roberto/0000-0002-3695-2244; Kato, Yuichiro K./0000-0002-9942-1459; Levy, Jeremy/0000-0002-5700-2977				BLOCH F, 1946, PHYS REV, V70, P460, DOI 10.1103/PhysRev.70.460; Chuang IL, 1998, NATURE, V393, P143, DOI 10.1038/30181; Crooker SA, 1997, PHYS REV B, V56, P7574, DOI 10.1103/PhysRevB.56.7574; DiVincenzo DP, 1999, J MAGN MAGN MATER, V200, P202, DOI 10.1016/S0304-8853(99)00315-7; ERNST RR, 1983, PRINCIPLES NUCL MAGN; GOSSARD AC, 1986, IEEE J QUANTUM ELECT, V22, P1649, DOI 10.1109/JQE.1986.1073165; Hubert C, 1999, REV SCI INSTRUM, V70, P3684, DOI 10.1063/1.1149978; IVCHENKO EL, 1992, SOV PHYS SEMICOND+, V26, P827; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; MARANOWSKI KD, 1995, APPL PHYS LETT, V66, P3459, DOI 10.1063/1.113387; MILLER RC, 1984, PHYS REV B, V29, P3740, DOI 10.1103/PhysRevB.29.3740; Salis G, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.195304; Salis G, 2001, NATURE, V414, P619, DOI 10.1038/414619a; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; [No title captured]	17	224	224	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1201	1204		10.1126/science.1080880	http://dx.doi.org/10.1126/science.1080880			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12543982				2022-12-28	WOS:000181065500031
J	Byrne, S; Ingersoll, AP				Byrne, S; Ingersoll, AP			A sublimation model for martian south polar ice features	SCIENCE			English	Article							SUMMER TEMPERATURES; CARBON-DIOXIDE; WATER-VAPOR; MARS; TOPOGRAPHY; STABILITY; MISSION; MERCURY; MOON; CO2	In their pioneering work, Leighton and Murray argued that the Mars atmosphere, which at present is 95% carbon dioxide, is controlled by vapor equilibrium with a much larger polar reservoir of solid carbon dioxide. Here we argue that the polar reservoir is small and cannot function as a long-term buffer to the more massive atmosphere. Our work is based on modeling of the circular depressions commonly found on the south polar cap. We argue that a carbon dioxide ice layer about 8 meters thick is being etched away to reveal water ice underneath. This is consistent with thermal infrared data from the Mars Odyssey mission.	CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Byrne, S (corresponding author), CALTECH, Div Geol & Planetary Sci, 1200 E Calif Blvd, Pasadena, CA 91125 USA.		Byrne, Shane/B-8104-2012					BARKER ES, 1970, SCIENCE, V170, P1308, DOI 10.1126/science.170.3964.1308; CHRISTENSEN PR, 1992, J GEOPHYS RES-PLANET, V97, P7719, DOI 10.1029/92JE00453; CHRISTENSEN PR, UNPUB; Durham WB, 1999, GEOPHYS RES LETT, V26, P3493, DOI 10.1029/1999GL008373; FARMER CB, 1976, SCIENCE, V194, P1339, DOI 10.1126/science.194.4271.1339; INGERSOL.AP, 1974, J GEOPHYS RES, V79, P3403, DOI 10.1029/JC079i024p03403; INGERSOLL AP, 1992, ICARUS, V100, P40, DOI 10.1016/0019-1035(92)90016-Z; JAMES PB, 1992, MARS, P934; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; MALIN MC, 1992, J GEOPHYS RES-PLANET, V97, P7699, DOI 10.1029/92JE00340; Malin MC, 2001, SCIENCE, V294, P2146, DOI 10.1126/science.1066416; MURRAY BC, 1973, SCIENCE, V182, P437, DOI 10.1126/science.182.4111.437; Nye JF, 2000, ICARUS, V144, P449, DOI 10.1006/icar.1999.6306; Schenk PM, 2000, J GEOPHYS RES-PLANET, V105, P24529, DOI 10.1029/1999JE001054; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Thomas P., 1992, MARS, P767; Thomas PC, 2000, NATURE, V404, P161, DOI 10.1038/35004528; Vasavada AR, 1999, ICARUS, V141, P179, DOI 10.1006/icar.1999.6175; WOOD SE, 1992, ICARUS, V99, P1, DOI 10.1016/0019-1035(92)90166-5	22	131	131	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1051	1053		10.1126/science.1080148	http://dx.doi.org/10.1126/science.1080148			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586939				2022-12-28	WOS:000180960000043
J	Delahaye, J; Hassel, J; Lindell, R; Sillanpaa, M; Paalanen, M; Seppa, H; Hakonen, P				Delahaye, J; Hassel, J; Lindell, R; Sillanpaa, M; Paalanen, M; Seppa, H; Hakonen, P			Low-noise current amplifier based on mesoscopic Josephson junction	SCIENCE			English	Article							SINGLE-ELECTRON TRANSISTOR; SMALL TUNNEL-JUNCTIONS; COULOMB BLOCKADE; QUANTUM-STATE; DEVICES	We used the band structure of a mesoscopic Josephson junction to construct low-noise amplifiers. By taking advantage of the quantum dynamics of a Josephson junction, i.e., the interplay of interlevel transitions and the Coulomb blockade of Cooper pairs, we created transistor-like devices, Bloch oscillating transistors, with considerable current gain and high-input impedance. In these transistors, the correlated supercurrent of Cooper pairs is controlled by a small base current made up of single electrons. Our devices reached current and power gains on the order of 30 and 5, respectively. The noise temperature was estimated to be around 1 kelvin, but noise temperatures of less than 0.1 kelvin can be realistically achieved. These devices provide quantum-electronic building blocks that will be useful at low temperatures in low-noise circuit applications with an intermediate impedance level.	Helsinki Univ Technol, Low Temp Lab, Espoo 02015, Finland; VTT Informat Technol, Microsensing, Espoo 02044, Finland	Aalto University; VTT Technical Research Center Finland	Hakonen, P (corresponding author), Helsinki Univ Technol, Low Temp Lab, POB 2200, Espoo 02015, Finland.	pertti.hakonen@hut.fi	Hakonen, Pertti J/E-7688-2012; Hassel, Juha/N-3044-2013; Sillanpaa, Mika/A-3554-2013	Hakonen, Pertti J/0000-0002-8247-4108; Hassel, Juha/0000-0003-1002-0614; 				Aassime A, 2001, APPL PHYS LETT, V79, P4031, DOI 10.1063/1.1424477; AVERIN DV, 1986, J LOW TEMP PHYS, V62, P345, DOI 10.1007/BF00683469; AVERIN DV, 1985, ZH EKSP TEOR FIZ, V61, P407; Clarke J, 1996, NATO ADV SCI I E-APP, V329, P1; De Wilde Y, 2001, IEEE T INSTRUM MEAS, V50, P231, DOI 10.1109/19.918109; DELAHAYE J, IN PRESS PHYSICA E; Devoret MH, 2000, NATURE, V406, P1039, DOI 10.1038/35023253; FULTON TA, 1987, PHYS REV LETT, V59, P109, DOI 10.1103/PhysRevLett.59.109; Golubev D, 2001, J APPL PHYS, V89, P6464, DOI 10.1063/1.1351002; Hassel J, 2001, IEEE T APPL SUPERCON, V11, P260, DOI 10.1109/77.919333; HAVILAND DB, 1991, EUROPHYS LETT, V16, P103, DOI 10.1209/0295-5075/16/1/018; INGOLD GL, 1992, NATO ADV SCI I B-PHY, V294, P21; Likharev KK, 1999, P IEEE, V87, P606, DOI 10.1109/5.752518; Makhlin Y, 2001, REV MOD PHYS, V73, P357, DOI 10.1103/RevModPhys.73.357; NAHUM M, 1993, APPL PHYS LETT, V63, P3075, DOI 10.1063/1.110237; Peacock A, 1996, NATURE, V381, P135, DOI 10.1038/381135a0; Schoelkopf RJ, 1999, IEEE T APPL SUPERCON, V9, P2935, DOI 10.1109/77.783645; SCHON G, 1990, PHYS REP, V198, P237, DOI 10.1016/0370-1573(90)90156-V; VANDERZIEL A, 1986, NOISE SOLID STATE DE, pCH3; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; ZAIKIN AD, 1988, PHYS LETT A, V131, P125, DOI 10.1016/0375-9601(88)90671-8; ZAIKIN AD, 1992, PHYS LETT A, V164, P337, DOI 10.1016/0375-9601(92)91117-A	22	52	52	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1045	1048		10.1126/science.299.5609.1045	http://dx.doi.org/10.1126/science.299.5609.1045			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586938	Green Published			2022-12-28	WOS:000180960000041
J	Bradley, DJ; Bradley, EA; Baughman, KL; Berger, RD; Calkins, H; Goodman, SN; Kass, DA; Powe, NR				Bradley, DJ; Bradley, EA; Baughman, KL; Berger, RD; Calkins, H; Goodman, SN; Kass, DA; Powe, NR			Cardiac resynchronization and death from progressive heart failure - A meta-analysis of randomized controlled trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BUNDLE-BRANCH-BLOCK; DILATED CARDIOMYOPATHY; VENTRICULAR-TACHYCARDIA; MULTISITE STIMULATION; EXERCISE PERFORMANCE; SUDDEN-DEATH; THERAPY; MORTALITY; DEFIBRILLATOR; IMPLANTATION	Context Progressive heart failure is the most common mechanism of death among patients with advanced heart failure. Cardiac resynchronization, a pacemaker-based therapy for heart failure, enhances cardiac performance and quality of life, but its effect on mortality is uncertain. Objective To determine whether cardiac resynchronization reduces mortality from progressive heart failure. Data Sources MEDLINE (1966-2002), EMBASE (1980-2002), the Cochrane Controlled Trials Register (Second Quarter, 2002), The National Institutes of Health ClinicalTrials.gov database, the US Food and Drug Administration Web site, and reports presented at scientific meetings (1994-2002). Search terms included pacemaker, pacing, heart failure, dual-site, multisite, biventricular, resynchronization, and left ventricular preexcitation. Study Selection Eligible studies were randomized controlled trials of cardiac resynchronization for the treatment of chronic symptomatic left ventricular dysfunction. Eligible studies reported death, hospitalization for heart failure, or ventricular arrhythmia as outcomes. Of the 6883 potentially relevant reports initially identified, 11 reports of 4 randomized trials with 1634 total patients were included in the meta-analysis. Data Extraction Trial reports were reviewed independently by 2 investigators in an unblinded standardized manner. Data Synthesis Follow-up in the included trials ranged from 3 to 6 months. Pooled data from the 4 selected studies showed that cardiac resynchronization reduced death from progressive heart failure by 51% relative to controls (odds ratio [OR], 0.49; 95% confidence interval [CI], 0.25-0.93). Progressive heart failure mortality was 1.7% for cardiac resynchronization patients and 3.5% for controls. Cardiac resynchronization also reduced heart failure hospitalization by 29% (OR, 0.71; 95% CI, 0.53-0.96) and showed a trend toward reducing all-cause mortality (OR, 0.77; 95% CI, 0.51-1.18). Cardiac resynchronization was not associated with a statistically significant effect on non-heart failure mortality (OR, 1.15; 95% CI, 0.65-2.02). Among patients with implantable cardioverter defibrillators, cardiac resynchronization had no clear impact on ventricular tachycardia or ventricular fibrillation (OR, 0.92; 95% CI, 0.67-1.27). Conclusions Cardiac resynchronization reduces mortality from progressive heart failure inpatients with symptomatic left ventricular dysfunction. This finding suggests that cardiac resynchronization may have a substantial impact on the most common mechanism of death among patients with advanced heart failure. Cardiac resynchronization also reduces heart failure hospitalization and shows a trend toward reducing all-cause mortality.	Johns Hopkins Sch Med, Dept Med, Div Cardiol, Baltimore, MD USA; Johns Hopkins Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD USA; Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA; Johns Hopkins Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Johns Hopkins Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; Johns Hopkins Sch Med, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; Johns Hopkins Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; Mayo Clin & Mayo Fdn, Dept Ophthalmol, Rochester, MN 55905 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Mayo Clinic	Bradley, DJ (corresponding author), Johns Hopkins Univ Hosp, Div Cardiol, Carnegie 568,600 N Wolfe St, Baltimore, MD 21287 USA.	DBradley@jhmi.edu		Goodman, Steven/0000-0002-3872-5723				Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Abraham WT, 2000, J CARD FAIL, V6, P369, DOI 10.1054/jcaf.2000.20841; *AM HEART ASS, 2001, 2002 HEART STROK STA; Ansalone G, 2002, J AM COLL CARDIOL, V39, P489, DOI 10.1016/S0735-1097(01)01772-7; Auricchio A, 2002, J AM COLL CARDIOL, V39, P1163, DOI 10.1016/S0735-1097(02)01727-8; Auricchio A, 2002, AM J CARDIOL, V89, P198, DOI 10.1016/S0002-9149(01)02200-7; Auricchio A, 1999, CIRCULATION, V99, P2993, DOI 10.1161/01.CIR.99.23.2993; AURICCHIO A, 2001, N AM SOC PAC EL 22 A; AURICCHIO A, 2001, PACE, V24, P540; Baldasseroni S, 2002, AM HEART J, V143, P398, DOI 10.1067/mhj.2002.121264; Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; BAROLD HS, 2002, US FOOD DRUG ADM CTR; BAROLD HS, 2001, PRELIMINARY CLIN REV; Barold SS, 2000, PACE, V23, P2117, DOI 10.1111/j.1540-8159.2000.tb00786.x; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; Birnie D, 2001, HEART, V86, P703, DOI 10.1136/heart.86.6.703; Braunwald E, 2000, CIRCULATION, V102, P14; Breithardt OA, 2002, AM HEART J, V143, P34, DOI 10.1067/mhj.2002.119616; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; CLARKE M, 2002, COCHRANE REV HDB 4 1; Cleland JGF, 1999, EUR J HEART FAIL, V1, P41, DOI 10.1016/S1388-9842(99)00009-4; COOK DJ, 1993, JAMA-J AM MED ASSOC, V269, P2749, DOI 10.1001/jama.269.21.2749; Daubert JC, 2000, CIRCULATION, V102, P693; DAUBERT JC, 2002, PACING CLIN ELECTROP, V25, P558; De Sutter J, 2000, PACE, V23, P1718; de Teresa E, 2000, AM J CARDIOL, V86, p126K, DOI 10.1016/S0002-9149(00)01192-9; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; EGGER M, 2001, SYSTEMATIC REV HLTH, P51; Farwell D, 2000, EUR HEART J, V21, P1246, DOI 10.1053/euhj.1999.1985; Garrigue S, 2000, PACE, V23, P1700, DOI 10.1046/j.1460-9592.2000.01700.x; GOLDMAN S, 1993, CIRCULATION, V87, P24; Gottlieb SS, 1997, LANCET, V349, P662, DOI 10.1016/S0140-6736(97)22010-6; Gras D, 2002, EUR J HEART FAIL, V4, P311, DOI 10.1016/S1388-9842(02)00018-1; Gregoratos G, 1998, J AM COLL CARDIOL, V31, P1175; GRINES CL, 1989, CIRCULATION, V79, P845, DOI 10.1161/01.CIR.79.4.845; Guyomar Y, 2001, AM J CARDIOL, V88, P688, DOI 10.1016/S0002-9149(01)01819-7; Hare JM, 2002, NEW ENGL J MED, V346, P1902, DOI 10.1056/NEJMed020028; Healthcare Cost and Utilization Project, HEALTHC COST UT PROJ; Higgins SL, 2000, J AM COLL CARDIOL, V36, P824, DOI 10.1016/S0735-1097(00)00795-6; HILL AB, 1971, PRINCIPLES MED STATI, P313; Hjalmarson A, 1999, LANCET, V353, P2001; Huth C, 2001, Z KARDIOL, V90, P10; Kass DA, 1999, CIRCULATION, V99, P1567, DOI 10.1161/01.CIR.99.12.1567; Krahn AD, 2002, CAN J CARDIOL, V18, P380; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Lechat P, 1999, LANCET, V353, P9; Leclercq C, 2002, J AM COLL CARDIOL, V39, P194, DOI 10.1016/S0735-1097(01)01747-8; Leclercq C, 2000, AM J CARDIOL, V85, P1154, DOI 10.1016/S0002-9149(00)00716-5; LEDERCQ C, 2002, N AM SOC PAC EL 23 A, V25, P601; Linde C, 2002, J AM COLL CARDIOL, V40, P111, DOI 10.1016/S0735-1097(02)01932-0; LINDE C, 2001, 23 ANN M EUR SOC CAR; Lozano I, 2000, PACE, V23, P1711; Lunati M, 2002, J CARDIOVASC ELECTR, V13, pS63, DOI 10.1111/j.1540-8167.2002.tb01956.x; Martinelli Filho Martino, 2002, Arq. Bras. Cardiol., V78, P110, DOI 10.1590/S0066-782X2002000100010; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; *MEDTR CORP, 2001, US FOOD DRUG ADM CTR, P236; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Murkofsky RL, 1998, J AM COLL CARDIOL, V32, P476, DOI 10.1016/S0735-1097(98)00242-3; Nelson GS, 2000, CIRCULATION, V102, P3053; Nelson GS, 2000, CIRCULATION, V101, P2703, DOI 10.1161/01.CIR.101.23.2703; Oguz E, 2002, EUR J HEART FAIL, V4, P83, DOI 10.1016/S1388-9842(01)00188-X; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer Milton, 2001, American Journal of Medicine, V110, p81S; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Saxon LA, 2002, CIRCULATION, V105, P1304, DOI 10.1161/hc1102.105730; *STAT CORP, 2001, STAT STAT SOFTW COMP; Stellbrink C, 2001, J AM COLL CARDIOL, V38, P1957, DOI 10.1016/S0735-1097(01)01637-0; Stellbrink C, 1999, AM J CARDIOL, V83, p143D; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; *US FDA, 2001, US FOOD DRUG ADM CTR; *US FDA, SUMM SAF EFF GUID CO; *US FDA, 2002, US FOOD DRUG ADM CTR; Walker S, 2000, AM J CARDIOL, V86, P231, DOI 10.1016/S0002-9149(00)00865-1; Werling C, 2002, THORAC CARDIOV SURG, V50, P67, DOI 10.1055/s-2002-26702; Yu CM, 2002, CIRCULATION, V105, P438, DOI 10.1161/hc0402.102623; Zagrodzky JD, 2001, AM J CARDIOL, V87, P1208, DOI 10.1016/S0002-9149(01)01498-9; 2001, SUMMARY SAFETY EFFEC	79	521	571	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2003	289	6					730	740		10.1001/jama.289.6.730	http://dx.doi.org/10.1001/jama.289.6.730			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643WP	12585952				2022-12-28	WOS:000180886000028
J	Kovacs, K				Kovacs, K			Sheehan syndrome	LANCET			English	Editorial Material							HYPOPITUITARISM		Univ Toronto, St Michaels Hosp, Dept Lab Med & Pathobiol, Div Pathol, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Kovacs, K (corresponding author), Univ Toronto, St Michaels Hosp, Dept Lab Med & Pathobiol, Div Pathol, Toronto, ON M5B 1W8, Canada.	kovacsk@smh.toronto.on.ca						Elhadd TA, 2001, ANN MED, V33, P477; GLINSKI LK, 1913, DEUTSCHE MED WCHNSCH, V39, P473; Glinski LKZ, 1913, PRZEGL LEKARSKI, V52, P13; KOVACS K, 1969, NEUROENDOCRINOLOGY, V4, P170, DOI 10.1159/000121751; KOVACS K, 1969, NEUROENDOCRINOLOGY, V4, P201, DOI 10.1159/000121753; Regal M, 2001, CLIN ENDOCRINOL, V55, P735, DOI 10.1046/j.1365-2265.2001.01406.x; SHEEHAN HL, 1949, Q J MED, V18, P319; Sheehan HL, 1939, Q J MED, V8, P277; SHEEHAN HL, 1961, ACTA ENDOCRINOL-COP, V37, P479, DOI 10.1530/acta.0.0370479; SHEEHAN HL, 1948, P ROY SOC MED, V41, P187; Sheehan HL, 1937, J PATHOL BACTERIOL, V45, P189, DOI 10.1002/path.1700450118; SHEEHAN HL, 1982, POSTPARTUM HYPOPITUI, P1; Simmonds M, 1916, DEUT MED WOCHENSCHR, V42, P190, DOI 10.1055/s-0028-1134972; Simmonds M, 1914, DEUT MED WOCHENSCHR, V40, P322, DOI 10.1055/s-0029-1190185; THODOU E, 1995, J CLIN ENDOCR METAB, V80, P2302, DOI 10.1210/jc.80.8.2302; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306	16	64	67	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					520	522		10.1016/S0140-6736(03)12490-7	http://dx.doi.org/10.1016/S0140-6736(03)12490-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583962				2022-12-28	WOS:000180900600026
J	Jia, CL; Lentzen, M; Urban, K				Jia, CL; Lentzen, M; Urban, K			Atomic-resolution imaging of oxygen in perovskite ceramics	SCIENCE			English	Article							ELECTRON-MICROSCOPY; PHASE-RETRIEVAL; SUPERCONDUCTORS	Using an imaging mode based on the adjustment of a negative value of the spherical-aberration coefficient of the objective lens of a transmission electron microscope, we successfully imaged all types of atomic columns in the dielectric SrTiO3 and the superconductor YBa2Cu3O7. In particular, we were able to view the oxygen atoms which, due to their low scattering power, were not previously accessible, and this allowed us to detect local nonstoichiometries or the degree of oxygen-vacancy ordering. This technique offers interesting opportunities for research into oxides, minerals, and ceramics. In particular, this holds for the huge group of perovskite-derived electroceramic materials in which the local oxygen content sensitively controls the electronic properties.	Res Ctr Juelich, Inst Solid State Res, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Urban, K (corresponding author), Res Ctr Juelich, Inst Solid State Res, D-52425 Julich, Germany.	k.urban@fz-juelich.de	Lentzen, Markus/K-8291-2013	Lentzen, Markus/0000-0003-1609-7823				Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; COENE W, 1992, PHYS REV LETT, V69, P3743, DOI 10.1103/PhysRevLett.69.3743; Haider M, 1998, NATURE, V392, P768, DOI 10.1038/33823; HORIUCHI S, 1991, ULTRAMICROSCOPY, V39, P231, DOI 10.1016/0304-3991(91)90202-H; HUXFORD NP, 1987, NATURE, V329, P812, DOI 10.1038/329812a0; Jia CL, 1999, PHYS REV LETT, V82, P5052, DOI 10.1103/PhysRevLett.82.5052; JORGENSEN JD, 1987, PHYS REV B, V36, P3608, DOI 10.1103/PhysRevB.36.3608; Kilaas R., 1987, P 45 ANN M EL MICR S, P66; KREKELS T, 1991, APPL PHYS LETT, V59, P3048, DOI 10.1063/1.105789; Lentzen M, 2002, ULTRAMICROSCOPY, V92, P233, DOI 10.1016/S0304-3991(02)00139-0; MORRIS DE, 1989, PHYS REV B, V40, P11406, DOI 10.1103/PhysRevB.40.11406; Ohtomo A, 2002, NATURE, V419, P378, DOI 10.1038/nature00977; OURMAZD A, 1987, NATURE, V329, P425, DOI 10.1038/329425a0; PENNYCOOK SJ, 1997, HDB MICROSCOPY, V2, P595; Poole C.P., 1995, SUPERCONDUCTIVITY, V1st; Spence, 1998, EXPT HIGH RESOLUTION; Tagantsev AK, 2001, J APPL PHYS, V90, P1387, DOI 10.1063/1.1381542; VANTENDELOO G, 2000, CHARACTERIZATION HIG, P161; Voyles PM, 2002, NATURE, V416, P826, DOI 10.1038/416826a; Waser R, 1997, INTEGR FERROELECTR, V15, P39, DOI 10.1080/10584589708015695; Williams and Carter, 2010, TRANSMISSION ELECT M; YAN Y, 1991, PHYS REV B, V43, P13717, DOI 10.1103/PhysRevB.43.13717; ZANDBERGEN HW, 1988, NATURE, V331, P596, DOI 10.1038/331596a0	23	444	462	7	353	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					870	873		10.1126/science.1079121	http://dx.doi.org/10.1126/science.1079121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574624				2022-12-28	WOS:000180830900046
J	Irifune, T; Kurio, A; Sakamoto, S; Inoue, T; Sumiya, H				Irifune, T; Kurio, A; Sakamoto, S; Inoue, T; Sumiya, H			Materials - Ultrahard polycrystalline diamond from graphite	NATURE			English	Article							MECHANICAL-PROPERTIES		Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan; Sumitomo Elect Ind Ltd, Itami Res Labs, Itami, Hyogo 6640016, Japan	Ehime University; Sumitomo Electric Industries	Irifune, T (corresponding author), Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan.	irifune@dpc.ehime-u.ac.jp		Sumiya, Hitoshi/0000-0002-0790-3216				Akaishi M, 1996, MAT SCI ENG A-STRUCT, V209, P54, DOI 10.1016/0921-5093(96)10111-8; BROOKES CA, 1991, DIAM RELAT MATER, V1, P13, DOI 10.1016/0925-9635(91)90006-V; BUNDY FP, 1955, NATURE, V176, P51, DOI 10.1038/176051a0; BUNDY FP, 1963, J CHEM PHYS, V38, P631, DOI 10.1063/1.1733716; De SR, 2001, EARTH PLANET SC LETT, V185, P315, DOI 10.1016/S0012-821X(00)00369-1; Decarli PS, 1995, MATER RES SOC SYMP P, V383, P21, DOI 10.1557/PROC-383-21; HALL HT, 1970, SCIENCE, V169, P868, DOI 10.1126/science.169.3948.868; KATZMAN H, 1971, SCIENCE, V172, P1132, DOI 10.1126/science.172.3988.1132; KAWAI N, 1970, REV SCI INSTRUM, V41, P1178, DOI 10.1063/1.1684753; Krauss AR, 2001, DIAM RELAT MATER, V10, P1952, DOI 10.1016/S0925-9635(01)00385-5; NAKA S, 1976, NATURE, V259, P38, DOI 10.1038/259038a0; Sumiya H, 1997, DIAM RELAT MATER, V6, P1841, DOI 10.1016/S0925-9635(97)00149-0; Yusa H, 1998, APPL PHYS LETT, V72, P1843, DOI 10.1063/1.121201	13	547	575	11	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					599	600		10.1038/421599b	http://dx.doi.org/10.1038/421599b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571587				2022-12-28	WOS:000180803200032
J	Weinstein, SL; Dolan, LA; Spratt, KF; Peterson, KK; Spoonamore, MJ; Ponseti, IV				Weinstein, SL; Dolan, LA; Spratt, KF; Peterson, KK; Spoonamore, MJ; Ponseti, IV			Health and function of patients with untreated idiopathic scoliosis - A 50-year natural history study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TERM FOLLOW-UP; LOW-BACK-PAIN; COHORT; PROGRESSION; SELF	Context Previous long-term studies of idiopathic scoliosis have included patients with other etiologies, leading to the erroneous conclusion that all types of idiopathic scoliosis inevitably end in disability. Late-onset idiopathic scoliosis (LIS) is a distinct entity with a unique natural history. Objective To present the outcomes related to health and function in untreated patients with LIS. Design, Setting, and Patients Prospective natural history study performed at a midwestern university with outpatient evaluation of patients who presented between 1932 and 1948. At 50-year follow-up, which began in 1992, 117 untreated patients were compared with 62 age- and sex-matched volunteers. The patients' mean age was 66 years (range, 54-80 years). Main Outcome Measures Mortality, back pain, pulmonary symptoms, general function, depression, and body image. Results The estimated probability of survival was approximately 0.55 (95% confidence interval [CI], 0.47-0.63) compared with 0.57 expected for the general population. There was no significant difference in the demographic characteristics of the 2 groups. Twenty-two (22%) of 98 patients complained of shortness of breath during everyday activities compared with 8 (15%) of 53 controls. An increased risk of shortness of breath was also associated with the combination of a Cobb angle greater than 80degrees and a thoracic apex (adjusted odds ratio, 9.75; 95% CI, 1.15-82.98). Sixty-six (61%) of 109 patients reported chronic back pain compared with 22 (35%) of 62 controls (P=.003). However, of those with pain, 48 (68%) of 71 patients and 12 (71%) of 17 controls reported only little or moderate back pain. Conclusions Untreated adults with LIS are productive and functional at a high level at 50-year follow-up. Untreated LIS causes little physical impairment other than back pain and cosmetic concerns.	Univ Iowa, Dept Orthopaed Surg, Iowa City, IA USA; Huxley Family Phys, Huxley, IA USA; Univ So Calif, Dept Orthopaed Surg, Los Angeles, CA USA	University of Iowa; University of Southern California	Weinstein, SL (corresponding author), Univ Iowa Hosp & Clin, Dept Orthopaed Surg, Iowa City, IA 52242 USA.			Weinstein, Stuart/0000-0002-3676-6687; Dolan, Lori/0000-0003-2455-2187	NCRR NIH HHS [RR00059] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Andersson Gunnar B. J., 1997, P93; ASCANI E, 1986, SPINE, V11, P784, DOI 10.1097/00007632-198610000-00007; BRANTHWAITE MA, 1986, BRIT J DIS CHEST, V80, P360, DOI 10.1016/0007-0971(86)90089-6; BROOKS H, 1980, CURRENT INCIDENCE SC; BROOKS HL, 1975, J BONE JOINT SURG AM, V57, P968, DOI 10.2106/00004623-197557070-00015; BURWELL RG, 1982, J BONE JOINT SURG BR, V64, P248; BURWELL RG, 1983, J BONE JOINT SURG BR, V65, P452, DOI 10.1302/0301-620X.65B4.6874719; Cobb J., 1948, AM ACADEMY ORTHOPAED, V5, P261; COLLIS DK, 1969, J BONE JOINT SURG AM, VA 51, P425, DOI 10.2106/00004623-196951030-00001; DAHLBERG LN, 1976, P 5 P ZOR SCOL S SEP; DANIELSSON A, 2002, SCOL RES SOC ANN M S; DICKSON JH, 1995, J BONE JOINT SURG AM, V77A, P513, DOI 10.2106/00004623-199504000-00003; DICKSON RA, 1988, 8 P ZOR SCOL S OCT 2; DICKSON RA, 1994, PEDIAT SPINE, V1, P421; *DIV PUBL HLTH CHI, 2000, SCREEN SCOL GEORG SC; *DIV VIT STAT, 1992, NAT DEATH IND; EDGAR MA, 1988, J BONE JOINT SURG BR, V70, P712, DOI 10.1302/0301-620X.70B5.3192566; Fairbank J C, 1980, Physiotherapy, V66, P271; FOWLES JV, 1978, CLIN ORTHOP RELAT R, P212; GOLDBERG MS, 1994, SPINE, V19, P1562, DOI 10.1097/00007632-199407001-00004; GOLDBERG MS, 1994, SPINE, V19, P1551, DOI 10.1097/00007632-199407001-00003; GRIMARD G, 2002, SCOL RES SOC ANN M S; Horal J, 1969, Acta Orthop Scand Suppl, V118, P1; JAMES JIP, 1954, J BONE JOINT SURG BR, V36, P36, DOI 10.1302/0301-620X.36B1.36; JOHNSON M, 1988, 8 P ZOR SCOL S OCT 2; KANE WJ, 1970, CLIN ORTHOP RELAT R, P216, DOI 10.1097/00003086-197003000-00022; KNIGHT RG, 1983, BRIT J CLIN PSYCHOL, V22, P245, DOI 10.1111/j.2044-8260.1983.tb00610.x; KOLINDSORENSEN V, 1972, SCAND ORTH SOC JUN H; Lonstein J E, 1989, Instr Course Lect, V38, P105; LONSTEIN JE, 1982, J BONE JOINT SURG AM, V64, P481, DOI 10.2106/00004623-198264040-00002; LONSTEIN JE, 1984, J BONE JOINT SURG AM, V66A, P1061, DOI 10.2106/00004623-198466070-00013; MAYO NE, 1994, SPINE, V19, P1573, DOI 10.1097/00007632-199407001-00005; MONTGOMERY F, 1990, J PEDIATR ORTHOPED, V10, P48; NACHEMSON A, 1968, ACTA ORTHOP SCAND, V39, P466, DOI 10.3109/17453676808989664; *NAT CTR HLTH STAT, 1995, NAT AMB MED CAR SURV; National Center for Health Statistics, 1998, VIT STAT US 1994 A, VII; National Center for Health Statistics, 1996, NAT HLTH NUTR EX SUR; NILSONNE U, 1968, ACTA ORTHOP SCAND, V39, P456, DOI 10.3109/17453676808989663; PEHRSSON K, 1991, THORAX, V46, P474, DOI 10.1136/thx.46.7.474; POITRAS B, 1994, SPINE, V19, P1582, DOI 10.1097/00007632-199407001-00006; PONSETI IV, 1950, J BONE JOINT SURG AM, V32, P131; ROGALA EJ, 1978, J BONE JOINT SURG AM, V60, P173, DOI 10.2106/00004623-197860020-00005; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; SHANDS AR, 1955, J BONE JOINT SURG AM, V37, P1243, DOI 10.2106/00004623-195537060-00012; Slade DP, 2012, PSYCHOL HEALTH, V4, P213, DOI 10.1080/08870449008400391; TORELL G, 1981, J BONE JOINT SURG AM, V63, P337, DOI 10.2106/00004623-198163030-00002; *US BUR CENS POP D, 2000, PROF GEN DEM CHAR US; WADDELL G, 1980, SPINE, V5, P117, DOI 10.1097/00007632-198003000-00005; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WEINSTEIN SL, 1983, J BONE JOINT SURG AM, V65, P447, DOI 10.2106/00004623-198365040-00004; WEINSTEIN SL, 1981, J BONE JOINT SURG AM, V63, P702, DOI 10.2106/00004623-198163050-00003; WILLNER S, 1982, ACTA ORTHOP SCAND, V53, P233, DOI 10.3109/17453678208992208; WILLNER S, 1988, P 8 P ZOR SCOL S OCT; World Health Organisation, 1977, INT CLASS DIS 9 REV; WYNNE-DAVIES R, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P24; Yawn BP, 1999, JAMA-J AM MED ASSOC, V282, P1427, DOI 10.1001/jama.282.15.1427; Yawn BP, 2000, SPINE, V25, P2387, DOI 10.1097/00007632-200009150-00019; ZAOUSSIS AL, 1958, J BONE JOINT SURG BR, V40, P442, DOI 10.1302/0301-620X.40B3.442; ZUNG WWK, 1993, J FAM PRACTICE, V37, P337; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	60	374	399	5	27	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2003	289	5					559	567		10.1001/jama.289.5.559	http://dx.doi.org/10.1001/jama.289.5.559			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CV	12578488	Bronze			2022-12-28	WOS:000180787500026
J	Sosin, M; Handa, S				Sosin, M; Handa, S			Lesson of the week - Low dose methotrexate and bone marrow suppression	BRITISH MEDICAL JOURNAL			English	Review							RHEUMATOID-ARTHRITIS		Sandwell Gen Hosp, Dept Haematol, W Bromwich B71 4HJ, W Midlands, England		Handa, S (corresponding author), Sandwell Gen Hosp, Dept Haematol, W Bromwich B71 4HJ, W Midlands, England.							*ADV DRUG REACT AD, 1994, MED J AUSTRALIA, V161, P152; *BRIT SOC RHEUM, NAT GUID MON 2 LIN D; Choi HK, 2002, LANCET, V359, P1173, DOI 10.1016/S0140-6736(02)08213-2; Griffith SM, 2000, RHEUMATOLOGY, V39, P1102, DOI 10.1093/rheumatology/39.10.1102; Grove ML, 2001, QJM-MON J ASSOC PHYS, V94, P309, DOI 10.1093/qjmed/94.6.309; Hirshberg B, 2000, POSTGRAD MED J, V76, P787, DOI 10.1136/pmj.76.902.787; LOMAESTRO BM, 1992, JAMA-J AM MED ASSOC, V268, P2031, DOI 10.1001/jama.1992.03490150083021; MCARTHUR GA, 1992, MED J AUSTRALIA, V156, P296, DOI 10.5694/j.1326-5377.1992.tb139776.x; ODell JR, 1997, RHEUM DIS CLIN N AM, V23, P779, DOI 10.1016/S0889-857X(05)70360-4; OMDAL R, 1993, CLIN RHEUMATOL, V12, P283, DOI 10.1007/BF02231548; STOCKLEY IH, 1999, DRUG INTERACTIONS	11	37	39	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					266	267		10.1136/bmj.326.7383.266	http://dx.doi.org/10.1136/bmj.326.7383.266			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560282	Green Published			2022-12-28	WOS:000180908300025
J	Fabiani, A; Hoelzel, AR; Galimberti, F; Muelbert, MMC				Fabiani, A; Hoelzel, AR; Galimberti, F; Muelbert, MMC			Long-range paternal gene flow in the southern elephant seal	SCIENCE			English	Article							MIROUNGA-LEONINA; POPULATIONS		Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; Elephant Seal Res Grp, I-20145 Milan, Italy; Univ Fed Rio Grande, BR-96200970 Rio Grande, Brazil	Durham University; Universidade Federal do Rio Grande	Hoelzel, AR (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England.		Fabiani, Anna/B-8623-2011; Muelbert, Monica/T-3935-2019					Cornuet JM, 1999, GENETICS, V153, P1989; Gemmell NJ, 1997, MOL ECOL, V6, P661, DOI 10.1046/j.1365-294X.1997.00235.x; Hindell MA, 2000, MAR MAMMAL SCI, V16, P504, DOI 10.1111/j.1748-7692.2000.tb00944.x; HOELZEL AR, 1993, J HERED, V84, P443, DOI 10.1093/oxfordjournals.jhered.a111370; HOELZEL AR, 2001, P R SOC LONDON B, V268, P1; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Slade RW, 1998, GENETICS, V149, P1945	8	49	51	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					676	676		10.1126/science.299.5607.676	http://dx.doi.org/10.1126/science.299.5607.676			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560542				2022-12-28	WOS:000180687700036
J	Nathoe, HM; van Dijk, D; Jansen, EWL; Suyker, WJL; Diephuis, JC; van Boven, WJ; de la Riviere, AB; Borst, C; Kalkman, CJ; Grobbee, DE; Buskens, E; de Jaegere, PPT				Nathoe, HM; van Dijk, D; Jansen, EWL; Suyker, WJL; Diephuis, JC; van Boven, WJ; de la Riviere, AB; Borst, C; Kalkman, CJ; Grobbee, DE; Buskens, E; de Jaegere, PPT		Octopus Study Grp	A comparison of on-pump and off-pump coronary bypass surgery in low-risk patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ARTERY-BYPASS; COST-EFFECTIVENESS; GRAFT-SURGERY; RANDOMIZED-TRIALS; BEATING HEART; REVASCULARIZATION; OUTCOMES; SURVIVAL; THERAPY; OCTOPUS	BACKGROUND: The performance of coronary bypass surgery without cardiopulmonary bypass ("off pump'') may reduce perioperative morbidity and costs, but it is uncertain whether the outcome is similar to that involving the use of cardiopulmonary bypass ("on pump''). METHODS: In a multicenter, randomized trial, we randomly assigned 139 patients with predominantly single- or double-vessel coronary disease to on-pump surgery and 142 to off-pump surgery. Cardiac outcome and cost effectiveness were determined one year after surgery. The uncertainty surrounding the cost-effectiveness ratio (cost differences per quality-adjusted year of life gained) was addressed by bootstrapping. RESULTS: At one year, the rate of freedom from death, stroke, myocardial infarction, and coronary reintervention was 90.6 percent after on-pump surgery and 88.0 percent after off-pump surgery (absolute difference, 2.6 percent; 95 percent confidence interval, - 4.6 to 9.8). Graft patency in a randomized subgroup of patients was 93 percent after on-pump surgery and 91 percent after off-pump surgery (absolute difference, 2.0 percent; 95 percent confidence interval, - 6.5 to 10.4). On-pump surgery was associated with $1,839 in additional direct costs per patient ($14,908 vs. $13,069 -- a difference of 14.1 percent) and an increase in quality-adjusted years of life of 0.83 as compared with 0.82 (difference, 0.01 year; 95 percent confidence interval, - 0.03 to 0.04). Off-pump surgery was more cost effective than on-pump surgery in 95 percent of bootstrap estimates. CONCLUSIONS: In low-risk patients, there was no difference in cardiac outcome at one year between those who underwent on-pump bypass surgery and those who underwent off-pump surgery. Off-pump surgery was more cost effective.	Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; Univ Med Ctr Utrecht, Dept Anesthesiol, Utrecht, Netherlands; Univ Med Ctr Utrecht, Dept Cardiothorac Surg, Utrecht, Netherlands; Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; Weezenlanden Hosp, Isala Clin, Dept Cardiothorac Surg, Zwolle, Netherlands; St Antonius Hosp, Dept Cardiothorac Surg, Nieuwegein, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Isala Clinics; St. Antonius Hospital Utrecht	de Jaegere, PPT (corresponding author), Univ Med Ctr Utrecht, Dept Cardiol HPN E 01 207, POB 85500, NL-3508 GA Utrecht, Netherlands.	p.p.t.dejaegere@hli.azu.nl	Kalkman, Cor/O-3215-2019; van Boven, Wim Jan/ABA-7343-2020; Grobbee, Diederick/C-7651-2014	Kalkman, Cor/0000-0002-8372-6960; van Boven, Wim Jan/0000-0002-4207-373X; Grobbee, Diederick/0000-0003-4472-4468				Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8; Arom KV, 1999, ANN THORAC SURG, V68, P1562, DOI 10.1016/S0003-4975(99)00962-5; Ascione R, 1999, EUR J CARDIO-THORAC, V15, P685, DOI 10.1016/S1010-7940(99)00072-X; Ascione R, 1999, ANN THORAC SURG, V68, P2237, DOI 10.1016/S0003-4975(99)01123-6; BENETTI FJ, 1991, J THORAC CARDIOV SUR, V102, P802; BERGMAN L, 1995, STROKE, V26, P1830, DOI 10.1161/01.STR.26.10.1830; Borst C, 1996, J AM COLL CARDIOL, V27, P1356, DOI 10.1016/0735-1097(96)00039-3; Borst C, 1999, CIRCULATION, V99, P1400, DOI 10.1161/01.CIR.99.11.1400; BRAUNWALD E, 1989, CIRCULATION, V80, P410, DOI 10.1161/01.CIR.80.2.410; Califf RM, 1998, J AM COLL CARDIOL, V31, P241, DOI 10.1016/S0735-1097(97)00506-8; CAMPEAU L, 1976, CIRCULATION, V54, P522, DOI 10.1161/circ.54.3.947585; Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5; Costa MA, 2001, CIRCULATION, V104, P2689, DOI 10.1161/hc4701.099789; Cowper PA, 1997, J AM COLL CARDIOL, V30, P908, DOI 10.1016/S0735-1097(97)00243-X; Davies RF, 1997, CIRCULATION, V95, P2037, DOI 10.1161/01.CIR.95.8.2037; DEBOER MJ, 1995, AM J CARDIOL, V76, P830, DOI 10.1016/S0002-9149(99)80238-0; Edmunds L H Jr, 1995, Adv Card Surg, V6, P131; Efron B., 1994, MONOGRAPHS STAT APPL; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; FITZGIBBON GM, 1986, J THORAC CARDIOV SUR, V91, P773; Hart JC, 2000, ANN THORAC SURG, V70, P1017, DOI 10.1016/S0003-4975(00)01799-9; Hernandez F, 2001, ANN THORAC SURG, V72, P1528, DOI 10.1016/S0003-4975(01)03202-7; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Kong TQ, 1997, JAMA-J AM MED ASSOC, V277, P461, DOI 10.1001/jama.277.6.461; Koutlas TC, 2000, ANN THORAC SURG, V69, P1042, DOI 10.1016/S0003-4975(00)01154-1; Mack MJ, 1998, ANN THORAC SURG, V66, P1055, DOI 10.1016/S0003-4975(98)00815-7; MUHLBAIER LH, 1992, CIRCULATION, V86, P198; O'Brien BJ, 2002, HEALTH ECON, V11, P175, DOI 10.1002/hec.655; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; Shennib H, 2001, ANN THORAC SURG, V72, pS993, DOI 10.1016/S0003-4975(01)02948-4; Subramanian VA, 1997, ANN THORAC SURG, V64, P1648, DOI 10.1016/S0003-4975(97)01099-0; van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036; Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405; van Dijk D, 2000, CONTROL CLIN TRIALS, V21, P595, DOI 10.1016/S0197-2456(00)00103-3; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; YUSUF, 1994, LANCET, V344, P1446; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	39	329	348	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					394	402		10.1056/NEJMoa021775	http://dx.doi.org/10.1056/NEJMoa021775			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12556542				2022-12-28	WOS:000180643800004
J	Fuat, A; Pali, A; Hungin, S; Murphy, JJ				Fuat, A; Pali, A; Hungin, S; Murphy, JJ			Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study	BRITISH MEDICAL JOURNAL			English	Article							OPEN-ACCESS ECHOCARDIOGRAPHY; GENERAL-PRACTITIONERS; INHIBITORS	Objective To ascertain the beliefs, current practices, and decision making of general practitioners in the diagnosis and management of suspected heart failure in primary care, with a view to identifying barriers to good care. Design A qualitative approach using focus groups with 30 general practitioners from four primary care groups. The sampling strategy was stratified and purposive. The contents of interviews were transcribed and analysed according to the principles of "pragmatic variant" grounded theory. Setting North east England. Results Three categories of difficulties contribute to variations in medical practice and to the reasons why general practitioners experience difficulties in diagnosing and managing heart failure. The first is uncertainty about clinical practice, including lack of confidence in establishing an accurate diagnosis and worries about using angiotensin converting enzyme inhibitors, beta blockers, and spironolactone in patients who are often elderly and frail, with comorbidity and polypharmacy. The second is a lack of awareness of relevant research evidence in what was perceived to be a complex and rapidly changing therapeutic field. Doubts about the applicability of research findings in primary care, and fear of information overload also ernerged. The third category consists of influences of individual preference and local organisational factors. Medical training, negative clinical experiences, and outside agencies influenced the behaviour of general practitioners and professional culture. Local factors included the availability of diagnostic services, resources (such as accessible cardiologists), and interactions between professionals in primary or secondary care, and they seemed to shape the practice and decision making processes in primary care. Conclusions The national service framework for coronary heart disease stresses that the substandard care of patients with heart failure is unacceptable. This study identified barriers to be overcome across primary and secondary care in implementation strategies that are specific to the locality and multifaceted. Single strategies-for example, the provision of guidelines-are unlikely to have an impact on clinical outcomes, and new, conjoint models of care need to be explored.	Univ Durham, Wolfson Res Inst, Ctr Integrated Hlth Care Res, Stockton On Tees TS17 6BH, England; Darlington Mem Hosp, Darlington DL3 6HX, Durham, England	Durham University	Fuat, A (corresponding author), Univ Durham, Wolfson Res Inst, Ctr Integrated Hlth Care Res, Stockton On Tees TS17 6BH, England.			hungin, amritpal Pali/0000-0001-7275-8927				Bloor M, 1997, CONTEXT METHOD QUALI, P37; CLARKE KW, 1994, BRIT HEART J, V71, P584; Cleland JGF, 1999, BRIT MED J, V318, P824, DOI 10.1136/bmj.318.7187.824; CLELAND JGF, 1988, BRIT MED J, P824; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Freeman AC, 2001, BRIT MED J, V323, P1100, DOI 10.1136/bmj.323.7321.1100; Glasser B.G., 1967, DISCOVERY GROUNDED T; GLASSER BG, 1967, DISCOVERY GROUNED TH; Guba E.G., 1994, HDB QUALITATIVE RES, V2, P105; Hobbs FDR, 2000, EUR HEART J, V21, P1877, DOI 10.1053/euhj.2000.2170; Hobbs FDR, 2000, BRIT J GEN PRACT, V50, P735; Horne R, 1999, BRIT J GEN PRACT, V49, P353; Houghton AR, 1997, INT J CARDIOL, V59, P7, DOI 10.1016/S0167-5273(96)02904-X; Khunti K, 2000, BRIT J GEN PRACT, V50, P50; MCMURRAY J, 1993, MED ECON, V6, P90; MCMURRAY J, 1993, BR J MED EC, V6, P99; McMurray JJ, 2000, HEART, V83, P596, DOI 10.1136/heart.83.5.596; Melia K.M, 1997, CONTEXT METHOD QUALI, P26; Murphy JJ, 1996, BRIT J GEN PRACT, V46, P475; ORAM JJ, 1997, CARING 4 AGE PRACTIC; Patton M. Q., 1990, QUALITATIVE EVALUATI; Patton MQ., 1999, QUALITATIVE EVALUATI; REMES J, 1991, EUR HEART J, V12, P315, DOI 10.1093/oxfordjournals.eurheartj.a059896; REMES J, 1996, EUR HEART J, V46, P475; Remme WJ, 1997, EUR HEART J, V18, P736; Rimington H, 1996, LANCET, V348, P555, DOI 10.1016/S0140-6736(05)64722-8; Toal M, 2000, EUR J HEART FAIL, V2, P201, DOI 10.1016/S1388-9842(00)00071-4; WHEELDON NM, 1993, Q J MED, V86, P17	28	188	194	0	20	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 25	2003	326	7382					196	200		10.1136/bmj.326.7382.196	http://dx.doi.org/10.1136/bmj.326.7382.196			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640LD	12543836	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000180689600018
J	Henkel, V; Mergl, R; Kohnen, R; Maier, W; Moller, HJ; Hegerl, U				Henkel, V; Mergl, R; Kohnen, R; Maier, W; Moller, HJ; Hegerl, U			Identifying depression in primary care: a comparison of different methods in a prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article								Depressive disorders are a major health problem in primary care, and at least half of these disorders remain undetected.(1) There are two recommended approaches to diagnosing depression in primary care: one is to perform routine screening, and the other is to evaluate patients only when the clinical presentation triggers the suspicion of depression. Our aim was to compare these two approaches, and to compare three different screening tools in order to evaluate which would be most appropriate for use in primary care. Front among the many available screening tools, we selected three brief, self rating instruments: one disorder-specific (the depression module of the brief patient health questionnaire (B-PHQ, 9 items)),(2) one broad based (the general health questionnaire (GHQ-12, 12 items)),(3) and one that is less restricted to both issues (WHO-5 wellbeing index (WHO-5, 5 items))(4).	Univ Munich, Dept Psychiat, D-80336 Munich, Germany; Inst Med Res Management & Biometr IMEREM, D-90478 Nurnberg, Germany; Univ Bonn, Dept Psychiat, D-53105 Bonn, Germany	University of Munich; University of Bonn	Henkel, V (corresponding author), Univ Munich, Dept Psychiat, Nussbaumstr 7, D-80336 Munich, Germany.			Hegerl, Ulrich/0000-0002-3039-7470				Andrews G, 1998, SOC PSYCH PSYCH EPID, V33, P80, DOI 10.1007/s001270050026; Goldberg D, 1978, MANUAL GEN HLTH QUES; Paykel ES, 1997, AM J PSYCHIAT, V154, P59; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; *WHO, 1998, WORLD HLTH ORG INF P	5	219	220	0	13	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 25	2003	326	7382					200	201		10.1136/bmj.326.7382.200	http://dx.doi.org/10.1136/bmj.326.7382.200			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640LD	12543837	Bronze, Green Published			2022-12-28	WOS:000180689600019
J	Cavallini, M; Biscarini, F; Leon, S; Zerbetto, F; Bottari, G; Leigh, DA				Cavallini, M; Biscarini, F; Leon, S; Zerbetto, F; Bottari, G; Leigh, DA			Information storage using supramolecular surface patterns	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPY		CNR, ISMN, Sez Bologna, I-40129 Bologna, Italy; Univ Bologna, Dipartimento Chim G Ciamician, I-40126 Bologna, Italy; Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland	Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio dei Materiali Nanostrutturati (ISMN-CNR); University of Bologna; University of Edinburgh	Cavallini, M (corresponding author), CNR, ISMN, Sez Bologna, Via P Gobetti 101, I-40129 Bologna, Italy.		Zerbetto, Francesco/D-2503-2014; Bottari, Giovanni/A-8957-2013; Biscarini, Fabio/I-6814-2012; Leigh, David/K-5965-2015; CABANILLAS, SALVADOR LEON/H-4675-2015; Cavallini, Massimiliano/I-2549-2012	Zerbetto, Francesco/0000-0002-2419-057X; Bottari, Giovanni/0000-0001-6141-7027; Biscarini, Fabio/0000-0001-6648-5803; Leigh, David/0000-0002-1202-4507; CABANILLAS, SALVADOR LEON/0000-0002-2757-9417; Cavallini, Massimiliano/0000-0001-9802-0058				Binnig G, 1999, APPL PHYS LETT, V74, P1329, DOI 10.1063/1.123540; Biscarini F, 2002, J AM CHEM SOC, V124, P225, DOI 10.1021/ja0159362; Collier CP, 1999, SCIENCE, V285, P391, DOI 10.1126/science.285.5426.391; Garcia R, 1999, J APPL PHYS, V86, P1898, DOI 10.1063/1.370985; Gatti FG, 2001, J AM CHEM SOC, V123, P5983, DOI 10.1021/ja001697r; Sauvage, 1999, MOL CATENANES ROTAXA; Stoddart JF, 2001, ACCOUNTS CHEM RES, V34, P410, DOI 10.1021/ar010084w	7	179	183	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					531	531		10.1126/science.1078012	http://dx.doi.org/10.1126/science.1078012			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543965	Green Submitted			2022-12-28	WOS:000180559800038
J	Eferl, R; Ricci, R; Kenner, L; Zenz, R; David, JP; Rath, M; Wagner, EF				Eferl, R; Ricci, R; Kenner, L; Zenz, R; David, JP; Rath, M; Wagner, EF			Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53	CELL			English	Article							NF-KAPPA-B; HUMAN HEPATOCELLULAR CARCINOMAS; STRESS-INDUCED APOPTOSIS; TERMINAL PHOSPHORYLATION; MOUSE DEVELOPMENT; TRANSGENIC MICE; JNK ACTIVATION; GENE; EXPRESSION; INDUCTION	The transcription factor c-Jun mediates several cellular processes, including proliferation and survival, and is upregulated in many carcinomas. Liver-specific inactivation of c-Jun at different stages of tumor development was used to study its role in chemically induced hepatocellular carcinomas (HCCs) in mice. The requirement for c-jun was restricted to early stages of tumor development, and the number and size of hepatic tumors was dramatically reduced when c-jun was inactivated after the tumor had initiated. The impaired tumor development correlated with increased levels of p53 and its target gene noxa, resulting in the induction of apoptosis without affecting cell proliferation. Primary hepatocytes lacking c-Jun showed increased sensitivity to TNF-alpha-induced apoptosis, which was abrogated in the absence of p53. These data indicate that c-Jun prevents apoptosis by antagonizing p53 activity, illustrating a mechanism that might contribute to the early stages of human HCC development.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Wagner, EF (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Ricci, Romeo/K-3009-2013	Ricci, Romeo/0000-0002-9766-4369; Kenner, Lukas/0000-0003-2184-1338; Wagner, Erwin F/0000-0001-7872-0196; Eferl, Robert/0000-0002-6074-7144				Alarcon-Vargas D, 2002, CARCINOGENESIS, V23, P541, DOI 10.1093/carcin/23.4.541; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; BELLET DH, 1984, P NATL ACAD SCI-BIOL, V81, P3869, DOI 10.1073/pnas.81.12.3869; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Gillet R, 2000, ONCOGENE, V19, P3498, DOI 10.1038/sj.onc.1203671; HACKER HJ, 1991, CANCER RES, V51, P1952; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Kanzler S, 2001, ONCOGENE, V20, P5015, DOI 10.1038/sj.onc.1204544; KATO M, 1993, FUND APPL TOXICOL, V20, P155, DOI 10.1006/faat.1993.1021; KEKULE AS, 1993, NATURE, V361, P742, DOI 10.1038/361742a0; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; Knight B, 2000, J EXP MED, V192, P1809, DOI 10.1084/jem.192.12.1809; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LEIST M, 1994, J IMMUNOL, V153, P1778; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Masui T, 1997, CANCER LETT, V112, P33, DOI 10.1016/S0304-3835(96)04543-0; MURAKAMI Y, 1991, CANCER RES, V51, P5520; OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Okuda K, 2000, J HEPATOL, V32, P225, DOI 10.1016/S0168-8278(00)80428-6; PINKUS R, 1993, BIOCHEM J, V290, P637, DOI 10.1042/bj2900637; PITOT HC, 1990, ANNU REV PHARMACOL, V30, P465; Preston GA, 1996, MOL CELL BIOL, V16, P211; ROGLER CE, 1994, J BIOL CHEM, V269, P13779; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; SCHULTEHERMANN R, 1992, TOXICOL LETT, V64-5, P569, DOI 10.1016/0378-4274(92)90233-A; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; VESSELINOVITCH SD, 1984, J CANCER RES CLIN, V108, P60, DOI 10.1007/BF00390974; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; ZHANG XK, 1990, ONCOGENE, V5, P909	47	390	412	1	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 24	2003	112	2					181	192		10.1016/S0092-8674(03)00042-4	http://dx.doi.org/10.1016/S0092-8674(03)00042-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553907	Bronze			2022-12-28	WOS:000181191600008
J	Geldner, N; Anders, N; Wolters, H; Keicher, J; Kornberger, W; Muller, P; Delbarre, A; Ueda, T; Nakano, A; Jurgens, G				Geldner, N; Anders, N; Wolters, H; Keicher, J; Kornberger, W; Muller, P; Delbarre, A; Ueda, T; Nakano, A; Jurgens, G			The Arabidopsis GNOM ARF-GEF mediates endosomal recycling, auxin transport, and auxin-dependent plant growth	CELL			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; ADP-RIBOSYLATION FACTOR-1; BREFELDIN-A; ENDOPLASMIC-RETICULUM; PATTERN-FORMATION; PLASMA-MEMBRANE; GOLGI NETWORK; RAB GTPASE; PROTEIN; EFFLUX	Exchange factors for ARF GTPases (ARF-GEFs) regulate vesicle trafficking in a variety of organisms. The Arabidopsis protein GNOM is a brefeldin A (BFA) sensitive ARF-GEF that is required for the proper polar localization of PIN1, a candidate transporter of the plant hormone auxin. Mutations in GNOM lead to developmental defects that resemble those caused by interfering with auxin transport. Both PIN1 localization and auxin transport are also sensitive to BFA. In this paper, we show that GNOM localizes to endosomes and is required for their structural integrity. We engineered a BFA-resistant version of GNOM. In plants harboring this fully functional GNOM variant, PIN1 localization and auxin transport are no longer sensitive to BFA, while trafficking of other proteins is still affected by the drug. Our results demonstrate that GNOM is required for the recycling of auxin transport components and suggest that ARF-GEFs regulate specific endosomal trafficking pathways.	Univ Tubingen, ZMBP, D-72076 Tubingen, Germany; CNRS, Inst Sci Vegetales, F-91198 Gif Sur Yvette, France; RIKEN, Mol Membrane Biol lab, Wako, Saitama 3510198, Japan	Eberhard Karls University of Tubingen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; RIKEN	Jurgens, G (corresponding author), Univ Tubingen, ZMBP, Morgenstelle 3, D-72076 Tubingen, Germany.	gerd.juergens@zmbp.uni-tuebingen.de	Nakano, Akihiko/C-6185-2009; UEDA, TAKASHI/G-4939-2014; Nakano, Akihiko/G-4942-2014; Ueda, Takashi/G-6984-2011; Nakano, Akihiko/A-6420-2016; Geldner, Niko/Y-2481-2019	Nakano, Akihiko/0000-0003-3635-548X; Ueda, Takashi/0000-0002-5190-892X; Nakano, Akihiko/0000-0003-3635-548X; Geldner, Niko/0000-0002-2300-9644; Anders, Nadine/0000-0001-9854-576X				AUSUBEL FM, 2002, CURRENT PROTOCOLS MO; Baluska F, 2002, PLANT PHYSIOL, V130, P422, DOI 10.1104/pp.007526; BarPeled M, 1997, PLANT PHYSIOL, V114, P315, DOI 10.1104/pp.114.1.315; Bassham DC, 2000, MOL BIOL CELL, V11, P2251, DOI 10.1091/mbc.11.7.2251; Bednarek SY, 2002, TRAFFIC, V3, P621, DOI 10.1034/j.1600-0854.2002.30904.x; Boman AL, 2001, J CELL SCI, V114, P3413; Busch M, 1996, MOL GEN GENET, V250, P681, DOI 10.1007/BF02172979; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Delbarre A, 1998, PLANT PHYSIOL, V116, P833, DOI 10.1104/pp.116.2.833; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Emans N, 2002, PLANT CELL, V14, P71, DOI 10.1105/tpc.010339; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, PLANT MOL BIOL, V49, P273, DOI 10.1023/A:1015248926412; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Gaynor EC, 1998, MOL BIOL CELL, V9, P653, DOI 10.1091/mbc.9.3.653; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Grebe M, 2002, CURR BIOL, V12, P329, DOI 10.1016/S0960-9822(02)00654-1; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Gu F, 2000, J BIOL CHEM, V275, P8154, DOI 10.1074/jbc.275.11.8154; Hadfi K, 1998, DEVELOPMENT, V125, P879; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Heese M, 2001, J CELL BIOL, V155, P239, DOI 10.1083/jcb.200107126; Holstein SEH, 2002, TRAFFIC, V3, P614, DOI 10.1034/j.1600-0854.2002.30903.x; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; Jurgens G, 2002, TRAFFIC, V3, P605, DOI 10.1034/j.1600-0854.2002.30902.x; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Lee MH, 2002, PLANT PHYSIOL, V129, P1507, DOI 10.1104/pp.003624; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Lukowitz W, 1996, CELL, V84, P61, DOI 10.1016/S0092-8674(00)80993-9; MAYER U, 1993, DEVELOPMENT, V117, P149; Morris DA, 1998, PLANTA, V205, P606, DOI 10.1007/s004250050363; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; ORCI L, 1991, CELL, V64, P1183; Parry G, 2001, PLANT J, V25, P399, DOI 10.1046/j.1365-313x.2001.00970.x; Parton RM, 2001, J CELL SCI, V114, P2685; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Peyroche A, 2001, J CELL SCI, V114, P2241; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Robineau S, 2000, P NATL ACAD SCI USA, V97, P9913, DOI 10.1073/pnas.170290597; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Sanderfoot AA, 2001, PLANT CELL, V13, P659, DOI 10.1105/tpc.13.3.659; Sata M, 1999, P NATL ACAD SCI USA, V96, P2752, DOI 10.1073/pnas.96.6.2752; SATIATJEUNEMAITRE B, 1992, J CELL SCI, V103, P1153; SHEVELL DE, 1994, CELL, V77, P1051, DOI 10.1016/0092-8674(94)90444-8; Shevell DE, 2000, PLANT CELL, V12, P2047, DOI 10.1105/tpc.12.11.2047; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Takeuchi M, 2002, PLANT J, V31, P499, DOI 10.1046/j.1365-313X.2002.01372.x; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; Ueda T, 2002, CURR OPIN PLANT BIOL, V5, P513, DOI 10.1016/S1369-5266(02)00299-6; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wee EGT, 1998, PLANT CELL, V10, P1759, DOI 10.1105/tpc.10.10.1759; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; Yahara N, 2001, MOL BIOL CELL, V12, P221, DOI 10.1091/mbc.12.1.221; Yasuhara H, 2000, PLANT CELL PHYSIOL, V41, P300, DOI 10.1093/pcp/41.3.300; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420	64	838	891	4	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 24	2003	112	2					219	230		10.1016/S0092-8674(03)00003-5	http://dx.doi.org/10.1016/S0092-8674(03)00003-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553910	Bronze			2022-12-28	WOS:000181191600011
J	Nair, SK; Burley, SK				Nair, SK; Burley, SK			X-ray structures of Myc-Max and Mad-Max recognizing DNA: Molecular bases of regulation by proto-oncogenic transcription factors	CELL			English	Article							C-MYC; CRYSTAL-STRUCTURE; LEUCINE ZIPPER; INDUCED-DIFFERENTIATION; TRANSFORMING ACTIVITY; NUCLEOTIDE-SEQUENCE; BURKITT-LYMPHOMA; GENE-REGULATION; REPRESSOR SIN3; TARGET GENES	X-ray structures of the basic/helix-loop-helix/leucine zipper (bHLHZ) domains of Myc-Max and Mad-Max heterodimers bound to their common DNA target (Enhancer or E box hexanucleotide, 5'-CACGTG-3') have been determined at 1.9 Angstrom and 2.0 Angstrom resolution, respectively. E box recognition by these two structurally similar transcription factor pairs determines whether a cell will divide and proliferate (Myc-Max) or differentiate and become quiescent (Mad-Max). Deregulation of Myc has been implicated in the development of many human cancers, including Burkitt's lymphoma, neuroblastomas, and small cell lung cancers. Both quasi-symmetric heterodimers resemble the symmetric Max homodimer, albeit with marked structural differences in the coiled-coil leucine zipper regions that explain preferential homo- and heteromeric dimerization of these three evolutionarily related DNA-binding proteins. The Myc-Max heterodimer, but not its Mad-Max counterpart, dimerizes to form a bivalent heterotetramer, which explains how Myc can upregulate expression of genes with promoters bearing widely separated E boxes.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Burley, SK (corresponding author), Struct Genomix Inc, 10505 Roselle St, San Diego, CA 92121 USA.	stephen_burley@stromix.com	Nair, Satish/AAY-2510-2021	Burley, Stephen K./0000-0002-2487-9713				AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BACA M, 1995, J AM CHEM SOC, V117, P1881, DOI 10.1021/ja00112a003; Bao JX, 1996, ONCOGENE, V12, P2171; BENVENISTY N, 1992, ONCOGENE, V7, P2399; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Brownlie P, 1997, STRUCTURE, V5, P509, DOI 10.1016/S0969-2126(97)00207-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DANG CV, 1992, P NATL ACAD SCI USA, V89, P599, DOI 10.1073/pnas.89.2.599; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; DANG CV, 1989, NATURE, V337, P664, DOI 10.1038/337664a0; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Eilers M, 1999, MOL CELLS, V9, P1; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FISHER DE, 1992, P NATL ACAD SCI USA, V89, P11779, DOI 10.1073/pnas.89.24.11779; GAUBATZ S, 1995, EMBO J, V14, P1508, DOI 10.1002/j.1460-2075.1995.tb07137.x; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; Grandori C, 1997, TRENDS BIOCHEM SCI, V22, P177, DOI 10.1016/S0968-0004(97)01025-6; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; HILL CP, 1993, P NATL ACAD SCI USA, V90, P5167, DOI 10.1073/pnas.90.11.5167; HURLIN PJ, 1994, COLD SPRING HARB SYM, V59, P109, DOI 10.1101/SQB.1994.059.01.014; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOHL NE, 1983, CELL, V35, P359, DOI 10.1016/0092-8674(83)90169-1; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kretzner L, 1992, Curr Top Microbiol Immunol, V182, P435; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Larsson LG, 1997, ONCOGENE, V15, P737, DOI 10.1038/sj.onc.1201390; LARSSON LG, 1994, ONCOGENE, V9, P1247; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; McArthur GA, 1998, COLD SPRING HARB SYM, V63, P423, DOI 10.1101/sqb.1998.63.423; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MOORE JP, 1987, ONCOGENE RES, V2, P65; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NEKLUDOVA L, 1994, P NATL ACAD SCI USA, V91, P6948, DOI 10.1073/pnas.91.15.6948; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; O'Hagan RC, 2000, NAT GENET, V24, P113, DOI 10.1038/72761; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parraga A, 1998, STRUCT FOLD DES, V6, P661, DOI 10.1016/S0969-2126(98)00067-7; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; Rudolph C, 1999, ANAL BIOCHEM, V269, P66, DOI 10.1006/abio.1999.3095; Sakamuro D, 1999, ONCOGENE, V18, P2942, DOI 10.1038/sj.onc.1202725; Saleh A, 1998, J BIOL CHEM, V273, P26559, DOI 10.1074/jbc.273.41.26559; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; SCHWAB M, 1984, NATURE, V308, P288, DOI 10.1038/308288a0; SHEINESS D, 1978, J VIROL, V28, P600, DOI 10.1128/JVI.28.2.600-610.1978; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Wang Q, 1998, ONCOGENE, V17, P1939, DOI 10.1038/sj.onc.1202403; WATSON DK, 1983, P NATL ACAD SCI-BIOL, V80, P3642, DOI 10.1073/pnas.80.12.3642; WATT R, 1983, NATURE, V303, P725, DOI 10.1038/303725a0; Winston RL, 2000, CHEM BIOL, V7, P245, DOI 10.1016/S1074-5521(00)00099-5; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	69	367	399	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 24	2003	112	2					193	205		10.1016/S0092-8674(02)01284-9	http://dx.doi.org/10.1016/S0092-8674(02)01284-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553908	Bronze			2022-12-28	WOS:000181191600009
J	Tulin, A; Spradling, A				Tulin, A; Spradling, A			Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci	SCIENCE			English	Article							EXPRESSION	Steroid response and stress-activated genes such as hsp70 undergo puffing in Drosophila larval salivary glands, a local loosening of polytene chromatin structure associated with gene induction. We find that puffs acquire elevated levels of adenosine diphosphate ( ADP)-ribose modified proteins and that poly( ADP) ribose polymerase ( PARP) is required to produce normal-sized puffs and normal amounts of Hsp70 after heat exposure. We propose that chromosomal PARP molecules become activated by developmental or environmental cues and strip nearby chromatin proteins off DNA to generate a puff. Such local loosening may facilitate transcription and may transiently make protein complexes more accessible to modi cation, promoting chromatin remodeling during development.	Carnegie Inst Sci, Dept Embryol, Howard Hughes Med Res Labs, Baltimore, MD 21210 USA	Carnegie Institution for Science	Tulin, A (corresponding author), Carnegie Inst Sci, Dept Embryol, Howard Hughes Med Res Labs, 115 W Univ Pkwy, Baltimore, MD 21210 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027875, R01GM027875] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM27875] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CARTWRIGHT IL, 1986, MOL CELL BIOL, V6, P779, DOI 10.1128/MCB.6.3.779; Hagstrom K, 1997, CURR OPIN GENET DEV, V7, P814, DOI 10.1016/S0959-437X(97)80045-7; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Kameoka M, 2000, BIOCHEM J, V346, P641, DOI 10.1042/0264-6021:3460641; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MEYEROWITZ EM, 1985, COLD SPRING HARB SYM, V50, P347, DOI 10.1101/SQB.1985.050.01.044; SIMON JA, 1985, CHROMOSOMA, V93, P26, DOI 10.1007/BF01259442; Thummel CS, 2002, INSECT BIOCHEM MOLEC, V32, P113, DOI 10.1016/S0965-1748(01)00112-6; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Ziegler M, 2001, BIOESSAYS, V23, P543, DOI 10.1002/bies.1074	10	370	381	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					560	562		10.1126/science.1078764	http://dx.doi.org/10.1126/science.1078764			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543974				2022-12-28	WOS:000180559800048
J	Nossal, GJV				Nossal, GJV			The double helix and immunology	NATURE			English	Article							REGIONS; SEQUENCES; PROTEINS; CHAINS; GENES; MYC	The immune system can recognize and produce antibodies to virtually any molecule in the Universe. This enormous diversity arises from the ingenious reshuffling of DNA sequences encoding components of the immune system. Immunology is an example of a field completely transformed during the past 50 years by the discovery of the structure of DNA and the emergence of DNA technologies that followed.	Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia	University of Melbourne	Nossal, GJV (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia.							BERNARD O, 1983, EMBO J, V2, P2375, DOI 10.1002/j.1460-2075.1983.tb01749.x; BERNARD O, 1978, CELL, V15, P1133, DOI 10.1016/0092-8674(78)90041-7; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Breinl F., 1930, Z PHYSL CHEM, V192, P45; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Burnet FM, 1949, PRODUCTION ANTIBODIE; Croonian lecture, 1900, P R SOC LOND, V66, P424, DOI [DOI 10.1098/RSPL.1899.0121, 10.1098/rspl.1899.0121]; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; DREYER WJ, 1965, P NATL ACAD SCI USA, V54, P864, DOI 10.1073/pnas.54.3.864; EDELMAN GM, 1969, ANNU REV BIOCHEM, V38, P415, DOI 10.1146/annurev.bi.38.070169.002215; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; HILSCHMANN N, 1965, P NATL ACAD SCI USA, V53, P1403, DOI 10.1073/pnas.53.6.1403; HOZUMI N, 1976, P NATL ACAD SCI USA, V73, P3628, DOI 10.1073/pnas.73.10.3628; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; KOCKS C, 1989, ANNU REV IMMUNOL, V7, P537, DOI 10.1146/annurev.iy.07.040189.002541; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Landsteiner K., 1945, SPECIFICITY SEROLOGI; NOSSAL GJV, 1958, NATURE, V181, P1419, DOI 10.1038/1821383a0; NOSSAL GJV, 1980, P NATL ACAD SCI-BIOL, V77, P1602, DOI 10.1073/pnas.77.3.1602; TALMAGE DW, 1957, ANNU REV MED, V8, P239, DOI 10.1146/annurev.me.08.020157.001323; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	24	21	23	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					440	444		10.1038/nature01409	http://dx.doi.org/10.1038/nature01409			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540919	Bronze			2022-12-28	WOS:000180533000060
J	Yamamoto, T; Koashi, M; Ozdemir, SK; Imoto, N				Yamamoto, T; Koashi, M; Ozdemir, SK; Imoto, N			Experimental extraction of an entangled photon pair from two identically decohered pairs	NATURE			English	Article							QUANTUM CRYPTOGRAPHY; PURIFICATION; STATE	Entanglement is considered to be one of the most important resources in quantum information processing schemes, including teleportation(1-3), densecoding(4) and entanglement-based quantum key distribution(5). Because entanglement cannot be generated by classical communication between distant parties, distribution of entangled particles between them is necessary. During the distribution process, entanglement between the particles is degraded by the decoherence and dissipation processes that result from unavoidable coupling with the environment. Entanglement distillation and concentration schemes(6-9) are therefore needed to extract pairs with a higher degree of entanglement from these less-entangled pairs; this is accomplished using local operations and classical communication. Here we report an experimental demonstration of extraction of a polarization-entangled photon pair from two decohered photon pairs. Two polarization-entangled photon pairs are generated by spontaneous parametric down-conversion and then distributed through a channel that induces identical phase fluctuations to both pairs; this ensures that no entanglement is available as long as each pair is manipulated individually. Then, through collective local operations and classical communication we extract from the two decohered pairs a photon pair that is observed to be polarization-entangled.	Grad Univ Adv Studies SOKENDAI, Sch Adv Sci, Kanagawa 2400193, Japan; CREST Interacting Carrier Elect Project, Kawaguchi 3310012, Japan; NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan	Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); Nippon Telegraph & Telephone Corporation	Imoto, N (corresponding author), Grad Univ Adv Studies SOKENDAI, Sch Adv Sci, Kanagawa 2400193, Japan.	imoto@soken.ac.jp	Ozdemir, Sahin Kaya/Y-9338-2019; , やまもとたかし/C-2838-2013; Ozdemir, Sahin K/C-8879-2009	Ozdemir, Sahin Kaya/0000-0002-2625-3992; , やまもとたかし/0000-0002-9526-6041; Ozdemir, Sahin K/0000-0002-2625-3992				BENNETT CH, 1992, PHYS REV LETT, V69, P2881, DOI 10.1103/PhysRevLett.69.2881; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bennett CH, 1996, PHYS REV A, V54, P3824, DOI 10.1103/PhysRevA.54.3824; Bennett CH, 1996, PHYS REV LETT, V76, P722, DOI 10.1103/PhysRevLett.76.722; Bennett CH, 1996, PHYS REV A, V53, P2046, DOI 10.1103/PhysRevA.53.2046; Bose S, 1999, PHYS REV A, V60, P194, DOI 10.1103/PhysRevA.60.194; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Bouwmeester D, 1999, PHYS REV LETT, V82, P1345, DOI 10.1103/PhysRevLett.82.1345; Deutsch D, 1996, PHYS REV LETT, V77, P2818, DOI 10.1103/PhysRevLett.77.2818; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; James DFV, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052312; Jennewein T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.017903; Kim YH, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.011802; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Koashi M, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.030301; Kwiat PG, 1999, PHYS REV A, V60, pR773, DOI 10.1103/PhysRevA.60.R773; Kwiat PG, 2001, NATURE, V409, P1014, DOI 10.1038/35059017; Lamas-Linares A, 2001, NATURE, V412, P887, DOI 10.1038/35091014; Nagata K, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.042314; Ozdemir SK, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.053809; Pan JW, 2001, PHYS REV LETT, V86, P4435, DOI 10.1103/PhysRevLett.86.4435; Pan JW, 1998, PHYS REV A, V57, P2208, DOI 10.1103/PhysRevA.57.2208; Pan JW, 2001, NATURE, V410, P1067, DOI 10.1038/35074041; Pittman TB, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.062311; Pittman TB, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.257902; RARITY JG, 1995, ANN NY ACAD SCI, V755, P624, DOI 10.1111/j.1749-6632.1995.tb39002.x; Yamamoto T, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.012304; Zhao Z, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.014301; ZUKOWSKI M, 1995, ANN NY ACAD SCI, V755, P91, DOI 10.1111/j.1749-6632.1995.tb38959.x	30	179	180	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					343	346		10.1038/nature01358	http://dx.doi.org/10.1038/nature01358			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540894				2022-12-28	WOS:000180533000034
J	Zheng, XY; Wang, J; Haerry, TE; Wu, AYH; Martin, J; O'Connor, MB; Lee, CHJ; Lee, T				Zheng, XY; Wang, J; Haerry, TE; Wu, AYH; Martin, J; O'Connor, MB; Lee, CHJ; Lee, T			TGF-beta signaling activates steroid hormone receptor expression during neuronal remodeling in the Drosophila brain	CELL			English	Article							REPRESSIBLE CELL MARKER; ECDYSONE RECEPTOR; MUSHROOM BODIES; CAENORHABDITIS-ELEGANS; LARVAL DEVELOPMENT; MOSAIC ANALYSIS; NERVOUS-SYSTEM; II RECEPTOR; C-ELEGANS; METAMORPHOSIS	Metamorphosis of the Drosophila brain involves pruning of many larval-specific dendrites and axons followed by outgrowth of adult-specific processes. From a genetic mosaic screen, we recovered two independent mutations that block neuronal remodeling in the mushroom bodies (MBs). These phenotypically indistinguishable mutations affect Baboon function, a Drosophila TGF-beta/activin type I receptor, and dSmad2, its downstream transcriptional effector. We also show that Punt and Wit, two type II receptors, act redundantly in this process. In addition, knocking out dActivin around the mid-third instar stage interferes with remodeling. Binding of the insect steroid hormone ecdysone to distinct ecdysone receptor isoforms induces different metamorphic responses in various larval tissues. Interestingly, expression of the ecdysone receptor B1 isoform (EcR-B1) is reduced in activin pathway mutants, and restoring EcR-B1 expression significantly rescues remodeling defects. We conclude that the Drosophila Activin signaling pathway mediates neuronal remodeling in part by regulating EcR-B1 expression.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Internal Med, Hematol Oncol Sect, Chicago, IL 60612 USA; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN 55455 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities	Lee, T (corresponding author), Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA.		O'Connor, Michael B/C-9977-2014; Zheng, Xiaoyan/AAG-1251-2020	O'Connor, Michael B/0000-0002-3067-5506; Zheng, Xiaoyan/0000-0003-4983-5503	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042049] Funding Source: NIH RePORTER; NINDS NIH HHS [NS42049] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Antebi A, 2000, GENE DEV, V14, P1512; Bender M, 1997, CELL, V91, P777, DOI 10.1016/S0092-8674(00)80466-3; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Chen YJ, 1998, DEVELOPMENT, V125, P1759; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Das P, 1999, GENES CELLS, V4, P123, DOI 10.1046/j.1365-2443.1999.00244.x; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Dockendorff TC, 2000, MOL GEN GENET, V263, P137, DOI 10.1007/s004380050040; Ebendal T, 1998, J NEUROSCI RES, V51, P139, DOI 10.1002/(SICI)1097-4547(19980115)51:2<139::AID-JNR2>3.0.CO;2-E; Feng XH, 1996, J BIOL CHEM, V271, P13123, DOI 10.1074/jbc.271.22.13123; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Henderson KD, 1998, BIOCHEM BIOPH RES CO, V252, P195, DOI 10.1006/bbrc.1998.9562; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Inoue T, 2000, DEV BIOL, V217, P192, DOI 10.1006/dbio.1999.9545; KONEV AY, 1994, GENETIKA+, V30, P201; Kutty G, 1998, BIOCHEM BIOPH RES CO, V246, P644, DOI 10.1006/bbrc.1998.8678; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; LEVINE RB, 1984, J EXP BIOL, V112, P27; Levine Richard B., 1995, Current Opinion in Neurobiology, V5, P28, DOI 10.1016/0959-4388(95)80083-2; Li H, 2001, NEUROSCIENCE, V106, P193, DOI 10.1016/S0306-4522(01)00263-9; Lo PCH, 1999, MECH DEVELOP, V86, P171, DOI 10.1016/S0925-4773(99)00108-2; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; MURAKAMI F, 1992, NEUROSCI RES, V15, P235, DOI 10.1016/0168-0102(92)90045-E; Newfeld SJ, 1999, GENETICS, V152, P783; Nguyen M, 2000, MECH DEVELOP, V95, P201, DOI 10.1016/S0925-4773(00)00338-5; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; Osada SI, 1999, DEVELOPMENT, V126, P3229; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Riddle DL, 1997, GENETIC ENV REGULATI, P739, DOI DOI 10.1101/087969532.33.739; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Savage-Dunn C, 2001, CYTOKINE GROWTH F R, V12, P305, DOI 10.1016/S1359-6101(01)00015-6; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; TRUMAN JW, 1994, DEVELOPMENT, V120, P219; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; YANG MY, 1995, NEURON, V15, P45; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F	55	173	177	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 7	2003	112	3					303	315		10.1016/S0092-8674(03)00072-2	http://dx.doi.org/10.1016/S0092-8674(03)00072-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581521	Bronze			2022-12-28	WOS:000181252200003
J	Kellermann, KI				Kellermann, KI			Grote Reber (1911-2002) - Obituary	NATURE			English	Biographical-Item									Natl Radio Astron Observ, Charlottesville, VA 22903 USA	National Radio Astronomy Observatory (NRAO)	Kellermann, KI (corresponding author), Natl Radio Astron Observ, 520 Edgemont Rd, Charlottesville, VA 22903 USA.	kkellerm@nrao.edu							0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2003	421	6923					596	596		10.1038/421596a	http://dx.doi.org/10.1038/421596a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571584				2022-12-28	WOS:000180803200030
J	Moore, G; Showstack, J				Moore, G; Showstack, J			Primary care medicine in crisis: Toward reconstruction and renewal	ANNALS OF INTERNAL MEDICINE			English	Article							DEPENDENT DIABETES-MELLITUS; UNITED-STATES; ALTERNATIVE MEDICINE; PHYSICIANS	Primary care is in crisis. Despite its proud history and theoretical advantages, the field has failed to hold its own among medical specialties. While the rest of medicine promises technology and sophistication, the basic model of primary care has changed little over the past half-century. Why has the transition from general practice to today's primary care been so difficult? Many of the causes of this struggle may lie within primary care itself, ranging from failure to articulate to the public (and insurers and policy-makers) what value it, and it alone, can offer, to taking on an ever-broadening set of roles and responsibilities while all too often failing short of its promises. Perhaps most important, in the emerging health care system, the lack of a discrete definition of primary care has allowed managed care organizations and payers, among others, to define the role of primary care to suit their own interests. In response to a changing marketplace, political uncertainty, and shifting consumer expectations, primary care will need to reconstruct itself. The reconstruction will not be easy. Nevertheless, a process should begin that moves the field in the right direction. Building on its unique abilities, primary care can emerge as a redefined product that is attractive to patients, payers, and primary care practitioners alike.	Univ Calif San Francisco, San Francisco, CA 94118 USA; Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care, Boston, MA USA	University of California System; University of California San Francisco; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School	Showstack, J (corresponding author), Univ Calif San Francisco, 3333 Calif St,Suite 265, San Francisco, CA 94118 USA.		Showstack, Jonathan/L-6556-2013	Showstack, Jonathan/0000-0002-1367-419X				Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Billings J., 2000, EMERGENCY DEP USE NE; Bodenheimer T, 1999, JAMA-J AM MED ASSOC, V281, P2045, DOI 10.1001/jama.281.21.2045; Donaldson M, 1996, PRIMARY CARE AM HLTH; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; GREENFIELD S, 1995, JAMA-J AM MED ASSOC, V274, P1436; Grumbach K, 1999, NEW ENGL J MED, V341, P2008, DOI 10.1056/NEJM199912233412611; Hiss RG, 1996, ANN INTERN MED, V124, P146, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00012; *I MED, 1978, MANP POL PRIM CAR; *I MED COMM QUAL H, 2001, CROSS QUAL CHASM NEW, P56; Larson EB, 2001, ANN INTERN MED, V134, P997, DOI 10.7326/0003-4819-134-10-200105150-00013; Lostumbo EM, 2002, ACAD MED, V77, P588; Mainous AG, 2001, FAM MED, V33, P22; Merlis ML., 2002, FAMILY OUT OF POCKET; Mundinger, 2000, JAMA, V283, P2521; Pear Robert, 2002, NY TIMES        0517, pA1; ROBINSON JC, RENEWED EMPHASIS CON; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; Rosenblatt RA, 1998, JAMA-J AM MED ASSOC, V279, P1364, DOI 10.1001/jama.279.17.1364; Rothman AA, 2003, ANN INTERN MED, V138, P256, DOI 10.7326/0003-4819-138-3-200302040-00034; Safran DG, 2003, ANN INTERN MED, V138, P248, DOI 10.7326/0003-4819-138-3-200302040-00033; Sandy LG, 2003, ANN INTERN MED, V138, P262, DOI 10.7326/0003-4819-138-3-200302040-00035; Starfield B, 1998, PRIMARY CARE BALANCI; Stevens RA, 2001, FAM MED, V33, P232; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Weiner JP, 2002, HEALTH AFFAIR, V21, P160, DOI 10.1377/hlthaff.21.1.160; Young GP, 1996, JAMA-J AM MED ASSOC, V276, P460, DOI 10.1001/jama.276.6.460	28	84	85	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					244	247		10.7326/0003-4819-138-3-200302040-00032	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00032			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558374				2022-12-28	WOS:000181018600024
J	Rona, PA				Rona, PA			Resources of the sea floor	SCIENCE			English	Editorial Material									Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Geol Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Rona, PA (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA.	rona@imcs.rutgers.edu						BROARD WJ, 1997, NY TIMES        0127, pA1; GARNETT RHT, 2000, MAR SCI SER, P103; HEIN JR, COMMUNICATION; Herzig P.M., 2000, MAR SCI SER, P347; HUMPHRIS SE, 1995, NATURE, V377, P713, DOI 10.1038/377713a0; Iizasa K, 1999, SCIENCE, V283, P975, DOI 10.1126/science.283.5404.975; JANNASCH HW, 1995, J MAR BIOTECHNOL, V3, P5; Koschinsky A, 2000, MAR SCI SER, P239; LENOBLE JP, 1995, MARINE MINERAL OCCUR, P1; MEADE C, 1991, SCIENCE, V252, P68, DOI 10.1126/science.252.5002.68; Mero J.L., 1965, MINERAL RESOURCES SE, DOI DOI 10.1016/S0422-9894(08)70765-7; Nawab Z, 2001, PROPOSED TECHNOLOGIE, P26; Rona PA, 2002, EPISODES, V25, P2, DOI 10.18814/epiiugs/2002/v25i1/001; RONA PA, 1993, ECON GEOL, V8, P1989; Yang KH, 1996, NATURE, V383, P420, DOI 10.1038/383420a0	15	109	117	3	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					673	674		10.1126/science.1080679	http://dx.doi.org/10.1126/science.1080679			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560541				2022-12-28	WOS:000180687700035
J	Baden, LR; Elliott, DD; Miseljic, S; Ryan, ET; Wain, JC				Baden, LR; Elliott, DD; Miseljic, S; Ryan, ET; Wain, JC			Case 4-2003: A 42-year-old woman with cough, fever, and abnormalities on thoracoabdominal computed tomography - Echinococcus granulosus infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PULMONARY HYDATID-DISEASE; SURGICAL-TREATMENT; PERCUTANEOUS TREATMENT; SEROLOGICAL TESTS; ALBENDAZOLE; DIAGNOSIS; CYSTS; LUNG; LIVER; CT		Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Baden, LR (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.							ACUNAS B, 1992, RADIOLOGY, V182, P541, DOI 10.1148/radiology.182.2.1732977; Akhan O, 1996, RADIOLOGY, V198, P259, DOI 10.1148/radiology.198.1.8539390; Aktan AO, 1996, EUR J GASTROEN HEPAT, V8, P877; BABBA H, 1994, AM J TROP MED HYG, V50, P64, DOI 10.4269/ajtmh.1994.50.64; BALDELLI F, 1992, PATHOLOGY, V24, P75, DOI 10.3109/00313029209063628; BARTLETT JG, 1974, AM REV RESPIR DIS, V109, P510; BARTLETT JG, 1974, AM REV RESPIR DIS, V110, P56; BARTLETT JG, 1987, CHEST, V91, P901, DOI 10.1378/chest.91.6.901; BEHRNS KE, 1991, MAYO CLIN PROC, V66, P1193, DOI 10.1016/S0025-6196(12)62469-0; Bhatia G, 1997, Semin Respir Infect, V12, P171; Biava MF, 2001, WORLD J SURG, V25, P10, DOI 10.1007/s002680020002; Bickel A, 1998, SURG ENDOSC-ULTRAS, V12, P1073, DOI 10.1007/s004649900783; BURGOS L, 1991, J THORAC CARDIOV SUR, V102, P427; Cobo F, 1998, TROP MED INT HEALTH, V3, P462; DOGAN R, 1989, THORAX, V44, P192, DOI 10.1136/thx.44.3.192; Erzurumlu K, 2000, HEPATO-GASTROENTEROL, V47, P247; FORCE L, 1992, CLIN INFECT DIS, V15, P473, DOI 10.1093/clind/15.3.473; GOULIAMOS AD, 1991, CHEST, V100, P1578, DOI 10.1378/chest.100.6.1578; HUXLEY EJ, 1978, AM J MED, V64, P564, DOI 10.1016/0002-9343(78)90574-0; JERRAY M, 1992, AM REV RESPIR DIS, V146, P185, DOI 10.1164/ajrccm/146.1.185; Kervancioglu R, 1999, ACTA RADIOL, V40, P510, DOI 10.3109/02841859909175576; Khuroo MS, 1997, NEW ENGL J MED, V337, P881, DOI 10.1056/NEJM199709253371303; KHUROO MS, 1993, GASTROENTEROLOGY, V104, P1452, DOI 10.1016/0016-5085(93)90355-G; Lewall DB, 1998, CLIN RADIOL, V53, P863, DOI 10.1016/S0009-9260(98)80212-2; Liu LX, 1996, NEW ENGL J MED, V334, P1178, DOI 10.1056/NEJM199605023341808; MADDISON SE, 1989, AM J TROP MED HYG, V40, P377, DOI 10.4269/ajtmh.1989.40.377; Men S, 1999, AM J ROENTGENOL, V172, P83, DOI 10.2214/ajr.172.1.9888745; OSLER W, 1914, MODERN MED ITS THEOR, V2, P265; OZCELIK C, 1994, J PEDIATR SURG, V29, P392, DOI 10.1016/0022-3468(94)90575-4; Pawlowski ZS, 2001, WHO/OIE MANUAL ON ECHINOCOCCOSIS IN HUMANS AND ANIMALS: A PUBLIC HEALTH PROBLEM OF GLOBAL CONCERN, P20; Ramos G, 2001, WORLD J SURG, V25, P46, DOI 10.1007/s002680020007; SAKSOUK FA, 1986, J COMPUT ASSIST TOMO, V10, P226, DOI 10.1097/00004728-198603000-00011; SHANTZ PM, 1999, TROPICAL INFECT DIS, V2, P1005; TAYLOR DH, 1989, BRIT J SURG, V76, P954, DOI 10.1002/bjs.1800760927; VONSINNER WN, 1991, EUR J RADIOL, V12, P150, DOI 10.1016/0720-048X(91)90119-G; VONSINNER WN, 1990, EUR J RADIOL, V11, P31, DOI 10.1016/0720-048X(90)90099-W; Vuitton DA, 1996, B WORLD HEALTH ORGAN, V74, P231; YASAWY MI, 1993, TROP MED PARASITOL, V44, P192; Zarzosa MP, 1999, DIAGN MICR INFEC DIS, V35, P255, DOI 10.1016/S0732-8893(99)00079-6	39	8	8	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					447	455		10.1056/NEJMcpc020027	http://dx.doi.org/10.1056/NEJMcpc020027			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12556547				2022-12-28	WOS:000180643800012
J	Aitken, D				Aitken, D			WHO responds	BRITISH MEDICAL JOURNAL			English	Article									WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Aitken, D (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.							Yamey G, 2002, BRIT MED J, V325, P1236, DOI 10.1136/bmj.325.7374.1236; Yamey G, 2002, BMJ-BRIT MED J, V325, P1107, DOI 10.1136/bmj.325.7372.1107; Yamey G, 2002, BMJ-BRIT MED J, V325, P1170, DOI 10.1136/bmj.325.7373.1170	3	1	1	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 25	2003	326	7382					217	218		10.1136/bmj.326.7382.217	http://dx.doi.org/10.1136/bmj.326.7382.217			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640LD	12543842	Green Published			2022-12-28	WOS:000180689600026
J	Tuohy, KA; Nicholson, WJ; Schiffman, F				Tuohy, KA; Nicholson, WJ; Schiffman, F			Agitation by sedation	LANCET			English	Editorial Material							OSMOLAR GAP		Brown Univ, Miriam Hosp, Dept Med, Providence, RI 02906 USA	Brown University; Lifespan Health Rhode Island; Miriam Hospital	Schiffman, F (corresponding author), Brown Univ, Miriam Hosp, Dept Med, 164 Summit Ave, Providence, RI 02906 USA.	fschiffman@lifespan.org						Arbour R, 2000, CHEST, V118, P545, DOI 10.1378/chest.118.2.545; BURKHART K K, 1990, Emergency Medicine Clinics of North America, V8, P913; NORDT SP, 1998, GOLDFRANKS TOXICOLOG, P913; Reynolds HN, 2000, CRIT CARE MED, V28, P1631, DOI 10.1097/00003246-200005000-00063; Tayar J, 2002, NEW ENGL J MED, V346, P1253, DOI 10.1056/NEJM200204183461618	5	15	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2003	361	9354					308	308		10.1016/S0140-6736(03)12326-4	http://dx.doi.org/10.1016/S0140-6736(03)12326-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559866				2022-12-28	WOS:000180643900013
J	Alonso, S; Sagues, F; Mikhailov, AS				Alonso, S; Sagues, F; Mikhailov, AS			Taming Winfree turbulence of scroll waves in excitable media	SCIENCE			English	Article							CARDIAC FIBRILLATION; PATTERN-FORMATION; CHEMICAL-SYSTEM; MECHANISMS; FEEDBACK; LIFETIME; MODEL; RINGS	Winfree turbulence of scroll waves is a special kind of spatiotemporal chaos that exists exclusively in three-dimensional excitable media and is currently considered one of the principal mechanisms of cardiac fibrillation. A chaotic wave pattern develops through the negative-tension instability of vortex filaments, which tend to spontaneously stretch, bend, loop, and produce an expanding tangle that fills up the volume. We demonstrate that such turbulence can readily be controlled by weak nonresonant modulation of the medium excitability. Depending on the forcing frequency, either suppression or induction of turbulence can be achieved.	Max Planck Gesell, Fritz Haber Inst, Phys Chem Abt, D-14195 Berlin, Germany; Univ Barcelona, Dept Quim Fis, E-08028 Barcelona, Spain	Max Planck Society; Fritz Haber Institute of the Max Planck Society; University of Barcelona	Mikhailov, AS (corresponding author), Max Planck Gesell, Fritz Haber Inst, Phys Chem Abt, Faradayweg 4-6, D-14195 Berlin, Germany.	mikhailov@fhi-berlin.mpg.de	Alonso, Sergio/L-6177-2014; Alonso, Sergio/GVR-8346-2022; Sagues, Francesc/K-6414-2015	Alonso, Sergio/0000-0002-3989-8757; Sagues, Francesc/0000-0002-2956-5676				ABRAMYCHEV A Y, 1990, Biophysics (English Translation of Biofizika), V35, P520; Alonso S., UNPUB; Amemiya T, 1998, CHAOS, V8, P872, DOI 10.1063/1.166373; Aranson I, 1998, PHYS REV E, V58, P4556, DOI 10.1103/PhysRevE.58.4556; BARKLEY D, 1990, PHYS REV A, V42, P2489, DOI 10.1103/PhysRevA.42.2489; BIKTASHEV VN, 1994, PHILOS T R SOC A, V347, P611, DOI 10.1098/rsta.1994.0070; BRAZHNIK PK, 1987, ZH EKSP TEOR FIZ, V66, P984; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Fiedler B., 2000, DOCUMENTA MATH, V5, P695; GRAY RA, 1995, SCIENCE, V270, P1222, DOI 10.1126/science.270.5239.1222; Henry H, 2000, PHYS REV LETT, V85, P5328, DOI 10.1103/PhysRevLett.85.5328; KEENER JP, 1988, SCIENCE, V239, P1284, DOI 10.1126/science.239.4845.1284; Kheowan OU, 2001, PHYS REV LETT, V86, P2170, DOI 10.1103/PhysRevLett.86.2170; Kim M, 2001, SCIENCE, V292, P1357, DOI 10.1126/science.1059478; Lin AL, 2000, PHYS REV LETT, V84, P4240, DOI 10.1103/PhysRevLett.84.4240; Mantel RM, 2001, PHYSICA D, V149, P107, DOI 10.1016/S0167-2789(00)00185-8; MIKHAILOV AS, 1995, FDN SYNERGETICS, V1; PANFILOV AV, 1995, SCIENCE, V270, P1223; PANFILOV AV, 1987, PHYSICA D, V28, P215, DOI 10.1016/0167-2789(87)90132-1; Perez-Munuzuri V, 2000, PHYS REV E, V62, P94, DOI 10.1103/PhysRevE.62.94; Petrov V, 1997, NATURE, V388, P655, DOI 10.1038/41732; Sakurai T, 2002, SCIENCE, V296, P2009, DOI 10.1126/science.1071265; SIEGERT F, 1992, P NATL ACAD SCI USA, V89, P6433, DOI 10.1073/pnas.89.14.6433; Vanag VK, 2000, NATURE, V406, P389, DOI 10.1038/35019038; Vinson M, 1997, NATURE, V386, P477, DOI 10.1038/386477a0; WINFREE AT, 1973, SCIENCE, V181, P937, DOI 10.1126/science.181.4103.937; WINFREE AT, 1994, SCIENCE, V266, P1003, DOI 10.1126/science.7973648	27	212	218	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2003	299	5613					1722	1725		10.1126/science.1080207	http://dx.doi.org/10.1126/science.1080207			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12560470	Green Published			2022-12-28	WOS:000181519500042
J	Huber, M; Caballero, R				Huber, M; Caballero, R			Eocene El Nino: Evidence for robust tropical dynamics in the "hothouse"	SCIENCE			English	Article							CLIMATE SYSTEM MODEL; OCEAN-ATMOSPHERE INTERACTION; SEA-SURFACE TEMPERATURES; PACIFIC COLD-TONGUE; EQUATORIAL PACIFIC; SOUTHERN-OSCILLATION; EAST; ENSO; CO2; CIRCULATION	Much uncertainty surrounds the interactions between the El Nino-Southern Oscillation (ENSO) and long-term global change. Past periods of extreme global warmth, exemplified by the Eocene (55 to 35 million years ago), provide a good testing ground for theories for this interaction. Here, we compare Eocene coupled climate model simulations with annually resolved variability records preserved in lake sediments. The simulations show Pacific deep-ocean and high-latitude surface warming of similar to10degreesC but little change in the tropical thermocline structure, atmosphere-ocean dynamics, and ENSO, in agreement with proxies. This result contrasts with theories linking past and future "hothouse" climates with a shift toward a permanent El Nino-like state.	Univ Copenhagen, Danish Ctr Earth Syst Sci, Niels Bohr Inst Astron Phys & Geophys, DK-2100 Copenhagen O, Denmark	University of Copenhagen; Niels Bohr Institute	Huber, M (corresponding author), Purdue Univ, Dept Earth & Atmospher Sci, 1397 Engn Bldg, W Lafayette, IN 47907 USA.		Huber, Matthew/A-7677-2008; /E-4637-2010	Huber, Matthew/0000-0002-2771-9977; /0000-0002-5507-9209				Allan R, 2000, NINO SO OSCILLATION, P3, DOI DOI 10.1017/CB09780511573125.002; BJERKNES J, 1969, MON WEATHER REV, V97, P163, DOI 10.1175/1520-0493(1969)097<0163:ATFTEP>2.3.CO;2; Blackmon M, 2001, B AM METEOROL SOC, V82, P2357, DOI 10.1175/1520-0477(2001)082<2357:TCCSM>2.3.CO;2; BRALOWER TJ, 1995, PALEOCEANOGRAPHY, V10, P841, DOI 10.1029/95PA01143; Cane MA, 1998, SCIENCE, V282, P59, DOI 10.1126/science.282.5386.59; Cane MA, 2001, NATURE, V411, P157, DOI 10.1038/35075500; Chaisson WP, 2000, PALEOCEANOGRAPHY, V15, P497, DOI 10.1029/1999PA000442; Clement AC, 2000, PALEOCEANOGRAPHY, V15, P731, DOI 10.1029/1999PA000466; Cole J, 2001, SCIENCE, V291, P1496, DOI 10.1126/science.1059111; Collins M, 2000, J CLIMATE, V13, P1299, DOI 10.1175/1520-0442(2000)013<1299:TENOSO>2.0.CO;2; Diaz HF, 2001, INT J CLIMATOL, V21, P1845, DOI 10.1002/joc.631; DIJKSTRA HA, 1995, J CLIMATE, V8, P1343, DOI 10.1175/1520-0442(1995)008<1343:OAIATT>2.0.CO;2; Fedorov AV, 2000, SCIENCE, V288, P1997, DOI 10.1126/science.288.5473.1997; Feely RA, 1999, NATURE, V398, P597, DOI 10.1038/19273; FRAEDRICH K, 1994, TELLUS A, V46, P541, DOI 10.1034/j.1600-0870.1994.00015.x; GHIL M, 2002, REV GEOPHYS    0913; Huber M, 2001, GEOPHYS RES LETT, V28, P3481, DOI 10.1029/2001GL012943; Huber M, 2000, PALEOCEANOGRAPHY, V15, P443, DOI 10.1029/1999PA000455; Jin FF, 1996, SCIENCE, V274, P76, DOI 10.1126/science.274.5284.76; Kang IS, 2002, J CLIMATE, V15, P2791, DOI 10.1175/1520-0442(2002)015<2791:IOAGSA>2.0.CO;2; Liu ZY, 1997, J CLIMATE, V10, P1662, DOI 10.1175/1520-0442(1997)010<1662:ACTOTC>2.0.CO;2; Mann ME, 2000, EL NINO SO OSCILLATI, P357, DOI 10.1017/CBO9780511573125.011; Meehl GA, 2000, J CLIMATE, V13, P1879, DOI 10.1175/1520-0442(2000)013<1879:ROTNCS>2.0.CO;2; Mingram J, 1998, PALAEOGEOGR PALAEOCL, V140, P289, DOI 10.1016/S0031-0182(98)00021-2; MOLNAR P, 2002, PALEOCEANOGRAPHY, V17; Morrill C, 2001, GLOBAL PLANET CHANGE, V29, P57, DOI 10.1016/S0921-8181(00)00084-9; Neelin JD, 1998, J GEOPHYS RES-OCEANS, V103, P14261, DOI 10.1029/97JC03424; Otto-Bliesner BL, 2001, J CLIMATE, V14, P3587, DOI 10.1175/1520-0442(2001)014<3587:TPVITN>2.0.CO;2; OTTOBLIESNER BL, 2002, EOS S, V83; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; Pierrehumbert RT, 2000, P NATL ACAD SCI USA, V97, P1355, DOI 10.1073/pnas.97.4.1355; RIPEPE M, 1991, J SEDIMENT PETROL, V61, P1155; Rittenour TM, 2000, SCIENCE, V288, P1039, DOI 10.1126/science.288.5468.1039; Rodbell DT, 1999, SCIENCE, V283, P516, DOI 10.1126/science.283.5401.516; Royer DL, 2001, EARTH-SCI REV, V54, P349, DOI 10.1016/S0012-8252(00)00042-8; Schrag DP, 1999, CHEM GEOL, V161, P215, DOI 10.1016/S0009-2541(99)00088-1; Sun DZ, 1997, GEOPHYS RES LETT, V24, P2031, DOI 10.1029/97GL01960; Sun DZ, 1998, GEOPHYS RES LETT, V25, P2659, DOI 10.1029/98GL01813; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Trenberth K. E., 2002, J GEOPHYS RES, V107; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Vallis GK, 2000, J PHYS OCEANOGR, V30, P933, DOI 10.1175/1520-0485(2000)030<0933:LSCAPO>2.0.CO;2; Van Oldenborgh GJ, 2000, INT J CLIMATOL, V20, P565, DOI [10.1002/(SICI)1097-0088(200004)20:5<565::AID-JOC488>3.0.CO;2-5, 10.1002/(SICI)1097-0088(200004)20:5&lt;565::AID-JOC488&gt;3.0.CO;2-5]; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	44	103	117	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					877	881		10.1126/science.1078766	http://dx.doi.org/10.1126/science.1078766			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574626				2022-12-28	WOS:000180830900048
J	Hwang, JS; Druffel, ERM				Hwang, JS; Druffel, ERM			Lipid-like material as the source of the uncharacterized organic carbon in the ocean?	SCIENCE			English	Article							MACROMOLECULAR CONSTITUENTS; SELECTIVE PRESERVATION; ISOTOPE FRACTIONATION; COMPOUND CLASSES; MATTER; PACIFIC; RADIOCARBON; SEDIMENTS; ORIGIN; VARIABILITY	The composition and formation mechanisms of the uncharacterized fraction of oceanic particulate organic carbon (POC) are not well understood. We isolated biologically important compound classes and the acid-insoluble fraction, a proxy of the uncharacterized fraction, from sinking POC in the deep Northeast Pacific and measured carbon isotope ratios to constrain the source(s) of the uncharacterized fraction. Stable carbon and radiocarbon isotope signatures of the acid-insoluble fraction were similar to those of the lipid fraction, implying that the acid-insoluble fraction might be composed of selectively accumulated lipid-like macromolecules.	Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine	Hwang, JS (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.	jeomshik@uci.edu; edruffel@uci.edu						Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; De Leeuw J.W., 1993, ORG GEOCHEM, V11, P23, DOI [10.1007/978-1-4615-2890-6_2, DOI 10.1007/978-1-4615-2890-6]; DEGENS ET, 1968, DEEP-SEA RES, V15, P11, DOI 10.1016/0011-7471(68)90025-9; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; DRUFFEL ERM, 1992, J GEOPHYS RES-OCEANS, V97, P15639, DOI 10.1029/92JC01511; EGLINTON TI, 1994, ORG GEOCHEM, V21, P721, DOI 10.1016/0146-6380(94)90015-9; FLAVIANO C, 1994, ORG GEOCHEM, V22, P759, DOI 10.1016/0146-6380(94)90137-6; Garcette-Lepecq A, 2000, ORG GEOCHEM, V31, P1663, DOI 10.1016/S0146-6380(00)00100-5; Gelinas Y, 2001, SCIENCE, V294, P145, DOI 10.1126/science.1062363; HATCHER PG, 1983, NATURE, V305, P498, DOI 10.1038/305498a0; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; HEDGES JI, 1978, GEOCHIM COSMOCHIM AC, V42, P69, DOI 10.1016/0016-7037(78)90218-1; Hedges JI, 2001, NATURE, V409, P801, DOI 10.1038/35057247; HENRICHS SM, 1995, MAR CHEM, V49, P127, DOI 10.1016/0304-4203(95)00012-G; HWANG JH, UNPUB; KEIL RG, 1994, NATURE, V370, P549, DOI 10.1038/370549a0; Knicker H, 1996, ORG GEOCHEM, V24, P661, DOI 10.1016/0146-6380(96)00057-5; Largeau C, 1995, ADV MICROB ECOL, V14, P77; Masiello CA, 1998, DEEP-SEA RES PT II, V45, P617, DOI 10.1016/S0967-0645(97)00096-9; Masiello CA, 2001, GLOBAL BIOGEOCHEM CY, V15, P407, DOI 10.1029/2000GB001290; McCarthy M, 1997, NATURE, V390, P150, DOI 10.1038/36535; MINOR EC, UNPUB GEOCHIM COSMOC; Peulve S, 1996, GEOCHIM COSMOCHIM AC, V60, P1239, DOI 10.1016/0016-7037(95)00442-4; QIAN Y, 1992, CHEM GEOL, V101, P201, DOI 10.1016/0009-2541(92)90002-M; Sherrell RM, 1998, DEEP-SEA RES PT II, V45, P733, DOI 10.1016/S0967-0645(97)00100-8; Smith KL, 2001, LIMNOL OCEANOGR, V46, P543, DOI 10.4319/lo.2001.46.3.0543; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; TEGELAAR EW, 1989, GEOCHIM COSMOCHIM AC, V53, P3103, DOI 10.1016/0016-7037(89)90191-9; TISSOT BP, 1984, PETROLEUM FORMATIO 2, pCH2; Wakeham SG, 1997, GEOCHIM COSMOCHIM AC, V61, P5363, DOI 10.1016/S0016-7037(97)00312-8; Wang XC, 2001, MAR CHEM, V73, P65, DOI 10.1016/S0304-4203(00)00090-6; Wang XC, 1998, GEOCHIM COSMOCHIM AC, V62, P1365, DOI 10.1016/S0016-7037(98)00074-X	32	71	74	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					881	884		10.1126/science.1078508	http://dx.doi.org/10.1126/science.1078508			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574627	Green Submitted			2022-12-28	WOS:000180830900049
J	Sulkowski, MS; Thomas, DL				Sulkowski, MS; Thomas, DL			Hepatitis C in the HIV-infected person	ANNALS OF INTERNAL MEDICINE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; TO-CHILD TRANSMISSION; INTERFERON-ALPHA-2B PLUS RIBAVIRIN; TRANSFUSION-ASSOCIATED HEPATITIS; LIVER FIBROSIS PROGRESSION; CHRONIC VIRAL-HEPATITIS; INTRAVENOUS-DRUG-USERS; DYNAMICS IN-VIVO; NATURAL-HISTORY; HEPATOCELLULAR-CARCINOMA	Because of shared routes of transmission, hepatitis C virus (HCV) infection is common in HIV-infected persons, who have been experiencing increasing HCV-related morbidity and mortality since the advent of effective antiretroviral therapy. Infection with HIV appears to adversely affect the outcome of hepatitis C, leading to increased viral persistence after acute infection, higher levels of viremia, and accelerated progression of HCV-related liver disease. In addition, hepatitis C may affect the course and management of HIV infection. The medical management of hepatitis C in HIV-infected persons is complicated by immune suppression, potential drug interactions and toxicities, and other forms of liver disease. In addition, there is little published experience with the safety and efficacy of the best available anti-HCV medications in HIV-infected persons. Thus, current efforts must be directed at preventing HCV and HIV infections and applying the principles learned in treating persons with either infection to manage those with both. Future efforts should include studies of the pathogenesis of HCV infection in HIV-infected persons and large, prospective studies that demonstrate the optimal management of persons co-infected with HIV and HCV. Such efforts will help to eliminate HCV-related liver disease as an emerging threat to HIV-infected persons.	Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21231 USA	Johns Hopkins University	Thomas, DL (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, 424 Bond St, Baltimore, MD 21231 USA.	dthomas@jhmi.edu			NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011602, R01DA016078, R37DA013806, R01DA013806] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-16078, DA-011602, DA-13806] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; *AM AC PED COMM IN, 2000, RED BOOK; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; [Anonymous], 1991, MMWR Recomm Rep, V40, P1; BABA M, 1987, ANTIMICROB AGENTS CH, V31, P1613, DOI 10.1128/AAC.31.10.1613; Barbaro G, 1999, AM J GASTROENTEROL, V94, P2198, DOI 10.1111/j.1572-0241.1999.01294.x; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; BOVE JR, 1987, NEW ENGL J MED, V317, P242, DOI 10.1056/NEJM198707233170411; BOYER N, 1992, J INFECT DIS, V165, P723, DOI 10.1093/infdis/165.4.723; Brunetto MR, 1998, LANCET, V351, P1535; BUCHBINDER SP, 1994, J INFECTION, V29, P263, DOI 10.1016/S0163-4453(94)91128-2; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; Cacoub P, 2001, CLIN INFECT DIS, V32, P1207, DOI 10.1086/319747; Cattelan AM, 1999, CLIN INFECT DIS, V29, P455, DOI 10.1086/520242; Causse X, 2000, J HEPATOL, V32, P1003, DOI 10.1016/S0168-8278(00)80105-1; CHAMOT E, 1990, AIDS, V4, P1275, DOI 10.1097/00002030-199012000-00016; Chung RT, 2002, AIDS, V16, P1915, DOI 10.1097/00002030-200209270-00008; CHUNG RT, 2002, 9 C RETR OPP INF; ConryCantilena C, 1996, NEW ENGL J MED, V334, P1691, DOI 10.1056/NEJM199606273342602; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; De Franceschi L, 2000, HEPATOLOGY, V31, P997, DOI 10.1053/he.2000.5789; den Brinker M, 2000, AIDS, V14, P2895, DOI 10.1097/00002030-200012220-00011; Di Martino V, 2001, HEPATOLOGY, V34, P1193, DOI 10.1053/jhep.2001.29201; DONAHUE JG, 1991, AM J EPIDEMIOL, V134, P1206, DOI 10.1093/oxfordjournals.aje.a116023; DORRUCCI M, 1995, J INFECT DIS, V172, P1503, DOI 10.1093/infdis/172.6.1503; EVERHART JE, 1990, ANN INTERN MED, V112, P544, DOI 10.7326/0003-4819-112-7-544; EYSTER ME, 1991, ANN INTERN MED, V115, P764, DOI 10.7326/0003-4819-115-10-764; EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602; EYSTER ME, 1994, BLOOD, V84, P1020; Fattovich G, 1996, J HEPATOL, V24, P38, DOI 10.1016/S0168-8278(96)80184-X; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Garcia-Samaniego J, 2001, AM J GASTROENTEROL, V96, P179, DOI 10.1111/j.1572-0241.2001.03374.x; Garfein RS, 1998, J ACQ IMMUN DEF SYND, V18, pS11, DOI 10.1097/00042560-199802001-00004; Gibb DM, 2000, LANCET, V356, P904, DOI 10.1016/S0140-6736(00)02681-7; Goletti D, 1996, J IMMUNOL, V157, P1271; Gow PJ, 2001, TRANSPLANTATION, V72, P177, DOI 10.1097/00007890-200107270-00001; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hershow RC, 1997, J INFECT DIS, V176, P414, DOI 10.1086/514058; Hoggard PG, 1997, ANTIMICROB AGENTS CH, V41, P1231, DOI 10.1128/AAC.41.6.1231; John M, 1998, AIDS, V12, P2289, DOI 10.1097/00002030-199817000-00010; Kaplan Jonathan E, 2002, MMWR Recomm Rep, V51, P1; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Kim WR, 2001, HEPATOLOGY, V33, P201, DOI 10.1053/jhep.2001.20798; KINGSLEY LA, 1987, LANCET, V1, P345; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Kostman JR, 2001, HEPATOLOGY, V34, p330A; Lafeuillade A, 2001, LANCET, V357, P280, DOI 10.1016/S0140-6736(00)03618-7; Lallemant M, 2000, NEW ENGL J MED, V343, P982, DOI 10.1056/NEJM200010053431401; Landau A, 2000, AIDS, V14, P1857, DOI 10.1097/00002030-200008180-00025; Landau A, 2001, AIDS, V15, P2149, DOI 10.1097/00002030-200111090-00010; Landesman SH, 1996, NEW ENGL J MED, V334, P1617, DOI 10.1056/NEJM199606203342501; LANE HC, 1990, ANN INTERN MED, V112, P805, DOI 10.7326/0003-4819-112-11-805; Laskus T, 2000, J INFECT DIS, V181, P442, DOI 10.1086/315283; Lemon SM, 1997, NEW ENGL J MED, V336, P196, DOI 10.1056/NEJM199701163360307; Lerat H, 1998, BLOOD, V91, P3841, DOI 10.1182/blood.V91.10.3841.3841_3841_3849; Lesens O, 1999, J INFECT DIS, V179, P1254, DOI 10.1086/314720; Lindsay KL, 2001, HEPATOLOGY, V34, P395, DOI 10.1053/jhep.2001.26371; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; MARCELLIN P, 1994, J INFECT DIS, V170, P433, DOI 10.1093/infdis/170.2.433; Marcellin P, 1997, ANN INTERN MED, V127, P875, DOI 10.7326/0003-4819-127-10-199711150-00003; MARRIOTT E, 1993, J MED VIROL, V40, P107, DOI 10.1002/jmv.1890400206; Martin-Carbonero L, 2001, AIDS RES HUM RETROV, V17, P1467, DOI 10.1089/08892220152644160; Martinez E, 2001, AIDS, V15, P1261, DOI 10.1097/00002030-200107060-00007; Mauss S., 1998, Infection, V26, P16, DOI 10.1007/BF02768746; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Monga HK, 2001, CLIN INFECT DIS, V33, P240, DOI 10.1086/321819; Moore RD, 1999, CLIN INFECT DIS, V29, P44, DOI 10.1086/520178; Nasti G, 2001, AIDS, V15, P1783, DOI 10.1097/00002030-200109280-00006; *NAT I DIAB DIG KI, 2002, CHRON HEP C CURR DIS; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; Nunez M, 2001, J ACQ IMMUN DEF SYND, V27, P426, DOI 10.1097/00126334-200108150-00002; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PECKHAM C, 1995, NEW ENGL J MED, V333, P298, DOI 10.1056/NEJM199508033330507; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perronne C, 2002, HEPATOLOGY, V36, p283A; Piroth L, 1998, AIDS, V12, P381, DOI 10.1097/00002030-199804000-00006; Pol S, 1998, J HEPATOL, V28, P945, DOI 10.1016/S0168-8278(98)80341-3; Poles MA, 1996, J ACQ IMMUN DEF SYND, V11, P170, DOI 10.1097/00042560-199602010-00008; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; RAGNI MV, 1993, BLOOD, V82, P1010, DOI 10.1182/blood.V82.3.1010.bloodjournal8231010; Ragni MV, 2001, J INFECT DIS, V183, P1112, DOI 10.1086/319273; Saadeh S, 2001, HEPATOLOGY, V33, P196, DOI 10.1053/jhep.2001.20534; Sauleda S, 2001, HEPATOLOGY, V34, P1035, DOI 10.1053/jhep.2001.29130; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; SEEFF LB, 1992, NEW ENGL J MED, V327, P1906, DOI 10.1056/NEJM199212313272703; Serfaty L, 2001, AIDS, V15, P2011, DOI 10.1097/00002030-200110190-00014; Sha BE, 2000, JAMA-J AM MED ASSOC, V284, P2723; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; Shimizu YK, 1996, HEPATOLOGY, V23, P205; Shiratori Y, 2000, ANN INTERN MED, V132, P517, DOI 10.7326/0003-4819-132-7-200004040-00002; Soriano V, 1996, CLIN INFECT DIS, V23, P585, DOI 10.1093/clinids/23.3.585; Soriano V, 1997, AIDS, V11, P400; Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3; Staples CT, 1999, CLIN INFECT DIS, V29, P150, DOI 10.1086/520144; Sulkowski MS, 2000, CLIN INFECT DIS, V30, pS77, DOI 10.1086/313842; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Thio CL, 2000, J CLIN MICROBIOL, V38, P575, DOI 10.1128/JCM.38.2.575-577.2000; Thomas DL, 2000, J INFECT DIS, V181, P844, DOI 10.1086/315314; Thomas DL, 1998, J INFECT DIS, V177, P1480, DOI 10.1086/515315; Thomas DL, 1996, J INFECT DIS, V174, P690, DOI 10.1093/infdis/174.4.690; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; THOMAS DL, 1995, J INFECT DIS, V171, P768, DOI 10.1093/infdis/171.4.768; TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202; Vento S, 1998, NEW ENGL J MED, V338, P286, DOI 10.1056/NEJM199801293380503; Veronese L, 2000, ANTIMICROB AGENTS CH, V44, P821, DOI 10.1128/AAC.44.4.821-826.2000; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; Villano SA, 1997, J CLIN MICROBIOL, V35, P3274, DOI 10.1128/JCM.35.12.3274-3277.1997; VOGT MW, 1987, SCIENCE, V235, P1376, DOI 10.1126/science.2435003; ZANETTI AR, 1995, LANCET, V345, P289, DOI 10.1016/S0140-6736(95)90277-5; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301; Zylberberg H, 2000, GUT, V47, P694, DOI 10.1136/gut.47.5.694; 1998, MMWR MORB MORTAL WKL, V7, P1	124	301	313	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					197	207		10.7326/0003-4819-138-3-200302040-00012	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00012			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558359				2022-12-28	WOS:000181018600006
J	Baker, R; Jones, DR; Goldblatt, P				Baker, R; Jones, DR; Goldblatt, P			Monitoring mortality rates in general practice after Shipman	BRITISH MEDICAL JOURNAL			English	Article							PERFORMANCE; DEATHS; BRISTOL		Univ Leicester, Leicester Gen Hosp, Clin Governance & Res Dev Unit, Dept Gen Practice & Primary Care, Leicester LE5 4PW, Leics, England; Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 7RH, Leics, England; Off Natl Stat, London SW1V 2QQ, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University of Leicester	Baker, R (corresponding author), Univ Leicester, Leicester Gen Hosp, Clin Governance & Res Dev Unit, Dept Gen Practice & Primary Care, Leicester LE5 4PW, Leics, England.							Adab P, 2002, BRIT MED J, V324, P95, DOI 10.1136/bmj.324.7329.95; Austin PC, 2001, J EVAL CLIN PRACT, V7, P35, DOI 10.1046/j.1365-2753.2001.00261.x; Aylin P, 2001, LANCET, V358, P181, DOI 10.1016/S0140-6736(01)05404-6; BAKER R, 2001, H SHIPMANS CLIN PRAC; Bolsin S, 2000, INT J QUAL HEALTH C, V12, P433, DOI 10.1093/intqhc/12.5.433; Dovey SM, 2002, QUAL SAF HEALTH CARE, V11, P233, DOI 10.1136/qhc.11.3.233; Dowie J, 2002, HEALTH ECON, V11, P1; Frankel S, 2000, BRIT MED J, V320, P489, DOI 10.1136/bmj.320.7233.489; HART JT, 1991, BMJ-BRIT MED J, V302, P1509, DOI 10.1136/bmj.302.6791.1509; HERMONI D, 1992, BRIT J GEN PRACT, V42, P521; Holden J, 1998, BRIT J GEN PRACT, V48, P1409; HOLDEN J, 2001, J CLIN EXCELLENCE, V3, P33; Khunti K, 1996, BRIT MED J, V312, P952; Lawrance RA, 2001, BRIT MED J, V323, P324, DOI 10.1136/bmj.323.7308.324; Mohammed MA, 2001, LANCET, V357, P463, DOI 10.1016/S0140-6736(00)04019-8; PAYNE JN, 1993, BRIT MED J, V307, P1027, DOI 10.1136/bmj.307.6911.1027; Ramsay C R, 2001, Health Technol Assess, V5, P1; ROBINSON LA, 1995, BRIT MED J, V311, P315, DOI 10.1136/bmj.311.7000.315; SPIEGELHALTER DJ, IN PRESS INT J QUAL; Stacy R, 1998, BRIT J GEN PRACT, V48, P1739; Steiner S H, 2000, Biostatistics, V1, P441, DOI 10.1093/biostatistics/1.4.441; Wolff AM, 2001, MED J AUSTRALIA, V174, P621, DOI 10.5694/j.1326-5377.2001.tb143469.x; 2002, SHIPMAN INQUIRY	23	24	24	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					274	276		10.1136/bmj.326.7383.274	http://dx.doi.org/10.1136/bmj.326.7383.274			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560285	Green Submitted, Green Published			2022-12-28	WOS:000180908300028
J	Fledelius, HC				Fledelius, HC			High atmospheric pressure and myopic shift in caisson workers	LANCET			English	Editorial Material							HYPERBARIC-OXYGEN THERAPY		Rigshosp, Univ Eye Dept, DK-2100 Copenhagen O, Denmark	Rigshospitalet	Fledelius, HC (corresponding author), Rigshosp, Univ Eye Dept, DK-2100 Copenhagen O, Denmark.							Anderson B Jr, 1978, Trans Am Ophthalmol Soc, V76, P116; CURTIN BJ, 1985, MYOPIAS BASIC SCI CL, P3; Fledelius HC, 2002, ACTA OPHTHALMOL SCAN, V80, P188, DOI 10.1034/j.1600-0420.2002.800213.x; Kindwall EP, 1994, HYPERBARIC MED, pS45; LYNE AJ, 1978, T OPHTHAL SOC UK, V98, P66; Onoo A, 2002, BRIT J OPHTHALMOL, V86, P1274, DOI 10.1136/bjo.86.11.1274; PALMQUIST BM, 1984, BRIT J OPHTHALMOL, V68, P113, DOI 10.1136/bjo.68.2.113; Ross ME, 1996, OPTOMETRY VISION SCI, V73, P487, DOI 10.1097/00006324-199607000-00006	8	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					362	362		10.1016/S0140-6736(03)12443-9	http://dx.doi.org/10.1016/S0140-6736(03)12443-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573370				2022-12-28	WOS:000180787000006
J	van Grootheest, K; Vrieling, T				van Grootheest, K; Vrieling, T			Thromboembolism associated with the new contraceptive Yasmin	BRITISH MEDICAL JOURNAL			English	Letter									Netherlands Pharmacovigilance Ctr Lareb, NL-5237 MH Shertogenbosch, Netherlands		van Grootheest, K (corresponding author), Netherlands Pharmacovigilance Ctr Lareb, Goudsbloemvallei 7, NL-5237 MH Shertogenbosch, Netherlands.							Sheldon T, 2002, BRIT MED J, V324, P869, DOI 10.1136/bmj.324.7342.869; WINKLER UH, 2001, GYNAECOL FORUM, V6, P23	2	36	36	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					257	257		10.1136/bmj.326.7383.257	http://dx.doi.org/10.1136/bmj.326.7383.257			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560278	Bronze, Green Published			2022-12-28	WOS:000180908300021
J	Brown, BR				Brown, BR			Sensing temperature without ion channels	NATURE			English	Article							NEURONS		Univ San Francisco, Dept Phys, San Francisco, CA 94117 USA	University of San Francisco	Brown, BR (corresponding author), Univ San Francisco, Dept Phys, San Francisco, CA 94117 USA.							Brown BR, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061903; CAREY FG, 1982, COPEIA, P254; GROSSO G, 2000, SOLID STATE PHYSICS; KALMIJN AJ, 1966, NATURE, V212, P1232, DOI 10.1038/2121232b0; MacDonald D. K. C, 1962, THERMOELECTRICITY IN; MONTGOMERY JC, 1984, COMP BIOCHEM PHYS A, V79, P189, DOI 10.1016/0300-9629(84)90731-X; MURRAY RW, 1960, NATURE, V187, P957, DOI 10.1038/187957a0; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Sand A, 1938, PROC R SOC SER B-BIO, V125, P524, DOI 10.1098/rspb.1938.0041; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Wilkens LA, 1997, P ROY SOC B-BIOL SCI, V264, P1723, DOI 10.1098/rspb.1997.0239; Wissing H, 1988, Prog Brain Res, V74, P99	13	40	40	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					495	495		10.1038/421495a	http://dx.doi.org/10.1038/421495a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556879	Bronze			2022-12-28	WOS:000180670600031
J	Hager, R; Johnstone, RA				Hager, R; Johnstone, RA			The genetic basis of family conflict resolution in mice	NATURE			English	Article							PARENT-OFFSPRING CONFLICT; MATERNAL-CARE; COADAPTATION; GROWTH; YOUNG	Asymmetries in the costs and benefits of parental investment for mothers, fathers and offspring result in family conflict over the production and provisioning of young(1-3). In species where females provide most resources before and after birth, the resolution of this conflict may be influenced by genes expressed in mothers and by maternally and paternally inherited genes expressed in offspring(4,5). Here we disentangle these effects by means of reciprocal mating and cross-fostering of litters between two strains of mice that differ with respect to the typical resolution of family conflict. We find that differences in litter size between these two strains are determined by paternal genotype, whereas differences in provisioning are under maternal control, showing that there is antagonistic coadaptation of maternal and paternal effects on distinct life-history traits. Maternal provisioning is also influenced by the type of foster offspring. Contradictory to theoretical expectations, however, we find no evidence for a negative correlation across strains between maternal provisioning and offspring demand. Instead, we show that there is positive coadaptation such that offspring obtain more resources from foster mothers of the same strain as their natural mother, irrespective of their father's strain.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Hager, R (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.		Hager, Reinmar/F-8659-2012					Agrawal AF, 2001, SCIENCE, V292, P1710, DOI 10.1126/science.1059910; Clutton-Brock T. H., 1991, EVOLUTION PARENTAL C; COWLEY DE, 1989, GENETICS, V122, P193; FUCHS S, 1982, BEHAV ECOL SOCIOBIOL, V10, P39, DOI 10.1007/BF00296394; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; Haig D, 1997, P ROY SOC B-BIOL SCI, V264, P1657, DOI 10.1098/rspb.1997.0230; Houston A.I., 1985, P471; Keverne EB, 2001, HORM BEHAV, V40, P146, DOI 10.1006/hbeh.2001.1685; Kolliker M, 2001, ANIM BEHAV, V62, P395, DOI 10.1006/anbe.2001.1792; Konig B, 1997, NATURWISSENSCHAFTEN, V84, P95, DOI 10.1007/s001140050356; Lessells CM, 2002, PHILOS T R SOC B, V357, P381, DOI 10.1098/rstb.2001.0928; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; MACNAIR MR, 1978, ANIM BEHAV, V26, P111, DOI 10.1016/0003-3472(78)90010-6; Parker GA, 2002, PHILOS T R SOC B, V357, P295, DOI 10.1098/rstb.2001.0950; Trivers R., 1972, SEXUAL SELECTION DES, P139; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wolf JB, 2000, EVOLUTION, V54, P1882, DOI 10.1111/j.0014-3820.2000.tb01235.x; Wolf JB, 1998, EVOLUTION, V52, P299, DOI [10.1111/j.1558-5646.1998.tb01632.x, 10.2307/2411068]	18	103	103	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					533	535		10.1038/nature01239	http://dx.doi.org/10.1038/nature01239			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556892				2022-12-28	WOS:000180670600045
J	Marcikic, I; de Riedmatten, H; Tittel, W; Zbinden, H; Gisin, N				Marcikic, I; de Riedmatten, H; Tittel, W; Zbinden, H; Gisin, N			Long-distance teleportation of qubits at telecommunication wavelengths	NATURE			English	Article							QUANTUM TELEPORTATION; ENTANGLEMENT; STATE; PHOTONS	Matter and energy cannot be teleported (that is, transferred from one place to another without passing through intermediate locations). However, teleportation of quantum states (the ultimate structure of objects) is possible(1): only the structure is teleported-the matter stays at the source side and must be already present at the final location. Several table-top experiments have used qubits(2-7) (two-dimensional quantum systems) or continuous variables(8-10) to demonstrate the principle over short distances. Here we report a long-distance experimental demonstration of probabilistic quantum teleportation. Qubits carried by photons of 1.3 mum wavelength are teleported onto photons of 1.55 mum wavelength from one laboratory to another, separated by 55 m but connected by 2 km of standard telecommunications fibre. The first (and, with foreseeable technologies, the only) application of quantum teleportation is in quantum communication, where it could help to extend quantum cryptography to larger distances(11-13).	Univ Geneva, Appl Phys Grp, CH-1211 Geneva 4, Switzerland; Univ Aarhus, Danish natl Res Fdn Ctr Quantum Opt, Inst Phys & Astron, DK-8000 Aarhus C, Denmark	University of Geneva; Aarhus University; Danmarks Grundforskningsfond	Gisin, N (corresponding author), Univ Geneva, Appl Phys Grp, CH-1211 Geneva 4, Switzerland.	Nicolas.Gisin@Physics.Unige.ch	Zbinden, Hugo/AAE-7258-2019; de Riedmatten, Hugues/P-7563-2017; Tittel, Wolfgang/AAW-7332-2020; Tittel, Wolfgang/A-1600-2011	Tittel, Wolfgang/0000-0003-3136-8919; de Riedmatten, Hugues/0000-0002-4418-0723				BABICHEV SA, 2002, QUANTPH0208066; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Boschi D, 1998, PHYS REV LETT, V80, P1121, DOI 10.1103/PhysRevLett.80.1121; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; BOWEN WP, 2002, QUANTPH0207179; Braunstein SL, 1998, PHYS REV LETT, V80, P869, DOI 10.1103/PhysRevLett.80.869; Brendel J, 1999, PHYS REV LETT, V82, P2594, DOI 10.1103/PhysRevLett.82.2594; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; De Riedmatten H, 2002, QUANTUM INFORM COMPU, V2, P425; DERIEDMATTEN H, 2002, QUANTPH0208174; DERIEDMATTEN H, IN PRESS PHYS REV A; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; Grangier P, 1998, NATURE, V396, P537, DOI 10.1038/25059; Jacobs BC, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.052307; Jennewein T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.017903; Kim YH, 2001, PHYS REV LETT, V86, P1370, DOI 10.1103/PhysRevLett.86.1370; Lamas-Linares A, 2001, NATURE, V412, P887, DOI 10.1038/35091014; Lutkenhaus N, 1999, PHYS REV A, V59, P3295, DOI 10.1103/PhysRevA.59.3295; Marcikic I, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.062308; MASSAR S, 1995, PHYS REV LETT, V74, P1259, DOI 10.1103/PhysRevLett.74.1259; Nielsen MA, 1998, NATURE, V396, P52, DOI 10.1038/23891; OWENS PCM, 1994, APPL OPTICS, V33, P6895, DOI 10.1364/AO.33.006895; Pan JW, 1998, PHYS REV LETT, V80, P3891, DOI 10.1103/PhysRevLett.80.3891; Stucki D, 2001, J MOD OPTIC, V48, P1967, DOI 10.1080/09500340110069246; Thew RT, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.062304; Tittel W, 2000, PHYS REV LETT, V84, P4737, DOI 10.1103/PhysRevLett.84.4737; Tittel W, 2001, QUANTUM INF COMPUT, V1, P3; Waks E, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.052310; ZUKOWSKI M, 1993, PHYS REV LETT, V71, P4287, DOI 10.1103/PhysRevLett.71.4287	32	366	376	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2003	421	6922					509	513		10.1038/nature01376	http://dx.doi.org/10.1038/nature01376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556886	Green Submitted			2022-12-28	WOS:000180670600038
J	Hill, CM; Mather, M; Goddard, M				Hill, CM; Mather, M; Goddard, M			Cross sectional survey of meningococcal C immunisation in children looked after by local authorities and those living at home	BRITISH MEDICAL JOURNAL			English	Article									Southampton Gen Hosp, Univ Child Hlth, Southampton SO16 6YD, Hants, England; Market St Hlth Ctr, London SE18 6QR, England; Univ Southampton, Hlth Care Hlth Ctr, Southampton SO9 5NH, Hants, England	University of Southampton; University of Southampton	Hill, CM (corresponding author), Southampton Gen Hosp, Univ Child Hlth, Mail Point 803, Southampton SO16 6YD, Hants, England.			Hill, Catherine/0000-0003-2372-5904				*DEP HLTH, 1999, MAK DIFF STRENGTH NU; *DEP HLTH, 2001, OUTC IND LOOK CHILD; *DEP HLTH, 1999, PLCMO994 DEP HLTH; *HOUS COMM HLTH CO, 1998, CHILD LOOKED LOCAL	4	11	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2003	326	7385					364	365		10.1136/bmj.326.7385.364	http://dx.doi.org/10.1136/bmj.326.7385.364			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648RZ	12586668	Bronze, Green Published			2022-12-28	WOS:000181165500018
J	Majeed, A; Gray, J; Ambler, G; Carroll, K; Bindman, AB				Majeed, A; Gray, J; Ambler, G; Carroll, K; Bindman, AB			Association between practice size and quality of care of patients with ischaemic heart disease: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE		UCL, Sch Publ Policy, Primary Care Res Unit, London WC1H 9QU, England; Bolingbroke Hosp, Battersea Res Grp, London SW11 6HN, England; UCL Hosp, Res & Dev Directorate, Med Stat Unit, London NW1 2LT, England; Univ Calif San Francisco, Dept Med, San Francisco, CA 94118 USA; Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94118 USA; Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94118 USA	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Majeed, A (corresponding author), UCL, Sch Publ Policy, Primary Care Res Unit, London WC1H 9QU, England.	a.majeed@ucl.ac.uk		Majeed, Azeem/0000-0002-2357-9858				BAKER R, 1995, BRIT J GEN PRACT, V45, P654; Campbell SM, 2001, BMJ-BRIT MED J, V323, P784, DOI 10.1136/bmj.323.7316.784; Gray J, 2000, BMJ-BRIT MED J, V321, P548, DOI 10.1136/bmj.321.7260.548; Kotseva K, 2001, LANCET, V357, P995, DOI 10.1016/S0140-6736(00)04235-5; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503	5	14	14	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2003	326	7385					371	372		10.1136/bmj.326.7385.371	http://dx.doi.org/10.1136/bmj.326.7385.371			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648RZ	12586672	Green Published, Bronze			2022-12-28	WOS:000181165500022
J	Ritson, D				Ritson, D			Fuel for thought - Stanford has signed up for a ride on a tiger. Will it survive the journey intact?	NATURE			English	Editorial Material									Stanford Univ, Varian Phys Dept, Stanford, CA 94305 USA	Stanford University	Ritson, D (corresponding author), Stanford Univ, Varian Phys Dept, Stanford, CA 94305 USA.								0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					575	576		10.1038/421575a	http://dx.doi.org/10.1038/421575a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571567				2022-12-28	WOS:000180803200016
J	Schiermeier, Q				Schiermeier, Q			Fading support ends Europe's dreams of neutron supremacy	NATURE			English	News Item																			0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					563	563		10.1038/421563b	http://dx.doi.org/10.1038/421563b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571557	Bronze			2022-12-28	WOS:000180803200006
J	Quill, TE; Cassel, CK				Quill, TE; Cassel, CK			Professional organizations' position statements on physician-assisted suicide: A case for studied neutrality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VOLUNTARY ACTIVE EUTHANASIA; OF-LIFE CARE; TERMINALLY-ILL; WASHINGTON-STATE; UNITED-STATES; OREGON DEATH; DIGNITY ACT; ATTITUDES; EXPERIENCES; DEPRESSION	Position statements opposing legalization of physician-assisted suicide by organizations such as the American College of Physicians-American Society of Internal Medicine rightly emphasize that palliative care should be the standard of care for the dying, and that the inadequacies that exist in its delivery should be remedied. But such position statements generally understate the limitations of palliative care to alleviate some end-of-life suffering, and they do not provide adequate guidance about how physicians should approach patients with intractable suffering who are prepared to die. In this manuscript, we briefly present. data about severe suffering before death for terminally ill patients, including those enrolled in hospice programs. We also review some of what is known about requests and responses for physician-assisted suicide in Oregon and in the rest of the United States. Preliminary data from Oregon suggest that legally sanctioned access to physician-assisted suicide is used by a very small number of patients and seems to be associated with improved delivery of hospice and palliative care. Physicians of good will, deep religious convictions, and considerable palliative care experience exist on both sides of the debate about legalization of physician-assisted suicide. In an effort to respect this diversity, and to encourage out profession to continue to struggle with the genuine dilemmas faced by some patients toward the end of their lives and by their families, we argue in favor of medical organizations' taking a position of studied neutrality on this contentious issue.	Univ Rochester, Med Ctr, Rochester, NY 14642 USA; Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97201 USA	University of Rochester; Oregon Health & Science University	Quill, TE (corresponding author), Univ Rochester, Med Ctr, 601 Elmwood Ave,Box 601, Rochester, NY 14642 USA.							[Anonymous], 1995, J Am Geriatr Soc, V43, P577; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BATTIN MP, 1995, ACAD MED, V70, P583; Block SD, 2000, ANN INTERN MED, V132, P209, DOI 10.7326/0003-4819-132-3-200002010-00007; Breitbart W, 1996, AM J PSYCHIAT, V153, P238; BROCK DW, 1992, HASTINGS CENT REP, V22, P10, DOI 10.2307/3562560; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; CHOCHINOV HM, 1994, AM J PSYCHIAT, V151, P537; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; COHEN JS, 1994, NEW ENGL J MED, V331, P89, DOI 10.1056/NEJM199407143310206; COHEN LM, 1995, ARCH INTERN MED, V155, P42, DOI 10.1001/archinte.155.1.42; Coyle N, 1990, J Pain Symptom Manage, V5, P83; DONNELLY S, 1995, SEMIN ONCOL, V22, P67; DUBERSEIN PR, 1995, J AM GERIATR SOC, V43, P395, DOI 10.1111/j.1532-5415.1995.tb05814.x; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; FOLEY KM, 1995, PAIN FORUM, V4, P163; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; Ganzini L, 2001, JAMA-J AM MED ASSOC, V285, P2363, DOI 10.1001/jama.285.18.2363; Ingham JM, 1996, HEMATOL ONCOL CLIN N, V10, P21, DOI 10.1016/S0889-8588(05)70325-7; JACOBSON JA, 1995, J CLIN ETHIC, V6, P149; KANE RL, 1985, JAMA-J AM MED ASSOC, V253, P2683, DOI 10.1001/jama.253.18.2683; KASTING GA, 1993, PHYSICIAN ASSISTED D, P25; KATHOL RG, 1990, PSYCHOSOMATICS, V31, P434, DOI 10.1016/S0033-3182(90)72140-8; Lee MA, 1996, NEW ENGL J MED, V334, P310, DOI 10.1056/NEJM199602013340507; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; *NAT AC, 1997, APPR DEATH IMPR CAR; NEU S, 1986, NEW ENGL J MED, V314, P14, DOI 10.1056/NEJM198601023140103; Orentlicher D, 1997, NEW ENGL J MED, V337, P1236, DOI 10.1056/NEJM199710233371713; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; QUILL TE, 1993, JAMA-J AM MED ASSOC, V270, P870, DOI 10.1001/jama.270.7.870; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Quill TE, 1998, ANN INTERN MED, V128, P552, DOI 10.7326/0003-4819-128-7-199804010-00006; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; Sachs GA, 2000, JAMA-J AM MED ASSOC, V284, P2423, DOI 10.1001/jama.284.19.2423; SHAPIRO RS, 1994, ARCH INTERN MED, V154, P575, DOI 10.1001/archinte.154.5.575; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Slome LR, 1997, NEW ENGL J MED, V336, P417, DOI 10.1056/NEJM199702063360606; Snyder L, 2001, ANN INTERN MED, V135, P209, DOI 10.7326/0003-4819-135-3-200108070-00015; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; Sullivan AD, 2001, NEW ENGL J MED, V344, P605, DOI 10.1056/NEJM200102223440811; *TASK FORC IMPR CA, 2002, OR DEATH DIG ACT GUI; Tolle SW, 1999, ANN INTERN MED, V130, P681, DOI 10.7326/0003-4819-130-8-199904200-00015; Ventafridda V, 1990, J Palliat Care, V6, P7; Whitney SN, 2001, J GEN INTERN MED, V16, P290, DOI 10.1046/j.1525-1497.2001.04159.x; 1996, BRIEF AMICUS CURIAE	46	28	28	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					208	211		10.7326/0003-4819-138-3-200302040-00013	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00013			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558360				2022-12-28	WOS:000181018600007
J	Li, Z; Gindler, J; Wang, H; Berry, RJ; Li, S; Correa, A; Zheng, JC; Erickson, JD; Wang, Y				Li, Z; Gindler, J; Wang, H; Berry, RJ; Li, S; Correa, A; Zheng, JC; Erickson, JD; Wang, Y			Folic acid supplements during early pregnancy and likelihood of multiple births: a population-based cohort study	LANCET			English	Article							NEURAL-TUBE DEFECTS; PERICONCEPTIONAL MULTIVITAMIN USE; CONOTRUNCAL HEART-DEFECTS; TWIN PREGNANCIES; RISK; CHINA; PREVENTION; GESTATIONS; SINGLETON	Background Folic acid supplements are recommended for women of childbearing age to prevent neural tube defects in their offspring. Results of some studies, however, suggest an increase in multiple births associated with use of vitamin supplements that contain folic acid during pregnancy. Our aim was to assess this association. Methods We used data from a population-based cohort study from which we assessed the occurrence of multiple births in women (n=242 015) who had participated in a campaign to prevent neural tube defects with folic acid supplements (400 mug per day) in China. Folic acid use was ascertained before pregnancy outcome was known. We studied the relation between multiple births and any use of folic acid pills before or during early pregnancy; additionally, we investigated mechanisms by which folic acid could potentially affect the occurrence of multiple births by examining pill-taking at three time periods: before ovulation, around the time of fertilisation, and after conception. Findings 1496 (0.62%) multiple births occurred in a cohort of 242 015 women who had registered with the study between October, 1993, and September, 1995, and who had a pregnancy not affected by a birth defect; the rate of multiple births in women who did and did not take folic acid before or during early pregnancy was 0.59% and 0.65%, respectively (rate ratio 0.91; 95% CI 0.82-1.00). Interpretation Our findings suggest that consumption of folic acid supplements during pregnancy is not associated with an increased occurrence of multiple births.	Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA; Peking Univ, Hlth Sci Ctr, Natl Ctr Maternal & Infant Hlth, Beijing, Peoples R China; Peking Univ, Hlth Sci Ctr, Dept Hlth Care Epidemiol, Beijing, Peoples R China	Centers for Disease Control & Prevention - USA; Peking University; Peking University	Berry, RJ (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Highway,MS F-45, Atlanta, GA 30341 USA.			Berry, Robert/0000-0002-7162-5046				Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Berry RJ, 2002, EPIDEMIOLOGY, V13, P114, DOI 10.1097/00001648-200201000-00021; Botto LD, 1996, PEDIATRICS, V98, P911; CHEN CJ, 1987, ACTA GENET MED GEMEL, V36, P335, DOI 10.1017/S0001566000006085; Cornel MC, 1997, TERATOLOGY, V55, P134; Czeizel A. E., 1994, Acta Geneticae Medicae et Gemellologiae, V43, P175; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Ericson A, 2001, Twin Res, V4, P63, DOI 10.1375/twin.4.2.63; Gindler J, 2001, LANCET, V358, P796, DOI 10.1016/S0140-6736(01)05969-4; Hasbargen U, 2000, HUM REPROD, V15, P2659, DOI 10.1093/humrep/15.12.2659; Kinzler WL, 2000, J SOC GYNECOL INVEST, V7, P321, DOI 10.1016/S1071-5576(00)00084-8; KIRKE PN, 1992, ARCH DIS CHILD, V67, P1442, DOI 10.1136/adc.67.12.1442; LI DK, 1995, EPIDEMIOLOGY, V6, P212, DOI 10.1097/00001648-199505000-00004; Little J., 1988, TWINNING TWINS, P37; LUKE B, 1990, Fetal Diagnosis and Therapy, V5, P61; Lumley J, 2001, BRIT J OBSTET GYNAEC, V108, P937, DOI 10.1111/j.1471-0528.2001.00228.x; Mastroiacovo P., 1994, Acta Geneticae Medicae et Gemellologiae, V43, P57; Mathews F, 1998, BRIT J OBSTET GYNAEC, V105, P954, DOI 10.1111/j.1471-0528.1998.tb10257.x; Mathews F, 1999, LANCET, V353, P291, DOI 10.1016/S0140-6736(05)74937-0; Myers MF, 2001, AM J EPIDEMIOL, V154, P1051, DOI 10.1093/aje/154.11.1051; NYLANDER PPS, 1979, ACTA GENET MED GEMEL, V28, P261, DOI 10.1017/S0001566000008746; POLLARD R, 1995, HUM BIOL, V67, P921; Schwartz DB, 1999, AM J OBSTET GYNECOL, V181, P912, DOI 10.1016/S0002-9378(99)70324-8; SHAW GM, 1995, AM J MED GENET, V59, P536, DOI 10.1002/ajmg.1320590428; Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P938, DOI 10.1016/S0002-9378(00)70350-4; TOLAROVA M, 1995, TERATOLOGY, V51, P71, DOI 10.1002/tera.1420510205; VOGEL F, 1997, HUMAN GENETICS PROBL, P230; WALD N, 1991, LANCET, V338, P131; Werler MM, 1997, AM J MED GENET, V71, P93; WHIPLEY PW, 1966, AM J EPIDEMIOL, V85, P147; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; 2001, FOLIC ACID PREVENTIO	32	54	61	1	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					380	384		10.1016/S0140-6736(03)12390-2	http://dx.doi.org/10.1016/S0140-6736(03)12390-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573374				2022-12-28	WOS:000180787000010
J	Steinhoff, M; Goldblatt, D				Steinhoff, M; Goldblatt, D			Conjugate Hib vaccines	LANCET			English	Editorial Material							B CONJUGATE; VACCINATION; EFFICACY; FAILURE; INFANTS		Johns Hopkins Univ, Sch Med, Sch Hyg, Baltimore, MD 21205 USA; Inst Child Hlth, London, England	Johns Hopkins University; University of London; University College London	Steinhoff, M (corresponding author), Johns Hopkins Univ, Sch Med, Sch Hyg, Baltimore, MD 21205 USA.		Goldblatt, David/C-5972-2008	Goldblatt, David/0000-0002-0769-5242				Breukels MA, 2001, CLIN INFECT DIS, V32, P1700, DOI 10.1086/320755; Eskola J, 1999, LANCET, V354, P2063, DOI 10.1016/S0140-6736(99)04377-9; Granoff DM, 2001, CLIN INFECT DIS, V33, pS278, DOI 10.1086/322563; Heath PT, 2000, CLIN INFECT DIS, V31, P973, DOI 10.1086/318132; Heath PT, 2002, ARCH DIS CHILD, V86, P396, DOI 10.1136/adc.86.6.396; *PUBL HLTH LAB SER, 2002, CDR WEEKLY      0124, P34; Richmond P, 2001, INFECT IMMUN, V69, P2378, DOI 10.1128/IAI.69.4.2378-2382.2001; Tanner K, 2002, BRIT MED J, V325, P1099, DOI 10.1136/bmj.325.7372.1099; van Alphen L, 1997, J PEDIATR-US, V131, P869, DOI 10.1016/S0022-3476(97)70035-0	9	28	29	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					360	361		10.1016/S0140-6736(03)12441-5	http://dx.doi.org/10.1016/S0140-6736(03)12441-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573368				2022-12-28	WOS:000180787000004
J	Folk, JA; Potok, RM; Marcus, CM; Umansky, V				Folk, JA; Potok, RM; Marcus, CM; Umansky, V			A gate-controlled bidirectional spin filter using quantum coherence	SCIENCE			English	Article							INJECTION	We demonstrate a quantum coherent electron spin filter by directly measuring the spin polarization of emitted current. The spin filter consists of an open quantum dot in an in-plane magnetic field; the in-plane field gives the two spin directions different Fermi wavelengths resulting in spin-dependent quantum interference of transport through the device. The gate voltage is used to select the preferentially transmitted spin, thus setting the polarity of the filter. This provides a fully electrical method for the creation and detection of spin-polarized currents. Polarizations of emitted current as high as 70% for both spin directions (either aligned or anti-aligned with the external field) are observed.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Weizmann Inst Sci, Braun Ctr Submicron Res, IL-76100 Rehovot, Israel	Harvard University; Weizmann Institute of Science	Folk, JA (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	jfolk@stanford.edu; marcus@harvard.edu	Marcus, Charles M./M-4526-2014; Umansky, Vladimir/P-1334-2019; Folk, Joshua A/E-6287-2017	Marcus, Charles M./0000-0003-2420-4692; Umansky, Vladimir/0000-0001-5727-2064; Folk, Joshua A/0000-0003-4455-5609				Beenakker CWJ, 1997, REV MOD PHYS, V69, P731, DOI 10.1103/RevModPhys.69.731; CHAN IH, 1995, PHYS REV LETT, V74, P3876, DOI 10.1103/PhysRevLett.74.3876; Fiederling R, 1999, NATURE, V402, P787, DOI 10.1038/45502; Hammar PR, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.066806; Jedema FJ, 2002, NATURE, V416, P713, DOI 10.1038/416713a; Ohno Y, 1999, NATURE, V402, P790, DOI 10.1038/45509; Potok RM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.266602; Sachrajda AS, 2001, PHYSICA E, V10, P493, DOI 10.1016/S1386-9477(01)00144-8; VANHOUTEN H, 1989, PHYS REV B, V39, P8556, DOI 10.1103/PhysRevB.39.8556	9	133	144	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					679	682		10.1126/science.1078419	http://dx.doi.org/10.1126/science.1078419			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560544				2022-12-28	WOS:000180687700038
J	Bakkenist, CJ; Kastan, MB				Bakkenist, CJ; Kastan, MB			DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation	NATURE			English	Article							S-PHASE CHECKPOINT; ATAXIA-TELANGIECTASIA GENE; NIJMEGEN BREAKAGE SYNDROME; FIELD GEL-ELECTROPHORESIS; TOPOISOMERASE-II; MAMMALIAN-CELLS; IN-VIVO; METAPHASE CHROMOSOMES; IONIZING IRRADIATION; CHROMATIN STRUCTURE	The ATM protein kinase, mutations of which are associated with the human disease ataxia-telangiectasia, mediates responses to ionizing radiation in mammalian cells. Here we show that ATM is held inactive in unirradiated cells as a dimer or higher-order multimer, with the kinase domain bound to a region surrounding serine 1981 that is contained within the previously described 'FAT' domain. Cellular irradiation induces rapid intermolecular autophosphorylation of serine 1981 that causes dimer dissociation and initiates cellular ATM kinase activity. Most ATM molecules in the cell are rapidly phosphorylated on this site after doses of radiation as low as 0.5 Gy, and binding of a phosphospecific antibody is detectable after the introduction of only a few DNA double-strand breaks in the cell. Activation of the ATM kinase seems to be an initiating event in cellular responses to irradiation, and our data indicate that ATM activation is not dependent on direct binding to DNA strand breaks, but may result from changes in the structure of chromatin.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kastan, MB (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	michael.kastan@stjude.org						Alligood KJ, 2000, HYBRIDOMA, V19, P317, DOI 10.1089/027245700429864; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; CEDERVALL B, 1995, RADIAT RES, V143, P8, DOI 10.2307/3578920; Chehab NH, 2000, GENE DEV, V14, P278; DEALMODOVAR JMR, 1994, INT J RADIAT BIOL, V65, P641, DOI 10.1080/09553009414550751; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; EARNSHAW WC, 1983, J CELL BIOL, V96, P84, DOI 10.1083/jcb.96.1.84; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HU SH, 1994, NATURE, V369, P581, DOI 10.1038/369581a0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JABERABOANSARI A, 1988, RADIAT RES, V114, P94, DOI 10.2307/3577147; JENSEN PB, 1994, CANCER RES, V54, P2959; JEPPESEN P, 1992, CHROMOSOMA, V101, P322, DOI 10.1007/BF00346011; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; KRAJEWSKI WA, 1995, FEBS LETT, V361, P149, DOI 10.1016/0014-5793(95)00144-X; Krajewski WA, 1999, J BIOMOL STRUCT DYN, V16, P1097, DOI 10.1080/07391102.1999.10508318; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; LINDSLEY JE, 1993, J BIOL CHEM, V268, P8096; Malyapa RS, 1996, INT J RADIAT ONCOL, V35, P963, DOI 10.1016/0360-3016(96)00211-8; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; MEISENHELDER J, 1999, CURRENT PROTOCOLS S, V48; Richardson C, 1999, METH MOL B, V113, P453; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; ROTI JLR, 1987, CYTOMETRY, V8, P461, DOI 10.1002/cyto.990080505; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Sarkaria JN, 1998, CANCER RES, V58, P4375; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Smith GCM, 1999, P NATL ACAD SCI USA, V96, P11134, DOI 10.1073/pnas.96.20.11134; Snyder RD, 2000, ENVIRON MOL MUTAGEN, V35, P13, DOI 10.1002/(SICI)1098-2280(2000)35:1<13::AID-EM3>3.0.CO;2-1; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; VOGELSTEIN B, 1980, CELL, V22, P79, DOI 10.1016/0092-8674(80)90156-7; WARD WS, 1989, CHROMOSOMA, V98, P153, DOI 10.1007/BF00329678; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Xu B, 2002, CANCER RES, V62, P4588; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Zhou BBS, 2000, J BIOL CHEM, V275, P10342, DOI 10.1074/jbc.275.14.10342	51	2552	2658	3	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					499	506		10.1038/nature01368	http://dx.doi.org/10.1038/nature01368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556884				2022-12-28	WOS:000180670600036
J	Carlip, S; Vaidya, S				Carlip, S; Vaidya, S			Do black holes constrain varying constants?	NATURE			English	Article									Univ Calif Davis, Dept Phys, Davis, CA 95616 USA	University of California System; University of California Davis	Carlip, S (corresponding author), Univ Calif Davis, Dept Phys, Davis, CA 95616 USA.							BARROW J, GRQC0211074; Carlip S, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.023507; Davies PCW, 2002, NATURE, V418, P602, DOI 10.1038/418602a; Dirac P. A. M., 1937, NATURE, V139, P323, DOI [10.1038/139323a0, DOI 10.1038/139323A0]; Dirac PAM, 1938, PROC R SOC LON SER-A, V165, P0199, DOI 10.1098/rspa.1938.0053; FLAMBAUM VV, ASTROPH0208384; GIBBONS GW, 1975, COMMUN MATH PHYS, V44, P245, DOI 10.1007/BF01609829; HAWKING SW, 1975, COMMUN MATH PHYS, V43, P199, DOI 10.1007/BF02345020; JACOBSON T, 1995, PHYS REV D, V52, P3518, DOI 10.1103/PhysRevD.52.3518; Webb JK, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.091301; Webb JK, 1999, PHYS REV LETT, V82, P884, DOI 10.1103/PhysRevLett.82.884	12	8	8	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					498	498		10.1038/421498a	http://dx.doi.org/10.1038/421498a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556883	Green Submitted, Bronze			2022-12-28	WOS:000180670600035
J	Huang, XMH; Zorman, CA; Mehregany, M; Roukes, ML				Huang, XMH; Zorman, CA; Mehregany, M; Roukes, ML			Nanodevice motion at microwave frequencies	NATURE			English	Article							NANOELECTROMECHANICAL SYSTEMS; RESONANCE		CALTECH 114 36, Pasadena, CA 91125 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA	California Institute of Technology; Case Western Reserve University	Huang, XMH (corresponding author), CALTECH 114 36, Pasadena, CA 91125 USA.		Roukes, Michael L/E-9787-2010					Armour AD, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.148301; Bocko MF, 1996, REV MOD PHYS, V68, P755, DOI 10.1103/RevModPhys.68.755; Carr DW, 1999, APPL PHYS LETT, V75, P920, DOI 10.1063/1.124554; Cho A, 2003, SCIENCE, V299, P36, DOI 10.1126/science.299.5603.36; CLARK JR, 2001, IEEE INT EL DEV M SA, P493; Cleland AN, 1998, NATURE, V392, P160, DOI 10.1038/32373; Ekinci KL, 2002, APPL PHYS LETT, V81, P2253, DOI 10.1063/1.1507833; Nguyen CTC, 1998, P IEEE, V86, P1756, DOI 10.1109/5.704281; Roukes M, 2001, SCI AM, V285, P48, DOI 10.1038/scientificamerican0901-48; Roukes M, 2001, PHYS WORLD, V14, P25; SIDLES JA, 1995, REV MOD PHYS, V67, P249, DOI 10.1103/RevModPhys.67.249; Swade Doron, 2001, DIFFERENCE ENGINE C; Yang YT, 2001, APPL PHYS LETT, V78, P162, DOI 10.1063/1.1338959	13	533	553	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					496	496		10.1038/421496a	http://dx.doi.org/10.1038/421496a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556880				2022-12-28	WOS:000180670600032
J	Natesh, R; Schwager, SLU; Sturrock, ED; Acharya, KR				Natesh, R; Schwager, SLU; Sturrock, ED; Acharya, KR			Crystal structure of the human angiotensin-converting enzyme-lisinopril complex	NATURE			English	Article							ACTIVE-SITE; COMPETITIVE INHIBITORS; MOLECULAR-CLONING; IDENTIFICATION; HYDROLYSIS; ACTIVATION; DEPENDENCE; SUBSTRATE; RESIDUES; BINDING	Angiotensin-converting enzyme (ACE) has a critical role in cardiovascular function by cleaving the carboxy terminal His-Leu dipeptide from angiotensin I to produce a potent vasopressor octapeptide, angiotensin II. Inhibitors of ACE are a first line of therapy for hypertension, heart failure, myocardial infarction and diabetic nephropathy. Notably, these inhibitors were developed without knowledge of the structure of human ACE, but were instead designed on the basis of an assumed mechanistic homology with carboxypeptidase A(1). Here we present the X-ray structure of human testicular ACE and its complex with one of the most widely used inhibitors, lisinopril (N-2-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline; also known as Prinivil or Zestril), at 2.0 Angstrom resolution. Analysis of the three-dimensional structure of ACE shows that it bears little similarity to that of carboxypeptidase A, but instead resembles neurolysin(2) and Pyrococcus furiosus carboxypeptidase(3)-zinc metallopeptidases with no detectable sequence similarity to ACE. The structure provides an opportunity to design domain-selective ACE inhibitors that may exhibit new pharmacological profiles.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Univ Cape Town, Sch Med, Div Med Biochem, ZA-7925 Observatory, South Africa; Univ Cape Town, Sch Med, MRC, UCT Liver Res Ctr, ZA-7925 Observatory, South Africa	University of Bath; University of Cape Town; University of Cape Town	Acharya, KR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	sturrock@curie.uct.ac.za; bsskra@bath.ac.uk	NATESH, Ramanathan/C-4488-2008	NATESH, Ramanathan/0000-0002-1145-5962; Acharya, K. Ravi/0000-0002-3009-4058				ABRAHAMS JP, 1996, ACTA CRYSTALLOGR D, V52, P110; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Arndt JW, 2002, STRUCTURE, V10, P215, DOI 10.1016/S0969-2126(02)00698-6; BERNSTEIN KE, 1990, BIOCHEM BIOPH RES CO, V167, P310, DOI 10.1016/0006-291X(90)91766-L; Brown CK, 2001, P NATL ACAD SCI USA, V98, P3127, DOI 10.1073/pnas.051633198; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUNNING P, 1978, BIOCHEM BIOPH RES CO, V83, P1442, DOI 10.1016/0006-291X(78)91382-7; BUNNING P, 1983, BIOCHEMISTRY-US, V22, P110, DOI 10.1021/bi00270a016; Chubb AJ, 2002, BIOCHEM BIOPH RES CO, V297, P1225, DOI 10.1016/S0006-291X(02)02324-0; CORVOL P, 1998, HDB PROTEOLYTIC ENZY, P1066; CUSHMAN DW, 1977, BIOCHEMISTRY-US, V16, P5484, DOI 10.1021/bi00644a014; DELAFORTELLE E, 1997, METHOD ENZYMOL, V276, P272; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P7118, DOI 10.1021/bi00243a012; EHLERS MRW, 1989, P NATL ACAD SCI USA, V86, P7741, DOI 10.1073/pnas.86.20.7741; Esther CR, 1997, J CLIN INVEST, V99, P2375, DOI 10.1172/JCI119419; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; JASPARD E, 1993, J BIOL CHEM, V268, P9496; Junot C, 2001, J PHARMACOL EXP THER, V297, P606; Liu XF, 2001, J BIOL CHEM, V276, P33518, DOI 10.1074/jbc.M101495200; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patchett A A, 1985, Adv Enzymol Relat Areas Mol Biol, V57, P1; PATCHETT AA, 1980, NATURE, V288, P280, DOI 10.1038/288280a0; SHAPIRO R, 1983, BIOCHEMISTRY-US, V22, P3850, DOI 10.1021/bi00285a021; SKIDGEL RA, 1984, PEPTIDES, V5, P769, DOI 10.1016/0196-9781(84)90020-2; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; WEI L, 1992, J BIOL CHEM, V267, P13398; WILLIAMS TA, 1994, J BIOL CHEM, V269, P29430; Yu XC, 1997, J BIOL CHEM, V272, P3511, DOI 10.1074/jbc.272.6.3511	30	614	656	9	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2003	421	6922					551	554		10.1038/nature01370	http://dx.doi.org/10.1038/nature01370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12540854				2022-12-28	WOS:000180670600050
J	Bonifacino, JS; Jackson, CL				Bonifacino, JS; Jackson, CL			Endosome-specific localization and function of the ARF activator GNOM	CELL			English	Article							NUCLEOTIDE EXCHANGE FACTOR; MDCK CELLS; COMPLEX; BIG2	ARF GTPases act at multiple steps of the secretory and vacuolar/lysosomal trafficking pathways, but little is known about the spatial regulation of ARF activation. In this issue of Cell, Geldner et al. demonstrate that the Arabidopsis ARF activator GNOM localizes to endosomes where it controls the polarized trafficking of the auxin efflux carrier PIN1 to the basal plasma membrane.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bonifacino, JS (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.		Jackson, Catherine/A-3421-2013; Jackson, Catherine/T-5688-2019	Jackson, Catherine/0000-0002-0843-145X; Bonifacino, Juan S./0000-0002-5673-6370	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008734, Z01HD001607] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		APODACA G, 1993, J BIOL CHEM, V268, P20380; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; Shinotsuka C, 2002, J BIOL CHEM, V277, P9468, DOI 10.1074/jbc.M112427200; Simmen T, 2002, NAT CELL BIOL, V4, P154, DOI 10.1038/ncb745; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420	10	19	19	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 24	2003	112	2					141	142		10.1016/S0092-8674(03)00038-2	http://dx.doi.org/10.1016/S0092-8674(03)00038-2			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553900	Bronze			2022-12-28	WOS:000181191600001
J	Klein, R				Klein, R			Screening interval for retinopathy in type 2 diabetes	LANCET			English	Editorial Material									Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Klein, R (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53705 USA.	kleinr@epi.ophth.wisc.edu		Klein, Ronald/0000-0002-4428-6237	NATIONAL EYE INSTITUTE [R01EY003083] Funding Source: NIH RePORTER; NEI NIH HHS [EY03083] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		[Anonymous], 1994, DIABETES CARE, V17, P616; [Anonymous], 1976, Am J Ophthalmol, V81, P383; BRECHNER RJ, 1993, JAMA-J AM MED ASSOC, V270, P1714, DOI 10.1001/jama.270.14.1714; Fong DS, 2001, ARCH OPHTHALMOL-CHIC, V119, P758, DOI 10.1001/archopht.119.5.758; *INT DIAB FED, 1990, DIABETIC MED, V7, P360; KLEIN R, 1995, NIH PUBLICATION, P293; *NIH, 1990, NAT EYE HLTH ED PROG; Vijan S, 2000, JAMA-J AM MED ASSOC, V283, P889, DOI 10.1001/jama.283.7.889; WITKIN SR, 1984, JAMA-J AM MED ASSOC, V251, P2534, DOI 10.1001/jama.251.19.2534	9	25	25	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2003	361	9353					190	191		10.1016/S0140-6736(03)12317-3	http://dx.doi.org/10.1016/S0140-6736(03)12317-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547536				2022-12-28	WOS:000180535400002
J	Morrison, J				Morrison, J			ABC of learning and teaching in medicine - Evaluation	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Morrison, J (corresponding author), Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland.							Cohen L., 1994, RES METHODS ED, V4th; Freeth D., 2000, EVALUATIONS INTERPRO; ROBSON C, 2000, SMALL SCALE EVALUATI; Snell L, 2000, MED EDUC, V34, P862, DOI 10.1046/j.1365-2923.2000.00754.x; Wilkes M, 1999, BRIT MED J, V318, P1269	5	101	109	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 15	2003	326	7385					385	387		10.1136/bmj.326.7385.385	http://dx.doi.org/10.1136/bmj.326.7385.385			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648RZ	12586676	Green Published			2022-12-28	WOS:000181165500026
J	Ptashne, M; Gann, A				Ptashne, M; Gann, A			Imposing specificity on kinases	SCIENCE			English	Editorial Material							SCAFFOLD PROTEIN; ACTIVATION; PATHWAY; STE5		Mem Sloan Kettering Canc Ctr, Dept Mol Biol, New York, NY 10021 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory	Ptashne, M (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Mol Biol, 1275 York Ave, New York, NY 10021 USA.							Elion EA, 2001, J CELL SCI, V114, P3967; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Lamson RE, 2002, MOL CELL BIOL, V22, P2939, DOI 10.1128/MCB.22.9.2939-2951.2002; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; PTASHNE M, 2002, GENES SIGNALS; Sette C, 2000, MOL BIOL CELL, V11, P4033, DOI 10.1091/mbc.11.11.4033	8	35	37	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1025	1027		10.1126/science.1081519	http://dx.doi.org/10.1126/science.1081519			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586931				2022-12-28	WOS:000180960000032
J	Hsieh, JC; Lee, L; Zhang, LQ; Wefer, S; Brown, K; DeRossi, C; Wines, ME; Rosenquist, T; Holdener, BC				Hsieh, JC; Lee, L; Zhang, LQ; Wefer, S; Brown, K; DeRossi, C; Wines, ME; Rosenquist, T; Holdener, BC			Mesd encodes an LRP5/6 chaperone essential for specification of mouse embryonic polarity	CELL			English	Article							RECEPTOR-RELATED PROTEIN; SUBCELLULAR-LOCALIZATION; MESODERM INDUCTION; PRIMITIVE ENDODERM; NODAL EXPRESSION; BODY PLAN; AXIS; GASTRULATION; DISABLED-2; RETENTION	Specification of embryonic polarity and pattern formation in multicellular organisms requires inductive signals from neighboring cells. One approach toward understanding these interactions is to study mutations that disrupt development. Here, we demonstrate that mesd, a gene identified in the mesoderm development (mesd) deletion interval on mouse chromosome 7, is essential for specification of embryonic polarity and mesoderm induction. MESD functions in the endoplasmic reticulum as a specific chaperone for LRP5 and LRP6, which in conjunction with Frizzled, are coreceptors for canonical WNT signal transduction. Disruption of embryonic polarity and mesoderm differentiation in mesd-deficient embryos likely results from a primary defect in WNT signaling. However, phenotypic differences between mesd-deficient and wnt3(-/-) embryos suggest that MESD may function on related members of the low-density lipoprotein receptor (LDLR) family, whose members mediate diverse cellular processes ranging from cargo transport to signaling.	SUNY Stony Brook, Dept Biochem & Cell Biol, Ctr Dev Genet, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Holdener, BC (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Ctr Dev Genet, Stony Brook, NY 11794 USA.	bernadette.holdener@stonybrook.edu			NICHD NIH HHS [HD53964] Funding Source: Medline; NIGMS NIH HHS [R01 GM053964] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053964] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANG SL, 1994, DEVELOPMENT, V120, P2979; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; BEDDINGTON RSP, 1994, DEVELOPMENT, V120, P613; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; HO SN, 1989, BIOTECHNIQUES, V16, P51; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HODGES RS, 1988, J BIOL CHEM, V263, P11768; HOGAN B, 1994, MANIPULATING MOUSE E, V1; HOLDENER BC, 1994, DEVELOPMENT, V120, P1335; HOLDENERKENNY B, 1992, BIOESSAYS, V14, P831, DOI 10.1002/bies.950141208; Jorgensen MM, 2000, J BIOL CHEM, V275, P33861, DOI 10.1074/jbc.M004663200; LAWSON KA, 1991, CIBA FOUND S, V165, P891; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; Morris SM, 2002, EMBO J, V21, P1555, DOI 10.1093/emboj/21.7.1555; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; SCHEDL A, 1992, GENOMICS, V14, P288, DOI 10.1016/S0888-7543(05)80218-6; Schumacher A, 1996, NATURE, V383, P250, DOI 10.1038/383250a0; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Tam PPL, 1999, DEVELOPMENT, V126, P5171; Tam PPL, 2001, BIOESSAYS, V23, P508, DOI 10.1002/bies.1070; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Varlet I, 1997, DEVELOPMENT, V124, P1033; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; Wines ME, 2001, GENOMICS, V72, P88, DOI 10.1006/geno.2000.6466; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810	39	198	220	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 7	2003	112	3					355	367		10.1016/S0092-8674(03)00045-X	http://dx.doi.org/10.1016/S0092-8674(03)00045-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581525	Bronze			2022-12-28	WOS:000181252200007
J	Campbell, R; Quilty, B; Dieppe, P				Campbell, R; Quilty, B; Dieppe, P			Discrepancies between patients' assessments of outcome: qualitative study nested within a randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							KNEE		Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Bristol, Dept Med, Bristol BS8 1TH, Avon, England; Univ Bristol, MRC Hlth Serv Res Collaborat, Bristol BS8 1TH, Avon, England	University of Bristol; University of Bristol; University of Bristol	Campbell, R (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.							BELLAMY N, 1988, J RHEUMATOL, V15, P1833; BOWLING A, 1995, MEASURING DIS REV DI; Campbell R, 2001, J EPIDEMIOL COMMUN H, V55, P132, DOI 10.1136/jech.55.2.132; QUILTY B, 1998, PATELLOFEMORAL JOINT; Streiner DL., 2001, HLTH MEASUREMENT SCA, V2nd	5	49	50	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					252	253		10.1136/bmj.326.7383.252	http://dx.doi.org/10.1136/bmj.326.7383.252			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560274	Green Published, Bronze			2022-12-28	WOS:000180908300017
J	Liu, XN; Duncan, JH				Liu, XN; Duncan, JH			The effects of surfactants on spilling breaking waves	NATURE			English	Article							DYNAMIC PROPERTIES; BREAKERS; SYSTEMS; WATER	Breaking waves markedly increase the rates of air-sea transfer of momentum, energy and mass(1-4). In light to moderate wind conditions, spilling breakers with short wavelengths are observed frequently. Theory and laboratory experiments have shown that, as these waves approach breaking in clean water, a ripple pattern that is dominated by surface tension forms at the crest(5-14). Under laboratory conditions and in theory, the transition to turbulent flow is triggered by flow separation under the ripples, typically without leading to overturning of the free surface(15). Water surfaces in nature, however, are typically contaminated by surfactant films that alter the surface tension and produce surface elasticity and viscosity(16,17). Here we present the results of laboratory experiments in which spilling breaking waves were generated mechanically in water with a range of surfactant concentrations. We find significant changes in the breaking process owing to surfactants. At the highest concentration of surfactants, a small plunging jet issues from the front face of the wave at a point below the wave crest and entraps a pocket of air on impact with the front face of the wave. The bubbles and turbulence created during this process are likely to increase air-sea transfer.	Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Duncan, JH (corresponding author), Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA.	duncan@eng.umd.edu	Duncan, James H/FVY-7148-2022	Duncan, James H/0000-0003-3740-9881				BARGER WR, 1974, DEEP-SEA RES, V21, P83, DOI 10.1016/0011-7471(74)90022-9; Ceniceros HD, 2003, PHYS FLUIDS, V15, P245, DOI 10.1063/1.1528940; Ceniceros HD, 1999, PHYS FLUIDS, V11, P1042, DOI 10.1063/1.869975; COKELET ED, 1977, NATURE, V267, P769, DOI 10.1038/267769a0; DUNCAN JH, 1994, PHYS FLUIDS, V6, pS2, DOI 10.1063/1.4739100; Duncan JH, 1999, J FLUID MECH, V379, P191, DOI 10.1017/S0022112098003152; DUNCAN JH, 1994, PHYS FLUIDS, V6, P2558, DOI 10.1063/1.868146; EBUCHI N, 1987, BOUND-LAY METEOROL, V39, P133, DOI 10.1007/BF00121871; Edwards D.A., 1991, INTERFACIAL TRANSPOR; Frew NM, 1997, SEA SURFACE GLOBAL C, P121, DOI DOI 10.1017/CBO9780511525025.006; Jessup AT, 1997, NATURE, V385, P52, DOI 10.1038/385052a0; LONGUETHIGGINS M, 1995, J PHYS OCEANOGR, V25, P2458, DOI 10.1175/1520-0485(1995)025<2458:OTDOTJ>2.0.CO;2; LONGUETHIGGINS MS, 1976, P ROY SOC LOND A MAT, V350, P1, DOI 10.1098/rspa.1976.0092; LonguetHiggins MS, 1997, J FLUID MECH, V336, P33, DOI 10.1017/S002211209600403X; LonguetHiggins MS, 1996, J PHYS OCEANOGR, V26, P1957, DOI 10.1175/1520-0485(1996)026<1957:CJODW>2.0.CO;2; LONGUETHIGGINS MS, 1994, P ROY SOC LOND A MAT, V446, P399, DOI 10.1098/rspa.1994.0111; LONGUETHIGGINS MS, 1992, J FLUID MECH, V240, P659, DOI 10.1017/S0022112092000259; LONGUETHIGGINS MS, 1976, P 10 S NAV HYDR CAMB, P597; Mass JT, 1998, J GEOPHYS RES-OCEANS, V103, P15695, DOI 10.1029/98JC01190; Melville WK, 1996, ANNU REV FLUID MECH, V28, P279, DOI 10.1146/annurev.fl.28.010196.001431; MELVILLE WK, 1985, NATURE, V317, P514, DOI 10.1038/317514a0; MIYANO K, 1983, J COLLOID INTERF SCI, V92, P297, DOI 10.1016/0021-9797(83)90151-0; OKUDA K, 1982, J OCEANOGR SOC JAPAN, V38, P313; POSKANZER AM, 1975, J PHYS CHEM-US, V79, P2122, DOI 10.1021/j100587a012; Qiao HB, 2001, J FLUID MECH, V439, P57, DOI 10.1017/S0022112001004207; Sokatch J.R., 2014, BACTERIAL PHYSL META; THORPE SA, 1985, NATURE, V318, P519, DOI 10.1038/318519a0; TING L, 1984, J COLLOID INTERF SCI, V102, P248, DOI 10.1016/0021-9797(84)90217-0; Tulin MP, 1996, FLUID MEC A, V34, P177; WEI Y, 1992, J GEOPHYS RES-OCEANS, V97, P5307, DOI 10.1029/91JC02820	30	34	34	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2003	421	6922					520	523		10.1038/nature01357	http://dx.doi.org/10.1038/nature01357			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556889				2022-12-28	WOS:000180670600041
J	Mikkola, HKA; Klintman, J; Yang, HD; Hock, H; Schlaeger, TM; Fujiwara, Y; Orkin, SH				Mikkola, HKA; Klintman, J; Yang, HD; Hock, H; Schlaeger, TM; Fujiwara, Y; Orkin, SH			Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene	NATURE			English	Article							TRANSCRIPTION FACTOR SCL; HEMATOPOIETIC LINEAGES; MICE; PROGENITOR; ERYTHROPOIESIS; MESODERM; PROTEINS; BINDING	The production of blood cells is sustained throughout the lifetime of an individual by haematopoietic stem cells (HSCs)(1). Specification of HSCs from mesoderm during embryonic development requires the stem cell leukaemia SCL/tal-1 gene product(2-6). Forced expression of SCL/tal-1 strongly induces blood formation in embryos, indicating that this gene has a dominant role in commitment to haematopoiesis(7,8). In the adult haematopoietic system, expression of SCL/tal-1 is enriched in HSCs and multipotent progenitors, and in erythroid and megakaryocytic lineages(9-11), consistent with roles for this factor in adult haematopoiesis. Here we assess by conditional gene targeting whether SCL/tal-1 is required continuously for the identity and function of HSCs. We find that SCL/tal-1 is dispensable for HSC engraftment, self-renewal and differentiation into myeloid and lymphoid lineages; however, the proper differentiation of erythroid and megakaryocytic precursors is dependent on SCL/tal-1. Thus, SCL/tal-1 is essential for the genesis of HSCs, but its continued expression is not essential for HSC functions. These findings contrast with lineage choice mechanisms, in which the identity of haematopoietic lineages requires continuous transcription factor expression(12,13).	Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA.			Klintman, Jenny/0000-0002-9544-5058; Schlaeger, Thorsten/0000-0002-1599-9908				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Cantor AB, 2002, MOL CELL BIOL, V22, P4268, DOI 10.1128/MCB.22.12.4268-4279.2002; Choi K, 1998, DEVELOPMENT, V125, P725; Elefanty AG, 1998, P NATL ACAD SCI USA, V95, P11897, DOI 10.1073/pnas.95.20.11897; Faloon P, 2000, DEVELOPMENT, V127, P1931; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Mead PE, 2001, DEVELOPMENT, V128, P2301; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Porcher C, 1999, DEVELOPMENT, V126, P4603; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Robb L, 1996, EMBO J, V15, P4123, DOI 10.1002/j.1460-2075.1996.tb00787.x; Robertson SM, 2000, DEVELOPMENT, V127, P2447; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Yamamoto Hiroyuki, 1995, Journal of Marine Biotechnology, V2, P95; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	24	295	299	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					547	551		10.1038/nature01345	http://dx.doi.org/10.1038/nature01345			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12540851				2022-12-28	WOS:000180670600049
J	Rose, EA				Rose, EA			Off-pump coronary-artery bypass-surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ Coll Phys & Surg, Dept Surg, New York, NY 10032 USA	Columbia University	Rose, EA (corresponding author), Columbia Univ Coll Phys & Surg, Dept Surg, 630 W 168th St, New York, NY 10032 USA.		Rose, Eric/AAJ-2281-2020						0	38	42	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					379	380		10.1056/NEJMp020171	http://dx.doi.org/10.1056/NEJMp020171			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12556540				2022-12-28	WOS:000180643800001
J	Rubins, K; Relman, DA				Rubins, K; Relman, DA			Progression of the lesion at the site of inoculation after smallpox vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Stanford Univ, Sch Med, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rubins, K (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.			Relman, David A./0000-0001-8331-1354					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					414	414		10.1056/NEJMicm020924	http://dx.doi.org/10.1056/NEJMicm020924			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12556544				2022-12-28	WOS:000180643800006
J	Bluher, M; Kahn, BB; Kahn, CR				Bluher, M; Kahn, BB; Kahn, CR			Extended longevity in mice lacking the insulin receptor in adipose tissue	SCIENCE			English	Article							LIFE-SPAN; FOOD RESTRICTION; CALORIC RESTRICTION; GENE; MUTATIONS; EXTENSION; ELEGANS; GROWTH; MUTANT; MUSCLE	Caloric restriction has been shown to increase longevity in organisms ranging from yeast to mammals. In some organisms, this has been associated with a decreased fat mass and alterations in insulin/insulin-like growth factor 1 (IGF-1) pathways. To further explore these associations with enhanced longevity, we studied mice with a fat-specific insulin receptor knockout (FIRKO). These animals have reduced fat mass and are protected against age-related obesity and its subsequent metabolic abnormalities, although their food intake is normal. Both male and female FIRKO mice were found to have an increase in mean life-span of similar to134 days (18%), with parallel increases in median and maximum life-spans. Thus, a reduction of fat mass without caloric restriction can be associated with increased longevity in mice, possibly through effects on insulin signaling.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Kahn, CR (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK043051, P01DK056116, R01DK043051] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK043051, DK 30136, DK 56116, DK 43051] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; BERTRAND HA, 1980, J GERONTOL, V35, P827, DOI 10.1093/geronj/35.6.827; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; HARMAN D, 1994, ANN NY ACAD SCI, V717, P1, DOI 10.1111/j.1749-6632.1994.tb12069.x; HARRISON DE, 1984, P NATL ACAD SCI-BIOL, V81, P1835, DOI 10.1073/pnas.81.6.1835; HARRISON DE, 1987, J NUTR, V117, P376, DOI 10.1093/jn/117.2.376; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIM H, 1992, DIABETOLOGIA, V35, P261, DOI 10.1007/BF00400927; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KROOK A, 1993, LANCET, V342, P277, DOI 10.1016/0140-6736(93)91820-C; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Lee SS, 2002, NATURE, V418, P287, DOI 10.1038/418287a; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; MASORO EJ, 1982, P NATL ACAD SCI-BIOL, V79, P4239, DOI 10.1073/pnas.79.13.4239; MCCARTER RJ, 1992, AM J PHYSIOL, V263, pE448, DOI 10.1152/ajpendo.1992.263.3.E448; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Piantanelli L, 2001, MECH AGEING DEV, V122, P463, DOI 10.1016/S0047-6374(00)00256-6; Pletcher SD, 2000, J GERONTOL A-BIOL, V55, pB381, DOI 10.1093/gerona/55.8.B381; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; TAYLOR SI, 1990, DIABETES CARE, V13, P257, DOI 10.2337/diacare.13.3.257; WEINDRUCH W, 1998, RETARDATION AGING DI; WERTHEIMER E, 1993, NAT GENET, V5, P71, DOI 10.1038/ng0993-71; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	33	985	1012	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					572	574		10.1126/science.1078223	http://dx.doi.org/10.1126/science.1078223			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543978				2022-12-28	WOS:000180559800052
J	Rabitz, H				Rabitz, H			Shaped laser pulses as reagents	SCIENCE			English	Editorial Material							OPTIMIZATION		Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University	Rabitz, H (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.							Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; Bartels R, 2000, NATURE, V406, P164, DOI 10.1038/35018029; Daniel C, 2003, SCIENCE, V299, P536, DOI 10.1126/science.1078517; Herek JL, 2002, NATURE, V417, P533, DOI 10.1038/417533a; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; Kunde J, 2000, APPL PHYS LETT, V77, P924, DOI 10.1063/1.1288603; Levis RJ, 2001, SCIENCE, V292, P709, DOI 10.1126/science.1059133; Rabitz H, 2000, SCIENCE, V288, P824, DOI 10.1126/science.288.5467.824; Vajda S, 2001, CHEM PHYS, V267, P231, DOI 10.1016/S0301-0104(01)00275-0; Weiner AM, 2000, REV SCI INSTRUM, V71, P1929, DOI 10.1063/1.1150614	10	84	88	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					525	+		10.1126/science.1080683	http://dx.doi.org/10.1126/science.1080683			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543961				2022-12-28	WOS:000180559800034
J	Axtell, MJ; Staskawicz, BJ				Axtell, MJ; Staskawicz, BJ			Initiation of RPS2-specified disease resistance in Arabidopsis is coupled to the AvrRpt2-directed elimination of RIN4	CELL			English	Article							NUCLEOTIDE-BINDING SITE; AVIRULENCE GENE AVRRPT2; LEUCINE-RICH REPEATS; PSEUDOMONAS-SYRINGAE; PLASMA-MEMBRANE; PTO KINASE; BACTERIAL PATHOGENESIS; MUTATIONAL ANALYSIS; PLANT IMMUNITY; PROTEIN	Plants have evolved a sophisticated innate immune system to recognize invading pathogens and to induce a set of host defense mechanisms resulting in disease resistance. Pathogen recognition is often mediated by plant disease resistance (R) proteins that respond specifically to one or a few pathogen-derived molecules. This specificity has led to suggestions of a receptor-ligand mode of R protein function. Delivery of the bacterial effector protein AvrRpt2 by Pseudomonas syringae specifically induces disease resistance in Arabidopsis plants expressing the RPS2 R protein. We demonstrate that RPS2 physically interacts with Arabidopsis RIN4 and that AvrRpt2 causes the elimination of RIN4 during activation of the RPS2 pathway. AvrRpt2-mediated RIN4 elimination also occurs in the rps2, ndr1, and Atrar1 mutant backgrounds, demonstrating that this activity can be achieved independent of an RPS2-mediated signaling pathway. Therefore, we suggest that RPS2 initiates signaling based upon perception of RIN4 disappearance rather than direct recognition of AvrRpt2.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Staskawicz, BJ (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.							Ausubel FM, 1994, CURRENT PROTOCOLS MO; Axtell MJ, 2001, MOL PLANT MICROBE IN, V14, P181, DOI 10.1094/MPMI.2001.14.2.181; Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; Bent AF, 2000, PLANT PHYSIOL, V124, P1540, DOI 10.1104/pp.124.4.1540; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Bonas U, 2002, CURR OPIN MICROBIOL, V5, P44, DOI 10.1016/S1369-5274(02)00284-9; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963; Chen ZY, 2000, MOL PLANT MICROBE IN, V13, P1312, DOI 10.1094/MPMI.2000.13.12.1312; CUPPELS DA, 1986, APPL ENVIRON MICROB, V51, P323, DOI 10.1128/AEM.51.2.323-327.1986; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Guttman DS, 2001, MOL PLANT MICROBE IN, V14, P145, DOI 10.1094/MPMI.2001.14.2.145; Harlow E., 1999, USING ANTIBODIES LAB; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; INNES RW, 1993, J BACTERIOL, V175, P4859, DOI 10.1128/JB.175.15.4859-4869.1993; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; KEARNEY B, 1990, NATURE, V346, P385, DOI 10.1038/346385a0; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; KUNKEL BN, 1993, PLANT CELL, V5, P865, DOI 10.1105/tpc.5.8.865; Leister RT, 2000, PLANT J, V22, P345, DOI 10.1046/j.1365-313x.2000.00744.x; Leister RT, 1996, P NATL ACAD SCI USA, V93, P15497, DOI 10.1073/pnas.93.26.15497; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Martinez-Garcia JF, 1999, PLANT J, V20, P251, DOI 10.1046/j.1365-313x.1999.00579.x; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Muskett PR, 2002, PLANT CELL, V14, P979, DOI 10.1105/tpc.001040; Nebenfuhr A, 1999, PLANT PHYSIOL, V121, P1127, DOI 10.1104/pp.121.4.1127; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; RITTER C, 1995, MOL PLANT MICROBE IN, V8, P444, DOI 10.1094/MPMI-8-0444; Ritter C, 1996, PLANT CELL, V8, P251, DOI 10.1105/tpc.8.2.251; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Schaller GE, 1995, METHOD CELL BIOL, V50, P129, DOI 10.1016/S0091-679X(08)61027-4; Schneider DS, 2002, CELL, V109, P537, DOI 10.1016/S0092-8674(02)00764-X; Sedbrook JC, 2002, PLANT CELL, V14, P1635, DOI 10.1105/tpc.002360; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; SIMONICH MT, 1995, MOL PLANT MICROBE IN, V8, P637, DOI 10.1094/MPMI-8-0637; STASKAWICZ BJ, 1995, SCIENCE, V268, P661, DOI 10.1126/science.7732374; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Swiderski MR, 2001, PLANT J, V26, P101, DOI 10.1046/j.1365-313x.2001.01014.x; Tai TH, 1999, P NATL ACAD SCI USA, V96, P14153, DOI 10.1073/pnas.96.24.14153; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; Tao Y, 2000, PLANT CELL, V12, P2541, DOI 10.1105/tpc.12.12.2541; Tornero P, 2001, PLANT J, V28, P475, DOI 10.1046/j.1365-313X.2001.01136.x; Tornero P, 2002, PLANT CELL, V14, P1005, DOI 10.1105/tpc.001032; Warren RF, 1998, PLANT CELL, V10, P1439, DOI 10.1105/tpc.10.9.1439	51	611	641	4	111	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 7	2003	112	3					369	377		10.1016/S0092-8674(03)00036-9	http://dx.doi.org/10.1016/S0092-8674(03)00036-9			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581526	Bronze			2022-12-28	WOS:000181252200008
J	Bernhard, JM				Bernhard, JM			Potential symbionts in bathyal foraminifera	SCIENCE			English	Article									Univ S Carolina, Dept Environm Hlth Sci, Norman J Arnold Sch Publ Hlth, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Bernhard, JM (corresponding author), Univ S Carolina, Dept Environm Hlth Sci, Norman J Arnold Sch Publ Hlth, Columbia, SC 29208 USA.		Bernhard, Joan/M-3260-2013	Bernhard, Joan/0000-0003-2121-625X				AHARON P, 2001, GEOL SOC AM ABSTR, V33, pA162; Bernhard JM, 1999, EARTH-SCI REV, V46, P149, DOI 10.1016/S0012-8252(99)00017-3; FENCHEL T, 1995, ECOLOGY EVOLUTION AN; Giere O, 1996, BIOSYST ECOL SER, P353; Grzymski J, 2002, LIMNOL OCEANOGR, V47, P1569, DOI 10.4319/lo.2002.47.6.1569; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; VETTER RD, 1985, MAR BIOL, V88, P33, DOI 10.1007/BF00393041	7	78	86	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					861	861		10.1126/science.1077314	http://dx.doi.org/10.1126/science.1077314			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574621				2022-12-28	WOS:000180830900042
J	Zalfa, F; Giorgi, M; Primerano, B; Moro, A; Di Penta, A; Reis, S; Oostra, B; Bagni, C				Zalfa, F; Giorgi, M; Primerano, B; Moro, A; Di Penta, A; Reis, S; Oostra, B; Bagni, C			The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at Synapses	CELL			English	Article							MENTAL-RETARDATION PROTEIN; MESSENGER-RNA; BC200 RNA; RIBONUCLEOPROTEIN PARTICLE; CLINICAL PHENOTYPE; DENDRITIC LOCATION; KNOCKOUT MICE; CGG REPEAT; GENE; IDENTIFICATION	The Fragile X syndrome, which results from the absence of functional FMRP protein, is the most common heritable form of mental retardation. Here, we show that FMRP acts as a translational repressor of specific mRNAs at synapses. Interestingly, FMRP associates not only with these target mRNAs, but also with the dendritic, non-translatable RNA BC1. Blocking of BC1 inhibits the interaction of FMRP with its target mRNAs. Furthermore, BC1 binds directly to FMRP and can also associate, in the absence of any protein, with the mRNAs regulated by FMRP. This suggests a mechanism where BC1 could determine the specificity of FMRP function by linking the regulated mRNAs and FMRP. Thus, when FMRP is not present, loss of translational repression of specific mRNAs at synapses could result in synaptic dysfunction phenotype of Fragile X patients.	Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy; IRCCS, Fdn Santa Lucia, Ist Neurosci Sperimentali, Rome, Italy; Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands	University of Rome Tor Vergata; IRCCS Santa Lucia; Erasmus University Rotterdam; Erasmus MC	Bagni, C (corresponding author), Univ Roma Tor Vergata, Dipartimento Biol, Via Ric Sci, I-00133 Rome, Italy.	bagni@uniroma2.it	Zalfa, Francesca/J-7759-2018	Zalfa, Francesca/0000-0002-1922-9468; Bagni, Claudia/0000-0002-4419-210X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038038] Funding Source: NIH RePORTER; NICHD NIH HHS [5 R01 HD38038] Funding Source: Medline; Telethon [GGP02357] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon)		Adinolfi S, 1999, RNA, V5, P1248, DOI 10.1017/S1355838299990647; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bagni C, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0004.2000; BAKKER CE, 1994, CELL, V78, P23; Bardoni B, 1999, HUM MOL GENET, V8, P2557, DOI 10.1093/hmg/8.13.2557; Bardoni B, 2002, CURR OPIN GENET DEV, V12, P284, DOI 10.1016/S0959-437X(02)00300-3; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Ceman S, 1999, MOL CELL BIOL, V19, P7925; Ceman S, 2000, BIOCHEM BIOPH RES CO, V279, P904, DOI 10.1006/bbrc.2000.4035; Cheng JG, 1997, NEUROSCI LETT, V224, P206, DOI 10.1016/S0304-3940(97)13471-1; Cheng JG, 1996, DNA CELL BIOL, V15, P549, DOI 10.1089/dna.1996.15.549; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Feng Y, 1997, J NEUROSCI, V17, P1539; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; HIRST M, 1995, AM J HUM GENET, V56, P67; Khandjian EW, 1996, NAT GENET, V12, P91, DOI 10.1038/ng0196-91; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; MEIJER H, 1994, HUM MOL GENET, V3, P615; Mila M, 2000, MOL CELL PROBE, V14, P115, DOI 10.1006/mcpr.2000.0293; Muller Dominique, 2002, Current Molecular Medicine (Hilversum), V2, P605, DOI 10.2174/1566524023362041; Muslimov IA, 1997, J NEUROSCI, V17, P4722; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Oostra BA, 2002, TRENDS MOL MED, V8, P102, DOI 10.1016/S1471-4914(02)02271-2; Preiss T, 1999, CURR OPIN GENET DEV, V9, P515, DOI 10.1016/S0959-437X(99)00005-2; Richter JD, 2002, CURR OPIN NEUROBIOL, V12, P300, DOI 10.1016/S0959-4388(02)00318-5; Rozhdestvensky TS, 2001, RNA, V7, P722, DOI 10.1017/S1355838201002485; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; Siomi MC, 1996, MOL CELL BIOL, V16, P3825; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Sung YJ, 2000, BIOCHEM BIOPH RES CO, V275, P973, DOI 10.1006/bbrc.2000.3405; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Tamanini F, 1996, HUM MOL GENET, V5, P809, DOI 10.1093/hmg/5.6.809; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; TIEDGE H, 1991, P NATL ACAD SCI USA, V88, P2093, DOI 10.1073/pnas.88.6.2093; TIEDGE H, 1993, J NEUROSCI, V13, P2382, DOI 10.1523/JNEUROSCI.13-06-02382.1993; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang HD, 2002, J NEUROSCI, V22, P10232; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; WOHRLE D, 1992, AM J HUM GENET, V51, P299; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; ZUKER M, 1989, METHOD ENZYMOL, V180, P262	62	518	541	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 7	2003	112	3					317	327		10.1016/S0092-8674(03)00079-5	http://dx.doi.org/10.1016/S0092-8674(03)00079-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581522	Bronze, Green Published			2022-12-28	WOS:000181252200004
J	Bochud, PY; Calandra, T				Bochud, PY; Calandra, T			Science, medicine, and the future - Pathogenesis of sepsis: new concepts and implications for future treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MIGRATION-INHIBITORY FACTOR; INNATE IMMUNE-RESPONSES; NECROSIS-FACTOR-ALPHA; LATE MEDIATOR; SEPTIC SHOCK; RECOGNITION; TLR4; ENDOTOXIN; THERAPY; MICE		CHU Vaudois, Div Infect Dis, CH-1011 Lausanne, Switzerland; Inst Syst Biol, Seattle, WA 98103 USA	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Institute for Systems Biology (ISB)	Calandra, T (corresponding author), CHU Vaudois, Div Infect Dis, CH-1011 Lausanne, Switzerland.	Thierry.Calandra@chuv.hospvd.ch	Bochud, Pierre-Yves/ABE-5979-2020; Calandra, Thierry/D-9017-2015	Calandra, Thierry/0000-0003-3051-1285; Bochud, Pierre-Yves/0000-0002-2208-4757				Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bochud PY, 2001, INTENS CARE MED, V27, pS33, DOI 10.1007/PL00003796; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Calandra T, 2001, J CHEMOTHERAPY, V13, P173, DOI 10.1179/joc.2001.13.Supplement-2.173; Calandra T, 2002, CURR CLIN TOPICS INF, V22, P1; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CDC, 1990, JAMA-J AM MED ASSOC, V263, P937; Cohen J, 1999, J INFECT DIS, V180, P116, DOI 10.1086/314839; CROSS AS, 1989, J EXP MED, V169, P2021, DOI 10.1084/jem.169.6.2021; Froidevaux C, 2001, CRIT CARE MED, V29, pS13, DOI 10.1097/00003246-200107001-00006; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vincent JL, 2002, CLIN INFECT DIS, V34, P1084, DOI 10.1086/339549; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang HH, 2001, AM J RESP CRIT CARE, V164, P1768, DOI 10.1164/ajrccm.164.10.2106117	30	146	163	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2003	326	7383					262	266		10.1136/bmj.326.7383.262	http://dx.doi.org/10.1136/bmj.326.7383.262			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560281	Green Published			2022-12-28	WOS:000180908300024
J	Gonzalez, D; Lesho, E				Gonzalez, D; Lesho, E			Sudden death following a ventral hernia repair	LANCET			English	Editorial Material									USA Med Act, Heidelberg, Germany		Gonzalez, D (corresponding author), USA Med Act, Heidelberg, Germany.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					391	391		10.1016/S0140-6736(03)12393-8	http://dx.doi.org/10.1016/S0140-6736(03)12393-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573377				2022-12-28	WOS:000180787000013
J	Rademakers, FE				Rademakers, FE			Magnetic resonance imaging in cardiology	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION; WALL-MOTION; PERFUSION; ISCHEMIA		Univ Hosp Leuven, Dept Cardiol, B-3000 Louvain, Belgium	KU Leuven; University Hospital Leuven	Rademakers, FE (corresponding author), Univ Hosp Leuven, Dept Cardiol, B-3000 Louvain, Belgium.		Rademakers, Frank E/B-5622-2013	Rademakers, Frank E/0000-0002-7786-4179				Al-Saadi N, 2000, CIRCULATION, V101, P1379, DOI 10.1161/01.CIR.101.12.1379; Bogaert J, 1999, CIRCULATION, V99, P36, DOI 10.1161/01.CIR.99.1.36; Ibrahim T, 2002, J AM COLL CARDIOL, V39, P864, DOI 10.1016/S0735-1097(01)01829-0; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kim WY, 2001, NEW ENGL J MED, V345, P1863, DOI 10.1056/NEJMoa010866; Klein C, 2002, CIRCULATION, V105, P162, DOI 10.1161/hc0202.102123; Nagel E, 1999, CIRCULATION, V99, P763, DOI 10.1161/01.CIR.99.6.763; Panting JR, 2002, NEW ENGL J MED, V346, P1948, DOI 10.1056/NEJMoa012369; Schwitter J, 2001, CIRCULATION, V103, P2230; Wahba FFM, 2001, NUCL MED COMMUN, V22, P663, DOI 10.1097/00006231-200106000-00010; Wu E, 2001, LANCET, V357, P21, DOI 10.1016/S0140-6736(00)03567-4	11	11	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					359	360		10.1016/S0140-6736(03)12440-3	http://dx.doi.org/10.1016/S0140-6736(03)12440-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573367				2022-12-28	WOS:000180787000003
J	Epstein, ND; Davis, JS				Epstein, ND; Davis, JS			Sensing stretch is fundamental	CELL			English	Review							DILATED CARDIOMYOPATHY; SKELETAL-MUSCLE; TITIN; CALCIUM; PROTEIN	Stretch induces changes in cardiomyocyte biology that are implicated in heart failure, but the mechanism by which stretch is sensed and signals are transduced is unknown. New understanding of the Z disc elements of contractile units are beginning to elucidate the mechanism of stretch sensing and its relation to cardiac adaptation and disease.	NHLBI, Mol Physiol Sect, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Epstein, ND (corresponding author), NHLBI, Mol Physiol Sect, Mol Cardiol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL004996, ZIAHL004996] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Cazorla O, 1999, J MOL CELL CARDIOL, V31, P1215, DOI 10.1006/jmcc.1999.0954; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Davis JS, 2001, CELL, V107, P631, DOI 10.1016/S0092-8674(01)00586-4; Faulkner G, 2001, IUBMB LIFE, V51, P275, DOI 10.1080/152165401317190761; Frey N, 2000, NAT MED, V6, P1221, DOI 10.1038/81321; Furukawa T, 2001, J MOL BIOL, V313, P775, DOI 10.1006/jmbi.2001.5053; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Granzier H, 2002, J PHYSIOL-LONDON, V541, P335, DOI 10.1113/jphysiol.2001.014381; Hoshijima M, 2002, NAT MED, V8, P864, DOI 10.1038/nm739; Huxley AF, 2000, PHILOS T ROY SOC B, V355, P433, DOI 10.1098/rstb.2000.0584; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6; Luther PK, 2002, J MOL BIOL, V319, P1157, DOI 10.1016/S0022-2836(02)00372-8; Maier LS, 2002, J MOL CELL CARDIOL, V34, P919, DOI 10.1006/jmcc.2002.2038; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Moss RL, 2002, CIRC RES, V90, P11, DOI 10.1161/res.90.1.11; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Takeda K, 2000, CELL MOTIL CYTOSKEL, V46, P59, DOI 10.1002/(SICI)1097-0169(200005)46:1<59::AID-CM6>3.0.CO;2-Q; Wang BL, 1997, J BIOL CHEM, V272, P17542, DOI 10.1074/jbc.272.28.17542	20	72	73	2	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 24	2003	112	2					147	150		10.1016/S0092-8674(03)00037-0	http://dx.doi.org/10.1016/S0092-8674(03)00037-0			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553903	Bronze			2022-12-28	WOS:000181191600004
J	Westneat, MW; Betz, O; Blob, RW; Fezzaa, K; Cooper, WJ; Lee, WK				Westneat, MW; Betz, O; Blob, RW; Fezzaa, K; Cooper, WJ; Lee, WK			Tracheal respiration in insects visualized with synchrotron X-ray imaging	SCIENCE			English	Article							VENTILATION	Insects are known to exchange respiratory gases in their system of tracheal tubes by using either diffusion or changes in internal pressure that are produced through body motion or hemolymph circulation. However, the inability to see inside living insects has limited our understanding of their respiration mechanisms. We used a synchrotron beam to obtain x-ray videos of living, breathing insects. Beetles, crickets, and ants exhibited rapid cycles of tracheal compression and expansion in the head and thorax. Body movements and hemolymph circulation cannot account for these cycles; therefore, our observations demonstrate a previously unknown mechanism of respiration in insects analogous to the inflation and deflation of vertebrate lungs.	Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; Univ Kiel, Dept Zool, Kiel, Germany; Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; Argonne Natl Lab, Adv Photon Source, Expt Facilities Div, Argonne, IL 60439 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	Field Museum of Natural History (Chicago); University of Kiel; Clemson University; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Westneat, MW (corresponding author), Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA.	mwestneat@fieldmuseum.org	Lee, Wah-Keat/GRR-9734-2022	Cooper, W. James/0000-0003-4204-4266; Blob, Richard/0000-0001-5026-343X				BRAINERD EL, 1989, SCIENCE, V246, P1593, DOI 10.1126/science.246.4937.1593; Carrier DR, 1996, J EXP BIOL, V199, P1455; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Cloetens P, 1996, J PHYS D APPL PHYS, V29, P133, DOI 10.1088/0022-3727/29/1/023; HILL AV, 1948, J PHYSIOL-LONDON, V107, P518, DOI 10.1113/jphysiol.1948.sp004296; KIER WM, 1985, ZOOL J LINN SOC-LOND, V83, P307, DOI 10.1111/j.1096-3642.1985.tb01178.x; Komai Y, 1998, J EXP BIOL, V201, P2359; Krogh A, 1920, PFLUG ARCH GES PHYS, V179, P95, DOI 10.1007/BF01722125; Mill P.J., 1985, P517; Miller P.L., 1981, P367; Schmidt-Nielsen K, 1979, ANIMAL PHYSL; Slama K, 1999, ANN ENTOMOL SOC AM, V92, P916, DOI 10.1093/aesa/92.6.916; SLAMA K, 1988, BIOL BULL-US, V175, P289, DOI 10.2307/1541570; Tartes U, 2000, PHYSIOL ENTOMOL, V25, P151, DOI 10.1046/j.1365-3032.2000.00180.x; WAINWRIGHT SA, 1978, SCIENCE, V202, P747, DOI 10.1126/science.202.4369.747; Wasserthal LT, 1996, ADV INSECT PHYSIOL, V26, P297, DOI 10.1016/S0065-2806(08)60033-8; WEISFOGH T, 1964, J EXP BIOL, V41, P207; Westneat MW, 1998, J EXP BIOL, V201, P3041	18	180	189	3	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					558	560		10.1126/science.1078008	http://dx.doi.org/10.1126/science.1078008			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543973				2022-12-28	WOS:000180559800047
J	Felsenfeld, G; Groudine, M				Felsenfeld, G; Groudine, M			Controlling the double helix	NATURE			English	Article							NUCLEAR ARCHITECTURE; ORDERED RECRUITMENT; NUCLEOSOME CORE; HISTONE H3; LYSINE 9; CHROMATIN; TRANSCRIPTION; METHYLATION; EXPRESSION; PROTEINS	Chromatin is the complex of DNA and proteins in which the genetic material is packaged inside the cells of organisms with nuclei. Chromatin structure is dynamic and exerts profound control over gene expression and other fundamental cellular processes. Changes in its structure can be inherited by the next generation, independent of the DNA sequence itself.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Washington, Sch Med, Dept Radiat Oncol, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Felsenfeld, G (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bldg 5,Room 212, Bethesda, MD 20892 USA.	gary.felsenfeld@nih.gov; markg@fhcrc.org			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK034001] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Alberts B., 1998, ESSENTIAL CELL BIOL; Allshire R, 2002, SCIENCE, V297, P1818, DOI 10.1126/science.1075874; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Bailey KA, 1999, RES MICROBIOL, V150, P701, DOI 10.1016/S0923-2508(99)00122-9; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Chadwick BP, 2002, J CELL BIOL, V157, P1113, DOI 10.1083/jcb.200112074; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Dinger ME, 2000, MOL MICROBIOL, V36, P876, DOI 10.1046/j.1365-2958.2000.01904.x; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Goll MG, 2002, GENE DEV, V16, P1739, DOI 10.1101/gad.1013902; Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7; Hager GL, 2002, CURR OPIN GENET DEV, V12, P137, DOI 10.1016/S0959-437X(02)00278-2; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hart CM, 1998, CURR OPIN GENET DEV, V8, P519, DOI 10.1016/S0959-437X(98)80005-1; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Kelley RL, 2000, CELL, V103, P9, DOI 10.1016/S0092-8674(00)00099-4; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Mutskov VJ, 2002, GENE DEV, V16, P1540, DOI 10.1101/gad.988502; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Ouzounis CA, 1996, J MOL EVOL, V42, P234, DOI 10.1007/BF02198849; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Sandman K, 1998, CELL MOL LIFE SCI, V54, P1350, DOI 10.1007/s000180050259; Sewalt RGAB, 2002, MOL CELL BIOL, V22, P5539, DOI 10.1128/MCB.22.15.5539-5553.2002; Smith MM, 2002, CURR OPIN CELL BIOL, V14, P279, DOI 10.1016/S0955-0674(02)00331-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WEINTRAUB H, 1977, COLD SPRING HARB SYM, V42, P401, DOI 10.1101/SQB.1978.042.01.042; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; WOLFFE AP, 1994, TRENDS BIOCHEM SCI, V19, P240, DOI 10.1016/0968-0004(94)90148-1; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	51	799	825	1	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					448	453		10.1038/nature01411	http://dx.doi.org/10.1038/nature01411			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540921	Bronze			2022-12-28	WOS:000180533000062
J	Robertson, WH; Diken, EG; Price, EA; Shin, JW; Johnson, MA				Robertson, WH; Diken, EG; Price, EA; Shin, JW; Johnson, MA			Spectroscopic determination of the OH- solvation shell in the OH-center dot(H2O)(n) clusters	SCIENCE			English	Article							HYDROGEN-BONDING NETWORK; FLUORIDE-WATER CLUSTERS; AB-INITIO; VIBRATIONAL SPECTROSCOPY; ARGON PREDISSOCIATION; INFRARED-SPECTROSCOPY; IONIC DISSOCIATION; HYDRATION; SPECTRA; BR	There has been long-standing uncertainty about the number of water molecules in the primary coordination environment of the OH- and F- ions in aqueous chemistry. We report the vibrational spectra of the OH-.(H2O)(n) and F-.(H2O)(n) clusters and interpret the pattern of OH stretching fundamentals with ab initio calculations. The spectra of the cold complexes are obtained by first attaching weakly bound argon atoms to the clusters and then monitoring the photoinduced evaporation of these atoms when an infrared laser is tuned to a vibrational resonance. The small clusters (n less than or equal to 3) display an isolated, sharp feature near the free OH stretching vibration, the signature of open solvation morphologies where each water molecule binds independently to the ion. Pronounced changes in the spectra are observed at n = 4 in the hydroxide ion and at n = 5 in the fluoride ion. In both cases, new features appear in the region typically associated with interwater hydrogen bonding. This behavior establishes that the primary hydration shells occur at n = 3 and 4 in hydroxide and fluoride, respectively.	Yale Univ, Dept Chem, Sterling Chem Lab, New Haven, CT 06520 USA	Yale University	Johnson, MA (corresponding author), Yale Univ, Dept Chem, Sterling Chem Lab, POB 208107, New Haven, CT 06520 USA.	mark.johnson@yale.edu	Shin, Joong-Won/D-5213-2009					Agmon N, 2000, CHEM PHYS LETT, V319, P247, DOI 10.1016/S0009-2614(00)00136-6; ARSHADI M, 1970, J PHYS CHEM-US, V74, P1483, DOI 10.1021/j100702a015; Ayotte P, 1999, J PHYS CHEM A, V103, P10665, DOI 10.1021/jp991963r; Ayotte P, 1998, J AM CHEM SOC, V120, P12361, DOI 10.1021/ja981979f; Ayotte P, 1998, CHEM PHYS, V239, P485, DOI 10.1016/S0301-0104(98)00287-0; Ayotte P, 2000, CHEM PHYS LETT, V316, P455, DOI 10.1016/S0009-2614(99)01257-9; Ayotte P, 1999, J CHEM PHYS, V110, P7129, DOI 10.1063/1.478616; Baik J, 1999, J CHEM PHYS, V110, P9116, DOI 10.1063/1.478833; Bakker HJ, 2002, SCIENCE, V297, P587, DOI 10.1126/science.1073298; Bernal JD, 1933, J CHEM PHYS, V1, P515, DOI 10.1063/1.1749327; Bryce RA, 1998, J CHEM PHYS, V109, P3077, DOI 10.1063/1.476900; Cabarcos OM, 1999, J CHEM PHYS, V110, P5, DOI 10.1063/1.478075; Chaudhuri C, 2001, MOL PHYS, V99, P1161, DOI 10.1080/00268970110046312; Chen B, 2002, J AM CHEM SOC, V124, P8534, DOI 10.1021/ja020350g; Choi JH, 1998, J PHYS CHEM A, V102, P503, DOI 10.1021/jp9729425; Conley C, 1999, CHEM PHYS LETT, V301, P29, DOI 10.1016/S0009-2614(99)00018-4; delValle CP, 1997, CHEM PHYS LETT, V269, P401, DOI 10.1016/S0009-2614(97)00315-1; Dorsett HE, 1999, J PHYS CHEM A, V103, P3351, DOI 10.1021/jp984248a; Gertner BJ, 1999, ISR J CHEM, V39, P273; HIRAOKA K, 1988, J PHYS CHEM-US, V92, P3943, DOI 10.1021/j100324a051; Hurley SM, 2002, SCIENCE, V298, P202, DOI 10.1126/science.1075307; JOHNSON MA, 1988, TECHNIQUES STUDY GAS, V591; Kim J, 2000, J CHEM PHYS, V113, P5259, DOI 10.1063/1.1290016; KLOTS CE, 1985, J CHEM PHYS, V83, P5854, DOI 10.1063/1.449615; Knipping EM, 2000, SCIENCE, V288, P301, DOI 10.1126/science.288.5464.301; Lee CT, 1996, J CHEM PHYS, V104, P7081, DOI 10.1063/1.471426; Mallard W. G., 2001, NIST STANDARD REFERE; Masamura M, 2001, CHEM PHYS LETT, V339, P279, DOI 10.1016/S0009-2614(01)00262-7; MEOTNER M, 1986, J PHYS CHEM-US, V90, P6616, DOI 10.1021/j100283a006; MOSKOVITS M, 1980, J AM CHEM SOC, V102, P2209, DOI 10.1021/ja00527a010; Novoa JJ, 1997, J PHYS CHEM A, V101, P7842, DOI 10.1021/jp970857r; OKUMURA M, 1986, J CHEM PHYS, V85, P2328, DOI 10.1063/1.451079; OWRUTSKY JC, 1985, J CHEM PHYS, V83, P5338, DOI 10.1063/1.449696; PERERA L, 1993, Z PHYS D ATOM MOL CL, V26, P166, DOI 10.1007/BF01429132; Pliego JR, 2000, J CHEM PHYS, V112, P4045, DOI 10.1063/1.480954; Price EA, 2002, CHEM PHYS LETT, V366, P412, DOI 10.1016/S0009-2614(02)01585-3; Robertson WH, 2000, REV SCI INSTRUM, V71, P4431, DOI 10.1063/1.1326931; Robertson WH, 2002, J PHYS CHEM A, V106, P10010, DOI 10.1021/jp020891s; Robertson WH, 2002, SCIENCE, V298, P69, DOI 10.1126/science.1076959; Robertson WH, 2002, J CHEM PHYS, V116, P4853, DOI 10.1063/1.1451249; TUCKERMAN M, 1995, J CHEM PHYS, V103, P150, DOI 10.1063/1.469654; Tuckerman ME, 2002, NATURE, V417, P925, DOI 10.1038/nature00797; Tuckerman ME, 1997, SCIENCE, V275, P817, DOI 10.1126/science.275.5301.817; Weber JM, 2000, SCIENCE, V287, P2461, DOI 10.1126/science.287.5462.2461; Weber JM, 2001, J CHEM PHYS, V114, P2698, DOI 10.1063/1.1338529; Woronowicz EA, 2002, J PHYS CHEM A, V106, P7086, DOI 10.1021/jp0211178; XANTHEAS SS, 1995, J AM CHEM SOC, V117, P10373, DOI 10.1021/ja00146a023; Xantheas SS, 1996, J PHYS CHEM-US, V100, P3989, DOI 10.1021/jp953114j; Xantheas SS, 2000, CHEM PHYS, V258, P225, DOI 10.1016/S0301-0104(00)00189-0; Zhan CG, 2002, J PHYS CHEM A, V106, P9737, DOI 10.1021/jp014533l	50	321	327	4	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1367	1372		10.1126/science.1080695	http://dx.doi.org/10.1126/science.1080695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12543981				2022-12-28	WOS:000181192300044
J	Karlsson, A; Parales, JV; Parales, RE; Gibson, DT; Eklund, H; Ramaswamy, S				Karlsson, A; Parales, JV; Parales, RE; Gibson, DT; Eklund, H; Ramaswamy, S			Crystal structure of naphthalene dioxygenase: Side-on binding of dioxygen to iron	SCIENCE			English	Article							SP STRAIN NCIB-9816; PSEUDOMONAS-PUTIDA CYTOCHROME-P-450; SOLUBLE METHANE MONOOXYGENASE; 1,2-DIOXYGENASE; ACTIVATION; COMPONENT; OXIDATION; DIHYDROXYLATION; FERREDOXINNAP; PURIFICATION	Binding of oxygen to iron is exploited in several biological and chemical processes. Although computational and spectroscopic results have suggested side-on binding, only end-on binding of oxygen to iron has been observed in crystal structures. We have determined structures of naphthalene dioxygenase that show a molecular oxygen species bound to the mononuclear iron in a side-on fashion. In a complex with substrate and dioxygen, the dioxygen molecule is lined up for an attack on the double bond of the aromatic substrate. The structures reported here provide the basis for a reaction mechanism and for the high stereospecificity of the reaction catalyzed by naphthalene dioxygenase.	Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; Swedish Univ Agr Sci, Ctr Biomed, Dept Mol Biol, S-75124 Uppsala, Sweden; Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Ctr Biocatalysis & Bioproc, Iowa City, IA 52242 USA	University of Iowa; Swedish University of Agricultural Sciences; University of Iowa; University of Iowa	Ramaswamy, S (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.		Subramanian, Ramaswamy/Q-8671-2019; ID, IMCACAT/D-5867-2014; Karlsson, Andreas/AAD-1984-2019	Subramanian, Ramaswamy/0000-0002-6709-190X; 	NIGMS NIH HHS [GM29909, GM62904] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029909, R01GM062904] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMAD S, 1988, INORG CHEM, V27, P2230, DOI 10.1021/ic00286a006; Boyd DR, 1998, NAT PROD REP, V15, P309; Carredano E, 2000, J MOL BIOL, V296, P701, DOI 10.1006/jmbi.1999.3462; Chen K, 1999, ANGEW CHEM INT EDIT, V38, P2227, DOI 10.1002/(SICI)1521-3773(19990802)38:15<2227::AID-ANIE2227>3.0.CO;2-B; Chen K, 2002, J AM CHEM SOC, V124, P3026, DOI 10.1021/ja0120025; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; HAIGLER BE, 1990, J BACTERIOL, V172, P457, DOI 10.1128/JB.172.1.457-464.1990; HAIGLER BE, 1990, J BACTERIOL, V172, P465, DOI 10.1128/JB.172.1.465-468.1990; Harris DL, 2001, CURR OPIN CHEM BIOL, V5, P724, DOI 10.1016/S1367-5931(01)00272-1; Hudlicky T, 1999, ALDRICHIM ACTA, V32, P35; JEFFREY AM, 1975, BIOCHEMISTRY-US, V14, P575, DOI 10.1021/bi00674a018; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; LI HY, 1995, J AM CHEM SOC, V117, P6297, DOI 10.1021/ja00128a019; LIPSCOMB JD, 1994, ANNU REV MICROBIOL, V48, P371, DOI 10.1146/annurev.mi.48.100194.002103; MATHER F, 2002, J AM CHEM SOC, V124, P4966; Neese F, 1998, J AM CHEM SOC, V120, P12829, DOI 10.1021/ja981561h; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Poulos TL, 1995, CURR OPIN STRUC BIOL, V5, P767, DOI 10.1016/0959-440X(95)80009-3; POULOS TL, 1992, FASEB J, V6, P674, DOI 10.1096/fasebj.6.2.1537455; POULOS TL, 1985, J BIOL CHEM, V260, P6122; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; Resnick SM, 1996, J IND MICROBIOL BIOT, V17, P438, DOI 10.1007/BF01574775; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; ROSENZWEIG AC, 1995, CHEM BIOL, V2, P409, DOI 10.1016/1074-5521(95)90222-8; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Wallar BJ, 1996, CHEM REV, V96, P2625, DOI 10.1021/cr9500489; Wolfe MD, 2003, J BIOL CHEM, V278, P829, DOI 10.1074/jbc.M209604200; Wolfe MD, 2002, BIOCHEMISTRY-US, V41, P9611, DOI 10.1021/bi025912n; Wolfe MD, 2001, J BIOL CHEM, V276, P1945, DOI 10.1074/jbc.M007795200	30	365	370	4	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1039	1042		10.1126/science.1078020	http://dx.doi.org/10.1126/science.1078020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586937				2022-12-28	WOS:000180960000039
J	Burke, JP				Burke, JP			Infection control - A problem for patient safety	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANTIBIOTIC-PROPHYLAXIS; EPIDEMIOLOGY		Latter Day St Hosp, Dept Clin Epidemiol & Infect Dis, Salt Lake City, UT 84143 USA; Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah	Burke, JP (corresponding author), Latter Day St Hosp, Dept Clin Epidemiol & Infect Dis, Salt Lake City, UT 84143 USA.							[Anonymous], 1996, Am J Infect Control, V24, P380; BURKE JP, 1971, NEW ENGL J MED, V284, P115, DOI 10.1056/NEJM197101212840301; BURKE JP, 1983, AM J INFECT CONTROL, V11, P165, DOI 10.1016/0196-6553(83)90076-7; BURKE JP, 1991, J HOSP INFECT, V18, P424, DOI 10.1016/0195-6701(91)90052-A; Burke JP, 2001, CLIN INFECT DIS, V33, pS78, DOI 10.1086/321861; Calfee DP, 2002, INFECT CONT HOSP EP, V23, P407, DOI 10.1086/502077; CLASSEN DC, 1992, NEW ENGL J MED, V326, P281, DOI 10.1056/NEJM199201303260501; CLASSEN DC, 1992, JAMA-J AM MED ASSOC, V267, P1922; Eggimann P, 2001, CHEST, V120, P2059, DOI 10.1378/chest.120.6.2059; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; Farr BM, 2000, INFECT CONT HOSP EP, V21, P411, DOI 10.1086/501783; Fleming CA, 2000, LUNG BIOL HEALTH DIS, V150, P53; GARIBALDI RA, 1974, NEW ENGL J MED, V291, P215, DOI 10.1056/NEJM197408012910501; Gaynes R, 2001, EMERG INFECT DIS, V7, P295, DOI 10.3201/eid0702.010230; HALEY RW, 1985, AM J EPIDEMIOL, V121, P159, DOI 10.1093/oxfordjournals.aje.a113988; HUNT TK, 1981, AM J MED, V70, P712, DOI 10.1016/0002-9343(81)90602-1; Jarvis WR, 2001, EMERG INFECT DIS, V7, P170, DOI 10.3201/eid0702.010202; JARVIS WR, 2001, SEMIN INFECT CONTROL, V1, P74; KRITCHEVSKY SB, 1995, INFECT CONT HOSP EP, V16, P33; LANGMUIR AD, 1980, PUBLIC HEALTH REP, V95, P470; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; LEDERBERG J, 1992, EMERGING INFECT MICR, P121; Leverstein-van Hall MA, 2002, J INFECT DIS, V186, P49, DOI 10.1086/341078; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; OLSEN MA, 2002, SEMIN INFECT CONTROL, V2, P26; Peterson LR, 2002, J CLIN MICROBIOL, V40, P1, DOI 10.1128/JCM.40.1.1-4.2002; Pittet D, 2001, EMERG INFECT DIS, V7, P234, DOI 10.3201/eid0702.010217; Pittet D, 2000, LANCET, V356, P2196; Platt R, 2002, INFECT CONT HOSP EP, V23, P361, DOI 10.1086/502066; ROTHMAN KJ, 1985, NEW ENGL J MED, V313, P258, DOI 10.1056/NEJM198507253130409; Scheckler WE, 1998, INFECT CONT HOSP EP, V19, P114; SCHECKLER WE, 2002, SEMIN INFECT CONTROL, V2, P81; Silver A, 1996, AM J SURG, V171, P548, DOI 10.1016/S0002-9610(96)00036-0; Stone PW, 2002, AM J INFECT CONTROL, V30, P145, DOI 10.1067/mic.2002.121099; Weinstein RA, 1998, EMERG INFECT DIS, V4, P416, DOI 10.3201/eid0403.980320; Weinstein RA, 2001, NEW ENGL J MED, V344, P1544, DOI 10.1056/NEJM200105173442009; Wenzel RP, 2001, EMERG INFECT DIS, V7, P174, DOI 10.3201/eid0702.010203; 2001, EVID REP TECHNOL ASS, V43, P1; 2000, MMWR MORB MORTAL WKL, V49, P149; 1992, MMWR MORB MORTAL WKL, V41, P783; 2000, MMWR MORB MORTAL WKL, V49, P189	41	684	722	3	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2003	348	7					651	656		10.1056/NEJMhpr020557	http://dx.doi.org/10.1056/NEJMhpr020557			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644HY	12584377				2022-12-28	WOS:000180912900013
J	Ramos, KD; Schafer, S; Tracz, SM				Ramos, KD; Schafer, S; Tracz, SM			Validation of the Fresno test of competence in evidence based medicine	BRITISH MEDICAL JOURNAL			English	Article								Objective To describe the development and validation of a test of knowledge and skills in evidence based medicine. Design Cross sectional study. Setting Family practice residency programme in California; a list server for those who teach evidence based medicine; and an evidence based medicine seminar series. Participants Family practice residents and faculty members (n=43); volunteers self identified as experts in evidence based medicine (n=53); family practice teachers (19) beginning a seminar series on evidence based medicine. Intervention The Fresno test is a performance based measure for use in medical education that assesses a wide range of evidence based medicine skills. Open ended questions are scored with standardised grading rubrics. Calculation skills are assessed by fill in the blank questions. Main outcome measures Inter-rater reliability, internal reliability, item analyses, and construct validity. Results Inter-rater correlations ranged from 0.76 to 0.98 for individual items. Cronbach's alpha was 0.88, Item difficulties ranged from moderate to difficult, all with positive and strong ability to discriminate between candidates. Experts scored consistently higher than novices. On the 212 point test, the novice mean was 95.6 and the expert mean was 147.5 (P<0.001). On individual items, a higher proportion of experts than novices earned passing scores on 15 of the 17 items. Conclusion The Fresno test is a reliable and valid test for detecting the effect of instruction in evidence based medicine. Its use in other settings requires further exploration.	Univ Calif San Francisco, Fresno Med Educ Program, Dept Family & Community Med, Fresno, CA 93702 USA; Calif State Univ Fresno, Kremen Sch Educ & Human Dev, Fresno, CA 93740 USA	University of California System; University of California San Francisco; University of California San Francisco at Fresno; California State University System; California State University Fresno	Ramos, KD (corresponding author), Univ Calif San Francisco, Fresno Med Educ Program, Dept Family & Community Med, 445 S Cedar Ave, Fresno, CA 93702 USA.							Bloom B. S., 1956, HDB 1 COGNITIVE DOMA; Grad R, 2001, FAM MED, V33, P602; Guyatt G., 2015, USERS GUIDES MED LIT; Hatala R, 2002, JAMA-J AM MED ASSOC, V288, P1110, DOI 10.1001/jama.288.9.1110; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Slawson DC, 2001, J FAM PRACTICE, V50, P209; Slawson DC, 1997, BRIT MED J, V314, P947, DOI 10.1136/bmj.314.7085.947; STERN DT, 1995, ACAD MED, V70, P152, DOI 10.1097/00001888-199502000-00021; Wiersma W., 1990, ED MEASUREMENT TESTI	9	238	246	1	17	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2003	326	7384					319	321		10.1136/bmj.326.7384.319	http://dx.doi.org/10.1136/bmj.326.7384.319			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645UD	12574047	Green Published, Bronze			2022-12-28	WOS:000180997000021
J	Wood, DF				Wood, DF			ABC of learning and teaching in medicine - Problem based learning	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CURRICULA		Univ London, Queen Marys Sch Med & Dent, Barts & London, London WC1E 7HU, England	University of London; Queen Mary University London	Wood, DF (corresponding author), Univ London, Queen Marys Sch Med & Dent, Barts & London, London WC1E 7HU, England.							Albanese M, 2000, MED EDUC, V34, P729, DOI 10.1046/j.1365-2923.2000.00753.x; Davis MH, 1999, MED TEACH, V21, P130, DOI 10.1080/01421599979743; Norman GR, 2000, MED EDUC, V34, P721, DOI 10.1046/j.1365-2923.2000.00749.x	3	531	571	9	84	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2003	326	7384					328	330		10.1136/bmj.326.7384.328	http://dx.doi.org/10.1136/bmj.326.7384.328			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645UD	12574050	Green Published			2022-12-28	WOS:000180997000024
J	Amrein, H; Bray, S				Amrein, H; Bray, S			Bitter-sweet solution in taste transduction	CELL			English	Editorial Material							RECEPTORS; CHANNEL; CELLS	A contentious issue in taste research might have come to a close. Zhang et al., in this issue of Cell, provide broad support for the notion that the recognition of sweet, umami, and bitter tastes use the same signalling molecules. Moreover, they show that individual taste cells are dedicated to the transduction of only one of these three taste qualities.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Amrein, H (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, 252CARL Bldg-Res Dr, Durham, NC 27710 USA.		Amrein, Hubert/AAG-9480-2021	Amrein, Hubert/0000-0001-8799-7250; Bray, Steven/0000-0002-0854-8121				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Caicedo A, 2002, J PHYSIOL-LONDON, V544, P501, DOI 10.1113/jphysiol.2002.027862; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Margolskee RF, 2002, J BIOL CHEM, V277, P1, DOI 10.1074/jbc.R100054200; Minke B, 2001, CELL MOL NEUROBIOL, V21, P629, DOI 10.1023/A:1015191702536; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	10	14	17	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 7	2003	112	3					283	284		10.1016/S0092-8674(03)00077-1	http://dx.doi.org/10.1016/S0092-8674(03)00077-1			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581516	Bronze			2022-12-28	WOS:000181252200011
J	Herz, J; Marschang, P				Herz, J; Marschang, P			Coaxing the LDL receptor family into the fold	CELL			English	Review							TYROSINE PHOSPHORYLATION; LIPOPROTEIN; PROTEIN; DOMAIN; HYPERCHOLESTEROLEMIA; CHAPERONE	Low-density-lipoprotein (LDL) receptor family members control diverse developmental and physiological pathways. In this issue of Cell, both Culi and Mann and Hsieh et al. report on Boca/MESD, a highly conserved chaperone required for transport of LDLR family proteins to the cell surface. Together with recent insights into the atomic structure of the LDL receptor, they shed new light on the synthesis and trafficking of this important class of multifunctional receptors.	Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Herz, J (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.			Marschang, Peter/0000-0002-8239-3447	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL063762] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nykjaer A, 2002, TRENDS CELL BIOL, V12, P273, DOI 10.1016/S0962-8924(02)02282-1; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Simmons T, 1997, J BIOL CHEM, V272, P25531, DOI 10.1074/jbc.272.41.25531; Springer TA, 1998, J MOL BIOL, V283, P837, DOI 10.1006/jmbi.1998.2115; Swertfeger DK, 2002, J BIOL CHEM, V277, P4141, DOI 10.1074/jbc.M109124200; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1	20	59	63	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 7	2003	112	3					289	292		10.1016/S0092-8674(03)00073-4	http://dx.doi.org/10.1016/S0092-8674(03)00073-4			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581519	Bronze			2022-12-28	WOS:000181252200001
J	Nisoli, E; Clementi, E; Paolucci, C; Cozzi, V; Tonello, C; Sciorati, C; Bracale, R; Valerio, A; Francolini, M; Moncada, S; Carruba, MO				Nisoli, E; Clementi, E; Paolucci, C; Cozzi, V; Tonello, C; Sciorati, C; Bracale, R; Valerio, A; Francolini, M; Moncada, S; Carruba, MO			Mitochondrial biogenesis in mammals: The role of endogenous nitric oxide	SCIENCE			English	Article							RECEPTOR-GAMMA COACTIVATOR-1; NECROSIS-FACTOR-ALPHA; SYNTHASE; GENE; DIFFERENTIATION; THERMOGENESIS; ADIPOCYTES; ACTIVATION; EXPRESSION; NUCLEAR	Nitric oxide was found to trigger mitochondrial biogenesis in cells as diverse as brown adipocytes and 3T3-L1, U937, and HeLa cells. This effect of nitric oxide was dependent on guanosine 3',5'-monophosphate (cGMP) and was mediated by the induction of peroxisome proliferator-activated receptor gamma coactivator 1alpha, a master regulator of mitochondrial biogenesis. Moreover, the mitochondrial biogenesis induced by exposure to cold was markedly reduced in brown adipose tissue of endothelial nitric oxide synthase null-mutant (eNOS(-/-)) mice, which had a reduced metabolic rate and accelerated weight gain as compared to wild-type mice. Thus, a nitric oxide-cGMP-dependent pathway controls mitochondrial biogenesis and body energy balance.	Univ Milan, L Sacco Hosp Vialba, Dept Preclin Sci, Ctr Study & Res Obes, I-20157 Milan, Italy; Ist Auxol Italiano, I-20149 Milan, Italy; Ist Sci San Raffaele, DIBIT H, I-20132 Milan, Italy; Univ Calabria, Dept Pharmacobiol, I-87036 Arcavacata Di Rende, Italy; Univ Brescia, Dept Biomed Sci & Biotechnol, I-25123 Brescia, Italy; CNR, Inst Neurosci, Cellular & Mol Pharmacol Sect, I-20129 Milan, Italy; UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of Milan; Luigi Sacco Hospital; IRCCS Istituto Auxologico Italiano; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Calabria; University of Brescia; Consiglio Nazionale delle Ricerche (CNR); University of London; University College London	Nisoli, E (corresponding author), Univ Milan, L Sacco Hosp Vialba, Dept Preclin Sci, Ctr Study & Res Obes, I-20157 Milan, Italy.	enzo.nisoli@unimi.it	Nisoli, Enzo/D-6526-2014; Valerio, Alessandra/B-3413-2009; sciorati, clara/K-4823-2016	Nisoli, Enzo/0000-0002-6670-1630; Valerio, Alessandra/0000-0001-5844-2256; FRANCOLINI, MAURA/0000-0002-3126-1575; Carruba, Michele/0000-0003-4589-387X; BRACALE, Renata/0000-0003-3650-7033; sciorati, clara/0000-0003-2030-9366				Boss O, 1999, BIOCHEM BIOPH RES CO, V261, P870, DOI 10.1006/bbrc.1999.1145; Bulotta S, 2001, J BIOL CHEM, V276, P6529, DOI 10.1074/jbc.M006535200; Cinti S, 2001, P NUTR SOC, V60, P319, DOI 10.1079/PNS200192; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; De Nadai C, 2000, P NATL ACAD SCI USA, V97, P5480, DOI 10.1073/pnas.070062397; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Giordano A, 2002, FEBS LETT, V514, P135, DOI 10.1016/S0014-5793(02)02245-7; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; HIMMSHAGEN J, 1995, P SOC EXP BIOL MED, V208, P159, DOI 10.3181/00379727-208-43847A; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; NECHAD M, 1983, EXP CELL RES, V149, P119, DOI 10.1016/0014-4827(83)90385-3; Nicholls DG, 2001, BIOCHEM SOC T, V29, P751, DOI 10.1042/bst0290751; Nisoli E, 1998, BRIT J PHARMACOL, V125, P888, DOI 10.1038/sj.bjp.0702131; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Shankar RR, 2000, DIABETES, V49, P684, DOI 10.2337/diabetes.49.5.684; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	20	968	1024	4	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					896	899		10.1126/science.1079368	http://dx.doi.org/10.1126/science.1079368			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574632				2022-12-28	WOS:000180830900054
J	Zhang, YF; Hoon, MA; Chandrashekar, J; Mueller, KL; Cook, B; Wu, DQ; Zuker, CS; Ryba, NJP				Zhang, YF; Hoon, MA; Chandrashekar, J; Mueller, KL; Cook, B; Wu, DQ; Zuker, CS; Ryba, NJP			Coding of sweet, bitter, and umami tastes: Different receptor cells sharing similar signaling pathways	CELL			English	Article							PHOSPHOLIPASE-C; TRP CHANNEL; TRANSDUCTION; RESPONSES; FAMILY; MICE; MOUSE; RAT; IDENTIFICATION; DISCRIMINATION	Mammals can taste a wide repertoire of chemosensory stimuli. Two unrelated families of receptors (T1Rs and T2Rs) mediate responses to sweet, amino acids, and bitter compounds. Here, we demonstrate that knockouts of TRPM5, a taste TRP ion channel, or PLCbeta2, a phospholipase C selectively expressed in taste tissue, abolish sweet, amino acid, and bitter taste reception, but do not impact sour or salty tastes. Therefore, despite relying on different receptors, sweet, amino acid, and bitter transduction converge on common signaling molecules. Using PLCbeta2 taste-blind animals, we then examined a fundamental question in taste perception: how taste modalities are encoded at the cellular level. Mice engineered to rescue PLCbeta2 function exclusively in bitter-receptor expressing cells respond normally to bitter tastants but do not taste sweet or amino acid stimuli. Thus, bitter is encoded independently of sweet and amino acids, and taste receptor cells are not broadly tuned across these modalities.	Univ Calif San Diego, Howard Hughes Med Inst, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, La Jolla, CA 92093 USA; Natl Inst Dent & Craniofacial Res, NIH, DHHS, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Zuker, CS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Biol, La Jolla, CA 92093 USA.	charies@flyeye.ucsd.edu		Ryba, Nicholas/0000-0002-2060-8393; Chandrashekar, jayaram/0000-0001-6412-0114	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Asano-Miyoshi M, 2001, CHEM SENSES, V26, P259, DOI 10.1093/chemse/26.3.259; Bernhardt SJ, 1996, J PHYSIOL-LONDON, V490, P325, DOI 10.1113/jphysiol.1996.sp021147; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Caicedo A, 2002, J PHYSIOL-LONDON, V544, P501, DOI 10.1113/jphysiol.2002.027862; CASSILL JA, 1991, P NATL ACAD SCI USA, V88, P11067, DOI 10.1073/pnas.88.24.11067; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Cummings TA, 1996, J NEUROPHYSIOL, V75, P1256, DOI 10.1152/jn.1996.75.3.1256; Dahl M, 1997, BRAIN RES, V756, P22, DOI 10.1016/S0006-8993(97)00131-5; Gilbertson TA, 2000, CURR OPIN NEUROBIOL, V10, P519, DOI 10.1016/S0959-4388(00)00118-5; Gilbertson TA, 2001, J NEUROSCI, V21, P4931, DOI 10.1523/JNEUROSCI.21-13-04931.2001; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; He W, 2002, CHEM SENSES, V27, P719, DOI 10.1093/chemse/27.8.719; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Jiang HP, 1997, P NATL ACAD SCI USA, V94, P7971, DOI 10.1073/pnas.94.15.7971; Kinnamon SC, 2000, NEURON, V25, P507, DOI 10.1016/S0896-6273(00)81054-5; KOLESNIKOV SS, 1995, NATURE, V376, P85, DOI 10.1038/376085a0; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Margolskee RF, 2002, J BIOL CHEM, V277, P1, DOI 10.1074/jbc.R100054200; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Minke B, 2001, CELL MOL NEUROBIOL, V21, P629, DOI 10.1023/A:1015191702536; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Misaka T, 1997, J BIOL CHEM, V272, P22623, DOI 10.1074/jbc.272.36.22623; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Rossler P, 1998, EUR J CELL BIOL, V77, P253; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Smith DV, 2001, SCI AM, V284, P32, DOI 10.1038/scientificamerican0301-32; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0	41	920	1021	13	208	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 7	2003	112	3					293	301		10.1016/S0092-8674(03)00071-0	http://dx.doi.org/10.1016/S0092-8674(03)00071-0			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581520	Bronze			2022-12-28	WOS:000181252200002
J	Torchin, ME; Lafferty, KD; Dobson, AP; McKenzie, VJ; Kuris, AM				Torchin, ME; Lafferty, KD; Dobson, AP; McKenzie, VJ; Kuris, AM			Introduced species and their missing parasites	NATURE			English	Article							POPULATION INTERACTIONS; STABILITY	Damage caused by introduced species results from the high population densities and large body sizes that they attain in their new location(1-4). Escape from the effects of natural enemies is a frequent explanation given for the success of introduced species(5,6). Because some parasites can reduce host density(7-13) and decrease body size(14), an invader that leaves parasites behind and encounters few new parasites can experience a demographic release and become a pest(4,15). To test whether introduced species are less parasitized, we have compared the parasites of exotic species in their native and introduced ranges, using 26 host species of molluscs, crustaceans, fishes, birds, mammals, amphibians and reptiles. Here we report that the number of parasite species found in native populations is twice that found in exotic populations. In addition, introduced populations are less heavily parasitized (in terms of percentage infected) than are native populations. Reduced parasitization of introduced species has several causes, including reduced probability of the introduction of parasites with exotic species (or early extinction after host establishment), absence of other required hosts in the new location, and the host-specific limitations of native parasites adapting to new hosts.	Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Marine Sci, Western Ecol Res Ctr, US Geol Survey, Santa Barbara, CA 93106 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara; Princeton University	Torchin, ME (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.		Lafferty, Kevin D./B-3888-2009					ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Chapman F. M., 1966, HDB BIRDS E N AM; CROFTON HD, 1971, PARASITOLOGY, V63, P343, DOI 10.1017/S0031182000079890; Dobson A.P., 1986, Ecological Studies, P58; GREGORY RD, 1991, PARASITOL TODAY, V7, P316, DOI 10.1016/0169-4758(91)90269-T; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; HAIR JD, 1970, AM MIDL NAT, V83, P555, DOI 10.2307/2423962; HARADA M, 1989, Japanese Journal of Parasitology, V38, P388; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; KURIS AM, 1992, CAN J FISH AQUAT SCI, V49, P327, DOI 10.1139/f92-037; MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Ruiz GM, 1999, LIMNOL OCEANOGR, V44, P950, DOI 10.4319/lo.1999.44.3_part_2.0950; RYBAKOV AV, 1988, TREMATODA ECHINOSTOM, V22, P224; SCOTT ME, 1987, PARASITOLOGY, V95, P111, DOI 10.1017/S0031182000057590; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; SHIMURA S, 1980, Japanese Journal of Parasitology, V29, P369; Torchin ME, 2001, BIOL INVASIONS, V3, P333, DOI 10.1023/A:1015855019360; Torchin ME, 2002, PARASITOLOGY, V124, pS137, DOI 10.1017/S0031182002001506; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	22	998	1055	3	329	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					628	630		10.1038/nature01346	http://dx.doi.org/10.1038/nature01346			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571595				2022-12-28	WOS:000180803200041
J	Freed, GL; Davis, MM; Clark, SJ				Freed, GL; Davis, MM; Clark, SJ			Variation in public and private supply of pneumococcal conjugate vaccine during a shortage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context In late August 2001, a serious shortage of the heptavalent pneumococcal conjugate vaccine (PCV7) developed in 34 state immunization programs. In September 2001, the Centers for Disease Control and Prevention published revised recommendations advising physicians to prioritize PCV7 to specific groups of children. The effect of the shortage at the practice level is unknown. Objective To determine the variation between public and private markets in the supply of PCV7 and the nature and extent of the PCV7 shortage at the practice level. Design, Setting, and Participants Semistructured interviews with office staff responsible for ordering vaccines at private practices in 12 states were conducted between October 19 and November 2, 2001. Main Outcome Measures Variation in supply of PCV7 obtained from public sources and through purchase on,the private market. Supply was characterized into 3 categories: "no problem," "problem obtaining a consistent supply, " and "out of stock. Results Interviews were completed at 405 practices, representing a response rate of 74%. Overall, 51% of practices reported at least 1 episode of being out of stock of public PCV7 and 64% of private PCV7, with significant state-to-state variation. Only 2 of 12 study states had a substantially higher proportion of practices experiencing out-of-stock episodes for public compared with private PCV7, while in 6 states public PCV7 was less frequently out of stock than private PCV7. Only 23% of practices in this study altered their administration policy for private PCV7, while 27% altered their policy for public PCV7. Conclusions The distribution and supply of PCV7 varied between public and private supplies and between states during the shortage. Few practices changed their administration schedules in response to revised recommendations.	Univ Michigan, Div Gen Pediat, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA; Univ Michigan, Div Gen Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Freed, GL (corresponding author), Univ Michigan, Div Gen Pediat, Child Hlth Evaluat & Res Unit, 300 N Ingalls 6E08, Ann Arbor, MI 48109 USA.							*CDC, 2001, JAMA-J AM MED ASSOC, V286, P2232; *CDC, 2001, MMWR-MORBID MORTAL W, V50, P783; Clements DA, 2001, ARCH PEDIAT ADOL MED, V155, P455, DOI 10.1001/archpedi.155.4.455; Davis MM, 2001, AMBUL PEDIATR, V1, P302, DOI 10.1367/1539-4409(2001)001<0302:PECRTT>2.0.CO;2; Freed GL, 2000, AM J PREV MED, V19, P32, DOI 10.1016/S0749-3797(00)00219-1; *I MED, 2000, CALL SHOTS REP COMM; ORENSTEIN WA, 1999, VACCINES; Wood D, 1998, ARCH PEDIAT ADOL MED, V152, P238	8	21	22	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2003	289	5					575	578		10.1001/jama.289.5.575	http://dx.doi.org/10.1001/jama.289.5.575			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CV	12578490	Bronze			2022-12-28	WOS:000180787500028
J	Wathen, CN; MacMillan, HL				Wathen, CN; MacMillan, HL			Interventions for violence against women - Scientific review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INTIMATE PARTNER VIOLENCE; LEAVING ABUSIVE PARTNERS; DOMESTIC VIOLENCE; BATTERED WOMEN; PREGNANT-WOMEN; FOLLOW-UP; ADVOCACY INTERVENTION; TREATMENT PROGRAM; PHYSICAL ABUSE; MENTAL-DISORDERS	Context Intimate partner violence is prevalent and is associated with significant impairment, yet it remains unclear which interventions, if any, reduce rates of abuse and reabuse. Objective To systematically review, from the perspective of primary healthcare, the available evidence on interventions aimed at preventing abuse or reabuse of women. Data Sources MEDLINE, PsycINFO, CINAHL, HealthStar, and Sociological Abstracts were searched from the database start dates to March 2001 using database-specific key words such as domestic violence, spouse abuse, partner abuse, shelters, and battered women. References of key articles were hand searched. The search was updated in December 2002. Study Selection Both authors reviewed all titles and abstracts using established inclusion/exclusion criteria. Twenty-two articles met the inclusion criteria for critical appraisal. Data Extraction Following the evidence-based methods of the Canadian Task Force on Preventive Health Care, both authors independently reviewed the 22 included studies using an established hierarchy of study designs and criteria for rating internal validity. Quality ratings of individual studies-good, fair, or poor-were determined based on a set of operational parameters specific to each design category developed with the US Preventive Services Task Force. Data Synthesis Screening instruments exist that can identify women who are experiencing intimate partner violence. No study has examined, in a comparative design, the effectiveness of screening when the end point is improved outcomes for women (as opposed to identification of abuse). No high-quality evidence exists to evaluate the effectiveness of shelter stays to reduce violence. Among women who have spent at least 1 night in a shelter, there is fair evidence that those who received a specific program of advocacy and counseling services reported a decreased rate of reabuse and an improved quality of life. The benefits of several other intervention strategies in treating both women and men are unclear, primarily because of a lack of suitably designed research measuring appropriate outcomes. In most cases, the potential harms of interventions are not assessed within the studies reviewed. Conclusions Much has been learned in, recent years about the epidemiology of violence against women, yet information about evidence-based approaches in the primary care setting for preventing intimate partner violence is seriously lacking. The evaluation of interventions to improve the health and well-being of abused women remains a key research priority.	Canadian Task Force Prevent Hlth Care, London, ON N6G 4X8, Canada; Univ Western Ontario, Fac Informat & Media Studies, London, ON, Canada; McMaster Univ, Canadian Ctr Studies Children Risk, McMaster Childrens Hosp, Hamilton Hlth Sci, Hamilton, ON, Canada	Western University (University of Western Ontario); McMaster University	Wathen, CN (corresponding author), Canadian Task Force Prevent Hlth Care, 100 Collip Circle,Suite 117, London, ON N6G 4X8, Canada.		MacMillan, Harriet/B-4530-2016	MacMillan, Harriet/0000-0002-1223-706X				Archer J, 2000, PSYCHOL BULL, V126, P651, DOI [10.1037/0033-2909.126.5.651, 10.1037//0033-2909.126.5.651]; ATTALA JM, 1994, WOMEN HEALTH, V21, P125, DOI 10.1300/J013v21n02_08; Ballard TJ, 1998, AM J PUBLIC HEALTH, V88, P274, DOI 10.2105/AJPH.88.2.274; Bell ME, 2001, VIOLENCE AGAINST WOM, V7, P1377, DOI 10.1177/10778010122183919; BERGMAN B, 1991, AM J PUBLIC HEALTH, V81, P1486, DOI 10.2105/AJPH.81.11.1486; BERK RA, 1986, J MARRIAGE FAM, V48, P481, DOI 10.2307/352034; Brannen SJ, 1996, RES SOCIAL WORK PRAC, V6, P405, DOI 10.1177/104973159600600401; Brown J B, 1996, Fam Med, V28, P422; Brown JB, 2000, J FAM PRACTICE, V49, P896; BROWN R, 1992, JAMA-J AM MED ASSOC, V267, P3184; Campbell J, 2002, ARCH INTERN MED, V162, P1157, DOI 10.1001/archinte.162.10.1157; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Campbell JC, 2001, ACAD EMERG MED, V8, P131, DOI 10.1111/j.1553-2712.2001.tb01277.x; CAMPBELL R, 1995, PSYCHOL WOMEN QUART, V19, P237, DOI 10.1111/j.1471-6402.1995.tb00290.x; *CDCP, 1994, MMWR-MORBID MORTAL W, V43, P132; Chalk R, 1998, VIOLENCE FAMILIES AS; Chen H., 1989, J FAM VIOLENCE, V4, P309, DOI [10.1007/BF00978573, DOI 10.1007/BF00978573]; Cokkinides VE, 1999, OBSTET GYNECOL, V93, P661, DOI 10.1016/S0029-7844(98)00486-4; Cole TB, 2000, JAMA-J AM MED ASSOC, V284, P551, DOI 10.1001/jama.284.5.551; Covington D L, 1997, Matern Child Health J, V1, P129, DOI 10.1023/A:1026278508610; COX JW, 1991, J FAM VIOLENCE, V6, P395, DOI 10.1007/BF00980541; Danielson KK, 1998, AM J PSYCHIAT, V155, P131, DOI 10.1176/ajp.155.1.131; Davis R. C., 1999, WOMEN CRIM JUSTICE, V10, P69; Davis RC, 1997, CRIMINOLOGY, V35, P307, DOI 10.1111/j.1745-9125.1997.tb00878.x; Dearwater SR, 1998, JAMA-J AM MED ASSOC, V280, P433, DOI 10.1001/jama.280.5.433; DOBASH R, 1996, RES FINDINGS, V46, P1; Dunford FW, 2000, J CONSULT CLIN PSYCH, V68, P468, DOI 10.1037//0022-006X.68.3.468; Dutton D G, 1986, Violence Vict, V1, P163; EDLESON JL, 1991, RES SOCIAL WORK PRAC, V1, P227, DOI 10.1177/104973159100100301; Eisenstat SA, 1999, NEW ENGL J MED, V341, P886, DOI 10.1056/NEJM199909163411206; Fanslow JL, 1999, AUST NZ J PUBL HEAL, V23, P418, DOI 10.1111/j.1467-842X.1999.tb01286.x; Fanslow JL, 1998, AUST NZ J PUBL HEAL, V22, P598, DOI 10.1111/j.1467-842X.1998.tb01445.x; Feldhaus KM, 1997, JAMA-J AM MED ASSOC, V277, P1357, DOI 10.1001/jama.277.17.1357; Ferris L, 1999, HDB DEALING WOMAN AB; GARNER J, 1995, J QUANT CRIMINOL, V11, P3, DOI 10.1007/BF02221298; Gazmararian JA, 1996, JAMA-J AM MED ASSOC, V275, P1915, DOI 10.1001/jama.275.24.1915; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Gondolf EW, 1999, J INTERPERS VIOLENCE, V14, P41, DOI 10.1177/088626099014001003; GRASLEY C, 2000, KNOWING WHAT WE DO B; HARRIS R, 1988, CANADIAN J COMMUNITY, V7, P147; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hegarty K, 1999, J FAM VIOLENCE, V14, P399, DOI 10.1023/A:1022834215681; Holt VL, 2002, JAMA-J AM MED ASSOC, V288, P589, DOI 10.1001/jama.288.5.589; HUDSON WW, 1981, J MARRIAGE FAM, V43, P873, DOI 10.2307/351344; Jaffe P G, 1992, Violence Vict, V7, P129; JOHNSON H, 2000, FAMILY VIOLENCE CANA, P20; Jones AS, 1999, WOMEN HEALTH ISS, V9, P295; Koziol-McLain J, 2001, AM J PREV MED, V21, P93, DOI 10.1016/S0749-3797(01)00325-7; Krajewski SS, 1996, J FAM VIOLENCE, V11, P93, DOI 10.1007/BF02336664; Leserman J, 1998, PSYCHOL MED, V28, P417, DOI 10.1017/S0033291797006508; MACMILLAN HL, 2001, 014 CTFPHC ONT CAN T; MARSHALL L, 1999, J FAM VIOLENCE, V7, P103; Martin SL, 2001, JAMA-J AM MED ASSOC, V285, P1581, DOI 10.1001/jama.285.12.1581; McFarlane J, 2000, PUBLIC HEALTH NURS, V17, P443, DOI 10.1046/j.1525-1446.2000.00443.x; McFarlane J, 1997, PUBLIC HEALTH NURS, V14, P244, DOI 10.1111/j.1525-1446.1997.tb00297.x; MCFARLANE J, 1992, JAMA-J AM MED ASSOC, V267, P3176, DOI 10.1001/jama.267.23.3176; Murphy CC, 2001, CAN MED ASSOC J, V164, P1567; NEWBERGER EH, 1992, JAMA-J AM MED ASSOC, V267, P2370, DOI 10.1001/jama.267.17.2370; NORTON LB, 1995, OBSTET GYNECOL, V85, P321, DOI 10.1016/0029-7844(94)00429-H; Oriel KA, 1998, J FAM PRACTICE, V46, P493; PALMER SE, 1992, AM J ORTHOPSYCHIAT, V62, P276, DOI 10.1037/h0079336; Parker B, 1999, RES NURS HEALTH, V22, P59; PATE AM, 1992, AM SOCIOL REV, V57, P691, DOI 10.2307/2095922; Plichta SB, 1996, AM J PREV MED, V12, P297, DOI 10.1016/S0749-3797(18)30282-4; POTEAT GM, 1990, J CLIN PSYCHOL, V46, P828, DOI 10.1002/1097-4679(199011)46:6<828::AID-JCLP2270460622>3.0.CO;2-T; Ramsay J, 2002, BRIT MED J, V325, P314, DOI 10.1136/bmj.325.7359.314; Rhodes KV, 2003, JAMA-J AM MED ASSOC, V289, P601, DOI 10.1001/jama.289.5.601; Roberts GL, 1998, WOMEN HEALTH, V28, P117; RODENBURG FA, 1993, J FAM VIOLENCE, V8, P203, DOI 10.1007/BF00988769; Rodriguez MA, 1999, JAMA-J AM MED ASSOC, V282, P468, DOI 10.1001/jama.282.5.468; Saunders D G, 1996, Violence Vict, V11, P393; SHEPARD MF, 1992, J INTERPERS VIOLENCE, V7, P291, DOI 10.1177/088626092007003001; SHERMAN LW, 1984, AM SOCIOL REV, V49, P261, DOI 10.2307/2095575; *STAT CAN, 2000, 85224XIE STAT CAN CA; *STAT CAN, 2002, 85224XIE STAT CAN CA; STEWART DE, 1994, CAN MED ASSOC J, V151, P1601; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; SULLIVAN CM, 1994, AM J COMMUN PSYCHOL, V22, P101, DOI 10.1007/BF02506819; SULLIVAN CM, 1992, AM J COMMUN PSYCHOL, V20, P309, DOI 10.1007/BF00937912; SULLIVAN CM, 1991, J INTERPERS VIOLENCE, V6, P41, DOI 10.1177/088626091006001004; Sullivan CM, 1999, J CONSULT CLIN PSYCH, V67, P43, DOI 10.1037/0022-006X.67.1.43; SULLIVAN CM, 1991, AM J COMMUN PSYCHOL, V19, P953, DOI 10.1007/BF00937893; SULLIVAN CM, 1998, OUTCOME EVALUATION S; Sutherland C, 1998, Womens Health, V4, P41; TAN C, 1995, J INTERPERS VIOLENCE, V10, P437, DOI 10.1177/088626095010004004; Tjaden P., 2000, FULL REPORT PREVALEN; Tolman R M, 1999, Violence Vict, V14, P25; Waalen J, 2000, AM J PREV MED, V19, P230, DOI 10.1016/S0749-3797(00)00229-4; WALTHER D J, 1986, Journal of Primary Prevention, V7, P84, DOI 10.1007/BF01325251; Wiist WH, 1999, AM J PUBLIC HEALTH, V89, P1217, DOI 10.2105/AJPH.89.8.1217; WOOLF SH, 1990, J CLIN EPIDEMIOL, V43, P891, DOI 10.1016/0895-4356(90)90073-X; YEGIDIS BL, 1989, ABUSE RISK INVENTORY; Zachary MJ, 2001, ACAD EMERG MED, V8, P796, DOI 10.1111/j.1553-2712.2001.tb00209.x	94	362	373	3	89	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2003	289	5					589	600		10.1001/jama.289.5.589	http://dx.doi.org/10.1001/jama.289.5.589			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	642CV	12578492	Bronze			2022-12-28	WOS:000180787500030
J	Culpeper, KS; Nousari, HC				Culpeper, KS; Nousari, HC			Purpura fulminans	LANCET			English	Editorial Material									Johns Hopkins Med Inst, Div Immunodermatol, Baltimore, MD 20905 USA	Johns Hopkins University; Johns Hopkins Medicine	Culpeper, KS (corresponding author), Johns Hopkins Med Inst, Div Immunodermatol, Baltimore, MD 20905 USA.								0	1	1	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					384	384		10.1016/S0140-6736(03)12391-4	http://dx.doi.org/10.1016/S0140-6736(03)12391-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573375				2022-12-28	WOS:000180787000011
J	Harrison, PJ; Owen, MJ				Harrison, PJ; Owen, MJ			Genes for schizophrenia? Recent findings and their pathophysiological implications	LANCET			English	Review							6P22.3 GENE; ASSOCIATION; SUSCEPTIBILITY; DYSBINDIN; LINKAGE; NEUREGULIN-1; METAANALYSIS; HYPOTHESIS; DISORDER; PROTEIN	Context Schizophrenia is highly heritable, but the genes have remained elusive. Identifying the genes is essential if the pathogenesis and pathophysiology of schizophrenia is, finally to be understood, and to give the prospect of more effective treatment. Starting point H Stefansson and colleagues (Am J Hum Genet 2002; 71: 877-92) showed association of the neuregulin (NRG1) gene with schizophrenia. Other recent papers describe six additional susceptibility genes. Replications are already being reported for some of them. The genes are biologically plausible, and, may, have convergent effects on glutamatergic and other synapses. We review the evidence for each gene, the possible pathogenic mechanisms, and the implications of the findings. Where next? Given earlier failures to replicate apparent breakthroughs, the results should be viewed with caution. Unequivocal replications remain the top priority. The respective contributions of each gene, epistatic effects, and functional interactions between the products, all need investigation Confirmation that any of the genes is a true susceptibility gene for schizophrenia could trigger the same rapid therapeutic progress as has occurred recently, in Alzheimer's disease.	Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; Cardiff Univ, Dept Psychol Med, Cardiff CF4 4XN, S Glam, Wales	University of Oxford; Cardiff University	Harrison, PJ (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Neurosci Bldg, Oxford OX3 7JX, England.	paul.harrison@psych.ox.ac.uk		Harrison, Paul/0000-0002-6719-1126				AKIL M, IN PRESS J NEUROSCI; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; CIONINGER CR, 2002, P NATL ACAD SCI USA, V99, P13365; De Blasi A, 2001, TRENDS PHARMACOL SCI, V22, P114, DOI 10.1016/S0165-6147(00)01635-7; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Gogos JA, 1999, NAT GENET, V21, P434, DOI 10.1038/7777; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Leonard S, 2002, ARCH GEN PSYCHIAT, V59, P1085, DOI 10.1001/archpsyc.59.12.1085; Levinson DF, 2002, AM J MED GENET, V114, P700; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Murphy KC, 2002, LANCET, V359, P426, DOI 10.1016/S0140-6736(02)07604-3; OWEN MJ, 2003, PSYCHIAT GENETICS GE, P247; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Straub, 2002, AM J HUM GENET, V71, P1007; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; WILLIAMS HJ, IN PRESS MOL PSYCHIA	34	436	467	0	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2003	361	9355					417	419		10.1016/S0140-6736(03)12379-3	http://dx.doi.org/10.1016/S0140-6736(03)12379-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573388				2022-12-28	WOS:000180787000023
J	Kerr, DJ; McArdle, CS; Ledermann, J; Taylor, I; Sherlock, DJ; Schlag, PM; Buckels, J; Mayer, D; Cain, D; Stephens, RJ				Kerr, DJ; McArdle, CS; Ledermann, J; Taylor, I; Sherlock, DJ; Schlag, PM; Buckels, J; Mayer, D; Cain, D; Stephens, RJ		MRC EORTC Colorectal Canc Study Gr	Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial	LANCET			English	Article							QUALITY-OF-LIFE; INTRAARTERIAL FLOXURIDINE; SYSTEMIC FLUOROURACIL; HEPATIC METASTASES; PLUS LEUCOVORIN; CHEMOTHERAPY; INFUSION; CARCINOMA; FLUORODEOXYURIDINE; ONCOLOGY	Background The liver is the most frequent site for metastases of colorectal cancer, which is the second largest contributor to cancer deaths in Europe. We did a randomised trial to compare an intrahepatic arterial (IHA) fluorouracil and folinic acid regimen with the standard intravenous de Gramont fluorouracil and folinic acid regimen for patients with adenocarcinoma of the colon or rectum, with metastases confined to the liver. Methods We randomly allocated 290 patients from 16 centres to receive either intravenous chemotherapy (folinic acid 200 mg/m(2), fluorouracil bolus 400 mg(2) and 22-h infusion 600 mg/m(2), day 1 and 2, repeated every 14 days), or IHA chemotherapy designed to be equitoxic (folinic acid 200 mg/m(2), fluorouracil 400 mg/m(2) over 15 mins and 22-h infusion 1600 mg/m(2), day 1 and 2, repeated every 14 days). The primary endpoint was overall survival, and analysis was by intention to treat. Findings 50 (37%) patients allocated to IHA did not start their treatment, and another 39 (29%) had to stop before receiving six cycles of treatment because of catheter failure. The IHA group received a median of two cycles (0-6), compared with 8.5 (6-12) for the intravenous group. 45 (51%) IHA patients who did not start or did not receive six cycles switched to intravenous treatment. In both groups, grade 3 or 4 toxicity was uncommon. Median overall survival was 14.7 months for the IHA group and 14.8 months for the intravenous group (hazard ratio 1.04 [95% CI 0.80-1.33], log-rank test p=0.79). Similarly, there was no significant difference in progression-free survival. Interpretation Our results showed no evidence of an advantage in progression-free survival or overall survival for the IHA group; thus continued use of this regimen cannot be recommended outside of a clinical trial.	Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England; Glasgow Royal Infirm, Dept Surg, Glasgow G4 0SF, Lanark, Scotland; UCL, Dept Surg & Oncol, London, England; N Manchester Grp Hosp, Manchester, Lancs, England; Humboldt Univ, Robert Roessle Klin, Dept Surg, Berlin, Germany; Univ Hosp Trust Birmingham, Liver Unit, Birmingham, W Midlands, England; MRC, Clin Trials Unit, Canc Div, London, England	Radcliffe Infirmary; University of Oxford; University of Glasgow; University of London; University College London; Humboldt University of Berlin; Medical Research Council Clinical Trials Unit	Kerr, DJ (corresponding author), Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England.	david.kerr@clinical-pharmacology.oxford.ac.uk		Sherlock, David/0000-0001-7630-0833				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; ALLENMERSH TG, 1994, LANCET, V344, P1255, DOI 10.1016/S0140-6736(94)90750-1; Anderson D, 1997, J CHROMATOGR B, V688, P87, DOI 10.1016/S0378-4347(97)88059-0; Blesing CH, 1996, J DRUG TARGET, V3, P341, DOI 10.3109/10611869608996825; BLESING CH, 1996, BRIT J RADIOL, V32, P14; Buyse M, 1996, J NATL CANCER I, V88, P252; CHANG AE, 1987, ANN SURG, V206, P685, DOI 10.1097/00000658-198712000-00001; Cohen AM, 1996, EUR J CANCER, V32A, P2195, DOI 10.1016/S0959-8049(96)00393-0; DETAKATS PG, 1994, BRIT J CANCER, V69, P372, DOI 10.1038/bjc.1994.68; Doci R, 1990, REG CANCER TREAT, V3, P13; HOHN DC, 1989, J CLIN ONCOL, V7, P1646, DOI 10.1200/JCO.1989.7.11.1646; KEMENY MM, 1986, CANCER, V57, P492, DOI 10.1002/1097-0142(19860201)57:3<492::AID-CNCR2820570315>3.0.CO;2-M; KEMENY N, 1987, ANN INTERN MED, V107, P459, DOI 10.7326/0003-4819-107-4-459; KERR DJ, 1995, J CLIN ONCOL, V13, P2968, DOI 10.1200/JCO.1995.13.12.2968; Koehne CH, 1999, ANN ONCOL, V10, P877, DOI 10.1023/A:1008348904180; Lorenz M, 2000, J CLIN ONCOL, V18, P243, DOI 10.1200/JCO.2000.18.2.243; MARTIN JK, 1990, ARCH SURG-CHICAGO, V125, P1022; Midgley R, 1999, LANCET, V353, P391, DOI 10.1016/S0140-6736(98)07127-X; Nicum S, 2000, J ROY SOC MED, V93, P416, DOI 10.1177/014107680009300807; O'Connell MJ, 1998, J CLIN ONCOL, V16, P2528, DOI 10.1200/JCO.1998.16.7.2528; ROUGIER P, 1992, J CLIN ONCOL, V10, P1112, DOI 10.1200/JCO.1992.10.7.1112; Seymour MT, 1996, J CLIN ONCOL, V14, P2280, DOI 10.1200/JCO.1996.14.8.2280; Sobrero A, 2000, EUR J CANCER, V36, P559, DOI 10.1016/S0959-8049(99)00314-7; Stephens R, 2001, LANCET ONCOL, V2, P9, DOI 10.1016/S1470-2045(00)00186-8; Wickremesekera JK, 2000, AUST NZ J SURG, V70, P496, DOI 10.1046/j.1440-1622.2000.01858.x; Young AN, 1999, CLIN PHARMACOKINET, V36, P391, DOI 10.2165/00003088-199936060-00001; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	27	189	195	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					368	373		10.1016/S0140-6736(03)12388-4	http://dx.doi.org/10.1016/S0140-6736(03)12388-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573372				2022-12-28	WOS:000180787000008
J	He, L; Lu, XY; Jolly, AF; Eldridge, AG; Watson, SJ; Jackson, PK; Barsh, GS; Gunn, TM				He, L; Lu, XY; Jolly, AF; Eldridge, AG; Watson, SJ; Jackson, PK; Barsh, GS; Gunn, TM			Spongiform degeneration in mahoganoid mutant mice	SCIENCE			English	Article							PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; AGOUTI PROTEIN; PIGMENTATION; MUTATIONS; ATTRACTIN; SUBSTRATE; RECEPTOR; OBESITY; SYSTEM	mahoganoid is a mouse coat-color mutation whose pigmentary phenotype and genetic interactions resemble those of Attractin (Atrn). Atrn mutations also cause spongiform neurodegeneration. Here, we show that a null mutation for mahoganoid causes a similar age-dependent neuropathology that includes many features of prion diseases but without accumulation of protease-resistant prion protein. The gene mutated in mahoganoid encodes a RING-containing protein with E3 ubiquitin ligase activity in vitro. Similarities in phenotype, expression, and genetic interactions suggest that mahoganoid and Atrn genes are part of a conserved pathway for regulated protein turnover whose function is essential for neuronal viability.	Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Pediat,Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Univ Michigan, Sch Med, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA	Cornell University; Howard Hughes Medical Institute; Stanford University; Stanford University; University of Michigan System; University of Michigan	Barsh, GS (corresponding author), Cornell Univ, Dept Biomed Sci, T4 018 VRT, Ithaca, NY 14853 USA.		Lu, Xin-Yun/M-8657-2016	Jackson, Peter/0000-0002-1742-2539; Gunn, Teresa/0000-0003-2688-6420				Barsh G, 2000, PIGM CELL RES, V13, P48, DOI 10.1034/j.1600-0749.13.s8.10.x; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Bronson RT, 2001, J NEUROPATH EXP NEUR, V60, P724, DOI 10.1093/jnen/60.7.724; GOMI H, 1994, BRAIN RES, V653, P66, DOI 10.1016/0006-8993(94)90373-5; Gunn TM, 2001, GENETICS, V158, P1683; He L, 2001, NAT GENET, V27, P40, DOI 10.1038/83741; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jackson IJ, 1999, TRENDS GENET, V15, P429, DOI 10.1016/S0168-9525(99)01824-7; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kuramoto T, 2002, MAMM GENOME, V13, P36, DOI 10.1007/s00335-001-2116-9; Kuramoto T, 2001, P NATL ACAD SCI USA, V98, P559, DOI 10.1073/pnas.98.2.559; LANE PW, 1960, MOUSE NEWS LETT, V22, P35; LIBERSKI PP, 1993, LIGHT ELECT MICROSCO, P155; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Milhavet O, 2002, BRAIN RES REV, V38, P328, DOI 10.1016/S0165-0173(01)00150-3; Miller KA, 1997, GENETICS, V146, P1407; Mouradian MM, 2002, NEUROLOGY, V58, P179, DOI 10.1212/WNL.58.2.179; Ollmann MM, 1998, GENE DEV, V12, P316, DOI 10.1101/gad.12.3.316; Phan LK, 2002, J CLIN INVEST, V110, P1449, DOI 10.1172/JC1200216131; Phillips R.J., 1963, MOUSE NEWS LETT, V29, P38; PHILLIPS RJS, 1979, MOUSE NEWS LETT, V60, P46; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; PRUSINER SB, 1997, MOL GENETIC BASIS NE, P103; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627	26	115	121	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					710	712		10.1126/science.1079694	http://dx.doi.org/10.1126/science.1079694			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560552				2022-12-28	WOS:000180687700048
J	Krider, PE				Krider, PE			Deciphering the energetics of lightning	SCIENCE			English	Editorial Material							AIR BREAKDOWN; RUNAWAY		Univ Arizona, Inst Atmospher Phys, Tucson, AZ 85721 USA	University of Arizona	Krider, PE (corresponding author), Univ Arizona, Inst Atmospher Phys, Tucson, AZ 85721 USA.							Babich L. P., 1982, Soviet Physics - Doklady, V27, P215; BAZELYAN EM, 2000, LIGHTNING PHYSICS LI; Bazelyan EM., 1998, SPARK DISCHARGE; Dwyer JR, 2003, SCIENCE, V299, P694, DOI 10.1126/science.1078940; FISHMAN GJ, 1994, SCIENCE, V264, P1313, DOI 10.1126/science.264.5163.1313; Gallimberti I., 1979, Journal de Physique Colloque, V40, pC7/193, DOI 10.1051/jphyscol:19797440; GUREVICH AV, 1992, PHYS LETT A, V165, P463, DOI 10.1016/0375-9601(92)90348-P; Lehtinen NG, 1996, GEOPHYS RES LETT, V23, P2645, DOI 10.1029/96GL02573; Moore CB, 2001, GEOPHYS RES LETT, V28, P2141, DOI 10.1029/2001GL013140; ROUSSELDUPRE RA, 1994, PHYS REV E, V49, P2257, DOI 10.1103/PhysRevE.49.2257; Suszcynsky DM, 1996, J GEOPHYS RES-ATMOS, V101, P23505, DOI 10.1029/96JD02134; UMAN MA, 1989, SCIENCE, V246, P457, DOI 10.1126/science.246.4929.457	12	6	6	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					669	670		10.1126/science.1082432	http://dx.doi.org/10.1126/science.1082432			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560538				2022-12-28	WOS:000180687700032
J	Xiao, YP; Wang, Y; Felleman, DJ				Xiao, YP; Wang, Y; Felleman, DJ			A spatially organized representation of colour in macaque cortical area V2	NATURE			English	Article							FUNCTIONAL-ORGANIZATION; FORM; SEGREGATION; MECHANISMS; DISPARITY; CORTEX; MONKEY; V4	Neurons responding selectively to different colours have been found in various cortical areas in macaque monkeys(1); however, little is known about whether and how the representation of colour is spatially organized in any cortical area. Cortical area V2 contains modules that respond preferentially to chromatic modulation, which are located in thin cytochrome oxidase stripes(2-4). Here we show that within and beyond these modules, gratings of different colours produce activations that peak at different locations. Optical recording of intrinsic signals revealed that the peak regions of the responses to different colours were spatially organized in the same order as colour stimuli are arranged in the DIN (German standard colour chart) colour system. Nearby regions represented colours of a similar hue. We found that the set of colour-specific regions formed 0.07-0.32-mm-wide and approximately 1.3-mm long bands that varied in shape from linear to nearly circular. Our finding suggests that thin stripes in V2 contain functional maps where the colour of a stimulus is represented by the location of its response activation peak.	Univ Texas, Houston Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Xiao, YP (corresponding author), Univ Texas, Houston Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA.			Xiao, Youping/0000-0003-3954-3443				BURKHALTER A, 1986, J NEUROSCI, V6, P2327; DEYOE EA, 1985, NATURE, V317, P58, DOI 10.1038/317058a0; Gegenfurtner KR, 1996, VISUAL NEUROSCI, V13, P161, DOI 10.1017/S0952523800007203; HUBEL DH, 1987, J NEUROSCI, V7, P3378; Kiper DC, 1997, VISUAL NEUROSCI, V14, P1061, DOI 10.1017/S0952523800011779; Komatsu H, 1998, CURR OPIN NEUROBIOL, V8, P503, DOI 10.1016/S0959-4388(98)80038-X; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Moutoussis K, 2002, J NEUROPHYSIOL, V87, P2104, DOI 10.1152/jn.00248.2001; PETERHANS E, 1993, EUR J NEUROSCI, V5, P509, DOI 10.1111/j.1460-9568.1993.tb00517.x; ROE AW, 1995, J NEUROSCI, V15, P3689; TOOTELL RBH, 1989, J NEUROSCI, V9, P2620; Ts'o DY, 2001, VISION RES, V41, P1333, DOI 10.1016/S0042-6989(01)00076-1; Xiao YP, 1999, CEREB CORTEX, V9, P792, DOI 10.1093/cercor/9.8.792; Yoshioka T, 1996, BEHAV BRAIN RES, V76, P51, DOI 10.1016/0166-4328(95)00183-2	15	169	172	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					535	539		10.1038/nature01372	http://dx.doi.org/10.1038/nature01372			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556893				2022-12-28	WOS:000180670600046
J	Vallance, P				Vallance, P			Uses of error - Clinical and research	LANCET			English	Editorial Material									UCL, BHF Labs, Ctr Clin Pharmacol, London WC1E 6JJ, England	University of London; University College London	Vallance, P (corresponding author), UCL, BHF Labs, Ctr Clin Pharmacol, Torrington Pl, London WC1E 6JJ, England.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					340	340		10.1016/S0140-6736(03)12330-6	http://dx.doi.org/10.1016/S0140-6736(03)12330-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559882				2022-12-28	WOS:000180643900028
J	Tang, Y; Katuri, V; Dillner, A; Mishra, B; Deng, CX; Mishra, L				Tang, Y; Katuri, V; Dillner, A; Mishra, B; Deng, CX; Mishra, L			Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice	SCIENCE			English	Article							TGF-BETA; LIVER DEVELOPMENT; EPITHELIAL-CELLS; SMAD PROTEINS; PATHWAY; CANCER	Disruption of the adaptor protein ELF, a beta-spectrin, leads to disruption of transforming growth factor-beta (TGF-beta) signaling by Smad proteins in mice. Elf(-/-) mice exhibit a phenotype similar to smad2(+/-)/smad3(+/-) mutant mice of midgestational death due to gastrointestinal, liver, neural, and heart defects. We show that TGF-beta triggers phosphorylation and association of ELF with Smad3 and Smad4, followed by nuclear translocation. ELF deficiency results in mislocalization of Smad3 and Smad4 and loss of the TGF-beta-dependent transcriptional response, which could be rescued by overexpression of the COOH-terminal region of ELF. This study reveals an unexpected molecular link between a major dynamic scaffolding protein and a key signaling pathway.	NIDDKD, Genet Dev & Dis Branch, NIH, US Dept HHS, Bethesda, MD 20878 USA; Georgetown Univ, Dept Med, Dev Biol Lab, Washington, DC 20007 USA; Dept Vet Affairs, Washington, DC 20422 USA; Temple Univ, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Georgetown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Mishra, B (corresponding author), NIDDKD, Genet Dev & Dis Branch, NIH, US Dept HHS, Bethesda, MD 20878 USA.	lm229@georgetown.edu	deng, chuxia/N-6713-2016	Mishra, Lopa/0000-0002-6850-0808	NIDDK NIH HHS [R01 DK56111, R03 DK53861, R01 DK58637] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056001, R01DK056111, ZIADK056001, R03DK053861] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bhanumathy CD, 2002, DEV DYNAM, V223, P59, DOI 10.1002/dvdy.1235; De Matteis MA, 2000, J CELL SCI, V113, P2331; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Einstein M, 2001, MOL CELL BIOL, V21, P5122, DOI 10.1128/MCB.21.15.5122-5131.2001; Engel ME, 1998, J CELL BIOCHEM, P111; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Mishra L, 1999, ONCOGENE, V18, P353, DOI 10.1038/sj.onc.1202313; Mishra L, 1998, INT J DEV BIOL, V42, P221; Moustakas A, 2002, GENE DEV, V16, P1867, DOI 10.1101/gad.1016802; Moustakas A, 2001, J CELL SCI, V114, P4359; NELSON WJ, 1986, J CELL BIOL, V103, P1751, DOI 10.1083/jcb.103.5.1751; Piek E, 1999, J CELL SCI, V112, P4557; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Sasaki A, 2001, J BIOL CHEM, V276, P17871, DOI 10.1074/jbc.M008422200; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Wrana JL, 2000, CYTOKINE GROWTH F R, V11, P5, DOI 10.1016/S1359-6101(99)00024-6; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	22	216	225	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					574	577		10.1126/science.1075994	http://dx.doi.org/10.1126/science.1075994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543979	Green Published			2022-12-28	WOS:000180559800053
J	Ball, P				Ball, P			Portrait of a molecule	NATURE			English	Article								The double helix is idealized for its aesthetic elegant structure, but the reality of DNA's physical existence is quite different. Most DNA in the cell is compressed into a tangled package that somehow still exposes itself to meticulous gene-regulatory control. Philip Ball holds a mirror up to what we truly know about the mysteries of DNA's life inside a cell.	Nature, London N1 9XW, England		Ball, P (corresponding author), Nature, Macmillan Bldg,4 Crinan St, London N1 9XW, England.							Asturias FJ, 2002, P NATL ACAD SCI USA, V99, P13477, DOI 10.1073/pnas.162504299; Poirier MG, 2002, P NATL ACAD SCI USA, V99, P15393, DOI 10.1073/pnas.232442599; VANDRIEL R, 1997, NUCL ORG CHROMATIN S	3	19	21	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					421	422		10.1038/nature01404	http://dx.doi.org/10.1038/nature01404			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540914	Bronze			2022-12-28	WOS:000180533000055
J	Seeman, NC				Seeman, NC			DNA in a material world	NATURE			English	Article							CONSTRUCTION; MOLECULES; HYBRIDIZATION; COMPUTATION; DESIGN	The specific bonding of DNA base pairs provides the chemical foundation for genetics. This powerful molecular recognition system can be used in nanotechnology to direct the assembly of highly structured materials with specific nanoscale features, as well as in DNA computation to process complex information. The exploitation of DNA for material purposes presents a new chapter in the history of the molecule.	NYU, Dept Chem, New York, NY 10003 USA	New York University	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.	ned.seeman@nyu.edu						ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; CARUTHERS MH, 1985, SCIENCE, V230, P281, DOI 10.1126/science.3863253; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Cuberes MT, 1996, APPL PHYS LETT, V69, P3016, DOI 10.1063/1.116824; Dekker C, 2001, PHYS WORLD, V14, P29; Eckardt LH, 2002, NATURE, V420, P286, DOI 10.1038/420286a; Fahlman RP, 2002, J AM CHEM SOC, V124, P4610, DOI 10.1021/ja012618u; HOFFMANN R, 1994, AM SCI, V82, P308; Jaeger L, 2001, NUCLEIC ACIDS RES, V29, P455, DOI 10.1093/nar/29.2.455; Keren K, 2002, SCIENCE, V297, P72, DOI 10.1126/science.1071247; LaBean TH, 2000, J AM CHEM SOC, V122, P1848, DOI 10.1021/ja993393e; Li XJ, 1996, J AM CHEM SOC, V118, P6131, DOI 10.1021/ja960162o; Mao CD, 1999, NATURE, V397, P144, DOI 10.1038/16437; Mao CD, 1999, J AM CHEM SOC, V121, P5437, DOI 10.1021/ja9900398; Mao CD, 2000, NATURE, V407, P493, DOI 10.1038/35035038; Niemeyer CM, 2002, CHEMBIOCHEM, V3, P242, DOI 10.1002/1439-7633(20020301)3:2/3<242::AID-CBIC242>3.0.CO;2-F; Pena SRN, 2002, J AM CHEM SOC, V124, P7314, DOI 10.1021/ja0177915; ROBINSON BH, 1987, PROTEIN ENG, V1, P295, DOI 10.1093/protein/1.4.295; SEEMAN NC, 1991, DNA CELL BIOL, V10, P475, DOI 10.1089/dna.1991.10.475; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Seeman NC, 1998, ANGEW CHEM INT EDIT, V37, P3220, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3220::AID-ANIE3220>3.0.CO;2-C; SEEMAN NC, 1995, CHEM INTELLIGENCER, V1, P38; Taton TA, 2000, J AM CHEM SOC, V122, P6305, DOI 10.1021/ja0007962; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Winfree E, 2000, J BIOMOL STRUCT DYN, P263; Winfree E., 1996, DNA BASED COMPUTERS, P199; Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zhang XP, 2002, J AM CHEM SOC, V124, P12940, DOI 10.1021/ja026973b	30	2209	2295	16	668	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					427	431		10.1038/nature01406	http://dx.doi.org/10.1038/nature01406			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540916	Bronze			2022-12-28	WOS:000180533000057
J	Thiele, A; Stoner, G				Thiele, A; Stoner, G			Neuronal synchrony does not correlate with motion coherence in cortical area MT	NATURE			English	Article							VISUAL-CORTEX; CONNECTIVITY; TRANSPARENCY; PERCEPTION; RESPONSES; RULES; CUE	Natural visual scenes are cluttered with multiple objects whose individual features must somehow be selectively linked (or 'bound') if perception is to coincide with reality. Recent neurophysiological evidence(1,2) supports a 'binding-by-synchrony' hypothesis3 : neurons excited by features of the same object fire synchronously, while neurons excited by features of different objects do not. Moving plaid patterns offer a straightforward means to test this idea. By appropriate manipulations of apparent transparency, the component gratings of a plaid pattern can be seen as parts of a single coherently moving surface or as two non-coherently moving surfaces. We examined directional tuning and synchrony of area-MT neurons in awake, fixating primates in response to perceptually coherent and non-coherent plaid patterns. Here we show that directional tuning correlated highly with perceptual coherence, which is consistent with an earlier study(4). Although we found stimulus-dependent synchrony, coherent plaids elicited significantly less synchrony than did non-coherent plaids. Our data therefore do not support the binding-by-synchrony hypothesis as applied to this class of motion stimuli in area MT.	Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Stoner, G (corresponding author), Univ Newcastle Upon Tyne, Henry Wellcome Bldg Neuroecol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.			Thiele, Alexander/0000-0003-4894-0213				AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; BATSCHELET E, 1972, ANIMAL ORIENTATION N, P61; Castelo-Branco M, 2000, NATURE, V405, P685, DOI 10.1038/35015079; deOliveira SC, 1997, J NEUROSCI, V17, P9248; Eggermont JJ, 1996, EXP BRAIN RES, V110, P379; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Lindsey DT, 1996, VISION RES, V36, P207, DOI 10.1016/0042-6989(95)00096-I; Movshon JA, 1985, STUDY GROUP PATTERN, P117, DOI [DOI 10.1007/978-3-662-09224-8_7., DOI 10.1007/978-3-662-09224-8_]; Pack CC, 2001, NATURE, V414, P905, DOI 10.1038/414905a; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; Stoner GR, 1998, VISION RES, V38, P387, DOI 10.1016/S0042-6989(97)00132-6; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; Stoner GR, 1996, VISION RES, V36, P1291, DOI 10.1016/0042-6989(95)00195-6; STONER GR, 1992, VISION RES, V32, P465, DOI 10.1016/0042-6989(92)90238-E; Thiele A, 1999, EUR J NEUROSCI, V11, P2044, DOI 10.1046/j.1460-9568.1999.00630.x	20	116	117	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					366	370		10.1038/nature01285	http://dx.doi.org/10.1038/nature01285			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540900				2022-12-28	WOS:000180533000041
J	de Araujo, T; Valencia, I; Federman, DG; Kirsner, RS				de Araujo, T; Valencia, I; Federman, DG; Kirsner, RS			Managing the patient with venous ulcers	ANNALS OF INTERNAL MEDICINE			English	Review							COLONY-STIMULATING FACTOR; CHRONIC LEG ULCERS; PLACEBO-CONTROLLED TRIAL; KERATINOCYTE GROWTH FACTOR-2; DOUBLE-BLIND; FIBRINOLYTIC ENHANCEMENT; COMPRESSION THERAPY; CLINICAL HISTORY; RANDOMIZED-TRIAL; RISK-FACTORS	Venous disease is the most common cause of leg ulcers. The refractory nature of venous ulcers affects the quality of life and work productivity of those persons afflicted. This, in combination with the high costs of long-term therapy, makes venous ulcers a major health problem in developed countries. Management of venous leg ulcers is based on understanding pathophysiologic abnormalities. In recent years, identifying prognostic factors for healing and developing novel therapeutic approaches for venous ulcers have offered valuable tools for the management of patients with this disorder.	Univ Miami, Vet Adm Med Ctr, Dept Dermatol, Sch Med, Miami, FL 33125 USA; Yale Univ, Sch Med, Vet Adm Med Ctr, New Haven, CT 06520 USA	University of Miami; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Kirsner, RS (corresponding author), Univ Miami, Vet Adm Med Ctr, Dept Dermatol, Sch Med, 1201 NW 16th St, Miami, FL 33125 USA.	Rkirsner@med.miami.edu						ABUOWN A, 1994, J VASC SURG, V20, P705, DOI 10.1016/S0741-5214(94)70157-1; Ahnlide I, 1997, ACTA DERM-VENEREOL, V77, P144; Bergqvist D, 1999, J VASC SURG, V29, P752, DOI 10.1016/S0741-5214(99)70330-7; BLAIR SD, 1988, BRIT MED J, V297, P1159, DOI 10.1136/bmj.297.6657.1159; BROWSE NL, 1980, BRIT MED J, V281, P1167, DOI 10.1136/bmj.281.6249.1167; BROWSE NL, 1982, LANCET, V2, P243; BURNAND K, 1980, BMJ-BRIT MED J, V280, P7, DOI 10.1136/bmj.280.6206.7; Cahall E, 1994, J Vasc Nurs, V12, P48; CALLAM MJ, 1987, BRIT MED J, V294, P1389, DOI 10.1136/bmj.294.6584.1389; CALLAM MJ, 1985, BRIT MED J, V290, P1855, DOI 10.1136/bmj.290.6485.1855; COLGAN MP, 1990, BRIT MED J, V300, P972, DOI 10.1136/bmj.300.6730.972; da Costa RM, 1999, WOUND REPAIR REGEN, V7, P17, DOI 10.1046/j.1524-475X.1999.00017.x; daCosta RM, 1997, AM J SURG, V173, P165, DOI 10.1016/S0002-9610(97)89589-X; Dale JJ, 1999, BRIT MED J, V319, P875, DOI 10.1136/bmj.319.7214.875; DAVIDSON JF, 1972, BRIT J HAEMATOL, V22, P543, DOI 10.1111/j.1365-2141.1972.tb05701.x; DICKEY JW, 1991, SOUTHERN MED J, V84, P557; DOUGLAS WS, 1995, BRIT J DERMATOL, V132, P446, DOI 10.1111/j.1365-2133.1995.tb08681.x; DUNN RM, 1994, J VASC SURG, V19, P525, DOI 10.1016/S0741-5214(94)70081-8; Eaglstein WH, 1997, SURG CLIN N AM, V77, P689, DOI 10.1016/S0039-6109(05)70575-2; ERICKSON CA, 1995, J VASC SURG, V22, P629, DOI 10.1016/S0741-5214(95)70051-X; Falabella A, 1998, CLIN PLAST SURG, V25, P467; FALANGA V, 1993, J DERMATOL SURG ONC, V19, P764, DOI 10.1111/j.1524-4725.1993.tb00422.x; FALANGA V, 1988, ARCH DERMATOL, V124, P872, DOI 10.1001/archderm.124.6.872; FALANGA V, 1991, LANCET, V338, P347, DOI 10.1016/0140-6736(91)90483-6; Falanga V, 1999, WOUND REPAIR REGEN, V7, P208, DOI 10.1046/j.1524-475X.1999.00208.x; Falanga V, 1996, WOUNDS, V8, P102; FALANGA V, 1993, LANCET, V341, P1006, DOI 10.1016/0140-6736(93)91085-Z; Falanga V, 1998, ARCH DERMATOL, V134, P293, DOI 10.1001/archderm.134.3.293; FALANGA V, 1999, DERMATOL THER, V9, P7; Falanga V, 1997, CHRONIC WOUND CARE, P165; Fletcher A, 1997, BRIT MED J, V315, P576; FRIEDMAN SA, 1990, CLIN DERMATOL, V8, P30, DOI 10.1016/0738-081X(90)90045-3; Gherardini G, 1998, PLAST RECONSTR SURG, V101, P90, DOI 10.1097/00006534-199801000-00015; GRAYSON ML, 1995, JAMA-J AM MED ASSOC, V273, P721, DOI 10.1001/jama.273.9.721; Guilhou JJ, 1997, ANGIOLOGY, V48, P77, DOI 10.1177/000331979704800113; HALABE A, 1995, MED SCI RES, V23, P65; HANSSON C, 1988, ACTA DERM-VENEREOL, V68, P245; HARRISON PV, 1988, CLIN EXP DERMATOL, V13, P4, DOI 10.1111/j.1365-2230.1988.tb00638.x; HELFMAN T, 1995, J AM ACAD DERMATOL, V33, P254, DOI 10.1016/0190-9622(95)90244-9; IBBOTSON SH, 1995, BRIT J DERMATOL, V132, P422, DOI 10.1111/j.1365-2133.1995.tb08676.x; Jaschke E, 1999, INT J DERMATOL, V38, P380, DOI 10.1046/j.1365-4362.1999.00665.x; JULIAN OC, 1954, AMA ARCH SURG, V68, P757, DOI 10.1001/archsurg.1954.01260050759005; Jull AB, 2002, COCHRANE DB SYST REV; Kennedy KL, 1997, CHRONIC WOUND CARE, P227; KIRSNER RS, 1993, J AM ACAD DERMATOL, V28, P623, DOI 10.1016/0190-9622(93)70085-8; KIRSNER RS, 1995, DERMATOL SURG, V21, P701, DOI 10.1111/j.1524-4725.1995.tb00273.x; KIRSNER RS, 1993, J DERMATOL SURG ONC, V19, P779, DOI 10.1111/j.1524-4725.1993.tb00424.x; Kunimoto B, 2001, OSTOMY WOUND MANAG, V47, P48; KUNIMOTO BT, 1999, DERMATOL THER, V9, P63; LABROPOULOS N, 1995, AM J SURG, V169, P572, DOI 10.1016/S0002-9610(99)80223-2; LAYTON AM, 1994, LANCET, V344, P164, DOI 10.1016/S0140-6736(94)92759-6; LEIGH IM, 1987, BRIT J DERMATOL, V117, P591, DOI 10.1111/j.1365-2133.1987.tb07491.x; LIMOVA M, 1995, WOUNDS, V7, P170; Lindgren C, 1998, BRIT J DERMATOL, V139, P271; LOFGREN KA, 1965, MAYO CLIN PROC, V40, P560; Lopez AP, 1998, WOUNDS, V10, P149; Lyon RT, 1998, AM J SURG, V176, P172, DOI 10.1016/S0002-9610(98)00136-6; Maessen-Visch MB, 1999, INT J DERMATOL, V38, P161, DOI 10.1046/j.1365-4362.1999.00581.x; MARGOLIS DJ, 1993, J AM ACAD DERMATOL, V28, P418, DOI 10.1016/0190-9622(93)70061-W; MARGOLIS DJ, 1994, CLIN DERMATOL, V12, P19, DOI 10.1016/0738-081X(94)90253-4; MAYBERRY JC, 1991, SURGERY, V109, P575; McGee SR, 1998, ARCH INTERN MED, V158, P1357, DOI 10.1001/archinte.158.12.1357; McGuckin M, 1996, OSTOMY WOUND MANAG, V42, P54; McGuckin M, 1996, OSTOMY WOUND MANAG, V42, P50; MCMULLIN GM, 1991, AUST NZ J SURG, V61, P306, DOI 10.1111/j.1445-2197.1991.tb00217.x; MOFFATT CJ, 1992, BRIT MED J, V305, P1389, DOI 10.1136/bmj.305.6866.1389; Nelzen O, 1997, EUR J VASC ENDOVASC, V13, P500, DOI 10.1016/S1078-5884(97)80179-7; NELZEN O, 1994, BRIT J SURG, V81, P182, DOI 10.1002/bjs.1800810206; NELZEN O, 1991, J VASC SURG, V14, P557, DOI 10.1016/0741-5214(91)90251-O; Olivencia JA, 2000, INT SURG, V85, P266; PARTSCH H, 1991, J DERMATOL SURG ONC, V17, P799, DOI 10.1111/j.1524-4725.1991.tb03263.x; PHILLIPS T, 1994, J AM ACAD DERMATOL, V31, P49, DOI 10.1016/S0190-9622(94)70134-2; Phillips TJ, 1999, POSTGRAD MED, V105, P159, DOI 10.3810/pgm.1999.05.1.744; PHILLIPS TJ, 1991, J AM ACAD DERMATOL, V25, P965, DOI 10.1016/0190-9622(91)70295-D; PHILLIPS TJ, 1989, J AM ACAD DERMATOL, V21, P191, DOI 10.1016/S0190-9622(89)70160-2; Phillips TJ, 2000, J AM ACAD DERMATOL, V43, P627, DOI 10.1067/mjd.2000.107496; POJDA Z, 1994, LANCET, V343, P1100, DOI 10.1016/S0140-6736(94)90211-9; Robson MC, 2001, WOUND REPAIR REGEN, V9, P347, DOI 10.1046/j.1524-475x.2001.00347.x; Ruckley CV, 1997, ANGIOLOGY, V48, P67, DOI 10.1177/000331979704800111; Samson RH, 1996, DERMATOL SURG, V22, P373, DOI 10.1111/j.1524-4725.1996.tb00334.x; Scondotto G, 1999, ANGIOLOGY, V50, P883, DOI 10.1177/000331979905001102; SCOTT TE, 1995, J VASC SURG, V22, P622, DOI 10.1016/S0741-5214(95)70050-1; Scriven JM, 1997, BRIT J SURG, V84, P334, DOI 10.1002/bjs.1800840319; SIBBALD RG, 1998, OSTOMY WOUND MANAG, V28, P34; SIMON DA, 1996, OSTOMY WOUND MANAG, V42, P40; Sinclair R D, 1994, Australas J Dermatol, V35, P35, DOI 10.1111/j.1440-0960.1994.tb01799.x; STEMMER R, 1980, DERMATOLOGIST, V31, P355; Stewart AJ, 1987, PHLEBOLOGY, V2, P115; Tallman P, 1997, ARCH DERMATOL, V133, P1231, DOI 10.1001/archderm.133.10.1231; TEH BT, 1979, PLAST RECONSTR SURG, V63, P323, DOI 10.1097/00006534-197903000-00005; THIBAULT PK, 1995, DERMATOL SURG, V21, P77, DOI 10.1111/j.1524-4725.1995.tb00116.x; THOMAS PRS, 1988, BRIT MED J, V296, P1693, DOI 10.1136/bmj.296.6638.1693; TRIER WC, 1970, PLAST RECONSTR SURG, V45, P20, DOI 10.1097/00006534-197001000-00003; Valencia IC, 2001, J AM ACAD DERMATOL, V44, P401, DOI 10.1067/mjd.2001.111633; Weingarten MS, 2001, CLIN INFECT DIS, V32, P949, DOI 10.1086/319360; Weinzweig N, 1997, ANN PLAS SURG, V38, P611, DOI 10.1097/00000637-199706000-00008; WEITHMANN KU, 1980, IRCS MED SCI-BIOCHEM, V8, P293; Westerhof W, 1994, PROTEOLYTIC ENZYMES, P99; WIERSEMABRYANT LA, 1998, WOUND CARE COLLABORA, P179; Xia YP, 1999, J PATHOL, V188, P431, DOI 10.1002/(SICI)1096-9896(199908)188:4<431::AID-PATH362>3.0.CO;2-B; Zacur H, 2002, WOUNDS, V14, p2E	101	71	74	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2003	138	4					326	334		10.7326/0003-4819-138-4-200302180-00012	http://dx.doi.org/10.7326/0003-4819-138-4-200302180-00012			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DK	12585831				2022-12-28	WOS:000181019400017
J	Fisher, ES; Wennberg, DE; Stukel, TA; Gottlieb, DJ; Lucas, FL; Pinder, EL				Fisher, ES; Wennberg, DE; Stukel, TA; Gottlieb, DJ; Lucas, FL; Pinder, EL			The implications of regional variations in medicare spending. Part 2: Health outcomes and satisfaction with care	ANNALS OF INTERNAL MEDICINE			English	Article							MORTALITY-RATES; QUALITY; EXPENDITURES; TERMINATION; POPULATION; IMPACT	Background: The health implications of regional differences in Medicare spending are unknown. Objective: To determine whether regions with higher Medicare spending achieve better survival, functional status, or satisfaction with care. Design: Cohort study. Setting: National study of Medicare beneficiaries. Patients: Patients hospitalized between 1993 and 1995 for hip fracture (n = 614 503), colorectal cancer (n = 195 429), or acute myocardial infarction (n = 159 393) and a representative sample (n = 18 190) drawn from the Medicare Current Beneficiary Survey (MCBS) (1992-1995). Exposure Measurement: End-of-life spending reflects the component of regional variation in Medicare spending that is unrelated to regional differences in illness. Each cohort member's exposure to different levels of spending was therefore defined by the level of end-of-life spending in his or her hospital referral region of residence (n = 306). Outcome Measurements: 5-year mortality rate (all four cohorts), change in functional status (MCBS cohort), and satisfaction (MCBS cohort). Results: Cohort members were similar in baseline health status, but those in regions with higher end-of-life spending received 60% more care. Each 10% increase in regional end-of-life spending was associated with the following relative risks for death: hip fracture cohort, 1.003 (95% CI, 0.999 to 1.006); colorectal cancer cohort, 1.012 (CI, 1.004 to 1.019); acute myocardial infarction cohort, 1.007 (CI, 1.001 to 1.014); and MCBS cohort, 1.01 (Cl, 0.99 to 1.03). There were no differences in the rate of decline in functional status across spending levels and no consistent differences in satisfaction. Conclusions: Medicare enrollees in higher-spending regions receive more care than those in lower-spending regions but do not have better health outcomes or satisfaction with care. Efforts to reduce spending should proceed with caution, but policies to better manage further spending growth are warranted.	Dartmouth Coll, Sch Med, Ctr Evaluat Clin Sci, Hanover, NH 03755 USA; White River Junct Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT 05001 USA; Inst Clin Evaluat Sci, Toronto, ON, Canada	Dartmouth College; VA Outcomes Group; University of Toronto	Fisher, ES (corresponding author), Dartmouth Coll, Sch Med, Ctr Evaluat Clin Sci, HB 7251, Hanover, NH 03755 USA.	elliott.s.fisher@dartmouth.edu	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Stukel, Therese/0000-0002-2951-1360	NCI NIH HHS [CA52192] Funding Source: Medline; NIA NIH HHS [P01 AG019783, P01 AG019783-03, 1PO1 AG19783-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA052192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BINDMAN AB, 1990, JAMA-J AM MED ASSOC, V264, P2899, DOI 10.1001/jama.264.22.2899; CUTLER DM, 2001, HEALTH AFFAIR, V20, P11; Erickson P, 1998, QUAL LIFE RES, V7, P101, DOI 10.1023/A:1008897107977; ERICKSON P, 2003, 7 NAT CTR HLTH STAT; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; HADLEY J, 1988, INQUIRY-J HEALTH CAR, V25, P485; Kessler DP, 2000, Q J ECON, V115, P577, DOI 10.1162/003355300554863; Kleinke JD, 2001, HEALTH AFFAIR, V20, P43, DOI 10.1377/hlthaff.20.5.43; Krakauer H, 1996, HEALTH SERV RES, V31, P191; Lee YH, 1998, HEALTH SERV RES, V32, P741; LIN DY, 1994, STAT MED, V13, P2233, DOI 10.1002/sim.4780132105; LURIE N, 1984, NEW ENGL J MED, V311, P480, DOI 10.1056/NEJM198408163110735; LURIE N, 1986, NEW ENGL J MED, V314, P1266, DOI 10.1056/NEJM198605083141934; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Pritchard RS, 1998, J AM GERIATR SOC, V46, P1242, DOI 10.1111/j.1532-5415.1998.tb04540.x; SELVIN HC, 1958, AM J SOCIOL, V63, P607, DOI 10.1086/222356; Shah BV, 1997, SUDAAN USERS MANUAL; Skinner J, 1997, NATL TAX J, V50, P413; SKINNER JS, 2001, NBER WORKING PAPERS; Thorndike EL, 1939, AM J PSYCHOL, V52, P122, DOI 10.2307/1416673; WELCH WP, 1993, NEW ENGL J MED, V328, P621, DOI 10.1056/NEJM199303043280906; WENNBERG JE, 2002, GEOGRAPHY DEBATE MED; Wennberg JE, 1999, DARTMOUTH ATLAS HLTH; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	25	1009	1019	4	47	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2003	138	4					288	298		10.7326/0003-4819-138-4-200302180-00007	http://dx.doi.org/10.7326/0003-4819-138-4-200302180-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	646DK	12585826				2022-12-28	WOS:000181019400002
J	Courcelle, J; Donaldson, JR; Chow, KH; Courcelle, CT				Courcelle, J; Donaldson, JR; Chow, KH; Courcelle, CT			DNA damage-induced replication fork regression and processing in Escherichia coli	SCIENCE			English	Article							AGAROSE-GEL ELECTROPHORESIS; ILLEGITIMATE RECOMBINATION; EXCISION-REPAIR; RECR PROTEINS; HELICASE; RESUMPTION; FILAMENTS; STRAND	DNA lesions that block replication are a primary cause of rearrangements, mutations, and lethality in all cells. After ultraviolet (UV)-induced DNA damage in Escherichia coli, replication recovery requires RecA and several other recF pathway proteins. To characterize the mechanism by which lesion-blocked replication forks recover, we used two-dimensional agarose get electrophoresis to show that replication-blocking DNA lesions induce a transient reversal of the replication fork in vivo. The reversed replication fork intermediate is stabilized by RecA and RecF and is degraded by the RecQ-RecJ helicase-nuclease when these proteins are absent. We propose that fork regression allows repair enzymes to gain access to the replication-blocking lesion, allowing processive replication to resume once the blocking lesion is removed.	Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA	Mississippi State University	Courcelle, J (corresponding author), Mississippi State Univ, Dept Biol Sci, Box GY, Mississippi State, MS 39762 USA.							Courcelle J, 1999, MOL GEN GENET, V262, P543, DOI 10.1007/s004380051116; Courcelle J, 1997, P NATL ACAD SCI USA, V94, P3714, DOI 10.1073/pnas.94.8.3714; Courcelle J, 1999, J BACTERIOL, V181, P916, DOI 10.1128/JB.181.3.916-922.1999; Courcelle J, 2001, P NATL ACAD SCI USA, V98, P8196, DOI 10.1073/pnas.121008898; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; GANESAN AK, 1971, MOL GEN GENET, V113, P285, DOI 10.1007/BF00272328; GANESAN AK, 1974, J MOL BIOL, V87, P103, DOI 10.1016/0022-2836(74)90563-4; Hanada K, 2000, P NATL ACAD SCI USA, V97, P5989, DOI 10.1073/pnas.100101297; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; HORII ZI, 1973, J MOL BIOL, V80, P327, DOI 10.1016/0022-2836(73)90176-9; HORII ZI, 1968, PHOTOCHEM PHOTOBIOL, V8, P93, DOI 10.1111/j.1751-1097.1968.tb05850.x; Karow JK, 2000, CURR OPIN GENET DEV, V10, P32, DOI 10.1016/S0959-437X(99)00039-8; KONFORTI BB, 1987, P NATL ACAD SCI USA, V84, P690, DOI 10.1073/pnas.84.3.690; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; MARTINPARRAS L, 1991, J MOL BIOL, V220, P843, DOI 10.1016/0022-2836(91)90357-C; McGlynn P, 2000, NUCLEIC ACIDS RES, V28, P2324, DOI 10.1093/nar/28.12.2324; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Rangarajan S, 2002, MOL MICROBIOL, V43, P617, DOI 10.1046/j.1365-2958.2002.02747.x; RUPP WD, 1971, J MOL BIOL, V61, P25, DOI 10.1016/0022-2836(71)90204-X; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SETLOW RB, 1963, SCIENCE, V142, P1464, DOI 10.1126/science.142.3598.1464; SETLOW RB, 1964, P NATL ACAD SCI USA, V51, P226, DOI 10.1073/pnas.51.2.226; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; TSUJIMURA T, 1990, P NATL ACAD SCI USA, V87, P1566, DOI 10.1073/pnas.87.4.1566; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3	28	186	192	3	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1064	1067		10.1126/science.1081328	http://dx.doi.org/10.1126/science.1081328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12543983				2022-12-28	WOS:000180960000047
J	Rennard, SI				Rennard, SI			COPD: treatments benefit patients	LANCET			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; GLOBAL BURDEN; MORTALITY; DISABILITY; SMOKING; RISK		Univ Nebraska, Med Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Rennard, SI (corresponding author), Univ Nebraska, Med Ctr, 600 S 42nd St, Omaha, NE 68198 USA.	srennard@unmc.edu						Altose MD, 2000, NEW ENGL J MED, V343, P1902; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Hubbard RB, 2002, AM J RESP CRIT CARE, V166, P1563, DOI 10.1164/rccm.200206-606OC; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; O'Brien A, 2001, AM J RESP CRIT CARE, V164, P365, DOI 10.1164/ajrccm.164.3.2002052; PAUWELS R, 2001, GLOBAL INITIATIVE CH; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Rennard S, 2000, EUR RESPIR J, V16, P1035, DOI 10.1034/j.1399-3003.2000.16f02.x; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Sin DD, 2001, AM J RESP CRIT CARE, V164, P580, DOI 10.1164/ajrccm.164.4.2009033; Soriano JB, 2002, EUR RESPIR J, V20, P819, DOI 10.1183/09031936.02.00301302	14	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					444	445		10.1016/S0140-6736(03)12467-1	http://dx.doi.org/10.1016/S0140-6736(03)12467-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583937				2022-12-28	WOS:000180900600002
J	Michel, P; Benz, W; Richardson, DC				Michel, P; Benz, W; Richardson, DC			Disruption of fragmented parent bodies as the origin of asteroid families	NATURE			English	Article							COLLISIONS; DENSITY	Asteroid families are groups of small bodies that share certain orbit(1) and spectral properties(2). More than 20 families have now been identified, each believed to have resulted from the collisional break-up of a large parent body(3) in a regime where gravity controls the outcome of the collision more than the material strength of the rock. The size and velocity distributions of the family members provide important constraints for testing our understanding of the break-up process, but erosion and dynamical diffusion of the orbits over time can erase the original signature of the collision(4,5). The recently identified young Karin family(6) provides a unique opportunity to study a collisional outcome almost unaffected by orbit evolution. Here we report numerical simulations modelling classes of collisions that reproduce the main characteristics of the Karin family. The sensitivity of the outcome of the collision to the internal structure of the parent body allows us to show that the family must have originated from the break-up of a pre-fragmented parent body, and that all large family members formed by the gravitational reaccumulation of smaller bodies. We argue that most of the identified asteroid families are likely to have had a similar history.	Observ Cote Azur, F-06304 Nice 4, France; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; Univ Maryland, Dept Astron, College Pk, MD 20742 USA	UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; University of Bern; University System of Maryland; University of Maryland College Park	Michel, P (corresponding author), Observ Cote Azur, BP 4229, F-06304 Nice 4, France.		Richardson, Derek C/J-4257-2018; Michel, Patrick/AGX-0167-2022	Richardson, Derek C/0000-0002-0054-6850; Michel, Patrick/0000-0002-0884-1993				Asphaug E, 1998, NATURE, V393, P437, DOI 10.1038/30911; BELTON MJS, 1995, NATURE, V374, P785, DOI 10.1038/374785a0; Benz W, 1999, ICARUS, V142, P5, DOI 10.1006/icar.1999.6204; Bottke WF, 2001, SCIENCE, V294, P1693, DOI 10.1126/science.1066760; BOTTKE WF, 1994, ICARUS, V107, P255, DOI 10.1006/icar.1994.1021; Farinella P, 1996, ASTR SOC P, V107, P45; Flynn GJ, 1999, ICARUS, V142, P97, DOI 10.1006/icar.1999.6210; Marzari F, 1999, ICARUS, V142, P63, DOI 10.1006/icar.1999.6208; Michel P, 2002, ICARUS, V160, P10, DOI 10.1006/icar.2002.6948; Michel P, 2001, SCIENCE, V294, P1696, DOI 10.1126/science.1065189; MILANI A, 1994, ICARUS, V107, P219, DOI 10.1006/icar.1994.1020; Nesvorny D, 2002, NATURE, V417, P720, DOI 10.1038/nature00789; Richardson DC, 2000, ICARUS, V143, P45, DOI 10.1006/icar.1999.6243; Thompson S. L., 1972, SCRR710714; TILLOTSON JH, 1962, GA3216 GEN AT; Yeomans DK, 2000, SCIENCE, V289, P2085, DOI 10.1126/science.289.5487.2085; ZAPPALA V, 1995, ICARUS, V116, P291, DOI 10.1006/icar.1995.1127	18	97	98	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					608	611		10.1038/nature01364	http://dx.doi.org/10.1038/nature01364			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571589				2022-12-28	WOS:000180803200035
J	Darby, S; McGale, P; Peto, R; Granath, F; Hall, P; Ekbom, A				Darby, S; McGale, P; Peto, R; Granath, F; Hall, P; Ekbom, A			Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women	BRITISH MEDICAL JOURNAL			English	Article							LATERALITY		Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Epidemiol Studies Unit, Oxford OX2 6HE, England; Karolinska Inst, Dept Med Epidemiol, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Med, S-10401 Stockholm, Sweden	Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford; Karolinska Institutet; Karolinska Institutet	Darby, S (corresponding author), Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England.							Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Paszat LF, 1998, J CLIN ONCOL, V16, P2625, DOI 10.1200/JCO.1998.16.8.2625; RUTQVIST LE, 1990, BRIT J CANCER, V61, P866, DOI 10.1038/bjc.1990.193; Shimizu Y, 1999, RADIAT RES, V152, P374, DOI 10.2307/3580222; Weiss HA, 1996, CANCER CAUSE CONTROL, V7, P539, DOI 10.1007/BF00051887	5	173	182	1	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					256	257		10.1136/bmj.326.7383.256	http://dx.doi.org/10.1136/bmj.326.7383.256			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560277	Green Published, Bronze			2022-12-28	WOS:000180908300020
J	de Jong-van den Berg, L; Tobi, H; Bijker, B; van den Berg, P				de Jong-van den Berg, L; Tobi, H; Bijker, B; van den Berg, P			Influence of the third generation pill controversy on prescriptions for oral contraceptives among first time users: population based study	BRITISH MEDICAL JOURNAL			English	Article							3RD-GENERATION		Univ Groningen, Inst Drug Explorat, Dept Social Pharm Pharmacoepidemiol & Pharmacothe, NL-9713 AV Groningen, Netherlands	University of Groningen	de Jong-van den Berg, L (corresponding author), Univ Groningen, Inst Drug Explorat, Dept Social Pharm Pharmacoepidemiol & Pharmacothe, Antonius Deusinglaan 2, NL-9713 AV Groningen, Netherlands.		Tobi, Hilde/A-1512-2013	Tobi, Hilde/0000-0002-8804-0298				de Vries CS, 1998, CONTRACEPTION, V57, P247, DOI 10.1016/S0010-7824(98)00021-3; Drife JO, 2001, BRIT MED J, V323, P119, DOI 10.1136/bmj.323.7305.119; GEIJER RMM, 1996, HUISARTS WET, V39, P110; Kemmeren JM, 2001, BRIT MED J, V323, P131, DOI 10.1136/bmj.323.7305.131; POULTER NR, 1995, LANCET, V346, P1575	5	5	5	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					254	254		10.1136/bmj.326.7383.254	http://dx.doi.org/10.1136/bmj.326.7383.254			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560275	Green Published, Bronze			2022-12-28	WOS:000180908300018
J	Wagner, A; Mahrholdt, H; Holly, TA; Elliott, MD; Regenfus, M; Parker, M; Klocke, FJ; Bonow, RO; Kim, RJ; Judd, RM				Wagner, A; Mahrholdt, H; Holly, TA; Elliott, MD; Regenfus, M; Parker, M; Klocke, FJ; Bonow, RO; Kim, RJ; Judd, RM			Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study	LANCET			English	Article							NON-Q-WAVE; LONG-TERM PROGNOSIS; RISK; STRATIFICATION; VISUALIZATION; VIABILITY	Background Myocardial infarcts are routinely detected by nuclear imaging techniques such as single photon emission computed tomography (SPECT) myocardial perfusion imaging. A newly developed technique for infarct detection based on contrast-enhanced cardiovascular magnetic resonance (CMR) has higher spatial resolution than SPECT. We postulated that this technique would detect infarcts missed by SPECT. Methods We did contrast-enhanced CMR and SPECT examinations in 91 patients with suspected or known coronary artery disease. All CMR and SPECT images were scored, using a 14-segment model, for the presence, location, and spatial extent of infarction. To compare each imaging modality to a gold standard, we also acquired contrast-enhanced CMR and SPECT images in 12 dogs with, and three dogs without, myocardial infarction as defined by histochemical staining. Findings In animals, contrast-enhanced CMR and SPECT detected all segments with nearly transmural infarction (>75% transmural extent of the left-ventricular wall). CMR also identified 100 of the 109 segments (92%) with subendocardial infarction (<50% transmural extent of the left-ventricular wall), whereas SPECT identified only 31 (28%). SPECT and CMR showed high specificity for the detection of infarction (97% and 98%, respectively). In patients, all segments with nearly transmural infarction, as defined by contrast-enhanced CMR, were detected by SPECT. However, of the 181 segments with subendocardial infarction, 85 (47%) were not detected by SPECT. On a per patient basis, six (13%) individuals with subendocardial infarcts visible by CMR had no evidence of infarction by SPECT. Interpretation SPECT and CMR detect transmural myocardial infarcts at similar rates. However, CMR systematically detects subendocardial infarcts that are missed by SPECT.	Duke Univ Hlth Syst, Duke Cardiovasc Magnet Resonance Ctr, Durham, NC 27710 USA; Northwestern Univ, Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL USA; Dept Med, Chicago, IL USA; Dept Biomed Engn, Chicago, IL USA	Duke University; Northwestern University	Judd, RM (corresponding author), Duke Univ Hlth Syst, Duke Cardiovasc Magnet Resonance Ctr, POB 3934, Durham, NC 27710 USA.	Robert.Judd@dcmrc.mc.duke.edu	Kim, Raymond J/B-1426-2008		NHLBI NIH HHS [R01-HL63268, R01-HL64726, KO2-HL04394] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL004394, R01HL064726, R01HL063268] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1981, JAMA-J AM MED ASSOC, V246, P2073; Antman EM, 1997, AM HEART J, V133, P596, DOI 10.1016/S0002-8703(97)70156-X; BALL SG, 1993, LANCET, V342, P821; Behar S, 1996, EUR HEART J, V17, P1532; BERGER CJ, 1992, JAMA-J AM MED ASSOC, V268, P1545, DOI 10.1001/jama.268.12.1545; CANNOM DS, 1976, AM J MED, V61, P452, DOI 10.1016/0002-9343(76)90322-3; CHIDA K, 1987, JPN HEART J, V28, P307; CHOUHAN L, 1991, AM J CARDIOL, V68, P446, DOI 10.1016/0002-9149(91)90776-H; Garvin A A, 1994, Am J Card Imaging, V8, P189; GIBBONS RJ, 1989, CIRCULATION, V80, P1277, DOI 10.1161/01.CIR.80.5.1277; GOLDBERG RJ, 1987, AM HEART J, V113, P273, DOI 10.1016/0002-8703(87)90265-1; Hachamovitch R, 1998, CIRCULATION, V97, P535; Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992; Klein C, 2002, CIRCULATION, V105, P162, DOI 10.1161/hc0202.102123; Kontos MC, 2001, AM HEART J, V141, P360, DOI 10.1067/mhj.2001.113079; KOSSOWSKY WA, 1976, CHEST, V69, P758, DOI 10.1378/chest.69.6.758; Kuikka JT, 1998, NUCL MED COMMUN, V19, P457, DOI 10.1097/00006231-199805000-00008; MADIAS JE, 1977, ANN INTERN MED, V86, P347, DOI 10.7326/0003-4819-86-3-347; Mahrholdt H, 2002, EUR HEART J, V23, P602, DOI 10.1053/euhj.2001.3038; MILLER TD, 1995, CIRCULATION, V92, P334, DOI 10.1161/01.CIR.92.3.334; OCONNOR MK, 1990, EUR J NUCL MED, V17, P69, DOI 10.1007/BF00819407; PEDERSEN TR, 1994, LANCET, V344, P1383; Rouleau JL, 1996, J AM COLL CARDIOL, V27, P1119, DOI 10.1016/0735-1097(95)00599-4; Simonetti OP, 2001, RADIOLOGY, V218, P215, DOI 10.1148/radiology.218.1.r01ja50215; Wu E, 2001, LANCET, V357, P21, DOI 10.1016/S0140-6736(00)03567-4	26	912	958	1	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2003	361	9355					374	379		10.1016/S0140-6736(03)12389-6	http://dx.doi.org/10.1016/S0140-6736(03)12389-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573373				2022-12-28	WOS:000180787000009
J	Tong, WP; Tao, NR; Wang, ZB; Lu, J; Lu, K				Tong, WP; Tao, NR; Wang, ZB; Lu, J; Lu, K			Nitriding iron at lower temperatures	SCIENCE			English	Article							SURFACE NANOCRYSTALLIZATION; COPPER	The microstructure in the surface layer of a pure iron plate was refined at the nanometer scale by means of a surface mechanical attrition treatment that generates repetitive severe plastic deformation of the surface layer. The subsequent nitriding kinetics of the treated iron with the nanostructured surface layer were greatly enhanced, so that the nitriding temperature could be as low as 300C, which is much lower than conventional nitriding temperatures (above 500degreesC). This enhanced processing method demonstrates the technological significance of nanomaterials in improving traditional processing techniques and provides a new approach for selective surface reactions in solids.	Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China; Univ Technol Troyes, Lab Syst Mecan & Ingn Simultanee, F-10000 Troyes, France	Chinese Academy of Sciences; Institute of Metal Research, CAS; Universite de Technologie de Troyes	Lu, K (corresponding author), Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China.		Wang, Zhenbo/B-4431-2012; Lu, Jian/C-6044-2013	Lu, Jian/0000-0001-5362-0316				Bell T, 1977, SOURCE BOOK NITRIDIN; Calka A, 1996, MATER SCI FORUM, V225, P527, DOI 10.4028/www.scientific.net/MSF.225-227.527; ELESKANDARANY MS, 1992, MATER SCI FORUM, V88, P801, DOI 10.4028/www.scientific.net/MSF.88-90.801; FAST JD, 1954, J IRON STEEL I, V176, P24; Fecht H. J., 1994, NANOPHASE MAT SYNTHE; GLEITER H, 1989, PROG MATER SCI, V33, P223, DOI 10.1016/0921-5093(89)90083-X; Hansen N, 2001, METALL MATER TRANS A, V32, P2917, DOI 10.1007/s11661-001-0167-x; Koch C. C., 1993, Nanostructured Materials, V2, P109, DOI 10.1016/0965-9773(93)90016-5; Lu K, 1996, MAT SCI ENG R, V16, P161, DOI 10.1016/0927-796X(95)00187-5; Lu K, 1999, J MATER SCI TECHNOL, V15, P193; LU K, IN PRESS MAT SCI E A; Lu L, 2000, SCIENCE, V287, P1463, DOI 10.1126/science.287.5457.1463; MONGIS J, 1984, HEAT TREAT MET, V3, P71; SCHUMACHER S, 1989, ACTA METALL MATER, V37, P2485, DOI 10.1016/0001-6160(89)90046-1; Suryanarayana C, 2001, PROG MATER SCI, V46, P1, DOI 10.1016/S0079-6425(99)00010-9; Tao NR, 1999, NANOSTRUCT MATER, V11, P433, DOI 10.1016/S0965-9773(99)00324-4; Tao NR, 2002, ACTA MATER, V50, P4603, DOI 10.1016/S1359-6454(02)00310-5; Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9	18	540	636	24	470	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					686	688		10.1126/science.1080216	http://dx.doi.org/10.1126/science.1080216			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560546				2022-12-28	WOS:000180687700040
J	Daniel, C; Full, J; Gonzalez, L; Lupulescu, C; Manz, J; Merli, A; Vajda, S; Woste, L				Daniel, C; Full, J; Gonzalez, L; Lupulescu, C; Manz, J; Merli, A; Vajda, S; Woste, L			Deciphering the reaction dynamics underlying optimal control laser fields	SCIENCE			English	Article							PUMP-PROBE SPECTROSCOPY; COHERENT CONTROL; THEORETICAL-ANALYSIS; QUANTUM CONTROL; PHOTODISSOCIATION; EXCITATION	Femtosecond high-resolution pump-probe experiments have been used together with theoretical ab initio quantum calculations and wave packet dynamics simulations to decode an optimal femtosecond pulse that is generated from adaptive learning algorithms. This pulse is designed to maximize the yield of the organometallic ion CpMn(CO)(5) while hindering the competing fragmentation. The sequential excitation and ionization of the target ion are accomplished by an optimized field consisting of two dominant subpulses with optimal frequencies and time delays.	Free Univ Berlin, Inst Chem Phys & Theoret Chem, D-14195 Berlin, Germany; Univ Strasbourg, CNRS,Inst Le Bel, UMR 7551, Lab Chim Quant, F-67000 Strasbourg, France; Free Univ Berlin, Fachbereich Phys, Inst Expt Phys, D-14195 Berlin, Germany	Free University of Berlin; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Free University of Berlin	Gonzalez, L (corresponding author), Free Univ Berlin, Inst Chem Phys & Theoret Chem, Takustr 3, D-14195 Berlin, Germany.	leti@chemie.fu-berlin.de; vajda@physik.fu-berlin.de	Gonzalez, Leticia/G-7770-2012; Vajda, Stefan/U-1865-2019	Gonzalez, Leticia/0000-0001-5112-794X; Vajda, Stefan/0000-0002-1879-2099				Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; Bardeen CJ, 1997, CHEM PHYS LETT, V280, P151, DOI 10.1016/S0009-2614(97)01081-6; Bartels R, 2000, NATURE, V406, P164, DOI 10.1038/35018029; BAUMERT T, 1995, FEMTOSECOND CHEM, V2, P397; Brixner T, 2001, ADV ATOM MOL OPT PHY, V46, P1, DOI 10.1016/S1049-250X(01)80062-8; Brixner T, 2001, NATURE, V414, P57, DOI 10.1038/35102037; BRUMER P, 1986, CHEM PHYS LETT, V126, P541, DOI 10.1016/S0009-2614(86)80171-3; Daniel C, 2001, CHEM PHYS, V267, P247, DOI 10.1016/S0301-0104(01)00315-9; Feurer T, 2001, CHEM PHYS, V267, P223, DOI 10.1016/S0301-0104(01)00257-9; Full J, 2003, PHYS CHEM CHEM PHYS, V5, P87, DOI 10.1039/b207765e; GAUBATZ U, 1988, CHEM PHYS LETT, V149, P463, DOI 10.1016/0009-2614(88)80364-6; Glass A, 2000, APPL PHYS B-LASERS O, V71, P267, DOI 10.1007/s003400000397; Gordon RJ, 1999, ACCOUNTS CHEM RES, V32, P1007, DOI 10.1021/ar970119l; Guillaumont D, 1997, INORG CHEM, V36, P1684, DOI 10.1021/ic960872v; Henriksen NE, 2001, INT REV PHYS CHEM, V20, P93, DOI 10.1080/01442350010028523; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; Levis RJ, 2001, SCIENCE, V292, P709, DOI 10.1126/science.1059133; Nicholson JW, 1999, OPT LETT, V24, P1774, DOI 10.1364/OL.24.001774; PARAMONOV GK, 1984, DOKL AKAD NAUK SSS F, V48, P449; Pearson BJ, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.063412; PEIRCE AP, 1988, PHYS REV A, V37, P4950, DOI 10.1103/PhysRevA.37.4950; Rabitz H, 2000, SCIENCE, V288, P824, DOI 10.1126/science.288.5467.824; RICE SA, 1992, SCIENCE, V258, P412, DOI 10.1126/science.258.5081.412; Rubner O, 2000, CHEM PHYS LETT, V316, P585, DOI 10.1016/S0009-2614(99)01352-4; Schon J, 1999, J PHYS CHEM A, V103, P8579, DOI 10.1021/jp991565o; TANNOR DJ, 1985, J CHEM PHYS, V83, P5013, DOI 10.1063/1.449767; VAJDA S, 2002, FEMTOCHEMISTRY FEMTO, P472; WARREN WS, 1993, SCIENCE, V259, P1581, DOI 10.1126/science.259.5101.1581; Zare RN, 1998, SCIENCE, V279, P1875, DOI 10.1126/science.279.5358.1875; Zewail AH, 2000, ANGEW CHEM INT EDIT, V39, P2587; Zhu L, 1997, PHYS REV LETT, V79, P4108, DOI 10.1103/PhysRevLett.79.4108	31	359	367	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					536	539		10.1126/science.1078517	http://dx.doi.org/10.1126/science.1078517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543966				2022-12-28	WOS:000180559800040
J	Chae, SH				Chae, SH			Is the match illegal?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Columbia University	Chae, SH (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, 622 W 168th St, New York, NY 10032 USA.		Morin, Daniel/M-7269-2019	Morin, Daniel/0000-0002-9637-9507				COHERTY MJ, 2002, NEUROLOGY, V58, P495; Collier VU, 2002, ANN INTERN MED, V136, P384, DOI 10.7326/0003-4819-136-5-200203050-00011; GREEN MJ, 1995, ANN INTERN MED, V123, P512, DOI 10.7326/0003-4819-123-7-199510010-00007; Roth A E, 1996, JAMA, V275, P1054, DOI 10.1001/jama.275.13.1054; SULLIVAN LA, 2000, LAW ANTITRUST INTEGR; Weinrich M, 1999, NEUROLOGY, V53, P1175, DOI 10.1212/WNL.53.6.1175; 1979, ENTERTAINMENT LAW RE, V1	7	7	7	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2003	348	4					352	356		10.1056/NEJMsb021241	http://dx.doi.org/10.1056/NEJMsb021241			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637JD	12540652				2022-12-28	WOS:000180507200014
J	Knight, J				Knight, J			Meeting aims to find brain's benchmarks for beauty	NATURE			English	News Item																			0	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					305	305		10.1038/421305b	http://dx.doi.org/10.1038/421305b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540868	Bronze			2022-12-28	WOS:000180533000012
J	Fattori, R; Piva, T				Fattori, R; Piva, T			Drug-eluting stents in vascular intervention	LANCET			English	Review							BALLOON ANGIOPLASTY; LONG-TERM; RESTENOSIS; IMPLANTATION; SIROLIMUS; RADIATION; OUTCOMES; INHIBIT; SYSTEM; TRIAL		Univ Hosp S Orsola, Dept Radiol, Cardiovasc Unit, I-40138 Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna	Fattori, R (corresponding author), Policlin S Orsola, Ist Cardiol, Via Massarenti 9,Padiglione 21, I-40138 Bologna, Italy.	ross@med.unibo.it	Fattori, Rossella/L-1017-2016					*AM HEART ASS, 2001, 2002 HEART STROK STA; Bennett MR, 2001, PHARMACOL THERAPEUT, V91, P149, DOI 10.1016/S0163-7258(01)00153-X; Degertekin M, 2002, CIRCULATION, V106, P1610, DOI 10.1161/01.CIR.0000034447.02535.D5; Ellis SG, 1999, CIRCULATION, V100, P799; Farb A, 2002, CIRCULATION, V105, P2974, DOI 10.1161/01.CIR.0000019071.72887.BD; Grise MA, 2002, CIRCULATION, V105, P2737, DOI 10.1161/01.CIR.0000018126.87045.E0; GRUNTZIG A, 1978, LANCET, V1, P263, DOI 10.1016/s0140-6736(78)90500-7; Holmes DR, 2002, CIRCULATION, V106, P1243, DOI 10.1161/01.CIR.0000028335.31300.DA; Klugherz BD, 2002, CORONARY ARTERY DIS, V13, P183, DOI 10.1097/00019501-200205000-00008; Leon MB, 2001, NEW ENGL J MED, V344, P250, DOI 10.1056/NEJM200101253440402; Liistro F, 2002, CIRCULATION, V105, P1883, DOI 10.1161/01.CIR.0000016042.69606.61; Moer R, 2001, J AM COLL CARDIOL, V38, P1598, DOI 10.1016/S0735-1097(01)01602-3; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Morneault JA, 2002, AM J CARDIOL, V90, p4H; Poon M, 2002, LANCET, V359, P619, DOI 10.1016/S0140-6736(02)07751-6; Schwartz RS, 2002, CIRCULATION, V106, P1867, DOI 10.1161/01.CIR.0000033485.20594.6F; Serruys PW, 1999, J AM COLL CARDIOL, V34, P1067, DOI 10.1016/S0735-1097(99)00308-3; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Topol EJ, 1999, LANCET, V354, P2019, DOI 10.1016/S0140-6736(99)10018-7; Virmani R, 2002, CIRCULATION, V106, P2649, DOI 10.1161/01.CIR.0000041632.02514.14; vom Dahl J, 2002, CIRCULATION, V105, P583, DOI 10.1161/hc0502.103347; Waksman R, 2002, LANCET, V359, P551, DOI 10.1016/S0140-6736(02)07741-3	22	263	304	1	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2003	361	9353					247	249		10.1016/S0140-6736(03)12275-1	http://dx.doi.org/10.1016/S0140-6736(03)12275-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547552				2022-12-28	WOS:000180535400027
J	Spranger, J; Kroke, A; Mohlig, M; Bergmann, MM; Ristow, M; Boeing, H; Pfeiffer, AFH				Spranger, J; Kroke, A; Mohlig, M; Bergmann, MM; Ristow, M; Boeing, H; Pfeiffer, AFH			Adiponectin and protection against type 2 diabetes mellitus	LANCET			English	Article							PROTEIN	Adiponectin is an adipocyte-derived peptide, which has anti-inflammatory and insulin-sensitising properties. We designed a nested case-control study to assess whether baseline adiponectin concentrations in plasma are independently associated with risk of type 2 diabetes. We found that adiponectin concentrations in plasma were lower among individuals who later developed type 2 diabetes than among controls (mean 5.34 mug/mL [SD 3.49] vs 6.87 mug/mL [4.58], p<0.0001). High concentrations of adiponectin were associated with a substantially reduced relative risk of type 2 diabetes after adjustment for age, sex, waist-to-hip ratio, body-mass index, smoking, exercise, alcohol consumption, education, and glycosylated haernoglobin A(1c) (odds ratio 4th vs 1st quartile 0.3 [95% CI 0.2-0.7], p=0.0051). We conclude that adiponectin is independently associated with a reduced risk of type 2 diabetes in apparently healthy individuals.	German Inst Human Nutr Potsdam Rehbrucke, Dept Clin Nutr, D-14558 Bergholz Rehbrucke, Germany; Free Univ Berlin, Benjamin Franklin Med Ctr, Dept Nut Endocrinol & Metab, D-1000 Berlin, Germany; Free Univ Berlin, Univ Clin Benjamin Franklin, Dept Epidemiol, D-1000 Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Spranger, J (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Clin Nutr, Arthur Scheunert Allee 114-116, D-14558 Bergholz Rehbrucke, Germany.	spranger@mail.dife.de	Pfeiffer, Andreas F.H./AAJ-2311-2020; Ristow, Michael/O-9858-2014	Pfeiffer, Andreas F.H./0000-0002-6887-0016; Ristow, Michael/0000-0003-2109-2453				Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; KUBOTA N, 2002, J BIOL CHEM, V24, P24; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746	5	837	885	0	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					226	228		10.1016/S0140-6736(03)12255-6	http://dx.doi.org/10.1016/S0140-6736(03)12255-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547549				2022-12-28	WOS:000180535400015
J	Kloner, RA; Rezkalla, SH				Kloner, RA; Rezkalla, SH			Cocaine and the heart.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Good Samaritan Hosp, Inst Heart, Los Angeles, CA 90017 USA; Univ So Calif, Keck Sch Med, Div Cardiovasc Med, Los Angeles, CA USA; Marshfield Clin Fdn Med Res & Educ, Dept Cardiol, Marshfield, WI 54449 USA	University of Southern California; Marshfield Clinic	Kloner, RA (corresponding author), Good Samaritan Hosp, Inst Heart, Los Angeles, CA 90017 USA.		Kloner, Robert A/B-2971-2012						0	49	52	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2003	348	6					487	488		10.1056/NEJMp020174	http://dx.doi.org/10.1056/NEJMp020174			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642JY	12571254				2022-12-28	WOS:000180801400001
J	Showstack, J; Lurie, N; Larson, EB; Rothman, AA; Hassmiller, S				Showstack, J; Lurie, N; Larson, EB; Rothman, AA; Hassmiller, S			Primary care: The next renaissance	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICINE	Three decades ago, a renaissance helped create the foundations of primary care as we know it today. In recent years, however, new challenges have confronted primary care. We believe that the current challenges can be overcome and may, in fact, present an opportunity for a new renaissance of primary care to address the needs of our population. In this paper, we suggest seven core principles and a set of actions that will support a renaissance in, and a positive future for, primary care. The seven principles are 1) Health care must be organized to serve the needs of patients; 2) the goal of primary care systems should be the delivery of the highest-quality care as documented by measurable outcomes; 3) information and information systems are the backbone of the primary care process; 4) current health care systems must be reconstructed; 5) the health care financing system must support excellent primary care practice; 6) primary care education must be revitalized, with an emphasis on new delivery models and training in sites that deliver excellent primary care; and 7) the value of primary care practice must be continually improved, documented, and communicated. At the start of the 21st century, a vital, patient-centered primary care system has much to offer a rapidly changing population with increasingly diverse needs and expectations. If we keep the needs of persons and patients clearly in sight and design systems to meet those needs, primary care will thrive and our patients will be well served.	Univ Calif San Francisco, San Francisco, CA 94118 USA	University of California System; University of California San Francisco	Showstack, J (corresponding author), Univ Calif San Francisco, 3333 Calif St,Suite 265, San Francisco, CA 94118 USA.		Showstack, Jonathan/L-6556-2013	Showstack, Jonathan/0000-0002-1367-419X				*AG HEALTHC RES QU, AHRQ SUPP CTR EXC NE; Agency for Healthcare Research and Quality, PRIM CAR PRACT BAS R; Gerteis M, 2002, PATIENTS EYES UNDERS; Institute of Medicine, 2001, CROSSING QUALITY CHA; Larson EB, 2001, ANN INTERN MED, V134, P997, DOI 10.7326/0003-4819-134-10-200105150-00013; Moore G, 2003, ANN INTERN MED, V138, P244, DOI 10.7326/0003-4819-138-3-200302040-00032; *NAT COMM QUAL ASS, HLTH PLAN EMPL DAT I; *NCI, DESCR CANC CTR PROGR; PEAR R, 2002, NY TIMES        0713, P1; Rothman AA, 2003, ANN INTERN MED, V138, P256, DOI 10.7326/0003-4819-138-3-200302040-00034; Safran DG, 2003, ANN INTERN MED, V138, P248, DOI 10.7326/0003-4819-138-3-200302040-00033; Sandy LG, 2003, ANN INTERN MED, V138, P262, DOI 10.7326/0003-4819-138-3-200302040-00035; SCHROEDER SA, 1978, MED CARE, V16, P289, DOI 10.1097/00005650-197804000-00002; SINGER AJ, 2001, MED INFORMATICS COMP, P663	14	27	30	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					268	272		10.7326/0003-4819-138-3-200302040-00036	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00036			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558378				2022-12-28	WOS:000181018600028
J	Colburn, KA; Johnson, PRS				Colburn, KA; Johnson, PRS			Air pollution concerns not changed by S-PLUS flaw	SCIENCE			English	Editorial Material									NESCAUM, Boston, MA 02114 USA		Johnson, PRS (corresponding author), NESCAUM, Boston, MA 02114 USA.	pjohnson@nescaum.org						[Anonymous], 2000, 94 HLTH EFF I; Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; DEVLIN RB, IN PRESS EUR RESP J; DOCKERY DW, 1993, NEW ENGL J MED, V329, P24; DOMINICI F, 2002, REPORT HLTH EFFECTS; Gold DR, 2000, CIRCULATION, V101, P1267, DOI 10.1161/01.CIR.101.11.1267; Health Effects Institute, 2001, AIRB PART HLTH HEI E; *HLTH EFF I, 2002, IMP NEW FIND NMMAPS; Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3; Katsouyanni K, 2001, EPIDEMIOLOGY, V12, P521, DOI 10.1097/00001648-200109000-00011; KATSOUYANNI K, 1997, BMJ-BRIT MED J, V314, P7095; Krewski D., 2000, REANALYSIS HARVARD 6; Peters A, 2000, EPIDEMIOLOGY, V11, P11, DOI 10.1097/00001648-200001000-00005; Peters A, 2002, LANCET, V360, P1184, DOI 10.1016/S0140-6736(02)11289-X; Peters A, 2001, CIRCULATION, V103, P2810; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; POPE CA, 1992, ARCH ENVIRON HEALTH, V47, P3; SAMOLI E, 2001, ENV HLTH PERSPECT, V109, P4; Schwartz J, 2001, EPIDEMIOLOGY, V12, P55, DOI 10.1097/00001648-200101000-00010; SCHWARTZ J, 2000, ENV HLTH PERSPECT, V108, P6; SCHWARTZ J, 1996, J AIR WASTE MANAGE, V46, P10; SCHWARTZ J, 2002, ENV HLTH PERSPECT, V110, P10; SCHWARTZ J, 2002, CLEAN AIR SCI ADV CO; SCHWARTZ J, 2002, REANALYSIS NMMAPS MO; Sunyer J, 2000, AM J EPIDEMIOL, V151, P50, DOI 10.1093/oxfordjournals.aje.a010121; Suwa T, 2002, J AM COLL CARDIOL, V39, P935, DOI 10.1016/S0735-1097(02)01715-1; *US EPA, 2002, CLEAN AIR SCI ADV CO, P175; Zanobetti A, 2002, EPIDEMIOLOGY, V13, P87, DOI 10.1097/00001648-200201000-00014; Zeger SL, 1999, EPIDEMIOLOGY, V10, P171, DOI 10.1097/00001648-199903000-00015; [No title captured]	30	15	15	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					665	666		10.1126/science.1082105	http://dx.doi.org/10.1126/science.1082105			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560535				2022-12-28	WOS:000180687700029
J	Breman, JG; Arita, I; Fenner, F				Breman, JG; Arita, I; Fenner, F			Preventing the return of smallpox	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Fogarty Int Ctr, Bethesda, MD 20892 USA; Agcy Cooperat Int Hlth, Kumamoto, Japan; Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Australian National University; John Curtin School of Medical Research	Breman, JG (corresponding author), Fogarty Int Ctr, Bldg 16,Rm 214,16 Ctr Dr, Bethesda, MD 20892 USA.							Alibek K, 1999, BIOHAZARD CHILLING T; Basu RN, 1979, ERADICATION SMALLPOX; BREMAN JG, 1980, NEW ENGL J MED, V303, P1263, DOI 10.1056/NEJM198011273032204; *CBW ARM ARMS LIM, 2003, CONV PROH DEV PROD S; Centers for Disease Control and Prevention, 2002, SMALLP RESP PLAN GUI; CONNOLLY C, 2002, WASHINGTON POST 1224, pA5; Connolly C, 2002, WASH POST, pA1; FOEGE WH, 1971, AM J EPIDEMIOL, V94, P311, DOI 10.1093/oxfordjournals.aje.a121325; Gellman B., 2002, WASHINGTON POST 0120, pA1; GELLMAN B, 2002, WASHINGTON POST 1104, pA4; Heymann D L, 2001, Lancet Infect Dis, V1, P345, DOI 10.1016/S1473-3099(01)00148-7; Jezek Z, 1988, HUMAN MONKEYPOX; Preston R., 2002, DEMON FREEZER TRUE S; *UN, 2002, BIOL WEAP CONV; WHO, 2002, WHOCDSCSRGAR20024, P6; *WHO, 2002, WHA5516 WHO; World Health Organisation, 2002, WHOCDSCSREPH200216; 2002, MONTEREY I INT STUDI	18	15	19	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					463	466		10.1056/NEJMp025175	http://dx.doi.org/10.1056/NEJMp025175			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12556549	Bronze			2022-12-28	WOS:000180643800015
J	Meisel, C; Kopke, K; Roots, I				Meisel, C; Kopke, K; Roots, I			Polymorphisms of adrenergic receptors and the risk of heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							GENE		Humboldt Univ, D-10098 Berlin, Germany	Humboldt University of Berlin	Meisel, C (corresponding author), Humboldt Univ, D-10098 Berlin, Germany.			Liggett, Stephen B./0000-0002-0128-3669				Borjesson M, 2000, EUR HEART J, V21, P1853, DOI 10.1053/euhj.1999.1994; Jones A, 2002, EUR HEART J, V23, P1071, DOI 10.1053/euhj.2001.3150; Levin MC, 2002, J BIOL CHEM, V277, P30429, DOI 10.1074/jbc.M200681200; Podlowski S, 2000, J MOL MED-JMM, V78, P87, DOI 10.1007/s001090000080; Ranade K, 2002, AM J HUM GENET, V70, P935, DOI 10.1086/339621; Small KM, 2002, NEW ENGL J MED, V347, P1135, DOI 10.1056/NEJMoa020803	6	3	5	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					468	469						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12556550				2022-12-28	WOS:000180643800018
J	Pal, C; Papp, B; Hurst, LD				Pal, C; Papp, B; Hurst, LD			Rate of evolution and gene dispensability	NATURE			English	Article							YEAST; GENOME		Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Eotvos Lorand Univ, Dept Plant Taxon & Ecol, H-1117 Budapest, Hungary	University of Bath; Eotvos Lorand University	Pal, C (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	l.d.hurst@bath.ac.uk	Hurst, Laurence/F-9215-2010	Hurst, Laurence/0000-0002-1002-1054; Papp, Balazs/0000-0003-3093-8852				Coghlan A, 2000, YEAST, V16, P1131, DOI 10.1002/1097-0061(20000915)16:12<1131::AID-YEA609>3.0.CO;2-F; Fielden J.D.G., 1993, J PHYSIOL-LONDON, V91, DOI [10.1113/JPHYSIOL.1993.SP019851, DOI 10.1113/JPHYSIOL.1993.SP019851]; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hurst LD, 1999, CURR BIOL, V9, P747, DOI 10.1016/S0960-9822(99)80334-0; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Pal C, 2001, GENETICS, V158, P927; Pal C, 2001, MOL BIOL EVOL, V18, P2323, DOI 10.1093/oxfordjournals.molbev.a003779; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	12	124	127	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					496	497		10.1038/421496b	http://dx.doi.org/10.1038/421496b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556881				2022-12-28	WOS:000180670600033
J	Pantelis, C; Velakoulis, D; McGorry, PD; Wood, SJ; Suckling, J; Phillips, LJ; Yung, AR; Bullmore, ET; Brewer, W; Soulsby, B; Desmond, P; McGuire, PK				Pantelis, C; Velakoulis, D; McGorry, PD; Wood, SJ; Suckling, J; Phillips, LJ; Yung, AR; Bullmore, ET; Brewer, W; Soulsby, B; Desmond, P; McGuire, PK			Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison	LANCET			English	Article							HIPPOCAMPAL VOLUME; FUNCTIONAL-PSYCHOSIS; MATTER CHANGES; SCHIZOPHRENIA; BRAIN; DISORDER; RISK; ENLARGEMENT; ILLNESS; ATLAS	Background Psychotic disorders, such as schizophrenia, are associated with neuroanatomical abnormalities, but whether these predate the onset of symptoms or develop progressively over the course of illness is unclear. We investigated this issue with MRI to study people with prodromal symptoms who are at ultra high-risk for the development of psychosis. Methods We did two comparisons, cross-sectional and longitudinal. For the cross-sectional comparison, 75 people with prodromal signs of psychosis were scanned with MRI. After at least 12 months of follow-up, 23 (31%) had developed psychosis and 52 (69%) had not. Baseline MRI data from these two subgroups were compared. For the longitudinal comparison, 21 of the ultra high-risk individuals were scanned again with MRI after at least 12 months. Ten of these had developed psychosis and 11 had not. MRI data from baseline and follow-up were compared within each group of people. Findings In the cross-sectional comparison, compared with people who did not develop psychosis, those who did develop the disorder had less grey matter in the right medial temporal, lateral temporal, and inferior frontal cortex, and in the cingulate cortex bilaterally. In the longitudinal comparison, when re-scanned, individuals who had developed psychosis showed a reduction in grey matter in the left parahippocampal, fusiform, orbitofrontal and cerebellar cortices, and the cingulate gyri. In those who had not become psychotic, longitudinal changes were restricted to the cerebellum. Interpretation Some of the grey-matter abnormalities associated with psychotic disorders predate the onset of frank symptoms, whereas others appear in association with their first expression.	Univ Melbourne, Dept Psychiat, Mental Hlth Programme, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia; Univ Melbourne, Cognit Neuropsychiat Res & Acad Unit, Melbourne, Vic, Australia; Sunshine Hosp, Melbourne, Vic, Australia; Mental Hlth Res Inst Victoria, Appl Schizophrenia Div, Melbourne, Vic, Australia; Univ Melbourne, Personal Assessment & Crisis Evaluat Clin, Early Psychosis Prevent & Intervent Ctr, Melbourne, Vic, Australia; Univ Melbourne, Dept Radiol, Melbourne, Vic, Australia; Royal Melbourne Hosp, Melbourne, Vic, Australia; Guys Kings & St Thomas Med Sch, Clin Age Res Unit, London, England; Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Cambridge CB2 1TN, England; Inst Psychiat, Sect Neuroimaging, London, England; S London & Maudsley NHS Trust, Outreach & Support S London, London, England	University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; University of London; King's College London; University of Cambridge; University of London; King's College London; South London & Maudsley NHS Trust	Pantelis, C (corresponding author), Sunshine Hosp, Cognit Neuropsychiat Res & Acad Unit, POB 294, St Albans, Vic 3021, Australia.	cpant@unimelb.edu.au	Yung, Alison/N-6729-2019; Wood, Stephen/ABF-4086-2020; Suckling, John/ABD-7246-2021; Bullmore, Ed/C-1706-2012; Wood, Stephen J/M-8652-2014; Velakoulis, Dennis/A-4778-2008; McGorry, Patrick/O-4115-2019; Pantelis, Christos/H-7722-2014; Desmond, Patricia/D-1966-2014	Yung, Alison/0000-0002-0401-9791; Wood, Stephen/0000-0003-4186-5919; Suckling, John/0000-0002-5098-1527; Bullmore, Ed/0000-0002-8955-8283; Wood, Stephen J/0000-0003-4186-5919; Velakoulis, Dennis/0000-0002-8842-8479; Pantelis, Christos/0000-0002-9565-0238; McGuire, Philip/0000-0003-4381-0532; Phillips, Lisa/0000-0003-1060-6068; Desmond, Patricia/0000-0002-4803-6323; McGorry, Patrick/0000-0002-3789-6168				AASLY J, 1993, ACTA NEUROL SCAND, V87, P210; Altshuler LL, 2000, BIOL PSYCHIAT, V48, P147, DOI 10.1016/S0006-3223(00)00836-2; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Cannon TD, 2001, NEUROIMAGE, V13, pS1034; Cardno AG, 2002, AM J PSYCHIAT, V159, P539, DOI 10.1176/appi.ajp.159.4.539; Crespo-Facorro B, 1999, AM J PSYCHIAT, V156, P386; CROW TJ, 1990, ACTA PSYCHIAT SCAND, V81, P401, DOI 10.1111/j.1600-0447.1990.tb05471.x; Dickey CC, 1999, BIOL PSYCHIAT, V45, P1393, DOI 10.1016/S0006-3223(99)00030-X; ELKIS H, 1995, ARCH GEN PSYCHIAT, V52, P735; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; JOHNSTONE EC, 1992, PSYCHOL MED, V22, P331, DOI 10.1017/S0033291700030270; KESHAVAN MS, 1994, LANCET, V344, P1434, DOI 10.1016/S0140-6736(94)90599-1; Lawrie SM, 1999, LANCET, V353, P30, DOI 10.1016/S0140-6736(98)06244-8; McGorry PD, 2002, ARCH GEN PSYCHIAT, V59, P921, DOI 10.1001/archpsyc.59.10.921; MCGORRY PD, 1990, SCHIZOPHR RES, V3, P221, DOI 10.1016/0920-9964(90)90002-O; PANTELIS C, 2001, COGNITIVE DEFICITS B, P217; Phillips LJ, 2002, SCHIZOPHR RES, V58, P145, DOI 10.1016/S0920-9964(01)00392-9; Rapoport JL, 1999, ARCH GEN PSYCHIAT, V56, P649, DOI 10.1001/archpsyc.56.7.649; Roy PD, 1998, BIOL PSYCHIAT, V44, P418, DOI 10.1016/S0006-3223(98)00105-X; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Sigmundsson T, 2001, AM J PSYCHIAT, V158, P234, DOI 10.1176/appi.ajp.158.2.234; Suckling J, 1999, MAGN RESON IMAGING, V17, P1065, DOI 10.1016/S0730-725X(99)00055-7; Talairach J., 1988, COPLANAR STEREOTAXIC; van Os J, 1999, SEARCH FOR THE CAUSES OF SCHIZOPHRENIA, VOL IV, P59; Velakoulis D, 1999, ARCH GEN PSYCHIAT, V56, P133, DOI 10.1001/archpsyc.56.2.133; Videbech P, 1997, ACTA PSYCHIAT SCAND, V96, P157, DOI 10.1111/j.1600-0447.1997.tb10146.x; Weinberger DR, 2002, ARCH GEN PSYCHIAT, V59, P553, DOI 10.1001/archpsyc.59.6.553; Wood SJ, 2001, SCHIZOPHR RES, V52, P37, DOI 10.1016/S0920-9964(01)00175-X; Wright IC, 1999, SCHIZOPHR RES, V35, P1, DOI 10.1016/S0920-9964(98)00094-2; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; WYATT RJ, 1995, BIOL PSYCHIAT, V38, P1, DOI 10.1016/0006-3223(95)00191-I; Yung AR, 1998, BRIT J PSYCHIAT, V172, P14, DOI 10.1192/S0007125000297602	32	978	994	1	79	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2003	361	9354					281	288		10.1016/S0140-6736(03)12323-9	http://dx.doi.org/10.1016/S0140-6736(03)12323-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559861	Green Submitted			2022-12-28	WOS:000180643900008
J	Sundareshwar, PV; Morris, JT; Koepfler, EK; Fornwalt, B				Sundareshwar, PV; Morris, JT; Koepfler, EK; Fornwalt, B			Phosphorus limitation of coastal ecosystem processes	SCIENCE			English	Article							NITROGEN-FIXATION; SPARTINA-ALTERNIFLORA; BACTERIA; GROWTH; BACTERIOPLANKTON	Primary production in coastal wetlands is conventionally thought to be limited by nitrogen. Although the plant community in a pristine salt marsh was found to be limited primarily by nitrogen availability, the bacterial community in the soil was limited by phosphorus. Hence, in coastal wetlands, and possibly in many ecosystems, individual trophic groups may respond differently to nitrogen and phosphorus loading. Phosphorus limitation of the growth of nitrogen-transforming bacteria will affect carbon fixation, storage, and release mediated by plants, a result that has important implications for ecosystem management.	Duke Univ, Wetland Ctr, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; Univ S Carolina, Marine Sci Program, Columbia, SC 29208 USA; Coastal Carolina Univ, Dept Marine Sci, Conway, SC 29526 USA	Duke University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Coastal Carolina University	Sundareshwar, PV (corresponding author), Duke Univ, Wetland Ctr, Nicholas Sch Environm & Earth Sci, Box 90333, Durham, NC 27708 USA.	pvs@duke.edu	morris, james/ABC-8111-2020; morris, james t/A-7003-2009					Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Bonin P, 2002, WATER RES, V36, P722, DOI 10.1016/S0043-1354(01)00269-X; BOYLE CD, 1981, NEW PHYTOL, V89, P275, DOI 10.1111/j.1469-8137.1981.tb07488.x; BROOME SW, 1975, SOIL SCI SOC AM J, V39, P301, DOI 10.2136/sssaj1975.03615995003900020022x; Cleveland CC, 2002, ECOSYSTEMS, V5, P680, DOI 10.1007/s10021-002-0202-9; Cotner JB, 1997, AQUAT MICROB ECOL, V13, P141, DOI 10.3354/ame013141; CREWS TE, 1993, BIOGEOCHEMISTRY, V21, P141, DOI 10.1007/BF00001115; deSouza MP, 1997, ESTUAR COAST SHELF S, V45, P547, DOI 10.1006/ecss.1996.0221; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; FINDLAY SEG, 1984, J MICROBIOL METH, V2, P57, DOI 10.1016/0167-7012(84)90031-9; GALLARDO A, 1994, SOIL BIOL BIOCHEM, V26, P1409, DOI 10.1016/0038-0717(94)90225-9; GOREAU TJ, 1980, APPL ENVIRON MICROB, V40, P526, DOI 10.1128/AEM.40.3.526-532.1980; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; JANSSON M, 1988, HYDROBIOLOGIA, V170, P157, DOI 10.1007/BF00024903; KROER N, 1993, LIMNOL OCEANOGR, V38, P1282, DOI 10.4319/lo.1993.38.6.1282; Loreau M, 1998, P ROY SOC B-BIOL SCI, V265, P33, DOI 10.1098/rspb.1998.0260; Mallin MA, 2000, AM SCI, V88, P26, DOI 10.1511/2000.15.762; MORRIS JT, 1990, ECOLOGY, V71, P2209, DOI 10.2307/1938633; Morris JT, 1999, LIMNOL OCEANOGR, V44, P699, DOI 10.4319/lo.1999.44.3.0699; NOWICKI BL, 1994, ESTUAR COAST SHELF S, V38, P137, DOI 10.1006/ecss.1994.1009; OVIATT C, 1995, MAR ECOL PROG SER, V116, P171, DOI 10.3354/meps116171; POMEROY LR, 1995, MAR ECOL PROG SER, V117, P259, DOI 10.3354/meps117259; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; SEITZINGER SP, 1983, SCIENCE, V222, P1244, DOI 10.1126/science.222.4629.1244; SMITH VH, 1992, BIOGEOCHEMISTRY, V18, P19, DOI 10.1007/BF00000424; Ulanowicz RE, 1999, J MARINE SYST, V19, P159, DOI 10.1016/S0924-7963(98)90017-3; VALIELA I, 1974, ECOLOGY HALOPHYTES, P547, DOI DOI 10.1016/B978-0-12-586450-3.50025-1; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Welsh DT, 2000, ECOL LETT, V3, P58, DOI 10.1046/j.1461-0248.2000.00111.x; WHEELER PA, 1986, LIMNOL OCEANOGR, V31, P998, DOI 10.4319/lo.1986.31.5.0998	30	273	301	14	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					563	565		10.1126/science.1079100	http://dx.doi.org/10.1126/science.1079100			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543975				2022-12-28	WOS:000180559800049
J	Butler, D				Butler, D			Mozambique prime minister tipped for global health post	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					302	302		10.1038/421302a	http://dx.doi.org/10.1038/421302a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540861	Bronze			2022-12-28	WOS:000180533000006
J	Martin, SG; St Johnston, D				Martin, SG; St Johnston, D			A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; TUMOR-SUPPRESSOR; RNA LOCALIZATION; PAR-1; LKB1/STK11; HOMOLOG; ENCODES; MOSAICS; PKA	The PAR-4 and PAR-1 kinases are necessary for the formation of the anterior-posterior (A-P) axis in Caenorhabditis elegans(1-3). PAR-1 is also required for A-P axis determination in Drosophila(4,5). Here we show that the Drosophila par-4 homologue, lkb1, is required for the early A-P polarity of the oocyte, and for the repolarization of the oocyte cytoskeleton that defines the embryonic A-P axis. LKB1 is phosphorylated by PAR-1 in vitro, and overexpression of LKB1 partially rescues the par-1 phenotype. These two kinases therefore function in a conserved pathway for axis formation in flies and worms. lkb1 mutant clones also disrupt apical-basal epithelial polarity, suggesting a general role in cell polarization. The human homologue, LKB1, is mutated in Peutz-Jeghers syndrome(6,7) and is regulated by prenylation and by phosphorylation by protein kinase A(8,9). We show that protein kinase A phosphorylates Drosophila LKB1 on a conserved site that is important for its activity. Thus, Drosophila and human LKB1 may be functional homologues, suggesting that loss of cell polarity may contribute to tumour formation in individuals with Peutz-Jeghers syndrome.	Univ Cambridge, Wellcome Trust Canc Res UK Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge	St Johnston, D (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	ds139@mole.bio.cam.ac.uk	Martin, Sophie/AAE-3198-2019; St Johnston, Daniel/C-9568-2009	Martin, Sophie/0000-0002-5317-2557; St Johnston, Daniel/0000-0001-5582-3301				Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Chou TB, 1996, GENETICS, V144, P1673; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Collins SP, 2000, BIOCHEM J, V345, P673, DOI 10.1042/0264-6021:3450673; Cox DN, 2001, CURR BIOL, V11, P75, DOI 10.1016/S0960-9822(01)00027-6; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hemminki A, 1999, CELL MOL LIFE SCI, V55, P735, DOI 10.1007/s000180050329; Huynh JR, 2001, DEVELOPMENT, V128, P1201; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; LANE ME, 1994, GENE DEV, V8, P2986, DOI 10.1101/gad.8.24.2986; Martin J, 2001, J TURBUL, V2, P1; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Spradling Allan C., 1993, P1; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; THEURKAUF WE, 1994, METHOD CELL BIOL, V44, P489, DOI 10.1016/S0091-679X(08)60928-0; Tomancak P, 2000, NAT CELL BIOL, V2, P458, DOI 10.1038/35017101; van Eeden F, 1999, CURR OPIN GENET DEV, V9, P396, DOI 10.1016/S0959-437X(99)80060-4; Watts JL, 2000, DEVELOPMENT, V127, P1467; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; XU T, 1993, DEVELOPMENT, V117, P1223; Yoo LI, 2002, NAT REV CANCER, V2, P529, DOI 10.1038/nrc843	30	239	248	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					379	384		10.1038/nature01296	http://dx.doi.org/10.1038/nature01296			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540903				2022-12-28	WOS:000180533000044
J	Timms, JM; Bell, A; Flavell, JR; Murray, PG; Rickinson, AB; Traverse-Glehen, A; Berger, F; Delecluse, HJ				Timms, JM; Bell, A; Flavell, JR; Murray, PG; Rickinson, AB; Traverse-Glehen, A; Berger, F; Delecluse, HJ			Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma	LANCET			English	Article							REED-STERNBERG CELLS; INFECTED B-CELLS; V-H GENES; SOMATIC HYPERMUTATION; IN-VIVO; EXPRESSION; DISORDERS; HETEROGENEITY; STRATEGIES; MUTATIONS	Background Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disease (PTLD) encompasses a histologically broad range of lesions, arising from the expanded pool of EBV-infected B cells in the immunocompromised host. Identification of the precise cellular origin of these tumours could clarify their pathogenesis. Methods Of 13 cases of EBV-positive cases of PTLD characterised by histological analysis, pattern of EBV gene expression, and clinical course, 11 had monoclonal or biclonal lesions in which we determined the progenitor B cell by immunoglobulin heavy chain (IgH) genotyping. Results Two tumours had a naive B cell genotype and two showed patterns of IgH somatic mutation typical of antigen-selected (post-germinal-centre) memory cells. All four arose early post-transplant and expressed the markers of EBV transformation-Epstein-Barr nuclear antigen (EBNA) 2 and latent membrane protein (LMP) 1. However, seven tumours, either of early or late onset and including some with downregulated EBNA 2 and LMP 1, arose from post-germinal cells with randomly mutated or sterile IgH genotypes usually incompatible with B-cell survival in vivo. Interpretation PTLD can arise from a broad range of target B cells and not only from the pool of antigen-selected memory cells that EBV generally colonises in immunocompetent individuals. Tumour development seems frequently associated with the EBV-induced rescue and expansion of B cells that have failed the physiological process of germinal centre selection into memory. This finding shows an unexpected connection between pathogenesis of PTLD and that of EBV-positive Hodgkin's lymphoma, another B-cell malignancy of atypical post-germinal-centre cell origin.	Univ Birmingham, Dept Pathol, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; Ctr Hosp Lyon Sud, Serv Anat Pathol, F-69310 Pierre Benite, France	University of Birmingham; Cancer Research UK; University of Birmingham; CHU Lyon	Delecluse, HJ (corresponding author), Univ Birmingham, Dept Pathol, Birmingham B15 2TT, W Midlands, England.	H.Delecluse@bham.ac.uk		Bell, Andrew/0000-0001-9520-4417; Delecluse, Henri-Jacques/0000-0002-1744-6274				AB RICKINSON, 2001, FIELDS VIROLOGY, P2575; AUBIN J, 1995, LEUKEMIA, V9, P471; Babcock GJ, 2000, IMMUNITY, V13, P497, DOI 10.1016/S1074-7613(00)00049-2; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Bierman PJ, 1996, ANN ONCOL, V7, P265; Brauninger A, 2001, J EXP MED, V194, P927, DOI 10.1084/jem.194.7.927; Cesarman E, 1998, BLOOD, V92, P2294, DOI 10.1182/blood.V92.7.2294.2294_2294_2302; CHAPMAN CJ, 1995, BLOOD, V85, P2176, DOI 10.1182/blood.V85.8.2176.bloodjournal8582176; DELECLUSE HJ, 1995, AM J PATHOL, V146, P1113; Garnier JL, 1996, TRANSPLANTATION, V61, P71, DOI 10.1097/00007890-199601150-00015; HANTO DW, 1989, TRANSPLANTATION, V47, P458, DOI 10.1097/00007890-198903000-00012; HERBST H, 1991, P NATL ACAD SCI USA, V88, P4766, DOI 10.1073/pnas.88.11.4766; Kanzler H, 1996, J EXP MED, V184, P1495, DOI 10.1084/jem.184.4.1495; Klein U, 1998, IMMUNOL REV, V162, P261; Kuppers R, 1998, ANNU REV IMMUNOL, V16, P471, DOI 10.1146/annurev.immunol.16.1.471; KUPPERS R, 1994, P NATL ACAD SCI USA, V91, P10962, DOI 10.1073/pnas.91.23.10962; Kurth J, 2000, IMMUNITY, V13, P485, DOI 10.1016/S1074-7613(00)00048-0; LEVY S, 1988, J EXP MED, V168, P475, DOI 10.1084/jem.168.2.475; Lossos IS, 2000, J IMMUNOL, V165, P5122, DOI 10.4049/jimmunol.165.9.5122; NALESNIK MA, 1993, CANCER-AM CANCER SOC, V72, P2568, DOI 10.1002/1097-0142(19931101)72:9<2568::AID-CNCR2820720910>3.0.CO;2-D; PALLESEN G, 1991, LANCET, V337, P320, DOI 10.1016/0140-6736(91)90943-J; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rowlings PA, 1999, J CLIN ONCOL, V17, P3122, DOI 10.1200/JCO.1999.17.10.3122; STARZL TE, 1984, LANCET, V1, P583; TAMARU J, 1995, AM J PATHOL, V147, P1398; THOMAS JA, 1990, TRANSPLANTATION, V49, P944, DOI 10.1097/00007890-199005000-00022; World Health Organization, 2001, PATH GEN TUM HAEM LY; YOUNG L, 1989, NEW ENGL J MED, V321, P1080, DOI 10.1056/NEJM198910193211604	29	119	120	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2003	361	9353					217	223		10.1016/S0140-6736(03)12271-4	http://dx.doi.org/10.1016/S0140-6736(03)12271-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547545				2022-12-28	WOS:000180535400011
J	Davies, CR; Kaye, P; Croft, SL; Sundar, S				Davies, CR; Kaye, P; Croft, SL; Sundar, S			Leishmaniasis: new approaches to disease control	BRITISH MEDICAL JOURNAL			English	Review							INDIAN VISCERAL LEISHMANIASIS; RANDOMIZED CONTROLLED TRIAL; CUTANEOUS LEISHMANIASIS; KALA-AZAR; SODIUM STIBOGLUCONATE; DOUBLE-BLIND; LUTZOMYIA-LONGIPALPIS; IMPREGNATED BEDNETS; LAMBDA-CYHALOTHRIN; AGGLUTINATION-TEST		Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Univ London London Sch Hyg & Trop Med, Dis Control & Vector Biol Unit, London WC1E 7HT, England; Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Banaras Hindu University (BHU)	Davies, CR (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.		Singh, Sarman/AAR-8914-2020	Singh, Sarman/0000-0002-0749-9647; Kaye, Paul/0000-0002-8796-4755				ALEXANDER B, 1995, MED VET ENTOMOL, V9, P279, DOI 10.1111/j.1365-2915.1995.tb00134.x; Alrajhi AA, 2002, NEW ENGL J MED, V346, P891, DOI 10.1056/NEJMoa011882; Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298; Arana BA, 2001, AM J TROP MED HYG, V65, P466, DOI 10.4269/ajtmh.2001.65.466; Arevalo I, 2001, CLIN INFECT DIS, V33, P1847, DOI 10.1086/324161; Ashford DA, 1998, AM J TROP MED HYG, V59, P53, DOI 10.4269/ajtmh.1998.59.53; Attar ZJ, 2001, ACTA TROP, V78, P11, DOI 10.1016/S0001-706X(00)00155-8; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Berman JD, 1996, CLIN DERMATOL, V14, P519, DOI 10.1016/0738-081X(96)00048-X; Bern C, 2000, AM J TROP MED HYG, V63, P184, DOI 10.4269/ajtmh.2000.63.184; Braga M D, 1998, Rev Soc Bras Med Trop, V31, P419, DOI 10.1590/S0037-86821998000500001; Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312; da Silva VO, 2000, VACCINE, V19, P1082, DOI 10.1016/S0264-410X(00)00339-X; David JR, 2001, MEM I OSWALDO CRUZ, V96, P839, DOI 10.1590/S0074-02762001000600018; Davies CR, 2000, T ROY SOC TROP MED H, V94, P631, DOI 10.1016/S0035-9203(00)90214-1; DAVIES CR, 1994, T ROY SOC TROP MED H, V88, P389, DOI 10.1016/0035-9203(94)90395-6; de la Rosa R, 2002, J CLIN MICROBIOL, V40, P762, DOI 10.1128/JCM.40.3.762-767.2002; Desjeux P, 2001, Med Trop (Mars), V61, P187; Dietze R, 2001, AM J TROP MED HYG, V65, P685, DOI 10.4269/ajtmh.2001.65.685; Elnaiem DA, 1999, MED VET ENTOMOL, V13, P310, DOI 10.1046/j.1365-2915.1999.00191.x; ELON J, 1992, J AM ACAD DERMATOL, V27, P227, DOI 10.1016/0190-9622(92)70175-F; Gavgani ASM, 2002, LANCET, V360, P374, DOI 10.1016/S0140-6736(02)09609-5; Gomes A.C., 1998, REV SOC BRAS MED TRO, V31, P553, DOI [10.1590/S0037-86821998000600008, DOI 10.1590/S0037-86821998000600008]; Gonzalo RM, 2002, VACCINE, V20, P1226, DOI 10.1016/S0264-410X(01)00427-3; Gradoni L, 2001, VET PARASITOL, V100, P87, DOI 10.1016/S0304-4017(01)00486-1; GUAN J, 1995, J VAC SCI TECHNOL A, V13, P1; Handman E, 2001, CLIN MICROBIOL REV, V14, P229, DOI 10.1128/CMR.14.2.229-243.2001; Jelinek T, 1999, EUR J CLIN MICROBIOL, V18, P669, DOI 10.1007/s100960050371; Jha TK, 1999, NEW ENGL J MED, V341, P1795, DOI 10.1056/NEJM199912093412403; Jha TK, 1998, BRIT MED J, V316, P1200, DOI 10.1136/bmj.316.7139.1200; Kelly DW, 1997, MED VET ENTOMOL, V11, P13, DOI 10.1111/j.1365-2915.1997.tb00285.x; Khalil EAG, 2000, LANCET, V356, P1565, DOI 10.1016/S0140-6736(00)03128-7; Kroeger A, 2002, BMJ-BRIT MED J, V325, P810, DOI 10.1136/bmj.325.7368.810; Lira R, 1999, J INFECT DIS, V180, P564, DOI 10.1086/314896; Maroli M, 2001, MED VET ENTOMOL, V15, P358, DOI 10.1046/j.0269-283x.2001.00321.x; Martin-Sanchez J, 2001, PARASITOLOGY, V122, P607, DOI 10.1017/S0031182001007909; Melby PC, 2001, INFECT IMMUN, V69, P4719, DOI 10.1128/IAI.69.8.4719-4725.2001; MISHRA M, 1994, LANCET, V344, P1599, DOI 10.1016/S0140-6736(94)90406-5; NADIM A, 1995, WHOLEISH9537; NAVIN TR, 1992, J INFECT DIS, V165, P528, DOI 10.1093/infdis/165.3.528; Reed SG, 2001, J EXP MED, V194, pF7, DOI 10.1084/jem.194.3.F7; Reithinger R, 2002, J CLIN MICROBIOL, V40, P2352, DOI 10.1128/JCM.40.7.2352-2356.2002; Reithinger R, 2001, EMERG INFECT DIS, V7, P872; Reyburn H, 2000, T ROY SOC TROP MED H, V94, P361, DOI 10.1016/S0035-9203(00)90104-4; Rhee EG, 2002, J EXP MED, V195, P1565, DOI 10.1084/jem.20020147; Sharifi I, 1998, LANCET, V351, P1540, DOI 10.1016/S0140-6736(98)09552-X; Soto J, 2001, Clin Infect Dis, V33, pE57, DOI 10.1086/322689; Soto JM, 2002, AM J TROP MED HYG, V66, P147, DOI 10.4269/ajtmh.2002.66.147; Sundar S, 1998, LANCET, V351, P563, DOI 10.1016/S0140-6736(97)04350-X; Sundar S, 1998, LANCET, V352, P1821, DOI 10.1016/S0140-6736(98)04367-0; Sundar S, 2001, BRIT MED J, V323, P419, DOI 10.1136/bmj.323.7310.419; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Tayeh A, 1997, WHOLEISH9741; Valenzuela JG, 2001, J EXP MED, V194, P331, DOI 10.1084/jem.194.3.331; *WHO, 2002, 1927 WHO; ZIJLSTRA EE, 1992, T ROY SOC TROP MED H, V86, P505, DOI 10.1016/0035-9203(92)90086-R; Zijlstra EE, 2001, TROP MED INT HEALTH, V6, P108, DOI 10.1046/j.1365-3156.2001.00680.x	58	184	203	0	22	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2003	326	7385					377	382		10.1136/bmj.326.7385.377	http://dx.doi.org/10.1136/bmj.326.7385.377			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648RZ	12586674	Green Published, Green Accepted			2022-12-28	WOS:000181165500024
J	August, P				August, P			Initial treatment of hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REDUCED DIETARY-SODIUM; BLOOD-PRESSURE; ANTIHYPERTENSIVE THERAPIES; SYSTOLIC HYPERTENSION; CALCIUM-ANTAGONISTS; RANDOMIZED-TRIAL; DRUG-TREATMENT; REDUCTION; OUTCOMES; METAANALYSIS		Cornell Univ, Weill Med Coll, New York, NY 10021 USA; New York Hosp Med Ctr Queens, Lang Res Ctr, New York, NY USA	Cornell University; NewYork-Presbyterian Hospital	August, P (corresponding author), Cornell Univ, Weill Med Coll, New York, NY 10021 USA.							ALDERMAN MH, 1995, HYPERTENSION, V25, P1144, DOI 10.1161/01.HYP.25.6.1144; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Appel LJ, 2001, ARCH INTERN MED, V161, P685, DOI 10.1001/archinte.161.5.685; Black HR, 1998, ARCH INTERN MED, V158, P573; Burt VL, 1996, HYPERTENSION, V27, P1192; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Chalmers J, 1999, J HYPERTENS, V17, P151; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Cutler JA, 1997, AM J CLIN NUTR, V65, P643, DOI 10.1093/ajcn/65.2.643S; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; De Giorgio L, 2000, NEW ENGL J MED, V342, P1376; DUSTAN HP, 1958, CIRCULATION, V18, P644, DOI 10.1161/01.CIR.18.4.644; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Furberg CD, 1996, CARDIOVASC DRUG THER, V10, P463, DOI 10.1007/BF00051111; Grimm RH, 1997, ARCH INTERN MED, V157, P638, DOI 10.1001/archinte.157.6.638; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HOES AW, 1995, J HYPERTENS, V13, P805; Hostetter TH, 2001, NEW ENGL J MED, V345, P910, DOI 10.1056/NEJM200109203451209; JACKSON R, 1993, BRIT MED J, V307, P107, DOI 10.1136/bmj.307.6896.107; KANNEL WB, 1992, EUR HEART J, V13, P34, DOI 10.1093/eurheartj/13.suppl_G.34; Kumanyika SK, 1997, J AM COLL NUTR, V16, P192, DOI 10.1080/07315724.1997.10718674; LEWIS EJ, 1994, NEW ENGL J MED, V330, P152; MANN SJ, 1995, HYPERTENSION PATHOPH, V2, P2531; MATERSON BJ, 1993, NEW ENGL J MED, V328, P914, DOI 10.1056/NEJM199304013281303; MATERSON BJ, 1994, NEW ENGL J MED, V330, P1689, DOI 10.1056/NEJM199406093302316; Midgley JP, 1996, JAMA-J AM MED ASSOC, V275, P1590, DOI 10.1001/jama.275.20.1590; Neal B, 2000, LANCET, V356, P1955; NEATON JD, 1993, JAMA-J AM MED ASSOC, V270, P713, DOI 10.1001/jama.270.6.713; Neutel Joel M., 1999, J Clin Hypertens (Greenwich), V1, P79; Pahor M, 2000, LANCET, V356, P1949, DOI 10.1016/S0140-6736(00)03306-7; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Pickering T, 1996, AM J HYPERTENS, V9, P1, DOI 10.1016/0895-7061(95)00341-X; PRISANT LM, 1995, AM HEART J, V130, P359, DOI 10.1016/0002-8703(95)90454-9; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; SAUNDERS E, 1990, ARCH INTERN MED, V150, P1707, DOI 10.1001/archinte.150.8.1707; Staessen JA, 2000, LANCET, V355, P865, DOI 10.1016/S0140-6736(99)07330-4; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; Staessen JA, 2002, LANCET, V359, P360; STAESSEN JA, 2001, LANCET, V357, P724; STAMLER J, 1991, HYPERTENSION, V18, P95, DOI 10.1161/01.HYP.18.3_Suppl.I95; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; UK Prospect Diabet Study Grp, 1999, BMJ-BRIT MED J, V318, P29; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Yusuf S, 2000, NEW ENGL J MED, V342, P145	53	63	70	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2003	348	7					610	617		10.1056/NEJMcp010357	http://dx.doi.org/10.1056/NEJMcp010357			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644HY	12584370				2022-12-28	WOS:000180912900007
J	Hill, JM; Zalos, G; Halcox, JPJ; Schenke, WH; Waclawiw, MA; Quyyumi, AA; Finkel, T				Hill, JM; Zalos, G; Halcox, JPJ; Schenke, WH; Waclawiw, MA; Quyyumi, AA; Finkel, T			Circulating endothelial progenitor cells, vascular function, and cardiovascular risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY DISEASE; POSTNATAL NEOVASCULARIZATION; ATHEROSCLEROSIS; DYSFUNCTION; INCREASE; THERAPY; BLOOD; VIVO	BACKGROUND: Cardiovascular risk factors contribute to atherogenesis by inducing endothelial-cell injury and dysfunction. We hypothesized that endothelial progenitor cells derived from bone marrow have a role in ongoing endothelial repair and that impaired mobilization or depletion of these cells contributes to endothelial dysfunction and cardiovascular disease progression. METHODS: We measured the number of colony-forming units of endothelial progenitor cells in peripheral-blood samples from 45 men (mean [+/-SE] age, 50+/-2 years). The subjects had various degrees of cardiovascular risk but no history of cardiovascular disease. Endothelium-dependent and endothelium-independent function was assessed by high-resolution ultrasonography of the brachial artery. RESULTS: We observed a strong correlation between the number of circulating endothelial progenitor cells and the subjects' combined Framingham risk factor score (r=-0.47, P=0.001). Measurement of flow-mediated brachial-artery reactivity also revealed a significant relation between endothelial function and the number of progenitor cells (r=0.59, P<0.001). Indeed, the levels of circulating endothelial progenitor cells were a better predictor of vascular reactivity than was the presence or absence of conventional risk factors. In addition, endothelial progenitor cells from subjects at high risk for cardiovascular events had higher rates of in vitro senescence than cells from subjects at low risk. CONCLUSIONS: In healthy men, levels of endothelial progenitor cells may be a surrogate biologic marker for vascular function and cumulative cardiovascular risk. These findings suggest that endothelial injury in the absence of sufficient circulating progenitor cells may affect the progression of cardiovascular disease.	NHLBI, Cardiovasc Branch, NIH, Bethesda, MD 20892 USA; NHLBI, Off Biostat Res, NIH, Bethesda, MD 20892 USA; Emory Univ Hosp, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Emory University	Finkel, T (corresponding author), NHLBI, Cardiovasc Branch, NIH, Bldg 10-6N-240,10 Ctr Dr, Bethesda, MD 20892 USA.	finkelt@nih.gov	Mordwinkin, Nicholas M/A-4347-2010	Halcox, Julian/0000-0001-6926-2947	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005012, ZIAHL005012] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Corretti M. C., 2002, J AM COLL CARDIOL, V39, P1082; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Decary S, 2000, NEUROMUSCULAR DISORD, V10, P113, DOI 10.1016/S0960-8966(99)00093-0; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Gokce N, 2002, CIRCULATION, V105, P1567, DOI 10.1161/01.CIR.0000012543.55874.47; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Ito H, 1999, CANCER RES, V59, P5875; Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI200113131; Luttun A, 2002, TRENDS CARDIOVAS MED, V12, P88, DOI 10.1016/S1050-1738(01)00152-9; Masuda H, 1999, CIRCULATION, V100, P691; Masuda H, 1999, CIRCULATION, V100, P475; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Perticone F, 2001, CIRCULATION, V104, P191, DOI 10.1161/01.CIR.104.2.191; Prasad A, 2001, J AM COLL CARDIOL, V38, P1089, DOI 10.1016/S0735-1097(01)01511-X; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; SHI Q, 1994, J VASC SURG, V20, P546, DOI 10.1016/0741-5214(94)90279-8; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; WEBSTER C, 1990, SOMAT CELL MOLEC GEN, V16, P557, DOI 10.1007/BF01233096; WILSON PWF, 1987, AM J CARDIOL, V59, pG91, DOI 10.1016/0002-9149(87)90165-2; WILSON PWF, 1987, AM J CARDIOL, V60, pA11	38	2839	3154	1	152	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2003	348	7					593	600		10.1056/NEJMoa022287	http://dx.doi.org/10.1056/NEJMoa022287			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644HY	12584367	Bronze			2022-12-28	WOS:000180912900004
J	Fara, P				Fara, P			Face values: How portraits win friends and influence people	SCIENCE			English	Editorial Material									Univ Cambridge Clare Coll, Dept Hist & Philosophy Sci, Cambridge CB2 1TL, England	University of Cambridge	Fara, P (corresponding author), Univ Cambridge Clare Coll, Dept Hist & Philosophy Sci, Cambridge CB2 1TL, England.							ATTERBURY F, 1783, EPISTOLARY CORRES VI, V1, P180; Browne Janet., 1998, SCI INCARNATE HIST E, P240; CROMPTON S, 1867, P LIT PHILOS SOC MAN, V7, P3; FARA P, 2003, NEWTON MAKING GENIUS, P33; FARA P, 1998, HIST TODAY, V42; FORTUNE BB, 1999, FRANKLIN HIS FRIENDS, P119; MAUDE T, 1782, VIATOR POEM JOURNEY, pR2; Prescott GM, 1985, FARADAY REDISCOVERED, P15; Yeo Richard, 1988, SCI CONTEXT, V2, P257, DOI DOI 10.1017/S0269889700000594	9	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					831	832		10.1126/science.1079668	http://dx.doi.org/10.1126/science.1079668			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574606				2022-12-28	WOS:000180830900027
J	Brainard, DM; Ryan, ET				Brainard, DM; Ryan, ET			Thoracic echinococcosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Brainard, DM (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.								0	4	4	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2003	348	6					528	528		10.1056/NEJMicm020330	http://dx.doi.org/10.1056/NEJMicm020330			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642JY	12571260				2022-12-28	WOS:000180801400006
J	Wright, TC; Schiffman, M				Wright, TC; Schiffman, M			Adding a test for human papillomavirus DNA to cervical cancer screening.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wright, TC (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, 630 W 168th St, New York, NY 10032 USA.		Schiffman, Mark/B-9766-2015					Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Sherman ME, 2003, JNCI-J NATL CANCER I, V95, P46, DOI 10.1093/jnci/95.1.46; Wright TC, 2002, JAMA-J AM MED ASSOC, V287, P2120, DOI 10.1001/jama.287.16.2120	3	177	186	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2003	348	6					489	490		10.1056/NEJMp020178	http://dx.doi.org/10.1056/NEJMp020178			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642JY	12571255				2022-12-28	WOS:000180801400002
J	Veysman, B				Veysman, B			Colostomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Yale Univ, Sch Med, New Haven, CT 06510 USA	Yale University	Veysman, B (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06510 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2003	289	5					615	616		10.1001/jama.289.5.615	http://dx.doi.org/10.1001/jama.289.5.615			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CV	12578500	Bronze			2022-12-28	WOS:000180787500035
J	Cawthon, RM; Smith, KR; O'Brien, E; Sivatchenko, A; Kerber, RA				Cawthon, RM; Smith, KR; O'Brien, E; Sivatchenko, A; Kerber, RA			Association between telomere length in blood and mortality in people aged 60 years or older	LANCET			English	Article								During normal ageing, the gradual loss of telomeric DNA in dividing somatic cells can contribute to replicative senescence, apoptosis, or neoplastic transformation. In the genetic disorder dyskeratosis congenita, telomere shortening Is accelerated, and patients have premature onset of many age-related diseases and early death. We aimed to assess an association between telomere length and mortality In 143 normal unrelated individuals over the age of 60 years. Those with shorter telomeres in blood DNA had poorer survival, attributable In part to a 3.18-fold higher mortality rate from heart disease (95% CI 1.36-7.45, p=0.0079), and an 8.54-fold higher mortality rate from infectious disease (1.52-47.9, p=0.015). These results lend support to the hypothesis that telomere shortening in human beings contributes to mortality in many age-related diseases.	Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Dept Family & Consumer Studies, Salt Lake City, UT 84112 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Cawthon, RM (corresponding author), Univ Utah, Dept Human Genet, 15 N 2030 E St,Room 2100, Salt Lake City, UT 84112 USA.		Smith, Ken/B-6451-2011; Kerber, Richard/B-8038-2009	Smith, Ken/0000-0003-0682-3705; 	NCI NIH HHS [R29CA69421] Funding Source: Medline; NIA NIH HHS [AG13478, K01 AG00767] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA069421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG000767, R01AG013478] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; Saretzki G, 2002, ANN NY ACAD SCI, V959, P24, DOI 10.1111/j.1749-6632.2002.tb02079.x; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0	5	1260	1305	3	145	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					393	395		10.1016/S0140-6736(03)12384-7	http://dx.doi.org/10.1016/S0140-6736(03)12384-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573379				2022-12-28	WOS:000180787000015
J	Summerfield, D				Summerfield, D			What is the WMA for? The case of the Israeli Medical Association	LANCET			English	Editorial Material							ETHICS		Inst Psychiat, London SE5 8AB, England	University of London; King's College London	Summerfield, D (corresponding author), Inst Psychiat, De Crespigny Pk, London SE5 8AB, England.							Amnesty International, 1996, CONST MED SUP TORT I; Bamber H, 2002, J ROY SOC MED, V95, P271, DOI 10.1258/jrsm.95.5.271; Blachar Y, 1997, LANCET, V350, P1247, DOI 10.1016/S0140-6736(97)26043-5; Blachar Y, 2001, J ROY SOC MED, V94, P658, DOI 10.1177/014107680109401229; Summerfield D, 1997, LANCET, V350, P63, DOI 10.1016/S0140-6736(05)66265-4	5	7	7	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					424	424		10.1016/S0140-6736(03)12381-1	http://dx.doi.org/10.1016/S0140-6736(03)12381-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573390				2022-12-28	WOS:000180787000025
J	Laurence, TA; Weiss, S				Laurence, TA; Weiss, S			How to detect weak pairs	SCIENCE			English	Editorial Material							SINGLE-MOLECULE; MICROSCOPY; DIFFUSION; EMISSION		Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Laurence, TA (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.		Laurence, Ted A/E-4791-2011; weiss, shimon/B-4164-2009	Laurence, Ted A/0000-0003-1474-779X; weiss, shimon/0000-0002-0720-5426				Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; Bian RX, 1995, PHYS REV LETT, V75, P4772, DOI 10.1103/PhysRevLett.75.4772; de Lange F, 2001, J CELL SCI, V114, P4153; Deniz AA, 2000, P NATL ACAD SCI USA, V97, P5179, DOI 10.1073/pnas.090104997; Dyba M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.163901; Foquet M, 2002, ANAL CHEM, V74, P1415, DOI 10.1021/ac011076w; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Starr TE, 2001, BIOPHYS J, V80, P1575, DOI 10.1016/S0006-3495(01)76130-9; Zander C., 2002, SINGLE MOL DETECTION; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	14	42	44	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					667	668		10.1126/science.1081025	http://dx.doi.org/10.1126/science.1081025			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560536				2022-12-28	WOS:000180687700030
J	Yanez-Mo, M; Lara-Pezzi, E; Selgas, R; Ramirez-Huesca, M; Dominguez-Jimenez, C; Jimenez-Heffernan, JA; Aguilera, A; Sanchez-Tomero, JA; Bajo, MA; Alvarez, V; Castro, MA; del Peso, G; Cirujeda, A; Gamallo, C; Sanchez-Madrid, F; Lopez-Cabrera, M				Yanez-Mo, M; Lara-Pezzi, E; Selgas, R; Ramirez-Huesca, M; Dominguez-Jimenez, C; Jimenez-Heffernan, JA; Aguilera, A; Sanchez-Tomero, JA; Bajo, MA; Alvarez, V; Castro, MA; del Peso, G; Cirujeda, A; Gamallo, C; Sanchez-Madrid, F; Lopez-Cabrera, M			Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSCRIPTION FACTOR SNAIL; EXTRACELLULAR-MATRIX; E-CADHERIN; TGF-BETA; GROWTH; ADHESION; EXPRESSION; MEMBRANE; GLUCOSE; JUNCTIONS	BACKGROUND: During continuous ambulatory peritoneal dialysis, the peritoneum is exposed to bioincompatible dialysis fluids that cause denudation of mesothelial cells and, ultimately, tissue fibrosis and failure of ultrafiltration. However, the mechanism of this process has yet to be elucidated. METHODS: Mesothelial cells isolated from effluents in dialysis fluid from patients undergoing continuous ambulatory peritoneal dialysis were phenotypically characterized by flow cytometry, confocal immunofluorescence, Western blotting, and reverse-transcriptase polymerase chain reaction. These cells were compared with mesothelial cells from omentum and treated with various stimuli in vitro to mimic the transdifferentiation observed during continuous ambulatory peritoneal dialysis. Results were confirmed in vivo by immunohistochemical analysis performed on peritoneal-biopsy specimens. RESULTS: Soon after dialysis is initiated, peritoneal mesothelial cells undergo a transition from an epithelial phenotype to a mesenchymal phenotype with a progressive loss of epithelial morphology and a decrease in the expression of cytokeratins and E-cadherin through an induction of the transcriptional repressor snail. Mesothelial cells also acquire a migratory phenotype with the up-regulation of expression of a(sub 2) integrin. In vitro analyses point to wound repair and profibrotic and inflammatory cytokines as factors that initiate mesothelial transdifferentiation. Immunohistochemical studies of peritoneal-biopsy specimens from patients undergoing continuous ambulatory peritoneal dialysis demonstrate the expression of the mesothelial markers intercellular adhesion molecule 1 and cytokeratins in fibroblast-like cells entrapped in the stroma, suggesting that these cells stemmed from local conversion of mesothelial cells. CONCLUSIONS: Our results suggest that mesothelial cells have an active role in the structural and functional alteration of the peritoneum during peritoneal dialysis. The findings suggest potential targets for the design of new dialysis solutions and markers for the monitoring of patients.	Univ Autonoma Madrid, Hosp Univ Princesa, Dept Biol Mol, Madrid 28006, Spain; Univ Autonoma Madrid, Hosp Univ Princesa, Serv Inmunol, Madrid 28006, Spain; Hosp Univ La Paz, Serv Nefrol, Madrid, Spain; Inst Reina Sofia Invest Nefrol, Madrid, Spain; Hosp Univ Guadalajara, Serv Anat Patol, Guadalajara, Spain	Autonomous University of Madrid; Hospital de La Princesa; Autonomous University of Madrid; Hospital de La Princesa; Hospital Universitario La Paz	Lopez-Cabrera, M (corresponding author), Univ Autonoma Madrid, Hosp Univ Princesa, Dept Biol Mol, C Diego de Leon 62, Madrid 28006, Spain.		SANCHEZ TOMERO, JOSE ANTONIO/Q-9346-2017; Sanchez-Madrid, Francisco/M-7889-2016; Lara-Pezzi, Enrique/E-2350-2015; YÃÃez-MÃ, Maria/AAI-4544-2020; Cabrera, Manuel López/AAA-5463-2019; Yáñez-Mó, María/K-8577-2014; Bajo, Maria A/ABF-6991-2020	Sanchez-Madrid, Francisco/0000-0001-5303-0762; Lara-Pezzi, Enrique/0000-0002-2743-1033; YÃÃez-MÃ, Maria/0000-0001-7484-2866; Yáñez-Mó, María/0000-0001-7484-2866; Bajo, Maria A/0000-0001-7364-557X; Lopez Cabrera, Manuel/0000-0002-0976-9719				Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Birchmeier C, 1996, ACTA ANAT, V156, P217; BRULEZ HFH, 1995, PERITON DIALYSIS INT, V15, pS24; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; CHAIMOVITZ C, 1994, KIDNEY INT, V45, P1226, DOI 10.1038/ki.1994.163; CHAIMOVITZ C, 1994, KIDNEY INT, V46, P285; CONNELL ND, 1983, CELL, V34, P245, DOI 10.1016/0092-8674(83)90155-1; DOBBIE JW, 1992, PERITON DIALYSIS INT, V12, P14; Fang CC, 2000, KIDNEY INT, V57, P2626, DOI 10.1046/j.1523-1755.2000.00123.x; Faull RJ, 2001, KIDNEY INT, V59, P614, DOI 10.1046/j.1523-1755.2001.059002614.x; Ha H, 2001, KIDNEY INT, V59, P463, DOI 10.1046/j.1523-1755.2001.059002463.x; Hay ED, 1995, ACTA ANAT, V154, P8; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; Ito T, 2000, J AM SOC NEPHROL, V11, P1969, DOI 10.1681/ASN.V11111969; Krediet RT, 1999, KIDNEY INT, V55, P341, DOI 10.1046/j.1523-1755.1999.00264.x; Lai KN, 2000, AM J KIDNEY DIS, V35, P644, DOI 10.1016/S0272-6386(00)70011-4; Lara-Pezzi E, 2001, HEPATOLOGY, V33, P1270, DOI 10.1053/jhep.2001.1270; Leavesley DI, 1999, NEPHROL DIAL TRANSPL, V14, P1208, DOI 10.1093/ndt/14.5.1208; Margetts PJ, 2001, J AM SOC NEPHROL, V12, P2029, DOI 10.1681/ASN.V12102029; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Medcalf JF, 2001, NEPHROL DIAL TRANSPL, V16, P1885, DOI 10.1093/ndt/16.9.1885; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Rampino T, 2001, AM J PATHOL, V159, P1275, DOI 10.1016/S0002-9440(10)62514-X; ROUSSELLE P, 1995, J BIOL CHEM, V270, P13766, DOI 10.1074/jbc.270.23.13766; SELGAS R, 1994, AM J KIDNEY DIS, V23, P64, DOI 10.1016/S0272-6386(12)80814-6; SUASSUNA JHR, 1994, KIDNEY INT, V46, P443, DOI 10.1038/ki.1994.292; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; Yanez-Mo M, 2001, J CELL SCI, V114, P577; Yang WS, 1999, PERITON DIALYSIS INT, V19, P211	31	583	616	0	35	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					403	413		10.1056/NEJMoa020809	http://dx.doi.org/10.1056/NEJMoa020809			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12556543				2022-12-28	WOS:000180643800005
J	Kaufman, DM				Kaufman, DM			ABC of learning and teaching in medicine - Applying educational theory in practice	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Simon Fraser Univ, Learning & Instruct Dev Ctr, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Kaufman, DM (corresponding author), Simon Fraser Univ, Learning & Instruct Dev Ctr, Burnaby, BC V5A 1S6, Canada.	dkaufman@sfu.ca		Sanchez-Fernandez, Gregorio Esteban/0000-0002-6059-7182				Bandura A., 1986, SOCIAL FDN THOUGHT A; Candy PC., 1991, SELF DIRECTION LIFEL; Kaufman DM, 2000, TEACHING LEARNING ME; Knowles M., 1984, ANDRAGOGY ACTION APP; Schon D.A., 1987, ED REFLECTIVE PRACTI	5	451	466	2	48	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2003	326	7382					213	216		10.1136/bmj.326.7382.213	http://dx.doi.org/10.1136/bmj.326.7382.213			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640LD	12543841	Green Published			2022-12-28	WOS:000180689600025
J	Wilson, AM; Watson, JC; Lichtwark, GA				Wilson, AM; Watson, JC; Lichtwark, GA			Biomechanics: A catapult action for rapid limb protraction	NATURE			English	Article							HORSE; MUSCLE		Univ London Royal Vet Coll, Dept Vet Basic Sci, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England; UCL, Inst Human Performance, Stanmore HA7 4LP, Middx, England	University of London; University of London Royal Veterinary College; University of London; University College London	Wilson, AM (corresponding author), Univ London Royal Vet Coll, Dept Vet Basic Sci, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England.	awilson@rvc.ac.uk	Lichtwark, Glen A/B-6002-2008	Lichtwark, Glen A/0000-0001-7366-3348; Wilson, Alan/0000-0001-9914-3455				Alexander RM., 1988, ELASTIC MECH ANIMAL; BENNETCLARK HC, 1975, J EXP BIOL, V63, P53; Biewener A A, 2000, Exerc Sport Sci Rev, V28, P99; Biewener AA, 1998, COMP BIOCHEM PHYS B, V120, P73, DOI 10.1016/S0305-0491(98)00024-8; DYCE KM, 1987, TXB VET ANATOMY, P542; HERMANSON JW, 1990, ACTA ANAT, V137, P146, DOI 10.1159/000146875; Hutchinson JR, 2002, NATURE, V415, P1018, DOI 10.1038/4151018a; Peplowski MM, 1997, J EXP BIOL, V200, P2861; PRATT GW, 1978, AM J VET RES, V39, P249; ROME LC, 1990, J PHYSIOL-LONDON, V431, P173, DOI 10.1113/jphysiol.1990.sp018325; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991; WOLEDGE R, 1985, MONOGR PHYSL SOC, V41	13	107	111	4	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					35	36		10.1038/421035a	http://dx.doi.org/10.1038/421035a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12569935				2022-12-28	WOS:000180165500027
J	Butler, D				Butler, D			Failed mission launch prompts ESA to reconsider comet target	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					301	302		10.1038/421301a	http://dx.doi.org/10.1038/421301a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540860	Bronze			2022-12-28	WOS:000180533000003
J	Butler, D				Butler, D			Report backs military axis on space	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					301	301		10.1038/421301b	http://dx.doi.org/10.1038/421301b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540860	Bronze			2022-12-28	WOS:000180533000004
